Citrus Sinensis ID: 015814
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | 2.2.26 [Sep-21-2011] | |||||||
| Q2QY53 | 438 | CBL-interacting protein k | yes | no | 0.945 | 0.863 | 0.842 | 0.0 | |
| Q2V452 | 441 | CBL-interacting serine/th | yes | no | 0.952 | 0.863 | 0.826 | 0.0 | |
| Q2RAX3 | 454 | CBL-interacting protein k | yes | no | 0.945 | 0.832 | 0.808 | 0.0 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.942 | 0.858 | 0.795 | 0.0 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.95 | 0.846 | 0.755 | 1e-178 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.957 | 0.794 | 0.720 | 1e-169 | |
| Q8LIG4 | 445 | CBL-interacting protein k | no | no | 0.955 | 0.858 | 0.706 | 1e-167 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.952 | 0.846 | 0.689 | 1e-165 | |
| Q9MAM1 | 447 | CBL-interacting serine/th | no | no | 0.955 | 0.854 | 0.696 | 1e-161 | |
| Q10SC8 | 456 | CBL-interacting protein k | no | no | 0.955 | 0.837 | 0.698 | 1e-161 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/380 (84%), Positives = 352/380 (92%), Gaps = 2/380 (0%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++TMKL+KHPNVVR+YEVMGSKTKI+IVLE+VTGGELFD IVNHGRM+EDEARRY
Sbjct: 57 QIKREISTMKLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGT
Sbjct: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW
Sbjct: 177 PNYVAPEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
SF A++L+ RILDPNPMTR+TIPEILEDEWFKK YK P F+EK DT LDDV AVF DSE
Sbjct: 237 TSFPAKRLLTRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEE P A+NAFELIS+S GLNLGNLFD+EQ+FKRETRFTS+CP EI+ KIEE
Sbjct: 297 EHHVTEKKEE-PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEE 355
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFDV KKNYK+RLE +KAGRKGNLNVATE+ QVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 356 AAKPLGFDVQKKNYKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKF 415
Query: 378 YKNLSTCLEDVVWKTEEDMQ 397
YKNLS L+DVVWK+ +D+Q
Sbjct: 416 YKNLSRTLKDVVWKS-DDLQ 434
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 679 bits (1753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/381 (82%), Positives = 349/381 (91%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI+RE+ATMKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRY
Sbjct: 58 QIRREIATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRY 117
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLI+AVDYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGT
Sbjct: 118 FQQLIHAVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGT 177
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPW
Sbjct: 178 PNYVAPEVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPW 237
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LS A KLI RILDPNPMTR+T E+ EDEWFKKDYKPPVFEE+ D+N+DD++AVFKDSE
Sbjct: 238 LSLGAMKLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSE 297
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EH VTE++EEQP A+NAFE+IS+S+GLNL NLFD EQ+FKRETR T R ANEII KIEE
Sbjct: 298 EHLVTEKREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEE 357
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFDV KKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMV+V K+KGDTLEFHKF
Sbjct: 358 AAKPLGFDVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKF 417
Query: 378 YKNLSTCLEDVVWKTEEDMQE 398
YK LS LE VVW E +E
Sbjct: 418 YKKLSNSLEQVVWTNNEVKKE 438
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/396 (80%), Positives = 352/396 (88%), Gaps = 18/396 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++TMKL+KHPNVVR+YEVMGSKT I+IVLE+VTGGELFD IVNHGRM+EDEARRY
Sbjct: 57 QIKREISTMKLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGT
Sbjct: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW
Sbjct: 177 PNYVAPEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
SF A++L+ RILDPNPMTRITIPEILEDEWFKK YK P F+EK DT LDDV+AVF DSE
Sbjct: 237 TSFPAKRLLTRILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEE P A+NAFELIS+S GLNLGNLFD+EQ+FKRETRFTS+CP EI+ KIEE
Sbjct: 297 EHHVTEKKEE-PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEE 355
Query: 318 AAKPLGFDVHKKNY----------------KMRLENMKAGRKGNLNVATEVFQVAPSLHM 361
AAKPLGFDV KKNY K+RLE +KAGRKGNLNVATE+ QVAPSLHM
Sbjct: 356 AAKPLGFDVQKKNYKICSPCLTTICMNIPFKLRLEKVKAGRKGNLNVATEILQVAPSLHM 415
Query: 362 VEVRKAKGDTLEFHKFYKNLSTCLEDVVWKTEEDMQ 397
VEVRKAKGDTLEFHKFYKNLS L+DVVWK+ +D+Q
Sbjct: 416 VEVRKAKGDTLEFHKFYKNLSRTLKDVVWKS-DDLQ 450
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 300/377 (79%), Positives = 339/377 (89%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI+RE+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+Y
Sbjct: 57 QIRREICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGT
Sbjct: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNY APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPW
Sbjct: 177 PNYAAPEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LS A+ LI RILDPNPMTRITIPE+L D WFKK+YKP VFEEK++ NLDDV+AVFKDSE
Sbjct: 237 LSPGAKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEEQP +MNAFELIS+S+ L+LGNLF+ E+ FKRETRF ++ AN+++ KIEE
Sbjct: 297 EHHVTEKKEEQPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEE 356
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
A+KPLGFD+ KKNYKMRLEN+ AGRKGNL VATE+FQV+PSLHM+EVRK KGDTLEFHKF
Sbjct: 357 ASKPLGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKF 416
Query: 378 YKNLSTCLEDVVWKTEE 394
YK LST L DVVWK+ E
Sbjct: 417 YKKLSTSLNDVVWKSGE 433
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1609), Expect = e-178, Method: Compositional matrix adjust.
Identities = 287/380 (75%), Positives = 339/380 (89%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI+RE+ TMKLVKHPNVVRL+EVMGSK +IFIVLE+VTGGELF+ I +GR+KE+EAR+Y
Sbjct: 64 QIRREICTMKLVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKY 123
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLK ENLLLDA GNLKVSDFGLSAL++QV+ DGLLHTTCGT
Sbjct: 124 FQQLINAVDYCHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGT 183
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEV+ DRGYDG+ AD+WSCGVIL+VLLAG+LPF+D N++ LYKKIS A+FTCP W
Sbjct: 184 PNYVAPEVIEDRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSW 243
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
S A+KLI RILDPNP TRITI +ILED WFKK YKPPVF+EK +T+ DDV+A F DSE
Sbjct: 244 FSTGAKKLITRILDPNPTTRITISQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSE 303
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
+ HV E+ E+QP +MNAFELISL++ LNL NLF+A++++KRETRFTS+CP EII KIEE
Sbjct: 304 DRHVKEETEDQPTSMNAFELISLNQALNLDNLFEAKKEYKRETRFTSQCPPKEIITKIEE 363
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFD+ KKNYKMR+EN+KAGRKGNLNVATEVFQVAPSLH+VE++KAKGDTLEF KF
Sbjct: 364 AAKPLGFDIQKKNYKMRMENLKAGRKGNLNVATEVFQVAPSLHVVELKKAKGDTLEFQKF 423
Query: 378 YKNLSTCLEDVVWKTEEDMQ 397
Y+ LST L+DVVWK + +++
Sbjct: 424 YRTLSTQLKDVVWKCDGEVE 443
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 593 bits (1529), Expect = e-169, Method: Compositional matrix adjust.
Identities = 281/390 (72%), Positives = 331/390 (84%), Gaps = 7/390 (1%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
++ QIKRE++TMKL+KHPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEA
Sbjct: 72 MIAQIKREISTMKLIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEA 131
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
R+YFQQLINAVDYCHSRGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTT
Sbjct: 132 RKYFQQLINAVDYCHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTT 191
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
CGTPNYVAPEV+N++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTC
Sbjct: 192 CGTPNYVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTC 251
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 254
PPW S +A+KLI RILDPNP TRIT E++E+EWFKK YK P FE D +LDDV+A+F
Sbjct: 252 PPWFSASAKKLIKRILDPNPATRITFAEVIENEWFKKGYKAPKFEN-ADVSLDDVDAIFD 310
Query: 255 DSEEHH--VTEQKEE---QPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPA 308
DS E V E++EE PV MNAFELIS S+GLNLG+LF+ + KR+TRFTS+ A
Sbjct: 311 DSGESKNLVVERREEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSA 370
Query: 309 NEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAK 368
NEI+ KIE AA P+GFDV NYKM+L K+GRKG L VATEVFQVAPSL+MVE+RK+
Sbjct: 371 NEIVTKIEAAAAPMGFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSG 430
Query: 369 GDTLEFHKFYKNLSTCLEDVVWKTEEDMQE 398
GDTLEFHKFYKNL+T L+D+VWKT ++ +E
Sbjct: 431 GDTLEFHKFYKNLTTGLKDIVWKTIDEEKE 460
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 587 bits (1513), Expect = e-167, Method: Compositional matrix adjust.
Identities = 270/382 (70%), Positives = 325/382 (85%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI+RE+ TMKL++HPNVV L+EVMGSKT+IFIVLE+V GGEL D I GR+KEDEAR+Y
Sbjct: 63 QIRREICTMKLIQHPNVVHLHEVMGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKY 122
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLK ENLLLD GN+KVSDFGLSA+S+QV+ DGLLHTTCGT
Sbjct: 123 FQQLINAVDYCHSRGVYHRDLKLENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGT 182
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEV+ D+GYDG+ ADLWSCGVILFVLLAGYLPF+D N+++LY KIS A+FTCP W
Sbjct: 183 PNYVAPEVIEDKGYDGALADLWSCGVILFVLLAGYLPFEDENIVSLYNKISGAQFTCPSW 242
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
S A++LIARILDPNP TRIT ++L+D+WFKK Y+ PVF++K DV F DSE
Sbjct: 243 FSAEAKRLIARILDPNPATRITTSQVLQDQWFKKGYESPVFDDKYYPYFHDVYDAFGDSE 302
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
E HV E EEQP MNAFELISL+KGLNL N F++++ +KRETRFTS+CP EIIN+IEE
Sbjct: 303 EKHVKEAMEEQPTLMNAFELISLNKGLNLDNFFESDKKYKRETRFTSQCPPKEIINRIEE 362
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AA LGF++ K+NY+MR+EN+K GRKG+LN+ATEVFQVAPSLH+VE++KAKGDTLEF KF
Sbjct: 363 AANLLGFNIQKRNYRMRMENIKEGRKGHLNIATEVFQVAPSLHVVELKKAKGDTLEFQKF 422
Query: 378 YKNLSTCLEDVVWKTEEDMQEM 399
Y+ LST L+DVVW+ E+ ++M
Sbjct: 423 YQTLSTQLKDVVWELEDAAEDM 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1494), Expect = e-165, Method: Compositional matrix adjust.
Identities = 266/386 (68%), Positives = 327/386 (84%), Gaps = 5/386 (1%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
++ QIKRE++TMKL++HPNV+R++EVM SKTKI+IV+E VTGGELFDKI + GR+KED+A
Sbjct: 54 MIAQIKREISTMKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDA 113
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
R+YFQQLINAVDYCHSRGVYHRDLKPENLLLDA G LKVSDFGLSALSQQVR+DGLLHTT
Sbjct: 114 RKYFQQLINAVDYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTT 173
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
CGTPNYVAPEV+N++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNLM+LYKKI A+F+C
Sbjct: 174 CGTPNYVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSC 233
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 254
P W S +A+KLI +ILDPNP TRITI E++ +EWFKK Y+PP F E D NLDD+ ++F
Sbjct: 234 PSWFSTSAKKLIKKILDPNPSTRITIAELINNEWFKKGYQPPRF-ETADVNLDDINSIFN 292
Query: 255 DS--EEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFD--AEQDFKRETRFTSRCPANE 310
+S + V E++EE+P MNAFELIS S+GLNLG LF+ ++ KRETRF SR PANE
Sbjct: 293 ESGDQTQLVVERREERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANE 352
Query: 311 IINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGD 370
I++KIE AA P+GF+V K+NYK++L+ GRKG L +ATEVF+V PSL+MVE+RK+ GD
Sbjct: 353 ILSKIEAAAGPMGFNVQKRNYKLKLQGENPGRKGQLAIATEVFEVTPSLYMVELRKSNGD 412
Query: 371 TLEFHKFYKNLSTCLEDVVWKTEEDM 396
TLEFHKFY N+S L+DV+WK E +
Sbjct: 413 TLEFHKFYHNISNGLKDVMWKPESSI 438
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 568 bits (1465), Expect = e-161, Method: Compositional matrix adjust.
Identities = 268/385 (69%), Positives = 326/385 (84%), Gaps = 3/385 (0%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
Q+KRE++TMKL+KHPNVV + EVM SKTKI+IVLE V GGELFDKI GR+KEDEARRY
Sbjct: 63 QLKREISTMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRY 122
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENL+LDA G LKVSDFGLSA S+QVR+DGLLHT CGT
Sbjct: 123 FQQLINAVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGT 182
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVL+D+GYDG+ AD+WSCGVILFVL+AGYLPFD+ NLM LYK+I AEF+CPPW
Sbjct: 183 PNYVAPEVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPW 242
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF-EEKKDTNLDDVEAVFKDS 256
S A+++I RIL+PNP+TRI+I E+LEDEWFKK YKPP F ++ +D +DDV+A F +S
Sbjct: 243 FSQGAKRVIKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNS 302
Query: 257 EEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAE-QDFKRETRFTSRCPANEIINKI 315
+E VTE+K E+PV+MNAFELIS S +L NLF+ + Q K+ETRFTS+ A+EI++K+
Sbjct: 303 KECLVTEKK-EKPVSMNAFELISSSSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKM 361
Query: 316 EEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFH 375
EE AKPLGF+V K NYK++++ K+GRKG L+VATEVF+VAPSLH+VE+RK GDTLEFH
Sbjct: 362 EETAKPLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFH 421
Query: 376 KFYKNLSTCLEDVVWKTEEDMQEMK 400
KFYKN S+ L+DVVW T+ +E K
Sbjct: 422 KFYKNFSSGLKDVVWNTDAAAEEQK 446
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10SC8|CIPK9_ORYSJ CBL-interacting protein kinase 9 OS=Oryza sativa subsp. japonica GN=CIPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 567 bits (1461), Expect = e-161, Method: Compositional matrix adjust.
Identities = 269/385 (69%), Positives = 318/385 (82%), Gaps = 3/385 (0%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++TMKL+KHPNVV+L+EVM SK+KI++VLE+V GGELFDKIVN GR+ EDEARRY
Sbjct: 71 QIKREISTMKLIKHPNVVQLHEVMASKSKIYMVLEYVDGGELFDKIVNSGRLGEDEARRY 130
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F QLINAVDYCHSRGVYHRDLKPENLLLD++G LKVSDFGLSA + Q ++DGLLHT CGT
Sbjct: 131 FHQLINAVDYCHSRGVYHRDLKPENLLLDSHGALKVSDFGLSAFAPQTKEDGLLHTACGT 190
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVL D+GYDG AD+WSCG+ILFVL+AGYLPFDD NLM LYK I A+ +CP W
Sbjct: 191 PNYVAPEVLADKGYDGMAADVWSCGIILFVLMAGYLPFDDPNLMTLYKLICKAKVSCPHW 250
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
S A+K I RILDPNP TRITI +ILED+WFKKDYKPP+FE+ +D +LDDV+A F SE
Sbjct: 251 FSSGAKKFIKRILDPNPCTRITIAQILEDDWFKKDYKPPLFEQGEDVSLDDVDAAFDCSE 310
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ--DFKRETRFTSRCPANEIINKI 315
E+ V E K E+P +MNAF LIS S+G NLGNLF+ E KRET FTS+C EI++KI
Sbjct: 311 ENLVAE-KREKPESMNAFALISRSQGFNLGNLFEKEMMGMVKRETSFTSQCTPQEIMSKI 369
Query: 316 EEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFH 375
EEA PLGF+V K+NYKM+L+ K GRKG L+VATEVF+VAPSLHMVE+RK GDTLEFH
Sbjct: 370 EEACGPLGFNVRKQNYKMKLKGDKTGRKGYLSVATEVFEVAPSLHMVELRKTGGDTLEFH 429
Query: 376 KFYKNLSTCLEDVVWKTEEDMQEMK 400
FY N S+ L+D+VWK+E D + K
Sbjct: 430 NFYNNFSSELKDIVWKSESDAKAAK 454
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | ||||||
| 255583653 | 466 | CBL-interacting serine/threonine-protein | 0.957 | 0.821 | 0.950 | 0.0 | |
| 225435981 | 439 | PREDICTED: CBL-interacting serine/threon | 0.957 | 0.872 | 0.942 | 0.0 | |
| 147815805 | 439 | hypothetical protein VITISV_010092 [Viti | 0.957 | 0.872 | 0.942 | 0.0 | |
| 224120590 | 440 | predicted protein [Populus trichocarpa] | 0.957 | 0.870 | 0.932 | 0.0 | |
| 449463875 | 444 | PREDICTED: CBL-interacting serine/threon | 0.957 | 0.862 | 0.906 | 0.0 | |
| 224106656 | 440 | predicted protein [Populus trichocarpa] | 0.957 | 0.870 | 0.914 | 0.0 | |
| 154425355 | 441 | CBL-interacting protein kinase [Vigna un | 0.95 | 0.861 | 0.902 | 0.0 | |
| 62857008 | 441 | Ser/Thr protein kinase [Lotus japonicus] | 0.952 | 0.863 | 0.900 | 0.0 | |
| 357493713 | 441 | CBL-interacting protein kinase [Medicago | 0.952 | 0.863 | 0.889 | 0.0 | |
| 357493719 | 476 | CBL-interacting protein kinase [Medicago | 0.952 | 0.800 | 0.814 | 0.0 |
| >gi|255583653|ref|XP_002532581.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223527690|gb|EEF29798.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/383 (95%), Positives = 375/383 (97%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKREVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRY
Sbjct: 84 QIKREVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRY 143
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGT
Sbjct: 144 FQQLINAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 203
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW
Sbjct: 204 PNYVAPEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 263
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LSF A KLI RILDPNPMTRITIPEIL DEWFKKDYK PVFEEK+DTNLDDVEAVFKDSE
Sbjct: 264 LSFGAMKLITRILDPNPMTRITIPEILVDEWFKKDYKVPVFEEKEDTNLDDVEAVFKDSE 323
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEEQP AMNAFELIS+SKGLNLGNLFD+EQ FKRETRFTS+CPANEII+KIEE
Sbjct: 324 EHHVTEKKEEQPTAMNAFELISMSKGLNLGNLFDSEQGFKRETRFTSKCPANEIIHKIEE 383
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 384 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHKF 443
Query: 378 YKNLSTCLEDVVWKTEEDMQEMK 400
YKNLSTCL+DVVWKTEEDMQEMK
Sbjct: 444 YKNLSTCLDDVVWKTEEDMQEMK 466
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435981|ref|XP_002271894.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3 [Vitis vinifera] gi|229609837|gb|ACQ83534.1| CBL-interacting protein kinase 18 [Vitis vinifera] gi|296083952|emb|CBI24340.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/383 (94%), Positives = 370/383 (96%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKREVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRY
Sbjct: 57 QIKREVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT
Sbjct: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPW
Sbjct: 177 PNYVAPEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LSF A KLI RILDPNPMTRITIPEILEDEWFKK YKPPVFEEK D NLDDVEAVFKDSE
Sbjct: 237 LSFGAMKLITRILDPNPMTRITIPEILEDEWFKKGYKPPVFEEKGDANLDDVEAVFKDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+ EEQP AMNAFELIS+S+GLNLGNLFD EQ FKRETRFTS+CPANEII+KIEE
Sbjct: 297 EHHVTEKTEEQPAAMNAFELISMSRGLNLGNLFDIEQGFKRETRFTSKCPANEIIHKIEE 356
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
A KPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AVKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 378 YKNLSTCLEDVVWKTEEDMQEMK 400
YKNLSTCLEDVVWKTE+DMQE K
Sbjct: 417 YKNLSTCLEDVVWKTEDDMQETK 439
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815805|emb|CAN70422.1| hypothetical protein VITISV_010092 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/383 (94%), Positives = 369/383 (96%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKREVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRY
Sbjct: 57 QIKREVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT
Sbjct: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPW
Sbjct: 177 PNYVAPEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LSF A KLI RILDPNPMTRITIPEILEDEWFKK YKPPVFEEK D NLDDVEAVFKDSE
Sbjct: 237 LSFGAMKLITRILDPNPMTRITIPEILEDEWFKKGYKPPVFEEKGDANLDDVEAVFKDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+ EEQP AMNAFELIS+S GLNLGNLFD EQ FKRETRFTS+CPANEII+KIEE
Sbjct: 297 EHHVTEKTEEQPAAMNAFELISMSXGLNLGNLFDIEQGFKRETRFTSKCPANEIIHKIEE 356
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
A KPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AVKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 378 YKNLSTCLEDVVWKTEEDMQEMK 400
YKNLSTCLEDVVWKTE+DMQE K
Sbjct: 417 YKNLSTCLEDVVWKTEDDMQETK 439
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120590|ref|XP_002330980.1| predicted protein [Populus trichocarpa] gi|116265926|gb|ABJ91211.1| CBL-interacting protein kinase 3 [Populus trichocarpa] gi|118485622|gb|ABK94661.1| unknown [Populus trichocarpa] gi|222872772|gb|EEF09903.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/384 (93%), Positives = 373/384 (97%), Gaps = 1/384 (0%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE+ TMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRY
Sbjct: 57 QIKREIETMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLIN VDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT
Sbjct: 117 FQQLINVVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSN+MNLYKKISAAEFTCPPW
Sbjct: 177 PNYVAPEVLNDRGYDGTTADLWSCGVILFVLLAGYLPFDDSNVMNLYKKISAAEFTCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LSF A KLI RILDPNPMTRITIPEIL DEWFKK YKPPVFEEK+DTNLDDVEAVFKDSE
Sbjct: 237 LSFGAMKLITRILDPNPMTRITIPEILVDEWFKKGYKPPVFEEKEDTNLDDVEAVFKDSE 296
Query: 258 EHHVTEQK-EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIE 316
EHHVTE+K EEQP AMNAFELIS+SKGLNLGNLFD EQ+FKRETRFTSRCPANEII+KIE
Sbjct: 297 EHHVTEKKEEEQPTAMNAFELISMSKGLNLGNLFDGEQEFKRETRFTSRCPANEIIHKIE 356
Query: 317 EAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 376
EAAKPLGFDVHKKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 357 EAAKPLGFDVHKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHK 416
Query: 377 FYKNLSTCLEDVVWKTEEDMQEMK 400
FYK+LSTCL+DVVWKTEEDMQE K
Sbjct: 417 FYKSLSTCLDDVVWKTEEDMQETK 440
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463875|ref|XP_004149656.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/383 (90%), Positives = 367/383 (95%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE+ATMKL++HP+VV+L+EVMGSKTKIFIVLEFVTGGELFDKIVNHGRM E+EARRY
Sbjct: 62 QIKREIATMKLIQHPHVVQLFEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMSENEARRY 121
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV+DDGLLHTTCGT
Sbjct: 122 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVKDDGLLHTTCGT 181
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW
Sbjct: 182 PNYVAPEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 241
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LS A KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE+K NLDDVEAVFKDSE
Sbjct: 242 LSLDAMKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEQKIANLDDVEAVFKDSE 301
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEE P AMNAFELIS+SKGLNL NLF EQ+FKRETRFTS+C ANEI+NKIEE
Sbjct: 302 EHHVTEKKEEHPAAMNAFELISMSKGLNLANLFGTEQEFKRETRFTSKCSANEIVNKIEE 361
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFDV KKNYKMRLEN+KAGRKGNLNVATE+ QVAPS+H+VE+RKAKGDTLEFHKF
Sbjct: 362 AAKPLGFDVQKKNYKMRLENVKAGRKGNLNVATEILQVAPSVHVVEMRKAKGDTLEFHKF 421
Query: 378 YKNLSTCLEDVVWKTEEDMQEMK 400
YKNLST LEDVVWKTEEDMQE K
Sbjct: 422 YKNLSTSLEDVVWKTEEDMQETK 444
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106656|ref|XP_002314239.1| predicted protein [Populus trichocarpa] gi|116265928|gb|ABJ91212.1| CBL-interacting protein kinase 4 [Populus trichocarpa] gi|222850647|gb|EEE88194.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/384 (91%), Positives = 369/384 (96%), Gaps = 1/384 (0%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKREVATMK +KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEAR Y
Sbjct: 57 QIKREVATMKRIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARGY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F QLINAVDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT
Sbjct: 117 FHQLINAVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+ ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW
Sbjct: 177 PNYVAPEVLNDRGYDGAPADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LSF A KLI RILDPNPMTRIT+ EIL DEWFKK YK PVFEEK+DTNLDDVEAVFKDSE
Sbjct: 237 LSFGAMKLITRILDPNPMTRITVSEILVDEWFKKGYKTPVFEEKEDTNLDDVEAVFKDSE 296
Query: 258 EHHVTEQK-EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIE 316
E+HVTE+K EEQP AMNAFELIS+S+GLNLGNLFD EQ+FKRETRFTS+CPANEII+KIE
Sbjct: 297 ENHVTEKKEEEQPTAMNAFELISMSRGLNLGNLFDGEQEFKRETRFTSKCPANEIIHKIE 356
Query: 317 EAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 376
EAAKPLGFDVHKKNYKMRLEN+KAGRKGNLNVATE+FQ+APSLHMVEVRKAKGDTLEFHK
Sbjct: 357 EAAKPLGFDVHKKNYKMRLENVKAGRKGNLNVATEIFQMAPSLHMVEVRKAKGDTLEFHK 416
Query: 377 FYKNLSTCLEDVVWKTEEDMQEMK 400
FYK+LSTCL+DVVWKTEEDMQE K
Sbjct: 417 FYKSLSTCLDDVVWKTEEDMQETK 440
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|154425355|dbj|BAF74756.1| CBL-interacting protein kinase [Vigna unguiculata] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/380 (90%), Positives = 363/380 (95%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI+REVATMKL+KHPNVVRLYEVMGSKTKI++VLEFVTGGELFDKIVNHGRM E+EARRY
Sbjct: 57 QIRREVATMKLIKHPNVVRLYEVMGSKTKIYVVLEFVTGGELFDKIVNHGRMSENEARRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGT
Sbjct: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLMNLYKKISAAEFTCPPW
Sbjct: 177 PNYVAPEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMNLYKKISAAEFTCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LSF+ARKLI RILDP+P TRITIPEIL+DEWFKKDYKPPVFEE + NLDDVEAVFKDSE
Sbjct: 237 LSFSARKLITRILDPDPTTRITIPEILDDEWFKKDYKPPVFEENGEINLDDVEAVFKDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEEQP +MNAFELIS+SKGLNL NLFD EQ FKRETRFTS+ PA+EIINKIEE
Sbjct: 297 EHHVTEKKEEQPTSMNAFELISMSKGLNLENLFDTEQGFKRETRFTSKSPADEIINKIEE 356
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFDV KKNYKMRL N+KAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AAKPLGFDVQKKNYKMRLANVKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 378 YKNLSTCLEDVVWKTEEDMQ 397
YK LST L+DVVWKTE+DMQ
Sbjct: 417 YKKLSTSLDDVVWKTEDDMQ 436
|
Source: Vigna unguiculata Species: Vigna unguiculata Genus: Vigna Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857008|dbj|BAD95889.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1882), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/381 (90%), Positives = 364/381 (95%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKREVATMKL+KHPNVV+LYEV+GSKTKI++VLEFVTGGELFDKIVNHGRM EDEARRY
Sbjct: 57 QIKREVATMKLIKHPNVVQLYEVLGSKTKIYMVLEFVTGGELFDKIVNHGRMCEDEARRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLIN VDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALSQQ++DDGLLHTTCGT
Sbjct: 117 FQQLINTVDYCHSRGVYHRDLKPENLLLDACGNLKVSDFGLSALSQQIKDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLND+GYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKISAAEFTCPPW
Sbjct: 177 PNYVAPEVLNDKGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISAAEFTCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LSF+ARKLI RILDPNPMTRITI EILEDEWFKKDYKPP+F+E +TNLDDVEAVFKDSE
Sbjct: 237 LSFSARKLITRILDPNPMTRITIAEILEDEWFKKDYKPPIFQENGETNLDDVEAVFKDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEEQP AMNAFELIS+SKGLNL NLFD EQ FKRETRFTS+ PANEII+KIEE
Sbjct: 297 EHHVTEKKEEQPTAMNAFELISMSKGLNLENLFDVEQGFKRETRFTSKSPANEIISKIEE 356
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFDV KKNYKMRL N+KAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AAKPLGFDVQKKNYKMRLANVKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 378 YKNLSTCLEDVVWKTEEDMQE 398
YK LSTCLEDVVWKTE+DMQ+
Sbjct: 417 YKKLSTCLEDVVWKTEDDMQK 437
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493713|ref|XP_003617145.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518480|gb|AET00104.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 722 bits (1863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/381 (88%), Positives = 361/381 (94%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE+ATMKL+KHPNVVRLYEVMGS+TKI+IVLEFVTGGELFDKIVNHGRM E EARRY
Sbjct: 57 QIKREIATMKLIKHPNVVRLYEVMGSRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLIN VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT
Sbjct: 117 FQQLINVVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPW
Sbjct: 177 PNYVAPEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISSADFTCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LSF+ARKLI RILDPNPMTRIT+ EIL+DEWFKKDYKPPVFEE +TNLDDVEAVFKDSE
Sbjct: 237 LSFSARKLITRILDPNPMTRITMAEILDDEWFKKDYKPPVFEESGETNLDDVEAVFKDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEEQP +MNAFELIS+S+GLNL NLFD EQ FKRETRFTS+ PA+EIINKIEE
Sbjct: 297 EHHVTEKKEEQPTSMNAFELISMSRGLNLENLFDVEQGFKRETRFTSQSPADEIINKIEE 356
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFDV KKN+KMRL N KAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF
Sbjct: 357 AAKPLGFDVQKKNFKMRLANSKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 416
Query: 378 YKNLSTCLEDVVWKTEEDMQE 398
YK LST L+ VVWKTE+DMQ+
Sbjct: 417 YKKLSTSLQGVVWKTEDDMQK 437
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493719|ref|XP_003617148.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518483|gb|AET00107.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/416 (81%), Positives = 361/416 (86%), Gaps = 35/416 (8%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV-----------------------------------MG 42
QIKRE+ATMKL+KHPNVVRLYEV MG
Sbjct: 57 QIKREIATMKLIKHPNVVRLYEVADMMTFLFINLTNHADTKFDDSVVLFAYPLAFSLVMG 116
Query: 43 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 102
S+TKI+IVLEFVTGGELFDKIVNHGRM E EARRYFQQLIN VDYCHSRGVYHRDLKPEN
Sbjct: 117 SRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQLINVVDYCHSRGVYHRDLKPEN 176
Query: 103 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162
LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG+TADLWSCG
Sbjct: 177 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGATADLWSCG 236
Query: 163 VILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPE 222
VILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+ARKLI RILDPNPMTRIT+ E
Sbjct: 237 VILFVLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFSARKLITRILDPNPMTRITMAE 296
Query: 223 ILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSK 282
IL+DEWFKKDYKPPVFEE +TNLDDVEAVFKDSEEHHVTE+KEEQP +MNAFELIS+S+
Sbjct: 297 ILDDEWFKKDYKPPVFEESGETNLDDVEAVFKDSEEHHVTEKKEEQPTSMNAFELISMSR 356
Query: 283 GLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGR 342
GLNL NLFD EQ FKRETRFTS+ PA+EIINKIEEAAKPLGFDV KKN+KMRL N KAGR
Sbjct: 357 GLNLENLFDVEQGFKRETRFTSQSPADEIINKIEEAAKPLGFDVQKKNFKMRLANSKAGR 416
Query: 343 KGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLSTCLEDVVWKTEEDMQE 398
KGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYK LST L+ VVWKTE+DMQ+
Sbjct: 417 KGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKKLSTSLQGVVWKTEDDMQK 472
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | ||||||
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.952 | 0.844 | 0.826 | 4.1e-175 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.942 | 0.858 | 0.795 | 6e-167 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.957 | 0.794 | 0.721 | 6e-151 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.937 | 0.840 | 0.608 | 4.4e-123 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.93 | 0.835 | 0.578 | 1.1e-117 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.907 | 0.823 | 0.540 | 8.3e-106 | |
| TAIR|locus:1005716169 | 831 | AT5G21222 [Arabidopsis thalian | 0.61 | 0.293 | 0.782 | 1.8e-103 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.91 | 0.829 | 0.522 | 4.7e-103 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.935 | 0.840 | 0.523 | 4.2e-102 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.947 | 0.831 | 0.510 | 2.3e-101 |
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1701 (603.8 bits), Expect = 4.1e-175, P = 4.1e-175
Identities = 315/381 (82%), Positives = 349/381 (91%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI+RE+ATMKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRY
Sbjct: 68 QIRREIATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRY 127
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLI+AVDYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGT
Sbjct: 128 FQQLIHAVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGT 187
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVLNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPW
Sbjct: 188 PNYVAPEVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPW 247
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LS A KLI RILDPNPMTR+T E+ EDEWFKKDYKPPVFEE+ D+N+DD++AVFKDSE
Sbjct: 248 LSLGAMKLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSE 307
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EH VTE++EEQP A+NAFE+IS+S+GLNL NLFD EQ+FKRETR T R ANEII KIEE
Sbjct: 308 EHLVTEKREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEE 367
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
AAKPLGFDV KKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMV+V K+KGDTLEFHKF
Sbjct: 368 AAKPLGFDVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKF 427
Query: 378 YKNLSTCLEDVVWKTEEDMQE 398
YK LS LE VVW E +E
Sbjct: 428 YKKLSNSLEQVVWTNNEVKKE 448
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1624 (576.7 bits), Expect = 6.0e-167, P = 6.0e-167
Identities = 300/377 (79%), Positives = 339/377 (89%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI+RE+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+Y
Sbjct: 57 QIRREICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGT
Sbjct: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGT 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNY APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPW
Sbjct: 177 PNYAAPEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LS A+ LI RILDPNPMTRITIPE+L D WFKK+YKP VFEEK++ NLDDV+AVFKDSE
Sbjct: 237 LSPGAKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSE 296
Query: 258 EHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE 317
EHHVTE+KEEQP +MNAFELIS+S+ L+LGNLF+ E+ FKRETRF ++ AN+++ KIEE
Sbjct: 297 EHHVTEKKEEQPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEE 356
Query: 318 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKF 377
A+KPLGFD+ KKNYKMRLEN+ AGRKGNL VATE+FQV+PSLHM+EVRK KGDTLEFHKF
Sbjct: 357 ASKPLGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKF 416
Query: 378 YKNLSTCLEDVVWKTEE 394
YK LST L DVVWK+ E
Sbjct: 417 YKKLSTSLNDVVWKSGE 433
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1473 (523.6 bits), Expect = 6.0e-151, P = 6.0e-151
Identities = 282/391 (72%), Positives = 332/391 (84%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
++ QIKRE++TMKL+KHPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEA
Sbjct: 72 MIAQIKREISTMKLIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEA 131
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
R+YFQQLINAVDYCHSRGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTT
Sbjct: 132 RKYFQQLINAVDYCHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTT 191
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
CGTPNYVAPEV+N++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTC
Sbjct: 192 CGTPNYVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTC 251
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 254
PPW S +A+KLI RILDPNP TRIT E++E+EWFKK YK P FE D +LDDV+A+F
Sbjct: 252 PPWFSASAKKLIKRILDPNPATRITFAEVIENEWFKKGYKAPKFENA-DVSLDDVDAIFD 310
Query: 255 DSEEHH--VTEQKEE---QPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPA 308
DS E V E++EE PV MNAFELIS S+GLNLG+LF+ + KR+TRFTS+ A
Sbjct: 311 DSGESKNLVVERREEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSA 370
Query: 309 NEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAK 368
NEI+ KIE AA P+GFDV NYKM+L K+GRKG L VATEVFQVAPSL+MVE+RK+
Sbjct: 371 NEIVTKIEAAAAPMGFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSG 430
Query: 369 GDTLEFHKFYKNLSTCLEDVVWKT-EEDMQE 398
GDTLEFHKFYKNL+T L+D+VWKT +E+ +E
Sbjct: 431 GDTLEFHKFYKNLTTGLKDIVWKTIDEEKEE 461
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1210 (431.0 bits), Expect = 4.4e-123, P = 4.4e-123
Identities = 232/381 (60%), Positives = 294/381 (77%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++ MK+V+HPN+VRLYEV+ S +KI+IVLEFVTGGELFD+IV+ GR++E E+R+Y
Sbjct: 55 QIKREISIMKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKY 114
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQL++AV +CH +GVYHRDLKPENLLLD GNLKVSDFGLSAL Q+ + LL TTCGT
Sbjct: 115 FQQLVDAVAHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGT 172
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVL+ +GYDGS AD+WSCGVILFV+LAGYLPF +++L LY+KI+AAEF+CPPW
Sbjct: 173 PNYVAPEVLSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPW 232
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
S + LI RILDPNP TRI I I +D WF+ +Y P E+++ NLDD+ AVF E
Sbjct: 233 FSAEVKFLIHRILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIE 292
Query: 258 EHHVTEQKE---EQPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIIN 313
+V E E E P+ MNAFE+I+LS+GLNL LFD QDF KR+TRF SR +EII
Sbjct: 293 GSYVAENVERNDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIA 352
Query: 314 KIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 373
IE A +GF H +N+K RLE + + + G L V E+++VAPSL MV+VRKA G+TLE
Sbjct: 353 NIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLE 412
Query: 374 FHKFYKNLSTCLEDVVWKTEE 394
+HKFYK L + LE+++W+ E
Sbjct: 413 YHKFYKKLCSKLENIIWRATE 433
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 218/377 (57%), Positives = 284/377 (75%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++ MKLV+HP VVRLYEV+ S+TKI+I+LE++TGGELFDKIV +GR+ E EAR+Y
Sbjct: 53 QIKREISIMKLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKY 112
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F QLI+ VDYCHS+GVYHRDLKPENLLLD+ GNLK+SDFGLSAL +Q +L TTCGT
Sbjct: 113 FHQLIDGVDYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQ--GVTILKTTCGT 170
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNYVAPEVL+ +GY+G+ AD+WSCGVIL+VL+AGYLPFD+ +L LY KI AEF+CP +
Sbjct: 171 PNYVAPEVLSHKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSY 230
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
+ A+ LI RILDPNP TRITI EI +DEWF KDY P + + NLDDV A F D E
Sbjct: 231 FALGAKSLINRILDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPE 290
Query: 258 EHHVTEQ--KEEQPVAMNAFELISLSKGLNLGNLFDAEQD-FKRETRFTSRCPANEIINK 314
E + ++ P+ +NAF+LI LS+GLNL LFD +D K +TRF S PAN +++
Sbjct: 291 EQTYAQDGTRDTGPLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSS 350
Query: 315 IEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 374
+E ++ +GF H +NYKMR+E + A + + +V EVF+VAPS+ MV+++ A GD E+
Sbjct: 351 MEVVSQSMGFKTHIRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEY 410
Query: 375 HKFYKNLSTCLEDVVWK 391
KFYK + L+D++WK
Sbjct: 411 LKFYKTFCSKLDDIIWK 427
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1047 (373.6 bits), Expect = 8.3e-106, P = 8.3e-106
Identities = 205/379 (54%), Positives = 274/379 (72%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++ M++VKHPN+V L+EVM SK+KI+ +E V GGELF K+ GR++ED AR Y
Sbjct: 68 QIKREISVMRMVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVY 126
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLI+AVD+CHSRGVYHRDLKPENLLLD GNLKV+DFGLSA ++ ++ DGLLHTTCGT
Sbjct: 127 FQQLISAVDFCHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGT 186
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P YVAPEV+ +GYDG+ ADLWSCGVILFVLLAGYLPF D NL+N+Y+KI +F CP W
Sbjct: 187 PAYVAPEVILKKGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGW 246
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LS AR+L+ ++LDPNP TRITI ++++ WFKK + + N + V A +E
Sbjct: 247 LSSDARRLVTKLLDPNPNTRITIEKVMDSPWFKK-------QATRSRN-EPVAATITTTE 298
Query: 258 EH--HVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ-DFKRETRFTSRCPANEIINK 314
E + + +E+ +NAF +I+LS+G +L LF+ ++ + KRE RF + PA+ +I+
Sbjct: 299 EDVDFLVHKSKEETETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISS 358
Query: 315 IEEAAKPLG--FDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTL 372
+EEAA+ +G FDV K ++R+E + GRKG L V E+F VAPS +VEV+K GDTL
Sbjct: 359 LEEAAR-VGNKFDVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTL 417
Query: 373 EFHKFYKN-LSTCLEDVVW 390
E++ F L L+D+ W
Sbjct: 418 EYNNFCSTALRPALKDIFW 436
|
|
| TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 1.8e-103, P = 1.8e-103
Identities = 191/244 (78%), Positives = 213/244 (87%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++ MKL+ HPNVV+LYEV+ SK KI+IVLEF++GG+LFDKI N GRM EDEA+RY
Sbjct: 57 QIKREISIMKLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRY 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLINAVDYCHSRGVYHRDLKPENLLLDA NLKV++FGL ALSQQ DGL HT CG
Sbjct: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGN 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P+Y APEVLND+GYDG+ ADLWSCGVILFVLLAGYLPF+DS+L LYKKIS+A+F+CPPW
Sbjct: 177 PDYAAPEVLNDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADFSCPPW 236
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
LS + LI RILDPNPMTRITIPEILED WFKKDYKP VFEEKK+ NL DVEAVFKDSE
Sbjct: 237 LSSGVKNLIVRILDPNPMTRITIPEILEDVWFKKDYKPAVFEEKKEANLADVEAVFKDSE 296
Query: 258 EHHV 261
E V
Sbjct: 297 EGRV 300
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1021 (364.5 bits), Expect = 4.7e-103, P = 4.7e-103
Identities = 197/377 (52%), Positives = 275/377 (72%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++ M+LV+HP+VV L+EVM SKTKI+ +E+V GGELFDK V+ G++KE+ AR+Y
Sbjct: 56 QIKREISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKY 114
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLI A+DYCHSRGVYHRDLKPENLLLD G+LK+SDFGLSAL + + DGLLHTTCGT
Sbjct: 115 FQQLIGAIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGT 174
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P YVAPEV+ +GYDG+ AD+WSCGV+L+VLLAG+LPF + NL+ +Y+KI+ EF CP W
Sbjct: 175 PAYVAPEVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNW 234
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
+KL++RILDPNP +RI I +I+E+ WF+K +K E K ++++ D
Sbjct: 235 FPPEVKKLLSRILDPNPNSRIKIEKIMENSWFQKGFKK--IETPKSPESHQIDSLISDV- 291
Query: 258 EHHVTEQKEEQPVAMNAFELIS-LSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIE 316
H K P++ NAF+LIS LS+G +L LF+ E+ + E++FT++ A EI++K E
Sbjct: 292 -HAAFSVK---PMSYNAFDLISSLSQGFDLSGLFEKEE--RSESKFTTKKDAKEIVSKFE 345
Query: 317 E-AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFH 375
E A F++ K + +++E+ + GRKG+L + E+F+V S HMVE +K+ GDT+E+
Sbjct: 346 EIATSSERFNLTKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYK 405
Query: 376 KFY-KNLSTCLEDVVWK 391
+F + L L+D+VWK
Sbjct: 406 QFCDRELRPSLKDIVWK 422
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
Identities = 201/384 (52%), Positives = 271/384 (70%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++ MKLV+HPN+V L EVM +KTKIF V+EFV GGELF KI + G++ ED ARRY
Sbjct: 57 QIKREISIMKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKI-SKGKLHEDAARRY 115
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQLI+AVDYCHSRGV HRDLKPENLLLD G+LK+SDFGLSAL +Q+ DGLLHT CGT
Sbjct: 116 FQQLISAVDYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGT 175
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P YVAPEVL +GYDG+ AD+WSCGV+L+VLLAG LPF D NLMN+Y+KI A+F PPW
Sbjct: 176 PAYVAPEVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPW 235
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 257
S AR+LI+++L +P RI+IP I+ W +K++ PP+ K D + + + E
Sbjct: 236 FSPEARRLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPL-AFKIDEPICSQSSKNNEEE 294
Query: 258 EHHVTEQKEEQPVA---MNAFELIS-LSKGLNLGNLFDAEQDFKRETRFTSRCPANEIIN 313
E + + +P++ NAFE IS +S G +L +LF++++ K ++ FTSR A E++
Sbjct: 295 EEDGDCENQTEPISPKFFNAFEFISSMSSGFDLSSLFESKR--KVQSVFTSRSSATEVME 352
Query: 314 KIEEAAKPLGFDVHK-KNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTL 372
KIE K + V + K++K+++E GRKG L++ EVF+VAP + +VE K+ GDTL
Sbjct: 353 KIETVTKEMNMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTL 412
Query: 373 EFHKFYKN-LSTCLEDVVWKTEED 395
E+ + Y+ + L D+VW D
Sbjct: 413 EYDRLYEEEVRPALNDIVWSWHGD 436
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
Identities = 199/390 (51%), Positives = 273/390 (70%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QIKRE++ M++ KHPNVV LYEVM +K++I+ V+E+ GGELF+K+ G++KED A +Y
Sbjct: 56 QIKREISVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAK-GKLKEDVAWKY 114
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F QLI+AVD+CHSRGVYHRD+KPENLLLD NLKVSDFGLSAL+ R DGLLHTTCGT
Sbjct: 115 FYQLISAVDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGT 174
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P YVAPEV+N +GY+G+ AD+WSCGV+LFVLLAGYLPF D+NLM +Y+KI A+F CP W
Sbjct: 175 PAYVAPEVINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSW 234
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY--KPPVFEEKKDTNLDDVEAVFK- 254
+ ++L+ ++LDPN TRITI +I E WF+K K E+ + + + +
Sbjct: 235 FAPEVKRLLCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEA 294
Query: 255 -DSEEHHVTEQKEEQPVA-MNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEII 312
S ++ E E +A +NAF++I+LS G L LF D KRE+RF S+ PA+EII
Sbjct: 295 GGSGQNENGENHEPPRLATLNAFDIIALSTGFGLAGLFGDVYD-KRESRFASQKPASEII 353
Query: 313 NKIEEAAKPLGFDVHKKNYKM-RLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDT 371
+K+ E AK L + K+ + +LE +K G+ G L + E+FQV P+ H+VEV+K GDT
Sbjct: 354 SKLVEVAKCLKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDT 413
Query: 372 LEFHKFYK-NLSTCLEDVVW--KTEEDMQE 398
+E+ K + +L L D+VW + E++ +E
Sbjct: 414 MEYQKLVEEDLRPALADIVWVWQGEKEKEE 443
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6X4A2 | CIPKV_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7552 | 0.95 | 0.8463 | no | no |
| Q2V452 | CIPK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8267 | 0.9525 | 0.8639 | yes | no |
| Q2QY53 | CIPKW_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8421 | 0.945 | 0.8630 | yes | no |
| Q8LIG4 | CIPK3_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7068 | 0.955 | 0.8584 | no | no |
| Q84VQ3 | CIPKQ_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7957 | 0.9425 | 0.8587 | no | no |
| Q2RAX3 | CIPKX_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8080 | 0.945 | 0.8325 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK018 | SubName- Full=Chromosome chr6 scaffold_15, whole genome shotgun sequence; (439 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 400 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-88 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-77 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-62 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-57 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-53 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 4e-53 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-49 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-49 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-46 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-42 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-42 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-42 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-40 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-40 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-39 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-39 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-38 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-37 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-37 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-37 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-37 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-37 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-36 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-36 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-36 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-36 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-35 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-34 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-34 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-34 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-34 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-34 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-34 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-34 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-33 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-33 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-33 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-32 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-31 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-31 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-31 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-31 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-31 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-31 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-31 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-31 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-30 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-30 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-29 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-29 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-29 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-29 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-28 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-28 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-28 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-27 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-27 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-27 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 6e-27 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-27 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-26 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-25 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-25 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-24 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-23 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-23 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-22 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-20 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-12 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 2e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 9e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.004 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 267 bits (686), Expect = 2e-88
Identities = 97/216 (44%), Positives = 143/216 (66%), Gaps = 8/216 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+I RE+ +K +KHPN+VRLY+V + K+++V+E+ GG+LFD + GR+ EDEAR Y
Sbjct: 43 RILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY 102
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+Q+++A++Y HS+G+ HRDLKPEN+LLD G++K++DFGL+ Q+ L T GT
Sbjct: 103 LRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGT 159
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAEFTCPP 196
P Y+APEVL +GY + D+WS GVIL+ LL G PF D L+ L+KKI + PP
Sbjct: 160 PEYMAPEVLLGKGYGKA-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP 218
Query: 197 W---LSFTARKLIARILDPNPMTRITIPEILEDEWF 229
+S A+ LI ++L +P R+T E L+ +F
Sbjct: 219 PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 2e-77
Identities = 86/219 (39%), Positives = 128/219 (58%), Gaps = 9/219 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+RE+ ++ + HPN+VRL + K +++V+E+ GG+LFD + G + EDEA++
Sbjct: 44 TARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKI 103
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
Q++ ++Y HS G+ HRDLKPEN+LLD G +K++DFGL+ + ++ L T GT
Sbjct: 104 ALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGT 161
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EF 192
P Y+APEVL G D+WS GVIL+ LL G PF N+++ + I EF
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF 221
Query: 193 TCPPWLSF--TARKLIARILDPNPMTRITIPEILEDEWF 229
P W S A+ LI + L+ +P R T EIL+ WF
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 4e-62
Identities = 82/216 (37%), Positives = 124/216 (57%), Gaps = 6/216 (2%)
Query: 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
E + + HP +V+L+ ++ K+++VLE+ GGELF + GR E+ AR
Sbjct: 38 EHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF 97
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
Y +++ A++Y HS G+ +RDLKPEN+LLDA G++K++DFGL+ + +T CG
Sbjct: 98 YAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCG 155
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 196
TP Y+APEVL +GY G D WS GV+L+ +L G PF + +Y+KI P
Sbjct: 156 TPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE 214
Query: 197 WLSFTARKLIARILDPNPMTRIT---IPEILEDEWF 229
+LS AR LI+ +L +P R+ EI +F
Sbjct: 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 4e-58
Identities = 79/218 (36%), Positives = 125/218 (57%), Gaps = 11/218 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+ E ++ ++HP +V LY + +++V+E+V GGELF + GR E AR Y
Sbjct: 47 HVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY 106
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
Q++ A++Y HS + +RDLKPENLLLD+ G +K++DFG + R G +T CGT
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGT 161
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P Y+APE++ +GY G D W+ G++++ +LAGY PF D N + +Y+KI + P +
Sbjct: 162 PEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF 220
Query: 198 LSFTARKLIARILDPNPMTRI-----TIPEILEDEWFK 230
S A+ LI +L + R+ + +I WF
Sbjct: 221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 1e-57
Identities = 80/211 (37%), Positives = 116/211 (54%), Gaps = 35/211 (16%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARR 76
++ RE+ +K + HPN+V+LY V + +++V+E+ GG L D + N G++ EDE R
Sbjct: 37 ELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILR 96
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Q++ ++Y HS G+ HRDLKPEN+LLD+ G +K++DFGLS L D LL T
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIV 154
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 195
GTP Y+APEVL +GY +D+WS GVIL+ L
Sbjct: 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------- 187
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILED 226
P L + LI ++L +P R + EILE
Sbjct: 188 PEL----KDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 79/224 (35%), Positives = 124/224 (55%), Gaps = 12/224 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
Q+ E + + P VV+LY K +++V+E++ GG+L + N G + ED AR Y
Sbjct: 39 QVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIY 98
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL------ 131
+++ A++Y HS G+ HRDLKP+N+L+D+ G+LK++DFGLS + R L
Sbjct: 99 IAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 132 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
GTP+Y+APEV+ +G+ T D WS G IL+ L G PF +++ I +
Sbjct: 159 KRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
Query: 192 FTCP--PWLSFTARKLIARILDPNPMTRI---TIPEILEDEWFK 230
P +S A LI+++L P+P R+ +I EI +FK
Sbjct: 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 3e-53
Identities = 74/211 (35%), Positives = 117/211 (55%), Gaps = 10/211 (4%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARR 76
EV +K + HPN+++ YE K K+ IV+E+ GG+L KI + E++
Sbjct: 48 NEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC 135
+F QL A+ Y HSR + HRD+KP+N+ L + G +K+ DFG+S LS L T
Sbjct: 108 WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---TVDLAKTVV 164
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-C 194
GTP Y++PE+ ++ Y+ +D+WS G +L+ L PF+ NL+ L KI ++
Sbjct: 165 GTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI 223
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILE 225
P S R L++ +L +P R +I +IL+
Sbjct: 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 4e-53
Identities = 70/111 (63%), Positives = 85/111 (76%), Gaps = 1/111 (0%)
Query: 273 NAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKN-Y 331
NAF+LISLS GL+L LF+ E + KRETRFTSR PA EII K+EEAAK LGF V KK
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 332 KMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLS 382
++LE K GRKG L V+ EVF+V PSL +VEV+K+ GDTLE+HKF+K+L
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLL 111
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 8e-53
Identities = 82/223 (36%), Positives = 127/223 (56%), Gaps = 17/223 (7%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
I E ++ HP +V+LY K I++++E+ GGEL+ + + G E AR Y
Sbjct: 39 HIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY 98
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++ A +Y H+RG+ +RDLKPENLLLD+ G +K+ DFG +++++ T CGT
Sbjct: 99 IACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG---FAKKLKSGQKTWTFCGT 155
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKI----SAAE 191
P YVAPE++ ++GYD + D WS G++L+ LL G PF DD + M +Y I E
Sbjct: 156 PEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE 214
Query: 192 FTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWF 229
F P ++ A+ LI ++L NP R+ I +I + +WF
Sbjct: 215 F--PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 8/218 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKEDEAR 75
++RE+ + ++HPN+VR Y + K I LE+V+GG L + G++ E R
Sbjct: 45 ALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR 104
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
+Y +Q++ + Y HS G+ HRD+K N+L+D+ G +K++DFG + + +
Sbjct: 105 KYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTC 194
GTP ++APEV+ Y G AD+WS G + + G P+ + N M KI ++
Sbjct: 165 GTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EP 222
Query: 195 PP---WLSFTARKLIARILDPNPMTRITIPEILEDEWF 229
P LS A+ + + L +P R T E+L+ +
Sbjct: 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-49
Identities = 72/235 (30%), Positives = 122/235 (51%), Gaps = 24/235 (10%)
Query: 18 QIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
+K E + +L HP +++LY + ++ VLE+ GEL I +G + E R
Sbjct: 47 YVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGL 130
Y +++ A++Y HS+G+ HRDLKPEN+LLD ++K++DFG + + + + D
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 131 LHTT------------CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 178
+ GT YV+PE+LN+ G ++DLW+ G I++ +L G PF S
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
Query: 179 NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWF 229
N ++KI E++ PP A+ LI ++L +P R+ + E+ +F
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 81/212 (38%), Positives = 118/212 (55%), Gaps = 19/212 (8%)
Query: 20 KREVATMKLVKH-------------PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH 66
KRE+ MK V+H P +V + + +++ +LEFV GGELF +
Sbjct: 53 KREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA 112
Query: 67 GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 126
GR D A+ Y +L+ A +Y HS+ + +RDLKPENLLLD G++KV+DFG +++V
Sbjct: 113 GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG---FAKKVP 169
Query: 127 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 186
D T CGTP Y+APEV+ +G+ G D W+ GV+L+ +AGY PF D +Y+K
Sbjct: 170 DR--TFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK 226
Query: 187 ISAAEFTCPPWLSFTARKLIARILDPNPMTRI 218
I A P W AR L+ +L + R+
Sbjct: 227 ILAGRLKFPNWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 70/192 (36%), Positives = 116/192 (60%), Gaps = 6/192 (3%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+ E +K V HP ++RL+ + +++++E+V GGELF + N GR Y
Sbjct: 48 VHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYA 107
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+++ A++Y HS+ + +RDLKPEN+LLD G++K++DFG ++++RD T CGTP
Sbjct: 108 SEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFG---FAKKLRDR--TWTLCGTP 162
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 198
Y+APEV+ +G+ D W+ G++++ +L GY PF D N +Y+KI A + P L
Sbjct: 163 EYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL 221
Query: 199 SFTARKLIARIL 210
A+ LI ++L
Sbjct: 222 DLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 76/221 (34%), Positives = 115/221 (52%), Gaps = 15/221 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLY--EVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKE 71
Q+ EV ++ +KHPN+VR Y + S ++IV+E+ GG+L I ++E
Sbjct: 45 QLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE 104
Query: 72 DEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 126
+ R QL+ A+ CH+R V HRDLKP N+ LDA N+K+ DFGL+ +
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-- 162
Query: 127 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 186
D T GTP Y++PE LN YD + D+WS G +++ L A PF N + L K
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKS-DIWSLGCLIYELCALSPPFTARNQLQLASK 221
Query: 187 ISAAEFTC-PPWLSFTARKLIARILDPNPMTRITIPEILED 226
I +F P S ++I +L+ +P R + E+L+
Sbjct: 222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 4e-42
Identities = 74/199 (37%), Positives = 118/199 (59%), Gaps = 3/199 (1%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
K E ++ VKHP +V L + K++++LE+++GGELF + G ED A Y
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
++ A+++ H +G+ +RDLKPEN+LLDA G++K++DFGL + + + + HT CGT
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIE 165
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 199
Y+APE+L G+ G D WS G +++ +L G PF N KI + PP+L+
Sbjct: 166 YMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLT 224
Query: 200 FTARKLIARILDPNPMTRI 218
AR L+ ++L NP +R+
Sbjct: 225 PEARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 79/225 (35%), Positives = 132/225 (58%), Gaps = 23/225 (10%)
Query: 29 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88
V HP +V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+
Sbjct: 55 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 114
Query: 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 148
HS G+ +RDLKPEN+LLD G++K++DFGLS + + + ++ CGT Y+APEV+N
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 149 RGYDGSTADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKL 205
RG+ S AD WS GV++F +L G LPF D M + I A+ P +LS A+ L
Sbjct: 173 RGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---ILKAKLGMPQFLSPEAQSL 228
Query: 206 IARILDPNPMTRI-TIPEILED----------EW---FKKDYKPP 236
+ + NP R+ P+ +E+ +W ++++ KPP
Sbjct: 229 LRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 71/206 (34%), Positives = 108/206 (52%), Gaps = 14/206 (6%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91
P V +LY SK +++V+E++ GG+ I G + ED A++Y +++ V+ H R
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151
G+ HRD+KPENLL+D G+LK++DFGLS + + GTP+Y+APE + G
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVG- 169
Query: 152 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIA 207
D +D WS G ++F L GY PF ++ I + P + S A LI
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229
Query: 208 RILDPNPMTRI---TIPEILEDEWFK 230
R+L +P R+ EI +FK
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 146 bits (368), Expect = 4e-40
Identities = 79/271 (29%), Positives = 126/271 (46%), Gaps = 25/271 (9%)
Query: 15 ILLQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MK 70
+ + RE+ + + HP N+V+LY+ + +++V+E+V GG L D + GR +
Sbjct: 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLS 99
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL----SQQV 125
E EA Q+++A++Y HS+G+ HRD+KPEN+LLD G +K+ DFGL+ L
Sbjct: 100 ESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159
Query: 126 RDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN- 182
L T+ GTP Y+APEVL Y S++D+WS G+ L+ LL G PF+ +
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 183 ---LYKKISAAEFTC---------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
K I P +S A L+ ++L +P R++ L +
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL- 278
Query: 231 KDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 261
K + DD +
Sbjct: 279 AHLKLKESDLSDLLKPDDSAPLRLSLPPSLE 309
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 8/215 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARR 76
+I E+ +K KHPN+V+ Y K +++IV+EF +GG L D + + + E +
Sbjct: 43 KIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY 102
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
++L+ ++Y HS G+ HRD+K N+LL + G +K+ DFGLSA Q+ D +T G
Sbjct: 103 VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVG 159
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFT 193
TP ++APEV+N + YD AD+WS G+ L G P+ + M KI+
Sbjct: 160 TPYWMAPEVINGKPYDY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR 218
Query: 194 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228
P S + + + L NP R T ++L+ +
Sbjct: 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 87/277 (31%), Positives = 129/277 (46%), Gaps = 50/277 (18%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91
P +V+LY + +++V+E++ GG+L + ++ E+ AR Y +L+ A+D H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSA---------------LSQQVRDDGLLH---- 132
G HRD+KP+N+L+DA G++K++DFGL + RD+ L+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 133 --------TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 184
+T GTP+Y+APEVL Y D WS GVIL+ +L G+ PF L Y
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 185 KKISAAE--FTCPP--WLSFTARKLIARIL-DP-NPMTRITIPEILEDEWFKK------- 231
KI + PP +S A LI R+L DP + + EI +FK
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFE--EIKSHPFFKGIDWENLR 297
Query: 232 DYKPPV---FEEKKDT-NLDDVEAVFKDSEEHHVTEQ 264
+ KPP DT N DD E D + Q
Sbjct: 298 ETKPPFVPELSSPLDTSNFDDFE---DDKDLSDYLSQ 331
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 61/253 (24%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE-----LFDKIVNHGRMKEDEAR 75
RE++ +K +KHPN+V+L +V+ ++ K+++V E+ + DK G + + +
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIK 101
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTT 134
QL+ + YCHS + HRDLKP+N+L++ G LK++DFGL+ A +R
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-------- 153
Query: 135 CGTPN-----YVAPEVL-NDRGYDGSTADLWSCGVIL------FVLLAG----------- 171
T Y APE+L + Y + D+WS G I L G
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212
Query: 172 ---------------YLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 216
LP D + + P L L++++L NP
Sbjct: 213 QILGTPTEESWPGVTKLP-DYKPTFPKFPPKDLEKVL--PRLDPEGIDLLSKMLQYNPAK 269
Query: 217 RITIPEILEDEWF 229
RI+ E L+ +F
Sbjct: 270 RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-37
Identities = 78/222 (35%), Positives = 119/222 (53%), Gaps = 15/222 (6%)
Query: 20 KREVA-------TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKED 72
K EVA ++ +HP + L + ++ V+E+ GGELF + ED
Sbjct: 36 KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
AR Y ++++A+ Y HS V +RDLK ENL+LD G++K++DFGL + + D +
Sbjct: 96 RARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC--KEGISDGATMK 153
Query: 133 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 192
T CGTP Y+APEVL D Y G D W GV+++ ++ G LPF + + L++ I E
Sbjct: 154 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 212
Query: 193 TCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWF 229
P LS A+ L+A +L +P R+ EI+E +F
Sbjct: 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 72/229 (31%), Positives = 119/229 (51%), Gaps = 22/229 (9%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
+ +I E+ ++L+KHPN+V+ Y V + K++I +E+ +GG L + ++ HGR+ DE
Sbjct: 42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEH 99
Query: 75 --RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDD 128
R Y QL+ + Y HS G+ HRD+KP N+ LD G +K+ DFG L + +
Sbjct: 100 VIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG-- 157
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDG--STADLWSCGVILFVLLAGYLPFD--DSNLMNLY 184
+ + GTP Y+APEV+ G AD+WS G ++ + G P+ D+ ++
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF 217
Query: 185 KKISAAEFTCPPW-----LSFTARKLIARILDPNPMTRITIPEILEDEW 228
+ A PP LS + + R L+ +P R T E+L+ +
Sbjct: 218 -HVGAGH--KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 88/270 (32%), Positives = 134/270 (49%), Gaps = 29/270 (10%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
E + V P +V L S K+++VL F+ GGELF + GR AR Y +L
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 141
+ A++ H V +RDLKPEN+LLD G++ + DFGL L+ ++DD +T CGTP Y+
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYL 160
Query: 142 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 201
APE+L GY D W+ GV+L+ +L G PF D N+ +Y+KI P
Sbjct: 161 APELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRD 219
Query: 202 ARKLIARILDPNPMTRITI---PEILEDEWFKK-------------DYKPPVFEEKKDTN 245
A+ L+ +L +P R+ EI +F + +KP V +N
Sbjct: 220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSN 279
Query: 246 LDD-------VEAVFKDSEEHHVTEQKEEQ 268
D+ +++V DS H++E ++Q
Sbjct: 280 FDEEFTREKPIDSVVDDS---HLSETVQQQ 306
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 68/189 (35%), Positives = 112/189 (59%), Gaps = 3/189 (1%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
KHP + +L+ +K ++F V+E+V GG+L I GR E AR Y +++ + + H
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
RG+ +RDLK +N+LLD+ G++K++DFG+ + + T CGTP+Y+APE+L+ +
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y + D W+ GV+L+ +LAG PF+ + L++ I E P WLS A+ ++
Sbjct: 172 PYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF 230
Query: 210 LDPNPMTRI 218
L NP R+
Sbjct: 231 LTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 67/189 (35%), Positives = 109/189 (57%), Gaps = 3/189 (1%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
HP + +LY + ++F V+EFV GG+L I R E AR Y ++ +A+ + H
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
+G+ +RDLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L +
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y G + D W+ GV+L+ +L G+ PF+ N +L++ I E P WLS A ++
Sbjct: 172 LY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF 230
Query: 210 LDPNPMTRI 218
+ NP R+
Sbjct: 231 MTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 7e-37
Identities = 70/197 (35%), Positives = 112/197 (56%), Gaps = 3/197 (1%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
E ++ +HP + L + ++ V+E+ GGELF + E+ AR Y ++
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 141
++A++Y HSR V +RD+K ENL+LD G++K++DFGL + + D + T CGTP Y+
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYL 162
Query: 142 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 201
APEVL D Y G D W GV+++ ++ G LPF + + L++ I E P LS
Sbjct: 163 APEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 221
Query: 202 ARKLIARILDPNPMTRI 218
A+ L+A +L +P R+
Sbjct: 222 AKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 76/237 (32%), Positives = 121/237 (51%), Gaps = 27/237 (11%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+ E + K +V+L +++ +E+V GG+ + N G + ED AR Y
Sbjct: 47 HVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY 106
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTC 135
++ AVD H G HRDLKPEN L+DA G++K++DFGLS ++ ++
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-------YANSVV 159
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-------NLMNLYKKIS 188
G+P+Y+APEVL +GYD T D WS G +L+ L G+ PF S NL + +
Sbjct: 160 GSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218
Query: 189 AAEFTCPPW-LSFTARKLIARILDPNPMTRI-TIPEILEDEWFKK-------DYKPP 236
+ P + LS A LI ++++ +P R ++ +I +FK+ + KPP
Sbjct: 219 RPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPP 274
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 59/203 (29%), Positives = 110/203 (54%), Gaps = 7/203 (3%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+ E ++ + HP +V L+ + +++V++ + GG+L + + E++ + +
Sbjct: 47 VLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWI 106
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+++ A++Y HS+G+ HRD+KP+N+LLD G++ ++DF ++ +V D L +T GTP
Sbjct: 107 CEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTP 163
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD--DSNLMNLYK-KISAAEFTCP 195
Y+APEVL +GY D WS GV + L G P+ + + + K A+ P
Sbjct: 164 GYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP 222
Query: 196 PWLSFTARKLIARILDPNPMTRI 218
S A I ++L+ +P R+
Sbjct: 223 ATWSTEAIDAINKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 10/218 (4%)
Query: 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
L I +E+ +K +KHPN+V+ + + ++I+LE+ G L I G E
Sbjct: 43 LKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA 102
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Y Q++ + Y H +GV HRD+K N+L G +K++DFG++ ++ +
Sbjct: 103 VYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVV 160
Query: 136 GTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
GTP ++APEV+ G STA D+WS G + LL G P+ D N M +I +
Sbjct: 161 GTPYWMAPEVIEMSGA--STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--VQDDH 216
Query: 195 PPW---LSFTARKLIARILDPNPMTRITIPEILEDEWF 229
PP +S + + + +P R T ++L+ W
Sbjct: 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 69/209 (33%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91
P +V L+ + TK+ ++L++V GGELF + E E R Y +++ A+D+ H
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN--DR 149
G+ +RD+K EN+LLD+ G++ ++DFGLS ++ ++ CGT Y+APEV+
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSG 183
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTARKL 205
G+D D WS GV+ F LL G PF N +IS P +S AR
Sbjct: 184 GHD-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDF 242
Query: 206 IARILDPNPMTRI---TIPEILEDEWFKK 231
I ++L+ +P R+ EI +F+
Sbjct: 243 IQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 76/218 (34%), Positives = 122/218 (55%), Gaps = 9/218 (4%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
+HP + L + ++ V+E+ GGELF + ED AR Y ++++A+DY H
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 112
Query: 90 S-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 148
S + V +RDLK ENL+LD G++K++DFGL + ++D + T CGTP Y+APEVL D
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLED 170
Query: 149 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 208
Y G D W GV+++ ++ G LPF + + L++ I E P LS A+ L++
Sbjct: 171 NDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSG 229
Query: 209 ILDPNPMTRI-----TIPEILEDEWFKKDYKPPVFEEK 241
+L +P R+ EI++ ++F V+E+K
Sbjct: 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-35
Identities = 71/197 (36%), Positives = 112/197 (56%), Gaps = 3/197 (1%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
E +K +HP + L +K ++ V+E+V GGELF + ED R Y ++
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104
Query: 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 141
++A+DY HS + +RDLK ENL+LD G++K++DFGL + + D + T CGTP Y+
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYL 162
Query: 142 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 201
APEVL D Y G D W GV+++ ++ G LPF + + L++ I + P LS
Sbjct: 163 APEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSAD 221
Query: 202 ARKLIARILDPNPMTRI 218
A+ L++ +L +P R+
Sbjct: 222 AKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 10/208 (4%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRY 77
E+ + V HPN++ E K+ IV+E+ G+L I + + E E R
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F QL+ + H + + HRDLK N+LL A +K+ D G+S + ++ + T GT
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGT 164
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPP 196
P+Y+APEV R Y +D+WS G +L+ + PF+ ++ +L K+ ++ PP
Sbjct: 165 PHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP 223
Query: 197 WLSFTARKLIARILDPNPMTRITIPEIL 224
S + I +L P R +IL
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 4/210 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++ E+ +K ++H +V+ Y + + I +E++ GG + D++ +G + E R+Y
Sbjct: 50 ALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY 109
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCG 136
+Q++ V+Y HS + HRD+K N+L D+ GN+K+ DFG S Q + G + + G
Sbjct: 110 TRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTC 194
TP +++PEV++ GY G AD+WS G + +L P+ + M KI+
Sbjct: 170 TPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL 228
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEIL 224
P +S AR + R N R + E+L
Sbjct: 229 PSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 9/220 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
Q+ RE+ T++ + P VV+ Y + +I IVLE++ GG L D + G++ E
Sbjct: 45 QLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYI 104
Query: 78 FQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+Q++ +DY H+ R + HRD+KP NLL+++ G +K++DFG+S + + D +T G
Sbjct: 105 ARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVG 162
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 196
T Y++PE + AD+WS G+ L G PF + ++ + A PP
Sbjct: 163 TVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 197 WL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
L S R I+ L +P R + E+L+ + KK
Sbjct: 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 70/193 (36%), Positives = 109/193 (56%), Gaps = 3/193 (1%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
+K VKHP +V L+ + K++ VL+++ GGELF + E AR Y ++ +A+
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 109
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 145
Y HS + +RDLKPEN+LLD+ G++ ++DFGL + + +G T CGTP Y+APEV
Sbjct: 110 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEV 167
Query: 146 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 205
L+ + YD T D W G +L+ +L G PF N +Y I P ++ +AR L
Sbjct: 168 LHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 226
Query: 206 IARILDPNPMTRI 218
+ +L + R+
Sbjct: 227 LEGLLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 70/193 (36%), Positives = 106/193 (54%), Gaps = 3/193 (1%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
+K VKHP +V L+ + K++ VL++V GGELF + E AR Y ++ +A+
Sbjct: 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASAL 109
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 145
Y HS + +RDLKPEN+LLD+ G++ ++DFGL + + T CGTP Y+APEV
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 146 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 205
L + YD T D W G +L+ +L G PF + +Y I P +S +AR L
Sbjct: 168 LRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHL 226
Query: 206 IARILDPNPMTRI 218
+ +L + R+
Sbjct: 227 LEGLLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 74/209 (35%), Positives = 112/209 (53%), Gaps = 7/209 (3%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
+K VKHP +V L+ + K++ VL+FV GGELF + E AR Y ++ +A+
Sbjct: 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASAL 109
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 145
Y HS + +RDLKPEN+LLD+ G++ ++DFGL D T CGTP Y+APEV
Sbjct: 110 GYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT--TFCGTPEYLAPEV 167
Query: 146 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 205
+ + YD +T D W G +L+ +L G PF ++ +Y I P S TA +
Sbjct: 168 IRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226
Query: 206 IARILDPNPMTRI----TIPEILEDEWFK 230
+ +L+ + R+ EI E +F+
Sbjct: 227 LEELLEKDRQRRLGAKEDFLEIQEHPFFE 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 71/227 (31%), Positives = 124/227 (54%), Gaps = 12/227 (5%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
+HP + L+ +K +F V+E++ GG+L I + GR E AR Y ++I + + H
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
+G+ +RDLK +N+LLD G++K++DFG+ + + +G T CGTP+Y+APE+L +
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y+ S D WS GV+L+ +L G PF + L+ I P W+S A+ ++++
Sbjct: 172 KYNESV-DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230
Query: 210 LDPNPMTRITIPEILEDEWFKK--DYK-------PPVFEEKKDTNLD 247
+ +P R+ + + F + D++ PP F+ K + D
Sbjct: 231 FERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSD 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-34
Identities = 74/224 (33%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
+K +KHP +V L+ + K++ VL++V GGELF + E AR Y ++ +A+
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAI 109
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 145
Y HS + +RDLKPEN+LLD+ G++ ++DFGL + V + T CGTP Y+APEV
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEV 167
Query: 146 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 205
L YD T D W G +L+ +L G PF ++ +Y I P + A L
Sbjct: 168 LRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDL 226
Query: 206 IARILDPNPMTRI-TIPEILE------------DEWFKKDYKPP 236
+ +L + R+ + LE D+ + K PP
Sbjct: 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPP 270
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 8e-34
Identities = 68/197 (34%), Positives = 115/197 (58%), Gaps = 12/197 (6%)
Query: 31 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90
HP +V L+ +++++F V+EFV+GG+L + ++ E+ AR Y ++ A+++ H
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114
Query: 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 150
RG+ +RDLK +N+LLDA G++K++D+G+ + +R T CGTPNY+APE+L
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 151 YDGSTADLWSCGVILFVLLAGYLPFD-----DSNLMN----LYKKISAAEFTCPPWLSFT 201
Y S D W+ GV++F ++AG PFD D+ N L++ I + P LS
Sbjct: 173 YGFSV-DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231
Query: 202 ARKLIARILDPNPMTRI 218
A ++ L+ +P R+
Sbjct: 232 ASSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 65/189 (34%), Positives = 110/189 (58%), Gaps = 3/189 (1%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
KHP + L+ +K ++F V+E+V GG+L +I + E +R Y ++ A+ + H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
GV +RDLK +N+LLDA G+ K++DFG+ + + + T CGTP+Y+APE+L +
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y G + D W+ GV+++ ++AG PF+ N +L++ I + P WLS A ++
Sbjct: 172 EY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF 230
Query: 210 LDPNPMTRI 218
+ NP R+
Sbjct: 231 MTKNPNKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 77/231 (33%), Positives = 126/231 (54%), Gaps = 19/231 (8%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91
P +V L + + +++V ++++GGELF + GR ED A+ Y +L+ A+++ H
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRG 150
+ +RDLKPEN+LLDA G++ + DFGLS + D+ +T CGT Y+APEV L+++G
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 151 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIARI 209
Y D WS GV++F + G+ PF + +Y+ I+ + P LS R+ + +
Sbjct: 174 Y-TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL 232
Query: 210 LDPNPMTRI----TIPEILEDEWF---------KKDYKPPVFEEKKDTNLD 247
L+ NP R+ E+ E +F KK PP F+ D++ D
Sbjct: 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPP-FKPIVDSDED 282
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 5/210 (2%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
Q+++E+A + ++HPN+V+ + ++I LE V GG L + +G E R Y
Sbjct: 48 QLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY 107
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+Q++ ++Y H R HRD+K N+L+D G +K++DFG +++QV + + G+
Sbjct: 108 TRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFG---MAKQVVEFSFAKSFKGS 164
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCP 195
P ++APEV+ +G G AD+WS G + + G P+ + KI S P
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIP 224
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILE 225
LS A+ I + L +P R T E+LE
Sbjct: 225 DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 68/214 (31%), Positives = 116/214 (54%), Gaps = 13/214 (6%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARR 76
+E+ +K + HPNV++ ++ IVLE G+L I + + K E +
Sbjct: 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTC 135
YF QL +A+++ HS+ + HRD+KP N+ + A G +K+ D GL S + H+
Sbjct: 111 YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLV 167
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFT 193
GTP Y++PE +++ GY+ + D+WS G +L+ + A PF D NL +L KKI ++
Sbjct: 168 GTPYYMSPERIHENGYNFKS-DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP 226
Query: 194 CPPWLSFTA--RKLIARILDPNPMTRITIPEILE 225
P ++ R L++R ++P+P R I +L+
Sbjct: 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 73/223 (32%), Positives = 121/223 (54%), Gaps = 33/223 (14%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
++R++ T ++P VV ++ +K + +V+E+V GG+ + N G + D AR YF
Sbjct: 50 VERDILTF--AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYF 107
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---- 134
+ + A++Y H+ G+ HRDLKP+NLL+ + G++K++DFGLS + GL+ T
Sbjct: 108 AETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI-------GLMSLTTNLY 160
Query: 135 ----------------CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 178
CGTP Y+APEV+ +GY G D W+ G+IL+ L G +PF
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGD 219
Query: 179 NLMNLYKKISAAEFTCPPW---LSFTARKLIARILDPNPMTRI 218
L+ ++ + + P L A+ LI+R+L NP+ R+
Sbjct: 220 TPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 70/215 (32%), Positives = 120/215 (55%), Gaps = 11/215 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
EV M+ +HPN+V +Y ++++V+EF+ GG L D IV H RM E++ +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124
Query: 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPN 139
+ A+ + H++GV HRD+K +++LL + G +K+SDFG A +S++V R L+ GTP
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPY 180
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNL--MNLYKKISAAEFTCPP 196
++APEV++ Y G+ D+WS G+++ ++ G P F++ L M + +
Sbjct: 181 WMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLH 239
Query: 197 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
+S R + R+L +P R T E+L + K
Sbjct: 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 72/222 (32%), Positives = 114/222 (51%), Gaps = 26/222 (11%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI RE+ ++ V HPNVV+ +++ +I ++LEF+ GG L + + D AR
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-- 175
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
Q+++ + Y H R + HRD+KP NLL+++ N+K++DFG+S + Q D +++ GT
Sbjct: 176 --QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGT 231
Query: 138 PNYVAPEV----LNDRGYDGSTADLWSCGVILFVLLAGYLPF------DDSNLMNLYKKI 187
Y++PE LN YDG D+WS GV + G PF D ++LM
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM------ 285
Query: 188 SAAEFTCPPWLSFTA----RKLIARILDPNPMTRITIPEILE 225
A + PP TA R I+ L P R + ++L+
Sbjct: 286 CAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 65/206 (31%), Positives = 116/206 (56%), Gaps = 10/206 (4%)
Query: 20 KREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+ E ++ V+ P +V L+ ++ K+ ++L++V+GGE+F + EDE R Y
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCG 136
++I A+++ H G+ +RD+K EN+LLD+ G++ ++DFGLS LS++ ++ CG
Sbjct: 112 GEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCG 168
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-- 194
T Y+APE++ +G G D WS G+++F LL G PF N ++S C
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP 228
Query: 195 --PPWLSFTARKLIARILDPNPMTRI 218
P ++ A+ L+ ++L +P R+
Sbjct: 229 PFPSFIGPEAQDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-31
Identities = 72/211 (34%), Positives = 115/211 (54%), Gaps = 9/211 (4%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRY 77
K+EV + +KHPN+V + ++FIV+E+ GG+L +I G + ED+ +
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC- 135
F Q+ + + H R + HRD+K +N+ L G + K+ DFG +++Q+ D L TC
Sbjct: 107 FVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFG---IARQLNDSMELAYTCV 163
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-C 194
GTP Y++PE+ +R Y+ T D+WS G +L+ L PF+ +NL L KI F
Sbjct: 164 GTPYYLSPEICQNRPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI 222
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILE 225
P S R LI+++ +P R +I IL+
Sbjct: 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 67/197 (34%), Positives = 115/197 (58%), Gaps = 12/197 (6%)
Query: 31 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90
HP +V L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 150
RG+ +RDLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 151 YDGSTADLWSCGVILFVLLAGYLPFD--------DSNLMN-LYKKISAAEFTCPPWLSFT 201
Y G + D W+ GV++F ++AG PFD D N + L++ I + P LS
Sbjct: 173 Y-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231
Query: 202 ARKLIARILDPNPMTRI 218
A ++ L+ +P R+
Sbjct: 232 AASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 21/227 (9%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---KIVNHGRMKEDEAR 75
+++EV M HPNVV+ Y ++++V+ +++GG L D G + E
Sbjct: 46 LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA 105
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHT 133
++++ ++Y HS G HRD+K N+LL G++K++DFG+SA L+ R + T
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 134 TCGTPNYVAPEVLN-DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAE 191
GTP ++APEV+ GYD AD+WS G+ L G P+ M L +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND- 223
Query: 192 FTCPPWLSFTA---------RKLIARILDPNPMTRITIPEILEDEWF 229
PP L A RK+I+ L +P R T E+L+ ++F
Sbjct: 224 ---PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 66/195 (33%), Positives = 115/195 (58%), Gaps = 10/195 (5%)
Query: 31 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90
+P +V L+ + +++F+V+E+V GG+L + ++ E+ AR Y ++ A+++ H
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 150
RG+ +RDLK +N+LLDA G++K++D+G+ + + T CGTPNY+APE+L
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 151 YDGSTADLWSCGVILFVLLAGYLPFD---DSNLMN----LYKKISAAEFTCPPWLSFTAR 203
Y G + D W+ GV++F ++AG PFD D+ MN L++ I P +LS A
Sbjct: 173 Y-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKAS 231
Query: 204 KLIARILDPNPMTRI 218
++ L+ +P R+
Sbjct: 232 HVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 57/160 (35%), Positives = 85/160 (53%), Gaps = 5/160 (3%)
Query: 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKED 72
I Q RE+ ++ +HP VV+L +V + +V+E++ L + + + R + E
Sbjct: 41 GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEA 99
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
+ + Y + L+ V Y H+ G+ HRDLKP NLL+ A G LK++DFGL+ L + L
Sbjct: 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYS 158
Query: 133 TTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG 171
T Y APE+L R YD DLW+ G I LL G
Sbjct: 159 HQVATRWYRAPELLYGARKYDPG-VDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 10/215 (4%)
Query: 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEA 74
L + E +KL+ HPN++ YE + IV+E+ GG L + I + ED
Sbjct: 44 LAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI 103
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLH 132
+F Q++ A+ + H++ + HRDLK +N+LLD + +K+ DFG+S LS + + +
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AY 159
Query: 133 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 192
T GTP Y++PE+ + Y+ +D+W+ G +L+ L + F+ +NL L KI + F
Sbjct: 160 TVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF 218
Query: 193 T-CPPWLSFTARKLIARILDPNPMTRITIPEILED 226
S R+LI +L+ +P R + +I+
Sbjct: 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 67/211 (31%), Positives = 116/211 (54%), Gaps = 10/211 (4%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARR 76
++EVA + +KHPN+V+ E ++IV+++ GG+L+ KI N R ED+
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILD 105
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC 135
+F Q+ A+ + H R + HRD+K +N+ L G +K+ DFG++ L+ V L T
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCI 162
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TC 194
GTP Y++PE+ +R Y+ + +D+W+ G +L+ + F+ N+ NL KI +
Sbjct: 163 GTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV 221
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILE 225
S+ R L++++ NP R ++ ILE
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-31
Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 18/220 (8%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQ 80
E+ + KHPN+V LYE + K++I++EF GG L ++ R + E + R +Q
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 140
++ A+++ HS V HRDLK N+LL G++K++DFG+SA ++ T GTP +
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYW 169
Query: 141 VAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 195
+APEV+ D YD AD+WS G+ L L P + N M + KI +E P
Sbjct: 170 MAPEVVACETFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---P 225
Query: 196 PWL------SFTARKLIARILDPNPMTRITIPEILEDEWF 229
P L S + + L +P R T E+L+ +
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 85/274 (31%), Positives = 124/274 (45%), Gaps = 56/274 (20%)
Query: 31 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90
+P VV+LY + +++++E++ GG++ ++ E+E R Y + I A+D H
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119
Query: 91 RGVYHRDLKPENLLLDAYGNLKVSDFGL-------------------------SALSQQV 125
G HRD+KP+NLLLDA G++K+SDFGL +S+ +
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 126 RDDGLLHT-----------TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174
T T GTP+Y+APEV GY D WS GVI++ +L GY P
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPP 238
Query: 175 FDDSNLMNLYKKISAAEFTC--PP--WLSFTARKLIARILDPNPMTRITIP---EILEDE 227
F N Y+KI + T P LS A+ LI R+ R+ EI
Sbjct: 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHP 297
Query: 228 WFK-------KDYKPPVFEEKK---DT-NLDDVE 250
+FK ++ P+ E K DT N DD E
Sbjct: 298 FFKGVDWEHIRERPAPIIPELKSITDTSNFDDFE 331
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 70/236 (29%), Positives = 122/236 (51%), Gaps = 21/236 (8%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
K P + +L+ + +++ V+E+V GG+L I G+ KE A Y ++ + + H
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
S+G+ +RDLK +N++LDA G++K++DFG+ + + T CGTP+Y+APE++ +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y G + D W+ GV+L+ +LAG PFD + L++ I + P LS A + +
Sbjct: 177 PY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235
Query: 210 LDPNPMTRITI-----PEILEDEWFKK-------------DYKPPVFEEKKDTNLD 247
L +P R+ +I E +F++ +KP V + N D
Sbjct: 236 LTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFD 291
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 9e-31
Identities = 70/249 (28%), Positives = 115/249 (46%), Gaps = 48/249 (19%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK--IFIVLEFV----TGGELFDKIVNHGRMK--ED 72
RE+ ++ ++HPN+VRL E++ SK K I++V E++ TG +++ +K E
Sbjct: 47 REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTES 100
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
+ + Y +QL+ + Y HS G+ HRD+K N+L++ G LK++DFGL A R+
Sbjct: 101 QIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYT 159
Query: 133 TTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---- 187
T Y PE+L Y D+WS G IL L G F S + +KI
Sbjct: 160 NRVITLWYRPPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218
Query: 188 ------SAAEFTCPPW---------------------LSFTARKLIARILDPNPMTRITI 220
+ + PW + +A L+ ++L +P RI+
Sbjct: 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278
Query: 221 PEILEDEWF 229
+ L+ E+F
Sbjct: 279 DQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 83/256 (32%), Positives = 129/256 (50%), Gaps = 28/256 (10%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
M +V+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLAL 155
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAP 143
D HS G HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISP 212
Query: 144 EVLNDRGYD---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPP 196
EVL +G D G D WS GV L+ +L G PF +L+ Y KI ++ F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272
Query: 197 WLSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY---------KPPVFEEKK--- 242
+S A+ LI L + R + EI +FK D PV E
Sbjct: 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDI 332
Query: 243 DT-NLDDVEAVFKDSE 257
DT N DD+E K+ E
Sbjct: 333 DTSNFDDIEDDDKNEE 348
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 65/222 (29%), Positives = 115/222 (51%), Gaps = 17/222 (7%)
Query: 19 IKREVATMKLVKHPNVVRLYE---VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEA 74
I E+ MK KHPN+V Y+ V +++V+E++ GG L D I + RM E +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDE---LWVVMEYMDGGSLTDIITQNFVRMNEPQI 118
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHT 133
++++ ++Y HS+ V HRD+K +N+LL G++K++DFG +A L+++ ++
Sbjct: 119 AYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK---SKRNS 175
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAA-- 190
GTP ++APEV+ + Y D+WS G++ + G P + L L+ I+
Sbjct: 176 VVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGI 233
Query: 191 -EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
P S + + + L +P R + E+L+ + KK
Sbjct: 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 84/256 (32%), Positives = 132/256 (51%), Gaps = 28/256 (10%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
M P VV+L+ +++V+E++ GG+L + + N+ + E A+ Y +++ A+
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLAL 155
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAP 143
D HS G+ HRD+KP+N+LLD +G+LK++DFG ++ + G++ T GTP+Y++P
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDYISP 212
Query: 144 EVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPP 196
EVL + GY G D WS GV LF +L G PF +L+ Y KI ++ F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272
Query: 197 WLSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY----------KPPVFEEKKD- 243
+S A+ LI L + R + EI + +FK D P V E D
Sbjct: 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDI 332
Query: 244 --TNLDDVEAVFKDSE 257
+N DD+E D E
Sbjct: 333 DSSNFDDIEDDKGDVE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 8/208 (3%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQ 79
E+ + L++HPN++ Y + I +E+ GG L+DKIV +E+ Y
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP 138
Q+++AV Y H G+ HRD+K N+ L G +K+ DFG +S+ + + + T GTP
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFG---ISKILGSEYSMAETVVGTP 165
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPW 197
Y++PE+ Y+ +D+W+ G +L+ LL FD +N +NL KI +T
Sbjct: 166 YYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSV 224
Query: 198 LSFTARKLIARILDPNPMTRITIPEILE 225
S L+ +L +P R T E+L+
Sbjct: 225 YSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 66/218 (30%), Positives = 112/218 (51%), Gaps = 9/218 (4%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
++ E+ T+K + H N+V+ ++ + I LE+V GG + + +GR +E R +
Sbjct: 55 LRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT 114
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+Q++ + Y HS+G+ HRDLK +NLL+DA G K+SDFG+S S + D+ + G+
Sbjct: 115 EQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 139 NYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP- 195
++APEV++ +GY D+WS G ++ + AG P+ D + K+ P
Sbjct: 175 FWMAPEVIHSYSQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233
Query: 196 -----PWLSFTARKLIARILDPNPMTRITIPEILEDEW 228
LS A + NP R T E+L+ +
Sbjct: 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 76/259 (29%), Positives = 114/259 (44%), Gaps = 62/259 (23%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRY 77
RE+ ++ +KHPN++ L +V G K+ I +V EF+ + DK + + + + Y
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSY 107
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+ ++Y HS + HRDLKP NLL+ + G LK++DFGL+ + G+
Sbjct: 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGS 154
Query: 138 PN-----------YVAPEVLNDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLY 184
PN Y APE+L + G D+WS G I LL +LP DS++ L
Sbjct: 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL- 212
Query: 185 KKISAA----------EFTCPP-WLSFTARK-----------------LIARILDPNPMT 216
KI A T P ++ F L+ R+L NP
Sbjct: 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNK 272
Query: 217 RITIPEILEDEWFKKDYKP 235
RIT + LE +F D P
Sbjct: 273 RITARQALEHPYFSNDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 61/191 (31%), Positives = 107/191 (56%), Gaps = 3/191 (1%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
+HP + LY +K +F V+E++ GG+L I + + A Y ++I + + H
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
S+G+ +RDLK +N+LLD G++K++DFG+ + + D T CGTP+Y+APE+L +
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y ++ D WS GV+L+ +L G PF + L++ I P WL+ A+ ++ ++
Sbjct: 172 KY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL 230
Query: 210 LDPNPMTRITI 220
P R+ +
Sbjct: 231 FVREPERRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 65/189 (34%), Positives = 103/189 (54%), Gaps = 6/189 (3%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
E + + HP V LY ++ +++VLEFV GGE F + + R D Y Q+
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 141
+ +Y S + +RDLKPENLLLD G +K++DFG + + D +T CGTP Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYI 195
Query: 142 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 201
APE+L + G+ G AD W+ G+ ++ +L G PF + + +Y+KI P +L
Sbjct: 196 APEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN 254
Query: 202 ARKLIARIL 210
+ L+ ++L
Sbjct: 255 CKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 64/213 (30%), Positives = 115/213 (53%), Gaps = 3/213 (1%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
++P + LY +K +F V+EF+ GG+L I + GR A Y +++ + + H
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
S+G+ +RDLK +N++LD G++K++DFG+ + V D T CGTP+Y+APE+L
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y S D WS GV+L+ +L G PF + L++ I P W++ ++ ++ ++
Sbjct: 172 KYTFSV-DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL 230
Query: 210 LDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 242
+ +P R+ + + F K E+++
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFKTINWTALEKRE 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 9/220 (4%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+++E+ M + HP+++R+ + + +E++ GG + + +G KE Y
Sbjct: 50 LRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYT 109
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLH-TTC 135
+QL+ + Y H + HRD+K NLL+D+ G L+++DFG +A L+ + G
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEF 192
GT ++APEVL Y G + D+WS G ++ + P++ N KI++A
Sbjct: 170 GTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
Query: 193 T--CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
P LS R + R L+ P R E+L+ F+
Sbjct: 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 74/258 (28%), Positives = 133/258 (51%), Gaps = 20/258 (7%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
K P + +L+ + +++ V+E+V GG+L +I GR KE A Y ++ + + H
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
S+G+ +RDLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ +
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y G + D W+ GV+L+ +LAG PF+ + L++ I P +S A + +
Sbjct: 177 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235
Query: 210 LDPNPMTRITI-PE----ILEDEWFK---------KDYKPPVFEEKKDTNLDDVEAVFKD 255
+ +P R+ PE I E +F+ K+ +PP + + ++ + F
Sbjct: 236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDAENFDKFFT- 294
Query: 256 SEEHHVTEQKEEQPVAMN 273
H +Q V MN
Sbjct: 295 --RHPPVLTPPDQEVIMN 310
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 64/172 (37%), Positives = 92/172 (53%), Gaps = 10/172 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV--TGGELFDKIVNHGRMKEDEARR 76
REV ++ ++H N+V L E K ++++V E+V T EL + + G + D R
Sbjct: 47 ALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRS 104
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC 135
Y QL+ A+ YCHS + HRD+KPEN+L+ G LK+ DFG + AL + L
Sbjct: 105 YIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYV 162
Query: 136 GTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYK 185
T Y APE+L D Y G D+W+ G I+ LL G F DS++ LY
Sbjct: 163 ATRWYRAPELLVGDTNY-GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 66/208 (31%), Positives = 118/208 (56%), Gaps = 6/208 (2%)
Query: 11 DAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK 70
D C +++ KR +A K P + +L+ + +++ V+E+V GG+L I G+ K
Sbjct: 43 DVECTMVE-KRVLALQD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK 99
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
E +A Y ++ + + H RG+ +RDLK +N++LD+ G++K++DFG+ + + D
Sbjct: 100 EPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC--KEHMVDGVT 157
Query: 131 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 190
T CGTP+Y+APE++ + Y G + D W+ GV+L+ +LAG PFD + L++ I
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216
Query: 191 EFTCPPWLSFTARKLIARILDPNPMTRI 218
+ P LS A + ++ +P R+
Sbjct: 217 NVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 43/264 (16%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQ 79
E + + HP + LY ++T + +V+++ GGELF + + E+ AR Y
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS----QQVRDDGL----- 130
+++ A++Y H G+ +RDLKPEN+LL G++ +SDF LS S V
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 131 ------LHTT------------CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172
T GT Y+APEV++ G+ GS D W+ G++L+ +L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGT 229
Query: 173 LPFDDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRI----TIPEILED 226
PF SN + I E T P P +S +AR LI ++L +P R+ EI +
Sbjct: 230 TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289
Query: 227 EWFK-------KDYKPPVFEEKKD 243
+F+ + PP+ D
Sbjct: 290 PFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 62/195 (31%), Positives = 114/195 (58%), Gaps = 8/195 (4%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
+ P +V L+ + TK+ ++L+++ GGELF + R KE E + Y +++ A+++ H
Sbjct: 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH 122
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--N 147
G+ +RD+K EN+LLD+ G++ ++DFGLS + + ++ CGT Y+AP+++
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGG 181
Query: 148 DRGYDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTAR 203
D G+D D WS GV+++ LL G PF + ++ + ++I +E P +S A+
Sbjct: 182 DGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240
Query: 204 KLIARILDPNPMTRI 218
+I R+L +P R+
Sbjct: 241 DIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 81/249 (32%), Positives = 127/249 (51%), Gaps = 28/249 (11%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
M P VV+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLAL 155
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAP 143
D HS G HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDYISP 212
Query: 144 EVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPP 196
EVL + GY G D WS GV L+ +L G PF +L+ Y KI ++ F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272
Query: 197 WLSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY----------KPPVFEEKKD- 243
+S A+ LI L + R + EI +FK D P V + D
Sbjct: 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDI 332
Query: 244 --TNLDDVE 250
+N DD+E
Sbjct: 333 DTSNFDDIE 341
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 67/205 (32%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARR 76
+E+ +K + HPNV++ Y ++ IVLE G+L I + + K E +
Sbjct: 51 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
YF QL +A+++ HSR V HRD+KP N+ + A G +K+ D GL H+ G
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVG 168
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTC 194
TP Y++PE +++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++
Sbjct: 169 TPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227
Query: 195 PPWLSFTA--RKLIARILDPNPMTR 217
P ++ R+L+ ++P+P R
Sbjct: 228 LPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 11/213 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARR 76
+E+ +K + HPNV++ + ++ IVLE G+L I + K E +
Sbjct: 51 KEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
YF QL +AV++ HSR V HRD+KP N+ + A G +K+ D GL H+ G
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVG 168
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTC 194
TP Y++PE +++ GY+ +D+WS G +L+ + A PF D NL +L +KI ++
Sbjct: 169 TPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
Query: 195 PPWLSFTA--RKLIARILDPNPMTRITIPEILE 225
P ++ R+L++ + P+P R I + +
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 70/228 (30%), Positives = 120/228 (52%), Gaps = 16/228 (7%)
Query: 19 IKREVATMKLVKH---PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
I+REVA + ++ PN+ + Y +++I++E+ GG + ++ G + E
Sbjct: 46 IQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYIS 104
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
++++ A+ Y H GV HRD+K N+L+ GN+K+ DFG++AL Q T
Sbjct: 105 VIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFV 162
Query: 136 GTPNYVAPEVLND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
GTP ++APEV+ + + YD + AD+WS G+ ++ + G P+ D + I ++
Sbjct: 163 GTPYWMAPEVITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--- 218
Query: 195 PPWL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237
PP L S R+ +A LD P R++ E+L+ +W K K PV
Sbjct: 219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 61/149 (40%), Positives = 85/149 (57%), Gaps = 11/149 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF 78
RE++ +K + HPN+VRL +V+ S+ K+++V EF+ + D G + + Y
Sbjct: 47 REISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYL 105
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 137
QL+ + YCHS V HRDLKP+NLL+D G LK++DFGL+ A VR H T
Sbjct: 106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-T 162
Query: 138 PNYVAPEV-LNDRGYDGSTA-DLWSCGVI 164
Y APE+ L R Y ST D+WS G I
Sbjct: 163 LWYRAPEILLGSRQY--STPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 71/245 (28%), Positives = 115/245 (46%), Gaps = 43/245 (17%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF 78
RE++ MK +KH N+VRL++V+ ++ K+ +V E++ + D G + + + +
Sbjct: 47 REISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFT 106
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 136
QL+ + +CH V HRDLKP+NLL++ G LK++DFGL+ R G+ T
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNE 160
Query: 137 --TPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKI--S 188
T Y AP+VL R Y S D+WS G I+ ++ G F ++ + + +I +
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT 219
Query: 189 AAEFTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEIL 224
E T P P L+ R+L NP RI+ + L
Sbjct: 220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279
Query: 225 EDEWF 229
+ WF
Sbjct: 280 QHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 70/227 (30%), Positives = 118/227 (51%), Gaps = 10/227 (4%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEAR 75
+ E+ + H +V+ ++ S K+ +++E+ +GG+L +I H +E E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTT 134
F Q++ A+D HSR + HRDLK N+ L G +K+ DFG S S V D + +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSF 231
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT- 193
CGTP Y+APE+ + Y AD+WS GVIL+ LL + PF + + +++ ++
Sbjct: 232 CGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 194 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
P +S + L+ +L NP R T ++L E+ K Y +F++
Sbjct: 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK--YVANLFQD 335
|
Length = 478 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-27
Identities = 37/58 (63%), Positives = 46/58 (79%), Gaps = 1/58 (1%)
Query: 272 MNAFELISLSKGLNLGNLFDAEQDFKR-ETRFTSRCPANEIINKIEEAAKPLGFDVHK 328
+NAF+LISLS GL+L LF+ E+ K+ ETRFTSR PA+EII+K+EE AK LGF V K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 59/183 (32%), Positives = 86/183 (46%), Gaps = 42/183 (22%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93
VV+LY K ++ V++++ GG++ ++ G +ED AR Y +L A++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 94 YHRDLKPENLLLDAYGNLKVSDFGLSA------------LSQQVRDDG------------ 129
HRD+KP+N+L+D G++K++DFGL R D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 130 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241
Query: 173 LPF 175
PF
Sbjct: 242 PPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 50/228 (21%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91
P VV LY +++++EF+ GG+L ++ + ED R Y + + A++ H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---------------------- 129
G HRD+KP+N+L+D G++K+SDFGLS + D
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 130 -----------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166
+ ++T GTP+Y+APE+ +GY G D WS G I+F
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239
Query: 167 VLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLSFTARKLIARIL 210
L G+ PF N Y+KI F LS A LI R++
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 10/202 (4%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYF 78
E + + ++R YE K K+ IV+E+ G+L + + ED+ R+F
Sbjct: 48 DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF 107
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 137
Q++ + + HS+ + HRD+K NL LDAY N+K+ D G++ LS +T GT
Sbjct: 108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGT 164
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P Y++PE+ D+ Y+ +D+W+ GV+L+ G PFD +N L KI F P
Sbjct: 165 PYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVS 222
Query: 198 LSFTAR--KLIARILDPNPMTR 217
++ + +LI + L + R
Sbjct: 223 QMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 12/214 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+ RE+A +K ++H N+V+ + I LE+V GG + + N+G +E R +
Sbjct: 53 LAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFV 112
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--- 135
+Q++ ++Y H+RG+ HRD+K N+L+D G +K+SDFG +S+++ + L T
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFG---ISKKLEANSLSTKTNGAR 169
Query: 136 ----GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAA 190
G+ ++APEV+ Y AD+WS G ++ +L G PF D + KI A
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228
Query: 191 EFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 224
P +S A + + + + R T E+L
Sbjct: 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 55/155 (35%), Positives = 87/155 (56%), Gaps = 10/155 (6%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYF 78
RE+ +K + HPN+++L +V K +++V EF+ K++ + + E + Y
Sbjct: 47 REIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYL 104
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGT 137
QL+ + +CHS G+ HRDLKPENLL++ G LK++DFG L++ +T T
Sbjct: 105 YQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFG---LARSFGSPVRPYTHYVVT 161
Query: 138 PNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG 171
Y APE+L D+GY + D+WS G I LL+
Sbjct: 162 RWYRAPELLLGDKGY-STPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 4/199 (2%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
KR T +HP +V L+ ++ + V+E+ GG+L I + E A Y
Sbjct: 50 KRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAA 108
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
++ + Y H + +RDLK +NLLLD G +K++DFGL D T CGTP
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPE 166
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 199
++APEVL + Y + D W GV+++ +L G PF + ++ I E P +LS
Sbjct: 167 FLAPEVLTETSYTRAV-DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 225
Query: 200 FTARKLIARILDPNPMTRI 218
A ++ R+L NP R+
Sbjct: 226 REAISIMRRLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 54/158 (34%), Positives = 86/158 (54%), Gaps = 6/158 (3%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--Q 79
E ++ V +V L +K + +V+ + GG+L I N G EAR F
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q+I +++ H R + +RDLKPEN+LLD +GN+++SD GL+ +++ + GTP
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPG 159
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 177
Y+APEVL YD + D ++ G L+ ++AG PF
Sbjct: 160 YMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 59/188 (31%), Positives = 104/188 (55%), Gaps = 10/188 (5%)
Query: 4 QDLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFD 61
Q+ SK ++A ++ E+ +K ++H +V+ Y + K+ I +E++ GG + D
Sbjct: 42 QETSKEVNA------LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD 95
Query: 62 KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121
++ +G + E+ RRY +Q++ V Y HS + HRD+K N+L D+ GN+K+ DFG S
Sbjct: 96 QLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
Query: 122 SQQVRDDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 180
Q + G + + GTP +++PEV++ GY G AD+WS + +L P+ +
Sbjct: 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEA 214
Query: 181 MNLYKKIS 188
M KI+
Sbjct: 215 MAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 69/216 (31%), Positives = 116/216 (53%), Gaps = 15/216 (6%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
EV M+ H NVV +Y ++++V+EF+ GG L D IV H RM E++ +
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127
Query: 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNY 140
+ A+ Y H++GV HRD+K +++LL + G +K+SDFG A +S++V L GTP +
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYW 184
Query: 141 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-- 198
+APEV++ Y G+ D+WS G+++ ++ G P+ + + ++I PP +
Sbjct: 185 MAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKD 240
Query: 199 ----SFTARKLIARILDPNPMTRITIPEILEDEWFK 230
S R + +L P R T E+L+ + K
Sbjct: 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-26
Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
E+ +K ++H +V+ Y + KT + I +E++ GG + D++ +G + E R+Y
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKT-LTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGT 137
+Q++ + Y HS + HRD+K N+L D+ GN+K+ DFG S Q + G + + GT
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P +++PEV++ GY G AD+WS G + +L P+ + M KI A + T P
Sbjct: 173 PYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTNPQL 230
Query: 198 LSFT---ARKLIARIL 210
S AR + I
Sbjct: 231 PSHISEHARDFLGCIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 6/208 (2%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRY 77
++E + +KHPN+V E + ++IV+E+ GG+L KI + G++ ED ++
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F Q+ V + H + V HRD+K +N+ L G +K+ DFG + L T GT
Sbjct: 106 FVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGT 163
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPP 196
P YV PE+ + Y+ + +D+WS G IL+ L PF ++ NL K+ + P
Sbjct: 164 PYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPS 222
Query: 197 WLSFTARKLIARILDPNPMTRITIPEIL 224
S+ R LI ++ NP +R + IL
Sbjct: 223 HYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 38/212 (17%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93
VV+++ K +++++EF+ GG++ ++ + E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 94 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 128
HRD+KP+NLLLDA G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 129 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 180
L ++T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 181 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 208
Y+K+ PP +S A+ LI R
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 73/301 (24%)
Query: 3 FQDLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGG 57
F DL +DA IL RE+ ++ ++H N++ L +++ + ++IV E
Sbjct: 37 FDDL---IDAKRIL----REIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE----- 84
Query: 58 ELFD----KIVNHGRMKEDEARRYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 112
L + K++ + D+ +YF Q++ + Y HS V HRDLKP N+L+++ +LK
Sbjct: 85 -LMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLK 143
Query: 113 VSDFGLSALSQQVRDDGLLHTTCGTPNYV------APEV-LNDRGYDGSTADLWSCGVIL 165
+ DFGL A +D T YV APE+ L+ Y + D+WS G I
Sbjct: 144 ICDFGL-ARGVDPDEDEKGFLT----EYVVTRWYRAPELLLSSSRYTKA-IDIWSVGCIF 197
Query: 166 FVLLAGYLPFDDSNLMNLYKKI------------------SAAEF-----TCPPWLSFT- 201
LL F + ++ I A + P +
Sbjct: 198 AELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPK-KPLSK 256
Query: 202 --------ARKLIARILDPNPMTRITIPEILEDEWFKKDYKP---PVFEEK-KDTNLDDV 249
A L+ ++L +P RIT E L + + + P PV + DD
Sbjct: 257 LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDD 316
Query: 250 E 250
E
Sbjct: 317 E 317
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 56/174 (32%), Positives = 91/174 (52%), Gaps = 6/174 (3%)
Query: 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDE 73
L +I +E++ +K P +V+ Y T ++IV+E+ G + D KI N + E+E
Sbjct: 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEE 100
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
Q + ++Y HS HRD+K N+LL+ G K++DFG+S Q +T
Sbjct: 101 IAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNT 158
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
GTP ++APEV+ + GY+ + AD+WS G+ + G P+ D + M I
Sbjct: 159 VIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 67/210 (31%), Positives = 116/210 (55%), Gaps = 13/210 (6%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
EV M+ +H NVV +Y+ ++++++EF+ GG L D IV+ R+ E++ + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESV 126
Query: 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 141
+ A+ Y HS+GV HRD+K +++LL G +K+SDFG A Q +D + GTP ++
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWM 184
Query: 142 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL--- 198
APEV++ Y G+ D+WS G+++ ++ G P+ + + K++ + PP L
Sbjct: 185 APEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNA 240
Query: 199 ---SFTARKLIARILDPNPMTRITIPEILE 225
S R + R+L P R T E+L+
Sbjct: 241 HKISPVLRDFLERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 52/159 (32%), Positives = 82/159 (51%), Gaps = 17/159 (10%)
Query: 21 REVATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMK 70
RE+A +K ++ HPN+VRL +V + K+ +V E V K G +
Sbjct: 47 REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LP 105
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
+ + +QL+ VD+ HS + HRDLKP+N+L+ + G +K++DFGL+ ++ +
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA----RIYSFEM 161
Query: 131 LHTTC-GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168
T+ T Y APEVL Y + D+WS G I L
Sbjct: 162 ALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 38/212 (17%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93
VV+++ K +++++EF+ GG++ ++ + E+E + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 94 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 128
HRD+KP+NLLLD+ G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 129 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 180
L +T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 181 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 208
YKK+ PP +S A+ LI R
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 52/146 (35%), Positives = 82/146 (56%), Gaps = 5/146 (3%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQ 79
RE++ +K + HPN+V+L +V+ ++ K+++V EF+ + F + + Y
Sbjct: 48 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLF 107
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP 138
QL+ + +CHS V HRDLKP+NLL++ G +K++DFGL+ A VR H T
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TL 164
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVI 164
Y APE+L Y + D+WS G I
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 14 CILLQIKREV-ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK-- 70
C+ L REV + KL +HPN+V+L EV +++ V E++ G L+ + +
Sbjct: 42 CMNL---REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFS 97
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
E R Q++ + + H G +HRDLKPENLL+ +K++DFG L++++R
Sbjct: 98 ESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG---LAREIRSRPP 154
Query: 131 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166
T Y APE+L S D+W+ G I+
Sbjct: 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 22 EVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
E+ +K + H +V+ Y + + + I +E + GG + D++ ++G + E+ R+Y +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTP 138
Q++ V Y HS + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPP 196
+++PEV++ GY G AD+WS G + +L P+ + M KI+ PP
Sbjct: 174 YWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP 232
Query: 197 WLSFTARKLIARIL 210
+S R + RI
Sbjct: 233 HVSDHCRDFLKRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I++E+ + + P + + Y +K++I++E+ GG D ++ G++ E
Sbjct: 46 IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFIL 104
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGT 137
++++ ++Y H G HRD+K N+LL G++K++DFG+S Q+ +T GT
Sbjct: 105 REVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGT 161
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P ++APEV+ GYD AD+WS G+ L G P D + M + I PP
Sbjct: 162 PFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPS 217
Query: 198 L-----SFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
L S + ++ L+ +P R + E+L+ ++ KK
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 70/221 (31%), Positives = 117/221 (52%), Gaps = 15/221 (6%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
EV M+ +H NVV +Y ++++V+EF+ GG L D IV H RM E++ +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125
Query: 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNY 140
+ A+ H++GV HRD+K +++LL G +K+SDFG A +S++V L GTP +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYW 182
Query: 141 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-- 198
+APE+++ Y G D+WS G+++ ++ G P+ + + K I PP L
Sbjct: 183 MAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKN 238
Query: 199 ----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235
S + + + R+L +P R T E+L+ + K P
Sbjct: 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 68/222 (30%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQ 80
E+ + HP +V+L K++I++EF GG + ++ R + E + + +Q
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGT 137
++ A+ Y HS + HRDLK N+LL G++K++DFG+SA + Q RD + GT
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GT 173
Query: 138 PNYVAPEV-----LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE- 191
P ++APEV + D YD AD+WS G+ L + P + N M + KI+ +E
Sbjct: 174 PYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP 232
Query: 192 --FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
+ P S R + LD +P TR + ++LE +
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 23 VATMKLVK----HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIV-NHGRMKEDEA 74
V+ + ++K HPN+VR Y+ +++IV++ + G GE F+ + R E+
Sbjct: 56 VSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115
Query: 75 RRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
F Q++ A+ Y H + + HRDL P N++L + ++DFG L++Q + + L +
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTS 172
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 193
GT Y PE++ + Y G AD+W+ G IL+ + PF +N+++L KI A +
Sbjct: 173 VVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231
Query: 194 CPPWLSFT--ARKLIARILDPNPMTRITIPEILE 225
P ++ +I L P+ R P+I++
Sbjct: 232 PLPEGMYSEDVTDVITSCLTPDAEAR---PDIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 7/215 (3%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I E+ M+ KHPN+V + ++++V+E++ GG L D +V M E +
Sbjct: 63 IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVC 121
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++ + A+++ HS V HRD+K +N+LL G++K++DFG A Q + T GTP
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 179
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCP 195
++APEV+ + Y G D+WS G++ ++ G P+ + N + I+ E P
Sbjct: 180 YWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
LS R + R L+ + R + E+L+ + K
Sbjct: 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 24/260 (9%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARR 76
+ E + + P + +L K +++V+E+ GG+L + + + ED A+
Sbjct: 47 FFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF 106
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-- 134
Y +L+ A+ H G HRD+KPEN+L+D G++K++DFG +A ++ + ++++
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLP 163
Query: 135 CGTPNYVAPEVLND-RGYDGST----ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-- 187
GTP+Y+APEVL G T D WS GVI + ++ G PF + Y I
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223
Query: 188 --SAAEFTCPPWLSFTARKLIARILDPNPMTRITI------PEILEDEWFKKDYKPPVFE 239
+F P +S LI +L R+ P + +W P F
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFV 282
Query: 240 EKKDTNLDDVEAVFKDSEEH 259
+ DD + F + E++
Sbjct: 283 PTLKS--DDDTSNFDEPEKN 300
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEAR 75
QI RE+ + P +V Y + I I +E++ GG L DKI GR+ E
Sbjct: 45 QILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILG 103
Query: 76 RYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ ++ + Y H + HRD+KP N+L+++ G +K+ DFG+S Q V + L T
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTF 159
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKISA 189
GT +Y+APE + Y +D+WS G+ L L G P+ N + L + I
Sbjct: 160 VGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN 218
Query: 190 AEFTCPPWL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
PP L S + + L +P R + E+LE + KK
Sbjct: 219 EP---PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 64/215 (29%), Positives = 112/215 (52%), Gaps = 7/215 (3%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I E+ MK +K+PN+V + ++F+V+E++ GG L D +V M E +
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVC 121
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++ + A+++ H+ V HRD+K +N+LL G++K++DFG A Q + T GTP
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 179
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCP 195
++APEV+ + Y G D+WS G++ ++ G P+ + N + I+ E P
Sbjct: 180 YWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
LS R + R L+ + R + E+L+ + K
Sbjct: 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 7e-24
Identities = 58/171 (33%), Positives = 97/171 (56%), Gaps = 11/171 (6%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF 78
RE++ +K ++HPN+V L +V+ +++++++ EF++ + D + M + + Y
Sbjct: 48 REISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL 107
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT-TCG 136
Q++ + +CHSR V HRDLKP+NLL+D G +K++DFGL+ A VR ++T
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVV 163
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYK 185
T Y APEVL + D+WS G I F +A P DS + L++
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 62/191 (32%), Positives = 97/191 (50%), Gaps = 15/191 (7%)
Query: 20 KREVATMKLVKHPNVVRLY-EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+RE A + HPN+V L +F V E+V G L + + G + E R
Sbjct: 26 RRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLM 85
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTT- 134
Q+++A+ H++G+ HRDLKP+N+++ G + KV DFG+ L VRD + T
Sbjct: 86 LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
Query: 135 ----CGTPNYVAPEVLNDRGYDGSTA--DLWSCGVILFVLLAGYLPFDDSNLMN-LYKKI 187
GTP Y APE L RG + T DL++ G+I L G +++ LY+++
Sbjct: 146 TTEVLGTPTYCAPEQL--RG-EPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL 202
Query: 188 SAAEFTCPPWL 198
S + + PPW+
Sbjct: 203 SPVDVSLPPWI 213
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 64/187 (34%), Positives = 88/187 (47%), Gaps = 46/187 (24%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93
VVRLY K ++ V++++ GG++ ++ G ED AR Y +L AV+ H G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 94 YHRDLKPENLLLDAYGNLKVSDFGL---------SALSQ---QVRDDG------------ 129
HRD+KP+N+L+D G++K++DFGL S Q VR D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 130 ---------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168
L H+ GTPNY+APEVL GY D WS GVIL+ +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 241
Query: 169 LAGYLPF 175
L G PF
Sbjct: 242 LVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 7e-24
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 9/217 (4%)
Query: 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKED 72
+Q +E + + HP +V+ + + I+ E+ G +L K+ + E+
Sbjct: 47 VQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN 106
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
+ +F QL+ V Y H R + HRDLK +N+ L LK+ DFG+S L D L
Sbjct: 107 QVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LAT 163
Query: 133 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 192
T GTP Y++PE L +GYD S +D+WS G IL+ + F+ N +++ +I
Sbjct: 164 TFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT 222
Query: 193 -TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228
+ P S ++ +L+ +P R + EIL + +
Sbjct: 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 9e-24
Identities = 66/249 (26%), Positives = 102/249 (40%), Gaps = 48/249 (19%)
Query: 21 REVATMKLVKHPNVVRLYE-VMGSK-TKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRY 77
RE+ + ++HPN+V + E V+GS KI++V+E+V +L + + E +
Sbjct: 53 REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL 111
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
QL++ V + H + HRDLK NLLL+ G LK+ DFGL+ T
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-------YT 164
Query: 138 PN-----YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----- 187
Y APE+L + D+WS G I LL F + ++ KI
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG 224
Query: 188 ----------------SAAEFTCPPW-----------LSFTARKLIARILDPNPMTRITI 220
FT P+ LS L+ R+L +P RI+
Sbjct: 225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284
Query: 221 PEILEDEWF 229
+ L+ +F
Sbjct: 285 EDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-23
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 7/215 (3%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I E+ M+ K+PN+V + ++++V+E++ GG L D +V M E +
Sbjct: 63 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVC 121
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++ + A+D+ HS V HRD+K +N+LL G++K++DFG A Q + T GTP
Sbjct: 122 RECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 179
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCP 195
++APEV+ + Y G D+WS G++ ++ G P+ + N + I+ E P
Sbjct: 180 YWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
LS R + R L+ + R + E+L+ + K
Sbjct: 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-23
Identities = 56/183 (30%), Positives = 92/183 (50%), Gaps = 5/183 (2%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+++ EV +K +KH N+V+ I I +EFV GG + + G + E +Y
Sbjct: 48 KLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKY 107
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHT 133
+Q+++ V Y H+ V HRD+K N++L G +K+ DFG L+ + +L +
Sbjct: 108 TKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 193
GTP ++APEV+N+ GY G +D+WS G +F + G P + + I A
Sbjct: 168 MHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL 226
Query: 194 CPP 196
P
Sbjct: 227 MPR 229
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 60/176 (34%), Positives = 96/176 (54%), Gaps = 6/176 (3%)
Query: 47 IFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 102
I +VL++ G+L +I + + +E EA F Q++ AV + HS+ + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 103 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162
+LL + G +K+ DFG S + D + T CGTP YVAPE+ + Y AD++S G
Sbjct: 174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLG 232
Query: 163 VILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTR 217
V+L+ LL PFD N+ + K A + PP +S ++++ +L +P R
Sbjct: 233 VLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 64/215 (29%), Positives = 112/215 (52%), Gaps = 7/215 (3%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I E+ M+ K+PN+V + ++++V+E++ GG L D +V M E +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVC 122
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++ + A+++ HS V HRD+K +N+LL G++K++DFG A Q + T GTP
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 180
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCP 195
++APEV+ + Y G D+WS G++ ++ G P+ + N + I+ E P
Sbjct: 181 YWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
LS R + R LD + R + E+L+ ++ K
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 60/187 (32%), Positives = 88/187 (47%), Gaps = 46/187 (24%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93
VV+LY K ++ V++++ GG++ ++ E AR Y +L A++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 94 YHRDLKPENLLLDAYGNLKVSDFGL---------SALSQQ---VRDDG------------ 129
HRD+KP+N+L+D G++K++DFGL S Q+ +R D
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 130 ---------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168
L H+ GTPNY+APEVL +GY D WS GVILF +
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEM 241
Query: 169 LAGYLPF 175
L G PF
Sbjct: 242 LVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 61/176 (34%), Positives = 102/176 (57%), Gaps = 15/176 (8%)
Query: 47 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 105
+++V+++ GG+L + R+ ED AR Y +++ A+D H G HRD+KP+N+LL
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 106 DAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL----NDRGYDGSTADLW 159
D G+++++DFG S L ++ DG + + GTP+Y++PE+L + +G G D W
Sbjct: 136 DKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192
Query: 160 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW---LSFTARKLIARIL 210
S GV ++ +L G PF +L+ Y KI + F PP +S A+ LI R++
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 6e-23
Identities = 75/243 (30%), Positives = 116/243 (47%), Gaps = 40/243 (16%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF 78
RE+ +K +KH N+VRLY+V+ S K+ +V E+ + FD +G + + + +
Sbjct: 48 REICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFM 105
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 137
QL+ + +CHS V HRDLKP+NLL++ G LK++DFGL+ A VR T
Sbjct: 106 FQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVT 162
Query: 138 PNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKI-----SAA 190
Y P+VL + Y S D+WS G I L P F +++ + K+I +
Sbjct: 163 LWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221
Query: 191 EFTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEILED 226
E + P P L+ T R L+ +L NP+ RI+ E L+
Sbjct: 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281
Query: 227 EWF 229
+F
Sbjct: 282 PYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 7e-23
Identities = 50/153 (32%), Positives = 83/153 (54%), Gaps = 13/153 (8%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARR 76
I++E++ +K +HPN+V + + K++IV+E+ GG L D V G + E +
Sbjct: 46 IIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY 105
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDGLLHT 133
++ + + Y H G HRD+K N+LL G++K++DFG+SA + R +
Sbjct: 106 VCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-----S 160
Query: 134 TCGTPNYVAPEVLNDR---GYDGSTADLWSCGV 163
GTP ++APEV GYDG D+W+ G+
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGK-CDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 8e-23
Identities = 54/145 (37%), Positives = 85/145 (58%), Gaps = 6/145 (4%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91
P +V + + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-RG 150
V +RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVA 172
Query: 151 YDGSTADLWSCGVILFVLLAGYLPF 175
YD S+AD +S G +LF LL G+ PF
Sbjct: 173 YD-SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 9e-23
Identities = 77/256 (30%), Positives = 112/256 (43%), Gaps = 52/256 (20%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTG--GELFDKIVNHGRMKEDEARR 76
RE+ + ++HPN+V L EV+ K IF+V+E+ L D + E + +
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKC 112
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
QL+ + Y H + HRDLK NLLL G LK++DFGL+ L
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-------LPAKPM 165
Query: 137 TPN-----YVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG--YLP----FDDSNLM--- 181
TP Y APE+L Y + D+W+ G IL LLA LP + +L+
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224
Query: 182 ------NLYKKIS----AAEFTCP-----------PWLSFTARKLIARILDPNPMTRITI 220
+++ S +FT P PWLS +L+ +L +P R T
Sbjct: 225 LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA 284
Query: 221 PEILEDEWFKKDYKPP 236
E LE +FK+ KP
Sbjct: 285 EEALESSYFKE--KPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 9e-23
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQ 79
E + MK + HPN+VRL V ++IV E++ GG+L D + HG + + +
Sbjct: 50 EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMAL 109
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP- 138
Q+ ++Y S+ HRDL N L+ +K+SDFG LS+ + +D G
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRGGGKL 166
Query: 139 --NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AA 190
++APE L D + S +D+WS GV+L+ + G P+ + + + +
Sbjct: 167 PIKWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR 225
Query: 191 EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226
CP L +L+ + +P R T E++ED
Sbjct: 226 PENCPDEL----YELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRM 69
RE+ ++L+KH NVV L E+ +K ++V EF G L +K V +
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KF 116
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDD 128
E ++ + L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 129 GLLHTT-CGTPNYVAPEV-LNDRGYDGSTADLWSCGVIL 165
+T T Y PE+ L +R Y G D+W G I+
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 52/144 (36%), Positives = 83/144 (57%), Gaps = 4/144 (2%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91
P +V + + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151
V +RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTA 172
Query: 152 DGSTADLWSCGVILFVLLAGYLPF 175
S+AD +S G +LF LL G+ PF
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 59/189 (31%), Positives = 105/189 (55%), Gaps = 15/189 (7%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 92
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 146
HRD+KP+N+L+D G+++++DFG S L ++ +DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 147 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSFT 201
+ +G G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 202 ARKLIARIL 210
A+ LI R++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 60/189 (31%), Positives = 103/189 (54%), Gaps = 15/189 (7%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 92
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 146
HRD+KP+N+LLD G+++++DFG S L ++ DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 147 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWL---SFT 201
+ G G D WS GV ++ +L G PF +L+ Y KI E F P + S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 202 ARKLIARIL 210
A+ LI R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 4e-22
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 20/220 (9%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF-- 78
+E MK + HPNVVRL V + +++VLE++ GG+L D + + +
Sbjct: 45 KEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSL 104
Query: 79 QQLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 131
+ L+ ++Y S+ HRDL N L+ +K+SDFG LS+ V DD
Sbjct: 105 KDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYY 161
Query: 132 HTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKK 186
G + APE L D + ++ D+WS GV+L+ + G P+ + + +
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGIF--TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY 219
Query: 187 ISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
+ P + +L+ +P R T E++E
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-22
Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I++E+ + P V + Y TK++I++E++ GG D ++ G E +
Sbjct: 49 IQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATML 107
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGT 137
++++ +DY HS HRD+K N+LL G++K++DFG++ Q+ D + T GT
Sbjct: 108 KEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGT 164
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P ++APEV+ YD S AD+WS G+ L G P D + M + I PP
Sbjct: 165 PFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPT 220
Query: 198 L----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234
L S ++ I L+ +P R T E+L+ ++ K+ K
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 58/171 (33%), Positives = 91/171 (53%), Gaps = 13/171 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
RE+ +K ++H N+V L EV K ++++V EFV L D + E R+Y Q
Sbjct: 49 REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ 108
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGT 137
++ +++CHS + HRD+KPEN+L+ G +K+ DFG + A +V D + T
Sbjct: 109 ILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----AT 163
Query: 138 PNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLYK 185
Y APE+L D Y G D+W+ G ++ +L G P DS++ LY
Sbjct: 164 RWYRAPELLVGDTKY-GRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 62/222 (27%), Positives = 111/222 (50%), Gaps = 15/222 (6%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I++E+ + P V + Y TK++I++E++ GG D ++ G + E +
Sbjct: 49 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATIL 107
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCG 136
++++ +DY HS HRD+K N+LL +G +K++DFG++ Q++ + + G
Sbjct: 108 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----G 163
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 196
TP ++APEV+ YD S AD+WS G+ L G P + + M + I PP
Sbjct: 164 TPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PP 219
Query: 197 WL----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234
L S ++ + L+ P R T E+L+ ++ + K
Sbjct: 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 68/232 (29%), Positives = 118/232 (50%), Gaps = 22/232 (9%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQ 80
E+ + HPN+V+L + + ++I++EF GG + ++ R + E + R +Q
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV--RDDGLLHTTCGTP 138
+ A++Y H + HRDLK N+L G++K++DFG+SA + + R D + GTP
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTP 167
Query: 139 NYVAPEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 193
++APEV+ DR YD AD+WS G+ L + P + N M + KI+ +E
Sbjct: 168 YWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-- 224
Query: 194 CPPWLSFTAR------KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 239
PP L+ +R + + L+ N R T ++L+ + + P+ E
Sbjct: 225 -PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRE 275
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 13/225 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I++E+ + P + R Y TK++I++E++ GG D ++ G ++E
Sbjct: 49 IQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATIL 107
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGT 137
++++ +DY HS HRD+K N+LL G++K++DFG++ Q+ D + T GT
Sbjct: 108 REILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGT 164
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P ++APEV+ YD AD+WS G+ L G P D + M + I PP
Sbjct: 165 PFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK---NSPPT 220
Query: 198 L----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 238
L S ++ + L+ +P R T E+L+ ++ + K F
Sbjct: 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEA--RRYF 78
E+A +KH N+V+ I +E V GG L + + G +K++E Y
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+Q++ + Y H + HRD+K +N+L++ Y G +K+SDFG S + + T GT
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS--KRLAGINPCTETFTGT 172
Query: 138 PNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC- 194
Y+APEV++ RGY G+ AD+WS G + + G PF + + AA F
Sbjct: 173 LQYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIE------LGEPQAAMFKVG 225
Query: 195 --------PPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228
P LS A+ I R +P+P R + ++L+D +
Sbjct: 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 4e-21
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRY 77
RE M+ + HPNVV+L V + ++IV+E++ GG+L + + ++ + +
Sbjct: 48 FLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSF 107
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
Q+ ++Y S+ HRDL N L+ +K+SDFG LS+ + DD G
Sbjct: 108 ALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYRKRGGK 164
Query: 138 -P-NYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF- 192
P ++APE L + + ++ D+WS GV+L+ + G P+ + + + +
Sbjct: 165 LPIRWMAPESLKEGKF--TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL 222
Query: 193 ----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
CPP L L+ + +P R T E++E
Sbjct: 223 PQPPNCPPEL----YDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 31/246 (12%)
Query: 18 QIKREVATMKLVKHPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
QI RE+ K K P +V+ Y + S + I I +E+ GG L D I + ++K+ R
Sbjct: 45 QILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSI--YKKVKKRGGR 101
Query: 76 -------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 128
+ + ++ + Y HSR + HRD+KP N+LL G +K+ DFG+S + V +
Sbjct: 102 IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELV--N 157
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--------NL 180
L T GT Y+APE + + Y T+D+WS G+ L + PF L
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216
Query: 181 MNLYKKISAAEFTCPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235
++ + E P W S + I + L+ +P R T ++LE W K K
Sbjct: 217 LSYIVNMPNPELKDEPGNGIKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275
Query: 236 PVFEEK 241
V K
Sbjct: 276 KVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-21
Identities = 76/248 (30%), Positives = 115/248 (46%), Gaps = 47/248 (18%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR---- 76
RE++ +K ++H N+VRL +V+ S+ ++++V E+ L + H D A+
Sbjct: 50 REISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLI 104
Query: 77 --YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLH 132
Y Q++ + YCHS V HRDLKP+NLL+D N LK++DFGL+ A VR H
Sbjct: 105 KTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTH 162
Query: 133 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKI--- 187
T Y APE+L + + D+WS G I F + P DS + L+K
Sbjct: 163 EVV-TLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRIL 220
Query: 188 ------------SAAEF--TCPPW-----------LSFTARKLIARILDPNPMTRITIPE 222
S ++ P W L L++++L +P RIT
Sbjct: 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280
Query: 223 ILEDEWFK 230
LE E+FK
Sbjct: 281 ALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 24/189 (12%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD----KIVNHGRMKEDEAR 75
RE+ ++ L HPN+V+L V+ ++ I L F E + ++ +++ R
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKR 110
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTT 134
QL+ A+ Y HS V HRDLKP N+LL++ +K++DFGL+ +LS+ + T
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 135 --CGTPNYVAPEVLNDRGYDGSTA-----DLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
T Y APE+L GST D+WS G IL +L G F ++ +N +KI
Sbjct: 171 DYVATRWYRAPEILL-----GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225
Query: 188 SAAEFTCPP 196
E PP
Sbjct: 226 --IEVIGPP 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 62/254 (24%)
Query: 21 REVATMK-LVKHPNVVRLYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDE 73
RE+ ++ L HPN++RL EV+ G +F +++ L++ I R + E
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKR 101
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+ Y QL+ ++D+ H G++HRD+KPEN+L+ LK++DFG S
Sbjct: 102 VKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC-----------RG 148
Query: 134 TCGTPNYV---------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----- 179
P Y APE L GY G D+W+ G + F +L+ + F +N
Sbjct: 149 IYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208
Query: 180 -------------LMNLYKKISAAEFTCP-----------PWLSFTARKLIARILDPNPM 215
++ ++K + P P S L+ ++L +P
Sbjct: 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPD 268
Query: 216 TRITIPEILEDEWF 229
RIT + L +F
Sbjct: 269 ERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARR 76
RE M+ + HPN+V+L V + + IV+E++ GG+L D + + + +
Sbjct: 48 FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLS 107
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ Q+ ++Y S+ HRDL N L+ +K+SDFG LS+ + DD G
Sbjct: 108 FALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYKVKGG 164
Query: 137 T-P-NYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF 192
P ++APE L + + ++ D+WS GV+L+ + G P+ + + + +
Sbjct: 165 KLPIRWMAPESLKEGKF--TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR 222
Query: 193 -----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
CPP L KL+ + +P R T E++E
Sbjct: 223 LPKPPNCPPEL----YKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 54/153 (35%), Positives = 80/153 (52%), Gaps = 6/153 (3%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
RE+ +K +KHPN+V L EV K K+ +V E+ L + N + E ++ Q
Sbjct: 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPN 139
+ AV++CH HRD+KPEN+L+ G +K+ DFG + + DD +T T
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRW 165
Query: 140 YVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG 171
Y APE+L D Y G D+W+ G + LL G
Sbjct: 166 YRAPELLVGDTQY-GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
MK +PN ++LY + + ++++++ G+LFD + G++ E E ++ +QL+ A+
Sbjct: 65 MK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 86 DYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNYVA 142
+ H + H D+K EN+L D + + D+GL + + D GT +Y +
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFS 174
Query: 143 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--------LMNLYKKISAAEFTC 194
PE + YD S D W+ GV+ + LL G PF + L+ +K +
Sbjct: 175 PEKIKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPF 229
Query: 195 PPWLSFTARKLIARILDPNPMTRIT 219
+S A + +L N R+T
Sbjct: 230 IKNVSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 14/166 (8%)
Query: 20 KREVATMKL--------VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKE 71
KR+ M L V VV L +K + +VL + GG+L I N G
Sbjct: 40 KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF 99
Query: 72 DEARRYF--QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 129
DE R F ++ ++ H + +RDLKPEN+LLD YG++++SD GL+ ++ +
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV---EIPEGE 156
Query: 130 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175
+ GT Y+APEV+ + Y + D W G +++ ++ G PF
Sbjct: 157 TIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 14/157 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQ 79
RE + +K +KH N+V L++++ +K + +V E++ +L + + G + R +
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
QL+ + YCH R V HRDLKP+NLL+ G LK++DFGL A ++ V + T
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGL-ARAKSVPSKTYSNEVV-TLW 168
Query: 140 YVAPEVLNDRGYDGSTA-----DLWSCGVILFVLLAG 171
Y P+VL GST D+W G I + + G
Sbjct: 169 YRPPDVLL-----GSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 77/277 (27%), Positives = 129/277 (46%), Gaps = 46/277 (16%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
RE+ ++ KH N++ + +++ + ++IV E + +L+ K++ + D +
Sbjct: 52 REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQ 109
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTT 134
+ Q++ + Y HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D G L
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 135 CGTPNYVAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF---DDSNLMNLYKKI-- 187
T Y APE+ LN +GY + A D+WS G IL +L+ F D + +NL +
Sbjct: 170 VATRWYRAPEIMLNSKGY--TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227
Query: 188 --SAAEFTC-------------P-----PWLSF------TARKLIARILDPNPMTRITIP 221
S + C P PW A L+ ++L NP RIT+
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287
Query: 222 EILEDEWFKKDYKP---PVFEEKKDTNLDDVEAVFKD 255
E L + ++ + P PV EE + + + + K+
Sbjct: 288 EALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKE 324
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 67/268 (25%), Positives = 108/268 (40%), Gaps = 51/268 (19%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK--------------IFIVLEFVTGGELFDKIVNH 66
RE+ ++ + H N+V++YEV+G ++IV E++ ++
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQ 108
Query: 67 GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQ 124
G + E+ AR + QL+ + Y HS V HRDLKP N+ ++ LK+ DFGL+ +
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168
Query: 125 VRDDGLLHTTCGTPNYVAPE-VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---L 180
G L T Y +P +L+ Y D+W+ G I +L G F ++
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227
Query: 181 MNL----------------------YKKISAAEFTCP-----PWLSFTARKLIARILDPN 213
M L + + E P P ++ A + +IL N
Sbjct: 228 MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFN 287
Query: 214 PMTRITIPEILEDEWFKKDYKPPVFEEK 241
PM R+T E L + Y P E
Sbjct: 288 PMDRLTAEEALMHPYM-SCYSCPFDEPV 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-19
Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 6/158 (3%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQ 79
E ++ V P +V L SKT + +V+ + GG+L I N G + R Y
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q+ + + HS + +RD+KPEN+LLD GN ++SD GL+ +++D + GT
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNG 159
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 177
Y+APE+L + Y D ++ G ++ ++AG PF D
Sbjct: 160 YMAPEILKEEPYSYPV-DWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-19
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 26/195 (13%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91
PN+V L++ + S+ +F+VL+ GG+L+ I + E+ +R+ +++ A+D H
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFG-LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 150
G+ RDL P N+LLD G+++++ F S + + + + C APEV G
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV---GG 155
Query: 151 YDGSTA--DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSFTAR 203
T D WS G ILF LL G L + + P W+S AR
Sbjct: 156 ISEETEACDWWSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEAR 206
Query: 204 KLIARILDPNPMTRI 218
L+ ++L NP R+
Sbjct: 207 SLLQQLLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 17/233 (7%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEA 74
QI E+ + P +V Y + +++ +E++ G +L+ V + ED
Sbjct: 45 QIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVL 104
Query: 75 RRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
RR ++ + + + HRD+KP N+L++ G +K+ DFG+S V L T
Sbjct: 105 RRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVAS--LAKT 160
Query: 134 TCGTPNYVAPEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 188
G +Y+APE + N +D+WS G+ + + G P+ N++ ++S
Sbjct: 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS 220
Query: 189 AAEFTCPPWL----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237
A PP L S A+ +A+ L+ P R T ++LE W K V
Sbjct: 221 AIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 48/144 (33%), Positives = 80/144 (55%), Gaps = 6/144 (4%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 91
VV L +K + +VL + GG+L I N G +E+ A Y +++ ++ H
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151
+RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEVLN++ Y
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 152 DGSTADLWSCGVILFVLLAGYLPF 175
+ D W G +++ ++ G PF
Sbjct: 179 -TLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 9e-19
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 11/215 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+++E+ MK KH N+V + + K++I +EF GG L D G + E +
Sbjct: 53 VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVS 112
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++ + + Y HS+G HRD+K N+LL G++K++DFG+SA Q + GTP
Sbjct: 113 RETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTP 170
Query: 139 NYVAPEV--LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 196
++APEV + +G D+W+ G+ L P D + M ++ + F PP
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PP 229
Query: 197 WL------SFTARKLIARILDPNPMTRITIPEILE 225
L S + + L NP R T ++L+
Sbjct: 230 KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 57/168 (33%), Positives = 87/168 (51%), Gaps = 13/168 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQ 79
+E +K HPN+VRL V K I+IV+E V GG+ + G R+K E + +
Sbjct: 42 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVE 101
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
++Y S+ HRDL N L+ LK+SDFG+S + +DG+ +T G
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQ 157
Query: 140 ----YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 182
+ APE LN Y S +D+WS G++L+ + G +P+ +NL N
Sbjct: 158 IPVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPY--ANLSN 202
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 30/233 (12%)
Query: 19 IKREVATM-KLVKHPNVVRLYEV------MGSKTKIFIVLEFVTGG---ELFDKIVNHG- 67
IK E + K HPN+ Y G+ ++++V+E GG +L + G
Sbjct: 49 IKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK 108
Query: 68 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
R+KE+ ++ + + Y H V HRD+K +N+LL +K+ DFG+SA Q
Sbjct: 109 RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDST 166
Query: 128 DGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 182
G +T GTP ++APEV+ D YD + +D+WS G+ L G P D + M
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMR 225
Query: 183 -LYKKISAAEFTCPPWLSFTAR------KLIARILDPNPMTRITIPEILEDEW 228
L+K PP L I+ L N R + E+LE +
Sbjct: 226 ALFKIPRNP----PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 15/195 (7%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH 89
+V L +KT + +V+ + GG+L I N + E A Y Q+I+ +++ H
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLN 147
R + +RDLKPEN+LLD GN+++SD GL+ Q + G GTP ++APE+L
Sbjct: 115 QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQ 170
Query: 148 DRGYDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTAR 203
YD S D ++ GV L+ ++A PF + L ++I T P S ++
Sbjct: 171 GEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229
Query: 204 KLIARILDPNPMTRI 218
+L +P R+
Sbjct: 230 SFCEALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 2e-18
Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 36/194 (18%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVN----HGRMKE 71
Q+ EV M+ +KH N+VR + +K K++I++EF G+L I G+++E
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 72 DEARRYFQQLINAVDYCHS-------RGVYHRDLKPENLLLDA-----------YGNL-- 111
+QL++A+ YCH+ V HRDLKP+N+ L NL
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 112 ----KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRGYDGSTADLWSCGVIL 165
K+ DFGLS + + + + H+ GTP Y +PE+L + YD +D+W+ G I+
Sbjct: 178 RPIAKIGDFGLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCII 233
Query: 166 FVLLAGYLPFDDSN 179
+ L +G PF +N
Sbjct: 234 YELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 7/209 (3%)
Query: 20 KREVATMKLVKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRM-KEDEARR 76
++E + +KHPN+V E G ++IV+ F GG+L+ K+ G++ E++
Sbjct: 47 EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+F Q+ A+ Y H + + HRDLK +N+ L +KV D G++ + + D + T G
Sbjct: 107 WFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIG 164
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAEFTCP 195
TP Y++PE+ +++ Y+ +D+W+ G ++ + F+ ++ +L Y+ I P
Sbjct: 165 TPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP 223
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEIL 224
S +LIA +L P R ++ IL
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 67/250 (26%), Positives = 111/250 (44%), Gaps = 45/250 (18%)
Query: 21 REVATMKLVKH-PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGR-----M 69
RE++ ++++ +VRL +V + K +++V E++ +L + ++GR +
Sbjct: 49 REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPL 107
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRD 127
+ + QL+ V +CH GV HRDLKP+NLL+D LK++D GL A S V+
Sbjct: 108 PAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 128 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDS---NLMNL 183
H T Y APEVL + + D+WS G I + F DS L+++
Sbjct: 168 --YTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224
Query: 184 YKKI-SAAEFTCP-----------------------PWLSFTARKLIARILDPNPMTRIT 219
+K + + E P P LS L+ ++L +P RI+
Sbjct: 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284
Query: 220 IPEILEDEWF 229
L +F
Sbjct: 285 AKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 6e-18
Identities = 41/132 (31%), Positives = 76/132 (57%), Gaps = 2/132 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
Q++ E + L K P +V LY + S +++V+E++ GG++ + +G E+ A +Y
Sbjct: 50 QVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY 109
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++ A+DY H G+ HRDLKP+N+L+ G++K++DFGLS ++ + + + T
Sbjct: 110 ISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT--LNRELNMMDILTT 167
Query: 138 PNYVAPEVLNDR 149
P+ P+ R
Sbjct: 168 PSMAKPKNDYSR 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 64/256 (25%), Positives = 102/256 (39%), Gaps = 43/256 (16%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQ 79
RE+ M +KH N++ L +V I +V++ + K+V+ R+ E + +
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILL 126
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCG 136
Q++N ++ H HRDL P N+ +++ G K++DFGL+ T
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 137 TPN---------YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNL 183
Y APE+L D+WS G I LL G F N L +
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 184 YKKISAAEFT-------CPPWLSFTARK-----------------LIARILDPNPMTRIT 219
++ + P + FT RK L+ +L NP+ RI+
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS 306
Query: 220 IPEILEDEWFKKDYKP 235
E L+ E+FK D P
Sbjct: 307 AKEALKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 51/148 (34%), Positives = 79/148 (53%), Gaps = 8/148 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF 78
RE+ ++ +K N+V L E + K+++V E+V EL +++ N + ++ R Y
Sbjct: 49 RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYI 106
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGT 137
QLI A+ +CH + HRD+KPENLL+ LK+ DFG + LS+ + T
Sbjct: 107 YQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG--SNANYTEYVAT 164
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVIL 165
Y +PE+L Y G D+WS G IL
Sbjct: 165 RWYRSPELLLGAPY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 19/159 (11%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK----------IFIVLEFVTG---GELFDKIVNHG 67
RE+ ++ + H N+V L E++ K ++V E++ G L +V+
Sbjct: 55 REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-- 112
Query: 68 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
ED + + +QL+ ++YCH + HRD+K N+LL+ G +K++DFGL+ L +
Sbjct: 113 -FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SE 169
Query: 128 DGLLHTT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165
+ +T T Y PE+L G D+WSCG IL
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 44/266 (16%)
Query: 21 REVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
RE+ +K ++H N++ L ++ S I+ V E + G +++ +++ + +
Sbjct: 58 RELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLY 115
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q++ + Y HS GV HRDLKP N+L++ +LK+ DFGL+ + Q + G + T
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTGYVSTR----Y 170
Query: 140 YVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 195
Y APE+ L + YD D+WS G I +L G F + +N + I+ T P
Sbjct: 171 YRAPEIMLTWQKYD-VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 196 ----------------------------PWLSFTARKLIARILDPNPMTRITIPEILEDE 227
+A L+ ++L +P RI+ E L
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 228 WFKKDYKP---PVFEEKKDTNLDDVE 250
+ + P PV EEK D + +D +
Sbjct: 290 YLAPYHDPTDEPVAEEKFDWSFNDAD 315
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 67/270 (24%), Positives = 117/270 (43%), Gaps = 48/270 (17%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE+ +K + H NV+ L +V + +++V + G +L + IV ++ +D
Sbjct: 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHI 120
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ Q++ + Y HS G+ HRDLKP N+ ++ LK+ DFGL+ + D +
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGY 175
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------- 187
T Y APE++ + + T D+WS G I+ LL G F S+ ++ K+I
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235
Query: 188 -----------SAAEF--TCP-----------PWLSFTARKLIARILDPNPMTRITIPEI 223
SA + + P + A L+ ++L +P RIT E
Sbjct: 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 224 LEDEWFKKDYKP---PVFEEKKDTNLDDVE 250
L + + + P PV D + + +
Sbjct: 296 LAHPYLAEYHDPEDEPV-APPYDQSFESRD 324
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 48/144 (33%), Positives = 78/144 (54%), Gaps = 6/144 (4%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSR 91
VV L +K + +VL + GG+L I + G +E R F ++ ++ H
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151
+ +RDLKPEN+LLD +G++++SD GL+ V + + GT Y+APEV+ + Y
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 152 DGSTADLWSCGVILFVLLAGYLPF 175
S D W+ G +L+ ++AG PF
Sbjct: 179 TFS-PDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 54/171 (31%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKI--FIVLEFVTG--GELFDKIVNHGRMKEDEARR 76
RE+ +K +KH NV+ L +V T I F + VT G + IV ++ ++ +
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
QL+ + Y HS G+ HRDLKP N+ ++ L++ DFG L++Q D+ +
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG---LARQADDE--MTGYVA 177
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
T Y APE++ + + T D+WS G I+ LL G F ++ ++ K+I
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE+ +K +KH NV+ L +V + ++V+ F+ G K++ H ++ ED
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRI 120
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ Q++ + Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D +
Sbjct: 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGY 175
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
T Y APEV+ + + T D+WS G I+ +L G F + ++ +I + T
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI--MKVTG 233
Query: 195 PPWLSFTAR 203
P F +
Sbjct: 234 TPSKEFVQK 242
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 58/160 (36%), Positives = 86/160 (53%), Gaps = 17/160 (10%)
Query: 17 LQIKREVATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTGG--ELFDKIVNH 66
L REVA ++ ++ HPNVVRL++V +TK+ +V E V DK+
Sbjct: 46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP 105
Query: 67 GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQV 125
G + + + QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + S Q+
Sbjct: 106 G-VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 164
Query: 126 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165
L + T Y APEVL Y + DLWS G I
Sbjct: 165 ----ALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 50/152 (32%), Positives = 84/152 (55%), Gaps = 4/152 (2%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQ 79
REV+ +K +KH N+V L++++ ++ + +V E++ +L + N G M + +
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF 110
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
QL+ + YCH R + HRDLKP+NLL++ G LK++DFGL A ++ V + T
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVV-TLW 168
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171
Y P+VL + D+W G IL+ + G
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 49/144 (34%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 34 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSR 91
VV L +K + +VL + GG+L I N G DE R F +L ++
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151
+ +RDLKPEN+LLD G++++SD GL+ Q+ + + GT Y+APEV+N+ Y
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 152 DGSTADLWSCGVILFVLLAGYLPF 175
S D W G +++ ++ G PF
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 13/215 (6%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I++E+ +K KH N+V + S+ K++I +E+ GG L D G + E +
Sbjct: 53 IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++ + + Y HS+G HRD+K N+LL G++K++DFG++A + + GTP
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTP 170
Query: 139 NYVAPEVL---NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 195
++APEV + GY+ D+W+ G+ L P D + M +S + F P
Sbjct: 171 YWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-P 228
Query: 196 PWL------SFTARKLIARILDPNPMTRITIPEIL 224
P L S T + L NP R T +L
Sbjct: 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 7/151 (4%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV---TGGELFDKIVNHGRMKEDEARRY 77
RE+ ++ KH N++ + +++ F + V +L I + + E+ R +
Sbjct: 53 RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYF 112
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTC 135
QL+ + Y HS V HRDLKP NLL++ L++ DFG+ S +
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 136 GTPNYVAPEVLNDRGYDGSTA-DLWSCGVIL 165
T Y APE+L + +TA D+WS G I
Sbjct: 173 ATRWYRAPELLLSLP-EYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 12/160 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF 78
RE + +K +KH N+V L++++ +K + +V E+V + DK + G + + + +
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFL 109
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 136
QL+ + Y H R + HRDLKP+NLL+ G LK++DFGL A ++ V HT
Sbjct: 110 FQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPS----HTYSNEV 164
Query: 137 -TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175
T Y P+VL + D+W G I ++ G F
Sbjct: 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 48/155 (30%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
RE + +K +KH N+V L++++ +K + V E++ +L ++ H G + R +
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMF 110
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCG 136
QL+ + Y H + + HRDLKP+NLL+ G LK++DFGL+ ++ Q ++
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV----- 165
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171
T Y P+VL S D+W G I +L G
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQ 80
E M + HP +V+LY V + ++IV EF+ G L + + G++ +D Q
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-- 138
+ ++Y HRDL N L+ + G +KVSDFG +++ V DD ++ G
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFG---MTRYVLDDEYT-SSSGAKFP 164
Query: 139 -NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPP 196
+ PEV N Y S +D+WS GV+++ V G +PF+ + + + IS P
Sbjct: 165 VKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP 223
Query: 197 WL-SFTARKLIARILDPNPMTRITIPEILE 225
L S T +++ P R T E+L
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE--ARRYF 78
+E +K HPN+V+L V K I+IV+E V GG L + R K++ ++
Sbjct: 41 QEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL----LTFLRKKKNRLTVKKLL 96
Query: 79 QQLINA---VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Q ++A ++Y S+ HRDL N L+ LK+SDFG+S + + G+ +
Sbjct: 97 QMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSD 152
Query: 136 GTPN----YVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYK----- 185
G + APE LN Y S +D+WS G++L+ G P+ + N
Sbjct: 153 GLKQIPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPY--PGMSNQQTRERIE 209
Query: 186 ---KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
++ A + CP + +L+ + +P R + EI
Sbjct: 210 SGYRMPAPQL-CPEEI----YRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 4/161 (2%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQ 79
REV+ +K +KH N+V L++++ + + +V E++ +L + + G M + +
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q++ + YCH R V HRDLKP+NLL++ G LK++DFGL A ++ V + T
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGL-ARAKSVPTKTYSNEVV-TLW 169
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 180
Y P+VL + D+W G I F + +G F S +
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 53/156 (33%), Positives = 85/156 (54%), Gaps = 17/156 (10%)
Query: 21 REVATMKLVK---HPNVVRLYEVMGS-----KTKIFIVLEFVTGG--ELFDKIVNHGRMK 70
REVA +K ++ HPN+VRL +V + +TK+ +V E V DK+ G +
Sbjct: 48 REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LP 106
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDG 129
+ + +Q + +D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ + S Q+
Sbjct: 107 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166
Query: 130 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165
++ T Y APEVL Y + D+WS G I
Sbjct: 167 VVVTLW----YRAPEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 17 LQIK--REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
L+IK E +K HPN+V+L V + I+IV+E V GG+ + R K+DE
Sbjct: 35 LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL----RKKKDEL 90
Query: 75 RRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
+ +QL+ A+D Y S+ HRDL N L+ LK+SDFG+S ++
Sbjct: 91 K--TKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR-----QE 143
Query: 128 DGLLHTTCGTPN----YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 182
D ++++ G + APE LN Y S +D+WS G++L+ + G P+
Sbjct: 144 DDGIYSSSGLKQIPIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
Query: 183 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226
+++ +CP K++ R D P R E+ ++
Sbjct: 203 AREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 11/157 (7%)
Query: 20 KREVATMKLVKHPNVVRL----YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
+RE+ ++ + H N+V+ + G ++ ++E++ G L D + H R + + R
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRL--IMEYLPSGSLRDYLQRH-RDQINLKR 110
Query: 76 --RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+ Q+ +DY S+ HRDL N+L+++ +K+SDFGL+ + + +D +
Sbjct: 111 LLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170
Query: 134 TCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169
+P + APE L + S +D+WS GV L+ L
Sbjct: 171 PGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 14/184 (7%)
Query: 6 LSKYLDAFCILLQIKREVATMKLV---KHPNVVRLYEVM-----GSKTKIFIVLEFVTGG 57
L K + F L+ KR +K++ KH NV+ +++ +I++V E +
Sbjct: 30 LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS- 88
Query: 58 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 117
+L IV+ + D + + Q++ + Y HS G+ HRD+KP NLL+++ LK+ DFG
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG 148
Query: 118 LSALSQQVRDDGLLHTT--CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175
L+ + + D H T T Y APE+L + S D+WS G I LL + F
Sbjct: 149 LARVEEP---DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
Query: 176 DDSN 179
+
Sbjct: 206 QAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 52/294 (17%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKED 72
+I RE+ ++L++HP++V + +M ++ I++V E + +L I + + +
Sbjct: 45 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPE 103
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
+ + QL+ A+ Y H+ V+HRDLKP+N+L +A LK+ DFGL+ ++ +
Sbjct: 104 HHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163
Query: 133 TT-CGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 190
T T Y APE+ + A D+WS G I +L G F N+++ I+
Sbjct: 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223
Query: 191 EFTCPP-------------WLS---------FT---------ARKLIARILDPNPMTRIT 219
T P +LS F+ A +L+ R+L +P R T
Sbjct: 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
Query: 220 IPEILEDEWFK----KDYKP---PV------FEEKKDTNLDDVEAVFKDSEEHH 260
E L D +FK + +P P+ FE ++ T D E ++++ E+H
Sbjct: 284 AEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYH 337
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQ 80
E M + HPN+V+LY V + IFIV E++ G L + + G++ +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-- 138
+ A++Y S G HRDL N L+ +KVSDFG L++ V DD + GT
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFG---LARYVLDDQYTSSQ-GTKFP 164
Query: 139 -NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFD 176
+ PEV D S +D+WS GV+++ V G +P++
Sbjct: 165 VKWAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 7/171 (4%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ- 79
+E A MK +KHPN+V+L V + +I+ EF+T G L D + R + + +
Sbjct: 51 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 110
Query: 80 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q+ +A++Y + HRDL N L+ +KV+DFGLS L D H P
Sbjct: 111 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP 168
Query: 139 -NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 187
+ APE L + +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 169 IKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 72/289 (24%), Positives = 115/289 (39%), Gaps = 69/289 (23%)
Query: 20 KREVATMKLVK----HPNVVRLYEVMGSKTKIFIVLEFVTGG---------ELFD----K 62
KR + +KL++ H N+ LY+ ++ V G EL + +
Sbjct: 46 KRALRELKLLRHFRGHKNITCLYD-----------MDIVFPGNFNELYLYEELMEADLHQ 94
Query: 63 IVNHGRMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121
I+ G+ D + F Q++ + Y HS V HRDLKP NLL++A LK+ DFGL+
Sbjct: 95 IIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154
Query: 122 SQ--QVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAG------- 171
+ G + T Y APE+ L+ + Y + D+WS G IL LL
Sbjct: 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGK 213
Query: 172 -----------YLPFDDSNLMNLYKKISAAEFT----CPPWLSFT---------ARKLIA 207
L D ++ A + P F A L+
Sbjct: 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273
Query: 208 RILDPNPMTRITIPEILE----DEWFKKDYKPPVFEEKKDTNLDDVEAV 252
++L +P RI++ E LE W D PV ++ D + + +++
Sbjct: 274 KLLAFDPTKRISVEEALEHPYLAIWHDPD-DEPVCQKPFDFSFESEDSM 321
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
E + M ++HPN+V+L V+ ++IV E++ G L D + + GR A Q
Sbjct: 50 EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-----AVITLAQQ 104
Query: 82 I-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ ++Y + HRDL N+L+ KVSDFGL+ + Q +D G L
Sbjct: 105 LGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--- 161
Query: 135 CGTP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA--- 189
P + APE L ++ + + +D+WS G++L+ + + G +P+ L ++ +
Sbjct: 162 ---PVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217
Query: 190 --AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
A CPP + K++ + +P R T ++ E
Sbjct: 218 MEAPEGCPPEV----YKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 10/172 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQ 80
E M + H +V+LY V + I+IV E+++ G L + + HG R + + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-- 138
+ + Y S+ HRDL N L+D G +KVSDFG LS+ V DD ++ G+
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG---LSRYVLDDEYT-SSVGSKFP 164
Query: 139 -NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 188
+ PEVL + S +D+W+ GV+++ V G +P++ N +K+S
Sbjct: 165 VRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 78/305 (25%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKED 72
RE+ MKLV H N++ L V + +++V+E + ++ ++H RM
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-- 121
Query: 73 EARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 131
Y Q++ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++
Sbjct: 122 ----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMM 174
Query: 132 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
T Y APEV+ GY D+WS G I+ ++ G + F ++ ++ + KI
Sbjct: 175 TPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233
Query: 192 FTCPP---------------------WLSFT----------------------ARKLIAR 208
T SF AR L+++
Sbjct: 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSK 293
Query: 209 ILDPNPMTRITIPEILEDE----WFKKD--YKPPVFEEKKDTNLDDVEAVFKDSEEHHVT 262
+L +P RI++ + L+ W+ PP D ++D+ EH V
Sbjct: 294 MLVIDPEKRISVDDALQHPYINVWYDPSEVEAPP--PAPYDHSIDER--------EHTVE 343
Query: 263 EQKEE 267
E KE
Sbjct: 344 EWKEL 348
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 18 QIKREVATMK-LVKHPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GR 68
+IK E+ +K H N+ Y G ++++V+EF G + D + N
Sbjct: 58 EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA 117
Query: 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 128
+KED ++++ + + H+ V HRD+K +N+LL +K+ DFG+SA Q R
Sbjct: 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTV 175
Query: 129 GLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 181
G +T GTP ++APEV+ D YD +D+WS G+ + G P D + M
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 48/165 (29%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF 78
REV+ +K +KH N+V L++++ ++ + +V E++ + D N M + +
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFL 110
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTC 135
QL+ ++YCH R V HRDLKP+NLL++ G LK++DFGL+ ++ + + ++
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV---- 166
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 180
T Y P++L + D+W G I + + G F S +
Sbjct: 167 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 13/184 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE+ +K +KH NV+ L +V +++V + G + IV ++ +D
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHV 122
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ Q++ + Y HS + HRDLKP NL ++ LK+ DFGL+ D +
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGY 177
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
T Y APE++ + + T D+WS G I+ LL G F ++ ++ K I T
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
Query: 195 PPWL 198
L
Sbjct: 238 GAEL 241
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 22/232 (9%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARR 76
I +EV ++ ++HPN + + ++V+E+ G ++ + V+ ++E E
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAA 119
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ + Y HS HRD+K N+LL G +K++DFG ++L ++ G
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVG 173
Query: 137 TPNYVAPEVL--NDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 193
TP ++APEV+ D G YDG D+WS G+ L P + N M+ I+ +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-- 230
Query: 194 CPPWLSFTA-----RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
P LS R + L P R + E+L+ + ++ P V +
Sbjct: 231 -SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIID 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 20/160 (12%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKE 71
RE+ ++ + H NV+ + ++M + ++IV E L D +I+ +
Sbjct: 53 REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLS 106
Query: 72 DEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
D+ +YF QL+ + Y HS V HRDLKP NLLL+A +LK+ DFGL+ + +
Sbjct: 107 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDF 164
Query: 131 LHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLL 169
+ T Y APE+ LN Y + D+WS G I LL
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 59/185 (31%), Positives = 90/185 (48%), Gaps = 18/185 (9%)
Query: 18 QIKREVATMK-LVKHPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKI---VNHG- 67
+I+ E +K L HPNVV+ Y + K ++++VLE GG + D + + G
Sbjct: 60 EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119
Query: 68 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
RM+E + + + + H HRD+K N+LL G +K+ DFG+SA R
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 128 DGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 182
+T+ GTP ++APEV+ D YD + D+WS G+ L G P D + M
Sbjct: 180 R--RNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMR 236
Query: 183 LYKKI 187
KI
Sbjct: 237 ALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 28/242 (11%)
Query: 24 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHG-RMKEDEARRYFQQ 80
+M+ V P V Y + + ++I +E + + + K+ + G + ED +
Sbjct: 52 ISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS 111
Query: 81 LINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
++ A++Y HS+ V HRD+KP N+L++ G +K+ DFG+S + D G
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKP 168
Query: 140 YVAPE----VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 195
Y+APE LN +GYD +D+WS G+ + L G P+D + ++++
Sbjct: 169 YMAPERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYD--SWKTPFQQLKQVVEEPS 225
Query: 196 PWL---SFTA--RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 250
P L F+ + + + L N R PE+L+ P FE N D
Sbjct: 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH---------PFFELHLSKNTDVAS 276
Query: 251 AV 252
V
Sbjct: 277 FV 278
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 18 QIKREVATMK-LVKHPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GR 68
+IK+E+ +K H N+ Y G ++++V+EF G + D I N
Sbjct: 48 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 107
Query: 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 128
+KE+ ++++ + + H V HRD+K +N+LL +K+ DFG+SA Q R
Sbjct: 108 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTV 165
Query: 129 GLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 181
G +T GTP ++APEV+ D YD +DLWS G+ + G P D + M
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 22/166 (13%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI RE+ + P +V Y S +I I +E + GG L D+++ EA+R
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLK-------EAKRI 100
Query: 78 FQQLINAVDYCHSRG---------VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 128
++++ V RG + HRD+KP N+L+++ G +K+ DFG+S Q + D
Sbjct: 101 PEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--D 156
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174
+ ++ GT +Y++PE L Y +D+WS G+ L L G P
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 53/248 (21%)
Query: 31 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR------------RYF 78
HP +V +Y + ++ + ++ G L ++ KE ++ F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------G 129
++ ++Y HS+GV HRDLKP+N+LL +G + + D+G + + +D
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 130 LLHTT-------CGTPNYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLPF---DDS 178
+ +++ GTP+Y+APE L G S + D+++ GVIL+ +L P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237
Query: 179 NLMNLYKKISAAEFT----CPPWLSFTARKLIARILDPNPMTRI-TIPEILED------- 226
+ +S E PP+LS ++ + L +P R ++ E+ +D
Sbjct: 238 KISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQELKQDLEPHLQG 293
Query: 227 --EWFKKD 232
EW K
Sbjct: 294 SPEWTVKA 301
|
Length = 932 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQ 79
E A M + H N+VRL V+ ++IV+E ++ G L + + GR + ++
Sbjct: 49 ETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
+ ++Y S+ + HRDL N+L+ G KVSDFGL+ + D+ L
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----K 162
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPP 196
+ APE L + + S +D+WS GV+L+ V G P+ +L + + + PP
Sbjct: 163 WTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 17/154 (11%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR----- 75
+E A M + H N++RLY V+ + + +V E G L D R+++D
Sbjct: 45 KEAAIMHSLDHENLIRLYGVVLTH-PLMMVTELAPLGSLLD------RLRKDALGHFLIS 97
Query: 76 ---RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
Y Q+ N + Y S+ HRDL N+LL + +K+ DFGL Q D ++
Sbjct: 98 TLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
Query: 133 TTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVIL 165
P + APE L R + +D+W GV L
Sbjct: 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 10/165 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARR 76
QI RE+ M + P +V Y ++ I + +EF+ G L D+I G + + +
Sbjct: 49 QILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK 107
Query: 77 YFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTT 134
++ + Y ++ + HRD+KP N+L+++ G +K+ DFG+S L + D T
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TF 162
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 179
GT Y++PE + Y +D+WS G+ + L G PF SN
Sbjct: 163 VGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 28 LVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYF 78
L HPNVV+ Y + K +++VLE GG EL ++ G R+ E
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCG 136
+ + + H+ + HRD+K N+LL G +K+ DFG+SA S ++R + T+ G
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVG 190
Query: 137 TPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYK 185
TP ++APEV+ D YD + D+WS G+ L G P FD + L+K
Sbjct: 191 TPFWMAPEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 15/156 (9%)
Query: 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCH 89
P +V+ Y + + +FI +E + DK++ G + ED + ++ A+ Y
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 90 SR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN 147
+ GV HRD+KP N+LLDA GN+K+ DFG+S + V D T + G Y+APE ++
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAAYMAPERID 187
Query: 148 ----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 179
+ YD AD+WS G+ L L G P+ +
Sbjct: 188 PPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI RE+ + P +V Y S +I I +E + GG L + GR+ E +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 108
Query: 78 FQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+I + Y + + HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ G
Sbjct: 109 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVG 164
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174
T +Y++PE L Y +D+WS G+ L + G P
Sbjct: 165 TRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 63/296 (21%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKED 72
RE+ +K V H N++ L V + +++V+E + ++ ++H RM
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS-- 126
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
Q++ + + HS G+ HRDLKP N+++ + LK+ DFG L++ + ++
Sbjct: 127 ---YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMT 180
Query: 133 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----- 187
T Y APEV+ GY D+WS G I+ L+ G + F ++ ++ + K+
Sbjct: 181 PYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239
Query: 188 -SAAEFTCP---------------PWLSFT---------------------ARKLIARIL 210
+AEF P +SF AR L++++L
Sbjct: 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299
Query: 211 DPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKE 266
+P RI++ E L + Y P E + D + + EH + E KE
Sbjct: 300 VIDPDKRISVDEALRHPYITVWYDPAE-AEAPPPQIYDAQL---EEREHAIEEWKE 351
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI E+ + P ++ Y + +I I EF+ GG L D + ++ E R
Sbjct: 45 QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DV---YRKIPEHVLGRI 100
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++ + Y S + HRD+KP N+L++ G +K+ DFG+S +Q V + + T GT
Sbjct: 101 AVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS--TQLV--NSIAKTYVGT 156
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175
Y+APE ++ Y G +D+WS G+ L G P+
Sbjct: 157 NAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 28/159 (17%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR-YFQ 79
+E MK ++H +V+LY V + I+IV E+++ G L D +K E ++
Sbjct: 50 QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLP 103
Query: 80 QLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
QL+ + Y SR HRDL N+L+ K++DFGL+ L + DD +
Sbjct: 104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EY 158
Query: 133 TTC-GTP---NYVAPEVLNDRGYDGST--ADLWSCGVIL 165
T G + APE N Y T +D+WS G++L
Sbjct: 159 TAREGAKFPIKWTAPEAAN---YGRFTIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE+ +K ++H NV+ L +V S ++V+ ++ KI+ H + ED+
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKV 119
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ Q++ + Y HS G+ HRDLKP NL ++ LK+ DFGL+ + D +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGY 174
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
T Y APEV+ + + T D+WS G I+ +L G F + ++ +I
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 17/175 (9%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKED 72
RE+ MK V H N++ L V + ++IV+E + ++ ++H RM
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-- 129
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
Q++ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++
Sbjct: 130 ---YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMT 183
Query: 133 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
T Y APEV+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 184 PYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 14/226 (6%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I +EV ++ +KHPN + + ++V+E+ G V+ ++E E
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT 127
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+ + Y HS + HRD+K N+LL G +K++DFG ++ S ++ GTP
Sbjct: 128 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTP 181
Query: 139 NYVAPEV---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---F 192
++APEV +++ YDG D+WS G+ L P + N M+ I+ +
Sbjct: 182 YWMAPEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 240
Query: 193 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 238
W + + R + L P R E+L ++ ++D V
Sbjct: 241 QSNEW-TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVL 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 21/168 (12%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
E + M HPN++RL V+ + I+ E++ G L DK ++E++ + Q
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQ 107
Query: 81 LIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
L+ + Y HRDL N+L+++ KVSDFG LS+++ D +T
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYT 164
Query: 134 TCG--TP-NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 177
T G P + APE + R + S +D+WS G++++ V+ G P+ D
Sbjct: 165 TKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 18/221 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKED 72
RE+ MK V H N++ L V + +++V+E + ++ ++H RM
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-- 122
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
Q++ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++
Sbjct: 123 ---YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMT 176
Query: 133 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 192
T Y APEV+ GY D+WS G I+ ++ + F + ++ + K+
Sbjct: 177 PYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 193 T-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232
T CP ++ + + + +T P++ D F D
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD 276
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I +EV ++ +KHPN + + ++V+E+ G V+ ++E E
Sbjct: 72 IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT 131
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+ + Y HS + HRD+K N+LL G +K++DFG ++++ ++ GTP
Sbjct: 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTP 185
Query: 139 NYVAPEV---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---F 192
++APEV +++ YDG D+WS G+ L P + N M+ I+ E
Sbjct: 186 YWMAPEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL 244
Query: 193 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAV 252
W + R + L P R T E+L+ + V E+ +T L D+
Sbjct: 245 QSNEWSDYF-RNFVDSCLQKIPQDRPTSEELLKHMF--------VLRERPETVLIDLIQR 295
Query: 253 FKDS 256
KD+
Sbjct: 296 TKDA 299
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 51/184 (27%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 22 EVATMKLVKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYF 78
E + M ++H N+V+L V+ K ++IV E++ G L D + + GR + D ++
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+ A++Y + HRDL N+L+ KVSDFGL+ + +D G L
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV----- 163
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-----AEF 192
+ APE L ++ + + +D+WS G++L+ + + G +P+ L ++ ++ A
Sbjct: 164 KWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 222
Query: 193 TCPP 196
CPP
Sbjct: 223 GCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 22/169 (13%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
I QI RE+ + P +V Y S +I I +E + GG L D+++ +A
Sbjct: 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLK-------KA 93
Query: 75 RRYFQQLINAVDYCHSRG---------VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 125
R + ++ + RG + HRD+KP N+L+++ G +K+ DFG+S Q +
Sbjct: 94 GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI 151
Query: 126 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174
D + ++ GT +Y++PE L Y + D+WS G+ L + G P
Sbjct: 152 --DSMANSFVGTRSYMSPERLQGTHYTVQS-DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 31/169 (18%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRM 69
RE+ +K +KHPNVV L ++ + +++V ++ G L + V +
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---L 112
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 129
E + + Y QL+ ++Y H + HRD+K N+L+D G LK++DFG L++
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG---LARPYDGPP 169
Query: 130 LLHTTCGTPN------------YVAPE-VLNDRGYDGSTADLWSCGVIL 165
G Y PE +L +R Y + D+W G +
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 7/151 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+ RE + M + HP +VRL V + + +V+E G L + + + +
Sbjct: 42 EFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKEL 100
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCG 136
Q+ + Y S+ HRDL N+LL K+SDFG+S AL D TT G
Sbjct: 101 AHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG--AGSDYYRATTAG 158
Query: 137 T-P-NYVAPEVLNDRGYDGSTADLWSCGVIL 165
P + APE +N + S +D+WS GV L
Sbjct: 159 RWPLKWYAPECINYGKFS-SKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 52/192 (27%), Positives = 98/192 (51%), Gaps = 15/192 (7%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV---LEFVTGGELFDKIVN-HGRMKEDE 73
Q++ E+ + + H N++++ E++ S+ +++ +F ++D+ + R +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG + ++ R + +
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYG 327
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS------NLMNLYKK 186
GT +PE+L GY T D+WSCG+IL +L+ + P D L+ +
Sbjct: 328 WVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386
Query: 187 ISAA--EFTCPP 196
+S EF PP
Sbjct: 387 LSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 51/173 (29%), Positives = 75/173 (43%), Gaps = 35/173 (20%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFD--KIVNHGRMKEDEARR 76
RE+A ++ +KH NVV L EV ++++ ++ D +I+ R R
Sbjct: 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQA---KRV 103
Query: 77 YFQ---------QLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGL----- 118
Q++N V Y HS V HRDLKP N+L+ G +K+ D GL
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 119 SALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLA 170
+ L D ++ T Y APE+ L R Y D+W+ G I LL
Sbjct: 164 APLKPLADLDPVVVTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 8/164 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARR 76
+I E M V HP+VVRL + S + ++ + + G L D + NH +
Sbjct: 55 EILDEAYVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLN 113
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ Q+ + Y + + HRDL N+L+ ++K++DFGL+ L D+ H G
Sbjct: 114 WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGG 171
Query: 137 -TP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 177
P ++A E + R Y +D+WS GV ++ L+ G P++
Sbjct: 172 KVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQ 80
E ++ V HP+V+R+ + + S +VL + +L+ + + D+A +Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPN 139
++ + Y H++ + HRD+K EN+ ++ + + D G + GL GT
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVE 221
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170
APEVL Y+ S AD+WS G++LF +LA
Sbjct: 222 TNAPEVLARDKYN-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 45/185 (24%), Positives = 88/185 (47%), Gaps = 13/185 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQ 79
+EV +K ++H +++ L+ V ++I+ E + G L + + G++ +
Sbjct: 51 KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMA 110
Query: 80 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q+ + Y + HRDL N+L+ KV+DFGL+ L +++D L + P
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIP 167
Query: 139 -NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AE 191
+ APE + + + +D+WS G++L+ + G +P+ N +Y +I+A
Sbjct: 168 YKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226
Query: 192 FTCPP 196
CP
Sbjct: 227 AKCPQ 231
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-12
Identities = 22/90 (24%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 296 FKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKM----RLENMKAGRKGNLNVATE 351
K E SR +EI I + + G ++ + +L N + E
Sbjct: 2 KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61
Query: 352 VFQVAPSLHMVEVRKAKGDTLEFHKFYKNL 381
V++V P L MV+ +K G T F K +
Sbjct: 62 VYEVGPGLFMVDFKKKTGSTKTFTKLATKI 91
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 1/88 (1%)
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+QL++A+DY H G+ HRD+K EN+L++ ++ + DFG + ++ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILF 166
+ APEVL Y + D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 10/188 (5%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYF 78
E M + HP +V+LY V ++ I +V EF+ G L D + G+ ++
Sbjct: 47 IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+ + Y S V HRDL N L+ +KVSDFG++ V DD +T GT
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF---VLDDQYTSST-GTK 162
Query: 139 ---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTC 194
+ +PEV + Y S +D+WS GV+++ V G P+++ + + + I+A
Sbjct: 163 FPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY 221
Query: 195 PPWLSFTA 202
P L+ +
Sbjct: 222 KPRLASQS 229
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQ 80
E M+ HP++V+L V+ ++ ++IV+E GEL + VN + Y Q
Sbjct: 57 EAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P- 138
L A+ Y S+ HRD+ N+L+ + +K+ DFGLS + D+ + G P
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPI 172
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 175
++APE +N R + S +D+W GV ++ +L+ G PF
Sbjct: 173 KWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 11/160 (6%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQ 79
E MK ++H +VRLY V+ + I+I+ E++ G L D K G++ + +
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP- 138
Q+ + Y + HRDL+ N+L+ K++DFGL+ +V +D G
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKF 166
Query: 139 --NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 175
+ APE +N G +D+WS G++L+ ++ G +P+
Sbjct: 167 PIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E + M HPN++ L V+ + IV E++ G L + H G+ + +
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP- 138
+ + + Y G HRDL N+L+++ KVSDFGLS + + D +TT G
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKI 171
Query: 139 --NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AA 190
+ APE + R + S +D+WS G++++ V+ G P+ + + ++ K I A
Sbjct: 172 PIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230
Query: 191 EFTCP 195
CP
Sbjct: 231 PMDCP 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 44/154 (28%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-- 75
+RE+ +K ++H N+V+ V S + + +V+E++ G L D + H R + D +
Sbjct: 53 EREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLL 111
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Y Q+ ++Y S+ HRDL N+L+++ +K+ DFGL+ + Q ++ +
Sbjct: 112 LYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG 171
Query: 136 GTPNY-VAPEVLNDRGYDGSTADLWSCGVILFVL 168
+P + APE L + + +D+WS GV+L+ L
Sbjct: 172 ESPIFWYAPESLTESKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQ 79
E + M HPN++ L V+ + I+ EF+ G L D + N G+ + +
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLR 113
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP- 138
+ + Y HRDL N+L+++ KVSDFGLS + D ++ G
Sbjct: 114 GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 139 --NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--FT 193
+ APE + R + S +D+WS G++++ V+ G P+ D M+ I+A E +
Sbjct: 174 PIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWD---MSNQDVINAIEQDYR 229
Query: 194 CPP 196
PP
Sbjct: 230 LPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 14/167 (8%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQ 79
E+ KL HPN+V + ++++V F+ G D I H M E Q
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
++ A+DY H G HR +K ++L+ G + +S GL + + L P
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166
Query: 140 Y-------VAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 177
Y ++PEVL N +GYD + +D++S G+ L G++PF D
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 10/176 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I +EV ++ ++HPN ++ + ++V+E+ G V+ ++E E
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+ + Y HS + HRD+K N+LL G +K+ DFG +++ + GTP
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTP 175
Query: 139 NYVAPEV---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
++APEV +++ YDG D+WS G+ L P + N M+ I+ E
Sbjct: 176 YWMAPEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---GRMKED 72
L +++E+ T + ++HPN++ +++++V + G D + H G + E
Sbjct: 43 LKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPEL 101
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
+ ++NA+DY HS+G HR +K ++LL G + +S GL ++
Sbjct: 102 AIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQR 159
Query: 133 TTCGTP-------NYVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 183
P +++PEVL N +GY+ +D++S G+ L G++PF D +
Sbjct: 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQM 218
Query: 184 Y 184
Sbjct: 219 L 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 18 QIKREV-ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEAR 75
++ ++ M+ P +V+ Y + + +I +E + + F K V + +K
Sbjct: 48 RLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYV-YEVLK----S 102
Query: 76 RYFQQLINAVDYCHSRG---------VYHRDLKPENLLLDAYGNLKVSDFGLSALSQ--- 123
++++ + + + HRD+KP N+LLD GN+K+ DFG+S
Sbjct: 103 VIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162
Query: 124 -QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS--TADLWSCGVILFVLLAGYLPFDDSN 179
+ RD G C P Y+APE ++ DG +D+WS G+ L+ + G P+ N
Sbjct: 163 AKTRDAG-----C-RP-YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 2/155 (1%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
RE+ +K + H ++ L K+ + +V+ +LF + G + ++A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 140
L+ A+ Y H RG+ HRD+K EN+ LD N + DFG + D + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 141 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175
+PE+L Y T D+WS G++LF + +
Sbjct: 254 NSPELLALDPYCAKT-DIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR------ 75
E + MK +VVRL V+ + +V+E + G+L + + R + +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPT 117
Query: 76 --RYFQ---QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRD 127
++ Q ++ + + Y ++ HRDL N ++ +K+ DFG++ + R
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 128 DG--LLHTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILF 166
G LL P ++APE L D G + +D+WS GV+L+
Sbjct: 178 GGKGLL------PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 29/231 (12%)
Query: 19 IKREVATMKLVKHPNVVRLYEVM--GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDE 73
+K+E+ ++ + H N+V+ + I +++EF+ G E + N +K+
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ-- 110
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+Y Q+ +DY SR HRDL N+L+++ +K+ DFGL+ + ++ +
Sbjct: 111 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170
Query: 134 TCGTPNY-VAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
+P + APE L + Y S D+WS GV L+ LL Y + S + K I
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIAS--DVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTH 227
Query: 192 -----------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
PP +L+ + + P R T ++E
Sbjct: 228 GQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYF 78
E MK ++HP +++LY V + I+IV E + G L + + +K +
Sbjct: 50 AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA 109
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q+ + + Y ++ HRDL N+L+ KV+DFGL+ +V + + G
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA----RVIKEDIYEAREGAK 165
Query: 139 ---NYVAPEVLNDRGYDGST--ADLWSCGVILFVLLA-GYLPF 175
+ APE Y+ + +D+WS G++L ++ G +P+
Sbjct: 166 FPIKWTAPEAAL---YNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR----- 76
E MK ++H +V+L+ V+ +K I+I+ EF+ G L D +K DE +
Sbjct: 51 EANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPK 103
Query: 77 ---YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+ Q+ + + R HRDL+ N+L+ A K++DFGL+ + + ++
Sbjct: 104 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTARE 161
Query: 134 TCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 175
P + APE +N G +D+WS G++L ++ G +P+
Sbjct: 162 GAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 8 KYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVN 65
K ++ I + RE+A ++ +KHPNV+ L +V S + K++++ ++ +L+ I
Sbjct: 34 KQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKF 92
Query: 66 HGRMKEDE---------ARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLK 112
H K ++ + Q+++ + Y H+ V HRDLKP N+L+ G +K
Sbjct: 93 HRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152
Query: 113 VSDFGLSAL-SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169
++D G + L + ++ L T Y APE+L + D+W+ G I LL
Sbjct: 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 17/178 (9%)
Query: 8 KYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVN 65
K ++ I + RE+A ++ +KHPNV+ L +V S K++++ ++ +L+ I
Sbjct: 34 KQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKF 92
Query: 66 HGRMKEDE---------ARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLK 112
H K ++ + Q+++ + Y H+ V HRDLKP N+L+ G +K
Sbjct: 93 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152
Query: 113 VSDFGLSAL-SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169
++D G + L + ++ L T Y APE+L + D+W+ G I LL
Sbjct: 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 19/160 (11%)
Query: 20 KREVATMKLVKHPNVVRLY---EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
K+E+ +K + H N+V+ G K + +++E+V G L D + H ++ +
Sbjct: 54 KKEINILKTLYHENIVKYKGCCSEQGGKG-LQLIMEYVPLGSLRDYLPKH-KLNLAQLLL 111
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGL 130
+ QQ+ + Y HS+ HRDL N+LLD +K+ DFGL+ +VR+DG
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG- 170
Query: 131 LHTTCGTPNY-VAPEVLNDRGYDGSTADLWSCGVILFVLL 169
+P + A E L + + ++ D+WS GV L+ LL
Sbjct: 171 -----DSPVFWYAVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 41/147 (27%), Positives = 74/147 (50%), Gaps = 7/147 (4%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQ 79
E MK ++HP +VRLY V+ ++ I+I+ E++ G L D K ++ ++
Sbjct: 51 EANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP- 138
Q+ + + + HRDL+ N+L+ K++DFGL+ L + ++ P
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPI 167
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVIL 165
+ APE +N G +D+WS G++L
Sbjct: 168 KWTAPEAIN-YGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 15/185 (8%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQ 79
E + M H N++RL V+ I+ E++ G L DK + + G + +
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLR 114
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP- 138
+ + Y HRDL N+L+++ KVSDFGLS + + D +TT G
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKI 172
Query: 139 --NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AA 190
+ APE + R + S +D+WS G++++ V+ G P+ D + + K I+ A
Sbjct: 173 PIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA 231
Query: 191 EFTCP 195
CP
Sbjct: 232 PMDCP 236
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 22 EVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ- 79
E+ MK++ KH N++ L V + +++V+E+ G L D + R + A
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPR 123
Query: 80 ----------------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123
Q+ +++ S+ HRDL N+L+ +K++DFGL+
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA---- 179
Query: 124 QVRD----DGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF 166
RD D TT G P ++APE L DR Y + D+WS GV+L+
Sbjct: 180 --RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 22/164 (13%)
Query: 22 EVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI---------VNHGRMKE 71
E+ MKL+ KH N++ L V + +++++E+ G L + + K
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 72 DEARRYFQQLINAV-------DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 124
E + F+ L++ +Y SR HRDL N+L+ +K++DFGL+
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 125 VRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF 166
+ D T+ G ++APE L DR Y +D+WS G++++
Sbjct: 187 I--DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 33/194 (17%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVN 65
E +K V HP+V++LY + +++E+ G L D N
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 66 HGRMKEDEAR--------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 117
+ + R + Q+ + Y + HRDL N+L+ +K+SDFG
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 118 LSALSQQVRDDGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF--VLLAG-- 171
LS +D + + G P ++A E L D Y + +D+WS GV+L+ V L G
Sbjct: 173 LS--RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNP 229
Query: 172 YLPFDDSNLMNLYK 185
Y L NL K
Sbjct: 230 YPGIAPERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 21 REVATMKLVKHPNVVRLYEV---MGSKTKI---FIVLEFVTGGELFDKIVNHGRMKEDEA 74
E A MK HPNV++L V S KI ++L F+ G+L ++ +
Sbjct: 50 SEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGL 106
Query: 75 RRYF--QQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 125
Q L+ VD Y +R HRDL N +L + V+DFG LS+++
Sbjct: 107 PEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG---LSKKI 163
Query: 126 RDDGLLHTTCGTP---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 175
++A E L DR Y S +D+W+ GV ++ + G P+
Sbjct: 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 47/169 (27%), Positives = 71/169 (42%), Gaps = 20/169 (11%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-FQQ 80
E M H N+VRL V + FI+LE + GG+L + R + + +
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKD 117
Query: 81 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSA---LSQQVRD 127
L+ A D Y HRD+ N LL G K++DFG++ + R
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 128 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 175
G ++ PE D G S D+WS GV+L+ + GY+P+
Sbjct: 178 GG---RAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEAR 75
L +EV + + HPNV++ +VLEF G+L + + N G + + +
Sbjct: 40 LLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK 99
Query: 76 RYFQQL----INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 131
Q++ + + + H H DL N L A ++K+ D+GL AL Q D +
Sbjct: 100 DVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL-ALEQYPEDYYIT 158
Query: 132 HTTCGTP-NYVAPEVLNDRGYDGSTAD------LWSCGVILFVLL-AGYLPFDD 177
P ++APE++ RG D D +WS GV ++ L A P+ D
Sbjct: 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 43/186 (23%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQ 80
E T+ H N+VRL V+ + IV E+++ G L + H G++ +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN- 139
L + + Y G H+ L +L+++ K+S F Q+ + + + T G
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172
Query: 140 -YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEF 192
+ APE + + S +D+WS G++++ +++ G P+ D + ++ K + A
Sbjct: 173 LWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR 231
Query: 193 TCPPWL 198
CP L
Sbjct: 232 NCPNLL 237
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 14/166 (8%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+I E M V +P+V RL + + T + ++ + + G L D + H K++ +Y
Sbjct: 55 EILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQY 110
Query: 78 FQ----QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
Q+ ++Y R + HRDL N+L+ ++K++DFGL+ L D+ H
Sbjct: 111 LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHA 168
Query: 134 TCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD 176
G P ++A E + R Y +D+WS GV ++ L+ G P+D
Sbjct: 169 EGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGR-MKEDEARRYFQ 79
E MK ++H +V+LY V+ S+ I+IV E+++ G L D + + GR +K
Sbjct: 51 EAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP- 138
Q+ + Y HRDL+ N+L+ K++DFGL+ L + ++ P
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPI 167
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 196
+ APE G +D+WS G++L L+ G +P+ N + +++ CP
Sbjct: 168 KWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQ 226
Query: 197 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233
+ +L+ + +P R T E L+ F +DY
Sbjct: 227 DCPISLHELMLQCWKKDPEERPTF-EYLQS--FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 36/155 (23%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 22 EVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
E ++ + HP++++L G+ K I+ + T +L+ + + +
Sbjct: 133 EAHILRAINHPSIIQL---KGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAI 187
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+ ++ A+ Y H + HRD+K EN+ ++ G++ + DFG + + + + GT
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGT 246
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172
APE+L Y G D+WS G++LF + +
Sbjct: 247 IATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 31/188 (16%)
Query: 22 EVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY--- 77
E+ MK++ KH N++ L +++++E+ + G L + + R + Y
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYCYN 128
Query: 78 ----------FQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120
F+ L++ ++Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
Query: 121 LSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 177
+ D TT G ++APE L DR Y +D+WS GV+L+ + G P+
Sbjct: 189 DIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPG 245
Query: 178 SNLMNLYK 185
+ L+K
Sbjct: 246 VPVEELFK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 25/180 (13%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA------------ 74
KL HPN++ L + +++ +E+ G L D + ++ D A
Sbjct: 51 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 110
Query: 75 ----RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
+ + +DY + HRDL N+L+ K++DFGLS +
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVY 165
Query: 131 LHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 187
+ T G ++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 166 VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 22/225 (9%)
Query: 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL--FDKIVNHGRMKEDE 73
+ +RE+ + + H NVVRL + +++LE+ G+L F + + ++ +
Sbjct: 52 QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRA-TKSKDEKLK 110
Query: 74 ARRYFQQLINAVDYCHSRGV--------YHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 125
+ A+ + G+ HRDL N L+ + +KVS LS
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVY 168
Query: 126 RDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF----DDSN 179
+ P ++APE + + + + D+WS GV+++ V G LPF D+
Sbjct: 169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKS-DVWSFGVLMWEVFTQGELPFYGLSDEEV 227
Query: 180 LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 224
L L + E P KL+ R NP R + E++
Sbjct: 228 LNRL--QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 21 REVATMKLVKHPNVVRLYE------VMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKED 72
RE+ MK + H N++ L + ++ IF +V+EF+ + K + H
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNH 165
Query: 73 E-----ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVR 126
+ Y QL A+ Y HS+ + HRDLKP+NLL+D + LK+ DFG + +
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLA 223
Query: 127 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175
+ C + Y APE++ + DLWS G I+ ++ GY F
Sbjct: 224 GQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 43/201 (21%), Positives = 83/201 (41%), Gaps = 23/201 (11%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
++E M ++HPN+V L V + ++ E++ G+L + +V + + A +
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 80 ----------------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123
Q+ ++Y S HRDL N L+ +K+SDFGLS
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 124 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSN 179
+ + ++ PE + G + +D+WS GV+L+ + L Y F +
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234
Query: 180 LMNLYKK--ISAAEFTCPPWL 198
++ + + + CP +
Sbjct: 235 VIEMIRSRQLLPCPEDCPARV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 22/175 (12%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV-MGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKE 71
+ RE A MK HPNV++L V + S+ K ++L F+ G+L ++ R+ E
Sbjct: 47 EFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGE 105
Query: 72 DEARRYFQQLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 124
+ Q L+ + ++Y S+ HRDL N +L+ + V+DFG LS++
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG---LSKK 162
Query: 125 VRDDGLLHTTCGTP---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 175
+ C + ++A E L D Y + +D+W+ GV ++ ++ G P+
Sbjct: 163 IYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 27/186 (14%)
Query: 22 EVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKIVNHGRM 69
E+ MK++ KH N++ L +++++E+ + G L D + ++
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 70 KEDEARRYFQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 122
E++ F+ L++ ++Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 127 PEEQLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 123 QQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSN 179
+ D TT G ++APE L DR Y +D+WS GV+L+ + G P+
Sbjct: 185 HNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 180 LMNLYK 185
+ L+K
Sbjct: 242 VEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 8/159 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYF 78
+E MK ++H +V+LY V+ S+ I+IV E+++ G L D K ++ +
Sbjct: 50 QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 108
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q+ + + Y HRDL+ N+L+ KV+DFGL+ L + ++ P
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP 166
Query: 139 -NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 175
+ APE G +D+WS G++L L G +P+
Sbjct: 167 IKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 27/165 (16%)
Query: 21 REVATMKLVKHPNVVRLYEV--MGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEA 74
E MK HPNV+RL V +++ + ++L F+ G+L ++ + R+ +
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQ 107
Query: 75 RRYFQQLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA------L 121
Q L+ + ++Y S+ HRDL N +L+ N+ V+DFGLS
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY 167
Query: 122 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166
+Q R + ++A E L DR Y + +D+WS GV ++
Sbjct: 168 YRQGRIAKM------PVKWIAIESLADRVYT-TKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 34/207 (16%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV------------- 64
+ ++E + M + HPN+V L V+ + + ++ E++ G+L + ++
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 65 NHGRMKEDEARRYFQ----QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-- 118
G +K F Q+ ++Y S H+DL N+L+ ++K+SD GL
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 119 ---SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAG 171
SA +V+ LL ++ PE + G S +D+WS GV+L+ + L
Sbjct: 173 EIYSADYYRVQPKSLLPI-----RWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQP 226
Query: 172 YLPFDDSNLMNLYKK--ISAAEFTCPP 196
Y F + ++ + +K + CPP
Sbjct: 227 YYGFSNQEVIEMVRKRQLLPCSEDCPP 253
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 23/184 (12%)
Query: 22 EVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI----------------V 64
E+ MK++ KH N++ L +++++E+ + G L + + V
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 65 NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 124
+M + Q+ ++Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189
Query: 125 VRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLM 181
+ D TT G ++APE L DR Y +D+WS GV+++ + G P+ +
Sbjct: 190 I--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
Query: 182 NLYK 185
L+K
Sbjct: 247 ELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 44/180 (24%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA------------ 74
KL HPN++ L ++ ++I +E+ G L D + ++ D A
Sbjct: 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 75 ----RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
++ + + Y + HRDL N+L+ K++DFGLS ++
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVY 172
Query: 131 LHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 187
+ T G ++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 25/180 (13%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA---------RRY 77
KL HPN++ L + +++ +E+ G L D + ++ D A
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 78 FQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
QQL++ +DY + HRDL N+L+ K++DFGLS Q+V
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV----Y 177
Query: 131 LHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 187
+ T G ++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 8/159 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYF 78
+E MK ++H +V LY V+ S+ I+IV EF+ G L D K + +K +
Sbjct: 50 QEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA 108
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q+ + + Y HRDL+ N+L+ K++DFGL+ L + ++ P
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFP 166
Query: 139 -NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 175
+ APE G +D+WS G++L L+ G +P+
Sbjct: 167 IKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 43/234 (18%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-------MKEDE 73
RE + +H N+V+ Y V +V E++ G+L + +HG
Sbjct: 57 REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116
Query: 74 AR-------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 126
+ Q+ + + Y S+ HRDL N L+ +K+ DFG+S R
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------R 170
Query: 127 DDGLLHTT-----CGTP----NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFD 176
D ++TT G ++ PE + R + + +D+WS GV+L+ + G P+
Sbjct: 171 D---VYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWY 226
Query: 177 DSNLMNLYKKISAAEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
+ + + I+ TCP ++ +P RI I +I E
Sbjct: 227 GLSNEEVIECITQGRLLQRPRTCPS----EVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQ 80
E M + HP++VRL V S T I +V + + G L D + H + + Q
Sbjct: 59 EALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ 117
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-- 138
+ + Y R + HRDL N+L+ + ++K++DFGL+ L + D+ + G
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPI 175
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD 176
++A E ++ R + +D+WS GV ++ L+ G P+D
Sbjct: 176 KWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 3/147 (2%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
RE M+ + +P +VR+ + +++ +V+E G L + + + E Q
Sbjct: 45 REANVMQQLDNPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQ 103
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-N 139
+ + Y HRDL N+LL K+SDFGLS + T P
Sbjct: 104 VSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILF 166
+ APE +N + S +D+WS GV+++
Sbjct: 164 WYAPECMNYYKFS-SKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEAR 75
++ EV +HPN++ + V + + ++++ F+ G L G M E
Sbjct: 46 LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIG 104
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
+ ++Y H G HR++K ++L+ G + +S GLS L VR+
Sbjct: 105 NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY 162
Query: 136 GTPNY-------VAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDD 177
P + ++PE+L GY+ +D++S G+ L G +PF D
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-- 75
++ RE M + +P +VR+ V ++ + +V+E +GG L + K+DE
Sbjct: 41 EMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSG----KKDEITVS 95
Query: 76 ---RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLL 131
Q+ + Y + HRDL N+LL K+SDFGLS AL DD
Sbjct: 96 NVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYY 152
Query: 132 HTTCGTP---NYVAPEVLNDRGYDGSTADLWSCGVILF 166
+ APE +N R + S +D+WS G+ ++
Sbjct: 153 KARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 32/148 (21%)
Query: 59 LFDKIVNHGRMKEDEARRYFQQLI----NAVDYCHSR-GVYHRDLKPENLLLDAYGN--- 110
L D I+ HG R+ Q+I A+DY H+ + H DLKPEN+L++
Sbjct: 218 LLDWIMKHGPFSH----RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273
Query: 111 -------------LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157
+++ D G + R T +Y +PEV+ G+ ST D
Sbjct: 274 PVTNRALPPDPCRVRICDLGGCCDERHSRT-----AIVSTRHYRSPEVVLGLGWMYST-D 327
Query: 158 LWSCGVILFVLLAGYLPFDD-SNLMNLY 184
+WS G I++ L G L +D NL +L+
Sbjct: 328 MWSMGCIIYELYTGKLLYDTHDNLEHLH 355
|
Length = 467 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
Q +E MK HPNV+ L + S+ +VL ++ G+L + I + +
Sbjct: 42 QFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI 101
Query: 77 YFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL---- 131
F Q+ ++Y S+ HRDL N +LD +KV+DFG L++ + D
Sbjct: 102 GFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHN 158
Query: 132 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY----- 184
HT P ++A E L + + + +D+WS GV+L+ L+ G P+ D + ++
Sbjct: 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217
Query: 185 -KKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226
+++ E+ CP L +++ P P R T E++
Sbjct: 218 GRRLLQPEY-CPDPLY----EVMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 33/105 (31%), Positives = 55/105 (52%), Gaps = 14/105 (13%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q+ + Y H RGV H+D+ N ++D +K++D +ALS RD + C N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALS---RDLFPMDYHCLGDN 178
Query: 140 ------YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 177
++A E L ++ Y S +D+WS GV+L+ L+ G P+ +
Sbjct: 179 ENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 16/124 (12%)
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 195
GTP+Y+APE+L + + G D W+ GV LF L G PF+D +++ I +
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI--- 597
Query: 196 PW------LSFTARKLIARILDPNPMTRITIPEILED------EWFKKDYKPPVFEEKKD 243
PW LS A+ I +L +P R + E+ + +W + F + D
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 244 TNLD 247
D
Sbjct: 658 DETD 661
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 26/174 (14%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
+E M HPN+V+L V +I++E + GG+L + + + ++
Sbjct: 48 KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE 107
Query: 81 LIN-AVDYCHSRGVY-------HRDLKPENLLLDAYGN-----LKVSDFGL-----SALS 122
L++ +D VY HRDL N L+ G +K+ DFGL +
Sbjct: 108 LLDICLDVAKG-CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 123 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 175
+ +GLL ++APE L D G + +D+WS GV+++ +L G P+
Sbjct: 167 YRKEGEGLLPV-----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------ 67
+RE + ++H ++V+ Y V G + +V E++ G+L + HG
Sbjct: 55 QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114
Query: 68 ----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--- 120
+ + Q+ + + Y S+ HRDL N L+ A +K+ DFG+S
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 174
Query: 121 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166
+ R G HT ++ PE + R + + +D+WS GVIL+
Sbjct: 175 STDYYRVGG--HTMLPI-RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 8/163 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARR 76
+I E M V P V RL + + T + +V + + G L D + + R+ +
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLN 113
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ Q+ + Y + HRDL N+L+ + ++K++DFGL+ L D+ H G
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGG 171
Query: 137 -TP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD 176
P ++A E + R + +D+WS GV ++ L+ G P+D
Sbjct: 172 KVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------- 67
RE + ++H ++V+ Y V + +V E++ G+L + HG
Sbjct: 56 REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPA 115
Query: 68 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQ 124
+ + + QQ+ + Y S+ HRDL N L+ +K+ DFG+S +
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175
Query: 125 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166
R G HT ++ PE + R + + +D+WS GV+L+
Sbjct: 176 YRVGG--HTMLPI-RWMPPESIMYRKFT-TESDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 28/111 (25%), Positives = 50/111 (45%), Gaps = 12/111 (10%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL------------FDKIVNHGR 68
+E+ M +K+PN++RL V S + ++ E++ G+L F N
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 119
+ Q+ + + Y S HRDL N L+ + +K++DFG+S
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 37 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR---RYFQQLINAVDYCHSRGV 93
L ++M SK + V + L K+ + + E E + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 94 YHRDLKPENLLLD-AYGNLKVSDFGLSA 120
HRD+KP+N++ G+ K+ D G +A
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 25/102 (24%)
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYK 225
Query: 137 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 166
P+YV APE + D+ Y + +D+WS GV+L+
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 26/163 (15%)
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLL 131
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD D +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVR 232
Query: 132 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMNLYK 185
+ P ++APE + D+ Y + +D+WS GV+L+ + + G P+ + K
Sbjct: 233 KGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
Query: 186 ---KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
++ A E P +++ +P R T ++E
Sbjct: 292 DGTRMRAPENATP-----EIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 26/112 (23%)
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
Y Q+ +++ SR HRDL N+LL +K+ DFG L++ + D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG---LARDIYKD-------- 232
Query: 137 TPNYV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 175
P+YV APE + DR Y +D+WS GV+L+ + + G P+
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 20/66 (30%), Positives = 35/66 (53%)
Query: 52 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 111
EF+ G+ + + + + +Q++ + H G+ HRD+KPENLL+ G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 112 KVSDFG 117
K+ DFG
Sbjct: 349 KIIDFG 354
|
Length = 507 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 63/261 (24%), Positives = 98/261 (37%), Gaps = 76/261 (29%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELF--------DKIVNHGRMKE-- 71
E + MK +VVRL V+ +V+E + G+L + N GR
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118
Query: 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 127
E + ++ + + Y +++ HRDL N ++ +K+ DFG++ RD
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIYET 172
Query: 128 -------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL--------------- 165
GLL ++APE L D G +++D+WS GV+L
Sbjct: 173 DYYRKGGKGLLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226
Query: 166 ------FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 219
FV+ GYL D+ CP ++ L+ NP R T
Sbjct: 227 NEQVLKFVMDGGYLDQPDN---------------CPERVT----DLMRMCWQFNPKMRPT 267
Query: 220 IPEILEDEWFKKDYKPPVFEE 240
EI+ K D P F E
Sbjct: 268 FLEIV--NLLKDDLHPS-FPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 42/203 (20%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKE 71
+ K E ++HPN+V L V+ + + ++ + + +L + +V + G +
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 72 D-------EARRYFQ---QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121
D E + Q+ +++ S V H+DL N+L+ N+K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 122 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDD 177
L+ + +++PE + G +D+WS GV+L+ + L Y + +
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232
Query: 178 SNLMNLY--KKISAAEFTCPPWL 198
+++ + +++ CP W+
Sbjct: 233 QDVIEMIRNRQVLPCPDDCPAWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 34/149 (22%), Positives = 68/149 (45%), Gaps = 7/149 (4%)
Query: 25 TMKLVKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLI 82
M + H +VRL + G+ ++ V + G L D + H + + Q+
Sbjct: 62 AMGSLDHAYIVRLLGICPGASLQL--VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 83 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYV 141
+ Y + HR+L N+LL + ++++DFG++ L D ++ TP ++
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYSEHKTPIKWM 178
Query: 142 APEVLNDRGYDGSTADLWSCGVILFVLLA 170
A E + Y +D+WS GV ++ +++
Sbjct: 179 ALESILFGRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 29/110 (26%), Positives = 49/110 (44%), Gaps = 11/110 (10%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARR 76
+E+ M +K PN++RL V + + ++ E++ G+L + H K D
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 77 YFQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 119
+ LI + Y S HRDL N L+ +K++DFG+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKED 72
+RE + +++H ++VR Y V + +V E++ G+L + +HG +
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 73 EARRYFQ-----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA- 120
E Q Q+ + + Y S HRDL N L+ +K+ DFG+S
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171
Query: 121 --LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166
+ R G T ++ PE + R + + +D+WS GV+L+
Sbjct: 172 IYSTDYYRVGG---RTMLPIRWMPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 9e-04
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 33/166 (19%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEA 74
E + MK +VVRL V+ +++E +T G+L ++ N+
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 75 RRYFQ---QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 127
++ Q ++ + + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYET 172
Query: 128 -------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166
GLL +++PE L D G + +D+WS GV+L+
Sbjct: 173 DYYRKGGKGLLPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 33 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92
NV +Y V I V+E++ G L D ++N M+E E R +L+ + HS G
Sbjct: 62 NVPAVYFVDPENFII--VMEYIEGEPLKD-LINSNGMEELELSREIGRLVGKL---HSAG 115
Query: 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
+ H DL N++L G + + DFGL+ S+ + D
Sbjct: 116 IIHGDLTTSNMILSG-GKIYLIDFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ---QLI 82
M+ V H ++V LY V + +V EFV G L + H + F+ QL
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKFKVAKQLA 115
Query: 83 NAVDYCHSRGVYHRDLKPENLLLDAYG-------NLKVSDFG--LSALSQQVRDDGLLHT 133
+A+ Y + + H ++ +N+LL G +K+SD G ++ LS+Q + +
Sbjct: 116 SALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--- 172
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNL 180
++APE + D AD WS G L+ + G +P D L
Sbjct: 173 -----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 32/121 (26%), Positives = 47/121 (38%), Gaps = 22/121 (18%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDE 73
RE A M HPN+V+L V + ++ E++ G+L + +
Sbjct: 57 REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 74 ARRYFQ---------QLINAVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 118
AR+ QL A Y R HRDL N L+ +K++DFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 119 S 119
S
Sbjct: 177 S 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 26/160 (16%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF-- 78
+ M + H ++V+LY V I +V E+V G L D ++ R K + + +
Sbjct: 50 ETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLH--REKNNVSLHWKLD 105
Query: 79 --QQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG--LSALSQQVRD 127
+QL +A+ Y + + H ++ +N+L+ YG +K+SD G ++ LS++ R
Sbjct: 106 VAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV 165
Query: 128 DGLLHTTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILF 166
+ + P ++APE + N + AD WS G L
Sbjct: 166 ERI-------P-WIAPECIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 30/123 (24%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q+ +++ S+ HRDL N+LL +K+ DFGL+ RD ++H + N
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA------RD--IMHDS----N 292
Query: 140 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 182
YV APE + D Y + +D+WS G++L+ + + G P+ DS N
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351
Query: 183 LYK 185
K
Sbjct: 352 KIK 354
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 11/110 (10%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL---------FDKIVNHG-RMK 70
+EV + + PN+ RL V + +++E++ G+L + +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 71 EDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 119
Y Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 46/184 (25%)
Query: 28 LVKHPNVVRLYEVMGSKTK---IFIVLEFVTGGELFDKIVNHGRMKE------DEARRYF 78
L H N+V L +G+ T I ++ E+ G+L +N R K ++ +
Sbjct: 95 LGNHENIVNL---LGACTIGGPILVITEYCCYGDL----LNFLRRKRESFLTLEDLLSFS 147
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q+ + + S+ HRDL N+LL +K+ DFGL+ RD +++ +
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS---- 195
Query: 139 NYV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLM 181
NYV APE + + Y +D+WS G++L+ + + G P+ DS
Sbjct: 196 NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY 254
Query: 182 NLYK 185
L K
Sbjct: 255 KLIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.56 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.37 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.08 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.08 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.69 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.52 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.51 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.47 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.22 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.15 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.06 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.78 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.78 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.5 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.89 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.69 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.14 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.03 | |
| PLN02236 | 344 | choline kinase | 95.65 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.37 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.61 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.51 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.42 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.94 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.54 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 93.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 93.2 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.42 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 92.17 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.95 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.84 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.65 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.25 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.19 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 91.03 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=442.07 Aligned_cols=216 Identities=62% Similarity=1.077 Sum_probs=208.2
Q ss_pred HHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+++++|+.++++++ ||||+++++++.+...+|+|||||.||+|+++|...++++|..++.+|+|+++|++|||++|
T Consensus 61 ~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g 140 (370)
T KOG0583|consen 61 KLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG 140 (370)
T ss_pred ccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC
Confidence 45788999999999998 99999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeeccCCCCcEEEccC-CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC-CCCChhhHHHHHHHHHHHHh
Q 015814 93 VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGiil~ellt 170 (400)
|+||||||||||++.+ +++||+|||++.... .....+.+.||||.|+|||++.+.+ |.+.++|||||||+||.|++
T Consensus 141 i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~ 218 (370)
T KOG0583|consen 141 IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC 218 (370)
T ss_pred EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh
Confidence 9999999999999999 999999999998764 3456788999999999999999988 99999999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCccCCCCCC-CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 171 GYLPFDDSNLMNLYKKISAAEFTCPPWL-SFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|+.||++.+...++.+|..+.+.+|.|+ |.++++|+++||.+||.+|+|+.+|+.||||+.
T Consensus 219 G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 219 GRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999999 999999999999999999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-57 Score=449.35 Aligned_cols=217 Identities=48% Similarity=0.886 Sum_probs=209.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....|.+||.||+.+.||||+++|+++++..++|+|+||++||+||+++...|++++.+|.++|+||+.|+.|||..+|+
T Consensus 55 ~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~ic 134 (786)
T KOG0588|consen 55 QPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNIC 134 (786)
T ss_pred cccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcce
Confidence 35779999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||||+|||..+++||+|||+|.+-. .+..+.+.||+|.|.|||++.+.+|+|.++||||||||||.||+|++|
T Consensus 135 HRDLKpENlLLd~~~nIKIADFGMAsLe~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LP 211 (786)
T KOG0588|consen 135 HRDLKPENLLLDVKNNIKIADFGMASLEV---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLP 211 (786)
T ss_pred eccCCchhhhhhcccCEeeeccceeeccc---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCC
Confidence 99999999999999999999999998643 467889999999999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|++.+...++.++..|.+..|..+|.++.+||++||+.||.+|+|.+||++|||+.....
T Consensus 212 FdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 212 FDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred CCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 999999999999999999999999999999999999999999999999999999997543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-57 Score=429.95 Aligned_cols=214 Identities=41% Similarity=0.756 Sum_probs=195.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+++|++||++|+|||||+++++|+.....||||||+.||+|++++..++.+.++..+.+++||+.|+.|||++||+|
T Consensus 220 ~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~H 299 (475)
T KOG0615|consen 220 TRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIH 299 (475)
T ss_pred hhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCccc
Confidence 45588999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcEEEccC---CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC--CCChhhHHHHHHHHHHHHh
Q 015814 96 RDLKPENLLLDAY---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 96 rDlKP~NILl~~~---g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DIwSlGiil~ellt 170 (400)
|||||+|||++.+ ..+||+|||+|++.+ ......|.||||.|+|||++..+++ +..++||||+||+||.+|+
T Consensus 300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs 376 (475)
T KOG0615|consen 300 RDIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS 376 (475)
T ss_pred ccCCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence 9999999999876 679999999998765 3556789999999999999987764 3457999999999999999
Q ss_pred CCCCCCCCchHH-HHHhhhcCccCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 171 GYLPFDDSNLMN-LYKKISAAEFTCPP--W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 171 G~~Pf~~~~~~~-~~~~i~~~~~~~~~--~--~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|.+||.+..... ++..|..+.+.+-| | +|+++.+||.+||..||++|||++|+|+||||+..
T Consensus 377 G~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 377 GYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred cCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 999998877655 88899999887643 4 89999999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=429.16 Aligned_cols=221 Identities=36% Similarity=0.676 Sum_probs=208.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 13 FCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 13 ~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...-+.+.+||+|+++|+|||||++|++|++.+++|||+|+|..|+|..+++..+.++|.+|+.|++||+.||.|||+++
T Consensus 59 ~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~ 138 (592)
T KOG0575|consen 59 PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG 138 (592)
T ss_pred cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC
Confidence 35578899999999999999999999999999999999999999999999998899999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+|||||..|++++++-+|||+|||||+..... .....+.||||.|+||||+.+.++ +..+||||+||++|.||.|+
T Consensus 139 IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~--~Erk~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~ 215 (592)
T KOG0575|consen 139 IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD--GERKKTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGR 215 (592)
T ss_pred ceecccchhheeecCcCcEEecccceeeeecCc--ccccceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCC
Confidence 999999999999999999999999999987642 233468999999999999998887 59999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
+||+..+..+.|.+|....+.+|..+|.++++||.+||++||.+|||+++||.|+||+.++.|.
T Consensus 216 PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 216 PPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred CCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 9999999999999999999999999999999999999999999999999999999998777554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-52 Score=389.45 Aligned_cols=215 Identities=38% Similarity=0.724 Sum_probs=200.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
+-++.++.|..||..++||+||+++..|+++..+|+|+||+.||+|+.+|++.+.++|+.|++|+..|+.||.|||++||
T Consensus 67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gI 146 (357)
T KOG0598|consen 67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGI 146 (357)
T ss_pred hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCe
Confidence 34788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||||||||.+|+++|+|||+++..-. ......+.|||+.|||||++.+.+|+ ..+|+|||||++|+|++|..
T Consensus 147 iyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 147 IYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DGDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred eeccCCHHHeeecCCCcEEEeccccchhccc--CCCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCC
Confidence 9999999999999999999999999985433 33455678999999999999999996 99999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCCC----CHHHHhcCccccc
Q 015814 174 PFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTRI----TIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~mL~~dP~~R~----t~~eil~h~~~~~ 231 (400)
||.+.+...++++|..+... .|..+|.+++++|+++|..||.+|. ++.+|.+||||..
T Consensus 224 PF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 224 PFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred CCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999999999999854 4455999999999999999999996 7899999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=374.39 Aligned_cols=212 Identities=37% Similarity=0.752 Sum_probs=201.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..++....|..+|+.+.||+++++++.+.+.+.+|+||||++||+||.++++.+++++..|++|+.|++.||+|||+++|
T Consensus 86 KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~i 165 (355)
T KOG0616|consen 86 KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDI 165 (355)
T ss_pred HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCe
Confidence 33677888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
++|||||||||+|.+|.+||+|||+|.... ....+.||||.|+|||+++.++|. .++|.|||||++|||++|.+
T Consensus 166 iYRDLKPENiLlD~~G~iKitDFGFAK~v~-----~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 166 IYRDLKPENLLLDQNGHIKITDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred eeccCChHHeeeccCCcEEEEeccceEEec-----CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999987543 236789999999999999999995 99999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
||...+...+|.+|..+...+|+.++.++++||+++|+.|-.+|. ...+|..||||+.
T Consensus 240 PF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 240 PFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred CCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 999999999999999999999999999999999999999999994 5788999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=382.25 Aligned_cols=216 Identities=28% Similarity=0.519 Sum_probs=197.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCE-EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-c
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTK-IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-R 91 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~ 91 (400)
...+||.+|++|++.++|||||.+|++|..+.. ++|+||||+||+|.+.+...++++|.....++.|+++||.|||+ +
T Consensus 119 ~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~ 198 (364)
T KOG0581|consen 119 ALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER 198 (364)
T ss_pred HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc
Confidence 557899999999999999999999999999995 99999999999999999988999999999999999999999996 8
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
+|+||||||+|||++..|.+||||||.|+.... ....+..||..|||||.+.+..|. .++||||||++++||++|
T Consensus 199 ~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn----S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~G 273 (364)
T KOG0581|consen 199 KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN----SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIG 273 (364)
T ss_pred CeeeccCCHHHeeeccCCCEEeccccccHHhhh----hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhC
Confidence 999999999999999999999999999876543 256788999999999999998885 889999999999999999
Q ss_pred CCCCCCC-----chHHHHHhhhcCc-cCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 172 YLPFDDS-----NLMNLYKKISAAE-FTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 172 ~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
+.||... +..+++..|..+. +..|.. +|+++++||..||++||.+|+|+.|+++|||+++...
T Consensus 274 rfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 274 RFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999874 5667778887754 456665 9999999999999999999999999999999997543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=360.31 Aligned_cols=213 Identities=41% Similarity=0.794 Sum_probs=197.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+++|++|-+.|+||||+++++.+.+....|+|+|++.||+|+.-|....-++|..+-.+++||++||.|||.+||+|
T Consensus 54 ~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvH 133 (355)
T KOG0033|consen 54 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVH 133 (355)
T ss_pred HHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCcee
Confidence 68899999999999999999999999999999999999999999998888777899999999999999999999999999
Q ss_pred ccCCCCcEEEccC---CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAY---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~---g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||+||+|+|+.+. --+||+|||+|.... .........|||.|||||++...+| +.++|||+||||||-||.|+
T Consensus 134 RDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~ 209 (355)
T KOG0033|consen 134 RDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGY 209 (355)
T ss_pred ccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCC
Confidence 9999999999764 349999999987554 4455677899999999999998888 59999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPP--W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+||.+.+...+|..|..+.+.+|+ | +++++++||++||..||.+|+|+.|.|+|||+...
T Consensus 210 ~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 210 PPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred CCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999887765 3 89999999999999999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=392.34 Aligned_cols=224 Identities=34% Similarity=0.635 Sum_probs=205.4
Q ss_pred HHHhhHHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 015814 7 SKYLDAFCILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 7 ~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l 85 (400)
++|+-.+...+-+.+|-.+|.+| +||+|++||..|.++..+|+|+||+++|+|+++|.+.|.|++..+++|+.||++||
T Consensus 108 K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAl 187 (604)
T KOG0592|consen 108 KRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDAL 187 (604)
T ss_pred HHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHH
Confidence 34555556677789999999999 89999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC-------C--c--cccccCCCCCCCChhhhcCCCCCC
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-------G--L--LHTTCGTPNYVAPEVLNDRGYDGS 154 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-------~--~--~~~~~gt~~y~APEvl~~~~~~~~ 154 (400)
+|||++|||||||||||||||++|++||+|||.|......... . . ..+.+||-.|++||+|.+... ++
T Consensus 188 eylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~ 266 (604)
T KOG0592|consen 188 EYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GP 266 (604)
T ss_pred HHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC-Cc
Confidence 9999999999999999999999999999999999876532211 1 1 145789999999999987654 69
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 155 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 155 ~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.+|||+||||||.|++|.+||.+.+...++++|....+.+|+.+++.+++||+++|..||.+|+|+++|.+||||..
T Consensus 267 ~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 267 SSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=379.31 Aligned_cols=224 Identities=42% Similarity=0.760 Sum_probs=209.5
Q ss_pred hhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 10 LDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 10 ~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
+++..-+-.|++||+||+.|+||||+.+|++|++.+.+.|||||+.||+|+|+|...+.++|.+++.+|+||++|+.|||
T Consensus 91 IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH 170 (668)
T KOG0611|consen 91 IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH 170 (668)
T ss_pred cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh
Confidence 44445578899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
.++|+|||||.+|||+|.++++||+|||++.++.. ...+.+.||+|.|.+||++.+.+|.|+.+|-|||||+||.|+
T Consensus 171 knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLV 247 (668)
T KOG0611|consen 171 KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLV 247 (668)
T ss_pred hccceecccchhheeecCCCCeeeeccchhhhhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHh
Confidence 99999999999999999999999999999988764 567899999999999999999999999999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCc
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~~ 237 (400)
.|.+||++.+...+.+.|..+.+.-|+ -+.++.-||+.||..||.+|.|+.+|-.|-|.+=++..+.
T Consensus 248 yGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V 314 (668)
T KOG0611|consen 248 YGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPV 314 (668)
T ss_pred hcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHhcCcccchhHHHHhhhheeeccccccc
Confidence 999999999999999999999887665 4678899999999999999999999999999987665443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=363.17 Aligned_cols=216 Identities=38% Similarity=0.728 Sum_probs=199.2
Q ss_pred HHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 12 AFCILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 12 ~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
...+.+.-++|+.||+++ .||||+++.++|++...+++|+|.|+.|+|||++.....++|..++.+++||++|++|||.
T Consensus 62 ~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa 141 (411)
T KOG0599|consen 62 PYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA 141 (411)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH
Confidence 456788889999999999 7999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc------CCCCCChhhHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND------RGYDGSTADLWSCGVI 164 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~------~~~~~~~~DIwSlGii 164 (400)
++|+||||||+|||++++.++||+|||+|+..+. ...+...||||+|+|||.+.. .+| +..+|+|+||||
T Consensus 142 ~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVI 217 (411)
T KOG0599|consen 142 RNIVHRDLKPENILLDDNMNIKISDFGFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVI 217 (411)
T ss_pred hhhhhcccChhheeeccccceEEeccceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHH
Confidence 9999999999999999999999999999986543 456778899999999999853 345 578999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCccCC--CCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~--~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
+|.||+|.+||......-+.+.|..|.+.+ |.| +|.++++||.+||+.||.+|+|++|+|.||||..
T Consensus 218 myTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 218 MYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 999999999999988888999999998754 667 8999999999999999999999999999999953
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=367.22 Aligned_cols=215 Identities=36% Similarity=0.662 Sum_probs=197.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+..||.||+.++|||||+++++....+.+|+|||||.||+|.++|...++++|+.++.+++||+.||++||+++|+
T Consensus 52 ~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~Ii 131 (429)
T KOG0595|consen 52 LVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNII 131 (429)
T ss_pred HHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccC------CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 95 HRDLKPENLLLDAY------GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 95 HrDlKP~NILl~~~------g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
||||||.||||+.. -.+||+|||+|+... ......+.||||.|||||++....|+ .++|+||+|+|||+|
T Consensus 132 HRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~ 207 (429)
T KOG0595|consen 132 HRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQC 207 (429)
T ss_pred eccCCcceEEeccCCCCCCCceEEecccchhhhCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHH
Confidence 99999999999875 358999999998765 35667889999999999999988897 899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCcc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
++|+.||+..+..+++..+..+.. ..+.+++....+|+...|..+|..|.+..+-+.|+++....
T Consensus 208 l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 208 LTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999999999999999888776654 34456888999999999999999999999999999998654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=368.73 Aligned_cols=219 Identities=31% Similarity=0.535 Sum_probs=187.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC--EEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.+|++++|||||++++...... .++++|||++||+|.+.+...+ +++|+.++.|.+|+++||+|||++|
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g 137 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG 137 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 678999999999999999999999854444 7999999999999999999987 7999999999999999999999999
Q ss_pred CeeccCCCCcEEEcc-CCCeeeecccccccccc-ccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 93 VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQ-VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~-~g~~kl~DFGla~~~~~-~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|+||||||+|||++. +|.+||+|||++..... ...........|||.|||||++........++||||+||++.||+|
T Consensus 138 ~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 138 IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 999999999999999 79999999999876553 1112233457899999999999863344458999999999999999
Q ss_pred CCCCCCC-CchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 171 GYLPFDD-SNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 171 G~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|..||.. .........+... .+..|.++|.++++||.+|+..||.+|||++++|+|||.+....
T Consensus 218 g~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 218 GKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999987 3443333333322 35778889999999999999999999999999999999987543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.56 Aligned_cols=220 Identities=37% Similarity=0.689 Sum_probs=195.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
++++++||.||++|.|||||+|+++..+ .+.+|||+|||..|++. +.-.+.. +++++|+.|++.++.||+|||.+|
T Consensus 152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg 230 (576)
T KOG0585|consen 152 IEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQG 230 (576)
T ss_pred HHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 5899999999999999999999999875 46799999999999874 3334445 899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccc---cCCCccccccCCCCCCCChhhhc---CCCCCChhhHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV---RDDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILF 166 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGiil~ 166 (400)
|+||||||.|+|++++|++||+|||.+..+... +.+..+....|||.|+|||.+.+ ..|.+.+.||||+||+||
T Consensus 231 iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLY 310 (576)
T KOG0585|consen 231 IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLY 310 (576)
T ss_pred eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHH
Confidence 999999999999999999999999998765322 12223455789999999999987 568889999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHhhhcCccCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 167 VLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
.|+.|++||-+....+++.+|......+|.. +.+.+++||.+||.+||.+|+++.+|..|||...+...+
T Consensus 311 CllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 311 CLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9999999999999999999999888777765 799999999999999999999999999999999875543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.54 Aligned_cols=215 Identities=36% Similarity=0.637 Sum_probs=192.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
-++.++.|-.||...++|+||+||..|++..++|+||||.+||++..+|...+.++++.+++|+.+++.|++.||+.|++
T Consensus 184 Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyI 263 (550)
T KOG0605|consen 184 QVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYI 263 (550)
T ss_pred hHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcc
Confidence 36889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccc--------------------cCCC-------------------------
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQV--------------------RDDG------------------------- 129 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~--------------------~~~~------------------------- 129 (400)
||||||+|+|||..|++||+||||++..... ..+.
T Consensus 264 HRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~ 343 (550)
T KOG0605|consen 264 HRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQ 343 (550)
T ss_pred cccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhh
Confidence 9999999999999999999999998542210 0000
Q ss_pred ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCc--cCCCCC--CCHHHHHH
Q 015814 130 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 205 (400)
Q Consensus 130 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~~~~l 205 (400)
...+..|||.|+||||+.+++|. ..+|+||||||+||||.|.+||.+.++.+.+++|..-. ..+|.. ++.++++|
T Consensus 344 ~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DL 422 (550)
T KOG0605|consen 344 LAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDL 422 (550)
T ss_pred hhhcccCCccccchHHHhcCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHH
Confidence 01235799999999999999984 99999999999999999999999999999999986654 455554 78999999
Q ss_pred HHHhcCCCCCCCCC---HHHHhcCccccc
Q 015814 206 IARILDPNPMTRIT---IPEILEDEWFKK 231 (400)
Q Consensus 206 i~~mL~~dP~~R~t---~~eil~h~~~~~ 231 (400)
|.+||. ||.+|.. ++||.+||||+.
T Consensus 423 I~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 423 ITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 999999 9999985 999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=348.89 Aligned_cols=202 Identities=33% Similarity=0.593 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeE-EE-EeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYE-VM-GSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~-~~-~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
-+++.+|+.+|++|+|||||++|+ .+ +++..++||||||.+|+|...|+. ...++|..+++||.||+.||.+||
T Consensus 62 rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH 141 (375)
T KOG0591|consen 62 RQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH 141 (375)
T ss_pred HHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh
Confidence 467889999999999999999998 34 444459999999999999998864 456999999999999999999999
Q ss_pred H--cC--CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 90 S--RG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 90 ~--~g--ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
+ .. |+||||||.||+++.+|.+||+|||+++++... ....++.+|||.||+||++.+.+|+ .++||||+||++
T Consensus 142 ~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCll 218 (375)
T KOG0591|consen 142 SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLL 218 (375)
T ss_pred ccccccceeeccCcchheEEcCCCceeeccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHH
Confidence 9 45 999999999999999999999999999987652 3345678999999999999999997 999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHhhhcCccC-CC-CCCCHHHHHHHHHhcCCCCCCCCCH
Q 015814 166 FVLLAGYLPFDDSNLMNLYKKISAAEFT-CP-PWLSFTARKLIARILDPNPMTRITI 220 (400)
Q Consensus 166 ~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~-~~~s~~~~~li~~mL~~dP~~R~t~ 220 (400)
|||++-+.||.+.+..++.++|.++.++ +| ..+|.++..+|..|+.+||..||+.
T Consensus 219 yEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 219 YEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 9999999999999999999999999876 55 4589999999999999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=363.36 Aligned_cols=218 Identities=40% Similarity=0.744 Sum_probs=205.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..++-+|++.|+.++|||||++|++..+...+|+|+|+-+||+|+|+|..+ .++.|+.+++||.||+.|+.|||+..||
T Consensus 61 t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVV 140 (864)
T KOG4717|consen 61 TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVV 140 (864)
T ss_pred hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 467889999999999999999999999999999999999999999999765 4799999999999999999999999999
Q ss_pred eccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 95 HRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
||||||||+.+-+ -|-|||.|||++..+.. ...+.+.||+..|-|||++.+..|+.+++||||||||||-|++|++
T Consensus 141 HRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~ 217 (864)
T KOG4717|consen 141 HRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQP 217 (864)
T ss_pred cccCCcceeEEeeecCceEeeeccccccCCC---cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCC
Confidence 9999999998866 59999999999876653 5568899999999999999999999999999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
||+..+..+....|....+..|..+|.++++||..||..||.+|.|.++|..|+|++....++
T Consensus 218 PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 218 PFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred ccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 999999999999999999999999999999999999999999999999999999999766543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=368.90 Aligned_cols=214 Identities=33% Similarity=0.622 Sum_probs=202.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+..+++|++|++.++|||||.++++|++..++|+|.|||.| +|+..+..++.++|+.++.+..|+++||.|||+.+|+|
T Consensus 45 l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilh 123 (808)
T KOG0597|consen 45 LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILH 123 (808)
T ss_pred HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 78899999999999999999999999999999999999998 99999999999999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
||+||.|||++..|.+|+||||+|+.... ....++...|||.|||||+..+.+|+ ..+|+||+|||+|||.+|++||
T Consensus 124 rd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 124 RDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred ccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCc
Confidence 99999999999999999999999987654 34456778899999999999998887 8899999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
-..+...+.+.|.......|...|..+.+|++.+|.+||.+|+|..+++.|||++...
T Consensus 201 ~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 201 YARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 9999999999999888888889999999999999999999999999999999998643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.80 Aligned_cols=218 Identities=30% Similarity=0.501 Sum_probs=190.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
+...-..|||.||++|+||||++|.+...+. ..+|+|+|||+. ||.-++... ..|++.+++.|++||+.||+|||+
T Consensus 158 ~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~ 236 (560)
T KOG0600|consen 158 GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS 236 (560)
T ss_pred cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh
Confidence 4456788999999999999999999998876 789999999998 888888763 489999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
+||+|||||..|||||.+|++||+|||||+++.... ...++..+-|+||+|||.+.+..-++..+|+||+||||.||++
T Consensus 237 ~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~ 315 (560)
T KOG0600|consen 237 RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL 315 (560)
T ss_pred cCeeeccccccceEEcCCCCEEeccccceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc
Confidence 999999999999999999999999999999876543 3346778889999999999988877899999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCcc----------CCC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHH
Q 015814 171 GYLPFDDSNLMNLYKKISAAEF----------TCP-------------------PWLSFTARKLIARILDPNPMTRITIP 221 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~----------~~~-------------------~~~s~~~~~li~~mL~~dP~~R~t~~ 221 (400)
|++.|++.+..++..+|..... ..| ..++.++.+|+..||..||.+|.|+.
T Consensus 316 gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~ 395 (560)
T KOG0600|consen 316 GKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTAS 395 (560)
T ss_pred CCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHH
Confidence 9999999998888777643211 111 12578899999999999999999999
Q ss_pred HHhcCcccccCC
Q 015814 222 EILEDEWFKKDY 233 (400)
Q Consensus 222 eil~h~~~~~~~ 233 (400)
++|+|+||....
T Consensus 396 ~aL~seyF~t~p 407 (560)
T KOG0600|consen 396 SALQSEYFTTEP 407 (560)
T ss_pred HHhcCcccccCC
Confidence 999999995443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=345.23 Aligned_cols=233 Identities=27% Similarity=0.452 Sum_probs=197.0
Q ss_pred cchhHHHhhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEe-----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHH
Q 015814 3 FQDLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGS-----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77 (400)
Q Consensus 3 ~~~~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~ 77 (400)
.|.+.+..++.-..++..||+++|+.++|+||+.+++++.. -..+|+|+|+++. +|...|+....++++.++.+
T Consensus 52 IKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f 130 (359)
T KOG0660|consen 52 IKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYF 130 (359)
T ss_pred hhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHHHcCccccHHHHHHH
Confidence 34556666666778999999999999999999999999865 4569999999954 88888888777999999999
Q ss_pred HHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhh
Q 015814 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 78 ~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
+.|++.||+|+|+.||+||||||.|+|++.++.+||+|||+|+...........+...-|.||+|||++....-++..+|
T Consensus 131 ~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiD 210 (359)
T KOG0660|consen 131 LYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAID 210 (359)
T ss_pred HHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhh
Confidence 99999999999999999999999999999999999999999987654333445577788999999999976665579999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCc-----------------------cCCC--------CCCCHHHHHHH
Q 015814 158 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-----------------------FTCP--------PWLSFTARKLI 206 (400)
Q Consensus 158 IwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~-----------------------~~~~--------~~~s~~~~~li 206 (400)
|||+|||+.||++|++-|.|.+..++...|...- +..| +..++.+.+|+
T Consensus 211 iWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLl 290 (359)
T KOG0660|consen 211 IWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLL 290 (359)
T ss_pred hhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHH
Confidence 9999999999999999999988766655543211 1111 23688999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 207 ARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 207 ~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
.+||..||.+|+|++|+|+|||+.....|.
T Consensus 291 ekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 291 EKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 999999999999999999999999766543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=341.42 Aligned_cols=214 Identities=26% Similarity=0.475 Sum_probs=183.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
+-+-..|||+.|++|+|||+|.++++|.....+++|+|||+. ++.+-++.. .+++++.++.|+.|++.|+.|||++++
T Consensus 44 VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~ 122 (396)
T KOG0593|consen 44 VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNC 122 (396)
T ss_pred HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCe
Confidence 344457899999999999999999999999999999999998 555666554 479999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||||||++.+|.+||||||+|+.... .....+.+..|.||+|||.+.+...+|.++||||+||++.||++|.+
T Consensus 123 IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~p 200 (396)
T KOG0593|consen 123 IHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEP 200 (396)
T ss_pred ecccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCc
Confidence 9999999999999999999999999987654 34566778899999999999986666899999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC---------------------ccCCC----------CCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 174 PFDDSNLMNLYKKISAA---------------------EFTCP----------PWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~---------------------~~~~~----------~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
.|++.+..++...|... .++.| +.++.-+.+|+++||+.||.+|++.+|
T Consensus 201 L~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~q 280 (396)
T KOG0593|consen 201 LWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQ 280 (396)
T ss_pred CCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHH
Confidence 99998876655444211 01111 125678899999999999999999999
Q ss_pred HhcCccccc
Q 015814 223 ILEDEWFKK 231 (400)
Q Consensus 223 il~h~~~~~ 231 (400)
++.||||..
T Consensus 281 ll~H~yFd~ 289 (396)
T KOG0593|consen 281 LLHHPYFDG 289 (396)
T ss_pred HhcChHHHH
Confidence 999999943
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=331.80 Aligned_cols=217 Identities=36% Similarity=0.706 Sum_probs=204.0
Q ss_pred hhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHH--hCCCCCHHHHHHHHHHHHHHHHH
Q 015814 10 LDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 10 ~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
+...++..|+++|++|.+.|+||||+++|++|.+...+|+++||+.+|+|+..+. ...++++..+..|++|++.|+.|
T Consensus 60 i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y 139 (281)
T KOG0580|consen 60 ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLY 139 (281)
T ss_pred HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHH
Confidence 4445778999999999999999999999999999999999999999999999998 66689999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||.++|+||||||+|+|++..|.+||+|||-+.... .....+.|||..|.|||...+.+++ ..+|+|++|++.||
T Consensus 140 ~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~ye 214 (281)
T KOG0580|consen 140 CHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYE 214 (281)
T ss_pred hccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHH
Confidence 999999999999999999999999999999876543 3344678999999999999999887 89999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
++.|..||...+..+.|++|....+.+|+.+|.++.+||.+||.++|.+|.+..|++.|||...
T Consensus 215 flvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 215 FLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999999999999999999999999999999999999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.52 Aligned_cols=210 Identities=30% Similarity=0.525 Sum_probs=186.7
Q ss_pred HHHHHHHHhCC-CCCcceeeEEEEeCC-EEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 20 KREVATMKLVK-HPNVVRLYEVMGSKT-KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 20 ~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.||+.-|++|+ |||||++.+++.+.. .+|+|||||+. +|+..++.++ .|++..++.|+.||++||+|+|.+|+.||
T Consensus 56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR 134 (538)
T KOG0661|consen 56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR 134 (538)
T ss_pred HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 47999999998 999999999998777 99999999986 8999997765 59999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
|+||||||+..+..+||+|||+|+.... ....+.++.|.||+|||++...++++.++|||++|||++|+.+-++.|+
T Consensus 135 DlKPENiLi~~~~~iKiaDFGLARev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP 211 (538)
T KOG0661|consen 135 DLKPENILISGNDVIKIADFGLAREVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP 211 (538)
T ss_pred cCChhheEecccceeEeccccccccccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence 9999999999999999999999986543 3456778899999999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcC-------------------ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 177 DSNLMNLYKKISAA-------------------EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 177 ~~~~~~~~~~i~~~-------------------~~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|.+..++..+|... .+.+| +..+.++.+||.+||..||.+|||++|+|+|
T Consensus 212 G~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 212 GASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 99988777666421 12222 2267899999999999999999999999999
Q ss_pred cccccCC
Q 015814 227 EWFKKDY 233 (400)
Q Consensus 227 ~~~~~~~ 233 (400)
|||+...
T Consensus 292 pffq~~~ 298 (538)
T KOG0661|consen 292 PFFQVGR 298 (538)
T ss_pred ccccccc
Confidence 9999654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=353.76 Aligned_cols=213 Identities=35% Similarity=0.635 Sum_probs=195.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.++++++||||+++++++...+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+|
T Consensus 39 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH 118 (323)
T cd05571 39 VAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118 (323)
T ss_pred HHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence 56788999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..| +.++||||+||++|+|++|..||
T Consensus 119 rDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 119 RDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred CCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecCccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCC
Confidence 99999999999999999999999864322 1223345689999999999987777 48999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
.+.+....+..+......+|..++.++.+||++||+.||.+|| ++.++++||||..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 196 YNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9988888888887788888889999999999999999999999 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=355.11 Aligned_cols=211 Identities=36% Similarity=0.717 Sum_probs=195.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.++++++||||+++++++..++.+|+||||+.||+|.+.+...+.+++..++.++.|++.||+|||++||+
T Consensus 61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 140 (329)
T PTZ00263 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII 140 (329)
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 35778999999999999999999999999999999999999999999999988999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 141 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p 214 (329)
T PTZ00263 141 YRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPP 214 (329)
T ss_pred ecCCCHHHEEECCCCCEEEeeccCceEcCC-----CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCC
Confidence 999999999999999999999999875422 1235689999999999988776 4899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
|.+.+....+..+..+...+|.+++..+++||++||+.||.+|++ +++++.||||..
T Consensus 215 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 215 FFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999888888888888888899999999999999999999999997 799999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=363.79 Aligned_cols=211 Identities=28% Similarity=0.550 Sum_probs=188.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
+-|..|+.+|+..+|+|||++++.|.-++.+|+||||++||+|.|.+.. ..++|.++..++++++.||+|||++||+||
T Consensus 315 eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHr 393 (550)
T KOG0578|consen 315 ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHR 393 (550)
T ss_pred hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeee
Confidence 5678899999999999999999999988999999999999999988866 459999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
|||.+|||++.+|.+||+|||++....... ....+..|||.|||||+...+.| ++++|||||||+++||+-|.+||-
T Consensus 394 DIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 394 DIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred ccccceeEeccCCcEEEeeeeeeecccccc--CccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCcc
Confidence 999999999999999999999987655432 24467789999999999999888 699999999999999999999998
Q ss_pred CCch-HHHHHhhhcCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 177 DSNL-MNLYKKISAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 177 ~~~~-~~~~~~i~~~~--~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
..+. .++|.-..++. ...|+.+|..+++||.+||+.||.+|+|+.|+|+||||+.
T Consensus 471 nE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 471 NENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 6655 45555444454 4567779999999999999999999999999999999954
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=356.10 Aligned_cols=213 Identities=41% Similarity=0.758 Sum_probs=196.0
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+++|+.||+++. |||||.++++|++...+|+|||+|.||+|++.|... .++|..+..+++|++.|++|||+.||+
T Consensus 79 ~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvv 157 (382)
T KOG0032|consen 79 REDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVV 157 (382)
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 478999999999998 999999999999999999999999999999999887 499999999999999999999999999
Q ss_pred eccCCCCcEEEccC----CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAY----GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~----g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
||||||||+|+... +.+|++|||+|..... .....+.||||.|+|||++...+|. ..+||||+||++|.|++
T Consensus 158 HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~ 233 (382)
T KOG0032|consen 158 HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLS 233 (382)
T ss_pred eccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhh
Confidence 99999999999653 4799999999987654 4567889999999999999988884 99999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCccCC--CCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 171 GYLPFDDSNLMNLYKKISAAEFTC--PPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~~~--~~~--~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
|..||.+.+....+..+..+.+.+ ++| +|..+++||++||..||.+|+|+.++|+|||++...
T Consensus 234 G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 234 GVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred CCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 999999999998888998887654 445 799999999999999999999999999999998753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=345.77 Aligned_cols=224 Identities=33% Similarity=0.525 Sum_probs=190.7
Q ss_pred hhHHHhhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHH
Q 015814 5 DLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 82 (400)
Q Consensus 5 ~~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll 82 (400)
|+.+..+. ++.|++|+..|+.++||||++++..|..+..+|+||.||.+|++++.+... .+++|..+..++++++
T Consensus 60 nLEkc~~~---ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~L 136 (516)
T KOG0582|consen 60 NLEKCNND---LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVL 136 (516)
T ss_pred ehhhhhhh---HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHH
Confidence 44444444 899999999999999999999999999999999999999999999999763 3699999999999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCC-cc-ccccCCCCCCCChhhh--cCCCCCChhhH
Q 015814 83 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LL-HTTCGTPNYVAPEVLN--DRGYDGSTADL 158 (400)
Q Consensus 83 ~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~~-~~~~gt~~y~APEvl~--~~~~~~~~~DI 158 (400)
.||.|||++|.+|||||+.||||+++|.|||+|||.+......+... .. .+..|||+|||||++. ..+|+ .++||
T Consensus 137 kaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDI 215 (516)
T KOG0582|consen 137 KALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADI 215 (516)
T ss_pred HHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCcc-chhhh
Confidence 99999999999999999999999999999999999876554433211 11 5668999999999954 35675 99999
Q ss_pred HHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCC----------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 159 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----------WLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 159 wSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~----------~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
||+||+..||.+|..||....++...-.-.++.++.+. .++.+++.+|..||+.||.+|||++++|+|+|
T Consensus 216 wSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 216 WSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred hhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 99999999999999999988777655443334433221 26778999999999999999999999999999
Q ss_pred cccC
Q 015814 229 FKKD 232 (400)
Q Consensus 229 ~~~~ 232 (400)
|+..
T Consensus 296 Fk~~ 299 (516)
T KOG0582|consen 296 FKKA 299 (516)
T ss_pred Hhhc
Confidence 9964
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.19 Aligned_cols=215 Identities=36% Similarity=0.633 Sum_probs=195.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+.+|+.++++++||||+++++++......|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+
T Consensus 36 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 115 (312)
T cd05585 36 EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115 (312)
T ss_pred HHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 35678899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+. .++||||+||++|+|++|+.|
T Consensus 116 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~p 192 (312)
T cd05585 116 YRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPP 192 (312)
T ss_pred eCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCC
Confidence 999999999999999999999999875322 12223456899999999999887774 889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCcccccC
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKKD 232 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~---t~~eil~h~~~~~~ 232 (400)
|.+.+....+..+......+|..++.++.+||.+||..||.+|| ++.+++.||||...
T Consensus 193 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 193 FYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred cCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99988888888888888888889999999999999999999997 57999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=347.64 Aligned_cols=210 Identities=34% Similarity=0.694 Sum_probs=194.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++.+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+|
T Consensus 45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 124 (291)
T cd05612 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVY 124 (291)
T ss_pred HHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 56788999999999999999999999999999999999999999999999889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||
T Consensus 125 ~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf 198 (291)
T cd05612 125 RDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPF 198 (291)
T ss_pred cCCCHHHeEECCCCCEEEEecCcchhccC-----CcccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999875432 1234679999999999988776 48999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
.+.+....+..+..+...+|..++..+++||++||+.||.+|++ ++++++||||+.
T Consensus 199 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 199 FDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99988888888888888888889999999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=366.08 Aligned_cols=216 Identities=42% Similarity=0.818 Sum_probs=206.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+++|+.|+|||||+++.+..+...+|+||||+.||++++++.+++++.+..++.+|.|+++|++|||+++|+|
T Consensus 99 ~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivH 178 (596)
T KOG0586|consen 99 RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVH 178 (596)
T ss_pred HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceec
Confidence 45589999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
||||++||||+.+-++||+|||+++.+. ....+.+.||+|.|.|||++.+..|+++.+|+||+|+++|.|+.|.+||
T Consensus 179 rdLk~eNilL~~~mnikIaDfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF 255 (596)
T KOG0586|consen 179 RDLKAENILLDENMNIKIADFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF 255 (596)
T ss_pred cccchhhcccccccceeeeccccceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence 9999999999999999999999999876 3567889999999999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
++.+...+......+.+..|-.++.+++++|+++|.++|.+|+++++++.|+|......
T Consensus 256 DG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 256 DGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred CCcccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 99999999988889999999999999999999999999999999999999999986553
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=353.69 Aligned_cols=211 Identities=32% Similarity=0.612 Sum_probs=195.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+++.++||||+++++++.++...|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 74 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 153 (340)
T PTZ00426 74 QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153 (340)
T ss_pred hHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 35678899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus 154 HrDLkp~NILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~P 227 (340)
T PTZ00426 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPP 227 (340)
T ss_pred ccCCCHHHEEECCCCCEEEecCCCCeecCC-----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCC
Confidence 999999999999999999999999875432 1245689999999999987766 5899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
|.+.+....+..+..+...+|+.++..+.++|++||+.||.+|+ |++++++||||..
T Consensus 228 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 228 FYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99988888888888888888999999999999999999999995 8999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=366.66 Aligned_cols=212 Identities=32% Similarity=0.627 Sum_probs=197.2
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
+++.+.|-+|+... +||.+++++..|++++++|+||||+.||++ -++...+.+++..|++|+..++.||.|||++|||
T Consensus 412 Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~II 490 (694)
T KOG0694|consen 412 VESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGII 490 (694)
T ss_pred HHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCce
Confidence 78899999999988 499999999999999999999999999994 4555668899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|||||.+|||||.+|++||+|||+++.. ........|.||||.|+|||++.+..|. ..+|.|||||+|||||.|..|
T Consensus 491 YRDlKLdNiLLD~eGh~kiADFGlcKe~--m~~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~P 567 (694)
T KOG0694|consen 491 YRDLKLDNLLLDTEGHVKIADFGLCKEG--MGQGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESP 567 (694)
T ss_pred eeecchhheEEcccCcEEeccccccccc--CCCCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999998743 2344567889999999999999998884 999999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
|.+.+..+++..|....+.+|.|+|.++.++++++|.+||.+|.. +++|.+||||+.
T Consensus 568 F~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 568 FPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 999999999999999999999999999999999999999999996 478999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=346.58 Aligned_cols=214 Identities=36% Similarity=0.653 Sum_probs=195.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+++|+.+|+.++||||+++++++..++.+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+|
T Consensus 44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 123 (323)
T cd05584 44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIY 123 (323)
T ss_pred HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 56788999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 124 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf 200 (323)
T cd05584 124 RDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPF 200 (323)
T ss_pred CCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCcccccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCC
Confidence 99999999999999999999999864322 1223345689999999999987766 48899999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKKD 232 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~~ 232 (400)
.+.+.......+..+....|+.++.++.+||++||+.||.+|| +++++++||||...
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 201 TAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9988888888888888888999999999999999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=347.32 Aligned_cols=214 Identities=35% Similarity=0.628 Sum_probs=194.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+.+|+.+++.++||||+++++++...+.+|+||||++||+|.+.+...+.+++..+..++.||+.||+|||++||+
T Consensus 38 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 117 (328)
T cd05593 38 EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117 (328)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 35678899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus 118 HrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~P 194 (328)
T cd05593 118 YRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLP 194 (328)
T ss_pred ecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCCcCccChhhhcCCCC-CccCCccccchHHHHHhhCCCC
Confidence 999999999999999999999999864322 1222345689999999999987766 5899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
|.+.+.......+......+|..++.++.+||++||+.||.+|+ ++.++++||||..
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 195 FYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99888888888877777888889999999999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=332.81 Aligned_cols=216 Identities=39% Similarity=0.720 Sum_probs=191.1
Q ss_pred HHHHHHHHHHHhC-CCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLV-KHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 17 ~~i~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH 89 (400)
...++|++.+-+. .|||||.++++|++ ...+.+|||.++||+||.+|+.++. ++|.+|..+++||..|+.|||
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH 178 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH 178 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH
Confidence 6688999998888 69999999999864 4567899999999999999998775 999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
+.+|+||||||||+|... +..+||+|||+|+.... ...+.+.|-||.|+|||++....|+ ..+|+||+||++|
T Consensus 179 ~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimY 254 (400)
T KOG0604|consen 179 SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMY 254 (400)
T ss_pred hcchhhccCChhheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHH
Confidence 999999999999999976 45699999999975432 4567889999999999999888886 8999999999999
Q ss_pred HHHhCCCCCCCCch----HHHHHhhhcCccCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 167 VLLAGYLPFDDSNL----MNLYKKISAAEFTCPP--W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 167 elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~--~--~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
.||+|.+||..... ..+..+|..+.+.+|. | +|++++++|+++|..+|.+|.|+.+++.|||+......|
T Consensus 255 IlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred HhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 99999999976543 3567888889887764 4 799999999999999999999999999999999765444
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.22 Aligned_cols=213 Identities=34% Similarity=0.642 Sum_probs=193.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+++.++||||+++++++.....+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+|
T Consensus 39 ~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 118 (323)
T cd05595 39 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 118 (323)
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 56778899999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||
T Consensus 119 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 119 RDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred cCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCCcCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCC
Confidence 99999999999999999999998764221 1222345679999999999987776 48999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
...+.......+......+|..+++++.+||.+||+.||.+|+ ++.++++||||..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 196 YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 9988888888877777888888999999999999999999998 8999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.47 Aligned_cols=213 Identities=34% Similarity=0.644 Sum_probs=193.7
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++..+ +||||+++++++.+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 39 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~iv 118 (320)
T cd05590 39 VECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGII 118 (320)
T ss_pred HHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 56677899998877 79999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus 119 H~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred eCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcccccccCccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCC
Confidence 999999999999999999999999864321 1223345689999999999987766 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI------PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~------~eil~h~~~~~ 231 (400)
|.+.+....+..+.......|.+++.++.+||++||+.||.+||++ +++++||||+.
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 196 FEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 9999988888888888888899999999999999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=335.92 Aligned_cols=216 Identities=31% Similarity=0.538 Sum_probs=191.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
-+.++.-|-+||++++||.++.||..+++....|++||||+||+|....+.+ +.++++.|++|+..++.||+|||..|
T Consensus 120 Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG 199 (459)
T KOG0610|consen 120 KLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG 199 (459)
T ss_pred HHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc
Confidence 3677888999999999999999999999999999999999999999888664 46999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeecccccccccc----------------------------------ccC-----------
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ----------------------------------VRD----------- 127 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~----------------------------------~~~----------- 127 (400)
||+|||||||||+-++|++-|+||.|+..... ...
T Consensus 200 ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~ 279 (459)
T KOG0610|consen 200 IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS 279 (459)
T ss_pred eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence 99999999999999999999999998632110 000
Q ss_pred ---------CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCC--
Q 015814 128 ---------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-- 196 (400)
Q Consensus 128 ---------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-- 196 (400)
.....+.+||-.|+|||++.+.+. +.++|+|+|||.+||||.|..||.+.+..+.+.+|......+|.
T Consensus 280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~ 358 (459)
T KOG0610|consen 280 LPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP 358 (459)
T ss_pred chhhhcCCCCccccccccccccccceeeecCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC
Confidence 000123479999999999999887 59999999999999999999999999999999998877776665
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCC----HHHHhcCccccc
Q 015814 197 WLSFTARKLIARILDPNPMTRIT----IPEILEDEWFKK 231 (400)
Q Consensus 197 ~~s~~~~~li~~mL~~dP~~R~t----~~eil~h~~~~~ 231 (400)
.+|..+++||+++|.+||.+|.. +.||.+||||+.
T Consensus 359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 47899999999999999999998 999999999986
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.50 Aligned_cols=213 Identities=30% Similarity=0.619 Sum_probs=191.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+..|..++..+ +||||+++++++.+.+.+|+||||+.||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 39 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 118 (316)
T cd05620 39 VECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118 (316)
T ss_pred HHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45677888888765 89999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..|
T Consensus 119 HrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999864221 12233457899999999999887774 889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-~eil~h~~~~~ 231 (400)
|.+.+.......+.......|.+++.++++||++||+.||.+||++ +++++||||..
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 196 FHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 9998888888888777788889999999999999999999999998 58999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=342.37 Aligned_cols=213 Identities=33% Similarity=0.601 Sum_probs=194.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+..|..++..+ +||||+++++++.++..+|+||||++||+|.+.+...+.+++..+..++.|++.||.|||++||+
T Consensus 39 ~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 118 (321)
T cd05591 39 VDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118 (321)
T ss_pred HHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 56677899999876 89999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus 119 HrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 119 YRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCGTPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred ccCCCHHHeEECCCCCEEEeecccceeccc--CCccccccccCccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCC
Confidence 999999999999999999999999864322 1223345689999999999987776 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-------CHHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-------TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-------t~~eil~h~~~~~ 231 (400)
|...+....+..+.......|.+++.++.++|.+||+.||.+|+ +++++++||||..
T Consensus 196 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 196 FEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999888898888888888999999999999999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=344.37 Aligned_cols=214 Identities=35% Similarity=0.636 Sum_probs=193.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~gi 93 (400)
....+.+|+.+++.++||||+++++++.....+|+||||++||+|.+++...+.+++..+..++.||+.||+|||+ +||
T Consensus 38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~i 117 (325)
T cd05594 38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 3567788999999999999999999999999999999999999999999888889999999999999999999997 799
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus 118 vHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~ 194 (325)
T cd05594 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL 194 (325)
T ss_pred EecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccCCcccCCHHHHccCCC-CCccccccccceeeeeccCCC
Confidence 9999999999999999999999999864322 1222345679999999999987776 489999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
||.+.+.......+......+|..+++++.+||.+||+.||.+|+ ++.++++||||..
T Consensus 195 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 195 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 999988888888887778888888999999999999999999997 9999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=343.27 Aligned_cols=207 Identities=29% Similarity=0.499 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC-EEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT-KIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+++.+|+.+|++++|||||++++++.+.. ..++||||+++|+|.+++.. .+.++...+..++.||+.|++|||+++
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 679999999999999999999999998887 79999999999999999987 578999999999999999999999999
Q ss_pred -CeeccCCCCcEEEccCC-CeeeeccccccccccccCCCccccccCCCCCCCChhhh--cCCCCCChhhHHHHHHHHHHH
Q 015814 93 -VYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 93 -ivHrDlKP~NILl~~~g-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~--~~~~~~~~~DIwSlGiil~el 168 (400)
||||||||+|||++.++ ++||+|||+++...... .......||+.|||||++. ...|+ .++||||+||++|||
T Consensus 163 ~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl 239 (362)
T KOG0192|consen 163 PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWEL 239 (362)
T ss_pred CeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHH
Confidence 99999999999999998 99999999998654321 2233468999999999999 45675 999999999999999
Q ss_pred HhCCCCCCCCchHHHHHhh--hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 169 LAGYLPFDDSNLMNLYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+||+.||.+.........+ ....+..|..+++.+..|+..||+.||.+||++.+|+.
T Consensus 240 ~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 240 LTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999998875444433 33455667779999999999999999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=344.95 Aligned_cols=215 Identities=32% Similarity=0.581 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+++|+.+++.++||||+++++.+.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 44 ~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~giv 123 (363)
T cd05628 44 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123 (363)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 35788999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccC---------------------------------CCccccccCCCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------------------------------DGLLHTTCGTPNYV 141 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~---------------------------------~~~~~~~~gt~~y~ 141 (400)
||||||+|||++.+|.+||+|||+++....... .....+.+||+.|+
T Consensus 124 HrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~ 203 (363)
T cd05628 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI 203 (363)
T ss_pred ecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcccc
Confidence 999999999999999999999999875322100 01123468999999
Q ss_pred CChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcC--ccCCCCC--CCHHHHHHHHHhcCCCCC--
Q 015814 142 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKLIARILDPNPM-- 215 (400)
Q Consensus 142 APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~--~s~~~~~li~~mL~~dP~-- 215 (400)
|||++.+.+|. .++||||+||++|+|++|+.||.+.+..+.+.++... ...+|+. +++++++||.+|+. +|.
T Consensus 204 aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r 281 (363)
T cd05628 204 APEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHR 281 (363)
T ss_pred CHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Chhhc
Confidence 99999887775 8999999999999999999999998888888777643 3344543 78999999999775 444
Q ss_pred -CCCCHHHHhcCccccc
Q 015814 216 -TRITIPEILEDEWFKK 231 (400)
Q Consensus 216 -~R~t~~eil~h~~~~~ 231 (400)
.||+++||++||||+.
T Consensus 282 ~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 282 IGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCCHHHHhCCCCCCC
Confidence 4689999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=340.85 Aligned_cols=215 Identities=31% Similarity=0.592 Sum_probs=188.4
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.....+++|+.+++.+ +||||+++++++.+...+|+||||++||+|.+++...+++++..++.++.|++.||+|||++|
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 116 (329)
T cd05588 37 EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116 (329)
T ss_pred hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999998 799999999999999999999999999999999988889999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+|||++.++.+||+|||++..... ......+.+||+.|+|||++.+..+. .++||||+||++|+|++|+
T Consensus 117 ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~ 193 (329)
T cd05588 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred eEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccCCccccCHHHHcCCCCC-CccceechHHHHHHHHHCC
Confidence 99999999999999999999999999864221 12233457899999999999887764 8999999999999999999
Q ss_pred CCCCCCc---------hHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 015814 173 LPFDDSN---------LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT------IPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~---------~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t------~~eil~h~~~~~ 231 (400)
.||+... ....+..+.......|..++.++.++|++||+.||.+|+| ++++++||||..
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 194 SPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9996321 1234555666677788899999999999999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.23 Aligned_cols=213 Identities=36% Similarity=0.640 Sum_probs=193.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..++.+|+.++++++||||+++++++.++..+|+||||++||+|.+++.....+++..++.++.|++.||+|||++||+|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 121 (318)
T cd05582 42 RVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121 (318)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 35677899999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 122 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~ 198 (318)
T cd05582 122 RDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPF 198 (318)
T ss_pred CCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCC
Confidence 99999999999999999999999875432 1223345689999999999987766 48899999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
...+.......+.......|..++.++.+||++||+.||.+||| +.+++.||||..
T Consensus 199 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 199 QGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 99888888888877888888899999999999999999999999 788999999985
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=318.02 Aligned_cols=216 Identities=31% Similarity=0.480 Sum_probs=187.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.--...|||+.|+.++||||+.+.++|...+.+.+|+||++. +|...|+... .++...++.|+.|++.||+|||++.|
T Consensus 44 i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~I 122 (318)
T KOG0659|consen 44 INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWI 122 (318)
T ss_pred ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhh
Confidence 345678999999999999999999999999999999999987 8988887654 68999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||.|+|++++|.+||+|||+|+.+.... ......+-|.||+|||.+.+...++..+||||.|||+.||+.|.+
T Consensus 123 lHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P 200 (318)
T KOG0659|consen 123 LHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP 200 (318)
T ss_pred hcccCCccceEEcCCCcEEeecccchhccCCCC--cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence 999999999999999999999999999887643 333444789999999999887777899999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCcc----------------------CCC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAAEF----------------------TCP------PWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~----------------------~~~------~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
-|.+.+.-++...|...-. +.| +..+.++.+|+.+||..||.+|+|+.|+++
T Consensus 201 ~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 201 FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred CCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 9999887777666532111 011 114678899999999999999999999999
Q ss_pred CcccccCC
Q 015814 226 DEWFKKDY 233 (400)
Q Consensus 226 h~~~~~~~ 233 (400)
|+||+...
T Consensus 281 ~~yf~~~P 288 (318)
T KOG0659|consen 281 HPYFKSLP 288 (318)
T ss_pred chhhhcCC
Confidence 99999743
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.14 Aligned_cols=213 Identities=31% Similarity=0.623 Sum_probs=191.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
......|..+++.+ +||||+++++++.+...+|+||||++||+|.+.+.....+++..+..++.|++.||+|||++||+
T Consensus 39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv 118 (316)
T cd05619 39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118 (316)
T ss_pred HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 45667788888765 99999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.++.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus 119 Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 119 YRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCGTPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred eCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecCCccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCC
Confidence 999999999999999999999999864321 1223345689999999999987776 4899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIP-EILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~-eil~h~~~~~ 231 (400)
|.+.+..+.+..+.......|.+++.++.++|.+||+.||.+||++. ++++||||..
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 196 FHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 99988888888877777778889999999999999999999999996 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.45 Aligned_cols=217 Identities=30% Similarity=0.559 Sum_probs=189.1
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.+++.+ +||||+++++++.....+|+||||++||+|.+++.....+++..++.++.|++.||+|||++|
T Consensus 46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 125 (332)
T cd05614 46 KTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125 (332)
T ss_pred hHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4467788999999999 599999999999999999999999999999999988888999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+|||++.+|.+||+|||+++...... .......+||+.|+|||++.+....+.++|||||||++|+|++|.
T Consensus 126 ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred cEecCCCHHHeEECCCCCEEEeeCcCCccccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 9999999999999999999999999987543221 122335689999999999986654568899999999999999999
Q ss_pred CCCCCCc----hHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 173 LPFDDSN----LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
.||.... .......+.......|..++..+.++|.+||+.||.+|| +++++++||||+.
T Consensus 205 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 205 SPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9996432 334445555566677778999999999999999999999 8889999999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.85 Aligned_cols=213 Identities=34% Similarity=0.650 Sum_probs=193.6
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.+ +||||+++++++.+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 39 ~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~iv 118 (318)
T cd05570 39 VECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118 (318)
T ss_pred HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 56778899999888 79999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++++|.+||+|||++..... ........+||+.|+|||++.+..+. .++||||+||++|+|++|+.|
T Consensus 119 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCGTPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred ccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceecCccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCC
Confidence 999999999999999999999999864221 12223456899999999999887774 899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-----~eil~h~~~~~ 231 (400)
|.+.+....+..+.......|..++.++.+||++||+.||.+|||+ .++++||||+.
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 196 FEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9998888888888877888888899999999999999999999999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.09 Aligned_cols=213 Identities=31% Similarity=0.660 Sum_probs=190.7
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+..|..++..+ +||||+++++++..+..+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 39 ~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv 118 (316)
T cd05592 39 VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118 (316)
T ss_pred HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 45566777777755 89999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus 119 H~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCGTPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred eCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccCCccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCC
Confidence 999999999999999999999999875322 1223345689999999999987776 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-~eil~h~~~~~ 231 (400)
|.+.+..+.+..+.......|.+++.++.+||.+||+.||.+||++ .++++||||..
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 196 FHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 9998888888888777778888999999999999999999999986 48999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.56 Aligned_cols=211 Identities=28% Similarity=0.475 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++||||+++++++.++...|+||||++| +|.+.+...+ .+++..+..++.|++.||+|||++||+
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 125 (288)
T cd07871 47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125 (288)
T ss_pred chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 35677899999999999999999999999999999999986 8999887654 479999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... .........||+.|+|||++.+....+.++||||+||++|+|++|+.|
T Consensus 126 H~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p 203 (288)
T cd07871 126 HRDLKPQNLLINEKGELKLADFGLARAKSV--PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM 203 (288)
T ss_pred cCCCCHHHEEECCCCCEEECcCcceeeccC--CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999865432 122234567899999999987654446899999999999999999999
Q ss_pred CCCCchHHHHHhhhcC-------------------ccCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 175 FDDSNLMNLYKKISAA-------------------EFTC-----------PPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~-------------------~~~~-----------~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
|.+.+..+....+... ...+ .+.++.++.+||++||+.||.+|||++|++
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 204 FPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred CCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 9887765444332110 0001 123678999999999999999999999999
Q ss_pred cCccc
Q 015814 225 EDEWF 229 (400)
Q Consensus 225 ~h~~~ 229 (400)
+||||
T Consensus 284 ~hp~f 288 (288)
T cd07871 284 RHSYF 288 (288)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=335.63 Aligned_cols=213 Identities=31% Similarity=0.578 Sum_probs=192.3
Q ss_pred HHHHHHHHHHHHhCCCC-CcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+..|+.++..++|+ +|+++++++...+.+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 123 (324)
T cd05587 44 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123 (324)
T ss_pred HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 56788899999999764 58899999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus 124 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~p 200 (324)
T cd05587 124 YRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPP 200 (324)
T ss_pred ecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCceeeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999864221 1223345689999999999988776 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-----~eil~h~~~~~ 231 (400)
|.+.+..+.+..+.......|..++.++.+++++||+.||.+|++. +++++||||..
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 201 FDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9998888888888888888888999999999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=336.04 Aligned_cols=212 Identities=29% Similarity=0.548 Sum_probs=188.9
Q ss_pred HHHHHHHHHHH---HhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATM---KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++ +.++||||+++++++.+....|+||||++||+|...+.. +.+++..+..++.|++.||+|||++|
T Consensus 43 ~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05589 43 VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK 121 (324)
T ss_pred HHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 56777777765 466799999999999999999999999999999988855 57999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+||+++.+|.+||+|||++..... ......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+
T Consensus 122 ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~ 198 (324)
T cd05589 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGE 198 (324)
T ss_pred eEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCC
Confidence 99999999999999999999999999764322 1222345689999999999987766 48899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
.||.+.+..+....+.......|..++.++.++|.+||+.||.+|| ++.++++||||+.
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 199 SPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999988888888888888888888999999999999999999999 7999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=332.03 Aligned_cols=213 Identities=28% Similarity=0.418 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+++.++||||+++++++......|+||||++++.+.........+++..++.++.|++.||.|||+.||+
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 122 (287)
T cd07848 43 VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122 (287)
T ss_pred chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 35678899999999999999999999999999999999999977765555556799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.++.+||+|||++...... .........||+.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus 123 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~p 200 (287)
T cd07848 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPL 200 (287)
T ss_pred cCCCCHHHEEEcCCCcEEEeeccCccccccc-ccccccccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCC
Confidence 9999999999999999999999998764321 1122334579999999999987776 4899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCc-------------------cCC-------------CCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 175 FDDSNLMNLYKKISAAE-------------------FTC-------------PPWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~-------------------~~~-------------~~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
|.+.+..+....+.... ... ...+|.++.+||++||++||.+|||+++
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 201 FPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred CCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 98766443322211100 001 1126788999999999999999999999
Q ss_pred HhcCccc
Q 015814 223 ILEDEWF 229 (400)
Q Consensus 223 il~h~~~ 229 (400)
+++||||
T Consensus 281 ~l~hp~f 287 (287)
T cd07848 281 CLNHPAF 287 (287)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=324.28 Aligned_cols=217 Identities=29% Similarity=0.383 Sum_probs=187.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEE--eCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
+..-.-.|||.+|.+++|||||.+-++.. +-+.+|+|||||+. +|...+...+ +|...+++.++.|++.|++|||.
T Consensus 117 GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~ 195 (419)
T KOG0663|consen 117 GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD 195 (419)
T ss_pred CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh
Confidence 33445678999999999999999999875 44679999999987 8999998766 89999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
+.|+||||||+|+|++..|.+||+|||+|+.+... ....+..+-|.||+|||.+.+...+++++|+||+|||+.||++
T Consensus 196 ~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~ 273 (419)
T KOG0663|consen 196 NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT 273 (419)
T ss_pred ceeEecccchhheeeccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence 99999999999999999999999999999977653 2335566789999999999987777899999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCc-------------------cCCCC-----------C--CCHHHHHHHHHhcCCCCCCCC
Q 015814 171 GYLPFDDSNLMNLYKKISAAE-------------------FTCPP-----------W--LSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~-------------------~~~~~-----------~--~s~~~~~li~~mL~~dP~~R~ 218 (400)
+++-|.+.+..++..+|...- ..++. + +|+...+|+..+|..||.+|.
T Consensus 274 ~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~ 353 (419)
T KOG0663|consen 274 QKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI 353 (419)
T ss_pred cCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc
Confidence 999999998887776653210 11111 1 458899999999999999999
Q ss_pred CHHHHhcCcccccCC
Q 015814 219 TIPEILEDEWFKKDY 233 (400)
Q Consensus 219 t~~eil~h~~~~~~~ 233 (400)
|+++.|+|+||....
T Consensus 354 tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 354 TAEDGLKHEYFRETP 368 (419)
T ss_pred cHHHhhcccccccCC
Confidence 999999999999754
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.57 Aligned_cols=212 Identities=33% Similarity=0.569 Sum_probs=188.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+.+|+.+++.++||||+++++++......|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+
T Consensus 44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 123 (333)
T cd05600 44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI 123 (333)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35778899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... .....+||+.|+|||++.+..+. .++||||+||++|+|++|..|
T Consensus 124 H~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~p 197 (333)
T cd05600 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPP 197 (333)
T ss_pred ccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCC
Confidence 999999999999999999999999875432 23456899999999999887664 899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCc--cCCCC------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 175 FDDSNLMNLYKKISAAE--FTCPP------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~--~~~~~------~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|...+..+.+..+.... ...|. .++.++.+||.+||..+|.+|||++++++||||...
T Consensus 198 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 198 FSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99888777666554321 22222 358999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=336.60 Aligned_cols=213 Identities=35% Similarity=0.601 Sum_probs=189.8
Q ss_pred HHHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..++.+|.. +++.++||||+++++.+.+....|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+
T Consensus 39 ~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~giv 118 (323)
T cd05575 39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118 (323)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 345555655 4678999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+. .++|||||||++|+|++|..|
T Consensus 119 H~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred eCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCC
Confidence 999999999999999999999999864321 12233456899999999999887764 889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~----~eil~h~~~~~ 231 (400)
|.+.+..+.+..+.......++.++.++.++|++||+.||.+||++ .++++||||..
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 9998888888888877777888899999999999999999999987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.41 Aligned_cols=215 Identities=31% Similarity=0.601 Sum_probs=187.5
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.....+.+|+.++.++ +||||+++++++.+.+.+|+||||++||+|..++...+.+++..++.++.|++.||+|||++|
T Consensus 37 ~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 116 (329)
T cd05618 37 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116 (329)
T ss_pred hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999998877 899999999999999999999999999999999988889999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+||+++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|+
T Consensus 117 ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~ 193 (329)
T cd05618 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred eeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccCCccccCHHHHcCCCC-CCccceecccHHHHHHhhCC
Confidence 99999999999999999999999999864322 1222345689999999999987776 48899999999999999999
Q ss_pred CCCCCC---------chHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 015814 173 LPFDDS---------NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT------IPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t------~~eil~h~~~~~ 231 (400)
.||... .....+..+.......|..++..+.+||++||+.||.+||| ++++++||||+.
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 194 SPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999521 12234455666677788889999999999999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.62 Aligned_cols=212 Identities=26% Similarity=0.421 Sum_probs=183.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.++++++||||+++++++.+.+..|+||||++||+|.+.+... ..+++..+..++.|++.||+|||++||
T Consensus 44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 346788999999999999999999999999999999999999998888543 368999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||+++++.+||+|||++..... ........||+.|+|||++.+..|. .++||||+||++|+|++|+.
T Consensus 124 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~ 199 (285)
T cd05631 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQS 199 (285)
T ss_pred EeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCeecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCC
Confidence 9999999999999999999999999875432 2223456799999999999877774 88999999999999999999
Q ss_pred CCCCCchH----HHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 174 PFDDSNLM----NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
||.+.+.. .....+.......+..++.++.+||++||+.||.+||| ++++++||||..
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 200 PFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred CCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 99875532 23333444455667779999999999999999999997 899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=341.94 Aligned_cols=216 Identities=35% Similarity=0.627 Sum_probs=187.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+++|+.+|+.++||||+++++++.++..+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iv 123 (364)
T cd05599 44 QVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYI 123 (364)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45678899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCC------------------------------------CccccccCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD------------------------------------GLLHTTCGTP 138 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~ 138 (400)
||||||+|||++.+|.+||+|||++......... ....+.+||+
T Consensus 124 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 203 (364)
T cd05599 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP 203 (364)
T ss_pred eccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCc
Confidence 9999999999999999999999998653211100 0112357999
Q ss_pred CCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCc--cCCCC--CCCHHHHHHHHHhcCCCC
Q 015814 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP--WLSFTARKLIARILDPNP 214 (400)
Q Consensus 139 ~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~mL~~dP 214 (400)
.|+|||++...++. .++|||||||++|+|++|..||.+.+..+.+..+.... ...|. .+++++++||++||. +|
T Consensus 204 ~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p 281 (364)
T cd05599 204 DYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EA 281 (364)
T ss_pred cccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CH
Confidence 99999999887774 89999999999999999999999888777776664432 23333 378999999999997 99
Q ss_pred CCCCC---HHHHhcCcccccC
Q 015814 215 MTRIT---IPEILEDEWFKKD 232 (400)
Q Consensus 215 ~~R~t---~~eil~h~~~~~~ 232 (400)
.+|++ +.++++||||+..
T Consensus 282 ~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 282 ERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred hhcCCCCCHHHHhcCCCcCCC
Confidence 99998 9999999999763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.21 Aligned_cols=216 Identities=34% Similarity=0.586 Sum_probs=185.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.....+.+|+.++++++||||+++++.+.++..+|+||||++||+|.+.+...+.+++..++.++.|++.||+|||++||
T Consensus 43 ~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~i 122 (382)
T cd05625 43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122 (382)
T ss_pred HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34678999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeecccccccccccc---------------------------------------------CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR---------------------------------------------DD 128 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~---------------------------------------------~~ 128 (400)
+||||||+|||++.+|.+||+|||++..+.... ..
T Consensus 123 vHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (382)
T cd05625 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQR 202 (382)
T ss_pred ecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccc
Confidence 999999999999999999999999975322100 00
Q ss_pred CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcC--ccCCC--CCCCHHHHH
Q 015814 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWLSFTARK 204 (400)
Q Consensus 129 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~ 204 (400)
....+.+||+.|+|||++.+.+|. .++||||+||++|+|++|+.||.+.+..+....+... ....| ..+++++.+
T Consensus 203 ~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 281 (382)
T cd05625 203 CLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASD 281 (382)
T ss_pred ccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHH
Confidence 011235799999999999888875 8999999999999999999999988776665555432 23333 347999999
Q ss_pred HHHHhcCCCCCCCCC---HHHHhcCccccc
Q 015814 205 LIARILDPNPMTRIT---IPEILEDEWFKK 231 (400)
Q Consensus 205 li~~mL~~dP~~R~t---~~eil~h~~~~~ 231 (400)
+|.+|+ .+|.+|++ ++++++||||+.
T Consensus 282 li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 282 LIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999987 59999997 999999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.15 Aligned_cols=215 Identities=34% Similarity=0.609 Sum_probs=184.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+++|+.+++.++||||+++++++.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 44 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~giv 123 (377)
T cd05629 44 QLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123 (377)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46788999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCC---------------------------------------------C
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------------------------------------------G 129 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~---------------------------------------------~ 129 (400)
||||||+|||++.+|.+||+|||+++.+...... .
T Consensus 124 HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (377)
T cd05629 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL 203 (377)
T ss_pred ccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence 9999999999999999999999998632210000 0
Q ss_pred ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcC--ccCCCC--CCCHHHHHH
Q 015814 130 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--WLSFTARKL 205 (400)
Q Consensus 130 ~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~l 205 (400)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+... ...+|. .++.++.+|
T Consensus 204 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dl 282 (377)
T cd05629 204 MAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDL 282 (377)
T ss_pred cccccCCCccccCHHHHccCCC-CCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHH
Confidence 0013579999999999988777 48999999999999999999999988877777666432 334444 378999999
Q ss_pred HHHhcCCCCCCC---CCHHHHhcCccccc
Q 015814 206 IARILDPNPMTR---ITIPEILEDEWFKK 231 (400)
Q Consensus 206 i~~mL~~dP~~R---~t~~eil~h~~~~~ 231 (400)
|.+||. +|.+| +|+.+++.||||+.
T Consensus 283 i~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 283 IRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred HHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999998 77765 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=341.84 Aligned_cols=217 Identities=32% Similarity=0.553 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.....+++|+.+++.++||||+++++++.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~gi 122 (381)
T cd05626 43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122 (381)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34678999999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccC---------------------------------------------C
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------------------------------------------D 128 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~---------------------------------------------~ 128 (400)
+||||||+|||++.+|.+||+|||++........ .
T Consensus 123 vHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (381)
T cd05626 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQR 202 (381)
T ss_pred eecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccc
Confidence 9999999999999999999999999754321000 0
Q ss_pred CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhc--CccCCCC--CCCHHHHH
Q 015814 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPP--WLSFTARK 204 (400)
Q Consensus 129 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~ 204 (400)
....+.+||+.|+|||++.+.+|. .++||||+||++|+|++|..||...+..+....+.. .....|+ .+++++.+
T Consensus 203 ~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 281 (381)
T cd05626 203 CLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVD 281 (381)
T ss_pred cccccccCCccccCHHHHcCCCCC-CccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHH
Confidence 011245799999999999887774 899999999999999999999988777665555432 2334444 47999999
Q ss_pred HHHHhc--CCCCCCCCCHHHHhcCccccc
Q 015814 205 LIARIL--DPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 205 li~~mL--~~dP~~R~t~~eil~h~~~~~ 231 (400)
||.+|| ..+|..|+|++++++||||..
T Consensus 282 li~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 282 LITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 999965 556666999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=330.30 Aligned_cols=214 Identities=27% Similarity=0.466 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.++||||+++++++.+....|+||||+. ++|.+++... +.+++..++.++.|++.||+|||++||+
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 125 (303)
T cd07869 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125 (303)
T ss_pred chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3467789999999999999999999999999999999996 5888887654 5689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus 126 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 203 (303)
T cd07869 126 HRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203 (303)
T ss_pred cCCCCHHHEEECCCCCEEECCCCcceeccC--CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999864322 122234567899999999987655556899999999999999999999
Q ss_pred CCCCch-HHHHHhhhc--Cc-------------------c--CCCC---------CCCHHHHHHHHHhcCCCCCCCCCHH
Q 015814 175 FDDSNL-MNLYKKISA--AE-------------------F--TCPP---------WLSFTARKLIARILDPNPMTRITIP 221 (400)
Q Consensus 175 f~~~~~-~~~~~~i~~--~~-------------------~--~~~~---------~~s~~~~~li~~mL~~dP~~R~t~~ 221 (400)
|.+... ......+.. +. . ..|. ..+.++.+||.+||+.||.+|||+.
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~ 283 (303)
T cd07869 204 FPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ 283 (303)
T ss_pred CCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence 987432 222221110 00 0 0000 1356889999999999999999999
Q ss_pred HHhcCcccccC
Q 015814 222 EILEDEWFKKD 232 (400)
Q Consensus 222 eil~h~~~~~~ 232 (400)
++++||||+..
T Consensus 284 ~~l~h~~f~~~ 294 (303)
T cd07869 284 AALSHEYFSDL 294 (303)
T ss_pred HHhcCcccccC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=338.03 Aligned_cols=214 Identities=33% Similarity=0.586 Sum_probs=188.7
Q ss_pred HHHHHHHHHHHHhC---CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLV---KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
......|..++.++ +||||+++++++.+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++|
T Consensus 37 ~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ 116 (330)
T cd05586 37 VAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD 116 (330)
T ss_pred HHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34555677777665 699999999999999999999999999999999998889999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|.
T Consensus 117 ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~ 194 (330)
T cd05586 117 IVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW 194 (330)
T ss_pred eEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCC
Confidence 99999999999999999999999999864322 2223446789999999999976554468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCCC-CCHHHHHHHHHhcCCCCCCCC----CHHHHhcCccccc
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPPW-LSFTARKLIARILDPNPMTRI----TIPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~~-~s~~~~~li~~mL~~dP~~R~----t~~eil~h~~~~~ 231 (400)
.||.+.+....+..+..+...+|.. ++.++.+||++||+.||.+|| ++.++++||||..
T Consensus 195 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 195 SPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 9999988888888887777666654 799999999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=333.08 Aligned_cols=213 Identities=30% Similarity=0.561 Sum_probs=192.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+..|..++..+ +||+|+++++++.+.+.+|+||||++||+|.+.+...+.+++..+..++.|++.||+|||++||+
T Consensus 44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 123 (323)
T cd05616 44 VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII 123 (323)
T ss_pred HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 45677888888877 58999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+. .++||||+||++|+|++|+.|
T Consensus 124 HrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~P 200 (323)
T cd05616 124 YRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAP 200 (323)
T ss_pred ecCCCHHHeEECCCCcEEEccCCCceecCC--CCCccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCC
Confidence 999999999999999999999999864322 12223456899999999999887774 899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-----~eil~h~~~~~ 231 (400)
|.+.+....+..+......+|..++.++.+++.+||+.||.+|++. .++++||||+.
T Consensus 201 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 201 FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred CCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999888888888888888888999999999999999999999984 89999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=350.06 Aligned_cols=216 Identities=30% Similarity=0.517 Sum_probs=190.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
....+++|+.+|+.++||||+++++++..++..|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 108 ~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 187 (478)
T PTZ00267 108 QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS 187 (478)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356788899999999999999999999999999999999999999987753 3468999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
+||+||||||+|||++.+|.+||+|||++.............+.+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 188 ~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~t 266 (478)
T PTZ00267 188 RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLT 266 (478)
T ss_pred CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHh
Confidence 9999999999999999999999999999976543222223455689999999999987766 589999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 171 GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|+.||.+.+..+....+..+.. ..|..++.++.++|.+||..||.+|||+.+++.|+|++.
T Consensus 267 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 267 LHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999998888777777655544 345568999999999999999999999999999999974
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=335.07 Aligned_cols=213 Identities=35% Similarity=0.599 Sum_probs=189.5
Q ss_pred HHHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|.. +++.++||||+++++++...+..|+||||++||+|..++...+.+++..+..++.||+.||+|||++||+
T Consensus 39 ~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~giv 118 (325)
T cd05604 39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 455666665 4677899999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..|
T Consensus 119 H~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCC
Confidence 999999999999999999999999864321 12233456899999999999887775 889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~----~eil~h~~~~~ 231 (400)
|...+..+.+..+.......++..+..+.++|++||..||.+||++ .++++||||..
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred CCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 9998888888888777777777899999999999999999999976 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=333.02 Aligned_cols=214 Identities=31% Similarity=0.602 Sum_probs=187.6
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.++.++ +||||+++++++.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||
T Consensus 38 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~i 117 (327)
T cd05617 38 DIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117 (327)
T ss_pred HHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 367788999999888 6999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|.+||+|||++..... ......+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus 118 vHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~ 194 (327)
T cd05617 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRS 194 (327)
T ss_pred eccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccCCcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCC
Confidence 9999999999999999999999999864221 1223345789999999999987777 489999999999999999999
Q ss_pred CCCCC-------chHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 015814 174 PFDDS-------NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT------IPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t------~~eil~h~~~~~ 231 (400)
||... .....+..+.......|..++..+.++|++||+.||.+|++ ++++++||||+.
T Consensus 195 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 195 PFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred CCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 99532 22344555566666788889999999999999999999998 579999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=324.97 Aligned_cols=213 Identities=28% Similarity=0.440 Sum_probs=183.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+.+..|+.+++.++||||+++++++..+...|+||||++||+|.+.+.. ...+++..+..++.|++.||+|||++
T Consensus 37 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 37 YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46678899999999999999999999999999999999999999887743 34689999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
||+||||||+||+++.++.+||+|||++...... ........||+.|+|||++.+..+. .++||||+||++|+|++|
T Consensus 117 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g 193 (280)
T cd05608 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAA 193 (280)
T ss_pred CcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccCCCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654331 1223345799999999999887774 889999999999999999
Q ss_pred CCCCCCCch----HHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 172 YLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
+.||...+. ......+.......|+.++..+.+++.+||+.||.+|| |++++++||||+.
T Consensus 194 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 194 RGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 999976542 23334444445566777999999999999999999999 8899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=333.32 Aligned_cols=216 Identities=29% Similarity=0.486 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
..++.+|+.++++++||||+++++++... ..+|+||||+. ++|.+.+.....+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~ 121 (338)
T cd07859 43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121 (338)
T ss_pred HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999999999987543 35899999995 6899999888889999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~e 167 (400)
+||+||||||+|||++.+|.+||+|||++........ .......+||+.|+|||++.+ ..+ +.++||||+||++|+
T Consensus 122 ~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~e 200 (338)
T cd07859 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAE 200 (338)
T ss_pred CCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHH
Confidence 9999999999999999999999999999875432211 112244679999999999865 344 589999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhc---------------------------Ccc-CC---CCCCCHHHHHHHHHhcCCCCCC
Q 015814 168 LLAGYLPFDDSNLMNLYKKISA---------------------------AEF-TC---PPWLSFTARKLIARILDPNPMT 216 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~---------------------------~~~-~~---~~~~s~~~~~li~~mL~~dP~~ 216 (400)
|++|+.||.+.+.......+.. ... .. -+.+++++.++|.+||+.||.+
T Consensus 201 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 280 (338)
T cd07859 201 VLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD 280 (338)
T ss_pred HHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCccc
Confidence 9999999987654332211100 000 00 1235788999999999999999
Q ss_pred CCCHHHHhcCcccccCC
Q 015814 217 RITIPEILEDEWFKKDY 233 (400)
Q Consensus 217 R~t~~eil~h~~~~~~~ 233 (400)
|||++++++||||+...
T Consensus 281 Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 281 RPTAEEALADPYFKGLA 297 (338)
T ss_pred CCCHHHHhcCchhhhcC
Confidence 99999999999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=332.04 Aligned_cols=213 Identities=34% Similarity=0.570 Sum_probs=189.3
Q ss_pred HHHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+. +++.++||||+++++++.+....|+||||++||+|...+.....+++..++.++.|++.||+|||++||+
T Consensus 39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv 118 (321)
T cd05603 39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII 118 (321)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 345556654 5788999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.+|.+||+|||++..... ........+||+.|+|||++.+..+. .++|||||||++|+|++|..|
T Consensus 119 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred eccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCC
Confidence 999999999999999999999999864321 12233456899999999999877765 889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~----~eil~h~~~~~ 231 (400)
|.+.+....+..+.......|+..+.++.++|.+||+.||.+|+++ .++++|+||..
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 196 FYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 9998888888888777778888899999999999999999999875 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=332.88 Aligned_cols=212 Identities=35% Similarity=0.617 Sum_probs=188.1
Q ss_pred HHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+.+|.. +++.++||||+++++++...+..|+||||++||+|.+.+...+.+++..++.++.|++.||+|||++||+|
T Consensus 40 ~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiH 119 (325)
T cd05602 40 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 34444544 56788999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||
T Consensus 120 rDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf 196 (325)
T cd05602 120 RDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPF 196 (325)
T ss_pred cCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccCCccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCC
Confidence 99999999999999999999999864322 22234456899999999999887764 8899999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH----HHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIP----EILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~----eil~h~~~~~ 231 (400)
.+.+..+.+..+.......++.++..+.++|.+||+.||.+|+++. ++++|+||..
T Consensus 197 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 197 YSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 9988888888887777777788999999999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=341.15 Aligned_cols=214 Identities=34% Similarity=0.577 Sum_probs=184.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+++|+.+|+.++||||+++++.+.+++.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+|
T Consensus 45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 124 (376)
T cd05598 45 AAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIH 124 (376)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 56788999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccC-----------------------------------------CCccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----------------------------------------DGLLHTT 134 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-----------------------------------------~~~~~~~ 134 (400)
|||||+|||++.+|.+||+|||+|..+..... .....+.
T Consensus 125 rDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (376)
T cd05598 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSL 204 (376)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccccccc
Confidence 99999999999999999999999753321000 0011235
Q ss_pred cCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcC--ccCCC--CCCCHHHHHHHHHhc
Q 015814 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWLSFTARKLIARIL 210 (400)
Q Consensus 135 ~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~li~~mL 210 (400)
+||+.|+|||++.+.++. .++||||+||++|+|++|+.||.+.+..+....+... ....| ..++.++.++|.+|+
T Consensus 205 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~ 283 (376)
T cd05598 205 VGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC 283 (376)
T ss_pred CCCccccCHHHHcCCCCC-cceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh
Confidence 799999999999887774 8999999999999999999999988876665554332 22333 348999999999987
Q ss_pred CCCCCCCC---CHHHHhcCccccc
Q 015814 211 DPNPMTRI---TIPEILEDEWFKK 231 (400)
Q Consensus 211 ~~dP~~R~---t~~eil~h~~~~~ 231 (400)
.+|.+|+ |+.++++||||+.
T Consensus 284 -~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 284 -CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred -cCHhhcCCCCCHHHHhCCCCcCC
Confidence 5999999 9999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=340.37 Aligned_cols=222 Identities=28% Similarity=0.497 Sum_probs=196.5
Q ss_pred hhHHHhhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHH
Q 015814 5 DLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 84 (400)
Q Consensus 5 ~~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~ 84 (400)
|+....+. ++.|.+|+.+|..+++|||.++|+.+..+..+|++||||.||++.+.++....+.|..+..++++++.|
T Consensus 47 ~Le~~~de---Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~ 123 (467)
T KOG0201|consen 47 DLEEAEDE---IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKG 123 (467)
T ss_pred chhhcchh---hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHH
Confidence 34444455 789999999999999999999999999999999999999999999999998888999999999999999
Q ss_pred HHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 85 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 85 l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
+.|||+++.+|||||+.|||+..+|.+|++|||.+......... ..+..|||.||||||+...+|+ .++|||||||+
T Consensus 124 l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGIT 200 (467)
T KOG0201|consen 124 LDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGIT 200 (467)
T ss_pred hhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhcccccc-chhhhhhhhHH
Confidence 99999999999999999999999999999999998765543222 2788999999999999988886 99999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.|||++|.+||....++.....|....+ .....+|..+++||..||++||+.|||+.++|+|+|++..
T Consensus 201 aiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 201 AIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999998887655555544333 2333589999999999999999999999999999999973
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=339.35 Aligned_cols=215 Identities=33% Similarity=0.616 Sum_probs=187.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+++|+.++..++||||+++++.+.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 44 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~giv 123 (360)
T cd05627 44 QVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI 123 (360)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 46788999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccC---------------------------------CCccccccCCCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------------------------------DGLLHTTCGTPNYV 141 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~---------------------------------~~~~~~~~gt~~y~ 141 (400)
||||||+|||++.+|.+||+|||++........ .....+.+||+.|+
T Consensus 124 HrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 203 (360)
T cd05627 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI 203 (360)
T ss_pred ccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCcccc
Confidence 999999999999999999999999864321100 01122457999999
Q ss_pred CChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcC--ccCCCCC--CCHHHHHHHHHhcCCCCCCC
Q 015814 142 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 142 APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~--~s~~~~~li~~mL~~dP~~R 217 (400)
|||++.+.+|. .++||||+||++|+|++|+.||.+.+....+.++... ...+|+. ++.++++||.+|+. ||.+|
T Consensus 204 APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R 281 (360)
T cd05627 204 APEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENR 281 (360)
T ss_pred CHHHHcCCCCC-CcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-Chhhc
Confidence 99999888775 8999999999999999999999998888777776542 2344443 78999999999874 99999
Q ss_pred C---CHHHHhcCccccc
Q 015814 218 I---TIPEILEDEWFKK 231 (400)
Q Consensus 218 ~---t~~eil~h~~~~~ 231 (400)
+ +++++++||||..
T Consensus 282 ~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 282 IGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCCHHHHhcCCCCCC
Confidence 8 5899999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=336.97 Aligned_cols=215 Identities=35% Similarity=0.653 Sum_probs=189.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+.+|+.++..++||||+++++++.++..+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gii 123 (350)
T cd05573 44 QIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFI 123 (350)
T ss_pred HHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 35678999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeecccccccccccc---------------------------CCCccccccCCCCCCCChhhh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVR---------------------------DDGLLHTTCGTPNYVAPEVLN 147 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~---------------------------~~~~~~~~~gt~~y~APEvl~ 147 (400)
||||||+|||++.+|.+||+|||++....... .........||+.|+|||++.
T Consensus 124 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (350)
T cd05573 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203 (350)
T ss_pred ccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 99999999999999999999999987544322 011233457999999999998
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhc--CccCCCCC--CCHHHHHHHHHhcCCCCCCCCC-HHH
Q 015814 148 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPW--LSFTARKLIARILDPNPMTRIT-IPE 222 (400)
Q Consensus 148 ~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~--~s~~~~~li~~mL~~dP~~R~t-~~e 222 (400)
+..+ +.++|||||||++|+|++|+.||...+....+..+.. .....|.. +++++.+||.+||. ||.+|++ +++
T Consensus 204 ~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ 281 (350)
T cd05573 204 GTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEE 281 (350)
T ss_pred CCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHH
Confidence 8766 4899999999999999999999999887777776655 33444443 59999999999997 9999999 999
Q ss_pred HhcCccccc
Q 015814 223 ILEDEWFKK 231 (400)
Q Consensus 223 il~h~~~~~ 231 (400)
+++||||+.
T Consensus 282 ll~hp~~~~ 290 (350)
T cd05573 282 IKSHPFFKG 290 (350)
T ss_pred HhcCCCcCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.88 Aligned_cols=215 Identities=34% Similarity=0.549 Sum_probs=186.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++++.++..+|+||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+|
T Consensus 87 ~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 165 (370)
T cd05596 87 SAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIH 165 (370)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 45678899999999999999999999999999999999999999998865 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC---CCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++.+|.+||+|||++....... .....+.+||+.|+|||++.... +.+.++||||+||++|+|++|+
T Consensus 166 rDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 244 (370)
T cd05596 166 RDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (370)
T ss_pred cCCCHHHEEEcCCCCEEEEeccceeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCC
Confidence 9999999999999999999999987543211 11223568999999999987532 3468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCc--cCCCC--CCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAE--FTCPP--WLSFTARKLIARILDPNPMT--RITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~mL~~dP~~--R~t~~eil~h~~~~~~ 232 (400)
.||.+.+....+.++.... ..+|. .+|.++.+||++||+.+|.+ |+|++++++||||+..
T Consensus 245 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 245 TPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 9999988888888775533 34444 47999999999999999998 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.65 Aligned_cols=213 Identities=31% Similarity=0.577 Sum_probs=191.2
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+..|+.++..+. ||+|+++++++.+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv 123 (323)
T cd05615 44 VECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123 (323)
T ss_pred HHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 567788999998885 5778899999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus 124 HrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~p 200 (323)
T cd05615 124 YRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPP 200 (323)
T ss_pred ccCCCHHHeEECCCCCEEEeccccccccCC--CCccccCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999864322 1222345679999999999987776 4899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
|.+.+.......+.......|..++.++.+++.+||+.||.+|++ .+++++||||..
T Consensus 201 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 201 FDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999888888888888888888899999999999999999999997 478999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=328.56 Aligned_cols=214 Identities=24% Similarity=0.428 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~-gi 93 (400)
...++.+|+++|+.++||||+++++++...+..|+||||++||+|.+++.....+++..+..++.|++.||.|||++ +|
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 125 (331)
T cd06649 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI 125 (331)
T ss_pred HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence 35789999999999999999999999999999999999999999999998888899999999999999999999986 69
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|.+||+|||++..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus 126 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~ 200 (331)
T cd06649 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRY 200 (331)
T ss_pred EcCCCChhhEEEcCCCcEEEccCcccccccc----cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865432 22344579999999999987766 489999999999999999999
Q ss_pred CCCCCchHHHHHhhhc----------------------------------------------Cc-cCC-CCCCCHHHHHH
Q 015814 174 PFDDSNLMNLYKKISA----------------------------------------------AE-FTC-PPWLSFTARKL 205 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~----------------------------------------------~~-~~~-~~~~s~~~~~l 205 (400)
||...+..++...+.. .. ... ...++.++.+|
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (331)
T cd06649 201 PIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF 280 (331)
T ss_pred CCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHH
Confidence 9987665443222110 00 001 11367899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 206 IARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 206 i~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
|.+||..||++|||+.++++||||+...
T Consensus 281 i~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 281 VNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred HHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 9999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=333.20 Aligned_cols=215 Identities=29% Similarity=0.500 Sum_probs=185.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+++|+.+++.++||||+++++++.+...+|+||||++||+|.+++... +.+++..++.++.|++.||+|||++||
T Consensus 44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i 123 (330)
T cd05601 44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123 (330)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4577889999999999999999999999999999999999999999999876 679999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-----CCCCCChhhHHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGiil~el 168 (400)
+||||||+|||++.+|.+||+|||++....... .......+||+.|+|||++.. ....+.++||||+||++|+|
T Consensus 124 ~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 202 (330)
T cd05601 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202 (330)
T ss_pred EcccCchHheEECCCCCEEeccCCCCeECCCCC-ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeee
Confidence 999999999999999999999999987543321 112234579999999999863 22335889999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCc--c--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAE--F--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~--~--~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
++|..||...+....+..+.... . +..+.++.++.+||++||. +|.+|||++++++||||..
T Consensus 203 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 203 IYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 99999999887777766654332 2 2234589999999999998 9999999999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.06 Aligned_cols=215 Identities=34% Similarity=0.586 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+++.++||||+++++++.++..+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+|
T Consensus 87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvH 165 (370)
T cd05621 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIH 165 (370)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 45678999999999999999999999999999999999999999999865 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC---CCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++++|.+||+|||+|....... .....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|+
T Consensus 166 rDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~ 244 (370)
T cd05621 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD 244 (370)
T ss_pred cCCCHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCC
Confidence 9999999999999999999999987643211 11224568999999999997643 3468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCc--cCCCC--CCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAE--FTCPP--WLSFTARKLIARILDPNPMT--RITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~mL~~dP~~--R~t~~eil~h~~~~~~ 232 (400)
.||.+.+....+..+.... ...|. .++..++++|.+||..+|.+ |+|++++++||||+..
T Consensus 245 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 245 TPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred CCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999988877777775432 44444 46999999999999866544 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=318.44 Aligned_cols=217 Identities=27% Similarity=0.456 Sum_probs=186.9
Q ss_pred HHHHHHHHHHHHHHhCCCCC-cceeeEEEEeCC------EEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPN-VVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLI 82 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~~~~----~l~e~~~~~~~~qll 82 (400)
++.....+|+.+|+.|+|+| |+++++++.+.+ .+|+|+||++- +|.+++...+ +++...++.+++||+
T Consensus 52 G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll 130 (323)
T KOG0594|consen 52 GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLL 130 (323)
T ss_pred CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHH
Confidence 45566789999999999999 999999998877 89999999986 9999998765 588899999999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 83 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 83 ~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
.||+|||++||+||||||.|||++++|.+||+|||+|+.+.. +........+|.+|+|||++.+...++..+||||+|
T Consensus 131 ~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~G 208 (323)
T KOG0594|consen 131 RGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLG 208 (323)
T ss_pred HHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHH
Confidence 999999999999999999999999999999999999986543 233456678999999999999886677999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHhhhcC------------------ccCCCCC------------CCHHHHHHHHHhcCC
Q 015814 163 VILFVLLAGYLPFDDSNLMNLYKKISAA------------------EFTCPPW------------LSFTARKLIARILDP 212 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~~~~~~------------~s~~~~~li~~mL~~ 212 (400)
||++||++++.-|++.+..++...|... ...++.| .+++..+++.+||+.
T Consensus 209 cIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y 288 (323)
T KOG0594|consen 209 CIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQY 288 (323)
T ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhcc
Confidence 9999999999999998877666555321 1122222 235889999999999
Q ss_pred CCCCCCCHHHHhcCcccccCC
Q 015814 213 NPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 213 dP~~R~t~~eil~h~~~~~~~ 233 (400)
+|.+|+|++.++.||||....
T Consensus 289 ~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 289 DPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CcccCcCHHHHhcChhhcccc
Confidence 999999999999999998754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=334.68 Aligned_cols=212 Identities=31% Similarity=0.511 Sum_probs=195.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCE-EEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTK-IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+|+.++++++|||||.+++.|..++. .+|||+||+||+|.+.|.... -++|+.+..||-|++.|+.|||+++|
T Consensus 48 ~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~i 127 (426)
T KOG0589|consen 48 RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRV 127 (426)
T ss_pred HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhh
Confidence 367889999999999999999999988777 999999999999999997654 58999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+|||||+.||+++.++.+||+|||+|+..... .....+..|||.|+.||++.+.+|. .++|||||||++|||++-+.
T Consensus 128 LHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~--~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~ 204 (426)
T KOG0589|consen 128 LHRDLKCANIFLTKDKKVKLGDFGLAKILNPE--DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKP 204 (426)
T ss_pred hcccchhhhhhccccCceeecchhhhhhcCCc--hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhccc
Confidence 99999999999999999999999999876542 2356788999999999999999995 99999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 174 PFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
+|...+...+..+|..+. .+.|...|.+++.||+.||..+|..||++.++|.+|....
T Consensus 205 aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 205 AFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 999999999999998887 5667779999999999999999999999999999988764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.85 Aligned_cols=213 Identities=33% Similarity=0.636 Sum_probs=198.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+..-.-|-++|+..+||.+..+-..|++.+.+|+||||+.||+|+-++.+...++|+.+++|-..|++||.|||+++||.
T Consensus 212 VAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivY 291 (516)
T KOG0690|consen 212 VAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVY 291 (516)
T ss_pred hhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeee
Confidence 34455678899999999999999999999999999999999999999999899999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
||||.+|+|+|.+|++||+|||+++. .........+.||||.|+|||++....| +..+|.|.+||++|||++|++||
T Consensus 292 RDlKLENLlLDkDGHIKitDFGLCKE--~I~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPF 368 (516)
T KOG0690|consen 292 RDLKLENLLLDKDGHIKITDFGLCKE--EIKYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPF 368 (516)
T ss_pred eechhhhheeccCCceEeeecccchh--cccccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcc
Confidence 99999999999999999999999864 2334456678999999999999998888 59999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
...+...++..|......+|..+|++++.|+..+|.+||.+|. .+.||.+|+||..
T Consensus 369 yn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 369 YNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred cccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999999999999999999999999999999999999997 4889999999985
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.20 Aligned_cols=214 Identities=20% Similarity=0.325 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
..+.+|+.+|++++||||+++++++..+...++|||++. ++|++++.....+++..+..++.|++.||+|||++||+||
T Consensus 128 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHr 206 (391)
T PHA03212 128 GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHR 206 (391)
T ss_pred hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 457889999999999999999999999999999999996 6899999888889999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
||||+|||++.+|.+||+|||+|....... .......+||+.|+|||++.+..| +.++||||+||++|+|++|..||.
T Consensus 207 DiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 207 DIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred CCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcC
Confidence 999999999999999999999986533211 122345689999999999988776 589999999999999999998874
Q ss_pred CCc-------hHHHHHhh--------------------------hcCc----cCCCC-----CCCHHHHHHHHHhcCCCC
Q 015814 177 DSN-------LMNLYKKI--------------------------SAAE----FTCPP-----WLSFTARKLIARILDPNP 214 (400)
Q Consensus 177 ~~~-------~~~~~~~i--------------------------~~~~----~~~~~-----~~s~~~~~li~~mL~~dP 214 (400)
... .......+ .... ...|. .++.++.+||.+||+.||
T Consensus 285 ~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP 364 (391)
T PHA03212 285 EKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDA 364 (391)
T ss_pred CcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCCh
Confidence 321 00011000 0000 01111 146689999999999999
Q ss_pred CCCCCHHHHhcCcccccCC
Q 015814 215 MTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 215 ~~R~t~~eil~h~~~~~~~ 233 (400)
.+|||++|+|+||||+...
T Consensus 365 ~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 365 HHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhCCCHHHHhcChhhccCC
Confidence 9999999999999998744
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=312.51 Aligned_cols=213 Identities=29% Similarity=0.532 Sum_probs=185.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+++|+.++++++||||+++++++......|+|+||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++|
T Consensus 48 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 127 (263)
T cd06625 48 VNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127 (263)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 56789999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|||+|+||++++++.++|+|||++......... .......|++.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus 128 ~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p 206 (263)
T cd06625 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPP 206 (263)
T ss_pred CCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCC
Confidence 999999999999999999999998754322111 11134568899999999987765 5899999999999999999999
Q ss_pred CCCCchHHHHHhhhc--CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 175 FDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 175 f~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
|...+.......+.. .....|..++..+.++|++||..+|.+|||+.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 207 WAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 987766555444332 2345566789999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=332.44 Aligned_cols=216 Identities=26% Similarity=0.462 Sum_probs=182.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...++.+|+.+++.++||||+++++++.... ..|+||||+. ++|.+.+.....+++..++.++.|++.||+|||
T Consensus 42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3577889999999999999999999998776 7999999997 589999988888999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++||+||||||+|||++.++.+||+|||+++..... .........||+.|+|||++.+....+.++||||+||++|+|+
T Consensus 121 ~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 199 (372)
T cd07853 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199 (372)
T ss_pred hCCeeCCCCChHHEEECCCCCEEeccccceeecccC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHH
Confidence 999999999999999999999999999998754322 1222334568999999999987655568999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhc-----------------------Ccc---------CCCCCCCHHHHHHHHHhcCCCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISA-----------------------AEF---------TCPPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~-----------------------~~~---------~~~~~~s~~~~~li~~mL~~dP~~R 217 (400)
+|+.||.+.+.......+.. ... ......++++.+||.+||+.||.+|
T Consensus 200 ~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 279 (372)
T cd07853 200 GRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR 279 (372)
T ss_pred cCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhC
Confidence 99999988766544433321 000 1223357899999999999999999
Q ss_pred CCHHHHhcCcccccC
Q 015814 218 ITIPEILEDEWFKKD 232 (400)
Q Consensus 218 ~t~~eil~h~~~~~~ 232 (400)
||+.++++||||...
T Consensus 280 ~t~~e~l~hp~~~~~ 294 (372)
T cd07853 280 ISAADALAHPYLDEG 294 (372)
T ss_pred cCHHHHhcCHhhCCC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=317.07 Aligned_cols=212 Identities=26% Similarity=0.440 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.+++.++||||+++++.+.+++..|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 456778999999999999999999999999999999999999999888653 468999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||++++++.++|+|||++..... .......+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus 124 vH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~ 199 (285)
T cd05605 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKS 199 (285)
T ss_pred EecCCCHHHEEECCCCCEEEeeCCCceecCC---CCccccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCC
Confidence 9999999999999999999999999875432 222245579999999999987666 488999999999999999999
Q ss_pred CCCCCchHHH----HHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 174 PFDDSNLMNL----YKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
||.+.+.... ...+.......+..++..+.+||.+||+.||.+|| +++++++||||..
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 200 PFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred CCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 9987655332 23333444556667899999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.08 Aligned_cols=215 Identities=35% Similarity=0.576 Sum_probs=184.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+++.++||||+++++++.++..+|+||||++||+|.+++.. ..+++..++.++.|++.||+|||++||+|
T Consensus 87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 165 (371)
T cd05622 87 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIH 165 (371)
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 45678899999999999999999999999999999999999999998866 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC---CCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++.+|.+||+|||++....... .....+.+||+.|+|||++.... +.+.++||||+||++|+|++|.
T Consensus 166 rDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~ 244 (371)
T cd05622 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (371)
T ss_pred CCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence 9999999999999999999999987543211 11224568999999999997543 3468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCc--cCCC--CCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAE--FTCP--PWLSFTARKLIARILDPNPMT--RITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~li~~mL~~dP~~--R~t~~eil~h~~~~~~ 232 (400)
.||.+.+....+..+.... ..+| ..++..+++||.+||..+|.+ |++++++++||||+..
T Consensus 245 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 245 TPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999988888888775432 3333 358999999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=315.92 Aligned_cols=205 Identities=17% Similarity=0.283 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
..+.+.+|+.+|++++||||+++++++.+ ...+++||||++||+|.+++...+.+++..+..++.|++.|+.|||+
T Consensus 61 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~ 140 (283)
T PHA02988 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK 140 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh
Confidence 46788899999999999999999999876 45789999999999999999888889999999999999999999998
Q ss_pred c-CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHH
Q 015814 91 R-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 91 ~-givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~e 167 (400)
. +++||||||+|||++++|.+||+|||++...... .....||+.|+|||++.+ ..| +.++||||+||++|+
T Consensus 141 ~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~e 214 (283)
T PHA02988 141 YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWE 214 (283)
T ss_pred cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHH
Confidence 5 9999999999999999999999999998754321 124568999999999976 445 589999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|++|+.||.+.+..+.+..+... .+..|...+..+.+++.+||+.||.+|||++++++
T Consensus 215 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 215 IFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999998887777776433 44555568999999999999999999999999985
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=322.35 Aligned_cols=213 Identities=25% Similarity=0.445 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~-giv 94 (400)
..++.+|+++++.++||||+++++++.+.+..|+||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+
T Consensus 47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~iv 126 (333)
T cd06650 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126 (333)
T ss_pred HHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEE
Confidence 5679999999999999999999999999999999999999999999999888899999999999999999999985 799
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++..... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus 127 H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p 201 (333)
T cd06650 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYP 201 (333)
T ss_pred ecCCChhhEEEcCCCCEEEeeCCcchhhhh----hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999865432 12234579999999999987666 4889999999999999999999
Q ss_pred CCCCchHHHHHhh--------------------------------------------hcC-ccCCC-CCCCHHHHHHHHH
Q 015814 175 FDDSNLMNLYKKI--------------------------------------------SAA-EFTCP-PWLSFTARKLIAR 208 (400)
Q Consensus 175 f~~~~~~~~~~~i--------------------------------------------~~~-~~~~~-~~~s~~~~~li~~ 208 (400)
|...........+ ... ....+ ..++.++.+||.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 281 (333)
T cd06650 202 IPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNK 281 (333)
T ss_pred CCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHH
Confidence 9865543332111 000 00111 1257889999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCC
Q 015814 209 ILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 209 mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
||+.||.+|||+.+++.||||+...
T Consensus 282 ~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 282 CLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hccCCcccCcCHHHHhhCHHHhcCc
Confidence 9999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=319.03 Aligned_cols=214 Identities=27% Similarity=0.478 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+.+|+.++++++||||+++++++..++..|+||||+.+ +|.+.+...+ .+++..++.++.|++.||+|||++||+|
T Consensus 49 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH 127 (309)
T cd07872 49 CTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127 (309)
T ss_pred hhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4567899999999999999999999999999999999986 8888886644 5899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.++.+||+|||++...... ........||+.|+|||++.+....+.++||||+||++|+|++|+.||
T Consensus 128 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf 205 (309)
T cd07872 128 RDLKPQNLLINERGELKLADFGLARAKSVP--TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205 (309)
T ss_pred CCCCHHHEEECCCCCEEECccccceecCCC--ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998653321 122234578999999999876554568999999999999999999999
Q ss_pred CCCchHHHHHhhhcC-------------------ccCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 176 DDSNLMNLYKKISAA-------------------EFTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~-------------------~~~~-----------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.+.+..+....+... .... .+.++.++.+||.+||+.||.+|||++|+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 206 PGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 887654433322110 0011 1236889999999999999999999999999
Q ss_pred CcccccCC
Q 015814 226 DEWFKKDY 233 (400)
Q Consensus 226 h~~~~~~~ 233 (400)
||||+...
T Consensus 286 h~~~~~~~ 293 (309)
T cd07872 286 HAYFRSLG 293 (309)
T ss_pred Chhhhhcc
Confidence 99998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.65 Aligned_cols=211 Identities=27% Similarity=0.375 Sum_probs=171.9
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeC--------CEEEEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHH
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSK--------TKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~--------~~~~lv~Ey~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~l 85 (400)
...+|+.+|+.++||||+++++++... ..+++||||+++ +|.+.+. ....+++..++.++.|++.||
T Consensus 105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 345799999999999999999887432 247799999986 6766664 345799999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCC-CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
+|||++||+||||||+|||++.++ .+||+|||+|+.... .....+.+||+.|+|||++.+....+.++||||+||+
T Consensus 184 ~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi 260 (440)
T PTZ00036 184 AYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260 (440)
T ss_pred HHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHH
Confidence 999999999999999999999765 699999999975432 1223356789999999998765544689999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcC-----------------c------------cCCCCCCCHHHHHHHHHhcCCCCC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAA-----------------E------------FTCPPWLSFTARKLIARILDPNPM 215 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~-----------------~------------~~~~~~~s~~~~~li~~mL~~dP~ 215 (400)
+|+|++|.+||.+.+..+....+... . ..+|...|.++.+||.+||+.||.
T Consensus 261 l~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~ 340 (440)
T PTZ00036 261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPL 340 (440)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChh
Confidence 99999999999887655444333210 0 012344678999999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q 015814 216 TRITIPEILEDEWFKKD 232 (400)
Q Consensus 216 ~R~t~~eil~h~~~~~~ 232 (400)
+|||+.|+++||||...
T Consensus 341 ~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 341 KRLNPIEALADPFFDDL 357 (440)
T ss_pred HCcCHHHHhCChhHHhh
Confidence 99999999999999764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.94 Aligned_cols=209 Identities=32% Similarity=0.469 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhC---CCCCcceeeEEEE-----eCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV---KHPNVVRLYEVMG-----SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l---~HpnIv~l~~~~~-----~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l 85 (400)
.....+|+.+++.+ +||||+++++++. ....+++||||+. ++|.+++... ..+++..+..++.|++.||
T Consensus 45 ~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 45 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Confidence 34566788887766 6999999999875 3456899999997 4899988653 3589999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
+|||++||+||||||+|||++.+|.+||+|||++..... ........||+.|+|||++.+..+. .++||||+||++
T Consensus 124 ~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il 199 (290)
T cd07862 124 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIF 199 (290)
T ss_pred HHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHH
Confidence 999999999999999999999999999999999875432 2233456799999999999877664 889999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHhhhcCcc---------------------------CCCCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 166 FVLLAGYLPFDDSNLMNLYKKISAAEF---------------------------TCPPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 166 ~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------~~~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
|+|++|..||.+.+..+....+..... ...+.++..+.+||.+||+.||++||
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 279 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence 999999999998776655554432110 01134678889999999999999999
Q ss_pred CHHHHhcCccc
Q 015814 219 TIPEILEDEWF 229 (400)
Q Consensus 219 t~~eil~h~~~ 229 (400)
|+.++++||||
T Consensus 280 s~~~~l~hp~f 290 (290)
T cd07862 280 SAYSALSHPYF 290 (290)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=325.94 Aligned_cols=213 Identities=30% Similarity=0.507 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+.+|+.+++.++||||+++++++...+.+|+||||++||+|.+. ...++..+..++.||+.||+|||++||+
T Consensus 115 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iv 190 (353)
T PLN00034 115 VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIV 190 (353)
T ss_pred HHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 357789999999999999999999999999999999999999998643 3467888899999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----CCCCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGiil~ellt 170 (400)
||||||+|||+++++.+||+|||++...... ........||+.|+|||++.. ..+.+.++|||||||++|+|++
T Consensus 191 HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~ 268 (353)
T PLN00034 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268 (353)
T ss_pred ecCCCHHHEEEcCCCCEEEcccccceecccc--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh
Confidence 9999999999999999999999998765432 112244679999999999743 3455678999999999999999
Q ss_pred CCCCCCCCchH---HHHHhhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 171 GYLPFDDSNLM---NLYKKIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 171 G~~Pf~~~~~~---~~~~~i~-~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
|+.||...... .....+. ......+..++.++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus 269 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 269 GRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999743322 2222222 223344566899999999999999999999999999999998754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=320.13 Aligned_cols=213 Identities=27% Similarity=0.426 Sum_probs=167.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNH---------GRMKEDEARRYFQQLINA 84 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~ 84 (400)
...+.+|+.+|++++||||+++++++.. ...+|++|||+.+ +|.+.+... ..+++..++.++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 3467889999999999999999999854 4678999999965 888887532 258999999999999999
Q ss_pred HHHHHHcCCeeccCCCCcEEE----ccCCCeeeecccccccccccc-CCCccccccCCCCCCCChhhhcCCCCCChhhHH
Q 015814 85 VDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 159 (400)
Q Consensus 85 l~~LH~~givHrDlKP~NILl----~~~g~~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw 159 (400)
|+|||++||+||||||+|||+ +.++.+||+|||+|....... ........+||+.|+|||++.+....+.++|||
T Consensus 121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07868 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence 999999999999999999999 456789999999997654321 112234567899999999998765556899999
Q ss_pred HHHHHHHHHHhCCCCCCCCchH---------HHHHhhhc----------------------------CccCC--------
Q 015814 160 SCGVILFVLLAGYLPFDDSNLM---------NLYKKISA----------------------------AEFTC-------- 194 (400)
Q Consensus 160 SlGiil~elltG~~Pf~~~~~~---------~~~~~i~~----------------------------~~~~~-------- 194 (400)
|+||++|+|++|+.||...... .....+.. .....
T Consensus 201 slG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (317)
T cd07868 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 280 (317)
T ss_pred HHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHH
Confidence 9999999999999999643310 11111100 00000
Q ss_pred --CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 195 --PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 195 --~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
....+..+.+||++||+.||.+|||++|+++||||
T Consensus 281 ~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 281 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=313.15 Aligned_cols=211 Identities=27% Similarity=0.440 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+..|++++++++||||+++++++.++...|+||||++||+|.+.+...+ .+++..+..++.|++.||+|||+.||+
T Consensus 38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 117 (277)
T cd05607 38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117 (277)
T ss_pred HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 456679999999999999999999999999999999999999998886543 588999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.++.++|+|||++..... ........||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus 118 H~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p 193 (277)
T cd05607 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTP 193 (277)
T ss_pred EccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCCCCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875432 122234579999999999987775 4899999999999999999999
Q ss_pred CCCCch----HHHHHhhhcCccCCC-CCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 015814 175 FDDSNL----MNLYKKISAAEFTCP-PWLSFTARKLIARILDPNPMTRITI----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~----~~~~~~i~~~~~~~~-~~~s~~~~~li~~mL~~dP~~R~t~----~eil~h~~~~~ 231 (400)
|..... ..............+ ..++.++++||++||+.||.+|||+ ++++.||||+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 194 FKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 976432 233333333333322 3579999999999999999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=313.66 Aligned_cols=211 Identities=36% Similarity=0.727 Sum_probs=193.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|++++++++||||+++++++..+...|+||||++||+|.+++...+.+++..+..++.|++.||+|||++|++
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~ 123 (290)
T cd05580 44 QVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIV 123 (290)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 46778999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||+|.||+++.+|.+||+|||++...... ....+|++.|+|||.+.+..+ +.++||||+|+++|+|++|..|
T Consensus 124 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p 197 (290)
T cd05580 124 YRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPP 197 (290)
T ss_pred cCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998764332 234579999999999987665 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
|...+....+..+..+....|..++..+.++|.+||..||.+|+ +++++++||||..
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 198 FFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 99888777777777777888888999999999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.55 Aligned_cols=203 Identities=28% Similarity=0.461 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
+.+.+|++||++|+|+|||++++++..+..+||||||++.|+|.++++. .+.+.......++.||++|++||+++++|
T Consensus 246 ~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~I 325 (468)
T KOG0197|consen 246 EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYI 325 (468)
T ss_pred hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5677999999999999999999999998899999999999999999987 44689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccC---CCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA- 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~g---t~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt- 170 (400)
||||-..|||+++++.+||+|||||+... +.......| ...|.|||.+....++ .++|||||||+||||+|
T Consensus 326 HRDLAARNiLV~~~~~vKIsDFGLAr~~~----d~~Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~ 400 (468)
T KOG0197|consen 326 HRDLAARNILVDEDLVVKISDFGLARLIG----DDEYTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTY 400 (468)
T ss_pred chhhhhhheeeccCceEEEcccccccccC----CCceeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhcc
Confidence 99999999999999999999999998432 122222222 3459999999987775 99999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 171 GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
|+.|+.+.+..+....+..| ..+.|+.+|+++.+++..||..+|++|||++.+.
T Consensus 401 G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 401 GRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999998877 4688889999999999999999999999999764
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=308.26 Aligned_cols=215 Identities=29% Similarity=0.514 Sum_probs=186.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+++|+.++++++||||+++++++......++||||+++++|.+++...+.+++..+..++.|++.||+|||++|+
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i 127 (267)
T cd06628 48 SMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127 (267)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCc
Confidence 34678999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCC----CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
+||||+|+||++++++.++|+|||++......... .......|++.|+|||.+.+..+ +.++||||+||++|+|+
T Consensus 128 vH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEML 206 (267)
T ss_pred ccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHh
Confidence 99999999999999999999999998765421111 11123468899999999987766 48899999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 170 AGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
+|+.||.+.+.......+... ....|..++..+.++|++||+.||.+||++.++++||||
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 207 TGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred hCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999887655444443332 345566789999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=328.95 Aligned_cols=214 Identities=26% Similarity=0.410 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
....+|+.+|++++||||+++++++......|+|||++. ++|.+++...+.+++..+..++.||+.||.|||++||+||
T Consensus 131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHr 209 (392)
T PHA03207 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR 209 (392)
T ss_pred ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 345689999999999999999999999999999999996 5899999877889999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
||||+|||++.++.++|+|||++................||+.|+|||++....|. .++||||+||++|+|++|+.||.
T Consensus 210 Dlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 210 DVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred CCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999998754432222223345799999999999877774 88999999999999999999997
Q ss_pred CCchH---HHHHhhh----c-------------------------CccCCCC-----CCCHHHHHHHHHhcCCCCCCCCC
Q 015814 177 DSNLM---NLYKKIS----A-------------------------AEFTCPP-----WLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 177 ~~~~~---~~~~~i~----~-------------------------~~~~~~~-----~~s~~~~~li~~mL~~dP~~R~t 219 (400)
+.... ..+..+. . ..+..|. .++.++.++|++||..||.+|||
T Consensus 289 ~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps 368 (392)
T PHA03207 289 GKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS 368 (392)
T ss_pred CCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC
Confidence 64321 1111110 0 0011111 24678899999999999999999
Q ss_pred HHHHhcCcccccC
Q 015814 220 IPEILEDEWFKKD 232 (400)
Q Consensus 220 ~~eil~h~~~~~~ 232 (400)
+.+++.||||.+.
T Consensus 369 a~e~l~~p~f~~~ 381 (392)
T PHA03207 369 AQDILSLPLFTKE 381 (392)
T ss_pred HHHHhhCchhhcc
Confidence 9999999999863
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=320.20 Aligned_cols=215 Identities=28% Similarity=0.521 Sum_probs=181.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+++|+.+++.++||||+++++++.++..+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 124 (331)
T cd05597 45 TACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124 (331)
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 56688999999999999999999999999999999999999999999976 45799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----CCCCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGiil~ellt 170 (400)
||||||+|||++.+|.+||+|||++........ ......+||+.|+|||++.. ....+.++||||+||++|+|++
T Consensus 125 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (331)
T cd05597 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred ECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh
Confidence 999999999999999999999999865432111 11223579999999999973 2344688999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCc--cCCC---CCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 015814 171 GYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFTARKLIARILDPNPMT--RITIPEILEDEWFKK 231 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~~~~li~~mL~~dP~~--R~t~~eil~h~~~~~ 231 (400)
|+.||.+.+..+.+..+.... ...| +.+|.++++||++||..++.+ |++++++++||||..
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 204 GETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999888777777664432 2333 347999999999999664444 889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=317.30 Aligned_cols=211 Identities=31% Similarity=0.502 Sum_probs=178.1
Q ss_pred HHHHHHHhCCCCCcceeeEEEEeC--C---EEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 21 REVATMKLVKHPNVVRLYEVMGSK--T---KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 21 ~Ei~il~~l~HpnIv~l~~~~~~~--~---~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
+|+.||+.++|||||++..+|... + ...+||||++. +|.+.++. +.+++.-.++-|..||..||+|||+.
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~ 144 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH 144 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc
Confidence 699999999999999999888542 2 35689999987 89998874 56899999999999999999999999
Q ss_pred CCeeccCCCCcEEEccC-CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 92 GVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 92 givHrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
||+||||||.|+|+|.+ |.+||||||.|+...... ...++..|..|+|||.+.+...++.+.||||+|||+.||+-
T Consensus 145 ~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 145 GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc
Confidence 99999999999999986 999999999998765422 22456679999999999887777799999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcC-----------------ccCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHH
Q 015814 171 GYLPFDDSNLMNLYKKISAA-----------------EFTCP------------PWLSFTARKLIARILDPNPMTRITIP 221 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~-----------------~~~~~------------~~~s~~~~~li~~mL~~dP~~R~t~~ 221 (400)
|++-|.+.+..++...|... ...+| ...++++.+|+.++|..+|.+|.++.
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 99999998877665554210 11111 22689999999999999999999999
Q ss_pred HHhcCcccccCCCC
Q 015814 222 EILEDEWFKKDYKP 235 (400)
Q Consensus 222 eil~h~~~~~~~~~ 235 (400)
|++.||||..-..+
T Consensus 302 ~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 302 EALAHPFFDELRDP 315 (364)
T ss_pred HHhcchhhHHhhCc
Confidence 99999999865443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=324.93 Aligned_cols=214 Identities=27% Similarity=0.488 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
....+.+|+.+++.++||||+++++++.... .+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.||
T Consensus 63 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~L 139 (359)
T cd07876 63 HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHL 139 (359)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHH
Confidence 3567889999999999999999999986443 57999999976 5766663 3589999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
|++||+||||||+|||++.+|.+||+|||++..... ........||+.|+|||++.+..+. .++||||+||++|+|
T Consensus 140 H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el 215 (359)
T cd07876 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEL 215 (359)
T ss_pred HhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHH
Confidence 999999999999999999999999999999864322 2223456789999999999887775 889999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhc----------------------CccC---------CCC-----------CCCHHHHHHH
Q 015814 169 LAGYLPFDDSNLMNLYKKISA----------------------AEFT---------CPP-----------WLSFTARKLI 206 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~----------------------~~~~---------~~~-----------~~s~~~~~li 206 (400)
++|+.||.+.+....+..+.. .... ++. ..+..+++||
T Consensus 216 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (359)
T cd07876 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295 (359)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHH
Confidence 999999987664333221110 0000 011 1357889999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 207 ARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 207 ~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
.+||..||.+|||+.|+++||||...+.+
T Consensus 296 ~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 296 SKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 99999999999999999999999875543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=308.42 Aligned_cols=218 Identities=31% Similarity=0.582 Sum_probs=189.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
-.++-+|++++.++ .|+||++++++|+++..+|+|||-+.||+|..+|....-|+|.+|.++.+.+++||.|||.+||+
T Consensus 119 R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIA 198 (463)
T KOG0607|consen 119 RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIA 198 (463)
T ss_pred HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcc
Confidence 35788999999999 69999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCC---Ceeeecccccccccccc-----CCCccccccCCCCCCCChhhh----cCCCCCChhhHHHHH
Q 015814 95 HRDLKPENLLLDAYG---NLKVSDFGLSALSQQVR-----DDGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCG 162 (400)
Q Consensus 95 HrDlKP~NILl~~~g---~~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DIwSlG 162 (400)
||||||||||-...+ -+|||||.+..-..... ....+.+.||+..|||||+.. ...++...+|.||||
T Consensus 199 HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG 278 (463)
T KOG0607|consen 199 HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG 278 (463)
T ss_pred cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence 999999999987654 48999999865433221 122356789999999999873 222444899999999
Q ss_pred HHHHHHHhCCCCCCCCc---------------hHHHHHhhhcCccCCCCC----CCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 163 VILFVLLAGYLPFDDSN---------------LMNLYKKISAAEFTCPPW----LSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 163 iil~elltG~~Pf~~~~---------------~~~~~~~i~~~~~~~~~~----~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
+|||.||+|++||.+.- ...++..|..+.+.+|.. +|.++++||+.+|..||.+|.++.++
T Consensus 279 vIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 279 VILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred HHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 99999999999996521 345788899999999863 89999999999999999999999999
Q ss_pred hcCcccccCC
Q 015814 224 LEDEWFKKDY 233 (400)
Q Consensus 224 l~h~~~~~~~ 233 (400)
++|||++.-.
T Consensus 359 lnhPw~~~~~ 368 (463)
T KOG0607|consen 359 LNHPWVQRCA 368 (463)
T ss_pred cCCccccccc
Confidence 9999998743
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=324.69 Aligned_cols=213 Identities=26% Similarity=0.451 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
....+.+|+.+++.++||||+++++++... ..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||+||
T Consensus 66 ~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~L 142 (364)
T cd07875 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHL 142 (364)
T ss_pred hHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999987543 457999999976 67777743 488999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
|++||+||||||+|||++.++.+||+|||+++.... ........||+.|+|||++.+..+. .++|||||||++|+|
T Consensus 143 H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el 218 (364)
T cd07875 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEM 218 (364)
T ss_pred hhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHH
Confidence 999999999999999999999999999999875432 2223456799999999999887774 899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCcc----------------------C--------------------CCCCCCHHHHHHH
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEF----------------------T--------------------CPPWLSFTARKLI 206 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~----------------------~--------------------~~~~~s~~~~~li 206 (400)
++|+.||.+.+..+.+.++..... . .+...+..+++||
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 999999988776554443321000 0 0001246789999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 207 ARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 207 ~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.+||+.||.+|||++++++||||.....
T Consensus 299 ~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 299 SKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHhcCcCcccCCCHHHHhcCcccccccC
Confidence 9999999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=321.61 Aligned_cols=212 Identities=26% Similarity=0.442 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+.+|+.++++++||||+++++++... ..+|++|+++ |++|.+.+. .+.+++..++.++.|++.||.|||
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH 135 (343)
T cd07878 58 ARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIH 135 (343)
T ss_pred HHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 46678899999999999999999987543 4579999988 678877765 467999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++||+||||||+||+++.++.+||+|||++..... .....+||+.|+|||++.+....+.++||||+||++|+|+
T Consensus 136 ~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 210 (343)
T cd07878 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210 (343)
T ss_pred HCCeecccCChhhEEECCCCCEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH
Confidence 99999999999999999999999999999875432 2345679999999999987555568999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCc-----------------------cCCC--------CCCCHHHHHHHHHhcCCCCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAE-----------------------FTCP--------PWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~-----------------------~~~~--------~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
+|+.||.+.+..+....+.... ...+ ...++.+.+||.+||..||.+||
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~ 290 (343)
T cd07878 211 KGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI 290 (343)
T ss_pred HCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC
Confidence 9999998766544333321100 0011 12466789999999999999999
Q ss_pred CHHHHhcCcccccCCC
Q 015814 219 TIPEILEDEWFKKDYK 234 (400)
Q Consensus 219 t~~eil~h~~~~~~~~ 234 (400)
|+.++++||||.....
T Consensus 291 s~~ell~hp~~~~~~~ 306 (343)
T cd07878 291 SASEALAHPYFSQYHD 306 (343)
T ss_pred CHHHHhcCcchhccCC
Confidence 9999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=305.46 Aligned_cols=214 Identities=29% Similarity=0.480 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...++++|+.++++++||||+++++++.+....|++|||++||+|.+++...+.+++..+..++.|++.||+|||+.|++
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 124 (265)
T cd06631 45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 35789999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeecccccccccccc----CCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|+||+|+||++++++.++|+|||++....... .........|++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 125 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~ 203 (265)
T cd06631 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMAT 203 (265)
T ss_pred cCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999987542211 1122234568999999999987766 488999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcC---ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 171 GYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
|..||...+.......+... ....+..++.++.++|++||..+|.+|||+.++++||||
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 204 GKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999876554433333222 234556689999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.67 Aligned_cols=215 Identities=29% Similarity=0.477 Sum_probs=191.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
-++.+.-||.||..++||+||++++.|.-++.+||..|||.||-....+.. ...+++++++.+++|++.||.|||+++|
T Consensus 72 ELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~i 151 (1187)
T KOG0579|consen 72 ELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNI 151 (1187)
T ss_pred HHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcch
Confidence 366778899999999999999999999999999999999999988777655 4579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh-----cCCCCCChhhHHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGiil~el 168 (400)
+|||||..|||++-+|.++|+|||.+..... ......+..|||+|||||+.. ..+|+ .++|||||||+|.||
T Consensus 152 IHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEM 228 (1187)
T KOG0579|consen 152 IHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEM 228 (1187)
T ss_pred hhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHH
Confidence 9999999999999999999999999864332 222345789999999999974 46676 899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCccC---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEFT---CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
..+.+|....+++...-+|....++ .|..+|..+.+++.+||.+||..||++++|++||||+..
T Consensus 229 AqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 229 AQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred hccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999998888776543 466789999999999999999999999999999999953
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.66 Aligned_cols=203 Identities=34% Similarity=0.605 Sum_probs=180.8
Q ss_pred HHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 18 QIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 18 ~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
+..+|+.++.+. +||||+++++++.++.+.|+|||++.||.+.+.+.....+. ..+..|++||+.|+.|||++||+||
T Consensus 361 ~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhR 439 (612)
T KOG0603|consen 361 DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHR 439 (612)
T ss_pred ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeec
Confidence 355688777766 79999999999999999999999999999999998876555 7888999999999999999999999
Q ss_pred cCCCCcEEE-ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 97 DLKPENLLL-DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 97 DlKP~NILl-~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
||||+|||+ ++.|+++|+|||.+...+.. +.+.|-|..|+|||++...+|+ +++||||||++||+||+|+.||
T Consensus 440 DLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~ 513 (612)
T KOG0603|consen 440 DLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLF 513 (612)
T ss_pred CCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCcc
Confidence 999999999 58899999999998754331 5567889999999999988886 9999999999999999999999
Q ss_pred CCCchH-HHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 176 DDSNLM-NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 176 ~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
...... ++...+..+.+. .++|.++++||++||+.||.+|+++.+++.||||
T Consensus 514 ~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 514 AAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCCchHHHHHhhcCCccc--cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 775554 677776655544 8899999999999999999999999999999999
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=317.35 Aligned_cols=217 Identities=23% Similarity=0.382 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.....+++|+.+++.++||||+++++++..++..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++
T Consensus 41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 120 (327)
T cd08227 41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120 (327)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34677889999999999999999999999999999999999999999999653 4589999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccC-----CCccccccCCCCCCCChhhhcC--CCCCChhhHHHHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVI 164 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGii 164 (400)
||+||||||+|||++.++.++++|||.+........ ........++..|+|||++.+. +| +.++||||+||+
T Consensus 121 ~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~i 199 (327)
T cd08227 121 GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGIT 199 (327)
T ss_pred CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCC-CchhhHHHHHHH
Confidence 999999999999999999999999986432211111 0111233577889999999753 34 589999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCccC----------------------------------------------CCCCC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEFT----------------------------------------------CPPWL 198 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------------------------------~~~~~ 198 (400)
+|+|++|+.||..............+..+ ....+
T Consensus 200 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (327)
T cd08227 200 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTF 279 (327)
T ss_pred HHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccccccc
Confidence 99999999999865443322221111000 01124
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 199 SFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 199 s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
++.+.+||++||+.||.+|||++++++||||+.
T Consensus 280 ~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 280 SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred CHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=303.27 Aligned_cols=211 Identities=26% Similarity=0.506 Sum_probs=182.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++++++|||++++++.+.. ....|++|||+++++|.+.+... ..+++..+..++.|++.|++|||++|
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ 122 (257)
T cd08223 43 RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122 (257)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5678899999999999999999998764 45689999999999999999763 35899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++||||||+||+++.++.++|+|||++...... ........|++.|+|||++.+..+. .++||||+||++|+|++|+
T Consensus 123 i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~ 199 (257)
T cd08223 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLK 199 (257)
T ss_pred eeccCCCchhEEEecCCcEEEecccceEEeccc--CCccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCC
Confidence 999999999999999999999999998765432 2233456789999999999877664 8899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 173 LPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
.||...+.......+..+.. ..+..++..+.+++.+||+.||.+|||+.++++||||
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 200 HAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99988776666555544443 4556689999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=335.78 Aligned_cols=215 Identities=31% Similarity=0.501 Sum_probs=187.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC--------EEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT--------KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLIN 83 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--------~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~ 83 (400)
...+.+|+.++..++|+||+++++.+.... .+++||||+++|+|.+.+... ..+++..+..++.|++.
T Consensus 75 ~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~ 154 (496)
T PTZ00283 75 KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154 (496)
T ss_pred HHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHH
Confidence 567889999999999999999998765322 478999999999999988642 46899999999999999
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
||.|||++||+||||||+|||++.++.+||+|||+++............+.+||+.|+|||++.+..|. .++||||+||
T Consensus 155 aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGv 233 (496)
T PTZ00283 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGV 233 (496)
T ss_pred HHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHH
Confidence 999999999999999999999999999999999998765443333334567899999999999887774 8999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 164 ILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 164 il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
++|+|++|+.||.+.+..+.+..+..+.. ..|+.+++++.+++.+||+.||.+|||+.++++|||++.
T Consensus 234 ilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 234 LLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999888777777655543 467779999999999999999999999999999999875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.33 Aligned_cols=215 Identities=27% Similarity=0.505 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+++|+.++..++||||+++++.+.+...+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ii 124 (332)
T cd05623 45 TACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124 (332)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45688999999999999999999999999999999999999999999977 45799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----CCCCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGiil~ellt 170 (400)
||||||+|||++.++.+||+|||++....... .......+||+.|+|||++.. ....+.++||||+||++|+|++
T Consensus 125 HrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~ 203 (332)
T cd05623 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY 203 (332)
T ss_pred ecCCCHHHEEECCCCCEEEeecchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc
Confidence 99999999999999999999999986432211 112234579999999999862 2334589999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCc--cCCCC---CCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 015814 171 GYLPFDDSNLMNLYKKISAAE--FTCPP---WLSFTARKLIARILDPNPMT--RITIPEILEDEWFKK 231 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~~~~li~~mL~~dP~~--R~t~~eil~h~~~~~ 231 (400)
|+.||...+..+.+..+.... ...|. .++.++++||++||..+|.+ |++++++++||||..
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 204 GETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999988888777765432 23333 47999999999999665554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=321.71 Aligned_cols=213 Identities=26% Similarity=0.473 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
....+.+|+.+++.++||||+++++++... ...|+||||+++ +|.+.+.. .+++..+..++.|++.||+||
T Consensus 59 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~L 135 (355)
T cd07874 59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHL 135 (355)
T ss_pred HHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999988643 357999999976 67777643 588999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
|++||+||||||+|||++.+|.+||+|||+++.... ........||+.|+|||++.+..+. .++||||+||++|+|
T Consensus 136 H~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el 211 (355)
T cd07874 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEM 211 (355)
T ss_pred HhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHH
Confidence 999999999999999999999999999999875432 2223456799999999999887775 889999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcC----------------------c-----cC---------------CCCCCCHHHHHHH
Q 015814 169 LAGYLPFDDSNLMNLYKKISAA----------------------E-----FT---------------CPPWLSFTARKLI 206 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~----------------------~-----~~---------------~~~~~s~~~~~li 206 (400)
++|+.||.+.+....+..+... . .. .+...+.++++||
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (355)
T cd07874 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHH
Confidence 9999999876654333221100 0 00 0111356789999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 207 ARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 207 ~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.+||+.||.+|||+.|+++||||...+.
T Consensus 292 ~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 292 SKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 9999999999999999999999986554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.48 Aligned_cols=214 Identities=31% Similarity=0.529 Sum_probs=192.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
..++.|-.||.--+.++|++++..|.++.++|+||||++||+|..++...++++|+.|++|+..++.||.-||+.|+|||
T Consensus 120 A~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHR 199 (1317)
T KOG0612|consen 120 ACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHR 199 (1317)
T ss_pred HHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceec
Confidence 56889999999999999999999999999999999999999999999998899999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----CCCCCChhhHHHHHHHHHHHHhCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||+|||||..|++||+|||.+-.....+ .-.....+|||.|++||++.. ++.+|..+|+||+||++|||+.|.
T Consensus 200 DiKPDNvLld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~ 278 (1317)
T KOG0612|consen 200 DIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGE 278 (1317)
T ss_pred cCCcceeEecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCC
Confidence 999999999999999999999875443221 112345689999999999963 356789999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcC--ccCCC--CCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAA--EFTCP--PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~li~~mL~~dP~~R~t---~~eil~h~~~~~~ 232 (400)
.||...+..+.|.+|... .+.+| ..+|.++++||++.+ -+|..|.. ++++..||||...
T Consensus 279 TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 279 TPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred CcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence 999999999999999776 67777 458999999999988 47888887 9999999999863
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=311.93 Aligned_cols=213 Identities=26% Similarity=0.459 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~gi 93 (400)
...++.+|++++++++||||+++++.+.+++.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+ .|+
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 121 (308)
T cd06615 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 3567889999999999999999999999999999999999999999999888889999999999999999999997 599
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.++.+||+|||++..... ....+.+|++.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus 122 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~ 196 (308)
T cd06615 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRY 196 (308)
T ss_pred EECCCChHHEEEecCCcEEEccCCCcccccc----cccccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998764322 12345678999999999876655 488999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC-------------------------------------ccCCCC-CCCHHHHHHHHHhcCCCCC
Q 015814 174 PFDDSNLMNLYKKISAA-------------------------------------EFTCPP-WLSFTARKLIARILDPNPM 215 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-------------------------------------~~~~~~-~~s~~~~~li~~mL~~dP~ 215 (400)
||...+.......+... ....|. .++.++.+|+.+||..||+
T Consensus 197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (308)
T cd06615 197 PIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPK 276 (308)
T ss_pred CCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChh
Confidence 99765544433222111 011111 2577899999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q 015814 216 TRITIPEILEDEWFKKD 232 (400)
Q Consensus 216 ~R~t~~eil~h~~~~~~ 232 (400)
+|||+.++++||||...
T Consensus 277 ~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 277 ERADLKELTKHPFIKRA 293 (308)
T ss_pred hCcCHHHHhcChhhhhc
Confidence 99999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=316.97 Aligned_cols=209 Identities=22% Similarity=0.372 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeC-CEEEEEEecCCCCChHHHHHhC---------------------------
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNH--------------------------- 66 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~-~~~~lv~Ey~~gg~L~~~i~~~--------------------------- 66 (400)
...+.+|+.+++.+ +||||+++++++... ..+|+||||++||+|.+++...
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (338)
T cd05102 54 HKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133 (338)
T ss_pred HHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcc
Confidence 56788999999999 899999999987654 4689999999999999998753
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCe
Q 015814 67 -----------------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 111 (400)
Q Consensus 67 -----------------------------------~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~ 111 (400)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~ 213 (338)
T cd05102 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVV 213 (338)
T ss_pred ccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcE
Confidence 236778889999999999999999999999999999999999999
Q ss_pred eeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCchHH-HHHhhhc
Q 015814 112 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISA 189 (400)
Q Consensus 112 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~-~~~~i~~ 189 (400)
||+|||+++............+..+++.|+|||++.+..+ +.++||||+||++|+|++ |..||.+..... ....+..
T Consensus 214 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 292 (338)
T cd05102 214 KICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292 (338)
T ss_pred EEeecccccccccCcchhcccCCCCCccccCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc
Confidence 9999999875432111111223346788999999987776 489999999999999997 999998765433 3333333
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 190 A-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 190 ~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+ ....|...++++.+++.+||+.||.+|||+.++++
T Consensus 293 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 293 GTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3 33456668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=304.59 Aligned_cols=213 Identities=37% Similarity=0.707 Sum_probs=189.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+++.++||||+++++.+.++...|++|||++||+|.+.+.....+++..+..++.|++.||+|||++|++
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 115 (262)
T cd05572 36 QQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115 (262)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 35789999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|+||+|+||+++.++.++|+|||++....... ......|++.|+|||.+....+. .++|+||+|+++|+|++|..|
T Consensus 116 h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p 191 (262)
T cd05572 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPP 191 (262)
T ss_pred cCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCC
Confidence 99999999999999999999999987554321 22345789999999998776664 889999999999999999999
Q ss_pred CCCCc--hHHHHHhhh--cCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 175 FDDSN--LMNLYKKIS--AAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~--~~~~~~~i~--~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
|.... ....+..+. ......|...+.++.++|.+||..||.+||| ++|+++||||+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 192 FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred cCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 98776 556666655 3455667778999999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=311.20 Aligned_cols=212 Identities=26% Similarity=0.487 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+.+|+.+++.++||||+++++++......|+||||+.+ +|.+.+... ..+++..+..++.|++.||+|||++||+|
T Consensus 49 ~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H 127 (301)
T cd07873 49 CTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127 (301)
T ss_pred hHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 4567899999999999999999999999999999999975 898888654 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.++.+||+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|++|+.||
T Consensus 128 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f 205 (301)
T cd07873 128 RDLKPQNLLINERGELKLADFGLARAKSIP--TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205 (301)
T ss_pred CCCCHHHEEECCCCcEEECcCcchhccCCC--CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998653321 122234567899999999876655568999999999999999999999
Q ss_pred CCCchHHHHHhhhcC-------------------ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 176 DDSNLMNLYKKISAA-------------------EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~-------------------~~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
...+..+....+... ....| +.+++.+++||.+||+.||.+|||++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 206 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 887765443322110 00111 246888999999999999999999999999
Q ss_pred Cccccc
Q 015814 226 DEWFKK 231 (400)
Q Consensus 226 h~~~~~ 231 (400)
||||+.
T Consensus 286 h~~f~~ 291 (301)
T cd07873 286 HPYFHC 291 (301)
T ss_pred Cccccc
Confidence 999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=315.31 Aligned_cols=210 Identities=31% Similarity=0.498 Sum_probs=187.9
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
-...|-.||.+++.|.||.+-..|++.+.+|+||..|.||+|.-+|.+.+ +++++.+++|+.+|+.||++||+.+||.
T Consensus 231 maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVY 310 (591)
T KOG0986|consen 231 MALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVY 310 (591)
T ss_pred HhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceee
Confidence 34568999999999999999999999999999999999999999998877 8999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||+|+.|+++|+|+|||..+.. ......+.||.+|||||++.+..|+ ..+|.||+||+||+|+.|+.||
T Consensus 311 RDLKPeNILLDd~GhvRISDLGLAvei~~---g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPF 386 (591)
T KOG0986|consen 311 RDLKPENILLDDHGHVRISDLGLAVEIPE---GKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPF 386 (591)
T ss_pred ccCChhheeeccCCCeEeeccceEEecCC---CCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCch
Confidence 99999999999999999999999986543 3445667999999999999988875 8899999999999999999999
Q ss_pred CCCch----HHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 176 DDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
..... .++-+.+......+|..+|++++++.+.+|.+||.+|.. ++++.+||||+.
T Consensus 387 r~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 387 RQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred hhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 65432 244555556666778889999999999999999999974 679999999986
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=300.91 Aligned_cols=211 Identities=29% Similarity=0.498 Sum_probs=185.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.+++.++||||+++++.+......|+||||++|++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i 122 (256)
T cd08529 43 REEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122 (256)
T ss_pred HHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 577889999999999999999999999999999999999999999999774 568999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||++++++.++|+|||++...... .......+|++.|+|||++.+..+. .++|||||||++|+|++|+.
T Consensus 123 ~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~ 199 (256)
T cd08529 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKH 199 (256)
T ss_pred ccCCCCcceEEEeCCCCEEEcccccceeccCc--cchhhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754432 1222345789999999999877664 88999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 174 PFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
||...+.......+..+.. ..+..++.++.++|.+||+.+|++||++.++++|||+
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 200 PFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 9998887666666655544 3344688999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=305.66 Aligned_cols=216 Identities=27% Similarity=0.445 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.+++.++||||+++++.+..+...|+||||+++|+|...+.. ...+++..+..++.|++.||.|||+.|++
T Consensus 46 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~ 125 (282)
T cd06643 46 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125 (282)
T ss_pred HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 56788999999999999999999999999999999999999999888764 45799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----CCCCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGiil~ellt 170 (400)
||||||+||+++.++.+||+|||++...... ........|++.|+|||++.. ....+.++||||+||++|+|++
T Consensus 126 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~ 203 (282)
T cd06643 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203 (282)
T ss_pred ecCCCcccEEEccCCCEEEcccccccccccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence 9999999999999999999999998654321 112234578999999999842 1222478999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 171 GYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
|..||...+.......+.... ...|..++.++.+||.+||+.||.+|||++++++||||....
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 204 IEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred CCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 999998877655555543332 234556889999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=306.40 Aligned_cols=216 Identities=31% Similarity=0.465 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.++++++||||+++++++.++...|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i 124 (280)
T cd06611 45 ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKV 124 (280)
T ss_pred HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3577889999999999999999999999999999999999999999998764 469999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC----CCCChhhHHHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DIwSlGiil~ell 169 (400)
+||||||+||+++.++.++|+|||++...... ........|++.|+|||++.... ..+.++||||+||++|+|+
T Consensus 125 ~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~ 202 (280)
T cd06611 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202 (280)
T ss_pred ccCCCChhhEEECCCCCEEEccCccchhhccc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence 99999999999999999999999987654322 11223457899999999985322 2246899999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|+.||...+.......+.... ...|..++.++.++|.+||+.+|.+|||+.++++||||...
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 203 QMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred hCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999998877666655555443 23455689999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=309.03 Aligned_cols=211 Identities=27% Similarity=0.448 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+|+.++++++||||+++++++.++...|+||||+. |+|.+++... ..+++..++.++.|++.||+|||++|
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ 121 (285)
T cd07861 43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121 (285)
T ss_pred hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4678899999999999999999999999999999999998 5888888643 46899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++||||||+||+++.+|.+||+|||++...... ........|++.|+|||++.+....+.++|||||||++|+|++|+
T Consensus 122 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~ 199 (285)
T cd07861 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199 (285)
T ss_pred eeecCCCHHHEEEcCCCcEEECcccceeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999998654321 122234467899999999876554468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhc----------------------------Cc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 173 LPFDDSNLMNLYKKISA----------------------------AE-FTCPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~----------------------------~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
.||.+.+.......+.. .. ......+++++.++|++||+.||.+|||+.++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l 279 (285)
T cd07861 200 PLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA 279 (285)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 99987654322211100 00 00122368899999999999999999999999
Q ss_pred hcCccc
Q 015814 224 LEDEWF 229 (400)
Q Consensus 224 l~h~~~ 229 (400)
+.||||
T Consensus 280 l~~~~~ 285 (285)
T cd07861 280 LNHPYF 285 (285)
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=308.08 Aligned_cols=210 Identities=35% Similarity=0.663 Sum_probs=177.7
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecc
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 97 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrD 97 (400)
...+|+.++++++||||+++++++......++||||+.+++|.+++...+.+++..+..++.|++.||++||++|++|||
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~d 123 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRD 123 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred hhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 44569999999999999999999999999999999999999999999778899999999999999999999999999999
Q ss_pred CCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 015814 98 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 177 (400)
Q Consensus 98 lKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~ 177 (400)
|||+||+++.++.++|+|||.+.... ..........||+.|+|||++......+.++||||||+++|+|++|..||..
T Consensus 124 ikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 124 IKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp BSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999986531 1223345567899999999998334456999999999999999999999998
Q ss_pred Cc---hHHHHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 178 SN---LMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 178 ~~---~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
.. ...............+. ..+..+.++|.+||+.||.+|||+.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 202 SNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 73 22333332222211111 124899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=310.36 Aligned_cols=212 Identities=28% Similarity=0.445 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.++++++|+||+++++.+.+.+..|+||||++||+|.+++...+ .+++..+..++.|++.||.|||+.||
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4567789999999999999999999999999999999999999999886543 58999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||+++.++.++|+|||++..... ........||+.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus 124 iH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~ 199 (285)
T cd05630 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQS 199 (285)
T ss_pred EeCCCCHHHEEECCCCCEEEeeccceeecCC---CccccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865432 122234579999999999987776 488999999999999999999
Q ss_pred CCCCCchH---HHHHh-hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 174 PFDDSNLM---NLYKK-ISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~---~~~~~-i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
||...... ..... ........+..+++++.+|+++||+.||.+||| ++|+++||||+.
T Consensus 200 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 200 PFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred CCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 99864321 11111 122223445668999999999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=303.84 Aligned_cols=210 Identities=29% Similarity=0.459 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+++|+.+++.++||||+++++.+......|+||||+++|+|.+++...+.+++..+..++.|++.|++|||++|++|
T Consensus 50 ~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 129 (267)
T cd06645 50 FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129 (267)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 45678899999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh---cCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+||+++.++.+||+|||++...... ........|++.|+|||++. ...+ +.++||||+||++|+|++|.
T Consensus 130 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~ 206 (267)
T cd06645 130 RDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQ 206 (267)
T ss_pred CCCCHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCC
Confidence 999999999999999999999998654321 11223457999999999984 2334 58899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
.||...................+ ..++..+.++|.+||..+|++|||++++++|||
T Consensus 207 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 207 PPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99976554333322222222211 236788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=305.04 Aligned_cols=211 Identities=21% Similarity=0.364 Sum_probs=182.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYF 78 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~ 78 (400)
....+.+|+.++++++||||+++++++......|++|||+++|+|.+++... ..+++..+..++
T Consensus 51 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 130 (283)
T cd05048 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHH
Confidence 3567899999999999999999999999999999999999999999999764 457888999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++|++||||||+||++++++.+||+|||++................+++.|+|||.+....+ +.++||
T Consensus 131 ~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv 209 (283)
T cd05048 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDI 209 (283)
T ss_pred HHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhH
Confidence 9999999999999999999999999999999999999999875432222222334567889999999987666 489999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||+||++|+|++ |..||.+.+..+....+.... ...|..++.++.+|+.+||+.||.+|||+.+|+++
T Consensus 210 ~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 210 WSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999998 999999888877777765543 34566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.84 Aligned_cols=212 Identities=33% Similarity=0.626 Sum_probs=200.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+..|-.||..++.|.||++|..|.+..++|+.||-|-||+|...++..+.|++..+++|...+++|++|||++||++
T Consensus 464 qeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIY 543 (732)
T KOG0614|consen 464 QEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIY 543 (732)
T ss_pred HHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCcee
Confidence 56788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||||++++.+|.+||.|||+|+... ......+.||||.|+|||++.+++.+ .++|.|||||++||||+|.+||
T Consensus 544 RDLKPENllLd~~Gy~KLVDFGFAKki~---~g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPF 619 (732)
T KOG0614|consen 544 RDLKPENLLLDNRGYLKLVDFGFAKKIG---SGRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPF 619 (732)
T ss_pred ccCChhheeeccCCceEEeehhhHHHhc---cCCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999998655 35567899999999999999999987 8899999999999999999999
Q ss_pred CCCchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
.+.+++..|..|..+ ...+|..++..+.+||+++...+|.+|.. +.+|.+|.||..
T Consensus 620 s~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 620 SGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred CCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999998776 46788999999999999999999999986 899999999975
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=307.67 Aligned_cols=208 Identities=31% Similarity=0.494 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHhC---CCCCcceeeEEEEe-----CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLV---KHPNVVRLYEVMGS-----KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 17 ~~i~~Ei~il~~l---~HpnIv~l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~ 86 (400)
..+.+|+.+++.+ +||||+++++++.. ...++++|||+.+ +|.+++... ..+++..++.++.|++.||+
T Consensus 44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 122 (288)
T cd07863 44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122 (288)
T ss_pred hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 4566788887766 69999999998754 3568999999985 898888663 35899999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
|||++||+||||||+||+++.+|.+||+|||++..... ........||+.|+|||++.+..+ +.++||||+||++|
T Consensus 123 ~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~ 198 (288)
T cd07863 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFA 198 (288)
T ss_pred HHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHH
Confidence 99999999999999999999999999999999876542 122234578999999999987766 48999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHhhhcC------------------cc---------CCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 015814 167 VLLAGYLPFDDSNLMNLYKKISAA------------------EF---------TCPPWLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~i~~~------------------~~---------~~~~~~s~~~~~li~~mL~~dP~~R~t 219 (400)
+|++|..||.+.+......++... .+ ...+.++..+.+||.+||+.||.+|||
T Consensus 199 ~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 199 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred HHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 999999999876655444333210 00 011246788999999999999999999
Q ss_pred HHHHhcCccc
Q 015814 220 IPEILEDEWF 229 (400)
Q Consensus 220 ~~eil~h~~~ 229 (400)
+.+++.||||
T Consensus 279 ~~~~l~hp~f 288 (288)
T cd07863 279 AFRALQHPFF 288 (288)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=305.10 Aligned_cols=213 Identities=27% Similarity=0.447 Sum_probs=183.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.+|++++|+||+.+++.+..++..|++|||+++|+|.+.+... .++++..+..++.|++.||.|||++||
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 456788999999999999999999999999999999999999999888653 369999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||++++++.+||+|||++..... ........|++.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus 124 iH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~ 199 (285)
T cd05632 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPE---GESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQS 199 (285)
T ss_pred eecCCCHHHEEECCCCCEEEecCCcceecCC---CCcccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998865322 122244579999999999987666 488999999999999999999
Q ss_pred CCCCCchHHH----HHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCcccccC
Q 015814 174 PFDDSNLMNL----YKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKKD 232 (400)
Q Consensus 174 Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~~ 232 (400)
||.+...... ...+.......++.++.++.+|+.+||+.||.+||| +.++++|+||+..
T Consensus 200 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 200 PFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred CCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9987654332 223333444556678999999999999999999999 8899999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=314.23 Aligned_cols=215 Identities=28% Similarity=0.491 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+++|+.+++.++||||+++++++.+.+..|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~ii 124 (331)
T cd05624 45 TACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV 124 (331)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 56688899999999999999999999999999999999999999999987 46799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC----CCCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~----~~~~~~~DIwSlGiil~ellt 170 (400)
||||||+|||++.+|.+||+|||++....... .......+||+.|+|||++... +..+.++||||+||++|+|++
T Consensus 125 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 203 (331)
T cd05624 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred eccCchHHEEEcCCCCEEEEeccceeeccCCC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh
Confidence 99999999999999999999999987543211 1112335799999999998752 233588999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCc--cCCCC---CCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 015814 171 GYLPFDDSNLMNLYKKISAAE--FTCPP---WLSFTARKLIARILDPNPMT--RITIPEILEDEWFKK 231 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~~~~li~~mL~~dP~~--R~t~~eil~h~~~~~ 231 (400)
|+.||...+..+.+..+.... ..+|. .++.+++++|.+||..+|.+ |++++++++||||+.
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 204 GETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999888777777765432 33343 36899999999999876655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.52 Aligned_cols=215 Identities=30% Similarity=0.509 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+++|+.+++.++||||+++++++......++||||++||+|.+++...+.+++..+..++.|++.||.|||++|++
T Consensus 51 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~ 130 (272)
T cd06629 51 MVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGIL 130 (272)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 35678999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC-CCCChhhHHHHHHHHHHHHhCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGiil~elltG~~ 173 (400)
||||+|+||+++.++.++|+|||++................|+..|+|||++.... ..+.++|+||+|+++|++++|..
T Consensus 131 H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 210 (272)
T cd06629 131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210 (272)
T ss_pred ecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999987544322222234457899999999987654 23588999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC--ccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 174 PFDDSNLMNLYKKISAA--EFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~--~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
||...........+... ....+. .++.++.++|.+||.++|.+|||++++++|||+
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 211 PWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 99766554433332211 222232 358899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=327.80 Aligned_cols=211 Identities=24% Similarity=0.369 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHHhCCC------CCcceeeEEEEeC-CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKH------PNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~H------pnIv~l~~~~~~~-~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
....+.|+.+++.++| ++++++++++..+ .++|+|||++ |++|.+++...+.+++..+..++.|++.||+||
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yL 247 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYF 247 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456678888777755 4588899888764 5789999988 779999998888999999999999999999999
Q ss_pred HH-cCCeeccCCCCcEEEccCC----------------CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC
Q 015814 89 HS-RGVYHRDLKPENLLLDAYG----------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151 (400)
Q Consensus 89 H~-~givHrDlKP~NILl~~~g----------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~ 151 (400)
|+ .||+||||||+|||++.++ .+||+|||++.... ......+||+.|+|||++.+..|
T Consensus 248 H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~ 322 (467)
T PTZ00284 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGW 322 (467)
T ss_pred HhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCC
Confidence 98 5999999999999998765 49999999875322 22345689999999999998777
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCC-----------------------C------------
Q 015814 152 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-----------------------P------------ 196 (400)
Q Consensus 152 ~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------~------------ 196 (400)
. .++|||||||++|||++|+.||++.+..+....+......+| +
T Consensus 323 ~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 323 M-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred C-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 4 899999999999999999999988765443332211100000 0
Q ss_pred -------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 197 -------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 197 -------~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
..+..+.+||.+||..||.+|||++|+|+||||...+
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 0134577999999999999999999999999998754
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=355.83 Aligned_cols=219 Identities=31% Similarity=0.524 Sum_probs=193.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+..+.+|..++..++|||+|++|++-......||.||||+||+|.+.++..+-.+|...+.|..|++.|++|||++||
T Consensus 1276 k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gI 1355 (1509)
T KOG4645|consen 1276 KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGI 1355 (1509)
T ss_pred ccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCc
Confidence 45678999999999999999999999999999999999999999999999998888999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeecccccccccccc--CCCccccccCCCCCCCChhhhcCC--CCCChhhHHHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--DDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGiil~ell 169 (400)
|||||||+||+|+.+|.+|++|||.|....... -.+.+....|||.|||||++.+.. -.+-++||||+|||+.||+
T Consensus 1356 VHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1356 VHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA 1435 (1509)
T ss_pred eecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee
Confidence 999999999999999999999999987654331 234566778999999999997643 2356899999999999999
Q ss_pred hCCCCCCCCc--hHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 170 AGYLPFDDSN--LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 170 tG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
||+.||...+ ..-+|.--....+.+|..+|++.++||.+||..||.+|.++.||++|.|-+..
T Consensus 1436 tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1436 TGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred cCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 9999997644 34555555556778898999999999999999999999999999999998753
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=311.11 Aligned_cols=213 Identities=26% Similarity=0.415 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEE--eCCEEEEEEecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGGELFDKIVNH---------GRMKEDEARRYFQQLINA 84 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv~Ey~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~ 84 (400)
...+.+|+.+++.++||||+++++++. ....+|+||||+.+ +|.+.+... ..+++..++.++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07867 42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence 346788999999999999999999885 45678999999875 788877532 248899999999999999
Q ss_pred HHHHHHcCCeeccCCCCcEEE----ccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHH
Q 015814 85 VDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 159 (400)
Q Consensus 85 l~~LH~~givHrDlKP~NILl----~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw 159 (400)
|+|||++||+||||||+|||+ +.++.+||+|||++........ ........||+.|+|||++.+....+.++|||
T Consensus 121 L~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07867 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence 999999999999999999999 4567899999999976543211 11234457899999999998755556899999
Q ss_pred HHHHHHHHHHhCCCCCCCCchH---------HHHHhhh----------------------------cCcc----------
Q 015814 160 SCGVILFVLLAGYLPFDDSNLM---------NLYKKIS----------------------------AAEF---------- 192 (400)
Q Consensus 160 SlGiil~elltG~~Pf~~~~~~---------~~~~~i~----------------------------~~~~---------- 192 (400)
|+||++|+|++|+.||...... .....+. ....
T Consensus 201 SlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (317)
T cd07867 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYME 280 (317)
T ss_pred hHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhh
Confidence 9999999999999999653211 0000000 0000
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 193 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 193 ~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
......+..+.+||.+||+.||.+|||++|+++||||
T Consensus 281 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 281 KHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=325.66 Aligned_cols=213 Identities=24% Similarity=0.409 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+.+|+.+|++++|||||++++++..+...|+|||++. |+|.+++... ..+++..+..++.|++.||.|||++||+|
T Consensus 205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 283 (461)
T PHA03211 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283 (461)
T ss_pred cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 456789999999999999999999999999999999996 5898888664 46999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..+. .++|||||||++|||++|..|+
T Consensus 284 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 284 RDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCc
Confidence 999999999999999999999998765432222223346799999999999887774 8999999999999999987654
Q ss_pred CCC--------chHHHHHhhhcCcc-----------------------------CCCCC-----CCHHHHHHHHHhcCCC
Q 015814 176 DDS--------NLMNLYKKISAAEF-----------------------------TCPPW-----LSFTARKLIARILDPN 213 (400)
Q Consensus 176 ~~~--------~~~~~~~~i~~~~~-----------------------------~~~~~-----~s~~~~~li~~mL~~d 213 (400)
... ....+.+.+..... ..+.| ++.++.+||.+||+.|
T Consensus 363 f~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~D 442 (461)
T PHA03211 363 FSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFD 442 (461)
T ss_pred ccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccC
Confidence 321 11222222221111 11112 4568999999999999
Q ss_pred CCCCCCHHHHhcCccccc
Q 015814 214 PMTRITIPEILEDEWFKK 231 (400)
Q Consensus 214 P~~R~t~~eil~h~~~~~ 231 (400)
|.+|||+.|+|+||||+.
T Consensus 443 P~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 443 GARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhhCcCHHHHhhCcccCC
Confidence 999999999999999974
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=307.72 Aligned_cols=211 Identities=31% Similarity=0.530 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++||||+++++++.+....|+++||+.+ +|.+.+.. .+.+++..++.++.|++.||.|||++|++
T Consensus 43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~ 121 (284)
T cd07839 43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121 (284)
T ss_pred ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 35678899999999999999999999999999999999975 78887765 56799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.++.+||+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus 122 H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p 199 (284)
T cd07839 122 HRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199 (284)
T ss_pred cCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999998754321 12223456789999999987765556899999999999999999888
Q ss_pred C-CCCchHHHHHhhhcC----------------c---c----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 175 F-DDSNLMNLYKKISAA----------------E---F----------TCPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 175 f-~~~~~~~~~~~i~~~----------------~---~----------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
+ .+.+..+.+..+... . . ...+.+++++++||++||+.||.+|||+++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il 279 (284)
T cd07839 200 LFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279 (284)
T ss_pred CcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence 5 444433333322110 0 0 01123688999999999999999999999999
Q ss_pred cCccc
Q 015814 225 EDEWF 229 (400)
Q Consensus 225 ~h~~~ 229 (400)
+||||
T Consensus 280 ~h~~f 284 (284)
T cd07839 280 QHPYF 284 (284)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=301.93 Aligned_cols=216 Identities=26% Similarity=0.486 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+++++|+.++++++||||+++++++......++||||++|++|.+.+...+.+++..+..++.|++.||.|||++|+
T Consensus 45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i 124 (268)
T cd06630 45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34688999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCC-CeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 94 YHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 94 vHrDlKP~NILl~~~g-~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
+||||+|+||+++.++ .+||+|||++........ ........||..|+|||.+.+..+ +.++||||+||++|+|++
T Consensus 125 ~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred ecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHh
Confidence 9999999999998876 599999999866543211 111223468899999999987666 488999999999999999
Q ss_pred CCCCCCCCchHHHHHhh-----hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 171 GYLPFDDSNLMNLYKKI-----SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
|..||...........+ .......|+.++.++.+++.+||..+|.+|||+.++++||||+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999765433222222 1223455667899999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=298.08 Aligned_cols=211 Identities=29% Similarity=0.458 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.++++++||||+++++++..+...|++|||+.|++|.+++... ..+++..+..++.|++.||.|||++|+
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i 122 (262)
T cd06613 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122 (262)
T ss_pred hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3678999999999999999999999999999999999999999999998776 689999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC---CCCCChhhHHHHHHHHHHHHh
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~---~~~~~~~DIwSlGiil~ellt 170 (400)
+|+||+|+||+++.+|.+||+|||++....... .......|+..|+|||.+... .++ .++||||+||++|+|++
T Consensus 123 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~t 199 (262)
T cd06613 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAE 199 (262)
T ss_pred eecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHh
Confidence 999999999999999999999999987644321 122345789999999998765 554 88999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCccC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 171 GYLPFDDSNLMNLYKKISAAEFT-----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
|..||...+.......+....+. .+..++.++.++|++||..+|..|||+++++.|+|
T Consensus 200 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 200 LQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred CCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999887655444433333221 22335788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.34 Aligned_cols=215 Identities=34% Similarity=0.656 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+++.++||||+++++.+.+++..|+||||++||+|.+++...+.+++..+..++.|++.|++|||++|++|
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 124 (305)
T cd05609 45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVH 124 (305)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 56788999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccC-------------CCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
|||||+||+++.+|.+||+|||++........ ........|++.|+|||.+....+ +.++||||+|
T Consensus 125 ~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG 203 (305)
T cd05609 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMG 203 (305)
T ss_pred cCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHH
Confidence 99999999999999999999998763210000 001123467889999999987666 5899999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHhhhcCccCCC---CCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 015814 163 VILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 231 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~~~~~li~~mL~~dP~~R~t---~~eil~h~~~~~ 231 (400)
|++|+|++|..||.+.+..+....+..+....| ..++.++.++|.+||+.||.+||| +.++++||||..
T Consensus 204 ~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 204 IILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 999999999999998877777776655443332 247899999999999999999998 799999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=299.91 Aligned_cols=217 Identities=35% Similarity=0.640 Sum_probs=191.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|+.++++++||||+++++.+..+...|++|||++|++|.+.+...+.+++..+..++.|++.||.|||++|+
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 114 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI 114 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence 34678999999999999999999999999999999999999999999999887889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccC------CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
+||||+|+||++++++.++|+|||++........ ........+++.|+|||.+....+ +.++||||+|+++|+
T Consensus 115 ~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~ 193 (265)
T cd05579 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYE 193 (265)
T ss_pred ecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHH
Confidence 9999999999999999999999999875432211 112234568899999999987665 588999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCccCCCCCC--CHHHHHHHHHhcCCCCCCCCCH---HHHhcCccccc
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAEFTCPPWL--SFTARKLIARILDPNPMTRITI---PEILEDEWFKK 231 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~mL~~dP~~R~t~---~eil~h~~~~~ 231 (400)
+++|..||........+..+..+....|... +..+.+++++||+.+|.+|||+ .++++||||+.
T Consensus 194 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 194 FLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 9999999998888888877766666666555 8999999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=315.60 Aligned_cols=218 Identities=26% Similarity=0.433 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCH-HHHHHHHHHHHHHHHHHHHc
Q 015814 14 CILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKE-DEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e-~~~~~~~~qll~~l~~LH~~ 91 (400)
.++.-++.||..|.+| .|.+||++|++-..++.+|+||||-+. +|...|.......+ ...++|.+|++.|+.++|.+
T Consensus 401 qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~ 479 (677)
T KOG0596|consen 401 QTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH 479 (677)
T ss_pred HHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh
Confidence 5688899999999999 599999999999999999999998765 89999988765443 68999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCC----------CChhhHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD----------GSTADLWSC 161 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~----------~~~~DIwSl 161 (400)
||||-||||.|+|+-. |.+||+|||.|.........-...+.+||+.||+||.+....+. +.++|||||
T Consensus 480 gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSL 558 (677)
T KOG0596|consen 480 GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSL 558 (677)
T ss_pred ceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhh
Confidence 9999999999999977 99999999999877655555556778999999999999654332 578999999
Q ss_pred HHHHHHHHhCCCCCCCCc-hHHHHHhhhcC--ccCCCCCCCHH-HHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 162 GVILFVLLAGYLPFDDSN-LMNLYKKISAA--EFTCPPWLSFT-ARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~~~~~s~~-~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
|||||+|+.|+.||..-. ...-+..|... .+.+|..-+.. +.++++.||..||.+|||+.++|+|||++...
T Consensus 559 GCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 559 GCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred hhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 999999999999996532 22223333332 34555543333 99999999999999999999999999998643
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=300.29 Aligned_cols=211 Identities=27% Similarity=0.401 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEe------CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~------~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~ 86 (400)
...+.+|+.+++++ +||||+++++.+.. ...+|++|||+.+|+|.+++... ..+++..+..++.|++.|++
T Consensus 46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~ 125 (272)
T cd06637 46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125 (272)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence 46788999999998 79999999999865 34689999999999999999864 36899999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-----CCCCCChhhHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSC 161 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSl 161 (400)
|||++||+||||||+||++++++.++|+|||++...... ........|++.|+|||++.. ..| +.++||||+
T Consensus 126 ~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~sl 202 (272)
T cd06637 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSL 202 (272)
T ss_pred HHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHH
Confidence 999999999999999999999999999999998754321 122345679999999999863 234 478999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHhhhcCcc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 162 GVILFVLLAGYLPFDDSNLMNLYKKISAAEF--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
||++|+|++|..||...........+..... ..+..++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 203 Gv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 203 GITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9999999999999977655444433322221 2233478999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.64 Aligned_cols=212 Identities=30% Similarity=0.471 Sum_probs=182.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.++++++||||+++++++...+..|+||||++|++|.+++.... .+++..+..++.|++.||.|||+.|+
T Consensus 37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 116 (277)
T cd05577 37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116 (277)
T ss_pred hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4456789999999999999999999999999999999999999999997765 79999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|+||++++++.++|+|||++..... ........|+..|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus 117 ~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~ 192 (277)
T cd05577 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRS 192 (277)
T ss_pred ccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCCCCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCC
Confidence 9999999999999999999999998875432 122234567889999999987665 488999999999999999999
Q ss_pred CCCCCch----HHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 174 PFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
||..... ..+...+.......++.+++.+.++|.+||+.||.+|| ++.+++.||||..
T Consensus 193 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 193 PFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred CCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 9977543 23333333444556667899999999999999999999 8888999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.46 Aligned_cols=212 Identities=29% Similarity=0.471 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++......|+||||++++.|...+.....+++..++.++.|++.||+|||++|++|
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H 123 (286)
T cd07847 44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123 (286)
T ss_pred cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 35578899999999999999999999999999999999999888877777678999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.+|.+||+|||++....... .......++..|+|||++.+....+.++||||+||++|+|++|..||
T Consensus 124 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~ 201 (286)
T cd07847 124 RDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW 201 (286)
T ss_pred cCCChhhEEEcCCCcEEECccccceecCCCc--ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999987654321 12234468899999999876554568999999999999999999999
Q ss_pred CCCchHHHHHhhhc---------------Cc----cCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 176 DDSNLMNLYKKISA---------------AE----FTCP------------PWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 176 ~~~~~~~~~~~i~~---------------~~----~~~~------------~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
.+.+..+....+.. .. ...| +.++..+.+||.+||+.||.+|||+.+++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 202 PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred CCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 87654332222110 00 0000 23578899999999999999999999999
Q ss_pred cCccc
Q 015814 225 EDEWF 229 (400)
Q Consensus 225 ~h~~~ 229 (400)
.||||
T Consensus 282 ~~~~f 286 (286)
T cd07847 282 EHPYF 286 (286)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.94 Aligned_cols=207 Identities=29% Similarity=0.455 Sum_probs=177.9
Q ss_pred HHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCC
Q 015814 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 101 (400)
Q Consensus 22 Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~ 101 (400)
.+..++..+||||+++++.+......|+||||++||+|.+++...+.+++..+..++.|++.||+|||+.||+||||||+
T Consensus 47 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ 126 (278)
T cd05606 47 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPA 126 (278)
T ss_pred HHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHH
Confidence 34455566899999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred cEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCC---
Q 015814 102 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--- 178 (400)
Q Consensus 102 NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~--- 178 (400)
||+++.++.+||+|||++...... .....+|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.
T Consensus 127 nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~ 202 (278)
T cd05606 127 NILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (278)
T ss_pred HEEECCCCCEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999998654321 2234579999999999975433458899999999999999999999876
Q ss_pred chHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 015814 179 NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKKD 232 (400)
Q Consensus 179 ~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~~ 232 (400)
........+.......|..+|.++.+++.+||..+|.+|| ++.++++||||+..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 203 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred chHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 3333344444445566667899999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.43 Aligned_cols=211 Identities=28% Similarity=0.417 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+++|+.++++++||||+++++++..+..+|+||||+++|+|.+.+...+.+++..+..++.|++.||+|||+.||+|
T Consensus 50 ~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 129 (267)
T cd06646 50 FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129 (267)
T ss_pred HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45688999999999999999999999999999999999999999999988788999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
|||||+||+++.++.+||+|||++...... ........|++.|+|||.+.. ....+.++||||+||++|+|++|..
T Consensus 130 ~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~ 207 (267)
T cd06646 130 RDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207 (267)
T ss_pred cCCCHHHEEECCCCCEEECcCccceeeccc--ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999998754321 111234578999999999853 2222478999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 174 PFDDSNLMNLYKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
||...+.......+....+..+ ..++..+.+||++||..+|.+|||++++++|+|
T Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 208 PMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9976554433333322222222 236889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=304.12 Aligned_cols=215 Identities=31% Similarity=0.488 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
+....+.+|+.++++++||||+++++++......|+||||+ |++|.+.+.. ...+++..++.++.|++.||+|||+.|
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 119 (286)
T cd07832 41 GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119 (286)
T ss_pred hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34578899999999999999999999999999999999999 9999999865 356899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++|+||||+||+++.++.++|+|||++....... ........|++.|+|||.+......+.++||||+||++|+|++|.
T Consensus 120 i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (286)
T cd07832 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198 (286)
T ss_pred eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999987654322 122345678999999999876555568999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcC-------------------ccC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 173 LPFDDSNLMNLYKKISAA-------------------EFT-----------CPPWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-------------------~~~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
.||.+.+....+..+... ... ..+..+..+.+||++||+.||.+|||+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 278 (286)
T cd07832 199 PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278 (286)
T ss_pred cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence 999876654443332110 000 01235788999999999999999999999
Q ss_pred HhcCcccc
Q 015814 223 ILEDEWFK 230 (400)
Q Consensus 223 il~h~~~~ 230 (400)
+++||||.
T Consensus 279 ~l~h~~~~ 286 (286)
T cd07832 279 ALRHPYFT 286 (286)
T ss_pred HhhCcCcC
Confidence 99999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=321.23 Aligned_cols=203 Identities=23% Similarity=0.436 Sum_probs=182.0
Q ss_pred HHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCC
Q 015814 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 100 (400)
Q Consensus 21 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP 100 (400)
-+|+-|++|+|||||.|.+++.....+|||||||..|-|...++....+.......|..+|+.|+.|||.+.|||||||.
T Consensus 161 TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKS 240 (904)
T KOG4721|consen 161 TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKS 240 (904)
T ss_pred hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCC
Confidence 48888999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCch
Q 015814 101 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 180 (400)
Q Consensus 101 ~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~ 180 (400)
-||||+.+..|||+|||.++..... ....+.+||..|||||++...+.. +++||||+||||||||||..||.+-+.
T Consensus 241 PNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 241 PNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred CceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccch
Confidence 9999999999999999988754432 334568999999999999988875 999999999999999999999988666
Q ss_pred HHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 015814 181 MNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 227 (400)
Q Consensus 181 ~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~ 227 (400)
..+..-+... ..+.|..++..++=||+.||+-.|.+||++.+|+.|-
T Consensus 317 sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 317 SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 5554433222 3466778999999999999999999999999999883
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.18 Aligned_cols=202 Identities=30% Similarity=0.479 Sum_probs=171.5
Q ss_pred HHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 015814 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 105 (400)
Q Consensus 26 l~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl 105 (400)
+...+||||+.+++.+..++..|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~ 130 (279)
T cd05633 51 VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130 (279)
T ss_pred HhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE
Confidence 34457999999999999999999999999999999999888889999999999999999999999999999999999999
Q ss_pred ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCch---HH
Q 015814 106 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MN 182 (400)
Q Consensus 106 ~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~---~~ 182 (400)
++++.++|+|||++...... ......||+.|+|||.+......+.++||||+||++|+|++|..||..... ..
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 206 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (279)
T ss_pred CCCCCEEEccCCcceecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH
Confidence 99999999999998644321 123457999999999986433345889999999999999999999975432 22
Q ss_pred HHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 183 LYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 183 ~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
............|+.++.++.++|++||+.||.+|+ |++++++||||+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 207 IDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 222222334456677899999999999999999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=306.81 Aligned_cols=217 Identities=29% Similarity=0.506 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++.+...+..|+||||++|++|.+++.. +.++++.+..++.|++.||+|||++||+|
T Consensus 63 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH 141 (292)
T cd06658 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIH 141 (292)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 56788999999999999999999999999999999999999999988754 57899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||++++++.++|+|||++...... ........|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||
T Consensus 142 ~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~ 218 (292)
T cd06658 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPY 218 (292)
T ss_pred cCCCHHHEEEcCCCCEEEccCcchhhcccc--cccCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998654321 122234678999999999987666 48899999999999999999999
Q ss_pred CCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 176 DDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
...+.......+.... .......+..+.+++.+||..||.+|||++++++||||.....|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 219 FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred CCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 8877655554443321 122234788999999999999999999999999999999765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.46 Aligned_cols=213 Identities=29% Similarity=0.509 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++.+..+...|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+.||+|
T Consensus 61 ~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H 139 (296)
T cd06654 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIH 139 (296)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46788999999999999999999999999999999999999999998865 56899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.++.+||+|||++...... ........|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||
T Consensus 140 ~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf 216 (296)
T cd06654 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPY 216 (296)
T ss_pred CCCCHHHEEEcCCCCEEECccccchhcccc--ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999988754321 112234578999999999987665 48999999999999999999999
Q ss_pred CCCchHHHHHhhh-cCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 176 DDSNLMNLYKKIS-AAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 176 ~~~~~~~~~~~i~-~~~--~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
...+.......+. ... ...+..++..+.++|.+||..||.+|||+.++++||||...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 8776543332222 221 23355688999999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=299.30 Aligned_cols=214 Identities=28% Similarity=0.509 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
....+++|+.++++++||||+++++++.. ....+++|||+++++|.+.+...+.+++.....++.|++.||+|||++|
T Consensus 47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 126 (266)
T cd06651 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126 (266)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678999999999999999999998865 4678999999999999999988788999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeecccccccccccc-CCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
++||||||+||+++.++.+||+|||++....... .........|+..|+|||.+.+..+ +.++||||+||++|+|++|
T Consensus 127 i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g 205 (266)
T cd06651 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTE 205 (266)
T ss_pred eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHC
Confidence 9999999999999999999999999986543211 1112233568999999999987665 4889999999999999999
Q ss_pred CCCCCCCchHHHHHhhhc--CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 172 YLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
+.||.............. .....|..++..++++| +||..+|.+|||++++++||||+
T Consensus 206 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 206 KPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999987665544443322 23445666889999999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=296.47 Aligned_cols=211 Identities=27% Similarity=0.483 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|+.++++++||||+++++.+.+....|+++||+++++|.+.+.. ...+++..+..++.|++.|+.|||+.|++
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~ 121 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 67899999999999999999999999999999999999999999999975 44689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||+|+||++++++.+||+|||++....... .......|+..|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus 122 H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred cCCCCcceEEECCCCcEEEcccccchhcccCc--cccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654321 12234458899999999987766 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcC---ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 175 FDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
|...+.......+... ....+..++.++.++|.+||+.||.+|||+.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9876654433332221 223344578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=301.37 Aligned_cols=214 Identities=29% Similarity=0.466 Sum_probs=181.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.+++.++||||+++++.+..+...|+||||++|++|...+.. ...+++..+..++.|++.|+.|||++|+
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 131 (292)
T cd06644 52 ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131 (292)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 367788999999999999999999999999999999999999999887754 4578999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-----CCCCCChhhHHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGiil~el 168 (400)
+||||||+||+++.+|.+||+|||++...... ........|++.|+|||++.. ..+ +.++||||+||++|+|
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el 208 (292)
T cd06644 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEM 208 (292)
T ss_pred eecCCCcceEEEcCCCCEEEccCccceecccc--ccccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHH
Confidence 99999999999999999999999987643221 112234568999999999853 223 4789999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCcc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
++|..||...+....+.++..... ..+..++.++.++|.+||..||.+||+++++++||||..
T Consensus 209 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 209 AQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred hcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999987766555555443322 234557899999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.93 Aligned_cols=212 Identities=29% Similarity=0.522 Sum_probs=182.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++++......|+|+||++||+|.+.+.. ..+++..+..++.|++.||+|||++|++|
T Consensus 60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H 138 (296)
T cd06655 60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIH 138 (296)
T ss_pred HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46788999999999999999999999999999999999999999998865 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.+|.+||+|||++...... ........|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||
T Consensus 139 ~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf 215 (296)
T cd06655 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPY 215 (296)
T ss_pred CCCCHHHEEECCCCCEEEccCccchhcccc--cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999987754322 112234578999999999987666 48899999999999999999999
Q ss_pred CCCchHHHHHhhhcC---ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
...+.......+... ....+..+++.+.++|++||..||.+|||+.++++||||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 216 LNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred CCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 887765443333222 22345568899999999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=294.99 Aligned_cols=211 Identities=31% Similarity=0.563 Sum_probs=186.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..++.+|+.++++++||||+++++++.+....+++|||++||+|.+.+... ..+++..+..++.|++.|+.|||+.|+
T Consensus 43 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (256)
T cd08221 43 RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 567889999999999999999999999999999999999999999999775 468999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|+||++++++.+||+|||++....... .......|++.|+|||.+.+..+ +.++||||+||++|+|++|..
T Consensus 123 ~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~ 199 (256)
T cd08221 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SMAETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKR 199 (256)
T ss_pred cccCCChHhEEEeCCCCEEECcCcceEEccccc--ccccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCC
Confidence 999999999999999999999999987654322 12345678999999999987665 488999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 174 PFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
||...+..+....+..+... .+..++.++.++|.+||..+|.+|||+.++++|||+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 200 TFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99988877777766555443 345578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=297.80 Aligned_cols=215 Identities=29% Similarity=0.510 Sum_probs=183.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..+.+.+|+.+++.++||||+++++.+......|+||||++|++|.+.+... ..+++..+..++.|++.||+|||++
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3678999999999999999999999999999999999999999999999764 4589999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCC--CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
|++||||+|+||++++++.++|+|||++......... .......|++.|+|||++......+.++|+||+||++|+|+
T Consensus 122 ~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201 (267)
T ss_pred CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence 9999999999999999999999999998765443221 12234578999999999987634468899999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCcc-CCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEF-TCP-----PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~-~~~-----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
+|+.||...+....+.+...... ..+ ..++..+.+++.+||..||.+|||+.++++||||
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred hCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999988776655554433322 111 2467899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=299.81 Aligned_cols=213 Identities=26% Similarity=0.493 Sum_probs=185.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+++.++||||+++++++..+...|+|+||+++++|.+++... ++++..+..++.|++.|+.|||++|++|
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h 121 (274)
T cd06609 43 IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIH 121 (274)
T ss_pred HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 567889999999999999999999999999999999999999999999764 8999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||+|+||+++++|.++|+|||+++...... .......|++.|+|||.+.+..+ +.++||||+||++|+|++|..||
T Consensus 122 ~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~ 198 (274)
T cd06609 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPL 198 (274)
T ss_pred CCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999999999999999999987654321 12234578899999999987775 48999999999999999999999
Q ss_pred CCCchHHHHHhhhcCc-cCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 176 DDSNLMNLYKKISAAE-FTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~-~~~~~~-~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
...+.......+.... ...+.. ++.++.+++.+||..+|.+|||++++++||||+..
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 199 SDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 8776655555444433 233344 78999999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=299.84 Aligned_cols=209 Identities=22% Similarity=0.342 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--------------CCCHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--------------RMKEDEARRYFQQL 81 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--------------~l~e~~~~~~~~ql 81 (400)
.+.+.+|+++++.++||||+++++++......|+||||++||+|.+++...+ .+++..+..++.|+
T Consensus 52 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i 131 (280)
T cd05049 52 RKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131 (280)
T ss_pred HHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHH
Confidence 5789999999999999999999999999999999999999999999997643 47888999999999
Q ss_pred HHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHH
Q 015814 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSC 161 (400)
Q Consensus 82 l~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSl 161 (400)
+.|+.|||++|++||||||+||+++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||
T Consensus 132 ~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~sl 210 (280)
T cd05049 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSF 210 (280)
T ss_pred HHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHH
Confidence 9999999999999999999999999999999999999864322111111223456788999999987776 488999999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHhhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 162 GVILFVLLA-GYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 162 Giil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||++|+|++ |..||.+.+.......+..+... .+..++..+.+++.+||+.||.+|||+.|+++
T Consensus 211 G~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 211 GVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999998 99999888777777776655543 34568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=305.94 Aligned_cols=217 Identities=33% Similarity=0.552 Sum_probs=187.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
....+.+|+++++.++||||+++++.+......|+||||+.|++|.+.+... ..+++..+..++.|++.||+|||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 123 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG 123 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3577899999999999999999999999999999999999999999998754 46899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCC---------------------------CccccccCCCCCCCChh
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------------------------GLLHTTCGTPNYVAPEV 145 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~---------------------------~~~~~~~gt~~y~APEv 145 (400)
++||||||+||+++.+|.++|+|||++......... .......||..|+|||+
T Consensus 124 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 203 (316)
T cd05574 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203 (316)
T ss_pred eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHH
Confidence 999999999999999999999999987643221100 01123468899999999
Q ss_pred hhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCC--CCHHHHHHHHHhcCCCCCCCCC----
Q 015814 146 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRIT---- 219 (400)
Q Consensus 146 l~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~s~~~~~li~~mL~~dP~~R~t---- 219 (400)
+.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......+.. ++.++.++|.+||..||.+|||
T Consensus 204 ~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 204 ISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred HcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 987666 589999999999999999999999888777776665555555444 6999999999999999999999
Q ss_pred HHHHhcCcccccC
Q 015814 220 IPEILEDEWFKKD 232 (400)
Q Consensus 220 ~~eil~h~~~~~~ 232 (400)
++++++||||+..
T Consensus 283 ~~~ll~~~~~~~~ 295 (316)
T cd05574 283 AAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHcCchhhcC
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=300.30 Aligned_cols=211 Identities=27% Similarity=0.553 Sum_probs=186.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|++++++++||||+++++.+.++...|+|+||+.|++|.+++.....+++..+..++.|+++||.|||++|++
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~ 122 (258)
T cd05578 43 SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGII 122 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46889999999999999999999999999999999999999999999998877899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|+||+|+||++++++.++|+|||++...... .......|+..|+|||++....+ +.++|+||+|+++|+|++|..|
T Consensus 123 h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred ccCCCHHHeEEcCCCCEEEeecccccccCCC---ccccccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCC
Confidence 9999999999999999999999998754332 12345678999999999987665 5889999999999999999999
Q ss_pred CCCCch---HHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH--HHHhcCccc
Q 015814 175 FDDSNL---MNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI--PEILEDEWF 229 (400)
Q Consensus 175 f~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~--~eil~h~~~ 229 (400)
|...+. ..............|+.++..+.++|.+||..||.+||++ +++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 199 YRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 987763 3333333335566777789999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=304.13 Aligned_cols=213 Identities=28% Similarity=0.471 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+++++.++||||+++++++..+...|+||||++++.|.........+++..+..++.|++.||+|||+.|++
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 122 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35678899999999999999999999999999999999999998888777766799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||+|+||++++++.++|+|||++...... ........|+..|+|||++.+....+.++||||+||++|+|++|+.|
T Consensus 123 h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~ 200 (286)
T cd07846 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL 200 (286)
T ss_pred ccCCCHHHEEECCCCcEEEEeeeeeeeccCC--ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999998754332 12233456899999999987655556889999999999999999999
Q ss_pred CCCCchHHHHHhhhcC-------------------cc------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 175 FDDSNLMNLYKKISAA-------------------EF------------TCPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~-------------------~~------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
|...+..+....+... .. ...+.++..+.+|+.+||+.+|.+|||+.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 280 (286)
T cd07846 201 FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280 (286)
T ss_pred CCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence 9876543332222110 00 0123468899999999999999999999999
Q ss_pred hcCccc
Q 015814 224 LEDEWF 229 (400)
Q Consensus 224 l~h~~~ 229 (400)
++||||
T Consensus 281 l~~~~~ 286 (286)
T cd07846 281 LHHEFF 286 (286)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=300.54 Aligned_cols=210 Identities=22% Similarity=0.347 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-------------CCCHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQL 81 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-------------~l~e~~~~~~~~ql 81 (400)
....+.+|+.++++++||||+++++++......|+||||+++|+|.+++...+ .+++..+..++.|+
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql 129 (288)
T cd05093 50 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHH
Confidence 35678999999999999999999999999999999999999999999997543 48999999999999
Q ss_pred HHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHH
Q 015814 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSC 161 (400)
Q Consensus 82 l~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSl 161 (400)
+.||+|||++|++||||||+||++++++.+||+|||++................+++.|+|||++.+..+ +.++||||+
T Consensus 130 ~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwsl 208 (288)
T cd05093 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSL 208 (288)
T ss_pred HHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHH
Confidence 9999999999999999999999999999999999999875432111111223346788999999987665 489999999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 162 GVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 162 Giil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||++|+|++ |..||...+.......+..+.. ..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 209 G~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 209 GVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999999998 9999988887777777766553 345568899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.86 Aligned_cols=211 Identities=30% Similarity=0.599 Sum_probs=184.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..++.+|+.++++++||||+++++++......|+||||++|++|.+.+.... .+++..+..++.|++.|+.|||++|+
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (256)
T cd08218 43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5688999999999999999999999999999999999999999999997643 57899999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+|+||+|+||+++.++.++|+|||++....... .......|++.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus 123 ~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~ 199 (256)
T cd08218 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKH 199 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hhhhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCC
Confidence 999999999999999999999999987543321 11223468899999999987665 488999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 174 PFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
||...+..+....+..+.. ..+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 200 AFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9988877777766655543 3556689999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.31 Aligned_cols=215 Identities=26% Similarity=0.459 Sum_probs=182.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-c
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS-R 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~l~~LH~-~ 91 (400)
..++.+|+.++++++||||+++++.+...+..|+||||++|++|..++... ..+++..+..++.|++.||.|||+ .
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 122 (286)
T cd06622 43 FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122 (286)
T ss_pred HHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 467889999999999999999999999999999999999999998888663 379999999999999999999997 5
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC-----CCChhhHHHHHHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILF 166 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DIwSlGiil~ 166 (400)
|++||||||+||+++.++.+||+|||++..... ....+..|++.|+|||.+.+... .+.++||||+||++|
T Consensus 123 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred CEeeCCCCHHHEEECCCCCEEEeecCCcccccC----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 999999999999999999999999999865422 22344578999999999864332 257899999999999
Q ss_pred HHHhCCCCCCCCchHHHHHh---hhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 167 VLLAGYLPFDDSNLMNLYKK---ISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~---i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
+|++|..||...+....+.. +..+ ....|+.++.++.++|.+||..+|.+||+++++++||||.....
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 99999999977655443332 2222 23456668999999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=300.15 Aligned_cols=215 Identities=29% Similarity=0.513 Sum_probs=185.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++++......|+++||++|++|.+.+.. ++++++.+..++.|++.||+|||++|++|
T Consensus 60 ~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H 138 (285)
T cd06648 60 RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIH 138 (285)
T ss_pred HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 45688999999999999999999999999999999999999999999877 67999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||+|+||+++.++.++|+|||++....... .......|++.|+|||.+.+..+ +.++||||+||++|+|++|..||
T Consensus 139 ~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~ 215 (285)
T cd06648 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPY 215 (285)
T ss_pred CCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999876543211 12234568999999999987666 48899999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCC---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 176 DDSNLMNLYKKISAAEFTC---PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~---~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
...+.......+....... +..++..+.+++++||+.+|.+|||+.++++||||++...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 216 FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred cCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 8877666666555443222 2337889999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=293.80 Aligned_cols=211 Identities=26% Similarity=0.401 Sum_probs=186.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~l 85 (400)
..+++.+|+.+++.++||||+++++++.+...+++||||++||+|.+++... ..+++..+..++.|++.||
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 3678999999999999999999999999999999999999999999999875 6799999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
+|||++|++||||||+||+++.++.+||+|||.+................+++.|+|||.+....+ +.++|||||||++
T Consensus 119 ~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il 197 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLL 197 (262)
T ss_pred HHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHH
Confidence 999999999999999999999999999999999876554322222344567899999999987665 5899999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|+|++ |..||...+.......+..+ ....|..+|.++.+++.+||..||.+|||+.+++++
T Consensus 198 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 198 WEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999 69999998877777776543 345677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=293.69 Aligned_cols=212 Identities=30% Similarity=0.519 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+++.+|+.+++.++||||+++++++.+....|++|||++|++|.+++...+.+++..+..++.|++.|++|||+.|++
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 124 (258)
T cd06632 45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124 (258)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 36788999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|+||+|+||+++.++.+||+|||++....... ......|++.|+|||.+......+.++|+||+||++|+|++|+.|
T Consensus 125 H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p 201 (258)
T cd06632 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201 (258)
T ss_pred cCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987543321 234567899999999987655235889999999999999999999
Q ss_pred CCCCchHHHHHhhhc--CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 175 FDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 175 f~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
|...........+.. .....|+.++.++.+++.+||..+|.+|||+.+++.|||+
T Consensus 202 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 202 WSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 987664444333322 2334566789999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=303.16 Aligned_cols=208 Identities=19% Similarity=0.277 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-------------------CCCHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------------RMKEDEARR 76 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-------------------~l~e~~~~~ 76 (400)
..++.+|+.++++++||||+++++++...+..|+||||+++|+|.+++.... .++...+..
T Consensus 63 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (304)
T cd05096 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLH 142 (304)
T ss_pred HHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHH
Confidence 5678899999999999999999999999999999999999999999986532 356778899
Q ss_pred HHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChh
Q 015814 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 156 (400)
Q Consensus 77 ~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~ 156 (400)
++.|++.||.|||+.||+||||||+|||++.++.+||+|||++................+++.|+|||++....+ +.++
T Consensus 143 i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~ 221 (304)
T cd05096 143 VALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTAS 221 (304)
T ss_pred HHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-Cchh
Confidence 999999999999999999999999999999999999999999875432211112223456788999999987666 5899
Q ss_pred hHHHHHHHHHHHHh--CCCCCCCCchHHHHHhhh--------cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 157 DLWSCGVILFVLLA--GYLPFDDSNLMNLYKKIS--------AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 157 DIwSlGiil~ellt--G~~Pf~~~~~~~~~~~i~--------~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
|||||||++|+|++ |..||.+.+.......+. ......|+.++..+.+|+.+||+.||.+|||+.+|.
T Consensus 222 Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 222 DVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred hhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 99999999999986 678888766554433321 112234566889999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=308.54 Aligned_cols=208 Identities=33% Similarity=0.608 Sum_probs=192.6
Q ss_pred HHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCC
Q 015814 21 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 99 (400)
Q Consensus 21 ~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlK 99 (400)
-|-++|... +-|.+++++..|++-+.+|+||||+.||+|.-+|++-+++.|..|.+|+..|+-||-+||++||+.||||
T Consensus 398 ~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK 477 (683)
T KOG0696|consen 398 VEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK 477 (683)
T ss_pred hhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeecc
Confidence 355666666 5789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCc
Q 015814 100 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 179 (400)
Q Consensus 100 P~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~ 179 (400)
.+||++|.+|++||+|||++.. +........+.||||.|+|||++...+| +..+|.||+||+||||++|+.||++.+
T Consensus 478 LDNvmLd~eGHiKi~DFGmcKE--ni~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 478 LDNVMLDSEGHIKIADFGMCKE--NIFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred ccceEeccCCceEeeecccccc--cccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999863 3334556678999999999999999888 599999999999999999999999999
Q ss_pred hHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 015814 180 LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-----PEILEDEWFKK 231 (400)
Q Consensus 180 ~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-----~eil~h~~~~~ 231 (400)
..++++.|......+|..+|.++.++.+..|.+.|.+|... .+|..||||+.
T Consensus 555 E~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 555 EDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999999999999999999999999999999864 67999999985
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.01 Aligned_cols=209 Identities=20% Similarity=0.353 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------------------
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---------------------------- 66 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~---------------------------- 66 (400)
...+.+|+.+++.+ +||||+++++++......|+||||+++|+|.+++...
T Consensus 85 ~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 85 REALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred HHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 56788999999999 8999999999999999999999999999999998542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 015814 67 ------------------------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 104 (400)
Q Consensus 67 ------------------------------------------~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NIL 104 (400)
.++++..+..++.|++.||.|||++||+||||||+|||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil 244 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVL 244 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEE
Confidence 13678889999999999999999999999999999999
Q ss_pred EccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCchHHH
Q 015814 105 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL 183 (400)
Q Consensus 105 l~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~ 183 (400)
+++++.+||+|||+++............+..+++.|+|||++....+ +.++||||+||++|+|++ |+.||........
T Consensus 245 ~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~ 323 (374)
T cd05106 245 LTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323 (374)
T ss_pred EeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence 99999999999999875432111111122335677999999987666 589999999999999997 9999987654433
Q ss_pred H-HhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 184 Y-KKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 184 ~-~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+ ..+..+ ....|...+.++.+++.+||+.||.+|||+.++++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 324 FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3 333222 34556678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=302.04 Aligned_cols=219 Identities=32% Similarity=0.462 Sum_probs=182.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+..|+.++++++||||+++++++.+....|+||||+ +|+|.+++.... .+++..+..++.|+++||.|||++|+
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 123 (298)
T cd07841 45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123 (298)
T ss_pred hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3566788999999999999999999999999999999999 889999998766 79999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||+++.+|.++|+|||++...... ........+++.|+|||.+.+....+.++||||+||++|+|++|..
T Consensus 124 ~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~ 201 (298)
T cd07841 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201 (298)
T ss_pred eecCCChhhEEEcCCCCEEEccceeeeeccCC--CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCc
Confidence 99999999999999999999999998765432 1222334578899999998665555689999999999999999988
Q ss_pred CCCCCchHHHHHhhhcCc-----------------------cC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAAE-----------------------FT-----CPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~-----------------------~~-----~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+..+.+.++.... .. .....+..+.++|.+||.+||.+|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 202 FLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 888766544443332110 00 01224788999999999999999999999999
Q ss_pred CcccccCCCCC
Q 015814 226 DEWFKKDYKPP 236 (400)
Q Consensus 226 h~~~~~~~~~~ 236 (400)
||||++...+.
T Consensus 282 ~~~~~~~~~~~ 292 (298)
T cd07841 282 HPYFSNDPAPT 292 (298)
T ss_pred CccccCCCCCC
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=298.58 Aligned_cols=195 Identities=27% Similarity=0.510 Sum_probs=168.4
Q ss_pred CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 015814 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 109 (400)
Q Consensus 30 ~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g 109 (400)
+||||+++++.+...+..|+||||++||+|.+++.....++++.+..++.|++.||.|||+.|++||||||+||+++.++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK 146 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC
Confidence 79999999999999999999999999999999998878899999999999999999999999999999999999999988
Q ss_pred -CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHH----H
Q 015814 110 -NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----Y 184 (400)
Q Consensus 110 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~----~ 184 (400)
.++|+|||++..... .....|++.|+|||++.+..+. .++||||+||++|+|++|..||........ .
T Consensus 147 ~~~~l~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T PHA03390 147 DRIYLCDYGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219 (267)
T ss_pred CeEEEecCccceecCC------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence 999999998865432 1234689999999999887774 889999999999999999999976543221 1
Q ss_pred HhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 015814 185 KKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-IPEILEDEWFKK 231 (400)
Q Consensus 185 ~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-~~eil~h~~~~~ 231 (400)
..........++.+|+.+.+||.+||+.||.+||+ ++++++||||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 220 LKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 11123334455568999999999999999999996 699999999963
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=297.29 Aligned_cols=216 Identities=30% Similarity=0.551 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHhCC---CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..++.+|+.++++++ ||||+++++++..+...|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.|
T Consensus 43 ~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~ 121 (277)
T cd06917 43 VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG 121 (277)
T ss_pred HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 567889999999997 99999999999999999999999999999998866 57999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++||||+|+||+++.++.++|+|||++....... .......|++.|+|||.+......+.++|+||+||++|+|++|.
T Consensus 122 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~ 199 (277)
T cd06917 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199 (277)
T ss_pred cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987654322 22234578999999999876554468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCcc-CCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 173 LPFDDSNLMNLYKKISAAEF-TCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.||...+.......+..... ..+.. ++.++.+++.+||+.||.+|||+.+++.|+||+....
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 200 PPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred CCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 99988766554444333322 22222 7889999999999999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=295.80 Aligned_cols=213 Identities=29% Similarity=0.532 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+++|+.++++++||||+++++++.+ ...+|++|||++||+|.+++...+.+++..+..++.|++.||+|||++|+
T Consensus 48 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i 127 (265)
T cd06652 48 VNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127 (265)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5788999999999999999999998865 35688999999999999999888889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+|+||||+||+++.++.++|+|||++........ ........|+..|+|||++.+..+ +.++||||+||++|+|++|+
T Consensus 128 ~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~ 206 (265)
T cd06652 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEK 206 (265)
T ss_pred ecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCC
Confidence 9999999999999999999999999875432211 112234568999999999987665 58899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 173 LPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
.||...+.......+... ....|+.++..+.++|++||. +|.+|||++++++|||+.
T Consensus 207 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 207 PPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999876554444433322 233455678899999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=300.26 Aligned_cols=211 Identities=28% Similarity=0.479 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|++++++++||||+++++++.+....|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.|+
T Consensus 43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (284)
T cd07860 43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121 (284)
T ss_pred chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3578899999999999999999999999999999999996 589888865 3568999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|+||+++.++.+||+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|+||+.
T Consensus 122 ~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 199 (284)
T cd07860 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199 (284)
T ss_pred ecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999998654321 1222344678999999998766555688999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC------------------ccC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 174 PFDDSNLMNLYKKISAA------------------EFT-----------CPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~------------------~~~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
||.+.+.......+... ... ..+.++.+++++|.+||+.||.+|||+++++
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 200 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 99876544332221110 000 1223678899999999999999999999999
Q ss_pred cCccc
Q 015814 225 EDEWF 229 (400)
Q Consensus 225 ~h~~~ 229 (400)
+||||
T Consensus 280 ~~~~f 284 (284)
T cd07860 280 AHPFF 284 (284)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=297.10 Aligned_cols=212 Identities=29% Similarity=0.430 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCC------EEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINA 84 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~ 84 (400)
.+++.+|+.+++++ +||||+++++++.... .+|+||||+++++|.+.+.. ...+++..+..++.|++.|
T Consensus 46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~a 125 (275)
T cd06608 46 EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125 (275)
T ss_pred HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHH
Confidence 46789999999999 7999999999986544 48999999999999998865 3579999999999999999
Q ss_pred HHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC----CCCChhhHHH
Q 015814 85 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWS 160 (400)
Q Consensus 85 l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DIwS 160 (400)
|.|||++|++|+||+|+||+++.++.+||+|||++...... ........|++.|+|||++.... ..+.++||||
T Consensus 126 l~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 203 (275)
T cd06608 126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203 (275)
T ss_pred HHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHH
Confidence 99999999999999999999999999999999998654321 12223457899999999985422 2247899999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHhhhcCcc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 161 CGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 161 lGiil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
+||++|+|++|..||...+.......+..... ..+..++.++.+||.+||..||++|||+.++++|||+
T Consensus 204 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 204 LGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999999999987655544444433322 2233367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.57 Aligned_cols=217 Identities=30% Similarity=0.542 Sum_probs=188.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l--~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+-+..||...++|+|.|||+++|.+..++.+-|+||-++||+|.+.++.. |++ .|..+-+|.+||++||.|||.+.
T Consensus 616 ~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~ 695 (1226)
T KOG4279|consen 616 VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK 695 (1226)
T ss_pred hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc
Confidence 577889999999999999999999999999999999999999999999874 566 78999999999999999999999
Q ss_pred CeeccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 93 ivHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~ell 169 (400)
|||||||-+|+|++. .|.+||+|||.++..... +....+..||..|||||++.. .+| |.++|||||||++.||.
T Consensus 696 IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMA 772 (1226)
T KOG4279|consen 696 IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMA 772 (1226)
T ss_pred eeeccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhccCCcCC-CchhhhhhccceeEeec
Confidence 999999999999986 699999999988765443 334567889999999999964 345 79999999999999999
Q ss_pred hCCCCCCCCc-h-HHHHHh-hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 170 AGYLPFDDSN-L-MNLYKK-ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 170 tG~~Pf~~~~-~-~~~~~~-i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
||++||-... + ..+++- .....++.|..+|.+++.||.+|+.+||..||++.++|++||++...+.
T Consensus 773 TGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 773 TGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred cCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 9999996533 2 244432 3345567788899999999999999999999999999999999987543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=299.75 Aligned_cols=215 Identities=30% Similarity=0.476 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|++++++++||||+++++++..++..|++|||++++.+...+.....+++..+..++.|++.|+.|||++|+
T Consensus 42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (288)
T cd07833 42 DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121 (288)
T ss_pred cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34578999999999999999999999999999999999999997777667666779999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|+||++++++.+||+|||++........ .......|++.|+|||++......+.++||||+|+++|+|++|+.
T Consensus 122 ~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 200 (288)
T cd07833 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200 (288)
T ss_pred ecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543221 123446789999999999877344689999999999999999999
Q ss_pred CCCCCchHHHHHhhhc----------------C-----c-----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 015814 174 PFDDSNLMNLYKKISA----------------A-----E-----------FTCPPWLSFTARKLIARILDPNPMTRITIP 221 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~----------------~-----~-----------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ 221 (400)
||.+.+..+....+.. . . ...+..++.++.+||++||..+|++|||++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 280 (288)
T cd07833 201 LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD 280 (288)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHH
Confidence 9987654433222110 0 0 012334588999999999999999999999
Q ss_pred HHhcCccc
Q 015814 222 EILEDEWF 229 (400)
Q Consensus 222 eil~h~~~ 229 (400)
++++||||
T Consensus 281 ~il~~~~f 288 (288)
T cd07833 281 ELLQHPYF 288 (288)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=302.60 Aligned_cols=214 Identities=29% Similarity=0.507 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++++......|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++|
T Consensus 60 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H 138 (297)
T cd06656 60 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIH 138 (297)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46688999999999999999999999999999999999999999998865 56899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.+|.++|+|||++...... ........|++.|+|||.+.+..+ +.++||||+||++|++++|..||
T Consensus 139 ~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf 215 (297)
T cd06656 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPY 215 (297)
T ss_pred CCCCHHHEEECCCCCEEECcCccceEccCC--ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998654321 112234578999999999987666 48999999999999999999999
Q ss_pred CCCchHHHHHhhhc-C--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNLYKKISA-A--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
...+.......+.. + ....|..++..+.+|+.+||..||.+|||++++++||||+...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 216 LNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 87655333222221 1 1223455789999999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=295.10 Aligned_cols=208 Identities=19% Similarity=0.287 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++||||+++++++......|+||||+++|+|.+++... +.+++..+..++.|++.||+|||++|++
T Consensus 50 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ii 129 (266)
T cd05064 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129 (266)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 467889999999999999999999999999999999999999999998764 5789999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+|++|||.+....... ........+++.|+|||++.+..+ +.++||||+||++|++++ |..
T Consensus 130 H~dikp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~ 207 (266)
T cd05064 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGER 207 (266)
T ss_pred eccccHhhEEEcCCCcEEECCCcccccccccc-hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999865432111 011112345678999999987766 489999999999999775 999
Q ss_pred CCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+..+....+..+. .+.|..++..+.+++.+||+.+|.+|||+++|++
T Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 208 PYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 999888777766665543 3456668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=294.81 Aligned_cols=212 Identities=28% Similarity=0.475 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l--~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++++++||||+++++++..+...|+|+||++|++|.+.+... ..+ ++..+..++.|++.||+|||++|
T Consensus 49 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 128 (268)
T cd06624 49 VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128 (268)
T ss_pred HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 568899999999999999999999999999999999999999999999764 445 88899999999999999999999
Q ss_pred CeeccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC-CCCChhhHHHHHHHHHHHHh
Q 015814 93 VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGiil~ellt 170 (400)
|+||||||+||+++. ++.++|+|||++...... ........|++.|+|||++.... ..+.++||||+|+++|+|++
T Consensus 129 i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~ 206 (268)
T cd06624 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206 (268)
T ss_pred EeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh
Confidence 999999999999986 679999999998654321 12223346899999999986533 23588999999999999999
Q ss_pred CCCCCCCCchH--HHHHh-hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 171 GYLPFDDSNLM--NLYKK-ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 171 G~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
|+.||...... ..+.. ........|..++.++.+++++||+.+|.+|||+.+++.||||
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 207 GKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999764322 22211 1223345566789999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.98 Aligned_cols=209 Identities=27% Similarity=0.419 Sum_probs=167.3
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
....|+.++++++||||+++++++......|+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++||+||
T Consensus 103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 181 (357)
T PHA03209 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181 (357)
T ss_pred ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 345799999999999999999999999999999999964 88888865 4579999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC-C
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-F 175 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P-f 175 (400)
||||+|||++.++.+||+|||++..... ........||+.|+|||++.+..| +.++||||+||++|+|+++..| |
T Consensus 182 Dlkp~Nill~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 182 DVKTENIFINDVDQVCIGDLGAAQFPVV---APAFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred CCCHHHEEECCCCCEEEecCcccccccc---CcccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccc
Confidence 9999999999999999999999864322 122234679999999999988777 4899999999999999985444 4
Q ss_pred CCCchH----------HHHHhhhcC---ccCCC------------------------------CCCCHHHHHHHHHhcCC
Q 015814 176 DDSNLM----------NLYKKISAA---EFTCP------------------------------PWLSFTARKLIARILDP 212 (400)
Q Consensus 176 ~~~~~~----------~~~~~i~~~---~~~~~------------------------------~~~s~~~~~li~~mL~~ 212 (400)
...... .+...+... ...+| ..++.++.+||.+||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 337 (357)
T PHA03209 258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF 337 (357)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcC
Confidence 332110 111111100 00011 12466788899999999
Q ss_pred CCCCCCCHHHHhcCccccc
Q 015814 213 NPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 213 dP~~R~t~~eil~h~~~~~ 231 (400)
||.+|||+.|+++||||++
T Consensus 338 dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 338 DAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CcccCcCHHHHhcCchhcc
Confidence 9999999999999999975
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=300.58 Aligned_cols=216 Identities=28% Similarity=0.446 Sum_probs=190.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
-++.|.+||.||.+++.|+||++|+.|-..+.+|||||||-.|++.|.++.. ..++|+++..+++..+.||+|||...-
T Consensus 71 DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~K 150 (502)
T KOG0574|consen 71 DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKK 150 (502)
T ss_pred hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHH
Confidence 3789999999999999999999999999999999999999999999999764 479999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+|||||..|||++.+|..||+|||.|...... -....+..|||-|||||++..-+|+ ..+||||||++..||..|++
T Consensus 151 IHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 151 IHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred HHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCC
Confidence 99999999999999999999999998654332 1223577899999999999999997 88999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 174 PFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
||.+-.++.....|.... +.-|..+|.++.++|++||.++|++|.|+-++++|||.+...
T Consensus 228 PYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 228 PYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred CcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 998877665444443222 233556899999999999999999999999999999998743
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=297.04 Aligned_cols=208 Identities=25% Similarity=0.423 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.++++++||||+++++.+......++||||+++|+|..+ ..+++..+..++.|++.||.|||+.||+|
T Consensus 43 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 118 (279)
T cd06619 43 QKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILH 118 (279)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 46788999999999999999999999999999999999999988544 45789999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
+||||+||+++.++.++|+|||++..... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||
T Consensus 119 ~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf 193 (279)
T cd06619 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPY 193 (279)
T ss_pred CCCCHHHEEECCCCCEEEeeCCcceeccc----ccccCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCc
Confidence 99999999999999999999999865432 12344689999999999987766 48999999999999999999999
Q ss_pred CCCch-------HHHHHhhhcCc-cCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 176 DDSNL-------MNLYKKISAAE-FTC-PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 176 ~~~~~-------~~~~~~i~~~~-~~~-~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
..... ......+.... ... ....++++.+++.+||+.||.+||+++++++||||...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 194 PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred hhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 65321 12222222221 111 23478899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=291.90 Aligned_cols=210 Identities=30% Similarity=0.526 Sum_probs=182.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.++++++||||+++++.+..+...++||||++|++|.+++... ..+++..+..++.|++.|++|||++|+
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 122 (256)
T cd08220 43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122 (256)
T ss_pred HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 577899999999999999999999999999999999999999999999764 348999999999999999999999999
Q ss_pred eeccCCCCcEEEccCC-CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+||||||+||++++++ .+||+|||++...... .......|++.|+|||.+.+..+ +.++||||+|+++|+|++|.
T Consensus 123 ~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~ 198 (256)
T cd08220 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---SKAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLK 198 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---ccccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCC
Confidence 9999999999998654 5899999998754332 12234568999999999987655 48899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
.||...+.......+.... ...+..++.++.+++.+||..||.+|||+.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 199 RAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999887776666654443 34566689999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=301.27 Aligned_cols=211 Identities=29% Similarity=0.415 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+|+.++++++||||+++++++... ...|+||||+.+ +|.+.+.... .+++..+..++.|++.||+|||++|
T Consensus 48 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 126 (293)
T cd07843 48 PITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126 (293)
T ss_pred hhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45677899999999999999999998777 899999999985 8988887644 5899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++||||||+||+++.+|.+||+|||++....... .......+++.|+|||.+.+....+.++||||+||++|+|++|.
T Consensus 127 i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (293)
T cd07843 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204 (293)
T ss_pred eeeccCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987554321 22334567899999999876555568999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcC-------------------------------ccCCCCC-CCHHHHHHHHHhcCCCCCCCCCH
Q 015814 173 LPFDDSNLMNLYKKISAA-------------------------------EFTCPPW-LSFTARKLIARILDPNPMTRITI 220 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-------------------------------~~~~~~~-~s~~~~~li~~mL~~dP~~R~t~ 220 (400)
.||...+......++... ...++.. ++..+.++|++||+.||++|||+
T Consensus 205 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~ 284 (293)
T cd07843 205 PLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284 (293)
T ss_pred CCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence 999877655444332110 0012222 58889999999999999999999
Q ss_pred HHHhcCccc
Q 015814 221 PEILEDEWF 229 (400)
Q Consensus 221 ~eil~h~~~ 229 (400)
.|+++||||
T Consensus 285 ~ell~~~~f 293 (293)
T cd07843 285 EDALKHPYF 293 (293)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=293.09 Aligned_cols=209 Identities=35% Similarity=0.600 Sum_probs=179.9
Q ss_pred HHHHHHHHHHH-HhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+..|..++ ...+||||+++++++..++..|+||||++||+|.+++...+.+++..+..++.|++.||.|||+.|++
T Consensus 40 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~ 119 (260)
T cd05611 40 VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119 (260)
T ss_pred HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34455565554 45589999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||+|+||+++.++.+||+|||++..... .....|++.|+|||.+.+..+ +.++||||+|+++|+|++|..|
T Consensus 120 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred cCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCC
Confidence 999999999999999999999998864322 223468899999999987664 5899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCC----CCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTC----PPWLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~li~~mL~~dP~~R~---t~~eil~h~~~~~ 231 (400)
|...+....+..+....... +..++..+.++|.+||+.||.+|| +++|++.||||++
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 99888777776665544332 234789999999999999999999 5589999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=301.32 Aligned_cols=215 Identities=28% Similarity=0.514 Sum_probs=184.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++++..+...|++|||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|
T Consensus 62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 140 (297)
T cd06659 62 RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIH 140 (297)
T ss_pred HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 46788999999999999999999999999999999999999999887754 57899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.++.+||+|||++...... .......+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||
T Consensus 141 ~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred CCCCHHHeEEccCCcEEEeechhHhhcccc--cccccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998654321 112234679999999999987666 58999999999999999999999
Q ss_pred CCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 176 DDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
...+.......+.... ...+..++..+.++|.+||+.+|.+|||++++++||||.+..-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 218 FSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred CCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 8776655555443322 2223457889999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.87 Aligned_cols=219 Identities=26% Similarity=0.505 Sum_probs=192.8
Q ss_pred HHHhhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCE--EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHH
Q 015814 7 SKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 84 (400)
Q Consensus 7 ~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~ 84 (400)
.++..+..-++++..|+.+|+.|+|||||++|+++.+... +-+|+|++..|+|..++.+.++++...++.|++||+.|
T Consensus 76 ~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkG 155 (632)
T KOG0584|consen 76 RDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKG 155 (632)
T ss_pred HHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHH
Confidence 3444455558999999999999999999999999987655 88999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CeeccCCCCcEEEccC-CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHH
Q 015814 85 VDYCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSC 161 (400)
Q Consensus 85 l~~LH~~g--ivHrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSl 161 (400)
|.|||++. |+|||||-+||+++.+ |.|||+|+|||++.+.. ......|||.|||||++- ..|+ +.+|||||
T Consensus 156 L~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaF 229 (632)
T KOG0584|consen 156 LVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAF 229 (632)
T ss_pred hhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc----ccceeccCccccChHHHh-hhcc-hhhhhhhh
Confidence 99999995 9999999999999985 99999999999986542 234478999999999987 5686 99999999
Q ss_pred HHHHHHHHhCCCCCCC-CchHHHHHhhhcCccC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 162 GVILFVLLAGYLPFDD-SNLMNLYKKISAAEFT--CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 162 Giil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|.++.||+|+..||.. .+...+|+++..|..+ +..--.++++++|.+||.. ...|+|+.|+|+||||..+
T Consensus 230 GMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 230 GMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred hHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 9999999999999976 6677999998877543 2222478999999999999 9999999999999999975
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=298.43 Aligned_cols=213 Identities=26% Similarity=0.403 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeC-----CEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l 85 (400)
..++.+|+.+++++ +||||+++++++... ...|+||||++||+|.+++.. ...+++..++.++.|++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 46788999999999 899999999998643 468999999999999998753 35789999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC----CCCChhhHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSC 161 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DIwSl 161 (400)
+|||+.|++||||||+||+++.++.+||+|||++....... .......|++.|+|||++.... ..+.++||||+
T Consensus 142 ~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 219 (291)
T cd06639 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219 (291)
T ss_pred HHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence 99999999999999999999999999999999987543211 1123456899999999986433 12588999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 162 GVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
||++|+|++|+.||...+.......+.... ...+...+..+.+||.+||+.+|.+|||+.++++||||+
T Consensus 220 Gvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 220 GITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 999999999999998766544444443322 223445778899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.43 Aligned_cols=209 Identities=23% Similarity=0.368 Sum_probs=178.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQ 79 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ 79 (400)
.+.+.+|+.++++++||||+++++++......++||||+++++|.+++...+ .+++..+..++.
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (291)
T cd05094 51 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130 (291)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHH
Confidence 4678899999999999999999999999999999999999999999997543 378999999999
Q ss_pred HHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHH
Q 015814 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 159 (400)
Q Consensus 80 qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw 159 (400)
|++.|++|||++|++||||||+||+++.++.++|+|||++................|++.|+|||++.+..+ +.++|||
T Consensus 131 ~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~ 209 (291)
T cd05094 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVW 209 (291)
T ss_pred HHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHH
Confidence 999999999999999999999999999999999999999865432211112233456889999999987666 4889999
Q ss_pred HHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 160 SCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 160 SlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|+||++|+|++ |..||...+..+....+..+.. ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 210 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 210 SFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 99999999998 9999988777766666655544 344557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=294.92 Aligned_cols=213 Identities=28% Similarity=0.486 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-cC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS-RG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~-~g 92 (400)
...++.+|++++++++||||+++++.+......|+++||+.|++|.+++... ..+++..+..++.|++.|++|||+ .|
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 121 (265)
T cd06605 42 IQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121 (265)
T ss_pred HHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3577889999999999999999999999999999999999999999999876 789999999999999999999999 99
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++||||||+||+++.+|.++|+|||.+....... .....|++.|+|||.+.+..+ +.++||||+||++|+|++|.
T Consensus 122 i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~ 196 (265)
T cd06605 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGR 196 (265)
T ss_pred eecCCCCHHHEEECCCCCEEEeecccchhhHHHH----hhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999986543221 122678999999999987766 48899999999999999999
Q ss_pred CCCCCC-----chHHHHHhhhcC-ccCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 173 LPFDDS-----NLMNLYKKISAA-EFTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.||... ...+..+.+... ....+.. ++.++.++|.+||..||.+|||+.+++.||||+..
T Consensus 197 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 197 FPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999764 223333333322 2333444 78899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.72 Aligned_cols=214 Identities=29% Similarity=0.482 Sum_probs=184.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+.+|+.++++++||||+++++++.+....|+||||++||+|.+++.. +++++..+..++.|++.|++|||+.|++
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~iv 123 (277)
T cd06640 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKI 123 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 367899999999999999999999999999999999999999999999875 5789999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus 124 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06640 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred CcCCChhhEEEcCCCCEEEcccccceeccCCc--cccccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999986543321 12233468899999999987665 5899999999999999999999
Q ss_pred CCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 175 FDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|...+.......+... ....+..++.++.+++.+||+.+|.+|||+.++++||||...
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 201 NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred CCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 9877665554444333 223344578899999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=290.68 Aligned_cols=212 Identities=39% Similarity=0.699 Sum_probs=191.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+..|+.++++++||||+++++.+.++...|++|||+++++|.+++.....+++..+..++.|++.|+.|||+.|++
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~ 115 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 46789999999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|+||+|+||+++.++.++|+|||++....... .......|+..|+|||...+... +.++|+||+|+++|++++|..|
T Consensus 116 H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p 192 (250)
T cd05123 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPP 192 (250)
T ss_pred ecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999987654321 22345578999999999977655 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH---HHHhcCccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI---PEILEDEWF 229 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~---~eil~h~~~ 229 (400)
|...+....+..+.......|...+..+.++|++||..||.+|||+ +++++||||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 193 FYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9888777777777777777888889999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.53 Aligned_cols=209 Identities=27% Similarity=0.457 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|++++++++||||+++++++......|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++
T Consensus 37 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 116 (252)
T cd05084 37 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116 (252)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5678999999999999999999999999999999999999999999997644 689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+||+|||++................++..|+|||.+.+..+ +.++||||+||++|+|++ |..
T Consensus 117 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~ 195 (252)
T cd05084 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAV 195 (252)
T ss_pred ccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999864332110000111123456999999987666 588999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||...+.......+... ....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 196 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 196 PYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99876665555544332 34556668999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=298.25 Aligned_cols=214 Identities=27% Similarity=0.470 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.++++++||||+++++++..+...|+||||++|++|.+.+.. +.+++..++.++.|++.|+.|||++|++
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~iv 123 (277)
T cd06642 45 EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKI 123 (277)
T ss_pred HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCee
Confidence 457899999999999999999999999999999999999999999998865 5789999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|+||+|+||++++++.++|+|||++...... ........|+..|+|||.+.+..+ +.++||||+||++|+|++|..|
T Consensus 124 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06642 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred ccCCChheEEEeCCCCEEEccccccccccCc--chhhhcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998654321 111223468899999999987766 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 175 FDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|...........+.... ...+...+.++.++|.+||+.+|.+|||+.++++||||...
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 201 NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 98765554444433322 23344578899999999999999999999999999999763
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.82 Aligned_cols=215 Identities=32% Similarity=0.466 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+|+.++++++||||+++++++... +.+|+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+.|+
T Consensus 51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 129 (309)
T cd07845 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129 (309)
T ss_pred chhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3567899999999999999999998654 578999999975 78888765 3578999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||+++.++.+||+|||++....... .......+++.|+|||++.+....+.++||||+||++|+|++|+.
T Consensus 130 ~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 207 (309)
T cd07845 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207 (309)
T ss_pred ecCCCCHHHEEECCCCCEEECccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654321 122333568889999998765545689999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC-------------------ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 174 PFDDSNLMNLYKKISAA-------------------EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-------------------~~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
||.+.+..+.+..+... .+..+ .+.++++.+||.+||+.||.+|||++++
T Consensus 208 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i 287 (309)
T cd07845 208 LLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287 (309)
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 99887776655543221 01111 2358889999999999999999999999
Q ss_pred hcCcccccCCC
Q 015814 224 LEDEWFKKDYK 234 (400)
Q Consensus 224 l~h~~~~~~~~ 234 (400)
+.||||+...-
T Consensus 288 l~h~~f~~~~~ 298 (309)
T cd07845 288 LESSYFKEKPL 298 (309)
T ss_pred hcChhhccCCC
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=291.73 Aligned_cols=209 Identities=31% Similarity=0.561 Sum_probs=182.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+.+|+.+++.++||||+++++.+.+.+..|++|||+++|+|.+++... ..++++.+..++.|++.||.|||++|
T Consensus 41 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 120 (255)
T cd08219 41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120 (255)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 3578899999999999999999999999999999999999999999988653 35899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++|+||||+||++++++.++++|||++....... .......|++.|+|||++.+..+ +.++|+||+|+++|+|++|.
T Consensus 121 i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~ 197 (255)
T cd08219 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLK 197 (255)
T ss_pred cccCCCCcceEEECCCCcEEEcccCcceeecccc--cccccccCCccccCHHHHccCCc-Cchhhhhhhchhheehhhcc
Confidence 9999999999999999999999999987554321 12234568999999999987665 48999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 173 LPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
.||...+.......+..+.. ..|..++..+.+||.+||+.||.+|||+.+++.-
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 198 HPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 99998887777666655544 3556689999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=297.31 Aligned_cols=211 Identities=27% Similarity=0.394 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEE------eCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMG------SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~------~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~ 86 (400)
..++..|+.+++++ +||||+++++++. ....+|++|||+.+|+|.+.+... ..+++..+..++.|++.|++
T Consensus 56 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 135 (282)
T cd06636 56 EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135 (282)
T ss_pred HHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence 46788999999998 7999999999984 346789999999999999998763 35889999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-----CCCCCChhhHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSC 161 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSl 161 (400)
|||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||++.. ..+ +.++|||||
T Consensus 136 ~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~Dvwsl 212 (282)
T cd06636 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSL 212 (282)
T ss_pred HHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHH
Confidence 999999999999999999999999999999998754321 112344678999999999863 234 478999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHhhhcCcc-C-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 162 GVILFVLLAGYLPFDDSNLMNLYKKISAAEF-T-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
||++|+|++|..||...........+..... . .+..++.++.+||++||..||.+|||+.+|++||||
T Consensus 213 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 213 GITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 9999999999999977654443333222211 1 123478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.25 Aligned_cols=211 Identities=34% Similarity=0.580 Sum_probs=183.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
.+++..|+.+++.++||||+++++.+.. +...|++|||+++++|.+.+.. ...+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 122 (265)
T cd08217 43 KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122 (265)
T ss_pred HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 5678899999999999999999997753 4568999999999999999875 357899999999999999999999
Q ss_pred -----HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 90 -----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 90 -----~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
+.+++|+||||+||+++.++.+||+|||++....... .......|++.|+|||++....+ +.++|+||||++
T Consensus 123 ~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~i 199 (265)
T cd08217 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCL 199 (265)
T ss_pred cCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHH
Confidence 8999999999999999999999999999987654322 11334578999999999987665 488999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
+|+|++|..||...+.......+..+.. ..+..++..+.+++.+||+.+|.+|||+.+|++|||+
T Consensus 200 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 200 IYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999998877676666665544 4556689999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.86 Aligned_cols=215 Identities=30% Similarity=0.567 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+++.++||||++++++..+....++|+||+++++|.+.+.....+++..++.++.|++.||+|||+.|++
T Consensus 42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~ 121 (264)
T cd06626 42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121 (264)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcc
Confidence 47889999999999999999999999999999999999999999999998877899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCC-c-cccccCCCCCCCChhhhcCC--CCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-L-LHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~-~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGiil~ellt 170 (400)
|+||+|+||++++++.+||+|||++.......... . .....|++.|+|||++.... ..+.++||||+|+++|++++
T Consensus 122 H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred cCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh
Confidence 99999999999999999999999987654322111 1 22457889999999997654 13588999999999999999
Q ss_pred CCCCCCCCch-HHHHHhhh-cCccCCCCCC--CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 171 GYLPFDDSNL-MNLYKKIS-AAEFTCPPWL--SFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 171 G~~Pf~~~~~-~~~~~~i~-~~~~~~~~~~--s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
|+.||..... ......+. ......|.+. +..+.++|.+||+.+|.+|||+.+++.|||+
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999976532 22222222 2233455554 8999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=307.81 Aligned_cols=213 Identities=27% Similarity=0.487 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+.+|+.++++++||||+++++++... ...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH 135 (353)
T cd07850 59 AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLH 135 (353)
T ss_pred HHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHH
Confidence 56778899999999999999999988643 357999999975 888887654 899999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++||+||||||+||+++.+|.+||+|||++..... ........||+.|+|||.+.+..+. .++||||+||++|+|+
T Consensus 136 ~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~ 211 (353)
T cd07850 136 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMI 211 (353)
T ss_pred hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHH
Confidence 99999999999999999999999999999875432 2223345789999999999887774 8899999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCc----------------------c--------------CC-------CCCCCHHHHHHH
Q 015814 170 AGYLPFDDSNLMNLYKKISAAE----------------------F--------------TC-------PPWLSFTARKLI 206 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~----------------------~--------------~~-------~~~~s~~~~~li 206 (400)
+|+.||...+....+.++.... . .. +...+..+.+||
T Consensus 212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (353)
T cd07850 212 RGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL 291 (353)
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHH
Confidence 9999998766444333321100 0 00 112356789999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 207 ARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 207 ~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
.+||+.||.+|||+.|+|+||||+.++.+
T Consensus 292 ~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 292 SKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred HHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 99999999999999999999999877654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.91 Aligned_cols=210 Identities=20% Similarity=0.353 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-----------------CCCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-----------------GRMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~~l~e~~~~~~~ 78 (400)
...+.+|+.+++.++||||+++++++..+...|+||||+++|+|.+++... ..+++..+..++
T Consensus 51 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 130 (283)
T cd05090 51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHH
Confidence 467889999999999999999999999999999999999999999998532 237888899999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++|++||||||+||++++++.+||+|||+++...............++..|+|||++.+..+ +.++||
T Consensus 131 ~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 209 (283)
T cd05090 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDI 209 (283)
T ss_pred HHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-Cchhhh
Confidence 9999999999999999999999999999999999999999875433222222234456778999999987665 589999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||+||++|+|++ |..||.+.+.......+.... ...+..++..+.+++.+||+.||.+||++.+|+++
T Consensus 210 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 210 WSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 999999999998 999998877666555554433 44566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=311.35 Aligned_cols=210 Identities=20% Similarity=0.357 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---------------------------
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--------------------------- 67 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--------------------------- 67 (400)
.+.+.+|+.+|+.+ +||||+++++++......|+||||++||+|.+++....
T Consensus 82 ~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (375)
T cd05104 82 REALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMS 161 (375)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhccc
Confidence 46788999999999 89999999999999999999999999999999986432
Q ss_pred ------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCC
Q 015814 68 ------------------------------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 99 (400)
Q Consensus 68 ------------------------------------------------~l~e~~~~~~~~qll~~l~~LH~~givHrDlK 99 (400)
.+++..+..++.|++.||+|||++||+|||||
T Consensus 162 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 241 (375)
T cd05104 162 CDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLA 241 (375)
T ss_pred chhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCc
Confidence 36778899999999999999999999999999
Q ss_pred CCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 015814 100 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 178 (400)
Q Consensus 100 P~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~ 178 (400)
|+|||++.++.+||+|||++................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||...
T Consensus 242 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 242 ARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred hhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999875433221111222345678999999987766 489999999999999998 99999876
Q ss_pred chH-HHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 179 NLM-NLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 179 ~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
... ...+.+..+ ....|...+.++.+|+.+||+.||.+|||+.++++.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 321 PVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 543 334444333 233455678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=295.15 Aligned_cols=210 Identities=19% Similarity=0.279 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~l 85 (400)
..++.+|+.+++.++||||+++++++..+...++||||+++|+|.+++.... .++...+..++.|++.||
T Consensus 53 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (277)
T cd05062 53 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHH
Confidence 4568899999999999999999999999999999999999999999986532 246678899999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
.|||+.|++||||||+||++++++.++|+|||++................+++.|+|||++.+..+ +.++|||||||++
T Consensus 133 ~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l 211 (277)
T cd05062 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVL 211 (277)
T ss_pred HHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHH
Confidence 999999999999999999999999999999999864332111111122356788999999987666 5899999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|+|++ |..||.+.+.......+.... ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 212 WEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999 799999888777666554443 35566688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=301.83 Aligned_cols=218 Identities=22% Similarity=0.401 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+++|+.+++.++||||+++++++......|++|||+++|+|.+++... ..+++..+..++.|++.||+|||++|
T Consensus 42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ 121 (314)
T cd08216 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121 (314)
T ss_pred HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3678999999999999999999999999999999999999999999999763 46899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccC-----CCccccccCCCCCCCChhhhcC--CCCCChhhHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVIL 165 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGiil 165 (400)
|+||||||+||+++.+|.+||+|||.+........ ........++..|+|||++... +| +.++||||+||++
T Consensus 122 ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il 200 (314)
T cd08216 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITA 200 (314)
T ss_pred eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHH
Confidence 99999999999999999999999998754322111 1112334578899999998753 34 4889999999999
Q ss_pred HHHHhCCCCCCCCchHHHH-HhhhcCc---------------------------------cCCCCCCCHHHHHHHHHhcC
Q 015814 166 FVLLAGYLPFDDSNLMNLY-KKISAAE---------------------------------FTCPPWLSFTARKLIARILD 211 (400)
Q Consensus 166 ~elltG~~Pf~~~~~~~~~-~~i~~~~---------------------------------~~~~~~~s~~~~~li~~mL~ 211 (400)
|+|++|..||......... .++.... ...+..++.++.+|+.+||.
T Consensus 201 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 280 (314)
T cd08216 201 CELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280 (314)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhh
Confidence 9999999999875543222 2211000 00011235678999999999
Q ss_pred CCCCCCCCHHHHhcCcccccCC
Q 015814 212 PNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 212 ~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||.+|||++++++||||+...
T Consensus 281 ~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 281 RDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCCCcCcCHHHHhcCchHhhhc
Confidence 9999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.68 Aligned_cols=218 Identities=28% Similarity=0.393 Sum_probs=182.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
..+.+|+.++++++||||+++++++..+...|+||||+. |+|.+.+.....+++..+..++.|++.||+|||+.|++||
T Consensus 65 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~ 143 (335)
T PTZ00024 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHR 143 (335)
T ss_pred hhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 367899999999999999999999999999999999997 5999999888889999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeecccccccccccc------------CCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVR------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
||+|+||+++.++.++|+|||++....... .........+++.|+|||.+.+....+.++||||+||+
T Consensus 144 dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 223 (335)
T PTZ00024 144 DLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223 (335)
T ss_pred cccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHH
Confidence 999999999999999999999987554110 11122334678899999999765555689999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCc--c--------------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAE--F--------------------------TCPPWLSFTARKLIARILDPNPMT 216 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~--~--------------------------~~~~~~s~~~~~li~~mL~~dP~~ 216 (400)
+|+|++|..||.+.+..+....+.... . ...+..+.++.++|.+||+.+|.+
T Consensus 224 l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 303 (335)
T PTZ00024 224 FAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303 (335)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchh
Confidence 999999999998877655444332100 0 001235788999999999999999
Q ss_pred CCCHHHHhcCcccccCCCC
Q 015814 217 RITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 217 R~t~~eil~h~~~~~~~~~ 235 (400)
|||+++++.||||+....+
T Consensus 304 R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 304 RISAKEALKHEYFKSDPLP 322 (335)
T ss_pred ccCHHHHhcCcccCCCCCC
Confidence 9999999999999976543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=295.14 Aligned_cols=206 Identities=30% Similarity=0.549 Sum_probs=171.6
Q ss_pred HHHHHHHHHhCC-CCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 19 IKREVATMKLVK-HPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 19 i~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+|+.+++++. ||||+++++++.+. +..++||||+.| +|.+.+... ..+++..+..++.|++.||+|||+.|++
T Consensus 44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~ 122 (282)
T cd07831 44 NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122 (282)
T ss_pred HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 347899999885 99999999999887 889999999975 888888763 4689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++. +.+||+|||++...... .......+++.|+|||.+...++.+.++||||+||++|+|++|..|
T Consensus 123 H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p 198 (282)
T cd07831 123 HRDIKPENILIKD-DILKLADFGSCRGIYSK---PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL 198 (282)
T ss_pred ecccCHHHEEEcC-CCeEEEecccccccccC---CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence 9999999999999 99999999998754321 1223346899999999886656667899999999999999999999
Q ss_pred CCCCchHHHHHhhhc------------------CccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 175 FDDSNLMNLYKKISA------------------AEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 175 f~~~~~~~~~~~i~~------------------~~~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|.+.+..+....+.. ..+..| +.++.++.++|.+||++||.+|||++++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 199 FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 988765544433321 011111 236789999999999999999999999999
Q ss_pred Cccc
Q 015814 226 DEWF 229 (400)
Q Consensus 226 h~~~ 229 (400)
||||
T Consensus 279 ~~~~ 282 (282)
T cd07831 279 HPYF 282 (282)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=296.81 Aligned_cols=210 Identities=29% Similarity=0.515 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+.+|+.+++.++||||+++++++.+....|+||||+.+ +|.+.+... +.+++..++.++.|++.||.|||++|++|
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H 126 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4567899999999999999999999999999999999985 999988664 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.+|.+||+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|++|+.||
T Consensus 127 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~ 204 (291)
T cd07844 127 RDLKPQNLLISERGELKLADFGLARAKSVP--SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204 (291)
T ss_pred ccCCHHHEEEcCCCCEEECccccccccCCC--CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998643221 111223457889999999876444468999999999999999999999
Q ss_pred CCCc-hHHHHHhhhcC-------------------ccC-----------CCCCCC--HHHHHHHHHhcCCCCCCCCCHHH
Q 015814 176 DDSN-LMNLYKKISAA-------------------EFT-----------CPPWLS--FTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 176 ~~~~-~~~~~~~i~~~-------------------~~~-----------~~~~~s--~~~~~li~~mL~~dP~~R~t~~e 222 (400)
.+.. ..+....+... ... ..+.++ .++.++|.+||+.+|.+|||+.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e 284 (291)
T cd07844 205 PGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284 (291)
T ss_pred CCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence 7655 22222211100 000 001234 78899999999999999999999
Q ss_pred HhcCccc
Q 015814 223 ILEDEWF 229 (400)
Q Consensus 223 il~h~~~ 229 (400)
+++||||
T Consensus 285 ~l~~~~f 291 (291)
T cd07844 285 AMKHPYF 291 (291)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.10 Aligned_cols=210 Identities=21% Similarity=0.308 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|+.+++.++||||+++++++. ....++||||+++|+|.+++.....+++..+..++.|++.||+|||++||
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 116 (257)
T cd05116 38 ALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34678999999999999999999999875 45678999999999999999887889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCC-ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
+||||||.||+++.++.+||+|||++.......... ......+++.|+|||.+....+ +.++|||||||++|+|++ |
T Consensus 117 ~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g 195 (257)
T cd05116 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYG 195 (257)
T ss_pred eecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999987543321110 1122344678999999876555 489999999999999998 9
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||...+.......+..+. ...|..++.++.++|.+||+.||.+|||+++|.+
T Consensus 196 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 196 QKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 99999877777776666543 4566779999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.47 Aligned_cols=215 Identities=26% Similarity=0.455 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...++++|+.+|++++||||+++++++...+..|+|++++.+ +|++++... .......++.++.||+.||+|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999964 788877542 22446678899999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++||+||||||+|||++.+|.+||+|||++....... .......+||+.|+|||++.+..|. .++|||||||++|||+
T Consensus 285 ~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell 362 (501)
T PHA03210 285 DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDML 362 (501)
T ss_pred hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999997654321 1122346799999999999887774 8999999999999999
Q ss_pred hCCC-CCCCCc--h-HHHHHhhhc---------------------Ccc-----CCC-----CCCCHHHHHHHHHhcCCCC
Q 015814 170 AGYL-PFDDSN--L-MNLYKKISA---------------------AEF-----TCP-----PWLSFTARKLIARILDPNP 214 (400)
Q Consensus 170 tG~~-Pf~~~~--~-~~~~~~i~~---------------------~~~-----~~~-----~~~s~~~~~li~~mL~~dP 214 (400)
+|.. ||.... . ..+...+.. ..+ ..+ ..++.++.++|.+||+.||
T Consensus 363 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP 442 (501)
T PHA03210 363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW 442 (501)
T ss_pred HCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence 9875 443221 1 111111110 000 000 1245678889999999999
Q ss_pred CCCCCHHHHhcCcccccC
Q 015814 215 MTRITIPEILEDEWFKKD 232 (400)
Q Consensus 215 ~~R~t~~eil~h~~~~~~ 232 (400)
.+|||+.|++.||||...
T Consensus 443 ~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 443 HLRPGAAELLALPLFSAE 460 (501)
T ss_pred ccCcCHHHHhhChhhhcC
Confidence 999999999999999764
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.74 Aligned_cols=214 Identities=25% Similarity=0.426 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~gi 93 (400)
...++.+|+++++.++||||+++++.+......|+||||+++|+|.+++...+.+++..++.++.|++.||.|||+ .|+
T Consensus 46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i 125 (284)
T cd06620 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI 125 (284)
T ss_pred HHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCe
Confidence 3578899999999999999999999999999999999999999999999887889999999999999999999997 599
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||++++++.++|+|||++...... .....+|+..|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus 126 ~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~ 200 (284)
T cd06620 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKF 200 (284)
T ss_pred eccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999987643221 1234579999999999977655 488999999999999999999
Q ss_pred CCCCCchH-----------HHHHhhhcC-ccCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 174 PFDDSNLM-----------NLYKKISAA-EFTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 174 Pf~~~~~~-----------~~~~~i~~~-~~~~~~~-~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
||...... .....+... ....+.. ++.++.+|+.+||+.||.+|||++|+++|+||....
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 201 PFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 99865431 222222222 2222222 778999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.43 Aligned_cols=211 Identities=28% Similarity=0.442 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEE-----eCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMG-----SKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~-----~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l 85 (400)
..++.+|+.+++.+ +||||+++++++. .+...|+||||++||+|.+.+.. ...+++..+..++.|++.||
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 36788899999999 7999999999873 45679999999999999988753 34689999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-----CCCCCChhhHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWS 160 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwS 160 (400)
.|||+++++||||||+||+++.++.+||+|||++...... ........|++.|+|||++.. ..+ +.++||||
T Consensus 138 ~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~s 214 (286)
T cd06638 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWS 214 (286)
T ss_pred HHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhh
Confidence 9999999999999999999999999999999998754321 112234579999999999853 224 47899999
Q ss_pred HHHHHHHHHhCCCCCCCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 161 CGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 161 lGiil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
+||++|+|++|+.||...+.......+.... ...|..++..+.+||.+||+.||.+|||+.++++|+||
T Consensus 215 lGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 215 LGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 9999999999999998776544443332221 22344568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.02 Aligned_cols=214 Identities=30% Similarity=0.473 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+.+|+.+|+.++|||||++++++.. ...+|+||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||
T Consensus 56 ~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH 135 (1021)
T PTZ00266 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135 (1021)
T ss_pred HHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5778899999999999999999998854 4679999999999999999865 357999999999999999999999
Q ss_pred Hc-------CCeeccCCCCcEEEcc-----------------CCCeeeeccccccccccccCCCccccccCCCCCCCChh
Q 015814 90 SR-------GVYHRDLKPENLLLDA-----------------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 145 (400)
Q Consensus 90 ~~-------givHrDlKP~NILl~~-----------------~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv 145 (400)
+. +|+||||||+|||++. .+.+||+|||++..... .......+||+.|+|||+
T Consensus 136 s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEv 212 (1021)
T PTZ00266 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPEL 212 (1021)
T ss_pred hcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHH
Confidence 84 4999999999999964 23589999999875432 222345679999999999
Q ss_pred hhcC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCchH-HHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 146 LNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 146 l~~~-~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
+... ...+.++||||||||||+|++|..||...+.. .....+...........+.++.+||..||..+|.+|||+.|+
T Consensus 213 L~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Ql 292 (1021)
T PTZ00266 213 LLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQC 292 (1021)
T ss_pred HhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence 8643 23458999999999999999999999765543 333333333222223478999999999999999999999999
Q ss_pred hcCcccccC
Q 015814 224 LEDEWFKKD 232 (400)
Q Consensus 224 l~h~~~~~~ 232 (400)
|.|||++..
T Consensus 293 L~h~~ik~i 301 (1021)
T PTZ00266 293 LGYQIIKNV 301 (1021)
T ss_pred hccHHHhhc
Confidence 999999754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=295.44 Aligned_cols=213 Identities=33% Similarity=0.636 Sum_probs=190.5
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++ ||||+++++++......|+||||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++
T Consensus 45 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~ 124 (280)
T cd05581 45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGII 124 (280)
T ss_pred HHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 477889999999998 9999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCC------------------CccccccCCCCCCCChhhhcCCCCCChh
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTA 156 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~ 156 (400)
|+||+|+||+++.+|.++++|||++......... .......|+..|+|||++....+ +.++
T Consensus 125 H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~ 203 (280)
T cd05581 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSS 203 (280)
T ss_pred ecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-Chhh
Confidence 9999999999999999999999998765432211 12223467899999999876654 5889
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q 015814 157 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWF 229 (400)
Q Consensus 157 DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~----~eil~h~~~ 229 (400)
||||+|++++++++|+.||...+....+..+.......|..+++.+.++|.+||+.+|.+|||+ +++++||||
T Consensus 204 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 204 DLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 9999999999999999999988877777777777778888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=290.13 Aligned_cols=211 Identities=32% Similarity=0.578 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++++|+.+++.++||||+++++.+......|+|+||+++++|.+++.... .+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (257)
T cd08225 43 KEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122 (257)
T ss_pred hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4678899999999999999999999999999999999999999999997644 47999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCC-eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~-~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+|+||||+||++++++. +||+|||.+...... ........|++.|+|||++....+ +.++|+||+||++|+|++|.
T Consensus 123 ~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~ 199 (257)
T cd08225 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLK 199 (257)
T ss_pred ccccCCHHHEEEcCCCCeEEecccccchhccCC--cccccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCC
Confidence 99999999999998864 699999998765431 122234568999999999887666 48899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 173 LPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
.||...+.......+..... ..++.++.++.++|.+||..+|.+|||+.++++||||
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 200 HPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99988776666555444332 3455678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=293.67 Aligned_cols=209 Identities=22% Similarity=0.353 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---------------CCCHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------------RMKEDEARRYFQQ 80 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~---------------~l~e~~~~~~~~q 80 (400)
...+.+|+++++.++||||+++++++......|++|||+++|+|.+++...+ .+++..+..++.|
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 130 (280)
T cd05092 51 RQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHH
Confidence 5789999999999999999999999999999999999999999999997643 4788999999999
Q ss_pred HHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHH
Q 015814 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWS 160 (400)
Q Consensus 81 ll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwS 160 (400)
++.|++|||++|++||||||+|||+++++.+||+|||++................+++.|+|||.+.+..+. .++||||
T Consensus 131 i~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s 209 (280)
T cd05092 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWS 209 (280)
T ss_pred HHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHH
Confidence 999999999999999999999999999999999999998654321111112233457889999999877764 8899999
Q ss_pred HHHHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 161 CGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 161 lGiil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||++|+|++ |..||...+..+....+..+ ....|..++..+.++|.+||+.||.+||+++++++
T Consensus 210 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 210 FGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999998 99999887766666655444 34456678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=306.86 Aligned_cols=220 Identities=25% Similarity=0.435 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEE----eCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMG----SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
....+.+|+.+|++++||||+++++++. .....|+||||+. |+|.+.+...+.+++..+..++.|++.||.|||+
T Consensus 47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 125 (334)
T cd07855 47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS 125 (334)
T ss_pred chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4577888999999999999999999875 3457899999996 5899999887889999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
+|++||||||+||+++++|.+||+|||++........ ........|+..|+|||++......+.++||||+||++|+|
T Consensus 126 ~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el 205 (334)
T cd07855 126 ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205 (334)
T ss_pred CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHH
Confidence 9999999999999999999999999999865433211 11223457899999999987644456899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhc-------------------------C-ccCC-----CCCCCHHHHHHHHHhcCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISA-------------------------A-EFTC-----PPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~-------------------------~-~~~~-----~~~~s~~~~~li~~mL~~dP~~R 217 (400)
++|+.||.+.+.......+.. . .... .+..+.++.++|++||+.+|.+|
T Consensus 206 ~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred HcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence 999999987654332222110 0 0001 13368899999999999999999
Q ss_pred CCHHHHhcCcccccCCCC
Q 015814 218 ITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 218 ~t~~eil~h~~~~~~~~~ 235 (400)
||+++++.||||.....+
T Consensus 286 pt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 286 ITVEQALQHPFLAQYHDP 303 (334)
T ss_pred cCHHHHHhChhhhhccCC
Confidence 999999999999865433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=294.64 Aligned_cols=215 Identities=21% Similarity=0.293 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~l 85 (400)
...+.+|+.++++++||||+++++++......|+||||+++|+|.+++...+ ..+...+..++.|++.||
T Consensus 53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (288)
T cd05061 53 RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132 (288)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence 3457789999999999999999999999999999999999999999997532 245678899999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
.|||++||+||||||+||++++++.++|+|||+++...............++..|+|||.+.+..+ +.++||||+||++
T Consensus 133 ~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l 211 (288)
T cd05061 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVL 211 (288)
T ss_pred HHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHH
Confidence 999999999999999999999999999999999875332111111122345678999999987666 5899999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------Cccccc
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE------DEWFKK 231 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~------h~~~~~ 231 (400)
|+|++ |..||.+.+..+....+..+ ....+...+..+.+++.+||+.||.+|||+.++++ ||||+.
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 99998 89999988777766665444 34456667899999999999999999999999986 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=294.50 Aligned_cols=211 Identities=31% Similarity=0.510 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++++++||||+++++.+...+..|+||||+++ +|.+.+...+ .+++..+..++.|++.||+|||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45677899999999999999999999999999999999986 8888886543 5899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++||||||+||++++++.++|+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|++|+
T Consensus 121 i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 198 (284)
T cd07836 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198 (284)
T ss_pred eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998654321 112234567899999999876555568999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCc------------------cC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 173 LPFDDSNLMNLYKKISAAE------------------FT-----------CPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~------------------~~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
.||.+.+..+....+.... .. ..+..+..+.++|.+||+.||.+|||+.++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 199 PLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred CCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 9998877655444322110 00 112357889999999999999999999999
Q ss_pred hcCccc
Q 015814 224 LEDEWF 229 (400)
Q Consensus 224 l~h~~~ 229 (400)
++||||
T Consensus 279 l~~~~f 284 (284)
T cd07836 279 LQHPWF 284 (284)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=298.08 Aligned_cols=212 Identities=26% Similarity=0.416 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCC--------EEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKT--------KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--------~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~ 87 (400)
..+.+|+.++++++||||+++++++.... ..|+||||+.+ +|.+.+.... .+++..+..++.|++.||+|
T Consensus 56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~ 134 (310)
T cd07865 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134 (310)
T ss_pred hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999876543 46999999975 8888876543 68999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC--CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
||++|++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+....+.++||||+|+++
T Consensus 135 lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l 214 (310)
T cd07865 135 IHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIM 214 (310)
T ss_pred HHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHH
Confidence 99999999999999999999999999999998755432211 1223456789999999987654446889999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHhhhcCcc-------------------CCC-------------CCCCHHHHHHHHHhcCCC
Q 015814 166 FVLLAGYLPFDDSNLMNLYKKISAAEF-------------------TCP-------------PWLSFTARKLIARILDPN 213 (400)
Q Consensus 166 ~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~~~-------------~~~s~~~~~li~~mL~~d 213 (400)
|+|++|+.||.+.+.......+..... ..| ...+..+.+||.+||..|
T Consensus 215 ~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~ 294 (310)
T cd07865 215 AEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD 294 (310)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCC
Confidence 999999999987765433322211000 001 113567889999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 015814 214 PMTRITIPEILEDEWF 229 (400)
Q Consensus 214 P~~R~t~~eil~h~~~ 229 (400)
|.+|||++++++||||
T Consensus 295 P~~R~t~~e~l~h~~f 310 (310)
T cd07865 295 PAKRIDADTALNHDFF 310 (310)
T ss_pred hhhccCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=290.25 Aligned_cols=208 Identities=26% Similarity=0.401 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+++++.++||||+++++++.....++++|||+++|+|.+++.... .+++..+..++.|++.||+|||++|+
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 125 (263)
T cd05052 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125 (263)
T ss_pred HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5678899999999999999999999999999999999999999999997543 58999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||++++++.+||+|||++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |.
T Consensus 126 ~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~ 203 (263)
T cd05052 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGM 203 (263)
T ss_pred eecccCcceEEEcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999875432111 11112234668999999987766 488999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+.+..+... ....|..++.++.++|.+||+.||++|||+.++++
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 204 SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 999988877777776543 44566678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=288.95 Aligned_cols=208 Identities=26% Similarity=0.442 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..++.+|+.++++++||||+++++++......|+||||++||+|.+++... +.+++..+..++.|++.||+|||++|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 467889999999999999999999999999999999999999999999753 4689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+||+|||+++....... .......++..|+|||++....+ +.++||||+|+++|+|++ |+.
T Consensus 123 H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~ 200 (256)
T cd05114 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKM 200 (256)
T ss_pred ccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCC
Confidence 999999999999999999999998875422111 11112234568999999987766 489999999999999999 999
Q ss_pred CCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||...+..+....+..+. ...|...+..+.+++.+||+.+|.+|||++++++
T Consensus 201 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 201 PFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999888777777766543 3345557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=292.92 Aligned_cols=210 Identities=22% Similarity=0.345 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~l~~L 88 (400)
...+.+|+.+++.++||||+++++++.+....|+||||++||+|.+++...+ .+++..+..++.|++.||+||
T Consensus 53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L 132 (277)
T cd05036 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4568889999999999999999999998889999999999999999997653 488899999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCC---CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
|++|++||||||+||+++.++ .+||+|||+++...............+++.|+|||++.+..+ +.++||||+||++
T Consensus 133 H~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il 211 (277)
T cd05036 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLL 211 (277)
T ss_pred HHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHH
Confidence 999999999999999998765 599999999875422111111112233567999999987766 5899999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|+|++ |..||.+.+.......+... ....|..++..+.+++.+||+.+|.+|||+.++++|
T Consensus 212 ~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 212 WEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99997 99999988777666655433 345566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=285.90 Aligned_cols=212 Identities=29% Similarity=0.523 Sum_probs=186.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|++++++++|||++++++++.+....|++|||+++++|.+.+...+.+++..+..++.|++.|+.|||+.|++
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (254)
T cd06627 42 ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121 (254)
T ss_pred HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 36789999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||+|+||+++.++.++|+|||++....... .......|++.|+|||.+....+ +.++||||+|+++|+|++|..|
T Consensus 122 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p 198 (254)
T cd06627 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPP 198 (254)
T ss_pred cCCCCHHHEEECCCCCEEEeccccceecCCCc--ccccccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654322 11334578999999999877664 5889999999999999999999
Q ss_pred CCCCchHHHHHhh-hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 175 FDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 175 f~~~~~~~~~~~i-~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
|...+......+. .......++.++..+.+++.+||..+|++|||+.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 199 YYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9876654444333 334445666789999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=292.42 Aligned_cols=211 Identities=23% Similarity=0.343 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe------CCEEEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLI 82 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lv~Ey~~gg~L~~~i~~~------~~l~e~~~~~~~~qll 82 (400)
..+.+.+|+.+++.++||||+++++++.. ....+++|||+.+|+|.+++... ..+++..+..++.|++
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 122 (272)
T cd05075 43 EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122 (272)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHH
Confidence 36788999999999999999999997632 23578999999999999887432 3478999999999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 83 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 83 ~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
.||+|||++||+||||||+|||+++++.+||+|||++................+++.|+|||.+....+ +.++||||+|
T Consensus 123 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG 201 (272)
T cd05075 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFG 201 (272)
T ss_pred HHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHH
Confidence 999999999999999999999999999999999999876533211111123346778999999987666 5899999999
Q ss_pred HHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 163 VILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 163 iil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|++|+|++ |..||.+......+..+..+. ...++.++..+.++|.+||+.||.+|||+.+++++
T Consensus 202 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 202 VTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999 899998877777777665544 34556688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=301.53 Aligned_cols=218 Identities=18% Similarity=0.295 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+++|+.+++.++||||+++++++..+...|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++|
T Consensus 42 ~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ 121 (328)
T cd08226 42 HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121 (328)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3688999999999999999999999999999999999999999999998764 35899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCC-c----cccccCCCCCCCChhhhcCC-CCCChhhHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-L----LHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILF 166 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~----~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGiil~ 166 (400)
++||||||+||+++.++.++++|||.+.......... . .....++..|+|||++.+.. ..+.++||||+||++|
T Consensus 122 ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~ 201 (328)
T cd08226 122 YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITAC 201 (328)
T ss_pred eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998654322111111 0 11123567799999997642 2358899999999999
Q ss_pred HHHhCCCCCCCCchHHHHHhhhcCcc-----------------------------------------------CCCCCCC
Q 015814 167 VLLAGYLPFDDSNLMNLYKKISAAEF-----------------------------------------------TCPPWLS 199 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~i~~~~~-----------------------------------------------~~~~~~s 199 (400)
+|++|+.||.+............... ..+..++
T Consensus 202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (328)
T cd08226 202 ELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFS 281 (328)
T ss_pred HHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhh
Confidence 99999999987654333322111100 0111256
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 200 FTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 200 ~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
..+.+||++||..||.+|||++++++||||+..
T Consensus 282 ~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 282 PAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 789999999999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=294.34 Aligned_cols=211 Identities=30% Similarity=0.469 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.+++.++|||++++++++.++...|++|||+. ++|.+.+.... .+++..+..++.|++.||+|||++|+
T Consensus 42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~ 120 (283)
T cd07835 42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120 (283)
T ss_pred hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4567889999999999999999999999999999999995 58999987765 68999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|+||+++.++.++|+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|++|..
T Consensus 121 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 198 (283)
T cd07835 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198 (283)
T ss_pred eCCCCCHHHEEEcCCCcEEEeecccccccCCC--ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998654321 1122334678999999998765444588999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC-----------------------------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 174 PFDDSNLMNLYKKISAA-----------------------------EFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-----------------------------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
||...+......++... .....+.++..+.++|.+||+.||.+|||+++++
T Consensus 199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 199 LFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 99876654332221110 0011234678999999999999999999999999
Q ss_pred cCccc
Q 015814 225 EDEWF 229 (400)
Q Consensus 225 ~h~~~ 229 (400)
.||||
T Consensus 279 ~~~~~ 283 (283)
T cd07835 279 QHPYF 283 (283)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=295.78 Aligned_cols=214 Identities=30% Similarity=0.453 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|++++++++||||+++++++.+....|+||||+++ +|.+.+..... +++..+..++.|++.||+|||++|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 123 (294)
T PLN00009 45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV 123 (294)
T ss_pred hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 46788999999999999999999999999999999999964 88888866443 5788999999999999999999999
Q ss_pred eeccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+||||+|+||+++. ++.+||+|||++...... ........|++.|+|||++.+....+.++||||+||++|+|++|.
T Consensus 124 ~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~ 201 (294)
T PLN00009 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201 (294)
T ss_pred eCCCCCcceEEEECCCCEEEEcccccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999986 457999999998654321 122234567899999999876544468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcC--c-------------------c--------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 173 LPFDDSNLMNLYKKISAA--E-------------------F--------TCPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~--~-------------------~--------~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
.||...+..+...++... . . ...+.+++++.++|.+||+.+|.+||++.++
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~ 281 (294)
T PLN00009 202 PLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281 (294)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence 999876654444332110 0 0 0123468889999999999999999999999
Q ss_pred hcCcccccC
Q 015814 224 LEDEWFKKD 232 (400)
Q Consensus 224 l~h~~~~~~ 232 (400)
++||||...
T Consensus 282 l~~~~~~~~ 290 (294)
T PLN00009 282 LEHEYFKDL 290 (294)
T ss_pred hcCchHhHH
Confidence 999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.18 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCE-----EEEEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINA 84 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~-----~~lv~Ey~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~ 84 (400)
...+.+|+.+++++. ||||+++++++..... .|+||||+++ +|.+++... ..+++..++.++.|++.|
T Consensus 44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 467888999999995 6999999999876655 8999999986 898888653 357999999999999999
Q ss_pred HHHHHHcCCeeccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 85 VDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 85 l~~LH~~givHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
|.|||++|++||||||+||+++. ++.+||+|||++...... ........+++.|+|||++.+....+.++||||+||
T Consensus 123 L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred HHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 99999999999999999999999 899999999998654321 112233467899999999876444468999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHhhhcCc--------------------cC--------CCCCCCHHHHHHHHHhcCCCCC
Q 015814 164 ILFVLLAGYLPFDDSNLMNLYKKISAAE--------------------FT--------CPPWLSFTARKLIARILDPNPM 215 (400)
Q Consensus 164 il~elltG~~Pf~~~~~~~~~~~i~~~~--------------------~~--------~~~~~s~~~~~li~~mL~~dP~ 215 (400)
++|+|++|..||.+.+......++.... .. ..+.++.++.+||.+||..||.
T Consensus 201 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 9999999999998766554433321100 00 0124788999999999999999
Q ss_pred CCCCHHHHhcCcccc
Q 015814 216 TRITIPEILEDEWFK 230 (400)
Q Consensus 216 ~R~t~~eil~h~~~~ 230 (400)
+|||+++++.||||+
T Consensus 281 ~R~~~~eil~~~~~~ 295 (295)
T cd07837 281 KRISAKAALTHPYFD 295 (295)
T ss_pred hcCCHHHHhcCCCcC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=292.89 Aligned_cols=210 Identities=20% Similarity=0.341 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYF 78 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~ 78 (400)
..+.+++|+.+++.++||||+++++++......++++||+.+++|.+++... ..+++..+..++
T Consensus 51 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (283)
T cd05091 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130 (283)
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 3577899999999999999999999999999999999999999999998532 247888899999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++||+||||||+||++++++.+||+|||+++...............+++.|+|||.+....+ +.++||
T Consensus 131 ~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 209 (283)
T cd05091 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDI 209 (283)
T ss_pred HHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhH
Confidence 9999999999999999999999999999999999999999875433222222234456789999999987666 488999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||+||++|+|++ |..||.+.+..+....+..... ..|..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 210 ~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 210 WSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 999999999998 9999998887777777765543 456678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=285.76 Aligned_cols=214 Identities=31% Similarity=0.562 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+++|+.++++++||||+++++.+... ...++++||+++++|.+++.....+++..+..++.|++.||+|||+.|
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (260)
T cd06606 42 ELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG 121 (260)
T ss_pred HHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 367899999999999999999999999888 899999999999999999988889999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++|+||+|+||+++.++.++|+|||.+................++..|+|||.+....+ +.++||||+|+++|+|++|.
T Consensus 122 ~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876554322112344678999999999987665 58999999999999999999
Q ss_pred CCCCCCc-hHHHHHhhh--cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 173 LPFDDSN-LMNLYKKIS--AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 173 ~Pf~~~~-~~~~~~~i~--~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
.||.... .......+. ......|..++..+.++|.+||..||.+|||+.++++||||
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 201 PPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9998765 223333333 23345566689999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=291.60 Aligned_cols=209 Identities=21% Similarity=0.295 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~l 85 (400)
...+.+|+.+++.++||||+++++++......|+||||+++|+|.+++.... .+++..+..++.|++.||
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 53 RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 4578899999999999999999999999999999999999999999996532 367789999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
.|||+.|++||||||+||+++.++.+||+|||+++...............++..|+|||.+....+ +.++|||||||++
T Consensus 133 ~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il 211 (277)
T cd05032 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVL 211 (277)
T ss_pred HHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHH
Confidence 999999999999999999999999999999999875433221122234457889999999977665 5889999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|++++ |..||.+.+.......+..+ ....|..++..+.+++.+||+.+|.+|||+.+++.
T Consensus 212 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99998 99999888777666665544 34566778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=289.23 Aligned_cols=210 Identities=22% Similarity=0.361 Sum_probs=179.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.++||||+++++++......|++|||+++|+|.+++... +.+++..+..++.|++.|++|||++||+
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~ 128 (266)
T cd05033 49 RLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128 (266)
T ss_pred HHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 567888999999999999999999999999999999999999999999764 4789999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||++++++.++|+|||++................+++.|+|||.+....+ +.++||||||+++|+|++ |..
T Consensus 129 H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~ 207 (266)
T cd05033 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGER 207 (266)
T ss_pred cCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCC
Confidence 999999999999999999999999887642111111112345678999999987766 488999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||...........+... ..+.+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 208 PYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99887777666666544 334456689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=295.65 Aligned_cols=210 Identities=24% Similarity=0.420 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----------------CCCCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----------------HGRMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----------------~~~l~e~~~~~~~ 78 (400)
...+.+|+.+++++ +||||+++++++......|++|||+++|+|.+++.. .+.+++..+..++
T Consensus 59 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 138 (293)
T cd05053 59 LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 46788999999999 899999999999999999999999999999999964 2458889999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++||+||||||+||+++.++.+||+|||++................++..|+|||++.+..+ +.++||
T Consensus 139 ~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 217 (293)
T cd05053 139 YQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDV 217 (293)
T ss_pred HHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-Ccccce
Confidence 9999999999999999999999999999999999999999876543221111222335678999999877666 488999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||+||++|+|++ |..||...+..+.+..+.... ...|...+..+.+|+.+||..||.+|||+.+++++
T Consensus 218 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 218 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred eehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 999999999997 999999888777777665443 34566688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=291.47 Aligned_cols=211 Identities=23% Similarity=0.330 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCE------EEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLI 82 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~------~~lv~Ey~~gg~L~~~i~~~------~~l~e~~~~~~~~qll 82 (400)
...++.+|+.+++.++||||+++++++..... .+++|||+++|+|...+... ..+++..+..++.|++
T Consensus 44 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~ 123 (273)
T cd05035 44 EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123 (273)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHH
Confidence 35789999999999999999999998765443 79999999999999888442 3589999999999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 83 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 83 ~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
.||.|||++|++||||||+||++++++.+||+|||++................++..|+|||++....+ +.++||||+|
T Consensus 124 ~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG 202 (273)
T cd05035 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFG 202 (273)
T ss_pred HHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHH
Confidence 999999999999999999999999999999999999875443221111222345678999999876666 5899999999
Q ss_pred HHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 163 VILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 163 iil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|++|||++ |..||.+.+..+.+..+..+ ....|..++.++.+++.+||+.||.+|||+.+++++
T Consensus 203 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 203 VTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999 99999887777776665544 345667789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=287.91 Aligned_cols=214 Identities=31% Similarity=0.550 Sum_probs=186.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~gi 93 (400)
....+.+|+.++++++||||+++++++......|+||||++|++|.+++.....+++..+..++.|++.|++|||+ .|+
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~ 121 (264)
T cd06623 42 FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121 (264)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCC
Confidence 3678999999999999999999999999999999999999999999999888889999999999999999999999 999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|+||+++.++.++|+|||++....... .......|+..|+|||.+....+ +.++|+||||+++|+|++|..
T Consensus 122 ~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~ 198 (264)
T cd06623 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKF 198 (264)
T ss_pred ccCCCCHHHEEECCCCCEEEccCccceecccCC--CcccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654321 11234568999999999987655 589999999999999999999
Q ss_pred CCCCC---chHHHHHhhhcC-ccCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 174 PFDDS---NLMNLYKKISAA-EFTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~---~~~~~~~~i~~~-~~~~~~~-~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
||... ...+....+... ....+.. ++..+.++|.+||..+|.+|||+.++++|||++.
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 199 PFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred CCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99876 344444444432 3344455 7899999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=288.03 Aligned_cols=208 Identities=25% Similarity=0.430 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.++.+|+.+++.++||||+++++++......|+||||++|++|.+++... +.+++..+..++.|++.|++|||++|++|
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 123 (256)
T cd05059 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123 (256)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46778999999999999999999999999999999999999999999763 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~P 174 (400)
|||||+||+++.+|.+||+|||+++...... ........++..|+|||.+.+..+ +.++||||+||++|+|++ |..|
T Consensus 124 ~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p 201 (256)
T cd05059 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMP 201 (256)
T ss_pred ccccHhhEEECCCCcEEECCcccceeccccc-ccccCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCC
Confidence 9999999999999999999999986543211 001111123457999999987766 488999999999999999 8999
Q ss_pred CCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 175 FDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|...+..+....+... ....|...+..+.+++.+||..+|.+|||+.++++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 202 YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9887776666665544 345566689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=293.60 Aligned_cols=217 Identities=30% Similarity=0.536 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.+++++ +||||+++++.+..+...|+||||++|++|.+++.....+++..+..++.|++.||.|||+.|+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i 126 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 356788999999999 6999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC-CCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGiil~elltG~ 172 (400)
+||||+|+|||++.++.+||+|||++....... ........|+..|+|||.+... ...+.++||||+||++|+|++|.
T Consensus 127 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~ 205 (290)
T cd05613 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA 205 (290)
T ss_pred eccCCCHHHeEECCCCCEEEeeCccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999999987543221 1222346789999999998753 23357899999999999999999
Q ss_pred CCCCCCc----hHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 015814 173 LPFDDSN----LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~~ 232 (400)
.||.... .......+.......|..++..+.+++++||+.||.+|| ++++++.||||+..
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 206 SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred CCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9997432 234444444455566677899999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=293.05 Aligned_cols=210 Identities=28% Similarity=0.443 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+.+|+.+++.++|+||+++++++..+...|+||||+. ++|.+.+.. ...+++..+..++.|++.||.|||++||+|
T Consensus 48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H 126 (291)
T cd07870 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126 (291)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 456789999999999999999999999999999999996 577777654 356888999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.+|.+||+|||++...... ........+++.|+|||++.+....+.++||||+||++|+|++|..||
T Consensus 127 ~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f 204 (291)
T cd07870 127 RDLKPQNLLISYLGELKLADFGLARAKSIP--SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204 (291)
T ss_pred CCCChHHEEEcCCCcEEEeccccccccCCC--CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998653321 122234567999999999876443458899999999999999999999
Q ss_pred CCCchH-HHHHhhhc--C--------------c-------cCCCC---------CCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 176 DDSNLM-NLYKKISA--A--------------E-------FTCPP---------WLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 176 ~~~~~~-~~~~~i~~--~--------------~-------~~~~~---------~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
...+.. +....+.. + . ...+. ..+.++.+++.+||+.||.+|||+.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~ 284 (291)
T cd07870 205 PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD 284 (291)
T ss_pred CCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHH
Confidence 765432 21111100 0 0 00000 12568899999999999999999999
Q ss_pred HhcCccc
Q 015814 223 ILEDEWF 229 (400)
Q Consensus 223 il~h~~~ 229 (400)
++.||||
T Consensus 285 ~l~h~~~ 291 (291)
T cd07870 285 ALLHPYF 291 (291)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=285.14 Aligned_cols=211 Identities=34% Similarity=0.612 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.+|+++++.++|||++++++.+......++|+||++|++|.+.+... ..+++..+..++.|++.||.|||++
T Consensus 43 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 122 (258)
T cd08215 43 REDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122 (258)
T ss_pred HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 567889999999999999999999999999999999999999999999764 6799999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|++|+||+|+||+++.++.++|+|||++....... .......|++.|+|||.+....+ +.++|+||+|+++|+|++|
T Consensus 123 ~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g 199 (258)
T cd08215 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTL 199 (258)
T ss_pred CEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcC
Confidence 99999999999999999999999999987654422 22344578999999999887766 4889999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
..||...+............ ...|..++..+.+++.+||..+|.+|||+.++++||||
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 200 KHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99998887766666554443 34455688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=296.98 Aligned_cols=214 Identities=29% Similarity=0.409 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~l~~ 87 (400)
....+.+|+.+++.++||||+++++++... ..+|+||||+.+ +|.+.+... ..+++..++.++.|++.||+|
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 123 (316)
T cd07842 45 ISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123 (316)
T ss_pred ccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHH
Confidence 356778899999999999999999999888 889999999975 777766432 368999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEcc----CCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDA----YGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~----~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
||++|++||||||+||+++. +|.+||+|||++........ .......++|+.|+|||++.+....+.++||||+|
T Consensus 124 lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 203 (316)
T cd07842 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203 (316)
T ss_pred HHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH
Confidence 99999999999999999999 89999999999876543222 11223457899999999987655446899999999
Q ss_pred HHHHHHHhCCCCCCCCchHH---------HHHhh--------------------------hcCccCCC-----------C
Q 015814 163 VILFVLLAGYLPFDDSNLMN---------LYKKI--------------------------SAAEFTCP-----------P 196 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~~~---------~~~~i--------------------------~~~~~~~~-----------~ 196 (400)
|++|+|++|+.||.+..... ....+ .......+ .
T Consensus 204 ~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (316)
T cd07842 204 CIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHK 283 (316)
T ss_pred HHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhcc
Confidence 99999999999997644321 00000 00000111 1
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 197 WLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 197 ~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
..+..+.++|.+||+.||.+|||+.++++||||
T Consensus 284 ~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 284 KPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=287.98 Aligned_cols=209 Identities=25% Similarity=0.377 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|+.++++++||||+++++++......|++|||+.+|+|.+++... ..+++..+..++.|++.||+|||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05113 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122 (256)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 356889999999999999999999999889999999999999999999764 3689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
|+||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..+ +.++||||+||++|+|++ |..
T Consensus 123 H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred ccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999998865432111 11111234567999999987666 488999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 174 PFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||...+.......+..+.. ..+...+..+.+++.+||+.||.+|||+.+++.+
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 201 PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9988777666666655433 3455578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=298.07 Aligned_cols=210 Identities=21% Similarity=0.349 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+++.+|+.+++.++||||+++++++... ..++++||+++|+|.+.+.... .+++..+..++.|++.||+|||++||
T Consensus 52 ~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 130 (316)
T cd05108 52 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence 357788999999999999999999998764 5679999999999999998744 68899999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..+. .++|||||||++|+|++ |.
T Consensus 131 iH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~ 209 (316)
T cd05108 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGS 209 (316)
T ss_pred eccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999865432211112223456789999999877764 89999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
.||.+....+....+..+ ..+.|+.++.++.+++.+||..||.+|||+.+++.+
T Consensus 210 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 210 KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999887766555444333 335566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=290.71 Aligned_cols=214 Identities=27% Similarity=0.476 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.++++++||||+++++.+..+...|+||||+++|+|.+++.. +.+++..+..++.|++.|+.|||+.|++|
T Consensus 46 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 124 (277)
T cd06641 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIH 124 (277)
T ss_pred HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeec
Confidence 57789999999999999999999999999999999999999999998865 56899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
+||+|+||+++.+|.++|+|||++....... .......|+..|+|||.+..... +.++|+||+||++|+|++|..||
T Consensus 125 ~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~ 201 (277)
T cd06641 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPH 201 (277)
T ss_pred CCCCHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999886543211 11233568999999999976655 48899999999999999999999
Q ss_pred CCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
...+.......+... ....+..++.++.+++.+||..+|.+||++.++++||||....
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 202 SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred CccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 877665555554433 2345566889999999999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=296.05 Aligned_cols=209 Identities=23% Similarity=0.418 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~ 78 (400)
...+.+|+.+++++ +||||+++++++.....+|++|||+++|+|.+++... ..++...+..++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred HHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence 56788999999999 6999999999999999999999999999999999653 247888899999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||.|||++|++||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||
T Consensus 141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 219 (314)
T cd05099 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDV 219 (314)
T ss_pred HHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-Cccchh
Confidence 9999999999999999999999999999999999999999875443221111222334568999999987666 488999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||+||++|+|++ |..||.+.+....+..+.... ...|..++.++.+++.+||+.||.+|||+.++++
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999 999999888777777665543 3456668899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=297.32 Aligned_cols=208 Identities=22% Similarity=0.364 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHH
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRY 77 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~ 77 (400)
...++.+|+.++.++ +||||+++++++...+..|+||||+++|+|.+++...+ .+++..++.+
T Consensus 50 ~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 129 (303)
T cd05088 50 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129 (303)
T ss_pred HHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHH
Confidence 356888999999999 89999999999999999999999999999999997542 4788999999
Q ss_pred HHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhh
Q 015814 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 78 ~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
+.|++.|++|||++|++||||||+|||++.++.+||+|||++....... ......++..|+|||++....+ +.++|
T Consensus 130 ~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~D 205 (303)
T cd05088 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSD 205 (303)
T ss_pred HHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-ccccc
Confidence 9999999999999999999999999999999999999999985322111 0111234567999999977665 58999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||+||++|+|++ |..||...+..+.+..+.... ...+..++.++.+||.+||+.+|.+|||+++++++
T Consensus 206 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 206 VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred chhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999998 999998877777776654432 23444578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=287.14 Aligned_cols=208 Identities=22% Similarity=0.374 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++.+|+.++++++||||+++++++...+..|++|||++|++|.+++.... .++...+..++.|++.||.|||++|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 124 (261)
T cd05068 45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124 (261)
T ss_pred HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4678899999999999999999999999999999999999999999997654 68999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||++++++.+||+|||++......... ......++..|+|||++....+ +.++||||+||++|+|++ |+
T Consensus 125 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~ 202 (261)
T cd05068 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred eeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999998765421111 1111223457999999887665 488999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+.......+... ....+...+.++.+++.+||+.+|.+||++.++++
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 203 MPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 999988777666665443 23455668899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=295.58 Aligned_cols=210 Identities=23% Similarity=0.406 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~ 78 (400)
..++.+|+.+++.+ +||||+++++++......|+||||+++|+|.+++.... .++...+..++
T Consensus 67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 146 (307)
T cd05098 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA 146 (307)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 56788999999999 79999999999999999999999999999999997642 47888999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++|++||||||+||+++.++.+||+|||++................+++.|+|||++.+..+ +.++||
T Consensus 147 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 225 (307)
T cd05098 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDV 225 (307)
T ss_pred HHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHH
Confidence 9999999999999999999999999999999999999999875432211111112234578999999987666 589999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||+||++|+|++ |..||.+.+..+....+.... ...|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 226 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 999999999998 999998877777766665543 35566689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=292.85 Aligned_cols=210 Identities=20% Similarity=0.261 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLIN 83 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~ 83 (400)
..+.+.+|++++++++||||+++++++..+...+++|||+++++|.+++.... .+++..+..++.|++.
T Consensus 62 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 46789999999999999999999999999999999999999999999997755 6899999999999999
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
||+|||++|++||||||+||+++.++.++|+|||++................+++.|+|||.+....+ +.++||||+||
T Consensus 142 al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~ 220 (296)
T cd05051 142 GMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGV 220 (296)
T ss_pred HHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHH
Confidence 99999999999999999999999999999999999875432221222234456788999999987655 58999999999
Q ss_pred HHHHHHh--CCCCCCCCchHHHHHhhhcC--------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 164 ILFVLLA--GYLPFDDSNLMNLYKKISAA--------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 164 il~ellt--G~~Pf~~~~~~~~~~~i~~~--------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
++|+|++ |..||...+........... ....++.++.++.+++.+||+.||.+|||+.+|++
T Consensus 221 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 221 TLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 9999998 78899876665555443221 12334557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=299.80 Aligned_cols=219 Identities=28% Similarity=0.490 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
....+.+|+.++++++||||+++++++... ...|+++||+.+ +|.+.+.. ..+++..++.++.|++.||+|||
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH 123 (336)
T cd07849 46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIH 123 (336)
T ss_pred hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 356678899999999999999999987543 358999999975 88887754 57999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
+.||+||||||+||+++.++.+||+|||++........ .......+||+.|+|||++.+....+.++||||+||++|+|
T Consensus 124 ~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el 203 (336)
T cd07849 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203 (336)
T ss_pred hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999875433211 11223457899999999986544446899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhc------------------------C--ccC-----CCCCCCHHHHHHHHHhcCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISA------------------------A--EFT-----CPPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~------------------------~--~~~-----~~~~~s~~~~~li~~mL~~dP~~R 217 (400)
++|+.||.+.+.......+.. . ... ..+..+.++.++|.+||+.||.+|
T Consensus 204 ~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 283 (336)
T cd07849 204 LSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283 (336)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhC
Confidence 999999987654332221100 0 000 112357889999999999999999
Q ss_pred CCHHHHhcCcccccCCCC
Q 015814 218 ITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 218 ~t~~eil~h~~~~~~~~~ 235 (400)
||+.++++||||+....+
T Consensus 284 pt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 284 ITVEEALAHPYLEQYHDP 301 (336)
T ss_pred cCHHHHhcCccccccCCC
Confidence 999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=287.01 Aligned_cols=205 Identities=20% Similarity=0.237 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+..|+.+++.++||||+++++++..+...++||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||
T Consensus 42 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (258)
T cd05078 42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL 121 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35678889999999999999999999999999999999999999999997654 58999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCC--------eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGN--------LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~--------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
+||||||+||+++.++. ++++|||++..... .....|++.|+|||++.+....+.++||||+||++
T Consensus 122 iH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred ecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 99999999999988765 69999998754321 12356889999999998755446889999999999
Q ss_pred HHHHhC-CCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 166 FVLLAG-YLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 166 ~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|+|++| ..||...+....... .......|...+.++.+||.+||+.||.+|||+++|++.
T Consensus 196 ~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 196 WEIFSGGDKPLSALDSQKKLQF-YEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHcCCCCChhhccHHHHHHH-HHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 999998 577766555443322 233445666677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=293.33 Aligned_cols=207 Identities=21% Similarity=0.360 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~ 78 (400)
.+.+.+|+.+++++ +||||+++++++...+..|++|||+++|+|.+++.... .+++..+..++
T Consensus 46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 125 (297)
T cd05089 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125 (297)
T ss_pred HHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHH
Confidence 56789999999999 79999999999999999999999999999999996532 47889999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ......+..|+|||++....+ +.++||
T Consensus 126 ~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 201 (297)
T cd05089 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVY-TTKSDV 201 (297)
T ss_pred HHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCC-CchhhH
Confidence 9999999999999999999999999999999999999999753221100 111223456999999987766 489999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||||++|+|++ |..||...+..+....+..+. ...|..++.++.+|+.+||..+|.+|||++++++.
T Consensus 202 wSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 202 WSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999997 999999888877777765443 34455689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=293.89 Aligned_cols=210 Identities=23% Similarity=0.408 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~ 78 (400)
...+.+|+.+++.+ +||||+++++++......|++|||+++|+|.+++... ..++...+..++
T Consensus 64 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (304)
T cd05101 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143 (304)
T ss_pred HHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHH
Confidence 57789999999999 8999999999999999999999999999999999763 236778899999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||.|||++|++||||||+||+++.++.+||+|||++................+++.|+|||++.+..+. .++||
T Consensus 144 ~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di 222 (304)
T cd05101 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDV 222 (304)
T ss_pred HHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhH
Confidence 99999999999999999999999999999999999999998765432222222234567889999999876664 88999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||||++|+|++ |..||.+.+..+....+.... ...+..++.++.+|+.+||..+|.+|||+.++++.
T Consensus 223 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 999999999998 899999888888777765443 34456688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=292.09 Aligned_cols=209 Identities=23% Similarity=0.348 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC------------------------CCCCH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH------------------------GRMKE 71 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------------------------~~l~e 71 (400)
..++.+|+.+++.++||||+++++.+...+..|++|||+.+|+|.+++... ..+++
T Consensus 47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 126 (290)
T cd05045 47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126 (290)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCH
Confidence 467899999999999999999999999999999999999999999988642 24778
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC
Q 015814 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151 (400)
Q Consensus 72 ~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~ 151 (400)
..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++...............+++..|+|||.+.+..+
T Consensus 127 ~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 206 (290)
T cd05045 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY 206 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc
Confidence 89999999999999999999999999999999999999999999999875432221111223456778999999877665
Q ss_pred CCChhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 152 DGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 152 ~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+.++||||+||++|+|++ |..||.+.........+... ....|..++.++.+++.+||+.+|.+|||++++++
T Consensus 207 -~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 207 -TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -chHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 489999999999999998 99999988777766655433 33456668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=287.90 Aligned_cols=201 Identities=29% Similarity=0.458 Sum_probs=170.7
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 98 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDl 98 (400)
..+|...+....||||+++++++......|++|||++||+|.+++.....+++..+..++.|+++||+|||++|++||||
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 111 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL 111 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 34455556666899999999999999999999999999999999988888999999999999999999999999999999
Q ss_pred CCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 015814 99 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 178 (400)
Q Consensus 99 KP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~ 178 (400)
||+||+++.++.++++|||++...... .....++..|+|||.+....+ +.++||||+||++|+|++|+.|+...
T Consensus 112 kp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 112 NPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEE-TEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred CHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcC
Confidence 999999999999999999987544321 233456788999999876666 48899999999999999999987643
Q ss_pred chHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccc
Q 015814 179 NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-----PEILEDEWF 229 (400)
Q Consensus 179 ~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-----~eil~h~~~ 229 (400)
... .. .......|++++..++++|.+||+.||.+|||+ +++++||||
T Consensus 186 ~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 186 PSG-IN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred chh-cc---cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 211 00 112345678899999999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=291.19 Aligned_cols=214 Identities=29% Similarity=0.519 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.++||||+++++.+......|+++||++|++|.+++.... .+++..+..++.|++.||.|||+.|++
T Consensus 59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~ 138 (286)
T cd06614 59 KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138 (286)
T ss_pred HHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 5778899999999999999999999999999999999999999999998876 899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|+||+|+||+++.+|.++|+|||++....... .......|++.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus 139 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p 215 (286)
T cd06614 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPP 215 (286)
T ss_pred eCCCChhhEEEcCCCCEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999876443221 12234468899999999987766 4889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCc-cC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 175 FDDSNLMNLYKKISAAE-FT--CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~-~~--~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|...+.......+.... .. .+..++.++.++|.+||+.+|.+|||+.+++.|+||.+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 216 YLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred CCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 98776654444433222 12 222378899999999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=292.92 Aligned_cols=217 Identities=28% Similarity=0.494 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+++.++||||+++++.+......|+||||+++++|.+.+.. +++++..+..++.|++.||+|||+.|++|
T Consensus 61 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH 139 (292)
T cd06657 61 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIH 139 (292)
T ss_pred HHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 56788999999999999999999999999999999999999999887754 57899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||+|+||+++.++.++|+|||++...... ........|++.|+|||.+....+ +.++|+||+|+++|+|++|..||
T Consensus 140 ~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~ 216 (292)
T cd06657 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPY 216 (292)
T ss_pred CCCCHHHEEECCCCCEEEcccccceecccc--cccccccccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999987643321 111234568999999999876655 58899999999999999999999
Q ss_pred CCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 176 DDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
.+.+.......+.... ......++..+.+++.+||+.||.+||++.+++.||||.+...+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 217 FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred CCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 8876655444433222 122334788999999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=286.66 Aligned_cols=207 Identities=22% Similarity=0.406 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..++.+|+.+++.++||||+++++++......|+||||+++|+|.+++... ..++...+..++.|++.||.|||++|+
T Consensus 46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 125 (261)
T cd05148 46 QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125 (261)
T ss_pred HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 567899999999999999999999999999999999999999999999753 358999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||++++++.+||+|||++...... ........++..|+|||++....+ +.++||||||+++|+|++ |+
T Consensus 126 ~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~ 202 (261)
T cd05148 126 IHRDLAARNILVGEDLVCKVADFGLARLIKED--VYLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQ 202 (261)
T ss_pred eccccCcceEEEcCCceEEEccccchhhcCCc--cccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999998754321 111123345678999999987666 488999999999999998 89
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||...+..+.+..+..+ ..+.+..++.++.+++.+||+.||.+|||+.++++
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 203 VPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999888877777766544 34556678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.79 Aligned_cols=214 Identities=33% Similarity=0.569 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+..++.|-.||..-+.+.||+||..|.+++.+|+||||++||++..+|.+.+-|+|+.|++|+..|.+|+++.|..|+||
T Consensus 673 vaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIH 752 (1034)
T KOG0608|consen 673 VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIH 752 (1034)
T ss_pred hhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcccee
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCC----------------------------------------cccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG----------------------------------------LLHTTC 135 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~----------------------------------------~~~~~~ 135 (400)
|||||+|||||.+|++||.||||++-++...... ..+..+
T Consensus 753 RDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslv 832 (1034)
T KOG0608|consen 753 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLV 832 (1034)
T ss_pred cccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhc
Confidence 9999999999999999999999987654221100 012346
Q ss_pred CCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhc----CccCCCCCCCHHHHHHHHHhcC
Q 015814 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA----AEFTCPPWLSFTARKLIARILD 211 (400)
Q Consensus 136 gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~s~~~~~li~~mL~ 211 (400)
||+.|+|||++...+|. ..+|+||.|||||||+.|+.||-..+..+...++.+ ..+..-..+|.++.+||.++.
T Consensus 833 gt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc- 910 (1034)
T KOG0608|consen 833 GTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC- 910 (1034)
T ss_pred CCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-
Confidence 99999999999999985 889999999999999999999987766544333321 223333459999999999865
Q ss_pred CCCCCCC---CHHHHhcCccccc
Q 015814 212 PNPMTRI---TIPEILEDEWFKK 231 (400)
Q Consensus 212 ~dP~~R~---t~~eil~h~~~~~ 231 (400)
-+++.|. .++++..||||+.
T Consensus 911 ~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 911 CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred cChhhhhcccchhhhhcCccccc
Confidence 4677776 4778999999985
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=287.37 Aligned_cols=205 Identities=23% Similarity=0.301 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+.+|+.+++.++||||+++++++......++||||+++|+|..++... +.+++..+..++.|++.||+|||++||
T Consensus 47 ~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 126 (262)
T cd05077 47 ISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDL 126 (262)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCe
Confidence 3567888999999999999999999999999999999999999998888653 568999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCC-------eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGN-------LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~-------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
+||||||+|||++.++. ++++|||++..... .....|+..|+|||++......+.++||||+||++|
T Consensus 127 vH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 200 (262)
T cd05077 127 VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLW 200 (262)
T ss_pred ECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHH
Confidence 99999999999987664 89999998764321 123467889999999875444468999999999999
Q ss_pred HHH-hCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 167 VLL-AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 167 ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+|+ +|..||......+... ............+.++.+||.+||+.||.+||++.+|+++
T Consensus 201 el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 201 EICYNGEIPLKDKTLAEKER-FYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHhCCCCCCCCcchhHHHH-HHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 998 5999998766544433 2223333333456889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.05 Aligned_cols=209 Identities=23% Similarity=0.336 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+++.+|+.+++.++||||+++++++. ....++||||+++|+|.+++.....+++..+..++.|++.||+|||++|++
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~ 117 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence 3578899999999999999999999876 456899999999999999998888899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCC-ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+||+++.++.+||+|||++.......... ......++..|+|||.+....+ +.++|||||||++|+|++ |.
T Consensus 118 H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~ 196 (257)
T cd05060 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGA 196 (257)
T ss_pred ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999987553321110 0111223567999999987666 489999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||...+..+....+.... ...|..++..+.++|.+||..+|.+|||+.++++
T Consensus 197 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 197 KPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9998877766666665443 3566678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=293.71 Aligned_cols=209 Identities=21% Similarity=0.349 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.+++++ +||||+++++++...+..|++|||+++|+|.+++.... .+++..+..++.|++.||.|||++|
T Consensus 82 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 161 (302)
T cd05055 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161 (302)
T ss_pred HHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 56789999999999 79999999999999999999999999999999997643 3899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
++|+||||+|||++.++.++++|||++................+++.|+|||.+....+ +.++||||+||++|+|++ |
T Consensus 162 ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g 240 (302)
T cd05055 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLG 240 (302)
T ss_pred eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875433211111122346788999999987766 489999999999999998 9
Q ss_pred CCCCCCCchHHHHHh-hhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKK-ISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~-i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||........+.. +..+ ....+...+..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 241 SNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999987665544333 3322 22345568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=288.31 Aligned_cols=206 Identities=22% Similarity=0.382 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~ 78 (400)
.+.+.+|+.+++++ +||||+++++++...+..|+||||+++|+|.+++.... .+++..+..++
T Consensus 39 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 118 (270)
T cd05047 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118 (270)
T ss_pred HHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHH
Confidence 56788999999999 89999999999999999999999999999999997532 47889999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++|++||||||+||++++++.+||+|||++........ ......++.|+|||++....+ +.++||
T Consensus 119 ~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~-~~~~Di 194 (270)
T cd05047 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDV 194 (270)
T ss_pred HHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCC-CchhhH
Confidence 9999999999999999999999999999999999999999753221110 111234567999999977665 489999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||||++|+|++ |..||.+.+....+..+... ....+..++.++.+++.+||..||.+|||++++++
T Consensus 195 ~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 195 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 999999999997 99999888777777666443 23445567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=284.23 Aligned_cols=210 Identities=26% Similarity=0.406 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.+.+|+.++++++||||+++++++.. ...++||||+++|+|.+.+.... .+++..++.++.|++.||+|||++
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 347889999999999999999999999888 88999999999999999997754 689999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|++||||||+||+++.++.+||+|||++......... .......++..|+|||.+....+ +.++||||+||++|+|++
T Consensus 117 ~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t 195 (257)
T cd05040 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFT 195 (257)
T ss_pred CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999998765432111 11123457788999999987666 488999999999999999
Q ss_pred -CCCCCCCCchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 -GYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 -G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|..||...+..+....+... ....+...+..+.+++.+||..+|.+|||+.++++
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 196 YGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 99999887777666655432 23344557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.65 Aligned_cols=208 Identities=22% Similarity=0.326 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.++++++||||+++++++. ....++||||++||+|.+++.. ...+++..+..++.|++.||+|||++|++
T Consensus 39 ~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 117 (257)
T cd05115 39 RDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117 (257)
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCee
Confidence 567899999999999999999999875 4578999999999999999875 45789999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCC-ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+||+++.++.+||+|||++.......... ......+++.|+|||.+....+ +.++|||||||++|++++ |.
T Consensus 118 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~ 196 (257)
T cd05115 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQ 196 (257)
T ss_pred ecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999987543221111 1111233578999999887665 488999999999999996 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.........+..+ ....|+..++++.++|.+||..||.+||++.++.+
T Consensus 197 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 197 KPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999887777666665543 35667778999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=289.89 Aligned_cols=214 Identities=30% Similarity=0.477 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~L 88 (400)
...++.+|++++++++||||+++++++.. ...+|+||||++|++|.+.+.. ...+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l 121 (287)
T cd06621 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121 (287)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 35778999999999999999999998854 4478999999999999887643 34589999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
|+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..+. .++||||+||++|+|
T Consensus 122 H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l 196 (287)
T cd06621 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEV 196 (287)
T ss_pred HHCCcccCCCCHHHEEEecCCeEEEeecccccccccc----ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHH
Confidence 9999999999999999999999999999997654321 11234678999999999877664 889999999999999
Q ss_pred HhCCCCCCCCc-----hHHHHHhhhcCc-cCCC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 169 LAGYLPFDDSN-----LMNLYKKISAAE-FTCP------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 169 ltG~~Pf~~~~-----~~~~~~~i~~~~-~~~~------~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
++|..||.... ..+....+.... ...+ ..+++.+.++|.+||..||.+|||+.|+++||||+...
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 197 AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred HhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 99999998652 223333332211 1111 12467899999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=294.05 Aligned_cols=214 Identities=29% Similarity=0.494 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++.+......|+|+||++||+|.+++.. ..+++..+..++.|++.|++|||++|++|
T Consensus 60 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H 138 (293)
T cd06647 60 KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIH 138 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 46788999999999999999999999999999999999999999998865 46889999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.++.++|+|||++...... ........|++.|+|||.+....+ +.++|+||+||++|++++|+.||
T Consensus 139 ~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf 215 (293)
T cd06647 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPY 215 (293)
T ss_pred ccCCHHHEEEcCCCCEEEccCcceeccccc--ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999987654332 112234568999999999987666 58899999999999999999999
Q ss_pred CCCchHHHHHhhh-cCcc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNLYKKIS-AAEF--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~~~i~-~~~~--~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
...+.......+. .+.. ..+..++..+.++|++||+.+|.+||++.+++.||||+...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 216 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 8766544333222 1222 22334688999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=301.12 Aligned_cols=214 Identities=28% Similarity=0.431 Sum_probs=178.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCE------EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~------~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
....+.+|+.+++.++||||+++++++..... .|+|+||+ |++|.+.+.. .++++..+..++.|++.||.||
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~L 134 (343)
T cd07851 57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 35677889999999999999999988765544 89999999 5699988876 5799999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
|+.||+||||||+||+++++|.++|+|||++..... ......+++.|+|||++.+....+.++||||+||++|+|
T Consensus 135 H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred HHCCeecCCCCHHHeEECCCCCEEEccccccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHH
Confidence 999999999999999999999999999999875432 133457899999999987654556899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCccC-------------------------------CCCCCCHHHHHHHHHhcCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEFT-------------------------------CPPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~~~~~s~~~~~li~~mL~~dP~~R 217 (400)
++|+.||.+.+....+..+...... .....+..+.++|.+||+.||.+|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 9999999877665554443221100 012358899999999999999999
Q ss_pred CCHHHHhcCcccccCCCC
Q 015814 218 ITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 218 ~t~~eil~h~~~~~~~~~ 235 (400)
||+.++++||||.....+
T Consensus 290 pt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 290 ITAAEALAHPYLAEYHDP 307 (343)
T ss_pred CCHHHHhcCCCccccCCC
Confidence 999999999999976544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=300.80 Aligned_cols=220 Identities=28% Similarity=0.440 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+.+.+|+.+++.++||||+++++++.... .+|++|||+.+ +|.+.+...+.+++..+..++.|++.||+|||
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH 120 (330)
T cd07834 42 DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120 (330)
T ss_pred hhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4578899999999999999999999987765 78999999985 89999988778999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
++||+||||||+||+++.++.++|+|||++........ ........||+.|+|||++.+....+.++||||+||++|+|
T Consensus 121 ~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l 200 (330)
T cd07834 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200 (330)
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence 99999999999999999999999999999876543211 11234456899999999998773446899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCccC-------------------------------CCCCCCHHHHHHHHHhcCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEFT-------------------------------CPPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~~~~~s~~~~~li~~mL~~dP~~R 217 (400)
++|..||.+.+..+.+..+...... ..+.++.++.++|.+||+.+|.+|
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 280 (330)
T cd07834 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR 280 (330)
T ss_pred HcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhC
Confidence 9999999887766555543321100 112367889999999999999999
Q ss_pred CCHHHHhcCcccccCCCC
Q 015814 218 ITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 218 ~t~~eil~h~~~~~~~~~ 235 (400)
||+++++.||||+....+
T Consensus 281 pt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 281 ITADEALAHPYLAQLHDP 298 (330)
T ss_pred CCHHHHHhCccHHhhccc
Confidence 999999999999875443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.40 Aligned_cols=208 Identities=20% Similarity=0.356 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.++++++||||+++++.+......|++|||+++|+|.+++... ..++......++.|++.||+|||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i 124 (261)
T cd05072 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124 (261)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 468899999999999999999999999999999999999999999999653 468889999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||+++.++.++|+|||++....... ........++..|+|||.+....+ +.++||||+||++|+|++ |.
T Consensus 125 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~ 202 (261)
T cd05072 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGK 202 (261)
T ss_pred eccccchhhEEecCCCcEEECCCccceecCCCc-eeccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCC
Confidence 999999999999999999999999987643211 111122345678999999987665 488999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||...+.......+.... .+.+..++.++.+++.+||..+|++|||++++.+
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 203 IPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9998877766666655442 2334457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=292.57 Aligned_cols=211 Identities=25% Similarity=0.384 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.+++.++||||+++++++......|+||||+.| ++.+.+.. ...+++..+..++.|++.||.|||+.||+
T Consensus 59 ~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~ 137 (307)
T cd06607 59 WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137 (307)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 56789999999999999999999999999999999999975 77777654 45689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||+|+||+++.++.++|+|||++..... .....|++.|+|||++.. ....+.++||||+|+++|+|++|+
T Consensus 138 H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~ 211 (307)
T cd06607 138 HRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (307)
T ss_pred ecCCCcccEEECCCCCEEEeecCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCC
Confidence 999999999999999999999998865322 124568899999998742 233358899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcC-ccCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTC-PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~-~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||.+.+.......+... .... +..++..+.++|.+||..||.+|||+.+++.||||....
T Consensus 212 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 212 PPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999887765544443322 2222 223688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=289.90 Aligned_cols=218 Identities=31% Similarity=0.522 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.+++++ +||||+++++.+..+...|+||||++||+|.+.+.....+++..+..++.|++.||.|||+.|
T Consensus 46 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 125 (288)
T cd05583 46 KTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125 (288)
T ss_pred hHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999999 699999999999999999999999999999999988778999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC-CCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGiil~elltG 171 (400)
++||||||.||+++.++.++|+|||++....... .......+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|
T Consensus 126 ~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg 204 (288)
T cd05583 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204 (288)
T ss_pred eeccCCCHHHeEECCCCCEEEEECcccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence 9999999999999999999999999987543321 11123356899999999986543 245889999999999999999
Q ss_pred CCCCCCCc----hHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCcccccC
Q 015814 172 YLPFDDSN----LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKD 232 (400)
Q Consensus 172 ~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t---~~eil~h~~~~~~ 232 (400)
..||.... ..+....+.......|..++.++.++|.+||+.||++||| +.++++||||+..
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 205 ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred CCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99996432 2333444445556667778999999999999999999998 5678999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=286.48 Aligned_cols=209 Identities=22% Similarity=0.272 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-----~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
...+.+|+.+++.++||||+++++.+......|+||||+++|+|.+++.... ..++..+..++.|++.||+|||+
T Consensus 39 ~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (269)
T cd05042 39 QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118 (269)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 4667889999999999999999999999999999999999999999997643 24678889999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC------CCCCChhhHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR------GYDGSTADLWSCGVI 164 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~------~~~~~~~DIwSlGii 164 (400)
+||+||||||+|||+++++.+||+|||++................+++.|+|||++... ...+.++||||+||+
T Consensus 119 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 198 (269)
T cd05042 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVT 198 (269)
T ss_pred cCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHH
Confidence 99999999999999999999999999997543221111111233456789999998532 223578999999999
Q ss_pred HHHHHh-CCCCCCCCchHHHHHhh-hcCccC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 165 LFVLLA-GYLPFDDSNLMNLYKKI-SAAEFT-----CPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 165 l~ellt-G~~Pf~~~~~~~~~~~i-~~~~~~-----~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|+|++ |..||......+..... ...... .+..++....+++..|+ .||.+|||++++++
T Consensus 199 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 199 MWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 999999 89999877655544433 222222 23347888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=286.80 Aligned_cols=204 Identities=24% Similarity=0.286 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.++||||+++++++......|+||||+++|+|...+.. .+.+++..+..++.|++.||+|||++||+
T Consensus 60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ii 139 (274)
T cd05076 60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLV 139 (274)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCcc
Confidence 46788899999999999999999999999999999999999999988865 45789999999999999999999999999
Q ss_pred eccCCCCcEEEccCC-------CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 95 HRDLKPENLLLDAYG-------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 95 HrDlKP~NILl~~~g-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||||||+|||++..+ .+|++|||++..... .....+++.|+|||.+.+....+.++||||+||++|+
T Consensus 140 H~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~e 213 (274)
T cd05076 140 HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213 (274)
T ss_pred CCCCCcccEEEeccCcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHH
Confidence 999999999998654 389999998753221 1234578899999998764444689999999999999
Q ss_pred HH-hCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 168 LL-AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 168 ll-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|+ +|..||...+........ ......|...+..+.++|.+||+.+|.+|||+.+++++
T Consensus 214 l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 214 ICFDGEVPLKERTPSEKERFY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhCCCCCccccChHHHHHHH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 85 799999876654433322 22334455567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.56 Aligned_cols=213 Identities=29% Similarity=0.503 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
....+++|+.++++++||||+++++.+.+. ..++++|||++|++|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 47 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~ 126 (264)
T cd06653 47 EVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126 (264)
T ss_pred HHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999999999999998654 568999999999999999988788999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
++||||||+||+++.++.++|+|||++........ ........|+..|+|||.+.+..+ +.++|+||+||++|+|++|
T Consensus 127 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g 205 (264)
T cd06653 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTE 205 (264)
T ss_pred EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875432211 112234568999999999987665 4889999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 172 YLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
+.||..........++... ....|..++..+.++|.+||+ +|.+|||+.+++.|||.
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 206 KPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999877655544443322 234577789999999999999 67999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=308.96 Aligned_cols=212 Identities=26% Similarity=0.411 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
-+.|.+|+..|++++|||+|.+-++|..+...|+|||||-| +-.|.+.- ..++.+..+..+..+.+.||+|||+.+.|
T Consensus 70 WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~I 148 (948)
T KOG0577|consen 70 WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRI 148 (948)
T ss_pred HHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHH
Confidence 57899999999999999999999999999999999999976 77888754 35799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh---cCCCCCChhhHHHHHHHHHHHHhC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGiil~elltG 171 (400)
|||||..|||+++.|.|||+|||.|..... ..+.+|||.||||||+. .+.|+ -++|||||||+..||...
T Consensus 149 HRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 149 HRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAER 221 (948)
T ss_pred hhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccC-Cccceeeccchhhhhhhc
Confidence 999999999999999999999999876543 35689999999999985 34465 789999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
++|+-+.+.+.....|.... +..+ +.+|..+++|+..||++-|..|||.++++.|+|......+
T Consensus 222 kPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 222 KPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred CCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 99998888875555554443 3333 3479999999999999999999999999999999876544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=299.42 Aligned_cols=215 Identities=28% Similarity=0.453 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
...+.+|+.+++.++||||+++++++... ...|+||||+. ++|.+.+...+.+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 126 (337)
T cd07858 48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126 (337)
T ss_pred hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45677899999999999999999987644 35899999996 5899999888889999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
+|++||||||+||+++.++.+||+|||++...... ........|+..|+|||.+......+.++||||+||++|+|++
T Consensus 127 ~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 204 (337)
T cd07858 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204 (337)
T ss_pred CCEecCCCCHHHEEEcCCCCEEECcCccccccCCC--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc
Confidence 99999999999999999999999999998754332 1223445789999999998754445689999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhc---------------------------C-c---cCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 015814 171 GYLPFDDSNLMNLYKKISA---------------------------A-E---FTCPPWLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~---------------------------~-~---~~~~~~~s~~~~~li~~mL~~dP~~R~t 219 (400)
|+.||.+.+.......+.. . . ....+.++.++.+||++||+.+|.+|||
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps 284 (337)
T cd07858 205 RKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT 284 (337)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC
Confidence 9999987654332221110 0 0 0012347889999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 015814 220 IPEILEDEWFKKDY 233 (400)
Q Consensus 220 ~~eil~h~~~~~~~ 233 (400)
++++++||||....
T Consensus 285 ~~ell~h~~~~~~~ 298 (337)
T cd07858 285 VEEALAHPYLASLH 298 (337)
T ss_pred HHHHHcCcchhhhc
Confidence 99999999998643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=284.76 Aligned_cols=207 Identities=31% Similarity=0.550 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.+|+.+++.++||||+++++++.+.+..|++|||+++|+|.+.+.. ...+++..+..++.|++.||+|||++
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08228 46 RQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125 (267)
T ss_pred HHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 56788999999999999999999999999999999999999999988853 34589999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..+. .++|+||+|+++|+|++|
T Consensus 126 ~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g 202 (267)
T cd08228 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred CeeCCCCCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999987654321 122345689999999999877664 889999999999999999
Q ss_pred CCCCCCCch--HHHHHhhhcCcc-CCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNL--MNLYKKISAAEF-TCP-PWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~--~~~~~~i~~~~~-~~~-~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||..... ......+..... +.+ ...+..+.++|.+||+.+|.+|||+.++++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 203 QSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred CCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 999965432 344444433322 222 347889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=286.69 Aligned_cols=208 Identities=18% Similarity=0.321 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+..|+.++++++||||+++++++. ....++++||+++|+|.+++... +.+++..+..++.|++.||+|||++|++
T Consensus 53 ~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ii 131 (279)
T cd05111 53 FQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131 (279)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 567888999999999999999999875 45578899999999999999764 4689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||++++++.+||+|||+++...............|+..|+|||.+....+ +.++||||+||++|||++ |..
T Consensus 132 H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~ 210 (279)
T cd05111 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAE 210 (279)
T ss_pred ccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999875432221122233457788999999987666 489999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.........+..+. ...+...+.++.+++.+||..||.+|||+.++++
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 211 PYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 998877666555554443 3334457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=279.68 Aligned_cols=210 Identities=32% Similarity=0.549 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...++.+|+.++++++||||+++++++......++++||++|++|.+.+... ..+++..+..++.|++.|+.|||++|+
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 119 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence 3678999999999999999999999999999999999999999999999776 579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|+||++++++.++|+|||.+........ .....|+..|+|||.+....+ +.++||||+|+++|+|++|..
T Consensus 120 ~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~ 195 (253)
T cd05122 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKP 195 (253)
T ss_pred ecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543221 345678999999999987654 588999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC-ccCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTC--PPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~--~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
||...+........... .... +..++..+.++|.+||+.||.+|||+.++++|||
T Consensus 196 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 196 PYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 99877544333322222 2222 2224899999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=289.96 Aligned_cols=209 Identities=29% Similarity=0.503 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|++++++++||||+++++++......++||||+++|+|.+++... ..+++.....++.|++.||.|||++++
T Consensus 45 ~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~i 124 (259)
T PF07714_consen 45 EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNI 124 (259)
T ss_dssp HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 688999999999999999999999999888899999999999999999886 679999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+|+||+|.||+++.++.+||+|||++................+...|+|||.+....+ +.++||||||+++||+++ |+
T Consensus 125 iH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~ 203 (259)
T PF07714_consen 125 IHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGK 203 (259)
T ss_dssp EEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 9999999999999999999999999876522111112233456778999999987765 589999999999999999 78
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+..+. ...|..++..+.++|..||..||.+|||+.+|++
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 204 FPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp GTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999888877777765443 3456678999999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=284.26 Aligned_cols=209 Identities=23% Similarity=0.358 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~~l~~L 88 (400)
...+.+|+.+++.++||||+++++++......|+||||++||+|.+++... ..+++..+..++.|++.|++||
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 122 (269)
T cd05044 43 KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122 (269)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH
Confidence 567889999999999999999999999989999999999999999999642 3478899999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCC-----CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g-----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
|+.|++|+||||+||+++.++ .++++|||++................++..|+|||++.+..+ +.++|||||||
T Consensus 123 H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~ 201 (269)
T cd05044 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGV 201 (269)
T ss_pred HhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHH
Confidence 999999999999999999887 899999999865432211112223356788999999987665 58999999999
Q ss_pred HHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 164 ILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 164 il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
++|+|++ |..||...+..+....+..+ .+..+..+|..+.++|.+||..+|.+|||++++++
T Consensus 202 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 202 LMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999998 99999887766666655433 34556668999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=285.93 Aligned_cols=208 Identities=21% Similarity=0.344 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.++||||+++++++.. ...+++|||+++|+|.+.+... +.+++..+..++.|++.||+|||++||+
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ii 131 (279)
T cd05109 53 NKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 5678899999999999999999998865 4578999999999999999764 5699999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+..+. .++||||+||++|||++ |..
T Consensus 132 H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~ 210 (279)
T cd05109 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999998765432111111223456789999999877764 89999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||...........+..+ ....+...+.++.+++.+||+.||.+|||+.++++
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 211 PYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99887766665555443 33445668999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=287.80 Aligned_cols=209 Identities=22% Similarity=0.340 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------------CCCCHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------------GRMKEDE 73 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------------------~~l~e~~ 73 (400)
..++.+|+.++++++||||+++++++..+...|++|||+++|+|.+++... ..+++..
T Consensus 52 ~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 131 (288)
T cd05050 52 QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131 (288)
T ss_pred HHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHH
Confidence 567999999999999999999999999999999999999999999999743 2367888
Q ss_pred HHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCC
Q 015814 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 153 (400)
Q Consensus 74 ~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~ 153 (400)
+..++.|++.||.|||++|++||||||+||++++++.++|+|||++................+++.|+|||++.+..+ +
T Consensus 132 ~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~ 210 (288)
T cd05050 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-T 210 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-C
Confidence 999999999999999999999999999999999999999999998764332111111222345678999999987776 4
Q ss_pred ChhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 154 STADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 154 ~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.++|||||||++|+|++ |..||.+.+..+....+..+.. ..|..++.++.+||.+||+.||.+|||+.|+++
T Consensus 211 ~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 89999999999999998 8899988777777766655543 446678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=309.47 Aligned_cols=210 Identities=30% Similarity=0.453 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHhCC-C-----CCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVK-H-----PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~-H-----pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~ 86 (400)
...|..-|+.||..|+ | -|+|+++++|.-.++.|||+|.+.. +|+++|+.+. +++...++.+++||+.||.
T Consensus 225 f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~ 303 (586)
T KOG0667|consen 225 FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALL 303 (586)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 3677788999999997 4 3899999999999999999999975 9999998765 6899999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccC--CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~--g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
+||+.||||.|||||||||... ..+||+|||.|..... ...+++.+..|+|||++.+.+|. .+.||||||||
T Consensus 304 ~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCI 377 (586)
T KOG0667|consen 304 FLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCI 377 (586)
T ss_pred HHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC-----cceeeeeccccccchhhccCCCC-Cccceeehhhh
Confidence 9999999999999999999764 4799999999876432 33488899999999999999996 89999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCcc----------------------------------------------------
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEF---------------------------------------------------- 192 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------------------------------- 192 (400)
++||++|.+.|.+.+..++...|.....
T Consensus 378 lAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~ 457 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLER 457 (586)
T ss_pred HHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccc
Confidence 9999999999999888777665531100
Q ss_pred CCCCC-----------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 193 TCPPW-----------LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 193 ~~~~~-----------~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
..|+. -...+.+||++||+.||.+|+|..++|+||||..
T Consensus 458 ~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 458 RGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred cCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 01100 0134689999999999999999999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=289.50 Aligned_cols=212 Identities=32% Similarity=0.521 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+.+|+.++++++||||+++++++..+...|+||||+.+ +|.+.+... ..+++..+..++.|++.||.|||++||
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 357888999999999999999999999999999999999976 888888663 579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+....+.++|+||+|+++|+|++|+.
T Consensus 120 ~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 197 (283)
T cd05118 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197 (283)
T ss_pred eecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654322 122335688899999999876344689999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC-------------------ccC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 174 PFDDSNLMNLYKKISAA-------------------EFT-----------CPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-------------------~~~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
||...+..+...++... ... ..+.++.++.++|.+||++||.+||++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l 277 (283)
T cd05118 198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277 (283)
T ss_pred CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence 99887765544332111 000 112367889999999999999999999999
Q ss_pred hcCccc
Q 015814 224 LEDEWF 229 (400)
Q Consensus 224 l~h~~~ 229 (400)
+.||||
T Consensus 278 l~~~~~ 283 (283)
T cd05118 278 LAHPYF 283 (283)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=282.72 Aligned_cols=205 Identities=23% Similarity=0.428 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+++.+|+.+++.++||||+++++++.+....|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~ 122 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 36789999999999999999999999998999999999999999999997765 6899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
++||||||+||+++.+|.+||+|||++...... .....++..|+|||.+....+ +.++||||||+++|+|++ |
T Consensus 123 i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g 196 (256)
T cd05039 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-----QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred ccchhcccceEEEeCCCCEEEcccccccccccc-----cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcC
Confidence 999999999999999999999999998754221 112344667999999876655 589999999999999997 9
Q ss_pred CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||...+.......+... ....|..+++.+.++|.+||..+|.+|||+.++++
T Consensus 197 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 197 RVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999888777666655443 33445668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.05 Aligned_cols=212 Identities=32% Similarity=0.517 Sum_probs=174.7
Q ss_pred hhHHHHHHHHHHHHHHHHhCC-CCCcceeeEE-EEe------CCEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHH
Q 015814 10 LDAFCILLQIKREVATMKLVK-HPNVVRLYEV-MGS------KTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQ 79 (400)
Q Consensus 10 ~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~-~~~------~~~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~ 79 (400)
..+...+..+++||++|++|+ |||||.+++. ... .-.++|.||||.||.|.|++.. ..+|+|.++.+||.
T Consensus 72 ~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~ 151 (738)
T KOG1989|consen 72 VNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFY 151 (738)
T ss_pred cCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHH
Confidence 334456899999999999995 9999999993 221 1347899999999999999974 35699999999999
Q ss_pred HHHHHHHHHHHcC--CeeccCCCCcEEEccCCCeeeeccccccccccccCCC----cc---ccccCCCCCCCChhhh---
Q 015814 80 QLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG----LL---HTTCGTPNYVAPEVLN--- 147 (400)
Q Consensus 80 qll~~l~~LH~~g--ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~----~~---~~~~gt~~y~APEvl~--- 147 (400)
|+++||.+||... |||||||-|||||+.+|+.||||||.|+-.-...... .+ -...-|+.|+|||++.
T Consensus 152 dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys 231 (738)
T KOG1989|consen 152 DVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS 231 (738)
T ss_pred HHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc
Confidence 9999999999998 9999999999999999999999999886432211100 00 1124589999999973
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 148 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--WLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 148 ~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+.+. ++++|||+|||+||-|+....||++... ..|..+.|.+|+ .+|..+.+||+.||+.||.+||++.|++.
T Consensus 232 g~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 232 GLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred CCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 4455 5999999999999999999999987532 346678888877 48999999999999999999999999886
Q ss_pred C
Q 015814 226 D 226 (400)
Q Consensus 226 h 226 (400)
+
T Consensus 307 ~ 307 (738)
T KOG1989|consen 307 E 307 (738)
T ss_pred H
Confidence 4
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=296.20 Aligned_cols=216 Identities=31% Similarity=0.458 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+|+.+++++ +||||+++++++.. ....|+||||+.+ +|...+... .+++..+..++.|++.||.|||+.|
T Consensus 50 ~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ 127 (337)
T cd07852 50 AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN 127 (337)
T ss_pred hhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35677899999999 99999999998864 3468999999975 999988775 7899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCC---CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
|+||||||+||+++.+|.+||+|||++......... .......||+.|+|||++.+....+.++||||+||++|+|+
T Consensus 128 i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~ 207 (337)
T cd07852 128 VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML 207 (337)
T ss_pred eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHH
Confidence 999999999999999999999999998765432211 22334568999999999876555568899999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcC---------------------------cc----CCCCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAA---------------------------EF----TCPPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~---------------------------~~----~~~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
+|+.||.+....+...++... .. ...+.++.++.++|.+||+.||.+||
T Consensus 208 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 287 (337)
T cd07852 208 LGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287 (337)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc
Confidence 999999876544433322111 00 01123688999999999999999999
Q ss_pred CHHHHhcCcccccCC
Q 015814 219 TIPEILEDEWFKKDY 233 (400)
Q Consensus 219 t~~eil~h~~~~~~~ 233 (400)
|+.++++|||++...
T Consensus 288 s~~~il~~~~~~~~~ 302 (337)
T cd07852 288 TAEEALEHPYVAQFH 302 (337)
T ss_pred CHHHHhhChhhhhhc
Confidence 999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.51 Aligned_cols=210 Identities=22% Similarity=0.383 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhC---------------------------
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNH--------------------------- 66 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~--------------------------- 66 (400)
.+.+.+|+.+++++ +||||+++++++.. +..++++|||++||+|.+.+...
T Consensus 54 ~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (337)
T cd05054 54 YKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133 (337)
T ss_pred HHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence 46778899999999 89999999998754 46789999999999999988542
Q ss_pred ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCee
Q 015814 67 ----------------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 112 (400)
Q Consensus 67 ----------------------------------~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~k 112 (400)
.+++...+..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vk 213 (337)
T cd05054 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK 213 (337)
T ss_pred ccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEE
Confidence 2578889999999999999999999999999999999999999999
Q ss_pred eeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCchHHHH-HhhhcC
Q 015814 113 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY-KKISAA 190 (400)
Q Consensus 113 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~-~~i~~~ 190 (400)
|+|||++................++..|+|||++.+..+. .++||||+||++|+|++ |..||.+....+.. ..+..+
T Consensus 214 L~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 292 (337)
T cd05054 214 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG 292 (337)
T ss_pred EeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc
Confidence 9999998764322111112233456789999999887775 88999999999999998 99999875543332 233322
Q ss_pred -ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 191 -EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 191 -~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
....|...++++.+++.+||+.+|.+|||+.++++|
T Consensus 293 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 234455678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=282.68 Aligned_cols=224 Identities=24% Similarity=0.402 Sum_probs=181.9
Q ss_pred chhHHHhhHHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHH
Q 015814 4 QDLSKYLDAFCILLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQL 81 (400)
Q Consensus 4 ~~~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql 81 (400)
+.|.+--++ .-.++|.+.+.++.+.+ .|+||+.+++|..+..+++.||.+.. ++..++.. .++++|..+-++...+
T Consensus 123 K~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~ 200 (391)
T KOG0983|consen 123 KQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAI 200 (391)
T ss_pred EeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHH
Confidence 445444444 33688999999987774 99999999999999999999999864 33333332 4579999999999999
Q ss_pred HHHHHHHHHc-CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc---CCCCCChhh
Q 015814 82 INAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND---RGYDGSTAD 157 (400)
Q Consensus 82 l~~l~~LH~~-givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~D 157 (400)
++||.||..+ ||+|||+||+|||+|+.|++|+||||.|...-. ........|.+.|||||.+.- ..|+ -.+|
T Consensus 201 v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtrsAGC~~YMaPERidp~~~~kYD-iRaD 276 (391)
T KOG0983|consen 201 VKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTRSAGCAAYMAPERIDPPDKPKYD-IRAD 276 (391)
T ss_pred HHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---ccccccccCCccccCccccCCCCCCccc-hhhh
Confidence 9999999965 999999999999999999999999999875433 233344579999999999863 3455 7899
Q ss_pred HHHHHHHHHHHHhCCCCCCCCch-HHHHHhhhcCccCC-CC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 158 LWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTC-PP--WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 158 IwSlGiil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-~~--~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
||||||+++||.||+.||.+-+. -+...++.+..++. |. .+|+.+.+|+..||.+|+.+||...++|+|||+....
T Consensus 277 VWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 277 VWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred hhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999999999999999998543 35555665554433 32 2899999999999999999999999999999998643
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=279.05 Aligned_cols=208 Identities=25% Similarity=0.442 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.++||||+++++++......++||||++||+|.+++... ..+++..+..++.|++.||.|||++|++
T Consensus 36 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 115 (250)
T cd05085 36 KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115 (250)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 456889999999999999999999999999999999999999999998753 4688999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+||+|||++....... ........+++.|+|||++....+ +.++||||+|+++|++++ |..
T Consensus 116 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~ 193 (250)
T cd05085 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVC 193 (250)
T ss_pred ecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCcccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999986432211 111112244667999999976655 488999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+.......+..+ ....+..++..+.+++.+||..+|.+|||+.++++
T Consensus 194 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 194 PYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99887766665555444 33556678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=297.96 Aligned_cols=212 Identities=27% Similarity=0.424 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC------EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+.+|+.+|+.++||||+++++++.... .+|+||||+ |++|.+.+.. ..+++..++.++.|++.||+|||
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH 135 (343)
T cd07880 58 AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIH 135 (343)
T ss_pred HHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999987543 468999999 7788877764 67999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
+.||+||||||+||+++.++.++|+|||++..... ......+++.|+|||.+.+....+.++|+||+||++|+|+
T Consensus 136 ~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~ 210 (343)
T cd07880 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210 (343)
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999865322 1234567999999999976444568999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCcc-------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEF-------------------------------TCPPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
+|..||.+.+....+..+..... ...+.++..+.++|.+||+.||.+||
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 290 (343)
T cd07880 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI 290 (343)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC
Confidence 99999987765444433221110 11235688899999999999999999
Q ss_pred CHHHHhcCcccccCCC
Q 015814 219 TIPEILEDEWFKKDYK 234 (400)
Q Consensus 219 t~~eil~h~~~~~~~~ 234 (400)
|+.+++.||||+....
T Consensus 291 t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 291 TAAEALAHPYFEEFHD 306 (343)
T ss_pred CHHHHhcCccHhhhcC
Confidence 9999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=282.68 Aligned_cols=206 Identities=23% Similarity=0.387 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
+++.+|+.++++++||||+++++++. ....|++|||+++++|.+++... ..+++..+..++.|++.||+|||++|++
T Consensus 46 ~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~ 124 (260)
T cd05070 46 ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124 (260)
T ss_pred HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 56889999999999999999999875 45689999999999999999753 3589999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||++++++.++|+|||++....... ........++..|+|||.+....+ +.++||||||+++|+|++ |..
T Consensus 125 H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~ 202 (260)
T cd05070 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred cCCCccceEEEeCCceEEeCCceeeeeccCcc-cccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999987543311 111112235567999999876665 489999999999999999 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+..+....+... ..+.+...+..+.+|+.+||.++|.+|||++++..
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 203 PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99887777766666543 34556668999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=284.77 Aligned_cols=223 Identities=29% Similarity=0.465 Sum_probs=180.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~l~~ 87 (400)
++-...-||+.+++.++||||+.+..++.+ +..+|+++||++. +|...|.-+ ..++...++.++.||+.|+.|
T Consensus 69 GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~Y 147 (438)
T KOG0666|consen 69 GISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHY 147 (438)
T ss_pred CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHH
Confidence 444566789999999999999999999877 8889999999987 898888643 358999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccC----CCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~----g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
||++-|+||||||.|||+..+ |.|||+|||+|+.+...-.. ......+-|.||+|||.+.+...++++.|||+.|
T Consensus 148 LH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 148 LHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIG 227 (438)
T ss_pred HhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHH
Confidence 999999999999999999887 89999999999988754322 2344556799999999999888778999999999
Q ss_pred HHHHHHHhCCCCCCCCch---------HHHHHhhhc--Ccc---------CCCCC-------------------------
Q 015814 163 VILFVLLAGYLPFDDSNL---------MNLYKKISA--AEF---------TCPPW------------------------- 197 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~---------~~~~~~i~~--~~~---------~~~~~------------------------- 197 (400)
||+.||+|-.+.|.+... .+...+|.. +.+ ..|.+
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 999999998888755321 122222211 000 11111
Q ss_pred -CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCc
Q 015814 198 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237 (400)
Q Consensus 198 -~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~~ 237 (400)
-++.+.+|+.+||+.||.+|+|+++.|+|+||..+..||.
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp~ 348 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPPL 348 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCCC
Confidence 2456899999999999999999999999999999876643
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.63 Aligned_cols=209 Identities=21% Similarity=0.362 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------------------
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---------------------------- 66 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~---------------------------- 66 (400)
.+.+.+|+.+|++++ ||||+++++++......|+|||||+||+|.++|...
T Consensus 84 ~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (400)
T cd05105 84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADEST 163 (400)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccc
Confidence 467899999999996 999999999999999999999999999999988542
Q ss_pred --------------------------------------------------------------------CCCCHHHHHHHH
Q 015814 67 --------------------------------------------------------------------GRMKEDEARRYF 78 (400)
Q Consensus 67 --------------------------------------------------------------------~~l~e~~~~~~~ 78 (400)
..+++..+..++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~ 243 (400)
T cd05105 164 RSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT 243 (400)
T ss_pred cchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHH
Confidence 236778889999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++||+||||||+|||++.++.+||+|||++................+++.|+|||++.+..+ +.++||
T Consensus 244 ~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 322 (400)
T cd05105 244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDV 322 (400)
T ss_pred HHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhH
Confidence 9999999999999999999999999999999999999999875433222112233457788999999987666 589999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchH-HHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||||++|+|++ |..||...... ..+..+..+ ....+..++.++.+++.+||+.||.+|||+.++.+
T Consensus 323 wSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 323 WSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 999999999997 99999876543 333333333 23445668999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=287.23 Aligned_cols=212 Identities=30% Similarity=0.486 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+|+.++++++|||++++++++... ...|+||||+++ +|.+.+... ..+++..+..++.|++.||+|||+.|
T Consensus 42 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ 120 (287)
T cd07840 42 PITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120 (287)
T ss_pred hHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46788999999999999999999999888 899999999985 898888765 57999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
++|+||||+||+++++|.+||+|||++........ .......++..|+|||.+.+....+.++||||+|+++|+|++|+
T Consensus 121 ~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~ 199 (287)
T cd07840 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199 (287)
T ss_pred ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876543221 12334567889999998876544468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCcc-----------------------CC-------CCC-CCHHHHHHHHHhcCCCCCCCCCHH
Q 015814 173 LPFDDSNLMNLYKKISAAEF-----------------------TC-------PPW-LSFTARKLIARILDPNPMTRITIP 221 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~-----------------------~~-------~~~-~s~~~~~li~~mL~~dP~~R~t~~ 221 (400)
.||...+.......+..... .. ... ++..+.++|++||..+|.+|||+.
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 279 (287)
T cd07840 200 PIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISAD 279 (287)
T ss_pred CCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99988776544443321100 00 011 388899999999999999999999
Q ss_pred HHhcCccc
Q 015814 222 EILEDEWF 229 (400)
Q Consensus 222 eil~h~~~ 229 (400)
++++||||
T Consensus 280 ~~l~~~~~ 287 (287)
T cd07840 280 QALQHEYF 287 (287)
T ss_pred HHhhCcCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=281.36 Aligned_cols=204 Identities=24% Similarity=0.435 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEE-EeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++++++||||+++++++ ..+...|++|||+++|+|.+++.... .+++..+..++.|++.||+|||++|
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 122 (256)
T cd05082 43 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 56788999999999999999999975 45567999999999999999997654 3789999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
++||||||+||+++.++.+||+|||++...... .....++..|+|||++....+ +.++||||+||++|+|++ |
T Consensus 123 i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g 196 (256)
T cd05082 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred EeccccchheEEEcCCCcEEecCCccceecccc-----CCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCC
Confidence 999999999999999999999999987643221 123345678999999987666 488999999999999998 9
Q ss_pred CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+.||...+.......+..+ ....++.++..+.+++.+||..+|.+|||+.++++
T Consensus 197 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 197 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999988777776666444 33445668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=287.44 Aligned_cols=210 Identities=20% Similarity=0.275 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLIN 83 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~ 83 (400)
...++.+|+.+++.++||||+++++++......|++|||+++|+|.+++.... .+++..+..++.|++.
T Consensus 62 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05095 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHH
Confidence 35688999999999999999999999999999999999999999999987643 3567789999999999
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
||+|||++|++||||||+||+++.++.++|+|||++................+++.|+|||+.....+ +.++|||||||
T Consensus 142 al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~ 220 (296)
T cd05095 142 GMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGV 220 (296)
T ss_pred HHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHH
Confidence 99999999999999999999999999999999999875432211111222345678999999877666 58999999999
Q ss_pred HHHHHHh--CCCCCCCCchHHHHHhhh--------cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 164 ILFVLLA--GYLPFDDSNLMNLYKKIS--------AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 164 il~ellt--G~~Pf~~~~~~~~~~~i~--------~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
++|+|++ |..||...+..+...... ....+.+..++..+.+|+.+||+.||.+|||+.+|.+
T Consensus 221 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 221 TLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999998 789998766554443221 1122345567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=287.75 Aligned_cols=209 Identities=20% Similarity=0.263 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC------------CCCHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------RMKEDEARRYFQQLIN 83 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~------------~l~e~~~~~~~~qll~ 83 (400)
...+.+|++++++++||||+++++++......|+||||+++++|.+++.... .+++..+..++.|++.
T Consensus 61 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 140 (295)
T cd05097 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIAS 140 (295)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999999999999986532 3678889999999999
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
||.|||++|++||||||+||++++++.+||+|||++................+++.|+|||++....+ +.++|||||||
T Consensus 141 al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~ 219 (295)
T cd05097 141 GMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGV 219 (295)
T ss_pred HHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHH
Confidence 99999999999999999999999999999999999865432211112223345778999999887666 58999999999
Q ss_pred HHHHHHh--CCCCCCCCchHHHHHhhhc--------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 164 ILFVLLA--GYLPFDDSNLMNLYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 164 il~ellt--G~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
++|+|++ |..||...+.......+.. .....++..+..+.+|+.+||+.||.+|||+++|++
T Consensus 220 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999988 7789987665554433211 112335557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=281.42 Aligned_cols=209 Identities=30% Similarity=0.500 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.+|+.+++.++||||+++++++.+....|+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~ 122 (256)
T cd08530 43 REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 45677899999999999999999999999999999999999999998866 35689999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|++||||+|+||+++.++.+||+|||++...... ......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|
T Consensus 123 ~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g 197 (256)
T cd08530 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATF 197 (256)
T ss_pred CcccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998765432 2334568999999999987766 4789999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 172 YLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
+.||...+.......+..+.+ ..+..++.++.+++.+||..+|.+|||+.++++||++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 198 APPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 999998887766666555443 3445688999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=282.64 Aligned_cols=207 Identities=31% Similarity=0.563 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..++.+|+.+++.++||||+++++++..+...+++|||++|++|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08229 46 RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125 (267)
T ss_pred HHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999998863 34689999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|++|+||||+||+++.++.++|+|||++...... .......+|++.|+|||.+.+..+. .++|+||+|+++|+|++|
T Consensus 126 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred CeecCCCCHHHEEEcCCCCEEECcchhhhccccC--CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998755432 1223445789999999999877664 889999999999999999
Q ss_pred CCCCCCCch--HHHHHhhhcCccC-C-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNL--MNLYKKISAAEFT-C-PPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||.+... ......+...... . +..++..+.++|.+||+.||.+|||+.+|++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 203 QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 999976543 2333444333222 2 2347889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.78 Aligned_cols=210 Identities=30% Similarity=0.526 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..++.+|+.+++.++||||+++++.+.+....++||||+++++|.+.+.. ...+++..+..++.|++.|+.|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 34677899999999999999999999999999999999999999988853 34689999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|++|+||||+||+++. +.++|+|||++..... .........|++.|+|||.+....+. .++|+||+|+++|+|++|
T Consensus 126 ~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~ 201 (260)
T cd08222 126 RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG--SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCL 201 (260)
T ss_pred CccccCCChhheEeec-CCEeecccCceeecCC--CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhC
Confidence 9999999999999975 6799999999865432 12223345689999999998776664 789999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
..||...+.......+..+. ...+..++.++.++|.+||..||.+||++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 202 AHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99998777666665554443 34455688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=304.41 Aligned_cols=209 Identities=33% Similarity=0.685 Sum_probs=185.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
-.+++.|+.||..+.||+||.+.-.+++...++.|||-+.| ++.+.|- ..+++++...++++.||+.||+|||-+||
T Consensus 607 esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knI 685 (888)
T KOG4236|consen 607 ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNI 685 (888)
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcce
Confidence 38899999999999999999999999999999999999976 7777663 45789999999999999999999999999
Q ss_pred eeccCCCCcEEEccC---CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 94 YHRDLKPENLLLDAY---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 94 vHrDlKP~NILl~~~---g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
+|.||||||||+.+. -++||||||+|++... .....+..|||.|+|||++..++|+ ..-|+||+|||+|.-|+
T Consensus 686 vHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLS 761 (888)
T KOG4236|consen 686 VHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLS 761 (888)
T ss_pred eeccCCchheeeccCCCCCceeeccccceeecch---hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEec
Confidence 999999999999764 4699999999998654 3445678999999999999999997 88999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCccCCC--CC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 171 GYLPFDDSNLMNLYKKISAAEFTCP--PW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|..||... +++...|.+..+-+| || +|..+.+||..+|+..-.+|.|++..+.|||++.
T Consensus 762 GTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 762 GTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 99999764 345556666665554 45 8999999999999999999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.95 Aligned_cols=220 Identities=23% Similarity=0.370 Sum_probs=191.6
Q ss_pred ccchhHHHhhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--------------
Q 015814 2 LFQDLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------- 67 (400)
Q Consensus 2 ~~~~~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-------------- 67 (400)
..|-|+...++ .+-++++||++.|..++|||||+|+|++..++.+|+|+|||..|||..++...+
T Consensus 520 AVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~ 598 (774)
T KOG1026|consen 520 AVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPP 598 (774)
T ss_pred hHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCC
Confidence 34566666655 457899999999999999999999999999999999999999999999997532
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh
Q 015814 68 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 147 (400)
Q Consensus 68 ~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~ 147 (400)
+++..+...++.||+.|+.||-++.+|||||-..|+|+.++-.|||+||||++..-.....+......-..+|||||.+.
T Consensus 599 ~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl 678 (774)
T KOG1026|consen 599 PLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL 678 (774)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh
Confidence 26778899999999999999999999999999999999999999999999997543322222221223356899999999
Q ss_pred cCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 148 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 148 ~~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
...|. +++||||+||+|||+++ |+.||.+.+.++....+..+. ..+|..+|.++.+|+..||+.+|.+||++.||
T Consensus 679 y~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 679 YGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 88885 99999999999999998 999999999999999888776 47888999999999999999999999999998
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=293.61 Aligned_cols=210 Identities=23% Similarity=0.411 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~ 78 (400)
.+++.+|+.+++++ +||||+++++++......|++|||+++|+|.+++.... .++...+..++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (334)
T cd05100 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA 140 (334)
T ss_pred HHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 57889999999999 89999999999999999999999999999999997532 36778889999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||.|||++|++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..+. .++||
T Consensus 141 ~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di 219 (334)
T cd05100 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDV 219 (334)
T ss_pred HHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhh
Confidence 99999999999999999999999999999999999999998754332111111223345679999999877664 88999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||||++|+|++ |..||.+.+..+.+..+.... ...+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 999999999998 899999888777777665443 34556688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=284.42 Aligned_cols=210 Identities=22% Similarity=0.365 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---------CCCHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAV 85 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~---------~l~e~~~~~~~~qll~~l 85 (400)
..+.+++|+.++++++||||+++++++......|+||||+++|+|.+++.... .+++..+..++.|++.||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 46789999999999999999999999999899999999999999999998765 689999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
+|||++||+||||||+||+++.++.++++|||++...... .........+++.|+|||.+.+..+ +.++||||+|+++
T Consensus 131 ~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l 208 (275)
T cd05046 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLM 208 (275)
T ss_pred HHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHH
Confidence 9999999999999999999999999999999987643221 1112233456778999999877665 4889999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcCcc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAAEF--TCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|+|++ |..||...........+..+.. ..+..++..+.+++.+||..+|.+|||+.+++.+
T Consensus 209 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 209 WEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 99998 8999987766666666554443 3345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=296.40 Aligned_cols=215 Identities=29% Similarity=0.490 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC--------------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK--------------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--------------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql 81 (400)
.+.+.+|+.++++++||||+++++++... ...|+||||+.+ +|.+.+.. +.+++..++.++.|+
T Consensus 46 ~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi 123 (342)
T cd07854 46 VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQL 123 (342)
T ss_pred HHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHH
Confidence 57788999999999999999999876543 358999999974 88887754 579999999999999
Q ss_pred HHHHHHHHHcCCeeccCCCCcEEEcc-CCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHH
Q 015814 82 INAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 159 (400)
Q Consensus 82 l~~l~~LH~~givHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw 159 (400)
++||.|||+.|++||||||+||+++. ++.+||+|||++........ ........|++.|+|||++......+.++|||
T Consensus 124 ~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 203 (342)
T cd07854 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 203 (342)
T ss_pred HHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHH
Confidence 99999999999999999999999985 56789999999875432111 11122346889999999886544456899999
Q ss_pred HHHHHHHHHHhCCCCCCCCchHHHHHhhhcC-------------------------cc-----CCCCCCCHHHHHHHHHh
Q 015814 160 SCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------------EF-----TCPPWLSFTARKLIARI 209 (400)
Q Consensus 160 SlGiil~elltG~~Pf~~~~~~~~~~~i~~~-------------------------~~-----~~~~~~s~~~~~li~~m 209 (400)
|+||++|+|++|+.||...+.......+... .. ...+.++.++.+||.+|
T Consensus 204 SlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 283 (342)
T cd07854 204 AAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQI 283 (342)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHH
Confidence 9999999999999999876544433322110 00 01234678899999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccC
Q 015814 210 LDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 210 L~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|+.||.+|||+.+++.||||+..
T Consensus 284 L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 284 LTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hCCCchhccCHHHHhCCCccccc
Confidence 99999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=281.29 Aligned_cols=207 Identities=24% Similarity=0.366 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.++++++|||++++++++. ....|++|||+.+|+|.+++.... .+++..+..++.|++.||+|||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i 123 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 356888999999999999999999875 456889999999999999997643 47899999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||++++++.++|+|||++....... ........++..|+|||.+.+..+ +.++||||+||++|+|++ |.
T Consensus 124 ~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~ 201 (260)
T cd05069 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGR 201 (260)
T ss_pred eecccCcceEEEcCCCeEEECCCccceEccCCc-ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987543211 111122345678999999876665 589999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+... ....+...+..+.+++++||.+||.+|||++++++
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 202 VPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999887776666665443 33445668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=291.28 Aligned_cols=212 Identities=25% Similarity=0.428 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeC--------CEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSK--------TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~--------~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~ 87 (400)
..+.+|+.++++++||||+++++++... ..+|+||||+.+ +|...+.. ...+++..+..++.|+++||+|
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~ 130 (311)
T cd07866 52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINY 130 (311)
T ss_pred hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999987433 357999999976 67777754 4479999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC---------CccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------GLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~---------~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
||++|++||||||+||++++++.++|+|||++......... .......|++.|+|||.+.+....+.++||
T Consensus 131 lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 210 (311)
T cd07866 131 LHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDI 210 (311)
T ss_pred HHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHh
Confidence 99999999999999999999999999999998754332111 111234678899999998765444688999
Q ss_pred HHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCcc-----------------------CCC-------CCCCHHHHHHHHH
Q 015814 159 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-----------------------TCP-------PWLSFTARKLIAR 208 (400)
Q Consensus 159 wSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------------~~~-------~~~s~~~~~li~~ 208 (400)
||+||++|+|++|+.||.+.+.......+..... ..+ ..++..+.++|.+
T Consensus 211 ~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 290 (311)
T cd07866 211 WGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK 290 (311)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHH
Confidence 9999999999999999988776655444321100 001 1245678899999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 015814 209 ILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 209 mL~~dP~~R~t~~eil~h~~~ 229 (400)
||+.||.+|||+.+++.||||
T Consensus 291 ~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 291 LLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HcccCcccCcCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=283.81 Aligned_cols=209 Identities=19% Similarity=0.235 Sum_probs=167.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-----~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
...+.+|+.++++++||||+++++++.+....|+||||+++|+|.+++.... ..++..++.++.|++.|++|||+
T Consensus 39 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 118 (269)
T cd05087 39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118 (269)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3578889999999999999999999999899999999999999999996532 35677888999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC------CCCChhhHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVI 164 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~------~~~~~~DIwSlGii 164 (400)
.|++||||||+||+++.++.+||+|||++................|++.|+|||++.... ..+.++||||+||+
T Consensus 119 ~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 198 (269)
T cd05087 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198 (269)
T ss_pred CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHH
Confidence 999999999999999999999999999986432211111122346788999999986432 12578999999999
Q ss_pred HHHHHh-CCCCCCCCchHHHHHh-hhcCcc--CCC---CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 165 LFVLLA-GYLPFDDSNLMNLYKK-ISAAEF--TCP---PWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 165 l~ellt-G~~Pf~~~~~~~~~~~-i~~~~~--~~~---~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|+|++ |..||...+..+.... +..... ..| ...+..+.++++.|+ .+|.+|||+++|+.
T Consensus 199 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 199 IWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 999996 9999987665554333 222212 111 236788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=279.48 Aligned_cols=209 Identities=26% Similarity=0.393 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|++++++++||||+++++++.+....|+||||+.|++|.+++... ..++...+..++.|++.||+|||++|++
T Consensus 36 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~ 115 (251)
T cd05041 36 KRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115 (251)
T ss_pred HHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 568899999999999999999999999999999999999999999999663 4689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+||+|||++................++..|+|||.+.+..+ +.++||||+||++|+|++ |..
T Consensus 116 h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~ 194 (251)
T cd05041 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDT 194 (251)
T ss_pred hhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCC
Confidence 999999999999999999999999865432111111112234567999999877665 589999999999999999 899
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||...........+... ....|...+..+.+++.+||..+|.+|||+.++++
T Consensus 195 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 195 PYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99887766666655443 33455568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=288.30 Aligned_cols=211 Identities=26% Similarity=0.400 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+.+|+.+++.++|||++++++++.+....|+||||+.| +|.+.+.. ...+++..+..++.|++.|+.|||++|+
T Consensus 64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi 142 (313)
T cd06633 64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142 (313)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 356788999999999999999999999999999999999965 78887765 4468999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHHHHhC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~elltG 171 (400)
+||||+|+||+++.++.+||+|||++.... ......|+..|+|||++.. .+..+.++||||+||++|+|++|
T Consensus 143 ~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 143 IHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ecCCCChhhEEECCCCCEEEeecCCCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999875322 1234578999999999842 23335789999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCcc-C-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 172 YLPFDDSNLMNLYKKISAAEF-T-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
..||...+.......+..... . ..+.++..+.+|+.+||+.+|.+|||+.+++.||||...
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999988765554444433222 1 123467889999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=289.34 Aligned_cols=212 Identities=27% Similarity=0.489 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC----------EEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT----------KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINA 84 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----------~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~ 84 (400)
...+.+|+.++++++||||+++++++.+.. .+|+|+||+++ ++.+.+... ..++++.+..++.|++.|
T Consensus 50 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~a 128 (302)
T cd07864 50 PITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG 128 (302)
T ss_pred hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence 356788999999999999999999987654 79999999987 777777653 468999999999999999
Q ss_pred HHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 85 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 85 l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
|.|||+.||+||||||+||++++++.+||+|||++........ .......+++.|+|||.+.+....+.++||||+||+
T Consensus 129 L~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 207 (302)
T cd07864 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 207 (302)
T ss_pred HHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHH
Confidence 9999999999999999999999999999999999876543211 122233568889999998765444689999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCc--c----------------------------CCCCCCCHHHHHHHHHhcCCCC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAE--F----------------------------TCPPWLSFTARKLIARILDPNP 214 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~--~----------------------------~~~~~~s~~~~~li~~mL~~dP 214 (400)
+|+|++|+.||...+.......+.... . .....++..+.++|.+||..||
T Consensus 208 ~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 287 (302)
T cd07864 208 LGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDP 287 (302)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCCh
Confidence 999999999998766554443322110 0 0011368899999999999999
Q ss_pred CCCCCHHHHhcCccc
Q 015814 215 MTRITIPEILEDEWF 229 (400)
Q Consensus 215 ~~R~t~~eil~h~~~ 229 (400)
.+|||+.+++.||||
T Consensus 288 ~~Rp~~~~il~~~~~ 302 (302)
T cd07864 288 SKRCTAEEALNSPWL 302 (302)
T ss_pred hhCCCHHHHhcCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=293.54 Aligned_cols=218 Identities=26% Similarity=0.386 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
.+++.+|+.+++++ +||||+++++.... ...+|+++||+. ++|.+.+.....+++..++.++.|++.||+|||+
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 123 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS 123 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 56788899999999 59999999987532 245889999986 5899999888889999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
+|++||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+....+.++||||+||++|+|
T Consensus 124 ~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l 203 (332)
T cd07857 124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203 (332)
T ss_pred CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999875432211 11223457899999999886543335899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcC----------------------------ccC---CCCCCCHHHHHHHHHhcCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAA----------------------------EFT---CPPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~----------------------------~~~---~~~~~s~~~~~li~~mL~~dP~~R 217 (400)
++|..||...+.......+... ... ..+..+..+.+|+.+||+.||.+|
T Consensus 204 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 283 (332)
T cd07857 204 LGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283 (332)
T ss_pred HhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccC
Confidence 9999999876543322211100 000 112357899999999999999999
Q ss_pred CCHHHHhcCcccccCCC
Q 015814 218 ITIPEILEDEWFKKDYK 234 (400)
Q Consensus 218 ~t~~eil~h~~~~~~~~ 234 (400)
||+.+++.|||++....
T Consensus 284 ~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 284 ISVEEALEHPYLAIWHD 300 (332)
T ss_pred CCHHHHhcChhhhhhcC
Confidence 99999999999986644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=286.76 Aligned_cols=213 Identities=22% Similarity=0.343 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHH---HH--hCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK---IV--NHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~---i~--~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+.+|+.++.++. ||||+++++++..+...+++|||+.+ ++.+. +. ..+.+++..+..++.|++.||+|||
T Consensus 46 ~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh 124 (288)
T cd06616 46 QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124 (288)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 567889999999996 99999999999999999999999875 54443 22 2357999999999999999999999
Q ss_pred Hc-CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC--CCCCChhhHHHHHHHHH
Q 015814 90 SR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILF 166 (400)
Q Consensus 90 ~~-givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGiil~ 166 (400)
+. |++||||||+||+++.++.+||+|||++..... ........|++.|+|||++... ...+.++||||+||++|
T Consensus 125 ~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 201 (288)
T cd06616 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201 (288)
T ss_pred hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHH
Confidence 85 999999999999999999999999999865432 1122344689999999999765 23458999999999999
Q ss_pred HHHhCCCCCCCCch-HHHHHhhhcCc-cCC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 167 VLLAGYLPFDDSNL-MNLYKKISAAE-FTC----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 167 elltG~~Pf~~~~~-~~~~~~i~~~~-~~~----~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|++|+.||..... ......+..+. ... +..++.++.+||.+||+.||.+|||+++++.||||+..
T Consensus 202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 202 EVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 99999999976542 12222222221 111 22378899999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=285.71 Aligned_cols=212 Identities=25% Similarity=0.454 Sum_probs=171.1
Q ss_pred HHHHHHHHH-HHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 17 LQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 17 ~~i~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.++..|+.+ ++.++||||+++++++...+..|++|||++| +|.+.+.. ...+++..+..++.|++.||+|||++
T Consensus 44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (283)
T cd06617 44 KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122 (283)
T ss_pred HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 455566665 6667999999999999999999999999974 77776643 34689999999999999999999998
Q ss_pred -CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----CCCCCChhhHHHHHHHHH
Q 015814 92 -GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILF 166 (400)
Q Consensus 92 -givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGiil~ 166 (400)
+++||||||+||+++.++.+||+|||++...... .......|+..|+|||++.+ .++ +.++|+||+||++|
T Consensus 123 ~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~ 198 (283)
T cd06617 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMI 198 (283)
T ss_pred CCeecCCCCHHHEEECCCCCEEEeecccccccccc---cccccccCCccccChhhcCCccccccc-CccccchhhHHHHH
Confidence 9999999999999999999999999998754321 11233568999999998864 233 57899999999999
Q ss_pred HHHhCCCCCCCCc-h-HHHHHhhhcCccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 167 VLLAGYLPFDDSN-L-MNLYKKISAAEFTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 167 elltG~~Pf~~~~-~-~~~~~~i~~~~~~~~-~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
+|++|+.||.... . ......+.......| ..+|.++.++|.+||..+|.+|||++++++||||....
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 199 ELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999997532 2 222222222233333 34789999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=277.39 Aligned_cols=221 Identities=26% Similarity=0.420 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEe--------CCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGS--------KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINA 84 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--------~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~ 84 (400)
+......+|+.+|..|+|+|++++++++.+ ...+|+||++|+. +|+..+... .+++...++.+++++++|
T Consensus 58 GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~G 136 (376)
T KOG0669|consen 58 GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNG 136 (376)
T ss_pred CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHH
Confidence 344556789999999999999999988743 3459999999987 899998775 689999999999999999
Q ss_pred HHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 85 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 85 l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
|.|+|...|+|||+||+|+|++.+|.+||+|||+++.+..... ....+.+.-|.+|++||.+.+..-++++.|||..|
T Consensus 137 L~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 137 LYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred HHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 9999999999999999999999999999999999976654322 12244566799999999999877778999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHhhhcCc--cC--------------------CCC-------------CCCHHHHHHHH
Q 015814 163 VILFVLLAGYLPFDDSNLMNLYKKISAAE--FT--------------------CPP-------------WLSFTARKLIA 207 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~~~~~~~i~~~~--~~--------------------~~~-------------~~s~~~~~li~ 207 (400)
||+.||.+|.+-+++.+.......|.... .+ .|. --++++.+|+.
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 99999999999999888776655543211 10 010 01457899999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 208 RILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 208 ~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
+||..||.+|++++++++|.||.++..|
T Consensus 297 ~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 297 KLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred HHhccCcccCcchHhhhchhhhhcCCcc
Confidence 9999999999999999999999987665
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=281.59 Aligned_cols=209 Identities=22% Similarity=0.368 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++||||+++++++.+....|+||||++||+|.+++... +.++...+..++.|++.|++|||++|++
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 128 (267)
T cd05066 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128 (267)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 568899999999999999999999999999999999999999999999764 4689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCC-ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..+ +.++|+||+||++|++++ |.
T Consensus 129 h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred ehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCC
Confidence 99999999999999999999999987654321111 0111223568999999987666 589999999999999886 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+..+. .+.+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 208 RPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 9998877766666655442 3334457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.50 Aligned_cols=208 Identities=23% Similarity=0.386 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++||||+++++++.+ ...++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++
T Consensus 53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~ 131 (279)
T cd05057 53 NKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLV 131 (279)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 5778899999999999999999999887 7889999999999999999774 4689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+||+|||++................++..|+|||.+....+. .++||||+||++|++++ |..
T Consensus 132 H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~ 210 (279)
T cd05057 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred ecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999998765422111111122345789999999766664 88999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+....+....+..+. .+.|...+..+.+++.+||..||.+|||+.++++
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 211 PYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999988777777665543 4556668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=278.19 Aligned_cols=209 Identities=26% Similarity=0.415 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+.+|+.+++.++||||+++++++.+.+..|++|||++|++|.+.+..... +++..+..++.|++.||+|||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 367899999999999999999999999999999999999999999999976554 999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
++||||||+||++++++.++|+|||++........... ....+++.|+|||.+....+ +.++||||+||++|+|++ |
T Consensus 124 ~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g 201 (258)
T smart00219 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLG 201 (258)
T ss_pred eeecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876543211111 11236789999999966555 589999999999999998 8
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||...+.......+.... ...+...+.++.+++.+||..||.+|||+.++++
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 202 ESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99998877777777665443 3455668999999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=281.69 Aligned_cols=210 Identities=22% Similarity=0.357 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...++..|+.+++.++||||+++++++.++...++||||+++|+|.+++... +.+++..+..++.|++.||+|||++|+
T Consensus 48 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~ 127 (269)
T cd05065 48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127 (269)
T ss_pred HHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 3578999999999999999999999999999999999999999999998763 468999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCcccccc---CCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC---GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~---gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
+||||||+||+++.++.+||+|||++................ ++..|+|||.+....+ +.++||||+||++||+++
T Consensus 128 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~ 206 (269)
T cd05065 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMS 206 (269)
T ss_pred eecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhc
Confidence 999999999999999999999999987543322111111112 2457999999987776 489999999999999886
Q ss_pred -CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 -GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 -G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|..||...+..+....+... ..+.++.++..+.+++.+||..+|.+||++.+++.
T Consensus 207 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 207 YGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999887777666665433 23445567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=279.00 Aligned_cols=208 Identities=25% Similarity=0.410 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.++.+|++++++++||||+++++++......|+||||++||+|.+++... +.+++..+..++.|++.|++|||+.|++|
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h 123 (256)
T cd05112 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 56889999999999999999999999999999999999999999999764 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~P 174 (400)
|||||+||+++.++.+||+|||++....... ........++..|+|||.+.+..+ +.++||||+||++|+|++ |..|
T Consensus 124 ~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p 201 (256)
T cd05112 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTP 201 (256)
T ss_pred cccccceEEEcCCCeEEECCCcceeecccCc-ccccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999986543211 111112235678999999987666 488999999999999998 9999
Q ss_pred CCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 175 FDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|...........+..+. ...|...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 202 YENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99887777777665442 33455578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=282.58 Aligned_cols=209 Identities=16% Similarity=0.229 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+.+.+|+.+++.++||||+++++.+......|+||||+++|+|.+++... ...++..+..++.|++.||+|||++
T Consensus 39 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 118 (268)
T cd05086 39 QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118 (268)
T ss_pred HHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 578899999999999999999999999999999999999999999999764 2356778889999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC------CCCChhhHHHHHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVIL 165 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~------~~~~~~DIwSlGiil 165 (400)
|++||||||+|||++.++.+||+|||++...............+|++.|+|||++.... ..+.++||||+||++
T Consensus 119 ~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 198 (268)
T cd05086 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTL 198 (268)
T ss_pred CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHH
Confidence 99999999999999999999999999875322111111123457899999999985321 124789999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcCc------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAAE------FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|+|++ |..||...+..+.+..+.... ...+..++..+.+++..|| .+|.+|||++++++
T Consensus 199 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 199 WELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 99997 688998777666555432221 1223347888999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=294.84 Aligned_cols=214 Identities=27% Similarity=0.412 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
.+.+.+|+.++++++||||+++++++... ...|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||
T Consensus 60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH 137 (345)
T cd07877 60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH 137 (345)
T ss_pred HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 46788899999999999999999988643 3478888887 7799877755 56999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++||+||||||+||+++++|.+||+|||++..... ......|++.|+|||++.+....+.++||||+||++|+|+
T Consensus 138 ~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred HCCeeecCCChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999999865322 2234578999999999876444468899999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCc-----------------------cCC--------CCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAE-----------------------FTC--------PPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~-----------------------~~~--------~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
+|+.||...+.......+.... ... ....+.++.+||.+||+.||.+||
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 9999997765443332221100 000 012578899999999999999999
Q ss_pred CHHHHhcCcccccCCCCC
Q 015814 219 TIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 219 t~~eil~h~~~~~~~~~~ 236 (400)
|+.+++.||||++...+.
T Consensus 293 t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 293 TAAQALAHAYFAQYHDPD 310 (345)
T ss_pred CHHHHhcChhhhhcCCCC
Confidence 999999999999755443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=279.74 Aligned_cols=207 Identities=31% Similarity=0.574 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+.+.+|+.++++++|+||+++++.+......++||||++||+|.+++.. ...+++..+..++.|++.||.|||+.
T Consensus 46 ~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 125 (267)
T cd08224 46 RQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125 (267)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 57889999999999999999999999999999999999999999998864 34589999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|++||||+|+||+++.+|.++|+|||++...... ........|++.|+|||.+.+..+. .++||||+||++|+|++|
T Consensus 126 ~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g 202 (267)
T cd08224 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred CEecCCcChhhEEECCCCcEEEeccceeeeccCC--CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHC
Confidence 9999999999999999999999999998754332 1223345789999999999877764 889999999999999999
Q ss_pred CCCCCCCc--hHHHHHhhhcCcc-CCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSN--LMNLYKKISAAEF-TCPP-WLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+.||.... .......+..+.. +.|. .++.++.++|.+||..+|.+|||+.+|++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 203 QSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99996543 2344444433332 2333 57889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=263.96 Aligned_cols=219 Identities=32% Similarity=0.498 Sum_probs=185.3
Q ss_pred hHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 11 DAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 11 ~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
+++++.....+||.+++.++|.|||+++++..++..+.+|+|||.. +|..+... ++.++.+.++.++.|++.||.+||
T Consensus 40 ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch 118 (292)
T KOG0662|consen 40 DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH 118 (292)
T ss_pred CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh
Confidence 4456677889999999999999999999999999999999999976 78777755 467999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++++.|||+||.|+|++.+|.+|++|||+|+-++.. -+-.....-|.+|++|.++.+...+++..|+||.|||+.|+.
T Consensus 119 shnvlhrdlkpqnllin~ngelkladfglarafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaela 196 (292)
T KOG0662|consen 119 SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_pred hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHh
Confidence 999999999999999999999999999999876542 112233457999999999998777779999999999999998
Q ss_pred h-CCCCCCCCchHHHHHhhhcC--cc------------------CCC---------CCCCHHHHHHHHHhcCCCCCCCCC
Q 015814 170 A-GYLPFDDSNLMNLYKKISAA--EF------------------TCP---------PWLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 170 t-G~~Pf~~~~~~~~~~~i~~~--~~------------------~~~---------~~~s~~~~~li~~mL~~dP~~R~t 219 (400)
. |++.|++.+..++..+|... .+ .+| |.++..-++|++++|.-+|.+|++
T Consensus 197 nagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris 276 (292)
T KOG0662|consen 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS 276 (292)
T ss_pred hcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC
Confidence 5 89999999988777765321 00 011 123456789999999999999999
Q ss_pred HHHHhcCcccccC
Q 015814 220 IPEILEDEWFKKD 232 (400)
Q Consensus 220 ~~eil~h~~~~~~ 232 (400)
+++.++||||...
T Consensus 277 aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 277 AEAALQHPYFSDF 289 (292)
T ss_pred HHHHhcCcccccc
Confidence 9999999999864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=280.38 Aligned_cols=207 Identities=23% Similarity=0.380 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++++|+.++++++||||+++++++. ....|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i 123 (262)
T cd05071 45 PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123 (262)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 357899999999999999999999874 45689999999999999999753 358899999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||++++++.++|+|||++....... ........++..|+|||++.+..+ +.++||||+||++|+|++ |.
T Consensus 124 ~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~ 201 (262)
T cd05071 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGR 201 (262)
T ss_pred cccccCcccEEEcCCCcEEeccCCceeeccccc-cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999987543221 111123346778999999887666 589999999999999999 89
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.........+... ....+..++..+.+++.+||+.||.+|||++++++
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 202 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 999887776666665443 23445568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=278.82 Aligned_cols=209 Identities=24% Similarity=0.350 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEE-eCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMG-SKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.+++.++||||+++++++. .++..|++|||+.+|+|.+++.... ..+...+..++.|++.||+|||+.|+
T Consensus 40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 119 (262)
T cd05058 40 VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119 (262)
T ss_pred HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 578889999999999999999999765 4566899999999999999997643 46777888999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA- 170 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt- 170 (400)
+||||||+|||+++++.+||+|||++........ ........+++.|+|||.+....+ +.++|||||||++|+|++
T Consensus 120 ~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~ 198 (262)
T cd05058 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTR 198 (262)
T ss_pred cccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999864332110 111123346778999999987666 489999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|.+||...+..+....+..+. ...+..++..+.+++.+||..+|++||++.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 199 GAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 577787776666665554443 3345557899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=279.54 Aligned_cols=202 Identities=21% Similarity=0.262 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++||||+++++++.. ...|+||||+++|+|.+++...+ .++...+..++.|++.||+|||++||+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 123 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV 123 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 5778899999999999999999999887 77899999999999999998766 789999999999999999999999999
Q ss_pred eccCCCCcEEEccCC-------CeeeeccccccccccccCCCccccccCCCCCCCChhhhcC-CCCCChhhHHHHHHHHH
Q 015814 95 HRDLKPENLLLDAYG-------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILF 166 (400)
Q Consensus 95 HrDlKP~NILl~~~g-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGiil~ 166 (400)
||||||+||+++.++ .+||+|||++..... .....++..|+|||++... ...+.++||||+||++|
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~ 197 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLL 197 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHH
Confidence 999999999999887 799999999875432 1234577889999999765 23468899999999999
Q ss_pred HHHh-CCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 167 VLLA-GYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 167 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|++ |..||...+.......... ....+...+..+.++|.+||+.+|.+|||+.++++
T Consensus 198 ~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 198 EICSNGEEPLSTLSSSEKERFYQD-QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHhCCCCCcccCCchhHHHHHhc-CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999 6888877654433333221 11222223488999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=279.66 Aligned_cols=208 Identities=24% Similarity=0.384 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++.+|+.++++++||||+++++++......|+||||+++++|.+++.... .++...+..++.|++.|+.|||++|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i 124 (261)
T cd05034 45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY 124 (261)
T ss_pred HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4678999999999999999999999999899999999999999999997643 68999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+|+||||+||++++++.+||+|||++....... ........++..|+|||.+.+..+ +.++||||+||++|+|++ |+
T Consensus 125 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~ 202 (261)
T cd05034 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred ccCCcchheEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987544211 011112234578999999987665 589999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+.......+..+ ....|...+.++.+++.+||..+|.+|||++++.+
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 203 VPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999887777666666544 23445567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=279.45 Aligned_cols=209 Identities=22% Similarity=0.353 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|++++++++||||+++++++......|+||||+++|+|.+++... +.+++..+..++.|++.|++|||+.|++
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~ 129 (268)
T cd05063 50 RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129 (268)
T ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 567889999999999999999999999999999999999999999998763 5789999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCcc-ccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL-HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+||+++.++.+||+|||++............ ....+++.|+|||++....+ +.++||||+||++|+|++ |.
T Consensus 130 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~ 208 (268)
T cd05063 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGE 208 (268)
T ss_pred ccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998755432111111 11123457999999987666 489999999999999997 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||...+.......+..+. .+.+..++.++.+++.+||..+|.+||++.++++
T Consensus 209 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 209 RPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9998877777776665442 2333447899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=286.78 Aligned_cols=213 Identities=26% Similarity=0.386 Sum_probs=179.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
....++.+|+.+++.++|||++++++++......|+||||+.| +|.+.+.. ...+++..+..++.|++.|+.|||++|
T Consensus 67 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 145 (317)
T cd06635 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145 (317)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3467899999999999999999999999999999999999975 78777754 456899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHHHHh
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~ellt 170 (400)
|+||||+|+||+++.++.+||+|||++..... .....|++.|+|||.+.. .+..+.++||||+||++|+|++
T Consensus 146 i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~ 219 (317)
T cd06635 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 219 (317)
T ss_pred cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999998764322 234578999999999842 2334588999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCcc-CC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 171 GYLPFDDSNLMNLYKKISAAEF-TC-PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
|..||...+.......+..... .. +..++..+.++|.+||+.+|.+|||+.++++|+|+....
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 220 RKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 9999987766555554443322 22 234788999999999999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=283.96 Aligned_cols=212 Identities=31% Similarity=0.512 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.++++++||||+++++++.+....|+||||+.+ +|.+.+... ..+++..+..++.|++.||+|||++|+
T Consensus 41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (282)
T cd07829 41 IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119 (282)
T ss_pred ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 356778899999999999999999999999999999999985 899999876 579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|+||++++++.++|+|||++...... ........++..|+|||.+......+.++||||+||++|+|++|..
T Consensus 120 ~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 197 (282)
T cd07829 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197 (282)
T ss_pred ccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765432 1122344568889999999766444688999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC------------------ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 174 PFDDSNLMNLYKKISAA------------------EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~------------------~~~~~-----------~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
||...+....+.++... ...++ +.++..+.++|++||..||.+||++.+++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 198 LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred CCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 99887655444332110 00011 12477899999999999999999999999
Q ss_pred cCccc
Q 015814 225 EDEWF 229 (400)
Q Consensus 225 ~h~~~ 229 (400)
.||||
T Consensus 278 ~~p~~ 282 (282)
T cd07829 278 KHPYF 282 (282)
T ss_pred hCcCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=283.10 Aligned_cols=208 Identities=22% Similarity=0.336 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.++++++||||+++++++.. ....|++|||+++|+|.+++.. ..+++..+..++.|++.||.|||++||
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i 128 (283)
T cd05080 50 TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHY 128 (283)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4678889999999999999999998765 3468999999999999999976 469999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+||||||+||++++++.+||+|||++......... .......++..|+|||.+....+ +.++||||+||++|+|++|.
T Consensus 129 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred eccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCC
Confidence 99999999999999999999999998765432111 11122345677999999987666 48999999999999999999
Q ss_pred CCCCCCchH--HHH-------------Hhhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLM--NLY-------------KKIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~--~~~-------------~~i~-~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||...... +.. .... ....+.|..++.++.+++.+||+.+|++|||++++++
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 998653311 111 0010 1112345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=285.95 Aligned_cols=210 Identities=25% Similarity=0.380 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..++.+|+++++.++|||++++++++......|+||||+. |+|.+.+.. ...+++..+..++.|++.|+.|||++|++
T Consensus 59 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~ 137 (308)
T cd06634 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137 (308)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5678899999999999999999999999999999999997 578777754 44689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||||+||+++.++.++|+|||++..... .....|++.|+|||.+.. ....+.++|||||||++|+|++|.
T Consensus 138 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 211 (308)
T cd06634 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (308)
T ss_pred cCCCCHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence 999999999999999999999998765332 123568999999999853 222357899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCcc-CC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAEF-TC-PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.||...+.......+..... .. +..++..+.+||++||..+|.+|||++++++|||+...
T Consensus 212 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 212 PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred CCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99977655444333333322 22 33478899999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=281.42 Aligned_cols=210 Identities=19% Similarity=0.287 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhC--------CCCCHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~~l 85 (400)
....+.+|+.++++++||||+++++++.. +...++++||+++|+|.+++... ..+++..+..++.|++.||
T Consensus 51 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 130 (280)
T cd05043 51 QVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130 (280)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence 36778899999999999999999998765 57789999999999999998653 3588999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
+|||++|++||||||+||++++++.+||+|||+++...............++..|+|||++.+..+ +.++||||+||++
T Consensus 131 ~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l 209 (280)
T cd05043 131 SYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLL 209 (280)
T ss_pred HHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHH
Confidence 999999999999999999999999999999999875432111111122345678999999987666 4889999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|++++ |+.||...+..+....+..+. ...+..+++++.+++.+||..||++|||+.++++
T Consensus 210 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 210 WELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999 999998877777666655442 2344567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=279.54 Aligned_cols=207 Identities=25% Similarity=0.381 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.+++.++||||+++++++.+ ...|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.|++
T Consensus 51 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 129 (270)
T cd05056 51 REKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV 129 (270)
T ss_pred HHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 5678999999999999999999998875 45789999999999999997644 589999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+||+|||++........ .......+++.|+|||.+....+ +.++|||||||++|++++ |..
T Consensus 130 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~ 207 (270)
T cd05056 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVK 207 (270)
T ss_pred ccccChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999865433211 11112234568999999877666 488999999999999986 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+..+....+..+ ....|+.++..+.+++.+||..+|.+|||+.+++.
T Consensus 208 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 208 PFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99888776666665544 34556678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=283.27 Aligned_cols=209 Identities=31% Similarity=0.480 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHhC---CCCCcceeeEEEEeCCE-----EEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV---KHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l---~HpnIv~l~~~~~~~~~-----~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l 85 (400)
...+.+|+.+++++ +||||+++++++..... +|++|||+.+ +|.+++.... .+++..+..++.|++.||
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al 120 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGV 120 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence 45566788887766 59999999999987776 9999999985 8998887643 589999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
.|||+.|++|+||+|+||+++.++.+||+|||++...... .......+++.|+|||++.+..+ +.++||||+||++
T Consensus 121 ~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l 196 (287)
T cd07838 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIF 196 (287)
T ss_pred HHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC---cccccccccccccChHHhccCCC-CCcchhhhHHHHH
Confidence 9999999999999999999999999999999998765332 22234468899999999987665 4889999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHhhhcCc-----c----------------------CCCCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 166 FVLLAGYLPFDDSNLMNLYKKISAAE-----F----------------------TCPPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 166 ~elltG~~Pf~~~~~~~~~~~i~~~~-----~----------------------~~~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
|+|++|..||.+.+..+...++.... . ...+.++..+.++|.+||+.||.+||
T Consensus 197 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 99999999998877665554432110 0 00012457789999999999999999
Q ss_pred CHHHHhcCccc
Q 015814 219 TIPEILEDEWF 229 (400)
Q Consensus 219 t~~eil~h~~~ 229 (400)
++++++.||||
T Consensus 277 ~~~~il~~~~~ 287 (287)
T cd07838 277 SAFEALQHPYF 287 (287)
T ss_pred CHHHHhcCcCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=283.79 Aligned_cols=213 Identities=29% Similarity=0.507 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+..+|...+..++|+||++++.+|... ..+|+||||+.. +|...+. -.++-..+..++.|++.|++|||
T Consensus 59 akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lh 135 (369)
T KOG0665|consen 59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLH 135 (369)
T ss_pred chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHH
Confidence 57788999999999999999999998643 458999999986 8877776 34677899999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
+.||+||||||+||++..++.+||.|||+|+.... .-..+....|..|.|||++.+.+|. +.+||||+||++.||+
T Consensus 136 s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 136 SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELI 211 (369)
T ss_pred hcceeecccCcccceecchhheeeccchhhcccCc---ccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHh
Confidence 99999999999999999999999999999875332 2345667889999999999999874 9999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCc---------------------------cC----CCCC-----------CCHHHHHHHH
Q 015814 170 AGYLPFDDSNLMNLYKKISAAE---------------------------FT----CPPW-----------LSFTARKLIA 207 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~---------------------------~~----~~~~-----------~s~~~~~li~ 207 (400)
+|..-|.+.+.-+.+.++...- .. +|.. -+..+++|+.
T Consensus 212 ~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~ 291 (369)
T KOG0665|consen 212 LGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLS 291 (369)
T ss_pred hceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHH
Confidence 9999999888777666542110 01 1111 1345899999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 208 RILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 208 ~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
+||..||++|+|++++|+|||++-++.+
T Consensus 292 ~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 292 KMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred HhhccChhhcccHHHHhcCCeeeeeccc
Confidence 9999999999999999999999865543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=292.58 Aligned_cols=210 Identities=28% Similarity=0.432 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+.+|+.+++.++||||+++++++... ..+|+||||+.+ +|...+ ...++++.+..++.|++.||+|||
T Consensus 58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH 134 (342)
T cd07879 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIH 134 (342)
T ss_pred hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 46688999999999999999999998654 357999999975 776655 346899999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++|++||||||+||+++.+|.+||+|||++..... ......||+.|+|||++.+....+.++||||+||++|+|+
T Consensus 135 ~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999864321 1234568899999999876444468999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCc-----------------------cCC--------CCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAE-----------------------FTC--------PPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~-----------------------~~~--------~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
+|+.||.+.+....+..+.... ..+ .+..+..+.+||.+||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 9999998876544433322100 000 123577899999999999999999
Q ss_pred CHHHHhcCcccccCC
Q 015814 219 TIPEILEDEWFKKDY 233 (400)
Q Consensus 219 t~~eil~h~~~~~~~ 233 (400)
|+++++.||||....
T Consensus 290 ~~~e~l~h~~f~~~~ 304 (342)
T cd07879 290 TATEALEHPYFDSFR 304 (342)
T ss_pred CHHHHhcCcchhhcc
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=296.26 Aligned_cols=210 Identities=20% Similarity=0.327 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---------------------------
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--------------------------- 67 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--------------------------- 67 (400)
.+.+.+|+.+|.++. ||||+++++++...+..|+||||+++|+|.+++...+
T Consensus 84 ~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (401)
T cd05107 84 KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ 163 (401)
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence 457889999999997 9999999999999999999999999999999996532
Q ss_pred -----------------------------------------------------------------------CCCHHHHHH
Q 015814 68 -----------------------------------------------------------------------RMKEDEARR 76 (400)
Q Consensus 68 -----------------------------------------------------------------------~l~e~~~~~ 76 (400)
.++...+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 243 (401)
T cd05107 164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG 243 (401)
T ss_pred cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence 256667888
Q ss_pred HHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChh
Q 015814 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 156 (400)
Q Consensus 77 ~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~ 156 (400)
++.|++.||+|||+.|++||||||+|||+++++.+||+|||+++...............|++.|+|||.+....+ +.++
T Consensus 244 ~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~ 322 (401)
T cd05107 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLS 322 (401)
T ss_pred HHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHh
Confidence 999999999999999999999999999999999999999999875432211111233467889999999987666 5899
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCchHHH-HHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 157 DLWSCGVILFVLLA-GYLPFDDSNLMNL-YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 157 DIwSlGiil~ellt-G~~Pf~~~~~~~~-~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||||||++|||++ |..||......+. ...+..+ ....|..++.++.+++.+||..+|.+||++++|++.
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999998 8999987655443 3333333 234566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=282.87 Aligned_cols=208 Identities=30% Similarity=0.461 Sum_probs=173.9
Q ss_pred HHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 18 QIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 18 ~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+|+..+++++ ||||+++++++..+...|+||||+ +|+|.+.+.... .+++..+..++.|++.||.|||++|++
T Consensus 43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~ 121 (283)
T cd07830 43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF 121 (283)
T ss_pred HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3457999999998 999999999999999999999999 779999987764 789999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|+||+|+||++++++.++|+|||++...... .......|+..|+|||++......+.++|+||+|+++|+|++|+.|
T Consensus 122 H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~ 198 (283)
T cd07830 122 HRDLKPENLLVSGPEVVKIADFGLAREIRSR---PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL 198 (283)
T ss_pred cCCCChhhEEEcCCCCEEEeecccceeccCC---CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence 9999999999999999999999998754321 2223456889999999986544446889999999999999999999
Q ss_pred CCCCchHHHHHhhhcCc-------------------cC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 175 FDDSNLMNLYKKISAAE-------------------FT-----------CPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~-------------------~~-----------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
|...+..+.+.++.... .. ..+..+..+.++|++||+.||.+|||++|++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 278 (283)
T cd07830 199 FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278 (283)
T ss_pred cCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 98776655443322100 00 0112367899999999999999999999999
Q ss_pred cCccc
Q 015814 225 EDEWF 229 (400)
Q Consensus 225 ~h~~~ 229 (400)
.||||
T Consensus 279 ~~~~~ 283 (283)
T cd07830 279 QHPYF 283 (283)
T ss_pred hCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=277.24 Aligned_cols=207 Identities=22% Similarity=0.362 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..++.+|+.++++++||||+++++++. ....|++|||+.+|+|.+++... ..+++..+..++.|++.||+|||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i 123 (260)
T cd05067 45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123 (260)
T ss_pred HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 467889999999999999999999874 46689999999999999998653 368999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||+++.++.++|+|||++....... ........++..|+|||++....+ +.++||||+|+++|++++ |+
T Consensus 124 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~ 201 (260)
T cd05067 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGR 201 (260)
T ss_pred ecccccHHhEEEcCCCCEEEccCcceeecCCCC-cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCC
Confidence 999999999999999999999999986543211 111123345678999999977665 488999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+.......+... ....+...+.++.+++.+||+.+|.+|||+++++.
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 202 IPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999888776666665443 23445567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=283.86 Aligned_cols=209 Identities=22% Similarity=0.362 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.++||||+++++++... ..++++||+++|+|.+.+.... .+++..+..++.|++.||.|||++||+
T Consensus 53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iv 131 (303)
T cd05110 53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131 (303)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence 34688999999999999999999998654 4679999999999999997654 689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..
T Consensus 132 H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~ 210 (303)
T cd05110 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGK 210 (303)
T ss_pred ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876543222112223456778999999987666 489999999999999997 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||.+.........+..+ ....++..+.++.+++.+||..+|.+||+++++++.
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 211 PYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99887655554444333 234455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.01 Aligned_cols=214 Identities=26% Similarity=0.452 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.+++.++||||+++++++.. ....|++|||+ +++|.+.+.. ..+++..+..++.|+++||+|||++||
T Consensus 52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i 129 (328)
T cd07856 52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGV 129 (328)
T ss_pred hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 35778899999999999999999999865 56789999998 5588777754 568999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||+|.||++++++.++|+|||++..... ...+..+++.|+|||++.+....+.++||||+||++|+|++|+.
T Consensus 130 iH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 130 VHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred ccCCCCHHHEeECCCCCEEeCccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999864321 12345678999999998663444689999999999999999999
Q ss_pred CCCCCchHHHHHhhhc------------------------C--ccCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 174 PFDDSNLMNLYKKISA------------------------A--EFTC-----PPWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~------------------------~--~~~~-----~~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
||...+....+..+.. . .... .+.++..+.++|++||+.+|.+|||+++
T Consensus 205 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 205 LFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 9987654322211110 0 0011 1246789999999999999999999999
Q ss_pred HhcCcccccCCCC
Q 015814 223 ILEDEWFKKDYKP 235 (400)
Q Consensus 223 il~h~~~~~~~~~ 235 (400)
++.||||.....+
T Consensus 285 ll~~~~~~~~~~~ 297 (328)
T cd07856 285 ALAHPYLAPYHDP 297 (328)
T ss_pred HhcCCccccccCC
Confidence 9999999876544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=274.02 Aligned_cols=203 Identities=25% Similarity=0.433 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.++++++||||+++++++... ..|++|||++||+|.+++.... .+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~ 121 (254)
T cd05083 43 AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121 (254)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 46788999999999999999999998654 4799999999999999997654 48899999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||+++.++.+||+|||++...... ......+..|+|||.+....+ +.++|+||+||++|+|++ |+
T Consensus 122 ~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~ 195 (254)
T cd05083 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGR 195 (254)
T ss_pred eccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998653221 122334567999999877665 488999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||...+..+....+..+. ...+..++..+.+++.+||+.+|.+|||++++++
T Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 196 APYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999888776666654442 3344558899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=274.40 Aligned_cols=207 Identities=22% Similarity=0.363 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++.+|+.++++++|+||+++++++.. ...|++|||+++|+|.+++... ..++...+..++.|++.||.|||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i 123 (260)
T cd05073 45 VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123 (260)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 5678899999999999999999999877 7789999999999999999763 357888999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||+++.++.+||+|||++....... ........++..|+|||++....+ +.++|+||+||++|++++ |.
T Consensus 124 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~ 201 (260)
T cd05073 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGR 201 (260)
T ss_pred cccccCcceEEEcCCCcEEECCCcceeeccCCC-cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCC
Confidence 999999999999999999999999987543211 111122345677999999976655 588999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+.......+..+. ...+...+.++.+++.+||+.+|.+||++.+++.
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 202 IPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999877766666554442 2345568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=271.85 Aligned_cols=211 Identities=26% Similarity=0.410 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEE-----eCCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMG-----SKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~ 86 (400)
++.+.+|++..++++||||++++++.. .....|++++|...|+|.+.|+.. .-++|.++..||.++++||+
T Consensus 62 ~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~ 141 (302)
T KOG2345|consen 62 IEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLE 141 (302)
T ss_pred HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHH
Confidence 688999999999999999999998743 234589999999999999999653 25999999999999999999
Q ss_pred HHHHcC--CeeccCCCCcEEEccCCCeeeeccccccccccccCCCc-------cccccCCCCCCCChhhhcCCC--CCCh
Q 015814 87 YCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-------LHTTCGTPNYVAPEVLNDRGY--DGST 155 (400)
Q Consensus 87 ~LH~~g--ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~-------~~~~~gt~~y~APEvl~~~~~--~~~~ 155 (400)
+||+.. ++||||||.|||+.+.+.++|.|||.++.....-..+. ......|.+|+|||.+.-+.+ .+++
T Consensus 142 ~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er 221 (302)
T KOG2345|consen 142 ALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER 221 (302)
T ss_pred HHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc
Confidence 999998 99999999999999999999999999876543211111 112346999999999864433 2589
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCchH--HHHHhhhcCccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 156 ADLWSCGVILFVLLAGYLPFDDSNLM--NLYKKISAAEFTCPP--WLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 156 ~DIwSlGiil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~--~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+|||||||+||+|+.|..||+..-.. .+.-.+..+.+.+|. .+|+.+.+||++||+.||.+||++.+++.+
T Consensus 222 tDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 222 TDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 99999999999999999999632110 111123344555553 389999999999999999999999999863
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=288.01 Aligned_cols=210 Identities=22% Similarity=0.373 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhCC--------------------------
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHG-------------------------- 67 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~~-------------------------- 67 (400)
...+.+|+.++.++ +||||+++++++.. +..++++|||+++|+|.+++....
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (343)
T cd05103 54 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED 133 (343)
T ss_pred HHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhh
Confidence 56788999999999 68999999998754 456899999999999999986531
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc
Q 015814 68 -----------------------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 106 (400)
Q Consensus 68 -----------------------------------------~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~ 106 (400)
.++...+..++.|++.||+|||++||+||||||+||+++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 213 (343)
T cd05103 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 213 (343)
T ss_pred hhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc
Confidence 356778889999999999999999999999999999999
Q ss_pred cCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCchHH-HH
Q 015814 107 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LY 184 (400)
Q Consensus 107 ~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~-~~ 184 (400)
.++.+||+|||++................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||....... ..
T Consensus 214 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 292 (343)
T cd05103 214 ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292 (343)
T ss_pred CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH
Confidence 999999999999875432111111122345678999999987766 489999999999999997 999998755432 22
Q ss_pred Hhhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 185 KKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 185 ~~i~~-~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
..+.. .....|.+.++++.+++.+||+.||.+|||+.+|++|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22222 2345566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.09 Aligned_cols=107 Identities=35% Similarity=0.675 Sum_probs=102.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....++.+|+.+++.++||||+++++++.....+|+||||+.||+|.+++...+.+++..++.|+.||+.||+|||++||
T Consensus 46 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gI 125 (669)
T cd05610 46 NMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125 (669)
T ss_pred HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34678999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeecccccc
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
+||||||+|||++.+|.+||+|||+++
T Consensus 126 iHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 126 IHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=278.48 Aligned_cols=211 Identities=22% Similarity=0.385 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
....+.+|+.+++.++||||+++++++... ...|+||||++|++|.+++.... .+++..+..++.|++.||+|||++
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~ 128 (284)
T cd05079 49 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 357799999999999999999999998765 67899999999999999996643 589999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|++||||||+||+++.++.++|+|||++......... .......|+..|+|||++.+..+ +.++||||+||++|+|++
T Consensus 129 gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt 207 (284)
T cd05079 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLT 207 (284)
T ss_pred CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCC-Cccccchhhhhhhhhhhc
Confidence 9999999999999999999999999998765432111 11223457778999999987665 488999999999999999
Q ss_pred CCCCCCCCch---------------HHHHHhhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 171 GYLPFDDSNL---------------MNLYKKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 171 G~~Pf~~~~~---------------~~~~~~i~~-~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+..|+..... ......+.. ...+.+..++..+.+|+.+||+.||.+|||+++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 208 YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 8776532211 111111111 1223345588999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=296.62 Aligned_cols=209 Identities=22% Similarity=0.393 Sum_probs=182.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.++.+|.|+.++++-+|.||+-+.|++..... .||.-+|+|-+|+.+|.-. .+|.-.....|++|+++|+.|||.++|
T Consensus 431 qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~I 509 (678)
T KOG0193|consen 431 QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNI 509 (678)
T ss_pred HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhh
Confidence 68999999999999999999999999988777 8999999999999999543 468889999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc---CCCCCChhhHHHHHHHHHHHHh
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGiil~ellt 170 (400)
+|||||..||++.+++.|||+|||+++..........+....|...|||||++.. .+| ++.+||||+||++|||+|
T Consensus 510 IHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELlt 588 (678)
T KOG0193|consen 510 IHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLT 588 (678)
T ss_pred hhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHh
Confidence 9999999999999999999999999998776655666677789999999999963 334 589999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCccCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 GYLPFDDSNLMNLYKKISAAEFTC-----PPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|.+||...+...+.-.+.+|.... -...+.++++|+..||..+|++||++.+||.
T Consensus 589 g~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 589 GELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 999999777666666555553221 1236779999999999999999999999986
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=274.78 Aligned_cols=210 Identities=23% Similarity=0.367 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------EEEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLI 82 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~~~------~~l~e~~~~~~~~qll 82 (400)
..+++.+|+++++.++||||+++++++.... ..++++||+.+|+|.+++... ..++...+..++.|++
T Consensus 44 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 123 (273)
T cd05074 44 DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123 (273)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Confidence 3677899999999999999999999875432 247899999999998887432 2478899999999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 83 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 83 ~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
.||+|||++||+||||||+||+++.++.+||+|||+++...............+++.|++||.+....+. .++||||||
T Consensus 124 ~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG 202 (273)
T cd05074 124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFG 202 (273)
T ss_pred HHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHH
Confidence 9999999999999999999999999999999999998754321111111233456789999999877664 889999999
Q ss_pred HHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 163 VILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 163 iil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|++|+|++ |..||.+.+..+.+..+... ....++..+..+.+++.+||+.+|.+|||+.++++
T Consensus 203 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 203 VTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred HHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999 99999888777777665444 33455678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=295.82 Aligned_cols=207 Identities=27% Similarity=0.442 Sum_probs=181.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+..+-+|+++|+.++|||||++||+......+|+|||+|+||+|.+++...+. ++..+...++.+.+.||+|||++++
T Consensus 204 ~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~ 283 (474)
T KOG0194|consen 204 QIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNC 283 (474)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCC
Confidence 378889999999999999999999999999999999999999999999999874 9999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCcccccc-CCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~-gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
+||||-..|+|++.++.+||+|||+|+..... ......+ -...|+|||.+...-| +.++||||+||++||+++ |
T Consensus 284 IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 284 IHRDIAARNCLYSKKGVVKISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred cchhHhHHHheecCCCeEEeCccccccCCcce---eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccC
Confidence 99999999999999999999999998754311 1111112 3467999999998765 599999999999999998 8
Q ss_pred CCCCCCCchHHHHHhhhcCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||.+....+...++.... .+.|...+.++..++.+|+..||+.|||+.++.+
T Consensus 360 ~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 360 AEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999984443 3455668889999999999999999999999865
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=275.38 Aligned_cols=209 Identities=23% Similarity=0.389 Sum_probs=166.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|++++++++||||+++++++.. ...+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++|
T Consensus 49 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~ 128 (284)
T cd05081 49 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128 (284)
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5788999999999999999999998643 35689999999999999999764 46899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCcc-ccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL-HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
++||||||+||++++++.+||+|||++............ ....++..|+|||++.+..+ +.++||||+||++|+|++|
T Consensus 129 i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~ 207 (284)
T cd05081 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTY 207 (284)
T ss_pred ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhc
Confidence 999999999999999999999999998765332111111 11223456999999987666 4899999999999999999
Q ss_pred CCCCCCCchHH----------------HHHhhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMN----------------LYKKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~----------------~~~~i~~-~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..|+....... +...+.. ...+.+..++.++.+|+.+||..+|.+|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 208 SDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 87765432211 1111111 122344568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=309.79 Aligned_cols=210 Identities=21% Similarity=0.400 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-----------CCCCHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-----------GRMKEDEARRYFQQLIN 83 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-----------~~l~e~~~~~~~~qll~ 83 (400)
..+++.+|+.++++++||||+++++++.+.+..|+||||++||+|.+.+... .+++...+..++.|++.
T Consensus 45 ~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~ 124 (932)
T PRK13184 45 LKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124 (932)
T ss_pred HHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHH
Confidence 3567899999999999999999999999999999999999999999988642 23455678899999999
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccC----------------CCccccccCCCCCCCChhhh
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD----------------DGLLHTTCGTPNYVAPEVLN 147 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~APEvl~ 147 (400)
||+|||++||+||||||+||+++.+|.+||+|||++........ .......+||+.|+|||++.
T Consensus 125 AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~ 204 (932)
T PRK13184 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL 204 (932)
T ss_pred HHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc
Confidence 99999999999999999999999999999999999876521110 00112347999999999998
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhh-cCccCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 148 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS-AAEFTC--PPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 148 ~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~-~~~~~~--~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
+..+ +.++||||+||++|+|++|..||...+......... ...... ...+++.+.+++.+||..||.+|++..+.+
T Consensus 205 g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 205 GVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred CCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 7776 589999999999999999999998765443322211 111111 134788999999999999999998765544
Q ss_pred c
Q 015814 225 E 225 (400)
Q Consensus 225 ~ 225 (400)
.
T Consensus 284 l 284 (932)
T PRK13184 284 K 284 (932)
T ss_pred H
Confidence 3
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=278.25 Aligned_cols=213 Identities=26% Similarity=0.441 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cC
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~-~g 92 (400)
...+.+|+.++.+. .||||+++++++.+....|++|||+.+ +|.+.+.. .+.+++..+..++.|++.|++|||+ .|
T Consensus 57 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 45666788777666 599999999999999999999999864 77766655 4578999999999999999999997 59
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC---CCCChhhHHHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGiil~ell 169 (400)
|+||||+|+||++++++.+||+|||++...... .......|++.|+|||.+.... ..+.++||||+|+++|+|+
T Consensus 136 i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~ 212 (296)
T cd06618 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212 (296)
T ss_pred EecCCCcHHHEEEcCCCCEEECccccchhccCC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH
Confidence 999999999999999999999999998654321 1122345788999999987543 2347899999999999999
Q ss_pred hCCCCCCCCch-HHHHHhhhcCc-cCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 170 AGYLPFDDSNL-MNLYKKISAAE-FTCPP--WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 170 tG~~Pf~~~~~-~~~~~~i~~~~-~~~~~--~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|+.||..... .+.+..+.... ...+. .++.++.+|+.+||..||.+|||++++++||||...
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 213 TGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred hCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 99999976332 23333332222 22222 368899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=275.51 Aligned_cols=213 Identities=31% Similarity=0.610 Sum_probs=190.7
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
++=++-|-.+..+- +||.+|-++..|++++.+++|.||++||+|.-++++.++++|+.|++|-..|+.||.|||++||+
T Consensus 294 idwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgii 373 (593)
T KOG0695|consen 294 IDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGII 373 (593)
T ss_pred chhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCee
Confidence 55566677777666 79999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
.||||.+|+|+|..|++|+.|+|+.+. ..+......+.||||.|+|||++.+..| +..+|.|+|||+++||++|+.|
T Consensus 374 yrdlkldnvlldaeghikltdygmcke--~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrsp 450 (593)
T KOG0695|consen 374 YRDLKLDNVLLDAEGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSP 450 (593)
T ss_pred eeeccccceEEccCCceeecccchhhc--CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999998753 3445667788999999999999999888 6999999999999999999999
Q ss_pred CCC--------CchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC------CHHHHhcCccccc
Q 015814 175 FDD--------SNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI------TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~--------~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~------t~~eil~h~~~~~ 231 (400)
|+- .+..-+++-|.......|..+|-.+..+++.-|++||.+|. .+.++..|+||+.
T Consensus 451 fdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 451 FDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred cceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 952 22334567777888899999999999999999999999996 4689999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=264.64 Aligned_cols=210 Identities=46% Similarity=0.833 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++.....++...+..++.|++.++.|||+.|++|
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 57899999999999999999999999999999999999999999999988767999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
+||+|.||++++++.++|+|||.+...... .......|+..|+|||.+....+. .++||||+|+++|++++|..||
T Consensus 111 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~ 186 (244)
T smart00220 111 RDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAPEVLLGKGYG-KAVDVWSLGVILYELLTGKPPF 186 (244)
T ss_pred CCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998765432 133456789999999999876664 7999999999999999999999
Q ss_pred CC-CchHHHHHhhhcCccCCCCC---CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 176 DD-SNLMNLYKKISAAEFTCPPW---LSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 176 ~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
.. .+.................. ++.++.+++.+||..+|.+||++.++++||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 187 PGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 87 55555555555444433322 88999999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=270.31 Aligned_cols=207 Identities=29% Similarity=0.550 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHHh-CCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKL-VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...++.+|+.++++ ++||||+++++++..++..|++|||++|++|.+.+.. ...+++..++.++.|++.||.|||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 35678889998875 7999999999999999999999999999999988743 346899999999999999999999
Q ss_pred H-cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 S-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~-~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
+ .|++||||+|+||+++.++.+||+|||++...... .......|+..|+|||.+.+..+ +.++||||+|+++|+|
T Consensus 131 ~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l 206 (269)
T cd08528 131 KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQM 206 (269)
T ss_pred cCCceeecCCCHHHEEECCCCcEEEecccceeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHH
Confidence 6 78999999999999999999999999998764332 13345678999999999987665 5899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCccCC-CC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEFTC-PP-WLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~~~-~~-~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
++|..||...+.......+....... +. .++..+.++|.+||+.||.+|||+.|+..
T Consensus 207 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 207 CTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 99999998877666665554444322 22 57899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=272.53 Aligned_cols=210 Identities=22% Similarity=0.371 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..+.+.+|+++++.++||||+++++++.. +...|++|||+++|+|.+++.... .++...+..++.|++.||+|||++
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 36789999999999999999999999877 567999999999999999997654 689999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|++||||||+||+++.++.++|+|||++......... .......++..|+|||.+....+ +.++||||+||++|+|++
T Consensus 129 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~t 207 (284)
T cd05038 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFT 207 (284)
T ss_pred CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeec
Confidence 9999999999999999999999999998765421111 11112344567999999977665 488999999999999999
Q ss_pred CCCCCCCCchHH---------------HHHhhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 GYLPFDDSNLMN---------------LYKKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 G~~Pf~~~~~~~---------------~~~~i~~-~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|..|+....... ....+.. ...+.+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 208 YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999986543221 1122221 223345567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.34 Aligned_cols=220 Identities=22% Similarity=0.375 Sum_probs=187.7
Q ss_pred chhHHHhhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-------CCCCHHHHHH
Q 015814 4 QDLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-------GRMKEDEARR 76 (400)
Q Consensus 4 ~~~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-------~~l~e~~~~~ 76 (400)
|.+.+..+. .-...+.+|..+|+.++|||||+++|++-+....+|++|||.||+|..+|++. ..++......
T Consensus 728 K~l~~~~~~-~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~ 806 (1025)
T KOG1095|consen 728 KSLKRLSSE-QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLA 806 (1025)
T ss_pred EeccccCCH-HHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHH
Confidence 455555454 44788999999999999999999999999999999999999999999999876 2478889999
Q ss_pred HHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChh
Q 015814 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 156 (400)
Q Consensus 77 ~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~ 156 (400)
++.|++.|++||+++++|||||...|+||+....+||+|||+|+..-.....+.-....-...|||||.+....+ +.++
T Consensus 807 ~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskS 885 (1025)
T KOG1095|consen 807 FALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKS 885 (1025)
T ss_pred HHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhccc-cccc
Confidence 999999999999999999999999999999999999999999983322111111011112357999999998655 6999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCchHHHHH-hhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 157 DLWSCGVILFVLLA-GYLPFDDSNLMNLYK-KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 157 DIwSlGiil~ellt-G~~Pf~~~~~~~~~~-~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||||||++||++| |..||.+.+..+... ....++...|..++..+.+++..||+.+|++||++..|++
T Consensus 886 DvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 886 DVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred chhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999998 999999988877766 4566788889999999999999999999999999999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=270.54 Aligned_cols=202 Identities=16% Similarity=0.206 Sum_probs=159.6
Q ss_pred HHHHHHHhCCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 21 REVATMKLVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 21 ~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.+...+..+.|+||+++++...... ..++++|++.. ++.+.+......++..+..++.|++.||+|||++||+||
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr 150 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG 150 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 4445566779999999998765443 45788888754 676777665567899999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccC-----CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
||||+|||++.++.++|+|||+|+.+..... ........||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus 151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999876532211 111223479999999999987776 5999999999999999999
Q ss_pred CCCCCCCch-HH--------HHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNL-MN--------LYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~-~~--------~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||.+.+. .. ....+..+.... +..+..+.++++.|+..+|.+||++++|++
T Consensus 230 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 230 KLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CCCCCccccchHHHHHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999987632 11 223333333332 346889999999999999999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=271.93 Aligned_cols=208 Identities=28% Similarity=0.468 Sum_probs=166.9
Q ss_pred HHHHHHHHHHhCC--CCC----cceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH
Q 015814 18 QIKREVATMKLVK--HPN----VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 18 ~i~~Ei~il~~l~--Hpn----Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+-|+++|.++. -|+ +|.+.++|.-.+++|||+|.+ |-+++|++.++. +++-+.++.+.+||+.+++|||
T Consensus 131 Aa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh 209 (415)
T KOG0671|consen 131 AALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH 209 (415)
T ss_pred HHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH
Confidence 3456999999994 233 788889999999999999988 559999998765 6899999999999999999999
Q ss_pred HcCCeeccCCCCcEEEcc--------------------CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC
Q 015814 90 SRGVYHRDLKPENLLLDA--------------------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~--------------------~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~ 149 (400)
+.+++|-||||||||+.+ +-.++++|||.|+.-.. .-.+...|..|+|||++.+-
T Consensus 210 ~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgL 284 (415)
T KOG0671|consen 210 DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGL 284 (415)
T ss_pred hcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheecc
Confidence 999999999999999832 23589999999876432 12566789999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHhCCCCCCCCchHH---HHHhhhc------------------CccCCCC------------
Q 015814 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISA------------------AEFTCPP------------ 196 (400)
Q Consensus 150 ~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~---~~~~i~~------------------~~~~~~~------------ 196 (400)
+++ .++||||+||||+|+.+|...|+..+..+ +.+.|.. +....|.
T Consensus 285 GwS-~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~ 363 (415)
T KOG0671|consen 285 GWS-QPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFE 363 (415)
T ss_pred CcC-CccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhc
Confidence 996 89999999999999999999998765333 2222211 0111000
Q ss_pred ---C----------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 197 ---W----------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 197 ---~----------~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
. --..+.+||++||..||.+|+|+.|+|.||||+..
T Consensus 364 ~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 364 PCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred CCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 0 01247799999999999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=276.34 Aligned_cols=207 Identities=27% Similarity=0.384 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC-EEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT-KIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..++..|+.++.+++|||+|+|+|+|.+.+ ..++|+||+++|+|.+++.... .+++....+|+.+++.||+|||+..
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 356999999999999999999999999888 5999999999999999997755 7899999999999999999999864
Q ss_pred ---CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccc-cCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 93 ---VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 93 ---ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
|+||||||+|||||++.+.||+|||+|...... .....+. .||..|+|||.+..... +.++||||+||+|.|+
T Consensus 195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllEl 271 (361)
T KOG1187|consen 195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLEL 271 (361)
T ss_pred CCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHH
Confidence 999999999999999999999999999654321 2222233 89999999999976444 6899999999999999
Q ss_pred HhCCCCCCCCc---h---HHHH-HhhhcCc------cCCC-CCCC--HH---HHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 169 LAGYLPFDDSN---L---MNLY-KKISAAE------FTCP-PWLS--FT---ARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 169 ltG~~Pf~~~~---~---~~~~-~~i~~~~------~~~~-~~~s--~~---~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
++|+.|.+... . .+.. ..+..+. .... ...+ .. +..+...|++.+|.+||++.|+++
T Consensus 272 itgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 272 ITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 99999887532 1 1111 1111111 1111 1122 22 456778999999999999999754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=278.87 Aligned_cols=204 Identities=25% Similarity=0.451 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|..+|+.++|||||+++|++.. ..+|||||+++-|+|..+++... .++......|+.||..||.|||+.+.|
T Consensus 435 tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfV 513 (974)
T KOG4257|consen 435 TEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFV 513 (974)
T ss_pred HHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchh
Confidence 6889999999999999999999999865 56899999999999999998754 688999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCC--CCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt--~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
||||-..|||+.+...+||+|||+|+..... .......|- ..|||||.+.-+.+ +.++|||-|||.+||++. |
T Consensus 514 HRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~---~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lG 589 (974)
T KOG4257|consen 514 HRDIAARNILVSSPQCVKLADFGLSRYLEDD---AYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLG 589 (974)
T ss_pred hhhhhhhheeecCcceeeecccchhhhcccc---chhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999876542 222223343 45999999987766 589999999999999886 9
Q ss_pred CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 172 YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
.-||.+-...+..-.+.+| ..++|+.+++.+..|+.+||+.+|.+||++.+|.
T Consensus 590 vkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 590 VKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 9999997777776666665 5689999999999999999999999999988764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=288.45 Aligned_cols=213 Identities=29% Similarity=0.433 Sum_probs=185.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEE-----eCCEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMG-----SKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~-----~~~~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~~ 87 (400)
-+.|+.|.+||+.+ .|||++.+|++|. .++.+|+|||||.||+.-|+++. ..++.|..+..+++.++.|+.|
T Consensus 59 deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~H 138 (953)
T KOG0587|consen 59 EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAH 138 (953)
T ss_pred cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHH
Confidence 57899999999988 7999999999985 35679999999999999999976 3579999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC-----CCCCChhhHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCG 162 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DIwSlG 162 (400)
||++.++|||||-.|||++.+|.||++|||.++..... .+...+..|||.|||||++... .|+ ..+|+||||
T Consensus 139 LH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLG 215 (953)
T KOG0587|consen 139 LHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLG 215 (953)
T ss_pred HhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcc-cccchhhcc
Confidence 99999999999999999999999999999998755432 3334678899999999999643 244 679999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHhhhcCccC---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 163 VILFVLLAGYLPFDDSNLMNLYKKISAAEFT---CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|+..||..|.+|+-+..++...-+|....++ .|..++.++.++|..||.+|-.+||+..++++|||.+.
T Consensus 216 ITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 216 ITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 9999999999999998887666666544332 24458999999999999999999999999999999984
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=275.53 Aligned_cols=204 Identities=27% Similarity=0.437 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
++.+.+|..+|+.++|||+|+++++|..+..+|||.|||..|+|.|+++...+ ++.-....++.||.+|++||..+++
T Consensus 307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknF 386 (1157)
T KOG4278|consen 307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNF 386 (1157)
T ss_pred HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhh
Confidence 68899999999999999999999999999999999999999999999987653 7777888999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccC---CCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~g---t~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|||||-..|.|+.++..+|++||||++++... ..+...| ...|.|||-+....+. .++|||+|||+|||+.|
T Consensus 387 IHRDLAARNCLVgEnhiVKvADFGLsRlMtgD----TYTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIAT 461 (1157)
T KOG4278|consen 387 IHRDLAARNCLVGENHIVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIAT 461 (1157)
T ss_pred hhhhhhhhhccccccceEEeeccchhhhhcCC----ceecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHh
Confidence 99999999999999999999999999987542 2222333 3569999999877664 89999999999999998
Q ss_pred -CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 171 -GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 171 -G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
|..||.+-+....|..+..+ ...-|..+++.+.+|++.||+.+|..||++.||-
T Consensus 462 YGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 462 YGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred cCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 99999999999999887666 4567888999999999999999999999999983
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=277.01 Aligned_cols=214 Identities=27% Similarity=0.430 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
....+.+|+.+|.+|+|||+|+||++..+ ..+.+|||++++|+|.+++... ..|.......|+.||+.|+.||.+++
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 57889999999999999999999999887 7788999999999999999873 35788899999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccc-cccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH-TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA- 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~-~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt- 170 (400)
.|||||-..|+|+-....||||||||.+-........... ...-...|+|||.+....+. .++|||++||++|||++
T Consensus 233 lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFty 311 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTY 311 (1039)
T ss_pred hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhcc
Confidence 9999999999999999999999999987655432211111 11223469999999987774 89999999999999998
Q ss_pred CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 171 GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
|..||.+-....+.++|..+ ..+.|+.+|+++.+++..||..+|.+|||+..|...-+..
T Consensus 312 GEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 312 GEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999999998755 4577888999999999999999999999999997554443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=245.30 Aligned_cols=209 Identities=25% Similarity=0.516 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhCC-CCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 17 LQIKREVATMKLVK-HPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
+.|++|+.||..|. ||||++++++..+. ....+++||+.+.+....- ..++...++.|+.|++.||.|||+.||
T Consensus 77 kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GI 153 (338)
T KOG0668|consen 77 KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGI 153 (338)
T ss_pred HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCc
Confidence 78999999999996 99999999998654 3467899999986643333 458889999999999999999999999
Q ss_pred eeccCCCCcEEEccC-CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+|||+||.|+++|.. -.++|+|+|+|.+... ......+..+..|--||.+..-..+...-|+||+||++..|+..+
T Consensus 154 mHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp---~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk 230 (338)
T KOG0668|consen 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 230 (338)
T ss_pred ccccCCcceeeechhhceeeeeecchHhhcCC---CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence 999999999999975 5699999999987653 333455678899999999987666668899999999999999998
Q ss_pred CCC-CCCchHHHHHhhhc--------------------------CccCCCCC-----------CCHHHHHHHHHhcCCCC
Q 015814 173 LPF-DDSNLMNLYKKISA--------------------------AEFTCPPW-----------LSFTARKLIARILDPNP 214 (400)
Q Consensus 173 ~Pf-~~~~~~~~~~~i~~--------------------------~~~~~~~~-----------~s~~~~~li~~mL~~dP 214 (400)
-|| .+.+..++.-+|.. +....-+| .++++.+|+.++|..|-
T Consensus 231 epFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 231 EPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred CcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 887 34443333333211 01111112 47899999999999999
Q ss_pred CCCCCHHHHhcCccccc
Q 015814 215 MTRITIPEILEDEWFKK 231 (400)
Q Consensus 215 ~~R~t~~eil~h~~~~~ 231 (400)
++|+|+.|++.||||..
T Consensus 311 qeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 311 QERLTAKEAMAHPYFAP 327 (338)
T ss_pred ccccchHHHhcCchHHH
Confidence 99999999999999974
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=256.57 Aligned_cols=214 Identities=24% Similarity=0.407 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHH-hCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-----VNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i-----~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
-.+++..|..... .-+.||||++|+..-.++..||.||+|+- +|..+- .....++|...-.+.--.+.||.||
T Consensus 105 eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yL 183 (361)
T KOG1006|consen 105 EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYL 183 (361)
T ss_pred HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHH
Confidence 3678888988755 44899999999999999999999999975 542221 2356799999999999999999999
Q ss_pred HHc-CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh--cCCCCCChhhHHHHHHHH
Q 015814 89 HSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 89 H~~-givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~--~~~~~~~~~DIwSlGiil 165 (400)
... .|+|||+||+|||++..|.+||||||.+..... .-..+...|..+|||||.+. +.+|+ -.+|||||||+|
T Consensus 184 K~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL 259 (361)
T KOG1006|consen 184 KEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITL 259 (361)
T ss_pred HHHhhhhhccCChhheEEecCCCEeeecccchHhHHH---HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceE
Confidence 965 999999999999999999999999998764432 12223457899999999985 34576 899999999999
Q ss_pred HHHHhCCCCCCCCch-HHHHHhhhcCccCC---CCC---CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 166 FVLLAGYLPFDDSNL-MNLYKKISAAEFTC---PPW---LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 166 ~elltG~~Pf~~~~~-~~~~~~i~~~~~~~---~~~---~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
||+.||..|+.+-+. .++...+..+.++. +.. +|..+..+|.-||.+|-+.||.+.+++++||++...
T Consensus 260 ~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 260 YEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred eeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 999999999976443 34444444444322 222 788999999999999999999999999999998643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=283.72 Aligned_cols=217 Identities=30% Similarity=0.472 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC---C-CHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---M-KEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~---l-~e~~~~~~~~qll~~l~~LH~ 90 (400)
.+-..+||..|+.- +|||||++|+.-.+....||..|.|.. +|.|+++..+. . ..-..+..+.|+++||+|||+
T Consensus 546 ~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs 624 (903)
T KOG1027|consen 546 FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS 624 (903)
T ss_pred HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh
Confidence 45678999999988 699999999999999999999999986 99999988521 1 114568899999999999999
Q ss_pred cCCeeccCCCCcEEEcc---CC--CeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDA---YG--NLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 91 ~givHrDlKP~NILl~~---~g--~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
.+|+||||||.||||+. ++ .++|+|||+++....... -....+..||-+|+|||++..... ..++||||+||+
T Consensus 625 l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCv 703 (903)
T KOG1027|consen 625 LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCV 703 (903)
T ss_pred cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCce
Confidence 99999999999999986 34 589999999976543322 223456679999999999987655 478999999999
Q ss_pred HHHHHh-CCCCCCCCchHHHHHhhhcCccCC---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 165 LFVLLA-GYLPFDDSNLMNLYKKISAAEFTC---PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 165 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
+|+.++ |..||.+.-..+ ..|..+.+.. .+.-..++.+||.+||+++|..||++.++|.||+|....+.-
T Consensus 704 fyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL 777 (903)
T KOG1027|consen 704 FYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL 777 (903)
T ss_pred EEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence 998888 599997643322 2233343322 111222899999999999999999999999999999865543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=262.70 Aligned_cols=222 Identities=30% Similarity=0.467 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCcceeeEEEE-eCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 12 AFCILLQIKREVATMKLVKHPNVVRLYEVMG-SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 12 ~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
..+..+..-+|..|.+.|+||-||++|+++. +.+.+|-|+|||+|.+|.-++..+.-++|.+|+.|+.|++.||.||..
T Consensus 507 KeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNE 586 (775)
T KOG1151|consen 507 KENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNE 586 (775)
T ss_pred hhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhc
Confidence 3456778889999999999999999999996 456689999999999999999999999999999999999999999997
Q ss_pred c--CCeeccCCCCcEEEcc---CCCeeeeccccccccccccCCC-----ccccccCCCCCCCChhhhc---CCCCCChhh
Q 015814 91 R--GVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDG-----LLHTTCGTPNYVAPEVLND---RGYDGSTAD 157 (400)
Q Consensus 91 ~--givHrDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~---~~~~~~~~D 157 (400)
. -|+|-||||.|||+-. .|.+||.|||++..+.....+. ......||-||++||.+.- .+..+.++|
T Consensus 587 ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVD 666 (775)
T KOG1151|consen 587 IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVD 666 (775)
T ss_pred cCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccccee
Confidence 6 5999999999999955 4789999999999876543221 2233479999999998742 334467899
Q ss_pred HHHHHHHHHHHHhCCCCCCCCch-HHHHHh--h-hcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 158 LWSCGVILFVLLAGYLPFDDSNL-MNLYKK--I-SAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 158 IwSlGiil~elltG~~Pf~~~~~-~~~~~~--i-~~~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|||+|||+|.++.|+.||..... .++.+. | ...+..+| |-+|.++++||++||+..-..|+.+.++-.||+|..
T Consensus 667 VWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 667 VWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred eEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 99999999999999999975432 344332 2 23344555 458999999999999999999999999999999976
Q ss_pred CC
Q 015814 232 DY 233 (400)
Q Consensus 232 ~~ 233 (400)
..
T Consensus 747 h~ 748 (775)
T KOG1151|consen 747 HI 748 (775)
T ss_pred hh
Confidence 43
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=300.07 Aligned_cols=203 Identities=18% Similarity=0.236 Sum_probs=151.1
Q ss_pred HHhCCC-CCcceeeEEE-------EeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 26 MKLVKH-PNVVRLYEVM-------GSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 26 l~~l~H-pnIv~l~~~~-------~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.+.++| +||.++++++ .....++.+|||+ +++|.++|.. ...+++..++.+++||+.||+|||++||+||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 356677 7899999987 2234577888987 5599999965 3469999999999999999999999999999
Q ss_pred cCCCCcEEEcc-------------------CCCeeeeccccccccccccC--------------CCccccccCCCCCCCC
Q 015814 97 DLKPENLLLDA-------------------YGNLKVSDFGLSALSQQVRD--------------DGLLHTTCGTPNYVAP 143 (400)
Q Consensus 97 DlKP~NILl~~-------------------~g~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~AP 143 (400)
||||+||||+. ++.+|++|||+++....... .......+||++|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 44566777777653211000 0001124689999999
Q ss_pred hhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 144 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 144 Evl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
|++.+..| +.++|||||||+||||++|..|+..... ....+..... ..+........+++.+||++||.+|||+.|
T Consensus 185 E~~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 185 EEDNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 99988877 5899999999999999999998764321 1111111111 111112456779999999999999999999
Q ss_pred HhcCcccccC
Q 015814 223 ILEDEWFKKD 232 (400)
Q Consensus 223 il~h~~~~~~ 232 (400)
+++||||...
T Consensus 262 il~h~~~~~~ 271 (793)
T PLN00181 262 LLQSEFINEP 271 (793)
T ss_pred Hhhchhhhhh
Confidence 9999999763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=280.32 Aligned_cols=190 Identities=19% Similarity=0.298 Sum_probs=139.5
Q ss_pred EeCCEEEEEEecCCCCChHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCC
Q 015814 42 GSKTKIFIVLEFVTGGELFDKIVNHGR--------------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 101 (400)
Q Consensus 42 ~~~~~~~lv~Ey~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~ 101 (400)
..+..+|+||||+.+++|.+++..... ..+..+..++.|++.||+|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 356679999999999999999875321 123456789999999999999999999999999
Q ss_pred cEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCC---------------------CChhhHH
Q 015814 102 NLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD---------------------GSTADLW 159 (400)
Q Consensus 102 NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~---------------------~~~~DIw 159 (400)
|||++. ++.+||+|||+|+..... ........+||+.|+|||.+....+. ..++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999996 589999999999754321 12223456899999999976432211 2456999
Q ss_pred HHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccC-----------C----------CCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 160 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-----------C----------PPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 160 SlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------~----------~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
|+||++|||+++..|++... ......+...... . ....+....+||.+||++||.+||
T Consensus 364 SlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 99999999999888765421 1111111111110 0 011233456899999999999999
Q ss_pred CHHHHhcCcccccCC
Q 015814 219 TIPEILEDEWFKKDY 233 (400)
Q Consensus 219 t~~eil~h~~~~~~~ 233 (400)
|+.++|+||||+...
T Consensus 443 ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 443 SAKAALAHPYFDREG 457 (566)
T ss_pred CHHHHhCCcCcCCCC
Confidence 999999999998743
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=272.47 Aligned_cols=200 Identities=31% Similarity=0.484 Sum_probs=159.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC------EEEEEEecCCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~~l~ 86 (400)
.+..-+|++||++++|||||+++++-++.. .-.+|||||.||||+..+.. ..+++|.....++..+..|+.
T Consensus 55 ~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~ 134 (732)
T KOG4250|consen 55 RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALR 134 (732)
T ss_pred HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHH
Confidence 477789999999999999999999865543 35799999999999999965 447999999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEcc--CC--CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDA--YG--NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~--~g--~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
|||++||+||||||+||++-. +| ..||+|||.|+-.. .+....+..||+.|.|||++-...+++..+|.||+|
T Consensus 135 ~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~G 211 (732)
T KOG4250|consen 135 HLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFG 211 (732)
T ss_pred HHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhh
Confidence 999999999999999999854 23 48999999998554 355778889999999999998656667999999999
Q ss_pred HHHHHHHhCCCCCCCCch-----HHHHHhhh--------------cC------ccCCCCCCCHH----HHHHHHHhcCCC
Q 015814 163 VILFVLLAGYLPFDDSNL-----MNLYKKIS--------------AA------EFTCPPWLSFT----ARKLIARILDPN 213 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~-----~~~~~~i~--------------~~------~~~~~~~~s~~----~~~li~~mL~~d 213 (400)
|++|+++||..||-.... .-++..+. ++ ..++|..++.. +..++..||..+
T Consensus 212 vtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~ 291 (732)
T KOG4250|consen 212 VTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWN 291 (732)
T ss_pred hHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhh
Confidence 999999999999943211 12222211 11 11223333433 456788899999
Q ss_pred CCCCC
Q 015814 214 PMTRI 218 (400)
Q Consensus 214 P~~R~ 218 (400)
|.+|-
T Consensus 292 ~~~~~ 296 (732)
T KOG4250|consen 292 PRKRG 296 (732)
T ss_pred HHHhC
Confidence 99998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=251.01 Aligned_cols=222 Identities=24% Similarity=0.440 Sum_probs=180.8
Q ss_pred HhhHHHHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH
Q 015814 9 YLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN 83 (400)
Q Consensus 9 ~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~ 83 (400)
+..+.-.-+.+-+|++.|...+|.||+..+++..... .+|++.|++.. +|...|..-..++.+.++-+++||+.
T Consensus 89 vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILR 167 (449)
T KOG0664|consen 89 VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILR 167 (449)
T ss_pred HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHh
Confidence 3333333567888999999999999999999876543 36889999976 88888888888999999999999999
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
||+|||+.||.||||||.|+|++++..+||||||+++..+... ....+...-|-.|+|||++.+...++.++||||.||
T Consensus 168 GLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGC 246 (449)
T KOG0664|consen 168 GLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGC 246 (449)
T ss_pred hhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhH
Confidence 9999999999999999999999999999999999998765432 223344456889999999998776679999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHhhhc-----------------------CccCCCC-----------CCCHHHHHHHHHh
Q 015814 164 ILFVLLAGYLPFDDSNLMNLYKKISA-----------------------AEFTCPP-----------WLSFTARKLIARI 209 (400)
Q Consensus 164 il~elltG~~Pf~~~~~~~~~~~i~~-----------------------~~~~~~~-----------~~s~~~~~li~~m 209 (400)
|+.||+..+..|...++.+....|.. +....|. .-..+...++.+|
T Consensus 247 IFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~ 326 (449)
T KOG0664|consen 247 IFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKL 326 (449)
T ss_pred HHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHH
Confidence 99999999999988776665554421 1111111 1124678899999
Q ss_pred cCCCCCCCCCHHHHhcCcccccC
Q 015814 210 LDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 210 L~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|..||.+|++.++.+.|++....
T Consensus 327 l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 327 LHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hCCCCcccccHhhhccccccccc
Confidence 99999999999999999998754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=268.32 Aligned_cols=214 Identities=24% Similarity=0.392 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHHHHHhCC------CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHH
Q 015814 12 AFCILLQIKREVATMKLVK------HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLI 82 (400)
Q Consensus 12 ~~~~~~~i~~Ei~il~~l~------HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll 82 (400)
+.-|-+.=.+|++||++|+ --|.++|+..|...+++|+|+|-..- +|.+.+...| ++....++.|.+||.
T Consensus 468 NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLf 546 (752)
T KOG0670|consen 468 NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLF 546 (752)
T ss_pred chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHH
Confidence 4445566678999999996 34799999999999999999998864 8888887755 688899999999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEccC-CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHH
Q 015814 83 NAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSC 161 (400)
Q Consensus 83 ~~l~~LH~~givHrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSl 161 (400)
.||..|-+.||+|-||||+|||+++. ..+||||||.|.... ...++.+.-+..|.|||++.+.+|+ .+.|+||+
T Consensus 547 lALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSv 621 (752)
T KOG0670|consen 547 LALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSV 621 (752)
T ss_pred HHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc----cccccHHHHHHhccCcceeecCccc-CCccceee
Confidence 99999999999999999999999985 569999999987543 3345556678889999999999997 88999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCC---------------------------------------------
Q 015814 162 GVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--------------------------------------------- 196 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------------------------- 196 (400)
||+||||.||+..|++.+...+.+........+|.
T Consensus 622 gctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl 701 (752)
T KOG0670|consen 622 GCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDL 701 (752)
T ss_pred ceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhH
Confidence 99999999999999998766665543322222221
Q ss_pred --------CCC-------HHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 197 --------WLS-------FTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 197 --------~~s-------~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.++ ..+++||.+||..||.+|+|+.++|+||||+.
T Consensus 702 ~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 702 GSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 011 24789999999999999999999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=275.99 Aligned_cols=208 Identities=23% Similarity=0.379 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
-..+..|+.||-+++||||++|.++......+.||.|||++|+|..+|+. ++.|+.-+..-+++-|++|++||-+.|+|
T Consensus 674 rrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YV 753 (996)
T KOG0196|consen 674 RRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYV 753 (996)
T ss_pred HhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCch
Confidence 45688899999999999999999999999999999999999999999975 56799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCC--CCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt--~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
||||-..|||++.+-.+|++|||++++.+... +....+..|. ..|.|||.+..+.+ +.++||||+||++||.++ |
T Consensus 754 HRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 754 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred hhhhhhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccC
Confidence 99999999999999999999999999776532 3334444443 57999999998877 589999999999998776 9
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.-||.+.+.++..+.|..+- .+.|..+|..+.+|+..||++|-.+||+++||+.
T Consensus 832 ERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 832 ERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 99999999999999887764 4556679999999999999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=267.17 Aligned_cols=212 Identities=20% Similarity=0.296 Sum_probs=157.2
Q ss_pred HHHHHHHHhCCCCCc-----ceeeEEEEe--------CCEEEEEEecCCCCChHHHHHhCC-------------------
Q 015814 20 KREVATMKLVKHPNV-----VRLYEVMGS--------KTKIFIVLEFVTGGELFDKIVNHG------------------- 67 (400)
Q Consensus 20 ~~Ei~il~~l~HpnI-----v~l~~~~~~--------~~~~~lv~Ey~~gg~L~~~i~~~~------------------- 67 (400)
..|+.++.+++|.++ +++++++.. ....|+||||+++|+|.+++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 357777888876654 666666542 356899999999999999886421
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCC
Q 015814 68 -----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 142 (400)
Q Consensus 68 -----~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 142 (400)
.++...++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ........+|+.|+|
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP 378 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence 23556789999999999999999999999999999999999999999999986543211 111112345899999
Q ss_pred ChhhhcCC--------------------CC-CChhhHHHHHHHHHHHHhCCC-CCCCCch-----------HHHHHhhhc
Q 015814 143 PEVLNDRG--------------------YD-GSTADLWSCGVILFVLLAGYL-PFDDSNL-----------MNLYKKISA 189 (400)
Q Consensus 143 PEvl~~~~--------------------~~-~~~~DIwSlGiil~elltG~~-Pf~~~~~-----------~~~~~~i~~ 189 (400)
||++.... |. ....||||+||++|+|++|.+ ||.+... ...++.+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99985322 11 124799999999999999986 7754221 112222333
Q ss_pred CccCCCC--CCCHHHHHHHHHhcCCCC---CCCCCHHHHhcCcccccC
Q 015814 190 AEFTCPP--WLSFTARKLIARILDPNP---MTRITIPEILEDEWFKKD 232 (400)
Q Consensus 190 ~~~~~~~--~~s~~~~~li~~mL~~dP---~~R~t~~eil~h~~~~~~ 232 (400)
..+.++. ..++.+++|+.+||..+| .+|+|++|+|+||||...
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 3444443 478999999999999876 689999999999999753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=262.00 Aligned_cols=214 Identities=19% Similarity=0.285 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..-..+.+||++|.+|+|||||++++++..+..+++++||++.|+|..++..+. .+.......++.||++|++||.+.
T Consensus 577 ~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~ 656 (807)
T KOG1094|consen 577 NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL 656 (807)
T ss_pred hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh
Confidence 335789999999999999999999999999999999999999999999998874 234455667999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA- 170 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt- 170 (400)
++|||||.|.|+|++.++++||+|||+|+-.-.....+......-...|||||.+.-..+ +.++|+|++|+++||+++
T Consensus 657 nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~ 735 (807)
T KOG1094|consen 657 NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFML 735 (807)
T ss_pred chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHH
Confidence 999999999999999999999999999874322111111112233578999999987666 599999999999999764
Q ss_pred -CCCCCCCCchHHHHHhhhc--------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 171 -GYLPFDDSNLMNLYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 171 -G~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
..-||...+.++....... .....|+-++..+.+|+-.||..+-.+|||++++ |.+|+
T Consensus 736 C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq 802 (807)
T KOG1094|consen 736 CREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQ 802 (807)
T ss_pred HhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHH
Confidence 8999988776665554321 1235567789999999999999999999999998 44554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=273.76 Aligned_cols=217 Identities=24% Similarity=0.418 Sum_probs=182.6
Q ss_pred hHHHhhHHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------C
Q 015814 6 LSKYLDAFCILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------R 68 (400)
Q Consensus 6 ~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~ 68 (400)
++...+. .-.+.+..|+++|+.+ +||||+.+.+++...+..++|+||+..|+|.++++..+ .
T Consensus 336 ~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~ 414 (609)
T KOG0200|consen 336 LKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDA 414 (609)
T ss_pred cccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCC
Confidence 3333344 3468899999999999 69999999999999999999999999999999998765 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCC--CCCChhh
Q 015814 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN--YVAPEVL 146 (400)
Q Consensus 69 l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~--y~APEvl 146 (400)
++......+..|++.|++||++..++||||-..|||+.++..+||+|||+|+......... .....|+.+ |||||.+
T Consensus 415 L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl 493 (609)
T KOG0200|consen 415 LTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESL 493 (609)
T ss_pred cCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHh
Confidence 8888999999999999999999999999999999999999999999999998543321111 111223344 9999999
Q ss_pred hcCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCc-hHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 147 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN-LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 147 ~~~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~~-~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
....| +.++||||+||+|||+++ |..||.+-. ..+++..+..|. ...|..++.++.++++.||+.+|.+||++.++
T Consensus 494 ~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 494 FDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred ccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 98666 589999999999999998 999999854 556676666664 47788899999999999999999999999998
Q ss_pred hc
Q 015814 224 LE 225 (400)
Q Consensus 224 l~ 225 (400)
.+
T Consensus 573 ~~ 574 (609)
T KOG0200|consen 573 VE 574 (609)
T ss_pred HH
Confidence 75
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=278.56 Aligned_cols=183 Identities=32% Similarity=0.546 Sum_probs=145.4
Q ss_pred EEEEEEecCCCCChHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccc-
Q 015814 46 KIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ- 123 (400)
Q Consensus 46 ~~~lv~Ey~~gg~L~~~i~~~~~l-~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~- 123 (400)
.+||-||||+...|.+.|..+... ..+.++++|+||++||.|+|++|||||||||.||+++++++|||+|||+|+...
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~ 749 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKE 749 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhh
Confidence 579999999986666666554333 478999999999999999999999999999999999999999999999998621
Q ss_pred -------------c--ccCCCccccccCCCCCCCChhhhcCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCc-hHHHHH
Q 015814 124 -------------Q--VRDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYK 185 (400)
Q Consensus 124 -------------~--~~~~~~~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGiil~elltG~~Pf~~~~-~~~~~~ 185 (400)
. .......++..||--|+|||++.+.. .+..++|+||||||++||+ .||...- ......
T Consensus 750 ~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~ 826 (1351)
T KOG1035|consen 750 NLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILT 826 (1351)
T ss_pred hhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHH
Confidence 0 01112445678999999999998766 2349999999999999998 5665432 234555
Q ss_pred hhhcCccCCCCCC----CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 186 KISAAEFTCPPWL----SFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 186 ~i~~~~~~~~~~~----s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.+..+..+.|+.+ -+.-..+|++||+.||.+|||+.|+|++.||..
T Consensus 827 ~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 827 NLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred hcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 5666666665322 245678999999999999999999999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=285.87 Aligned_cols=215 Identities=31% Similarity=0.548 Sum_probs=184.1
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecc
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 97 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrD 97 (400)
.+..|+.+-..++|||++.....+.....++-+||||++ +|+..+...+.+....+..+++||+.||+|+|..||.|||
T Consensus 367 ~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrd 445 (601)
T KOG0590|consen 367 NITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRD 445 (601)
T ss_pred hhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceecc
Confidence 378899999999999998887777666666666999999 9999999988999999999999999999999999999999
Q ss_pred CCCCcEEEccCCCeeeeccccccccccccCC--CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 98 LKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 98 lKP~NILl~~~g~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
+||+|++++.+|.+||+|||.+.++...... ......+|+.+|+|||++....|+...+||||+|+++..|.+|+.||
T Consensus 446 lK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~W 525 (601)
T KOG0590|consen 446 LKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPW 525 (601)
T ss_pred CccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcc
Confidence 9999999999999999999999887765554 45667899999999999999999999999999999999999999999
Q ss_pred CCCchHHHH--Hhh-------hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNLY--KKI-------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~--~~i-------~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
..+...+.. ... ..+....-..++...+.+|.+||++||.+|+|+++|++++||+.-.
T Consensus 526 k~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 526 KVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 776544221 111 1111112223788999999999999999999999999999998643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=287.07 Aligned_cols=196 Identities=21% Similarity=0.338 Sum_probs=154.9
Q ss_pred HHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HcCCeec
Q 015814 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH---SRGVYHR 96 (400)
Q Consensus 20 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH---~~givHr 96 (400)
.+|++++++++|||||++++++.+....|+||||++||+|.+++. .+++..+..++.|++.|++||| +.+|+||
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 807 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence 457899999999999999999999999999999999999999995 3889999999999999999999 6699999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
||||+||+++.++..++. ||.+..... .....||+.|+|||++.+..|. .++||||+||++|||++|+.||+
T Consensus 808 dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred CCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCC
Confidence 999999999998888876 665433211 1234689999999999877774 89999999999999999999996
Q ss_pred CCch-----HHHHHhhh-cC------ccCC------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 177 DSNL-----MNLYKKIS-AA------EFTC------PPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 177 ~~~~-----~~~~~~i~-~~------~~~~------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
.... .+..+... .. .... +.....++.+++.+||+.||.+|||+.|+++.
T Consensus 880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 4221 11111100 00 0000 01112356789999999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=227.13 Aligned_cols=159 Identities=21% Similarity=0.245 Sum_probs=129.1
Q ss_pred CChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCcccccc
Q 015814 57 GELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135 (400)
Q Consensus 57 g~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~ 135 (400)
|+|.+.+... .++++..++.++.|++.||+|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 6899999874 46999999999999999999999999 999999999999999 9998764331 236
Q ss_pred CCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchH-HHHHhhhcCccC-------CCCCCCH--HHHHH
Q 015814 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFT-------CPPWLSF--TARKL 205 (400)
Q Consensus 136 gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~-~~~~~i~~~~~~-------~~~~~s~--~~~~l 205 (400)
||+.|+|||++.+..|. .++||||+||++|+|++|+.||...... .....+...... .+..++. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999888775 8999999999999999999999765432 333332221111 1112333 69999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 206 IARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 206 i~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|.+||..||.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=224.89 Aligned_cols=167 Identities=25% Similarity=0.500 Sum_probs=137.7
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK----IVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~----i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+++.+|+.+..+. ..|.+|++|+.+..+..+||.||.+.. +|..+ +...+.++|..+-+++..++.||.|||
T Consensus 87 ~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~ 165 (282)
T KOG0984|consen 87 EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH 165 (282)
T ss_pred HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH
Confidence 367788899886555 899999999999999999999999976 66433 344567999999999999999999999
Q ss_pred Hc-CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCcccc-ccCCCCCCCChhhh----cCCCCCChhhHHHHHH
Q 015814 90 SR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN----DRGYDGSTADLWSCGV 163 (400)
Q Consensus 90 ~~-givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~-~~gt~~y~APEvl~----~~~~~~~~~DIwSlGi 163 (400)
++ .|+|||+||.|||++.+|++||||||.+..... ....+ ..|..+|||||.+. ..+|+ -++||||||+
T Consensus 166 ~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d----SiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGI 240 (282)
T KOG0984|consen 166 SKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD----SIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGI 240 (282)
T ss_pred HHhhhhhccCCcceEEEccCCcEEEcccccceeehh----hhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhh
Confidence 88 999999999999999999999999999876542 22223 57889999999984 34565 8999999999
Q ss_pred HHHHHHhCCCCCCCC-chHHHHHhh
Q 015814 164 ILFVLLAGYLPFDDS-NLMNLYKKI 187 (400)
Q Consensus 164 il~elltG~~Pf~~~-~~~~~~~~i 187 (400)
+++||.+++.||+.- ++-++.+.+
T Consensus 241 tmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 241 TMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hhhhhhhccccccccCCHHHHHHHH
Confidence 999999999999753 333444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=256.85 Aligned_cols=157 Identities=31% Similarity=0.586 Sum_probs=145.1
Q ss_pred HHHHHHHHHHHhCC---CCCcceeeEEEEeCCEEEEEEec-CCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 17 LQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 17 ~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~Ey-~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
-.+-.||+||..|+ |+||++++++|++.+++|++||- -+|-+||++|+-..+++|.++..+|+|++.|+++||++|
T Consensus 611 GtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ 690 (772)
T KOG1152|consen 611 GTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG 690 (772)
T ss_pred CccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC
Confidence 34567999999998 99999999999999999999996 456799999999999999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+|||||-||+.++.+|-+||+|||.|...+ .+......||..|.|||++.+.+|.|.+-|||++||+||.++...
T Consensus 691 ivhrdikdenvivd~~g~~klidfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred ceecccccccEEEecCCeEEEeeccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence 9999999999999999999999999987654 455678899999999999999999999999999999999999988
Q ss_pred CCCCC
Q 015814 173 LPFDD 177 (400)
Q Consensus 173 ~Pf~~ 177 (400)
.||.+
T Consensus 767 npyyn 771 (772)
T KOG1152|consen 767 NPYYN 771 (772)
T ss_pred CCCcC
Confidence 88853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=258.67 Aligned_cols=214 Identities=27% Similarity=0.450 Sum_probs=186.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..-+.+||-+++-++|||||-+++.|-.....|+.||||.||+|.+.-.-.+.++|.++....+..+.|++|||++|-+|
T Consensus 56 ~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~h 135 (829)
T KOG0576|consen 56 FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIH 135 (829)
T ss_pred ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCccc
Confidence 46678899999999999999999999999999999999999999998888899999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh---cCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||-.|||+++.|.+|++|||.+...... -....+..|||.|||||+.. ..+|. ..+|||++|+...|+---+
T Consensus 136 RdiKGanilltd~gDvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLq 212 (829)
T KOG0576|consen 136 RDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQ 212 (829)
T ss_pred ccccccceeecccCceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcC
Confidence 999999999999999999999988654432 12234678999999999873 45564 9999999999999999989
Q ss_pred CCCCCCchHHHHHhhhcCccCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~-----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.|......+..........+..|. .+++.+-+|++.+|.++|.+|||++.+|+|||....
T Consensus 213 pplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 213 PPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 997776666655555555554443 378999999999999999999999999999999753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=239.33 Aligned_cols=214 Identities=26% Similarity=0.427 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....|..|++.|..+ .+.||+++.+++..++...+||||++..+-.++... ++-..++.|++.++.||+++|.+||
T Consensus 77 ~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GI 153 (418)
T KOG1167|consen 77 SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGI 153 (418)
T ss_pred CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCc
Confidence 357799999999999 699999999999999999999999999877777643 6789999999999999999999999
Q ss_pred eeccCCCCcEEEccC-CCeeeecccccccccccc--------------C-----------------C-----------Cc
Q 015814 94 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVR--------------D-----------------D-----------GL 130 (400)
Q Consensus 94 vHrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~--------------~-----------------~-----------~~ 130 (400)
|||||||.|+|.+.. +.-.|.|||+|....... . . ..
T Consensus 154 vHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~ 233 (418)
T KOG1167|consen 154 VHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSE 233 (418)
T ss_pred cccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccce
Confidence 999999999999874 778999999986211000 0 0 00
Q ss_pred cccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCc-----hHHHH---------------------
Q 015814 131 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-----LMNLY--------------------- 184 (400)
Q Consensus 131 ~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~-----~~~~~--------------------- 184 (400)
...+.|||+|+|||++..-+-.++++||||+|||+..+++++.||-... ..++.
T Consensus 234 ~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~ 313 (418)
T KOG1167|consen 234 RANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLW 313 (418)
T ss_pred ecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeee
Confidence 1124699999999999988888899999999999999999999983211 01100
Q ss_pred H---------------hhh-cCccCCC----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 185 K---------------KIS-AAEFTCP----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 185 ~---------------~i~-~~~~~~~----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
+ ... ....... ...+..+.+|+.+||..||.+|+|+++.|+||||..
T Consensus 314 ~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 314 QKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0 000 0000000 114568999999999999999999999999999983
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=255.34 Aligned_cols=208 Identities=23% Similarity=0.380 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+..|+-+|.+++|||++++++++.... ..||++|+++|+|.|+++.++ .+.......|..||++|+.|||.++++
T Consensus 742 s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlV 820 (1177)
T KOG1025|consen 742 SIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLV 820 (1177)
T ss_pred hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchh
Confidence 577889999999999999999999987655 889999999999999998754 789999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||-..|+|+.+-.++||.|||+|+.......+.......-.+.|||=|.+....| +.++||||+||++||++| |.-
T Consensus 821 HrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~ 899 (1177)
T KOG1025|consen 821 HRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAK 899 (1177)
T ss_pred hhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCC
Confidence 999999999999999999999999988765433322222223467999999998877 499999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|+++....++...+..+ +.+.|+.++.++..++.+||..|+..||+++++-.
T Consensus 900 Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 900 PYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999988888777655 46889999999999999999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=214.45 Aligned_cols=179 Identities=43% Similarity=0.791 Sum_probs=159.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.+++.+.|++|+++++++......+++|||+.|++|.+++... ..++...+..++.|++.++.+||+.|++
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 114 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 478999999999999999999999999999999999999999999999775 4789999999999999999999999999
Q ss_pred eccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 95 HRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
|+||+|.||+++. ++.++|+|||.+........ ......++..|++||.+......+.++|+||+|++++++
T Consensus 115 H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----- 187 (215)
T cd00180 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----- 187 (215)
T ss_pred ccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----
Confidence 9999999999999 89999999999876543211 123456788999999997652445889999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 227 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~ 227 (400)
..+.+++.+||..||.+||++.++++|+
T Consensus 188 --------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6788999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=236.56 Aligned_cols=95 Identities=26% Similarity=0.421 Sum_probs=81.6
Q ss_pred hhHHHHHHHHHHHHHHHHhCC-----C---CCcceeeEEEE----eCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHH
Q 015814 10 LDAFCILLQIKREVATMKLVK-----H---PNVVRLYEVMG----SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEAR 75 (400)
Q Consensus 10 ~~~~~~~~~i~~Ei~il~~l~-----H---pnIv~l~~~~~----~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~ 75 (400)
..+....+....||.+|++++ | .+||+|++.|. ++.++|+|+|+. |.+|..+|... ++++...++
T Consensus 112 KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK 190 (590)
T KOG1290|consen 112 KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVK 190 (590)
T ss_pred ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHH
Confidence 344455677788999999884 3 36999999986 467899999999 66999999764 479999999
Q ss_pred HHHHHHHHHHHHHHHc-CCeeccCCCCcEEE
Q 015814 76 RYFQQLINAVDYCHSR-GVYHRDLKPENLLL 105 (400)
Q Consensus 76 ~~~~qll~~l~~LH~~-givHrDlKP~NILl 105 (400)
.|++|++.||.|||.+ ||+|-||||||||+
T Consensus 191 ~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 191 EICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 9999999999999976 99999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=211.14 Aligned_cols=180 Identities=41% Similarity=0.695 Sum_probs=154.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+..++.++|+|++++++.+......++++||+++++|.+.+..... +++..+..++.|++.++.+||++|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 119 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI 119 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 467899999999999999999999999999999999999999999999988766 8999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhh-hcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl-~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+|+||+|.||+++.++.++|+|||++........ .......++..|++||.+ ....+. .++|+||||+++++|++|+
T Consensus 120 ~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~ 197 (225)
T smart00221 120 VHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGP 197 (225)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999876544321 123456788999999998 444454 6899999999999999999
Q ss_pred CCCCC-Cc-hHHHHHhhhcCccCCCC
Q 015814 173 LPFDD-SN-LMNLYKKISAAEFTCPP 196 (400)
Q Consensus 173 ~Pf~~-~~-~~~~~~~i~~~~~~~~~ 196 (400)
.||+. .+ ...+.+.+..+.+...+
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 198 EPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred CCccccchhHHHHHHHHhcCCccccc
Confidence 99987 44 44777777776655444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=226.62 Aligned_cols=207 Identities=22% Similarity=0.307 Sum_probs=162.1
Q ss_pred HHHHHHHHHHHH--hCCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMK--LVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~--~l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
.+++..|-+|.+ .++|+||+++++.-...+ .+++|++|.+.|+|.+++..+ .++.....+++..++.||+|||
T Consensus 246 kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LH 324 (534)
T KOG3653|consen 246 KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLH 324 (534)
T ss_pred HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhc
Confidence 356666777766 458999999998866555 799999999999999999884 5899999999999999999999
Q ss_pred H---------cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCC-----CCh
Q 015814 90 S---------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-----GST 155 (400)
Q Consensus 90 ~---------~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~-----~~~ 155 (400)
+ ..|+|||||..|||+.++++.-|+|||||..+......+......||.+|||||++-+.-.. -..
T Consensus 325 ee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr 404 (534)
T KOG3653|consen 325 EELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKR 404 (534)
T ss_pred ccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHH
Confidence 6 35999999999999999999999999999887765555666678999999999999653221 136
Q ss_pred hhHHHHHHHHHHHHhCC------------CCCC-----CCchHHHHHhh--hcCccCCCCC-----CCHHHHHHHHHhcC
Q 015814 156 ADLWSCGVILFVLLAGY------------LPFD-----DSNLMNLYKKI--SAAEFTCPPW-----LSFTARKLIARILD 211 (400)
Q Consensus 156 ~DIwSlGiil~elltG~------------~Pf~-----~~~~~~~~~~i--~~~~~~~~~~-----~s~~~~~li~~mL~ 211 (400)
.||||+|.||||+++.- +||. .++..++.... .+.++.+|.. -..-+++.+..||+
T Consensus 405 ~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWD 484 (534)
T KOG3653|consen 405 IDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWD 484 (534)
T ss_pred HHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcC
Confidence 89999999999999842 2332 13333333332 2233444432 23467899999999
Q ss_pred CCCCCCCCHHHH
Q 015814 212 PNPMTRITIPEI 223 (400)
Q Consensus 212 ~dP~~R~t~~ei 223 (400)
.||+-|.|+.=+
T Consensus 485 hDaeARLTA~Cv 496 (534)
T KOG3653|consen 485 HDAEARLTAGCV 496 (534)
T ss_pred CchhhhhhhHHH
Confidence 999999998644
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=223.57 Aligned_cols=208 Identities=24% Similarity=0.426 Sum_probs=159.7
Q ss_pred HHHHHHHHHHH--hCCCCCcceeeEEEEe--C--CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMK--LVKHPNVVRLYEVMGS--K--TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 17 ~~i~~Ei~il~--~l~HpnIv~l~~~~~~--~--~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
....+|.+|.. .|+|+||+.+++.-.. + +.+|+|.+|-+.|+|+|++.. ..++...+.+++..+++||+|||.
T Consensus 248 ~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~ 326 (513)
T KOG2052|consen 248 RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHM 326 (513)
T ss_pred hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHH
Confidence 45566666665 5699999999987432 2 358999999999999999988 679999999999999999999995
Q ss_pred c--------CCeeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCC----CCC-Ch
Q 015814 91 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRG----YDG-ST 155 (400)
Q Consensus 91 ~--------givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~----~~~-~~ 155 (400)
. .|+|||||..|||+.++|.+-|+|+|||-....... +-..+.++||..|||||++...- +.+ ..
T Consensus 327 eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ 406 (513)
T KOG2052|consen 327 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKR 406 (513)
T ss_pred HHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhH
Confidence 2 499999999999999999999999999976554321 22345789999999999996422 111 46
Q ss_pred hhHHHHHHHHHHHHhC----------CCCCCC-----CchHHHHHhh--hcCccCCCC-CCCH----HHHHHHHHhcCCC
Q 015814 156 ADLWSCGVILFVLLAG----------YLPFDD-----SNLMNLYKKI--SAAEFTCPP-WLSF----TARKLIARILDPN 213 (400)
Q Consensus 156 ~DIwSlGiil~elltG----------~~Pf~~-----~~~~~~~~~i--~~~~~~~~~-~~s~----~~~~li~~mL~~d 213 (400)
+||||+|.|+||++.. ++||.+ ++.+++.+-+ .+..+..|. |-|. .+..+++.||..|
T Consensus 407 ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~N 486 (513)
T KOG2052|consen 407 ADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYAN 486 (513)
T ss_pred HHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCC
Confidence 9999999999998752 678854 4445555443 333444544 4343 3457889999999
Q ss_pred CCCCCCHHHHhc
Q 015814 214 PMTRITIPEILE 225 (400)
Q Consensus 214 P~~R~t~~eil~ 225 (400)
|.-|.|+--|.+
T Consensus 487 p~aRltALriKK 498 (513)
T KOG2052|consen 487 PAARLTALRIKK 498 (513)
T ss_pred chhhhHHHHHHH
Confidence 999999866643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=216.55 Aligned_cols=218 Identities=25% Similarity=0.418 Sum_probs=168.7
Q ss_pred HhhHHHHHHHHHHHHHHHHhC-CCCCcceeeEE-EEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 015814 9 YLDAFCILLQIKREVATMKLV-KHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 9 ~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~-~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~ 86 (400)
+....-.+..+.+|...--.| .|.||+.-|++ |++.+.+.+++||++.|+|..-+.. .++.|.....++.|+++|++
T Consensus 57 vp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~ 135 (378)
T KOG1345|consen 57 VPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIE 135 (378)
T ss_pred cCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHH
Confidence 334445578888998876666 59999998876 7888899999999999999988876 56899999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEcc--CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC---C-CCChhhHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG---Y-DGSTADLWS 160 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~--~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~-~~~~~DIwS 160 (400)
|||++++||||||.+|||+-. .-.+|+||||+++..+ ......--+..|.|||++.... + -.+.+|||.
T Consensus 136 fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wq 210 (378)
T KOG1345|consen 136 FMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQ 210 (378)
T ss_pred HhhccchhhcccccceEEEecCCccEEEeeecccccccC-----ceehhhhhhcccCCcHHHhhccccceEecccccchh
Confidence 999999999999999999954 3479999999876432 2223334567899999885432 1 135689999
Q ss_pred HHHHHHHHHhCCCCCCCCchHH----HHHhhhcC-ccCCCCC---CCHHHHHHHHHhcCCCCCCC---CCHHHHhcCccc
Q 015814 161 CGVILFVLLAGYLPFDDSNLMN----LYKKISAA-EFTCPPW---LSFTARKLIARILDPNPMTR---ITIPEILEDEWF 229 (400)
Q Consensus 161 lGiil~elltG~~Pf~~~~~~~----~~~~i~~~-~~~~~~~---~s~~~~~li~~mL~~dP~~R---~t~~eil~h~~~ 229 (400)
|||++|.++||.+||+....++ .+.++..+ ....|.. +|+.+..+.++-|..+|++| -++..-....|.
T Consensus 211 fGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 211 FGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred eeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 9999999999999998544332 22233333 2334433 79999999999999999999 566666777776
Q ss_pred ccC
Q 015814 230 KKD 232 (400)
Q Consensus 230 ~~~ 232 (400)
...
T Consensus 291 E~~ 293 (378)
T KOG1345|consen 291 EKL 293 (378)
T ss_pred Hhh
Confidence 543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=212.31 Aligned_cols=209 Identities=20% Similarity=0.242 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhCC--------CCCHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHG--------RMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~~--------~l~e~~~~~~~~qll~~l~ 86 (400)
+..+..|--.+.-+.|||+..+.++... ...-+.++.+..-|+|..++...+ .++..+...++.|+..|++
T Consensus 331 v~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~ 410 (563)
T KOG1024|consen 331 VNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAME 410 (563)
T ss_pred HHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHH
Confidence 3446678778888899999999998754 445677788888899999887322 3566778889999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
|||++||+|.||-..|.++|+.-++||+|=.+++..........-........||+||.+....|+ ..+|+||||++||
T Consensus 411 hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllW 489 (563)
T KOG1024|consen 411 HLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLW 489 (563)
T ss_pred HHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHH
Confidence 999999999999999999999999999999988754433322222223345679999999998885 8999999999999
Q ss_pred HHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 167 VLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 167 ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||+| |+.|+.+-++.+++..+..|. ...|-.+|.++..++..||...|++||+++|+..
T Consensus 490 ELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 490 ELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9998 999999999999988887774 5677789999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-24 Score=202.72 Aligned_cols=219 Identities=34% Similarity=0.597 Sum_probs=180.9
Q ss_pred HHHHHHHHHHHHHhCCCC-CcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
....+.+|+.++..+.|+ +|+++++.+......+++++|+.|+++.+.+.... .+++..+..++.|++.+++|+|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999988 79999999988888999999999999998887765 79999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCC-CeeeeccccccccccccCCC----ccccccCCCCCCCChhhhcC--CCCCChhhHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDG----LLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGV 163 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g-~~kl~DFGla~~~~~~~~~~----~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGi 163 (400)
.|++|||+||+||+++..+ .++++|||++.......... .....+||+.|+|||.+... .+.....|+||+|+
T Consensus 120 ~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~ 199 (384)
T COG0515 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199 (384)
T ss_pred CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHH
Confidence 9999999999999999988 69999999987544322211 34677899999999999874 45568999999999
Q ss_pred HHHHHHhCCCCCCCCch----HHHHHhhhcCccC-CCCCC--------CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 164 ILFVLLAGYLPFDDSNL----MNLYKKISAAEFT-CPPWL--------SFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 164 il~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~~~~~--------s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
+++++++|..||..... ......+...... ..... ...+.+++..++..+|..|.+..+...++|..
T Consensus 200 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 200 TLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred HHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 99999999999887763 3444444433332 22221 15789999999999999999999999887766
Q ss_pred cCC
Q 015814 231 KDY 233 (400)
Q Consensus 231 ~~~ 233 (400)
...
T Consensus 280 ~~~ 282 (384)
T COG0515 280 HLK 282 (384)
T ss_pred Ccc
Confidence 543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-27 Score=243.56 Aligned_cols=218 Identities=35% Similarity=0.618 Sum_probs=193.4
Q ss_pred HHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-
Q 015814 14 CILLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHG-RMKEDEARRYFQQLINAVDYCH- 89 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i-~~~~-~l~e~~~~~~~~qll~~l~~LH- 89 (400)
....++..|..+.+.+. |+|++++++........+++++|..||++++.+ ..+. ..++..+..++.|+..|+.|+|
T Consensus 62 ~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~ 141 (601)
T KOG0590|consen 62 DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP 141 (601)
T ss_pred chhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc
Confidence 34678889999999997 999999999999999999999999999999999 7776 7899999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCC-Ceeeecccccccccc-ccCCCccccccC-CCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQ-VRDDGLLHTTCG-TPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g-~~kl~DFGla~~~~~-~~~~~~~~~~~g-t~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
..++.||||||+|.+++..+ +++++|||+|+.+.. .+........|| ++.|+|||...+..|.++..|+||+|+++.
T Consensus 142 ~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~ 221 (601)
T KOG0590|consen 142 ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLS 221 (601)
T ss_pred ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccc
Confidence 99999999999999999999 999999999998877 566777788899 999999999998889999999999999999
Q ss_pred HHHhCCCCCCCCchHHHH-HhhhcC--ccCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 167 VLLAGYLPFDDSNLMNLY-KKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~-~~i~~~--~~~~~~~--~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.+++|..||......... ..+... .....+| ++....+++.++|..+|..|.+.+++..+||+..
T Consensus 222 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 222 AMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 999999999876654322 222222 2223334 8899999999999999999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=230.25 Aligned_cols=201 Identities=37% Similarity=0.623 Sum_probs=181.6
Q ss_pred HHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 18 QIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 18 ~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.-+.|-.++..++ ||.+++++..+++++..|++++|..||+|+..+.....+.+.....|...++-|++++|+.||+||
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyr 121 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYR 121 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence 3445778888886 999999999999999999999999999999999998899999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
|+|++||+++.+|++++.|||+++..-... ..|||.-|||||++. +.. ..+|.||+|++.|+|++|..||.
T Consensus 122 d~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 122 DYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred cccccceeecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCc
Confidence 999999999999999999999987643321 129999999999998 443 77999999999999999999998
Q ss_pred CCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 177 DSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 177 ~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
+ +....|...+...|..++..+.+++..++..+|.+|.. +.|+++|+||+.
T Consensus 193 ~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 193 G----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred h----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 8 66777777888999999999999999999999999975 479999999985
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=185.98 Aligned_cols=190 Identities=25% Similarity=0.378 Sum_probs=143.4
Q ss_pred CCCCcceeeEEEE---------------------------eCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHH
Q 015814 30 KHPNVVRLYEVMG---------------------------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 82 (400)
Q Consensus 30 ~HpnIv~l~~~~~---------------------------~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll 82 (400)
+|||||++..+|. .+..+|+||.-++. +|..++-. ...+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHH
Confidence 5999999998763 23468999998876 88888865 3467778888999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEc--cCC--Ceeeecccccccccccc----CCCccccccCCCCCCCChhhhcCC----
Q 015814 83 NAVDYCHSRGVYHRDLKPENLLLD--AYG--NLKVSDFGLSALSQQVR----DDGLLHTTCGTPNYVAPEVLNDRG---- 150 (400)
Q Consensus 83 ~~l~~LH~~givHrDlKP~NILl~--~~g--~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~---- 150 (400)
+|+.|||.+||.|||+|.+|||+. +++ .+.|+|||.+---...+ ...-.....|.-.-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999983 333 58999999753211100 011122456888999999986433
Q ss_pred -CCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHH-hh-hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 015814 151 -YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK-KI-SAAEFTCPPWLSFTARKLIARILDPNPMTRITIP 221 (400)
Q Consensus 151 -~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~-~i-~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ 221 (400)
.+-.++|.|++|.+.||+++...||.+...+.+-. .. ...-+..|..+++.+++|+..+|+.||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 12268999999999999999999998744332111 11 2233566777999999999999999999999853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=211.16 Aligned_cols=166 Identities=36% Similarity=0.695 Sum_probs=137.7
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeecccccccccccc----CCC---
Q 015814 57 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----DDG--- 129 (400)
Q Consensus 57 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~----~~~--- 129 (400)
|+-...+...+.++.+. +.+++|+|+.||+|||+||+|++++.-|++|+.|||++...--.. ...
T Consensus 136 gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~ 207 (1205)
T KOG0606|consen 136 GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE 207 (1205)
T ss_pred chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence 45566666666666554 889999999999999999999999999999999999975421100 000
Q ss_pred -----c-cccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCC---CCH
Q 015814 130 -----L-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW---LSF 200 (400)
Q Consensus 130 -----~-~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~s~ 200 (400)
. -...||||.|+||||+..++| |.++|+|++|+|+|+++-|..||.+.+.++++..........|.. +++
T Consensus 208 k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~ 286 (1205)
T KOG0606|consen 208 KDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPP 286 (1205)
T ss_pred HHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCH
Confidence 1 123499999999999999998 699999999999999999999999999999998877666555543 789
Q ss_pred HHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 015814 201 TARKLIARILDPNPMTRI---TIPEILEDEWFKK 231 (400)
Q Consensus 201 ~~~~li~~mL~~dP~~R~---t~~eil~h~~~~~ 231 (400)
+++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 287 Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 287 EAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred HHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 999999999999999996 5678999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-22 Score=212.82 Aligned_cols=204 Identities=24% Similarity=0.384 Sum_probs=155.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.+-..|++ ...++|||.+.+.-+..+....|+|-+|... +|+|+|..+.-+..-+.+.|+.||+.||.-||..||+|+
T Consensus 67 ~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHG 144 (1431)
T KOG1240|consen 67 KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHG 144 (1431)
T ss_pred HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 34444555 6677999999999998888999999999987 999999988888899999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCC-----ccccccCCCCCCCChhhhcCC----------CCCChhhHHHH
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-----LLHTTCGTPNYVAPEVLNDRG----------YDGSTADLWSC 161 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~~~----------~~~~~~DIwSl 161 (400)
|||.||||++.-+.+.|+||...+..-...++. ...+...-.+|.|||.+.... .-.++-||||+
T Consensus 145 DIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~ 224 (1431)
T KOG1240|consen 145 DIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSA 224 (1431)
T ss_pred ccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhh
Confidence 999999999999999999997543211111111 112333445899999886422 12457899999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHhhhcCccCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 162 GVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 162 Giil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||+++||++ |++||.-.. ++.- ..+.-..+ .--+...+.||..|++.||++|.++++.|+.
T Consensus 225 GCViaELf~Eg~PlF~LSQ---L~aY-r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 225 GCVIAELFLEGRPLFTLSQ---LLAY-RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHHHHHHHhcCCCcccHHH---HHhH-hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 999999987 899995321 1111 11111111 1124578999999999999999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-20 Score=178.61 Aligned_cols=207 Identities=26% Similarity=0.306 Sum_probs=161.6
Q ss_pred HHHHHHHHHHhCCC----CCcceeeEEE-EeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 18 QIKREVATMKLVKH----PNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 18 ~i~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
.++.|+.++..+.. +++..+++.. ..+...|+||+.+ |.+|.+..... ++++..++..++.|++.+|++||+
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 68889999999973 6899999999 5888999999988 67999977543 579999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccC-----CCeeeeccccccccccccCCC-------c-cccccCCCCCCCChhhhcCCCCCChhh
Q 015814 91 RGVYHRDLKPENLLLDAY-----GNLKVSDFGLSALSQQVRDDG-------L-LHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~-----g~~kl~DFGla~~~~~~~~~~-------~-~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
.|++||||||+|+++... ..+.|.|||+|+.+....... . .....||..|+++.+..+... +...|
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DD 219 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDD 219 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchh
Confidence 999999999999999865 359999999998433211111 1 123459999999999987665 58999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHH---HhhhcCccC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLAGYLPFDDSNLMNLY---KKISAAEFT--CPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~elltG~~Pf~~~~~~~~~---~~i~~~~~~--~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+||++-++.+++.|.+||.+....... ......... .....+.++..+...+-..+...+|....+...
T Consensus 220 les~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 220 LESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 999999999999999999775532222 222211111 233456777888888888899999998887653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=185.37 Aligned_cols=123 Identities=25% Similarity=0.270 Sum_probs=99.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcce-eeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVR-LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~-l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+++|+++|++++|+||+. +++. ...|+||||++|++|.. +.. .. ...++.|++.||+|||++||
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gI 132 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGI 132 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCC
Confidence 3567999999999999999985 5442 45799999999999963 211 11 14689999999999999999
Q ss_pred eeccC-CCCcEEEccCCCeeeeccccccccccccCCCc------cccccCCCCCCCChhhhc
Q 015814 94 YHRDL-KPENLLLDAYGNLKVSDFGLSALSQQVRDDGL------LHTTCGTPNYVAPEVLND 148 (400)
Q Consensus 94 vHrDl-KP~NILl~~~g~~kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~APEvl~~ 148 (400)
+|||| ||+|||++.++.+||+|||+|+.......... +.+.+|++.|+|||.+..
T Consensus 133 iHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 133 THNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999 99999999999999999999987654332221 246689999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=163.46 Aligned_cols=150 Identities=18% Similarity=0.227 Sum_probs=115.2
Q ss_pred HHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 18 QIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 18 ~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.+++|+++|++|. |++|++++++ ...|++|||+.|.+|...+.. . ...++.|++.+|+++|++||+||
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHr 115 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHN 115 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccC
Confidence 4789999999995 5889999886 346999999999998654321 1 13578999999999999999999
Q ss_pred cC-CCCcEEEccCCCeeeeccccccccccccCC-Cc----------cccccCCCCCCCChhhhcC-CCCCChhhHHHHHH
Q 015814 97 DL-KPENLLLDAYGNLKVSDFGLSALSQQVRDD-GL----------LHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGV 163 (400)
Q Consensus 97 Dl-KP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~----------~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGi 163 (400)
|| ||+|||++.+|.++|+|||+|......... .. ..-...++.|++|+.-.-- ..+-...+.++-|+
T Consensus 116 DL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~ 195 (218)
T PRK12274 116 DLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGK 195 (218)
T ss_pred CCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence 99 799999999999999999999754432110 00 1123478899999864322 12225678889999
Q ss_pred HHHHHHhCCCCCCCC
Q 015814 164 ILFVLLAGYLPFDDS 178 (400)
Q Consensus 164 il~elltG~~Pf~~~ 178 (400)
-+|.++|+.+|+.+.
T Consensus 196 ~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 196 PVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHhccCCcccc
Confidence 999999999997543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-20 Score=167.68 Aligned_cols=199 Identities=22% Similarity=0.380 Sum_probs=163.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcC--
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRG-- 92 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH~~g-- 92 (400)
..+..|.-.|+...||||+.+++.+.+..+..++..|++.|+|+..+..... ++..+|.+++..++.|++|||+..
T Consensus 232 rdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ 311 (448)
T KOG0195|consen 232 RDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM 311 (448)
T ss_pred chhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh
Confidence 3456677788889999999999999999999999999999999999977553 577899999999999999999873
Q ss_pred CeeccCCCCcEEEccCCCeeee--ccccccccccccCCCccccccCCCCCCCChhhhcCCCC--CChhhHHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVS--DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD--GSTADLWSCGVILFVL 168 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~--~~~~DIwSlGiil~el 168 (400)
|----|....+++|++-+.+|+ |--++. + ...+.-+|.||+||.++.++-+ -.++|+||+++++|||
T Consensus 312 ipr~~lns~hvmidedltarismad~kfsf--q-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel 382 (448)
T KOG0195|consen 312 IPRFYLNSKHVMIDEDLTARISMADTKFSF--Q-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWEL 382 (448)
T ss_pred hhhhhcccceEEecchhhhheecccceeee--e-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHh
Confidence 4444688899999998776654 433221 1 1123458999999999877644 3579999999999999
Q ss_pred HhCCCCCCCCchHHHHHhh--hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 169 LAGYLPFDDSNLMNLYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil 224 (400)
.|...||.+-+.++.--++ .......||.+|..+..|+.-|++.||.+||.++.|.
T Consensus 383 ~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 383 NTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999998887765554 4456789999999999999999999999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=186.28 Aligned_cols=209 Identities=23% Similarity=0.351 Sum_probs=151.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeE-------EEE-----eCCEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYE-------VMG-----SKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYF 78 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~-------~~~-----~~~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~ 78 (400)
+......+++-.+....|.+..-+.+ .+. ...+.||.|++|...+|.++|.... .-+...+..++
T Consensus 286 ~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~ 365 (516)
T KOG1033|consen 286 CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIF 365 (516)
T ss_pred hhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHH
Confidence 34455566666666664444433333 111 1235899999999999999997544 35667899999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeecccccccccccc----CCCccccccCCCCCCCChhhhcCCCCCC
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----DDGLLHTTCGTPNYVAPEVLNDRGYDGS 154 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~~~~~ 154 (400)
.|+..|++| +|.+|||+||.||+...++.+||+|||+.+-..... .....+...||++||+||.+.+..|. .
T Consensus 366 ~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~ 441 (516)
T KOG1033|consen 366 KQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-E 441 (516)
T ss_pred Hhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-h
Confidence 999999999 999999999999999999999999999977544322 11123456799999999999998885 9
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCccCCCCCC-CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 155 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPPWL-SFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 155 ~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
++||||||+||+|++. =..++.. ......+..+.++..-+. .+.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 442 kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 442 KVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 9999999999999986 3333321 222333344443321222 2455699999999999999988877777775
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-19 Score=178.76 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=157.3
Q ss_pred HHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC-eeccCCCCcE
Q 015814 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV-YHRDLKPENL 103 (400)
Q Consensus 26 l~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~gi-vHrDlKP~NI 103 (400)
|+.+.|.|+.++++...++...++|.+||.-|+|.|.+.. ..+++.-....+.+.++.|+.|+|+--| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 4467888888899999999999998755 9999999999
Q ss_pred EEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC------CCChhhHHHHHHHHHHHHhCCCCCCC
Q 015814 104 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY------DGSTADLWSCGVILFVLLAGYLPFDD 177 (400)
Q Consensus 104 Ll~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~------~~~~~DIwSlGiil~elltG~~Pf~~ 177 (400)
++|....+||+|||+.................-..-|.|||.+..... -+.++||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999776542111111122223456999999976422 24569999999999999999999976
Q ss_pred Cch----HHHHHhhhc-CccCCCC------CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 178 SNL----MNLYKKISA-AEFTCPP------WLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 178 ~~~----~~~~~~i~~-~~~~~~~------~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
... .++...+.. +...+-| ...+++..+++.||..+|..||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 332 234444444 2222222 23457899999999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=164.01 Aligned_cols=161 Identities=27% Similarity=0.337 Sum_probs=105.9
Q ss_pred EEEEEecCCCCChHHHHHh---CCCC---CHHHH-HHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccc
Q 015814 47 IFIVLEFVTGGELFDKIVN---HGRM---KEDEA-RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 119 (400)
Q Consensus 47 ~~lv~Ey~~gg~L~~~i~~---~~~l---~e~~~-~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla 119 (400)
.+++|+-+.+ +|.+.+.. .... ....| ..+..|++..+++||+.|++|+||||+|++++.+|.+.|+||+..
T Consensus 114 ~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 114 RFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp EEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 3678888865 88777642 2222 12234 344589999999999999999999999999999999999999865
Q ss_pred cccccccCCCccccccCCCCCCCChhhhcCC-------CCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCcc
Q 015814 120 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-------YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 192 (400)
Q Consensus 120 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-------~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~ 192 (400)
...+.. ......+..|.+||...... ..+.+.|.|+||+++|.|.+|..||........... .--
T Consensus 193 ~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---~f~ 264 (288)
T PF14531_consen 193 VRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---DFS 264 (288)
T ss_dssp EETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---GGT
T ss_pred eecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---cch
Confidence 543321 11134567899999875531 124789999999999999999999987654322221 111
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCC
Q 015814 193 TCPPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 193 ~~~~~~s~~~~~li~~mL~~dP~~R 217 (400)
.|. .+|+.++.||+.+|+.||.+|
T Consensus 265 ~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 265 RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TSS----HHHHHHHHHHT-SSGGGS
T ss_pred hcC-CcCHHHHHHHHHHccCCcccC
Confidence 334 789999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.2e-19 Score=160.87 Aligned_cols=127 Identities=16% Similarity=0.264 Sum_probs=100.2
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEeC--------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGSK--------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~~--------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
+++|+..+.++.||||..+.+++... +..+++|||++|.+|.+.. .+++ ....+++.++..||+
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~ 153 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQ 153 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHH
Confidence 68999999999999999999886543 3578999999999997763 2333 246699999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
.|++|||+||+||+++++| ++|+|||.+....... .. ..+.....|. .++||||+|+++..+.
T Consensus 154 ~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~---a~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 154 HGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK---AK-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred cCCccCCCChHHEEEeCCC-EEEEECCCcccccchh---hH-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 9999999999999999988 9999999865432111 00 1144556676 7899999999877553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=156.52 Aligned_cols=205 Identities=20% Similarity=0.295 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
+-|++.|.+..+.| ..++|...|.+...+-+-.+|||+. |-+|.|+..-. ++|+...+..++.|++.-++|+|++..
T Consensus 67 APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~L 145 (449)
T KOG1165|consen 67 APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDL 145 (449)
T ss_pred cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcce
Confidence 46899999999999 5799999999999999999999988 55777776544 469999999999999999999999999
Q ss_pred eeccCCCCcEEEccCC-----CeeeeccccccccccccCCC-----ccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 94 YHRDLKPENLLLDAYG-----NLKVSDFGLSALSQQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 94 vHrDlKP~NILl~~~g-----~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
|.|||||+|+||..-| .+-|+|||+|+.+....... ...+..||..||+--...++.. +..-|+=|||-
T Consensus 146 IYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGH 224 (449)
T KOG1165|consen 146 IYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGH 224 (449)
T ss_pred eecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhh
Confidence 9999999999997543 48999999998776543322 2234579999999888887765 47899999999
Q ss_pred HHHHHHhCCCCCCCC---chHHHHHhhhcCccCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 164 ILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 164 il~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~-----~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
+++.+|.|.+||++. +..+-|++|....-..| ..+|.++..-++-.-..+-.+-|..+-
T Consensus 225 vFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 225 VFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred hhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 999999999999874 45567778765544333 236777777777777777777777654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-18 Score=153.08 Aligned_cols=104 Identities=19% Similarity=0.257 Sum_probs=85.8
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L-H~~givH 95 (400)
...++|+.++.++.++++.....+... ..++||||++|+++...+...+++++..+..++.|++.+|.|+ |+.||+|
T Consensus 64 ~~~~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiH 141 (190)
T cd05147 64 TWAEKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVH 141 (190)
T ss_pred HHHHHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 345679999999998887554433222 2389999999988776655567899999999999999999999 7999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQ 123 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~ 123 (400)
|||||+|||++ ++.++|+|||+|....
T Consensus 142 rDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 142 ADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 99999999998 4889999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-18 Score=153.81 Aligned_cols=101 Identities=20% Similarity=0.267 Sum_probs=84.3
Q ss_pred HHHHHHHHHHHHhC-----CCCCcceeeEEEEeCC---EEE-EEEec--CCCCChHHHHHhCCCCCHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-----KHPNVVRLYEVMGSKT---KIF-IVLEF--VTGGELFDKIVNHGRMKEDEARRYFQQLINA 84 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~-lv~Ey--~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~ 84 (400)
.+++++|+.+++.+ +||||+++|++++++. .++ +|||| +.+|+|.+++.. +.+++. ..++.|++.+
T Consensus 40 ~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~ 116 (210)
T PRK10345 40 DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKK 116 (210)
T ss_pred HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHH
Confidence 56799999999999 5799999999998874 434 78999 667999999976 457766 3568888877
Q ss_pred H-HHHHHcCCeeccCCCCcEEEccC----CCeeeeccccc
Q 015814 85 V-DYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFGLS 119 (400)
Q Consensus 85 l-~~LH~~givHrDlKP~NILl~~~----g~~kl~DFGla 119 (400)
+ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 117 l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 117 LKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7 99999999999999999999743 37999995533
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=149.23 Aligned_cols=205 Identities=20% Similarity=0.268 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
-++..|..+.+.|+ ..+|..+..+..++.+-.+|||+. |-+|.+...- ...++-.++.-++-|++.-++|+|.++.+
T Consensus 55 pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fi 133 (341)
T KOG1163|consen 55 PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFI 133 (341)
T ss_pred cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccc
Confidence 46778999999996 478888888888999999999988 5688777754 34689999999999999999999999999
Q ss_pred eccCCCCcEEEcc---CCCeeeeccccccccccccCCCc-----cccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 95 HRDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGL-----LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 95 HrDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~-----~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
||||||+|.|+.- ...+-++|||+|+.+........ -..-.||..|.+--...+... +..-|+=|+|-+|.
T Consensus 134 HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLm 212 (341)
T KOG1163|consen 134 HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLM 212 (341)
T ss_pred cccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceee
Confidence 9999999999854 34689999999987765443322 223469999998776665443 47789999999999
Q ss_pred HHHhCCCCCCCCch---HHHHHhhhcCccCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 167 VLLAGYLPFDDSNL---MNLYKKISAAEFTCPP-----WLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 167 elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~-----~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
.+..|.+||++... ..-|.+|.....+.|. .+|.++...+.-|-..--.+-|...-+
T Consensus 213 YfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 213 YFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred eeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 99999999998554 3456667666655553 378899999999988888888876544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=148.54 Aligned_cols=104 Identities=18% Similarity=0.236 Sum_probs=86.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~givH 95 (400)
...++|+..+.++.|++|.....+.... .|+||||++|+++........++++..+..++.|++.++.++|+ +||+|
T Consensus 64 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givH 141 (190)
T cd05145 64 AWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVH 141 (190)
T ss_pred HHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 3457899999999999986555443332 47999999998665544445678899999999999999999999 99999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQ 123 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~ 123 (400)
|||||+||+++ ++.++|+|||+|....
T Consensus 142 rDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 142 GDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999 7999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.2e-17 Score=169.92 Aligned_cols=215 Identities=30% Similarity=0.513 Sum_probs=177.6
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecc
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 97 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrD 97 (400)
.++++-.++....||-++.....+......+++++|+.||+|..++..-+..+++.++.++..+..+++|||+..+.|||
T Consensus 850 s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~ 929 (1205)
T KOG0606|consen 850 SIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRD 929 (1205)
T ss_pred ccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhccc
Confidence 34444445555566777766666667788999999999999999999988899999999999999999999999999999
Q ss_pred CCCCcEEEccCCCeeeeccccccccccc----------c------------CC-------CccccccCCCCCCCChhhhc
Q 015814 98 LKPENLLLDAYGNLKVSDFGLSALSQQV----------R------------DD-------GLLHTTCGTPNYVAPEVLND 148 (400)
Q Consensus 98 lKP~NILl~~~g~~kl~DFGla~~~~~~----------~------------~~-------~~~~~~~gt~~y~APEvl~~ 148 (400)
++|.|+|...+|+.+++|||........ . .. +......||+.|.|||.+.+
T Consensus 930 ~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 930 LKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred ccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 9999999999999999999843211100 0 00 01123468999999999988
Q ss_pred CCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCC---CCCCHHHHHHHHHhcCCCCCCCCCHH---H
Q 015814 149 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---PWLSFTARKLIARILDPNPMTRITIP---E 222 (400)
Q Consensus 149 ~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~~~~~li~~mL~~dP~~R~t~~---e 222 (400)
... +..+|+|+.|+++++.++|..||+.......++.+..+..+.| ...+.++.+++...|..+|.+|..+. +
T Consensus 1010 ~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e 1088 (1205)
T KOG0606|consen 1010 RRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE 1088 (1205)
T ss_pred ccC-CCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccc
Confidence 765 6889999999999999999999999999999999887766554 34799999999999999999999887 8
Q ss_pred HhcCcccccCC
Q 015814 223 ILEDEWFKKDY 233 (400)
Q Consensus 223 il~h~~~~~~~ 233 (400)
+..|+||+...
T Consensus 1089 ~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1089 VKGHPFFQDVD 1099 (1205)
T ss_pred cccCCccCCCC
Confidence 99999998643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=5e-15 Score=134.97 Aligned_cols=101 Identities=27% Similarity=0.389 Sum_probs=89.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.++..+.|+||.....++......+++|||++|++|.+.+..... ....++.+++.+|.++|+.|++|
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H 118 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIH 118 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCccc
Confidence 35688999999999999988777777777788999999999999998865432 78899999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
||++|.|||++ ++.++|+|||++..
T Consensus 119 ~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 119 GDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999 78999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=134.69 Aligned_cols=99 Identities=22% Similarity=0.301 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..++.+|+++++.+.|+++....-++......+++|||++|++|.+.+..... .++.|++.+|.+||+.|++|
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H 113 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVH 113 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeec
Confidence 47788999999999988766555555566677899999999999988755321 78999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeecccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALS 122 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~ 122 (400)
||++|.||+++ ++.++++|||++...
T Consensus 114 ~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 114 GDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999999 799999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.3e-15 Score=137.83 Aligned_cols=101 Identities=19% Similarity=0.288 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHhCCCCC--cceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC-C
Q 015814 17 LQIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-V 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g-i 93 (400)
..+++|+.+++++.+.+ +.++++. ...|+||||+.|++|.........+....+..++.|++.++.+||++| +
T Consensus 95 ~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~i 170 (237)
T smart00090 95 LWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGEL 170 (237)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence 45789999999997633 4444442 235899999999888776545556777788899999999999999999 9
Q ss_pred eeccCCCCcEEEccCCCeeeecccccccc
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALS 122 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~ 122 (400)
+||||||+||+++ ++.++|+|||.|...
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999999 889999999987643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.4e-15 Score=159.71 Aligned_cols=181 Identities=22% Similarity=0.291 Sum_probs=139.9
Q ss_pred CCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc----
Q 015814 32 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---- 107 (400)
Q Consensus 32 pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~---- 107 (400)
+.|.+++..+.-.+.-++|+||.+.|+|.+++...+.+++..+..+..|++.-|++||..||||+||||+|.||..
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 4466666555555667799999999999999998889999999999999999999999999999999999999943
Q ss_pred ---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 015814 108 ---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 184 (400)
Q Consensus 108 ---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~ 184 (400)
.--++|+|||.|-.+............++|-.+-.+|...++++. ..+|.|.++.+++.||.|+.- +
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-------q-- 903 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-------E-- 903 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-------H--
Confidence 234999999998766655555566778999999999999999985 999999999999999998652 1
Q ss_pred HhhhcCcc-----CCCCCCCH-HHHHHHHHhcCCCCCCCCCHHHHh
Q 015814 185 KKISAAEF-----TCPPWLSF-TARKLIARILDPNPMTRITIPEIL 224 (400)
Q Consensus 185 ~~i~~~~~-----~~~~~~s~-~~~~li~~mL~~dP~~R~t~~eil 224 (400)
...+.. .++..+-. -...+...+|+.|-..=|.+.+|.
T Consensus 904 --~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 904 --VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred --hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 111111 12333333 345677888885544445555543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-14 Score=135.09 Aligned_cols=101 Identities=23% Similarity=0.336 Sum_probs=82.5
Q ss_pred HHHHHHHHHHHHhCCCCCc--ceeeEEEEeC-CE---EEEEEecCCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNV--VRLYEVMGSK-TK---IFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnI--v~l~~~~~~~-~~---~~lv~Ey~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
..++.+|+.++.+|.|++| ++.+++.... .. .++||||++| .+|.+.+.. ..+++.. +.|++.+|.+|
T Consensus 84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~l 158 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARF 158 (239)
T ss_pred hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHH
Confidence 4678899999999998885 6777664332 22 2599999998 688888755 4566543 57899999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
|++||+||||||+|||++.++.++|+|||.+..
T Consensus 159 H~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 159 HDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999999999999999999999999999998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-14 Score=151.11 Aligned_cols=97 Identities=21% Similarity=0.281 Sum_probs=87.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+++++.++|+|++..+.+.......++||||++|++|.+.+. ....++.|++.+|.|||+.|++|
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH 451 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH 451 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence 4678899999999999999988777777777899999999999998885 35678999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
|||||+|||+ .++.++|+|||+++.
T Consensus 452 rDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 452 GDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999 678999999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-13 Score=124.56 Aligned_cols=95 Identities=19% Similarity=0.346 Sum_probs=78.2
Q ss_pred HHHHHHHHHHhCCCCC--cceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 18 QIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 18 ~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+|+.++..+.|++ ++..++ ....++||||++|++|...... ..+..++.|++.++.++|+.|++|
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H 148 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIH 148 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCc
Confidence 4678999999998874 444443 2345899999999988654321 346678999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeecccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALS 122 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~ 122 (400)
|||||+||++++++.++|+|||++...
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-13 Score=130.18 Aligned_cols=211 Identities=14% Similarity=0.239 Sum_probs=148.3
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEe-----CCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGS-----KTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~~ 87 (400)
+.++.=+..+-++-|.|||+++.++.+ .....++.||+..|+|..++++. ..+......+|+-|+++||.|
T Consensus 112 ek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 112 EKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhh
Confidence 334444556677789999999998754 34578999999999999999764 357888899999999999999
Q ss_pred HHHc--CCeeccCCCCcEEEccCCCeeeeccccccccccccCCC--ccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 88 CHSR--GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 88 LH~~--givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
||+. -|+|+++....|++..+|-+|++--............. ......|-++|.|||.-..... ..++|||++|.
T Consensus 192 Lhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgm 270 (458)
T KOG1266|consen 192 LHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGM 270 (458)
T ss_pred hhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhH
Confidence 9988 49999999999999999999986432222111111111 1112246788999997654443 46799999999
Q ss_pred HHHHHHhCCCCC-CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 164 ILFVLLAGYLPF-DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 164 il~elltG~~Pf-~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
...+|..|..-- .+.+....-..+....+... ..--+.++.+||+..|..||++.+++-||-.-.
T Consensus 271 cAlemailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HHHHHHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 999998887642 22222222222221111111 112357899999999999999999999997643
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-13 Score=98.45 Aligned_cols=60 Identities=58% Similarity=0.935 Sum_probs=48.3
Q ss_pred ccchhhhHHhhcCCCCCCCCCCccccc--ccccceEEecCCHHHHHHHHHHHhccCCceEee
Q 015814 269 PVAMNAFELISLSKGLNLGNLFDAEQD--FKRETRFTSRCPANEIINKIEEAAKPLGFDVHK 328 (400)
Q Consensus 269 ~~~~~~~~~~~~s~~~~~~~~~~~~~~--~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~ 328 (400)
|..+|||++|++|+|+||++||+.... .++.+||+|..|++.|+++||++++.+|+.|++
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 678999999999999999999976543 578999999999999999999999999999875
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2e-12 Score=131.72 Aligned_cols=149 Identities=18% Similarity=0.337 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH-~~gi 93 (400)
..+.+++-++-|+.++||||+++++.++..+.+|+|+|-+. .|-.++..-+ ......-+.||+.||.||| ..++
T Consensus 52 ~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~l 126 (690)
T KOG1243|consen 52 VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNL 126 (690)
T ss_pred hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCe
Confidence 35778899999999999999999999999999999999885 4666665533 6677778899999999998 5689
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+|++|.-..|+++..|..||++|.++......... .....---.|..|+.+.... -..|.|-|||++++++.|..
T Consensus 127 vHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 127 VHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred eeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCccc
Confidence 99999999999999999999999876543332210 11111122366676654333 23799999999999999933
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.7e-13 Score=134.84 Aligned_cols=207 Identities=20% Similarity=0.237 Sum_probs=158.4
Q ss_pred HHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHcCCe
Q 015814 21 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLIN----AVDYCHSRGVY 94 (400)
Q Consensus 21 ~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~----~l~~LH~~giv 94 (400)
+|+.-.+.+ .|+|.++.+..+...+..|+-+|+|. .+|..+...... +++..++.++.+... ||.++|+.+++
T Consensus 166 ~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~ 244 (524)
T KOG0601|consen 166 REFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIV 244 (524)
T ss_pred chhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCccc
Confidence 466666666 49999999999999999999999996 588888877665 899999999999999 99999999999
Q ss_pred eccCCCCcEEEccC-CCeeeeccccccccccccCCC---ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 95 HRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDG---LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 95 HrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|-|+||+||++..+ ..++++|||+........-.. .....-|...|++||.+.+ ..+...||+|+|.+..+-.+
T Consensus 245 ~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l 322 (524)
T KOG0601|consen 245 HDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAIL 322 (524)
T ss_pred ccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHh
Confidence 99999999999999 889999999977654422111 1111257788999999864 44688999999999998888
Q ss_pred CCCCCCCCchHHHHHhhhcCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 171 GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|..+....-.. .+..+.++. ..+-...+.++...+..|++.+|-.|++.+.++.|++...
T Consensus 323 ~~~~~~~g~~~-~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 323 GSHLPSVGKNS-SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hcccccCCCCC-CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 76665332100 011111111 1111224666777999999999999999999999999874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.3e-12 Score=111.02 Aligned_cols=99 Identities=24% Similarity=0.331 Sum_probs=86.4
Q ss_pred HHHHHHHHHHHHhCCC--CCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--
Q 015814 16 LLQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-- 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~-- 91 (400)
...+.+|+.+++.+.| +++++++.+....+..|++|||+.|+++... +......++.+++.+++++|..
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~ 107 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL 107 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence 3578899999999976 5899999988888889999999999877543 5566778899999999999985
Q ss_pred -CCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 92 -GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 92 -givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
+++|+|++|+||++++.+.++++|||.+..
T Consensus 108 ~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.5e-12 Score=112.65 Aligned_cols=96 Identities=19% Similarity=0.378 Sum_probs=72.7
Q ss_pred HHHHHHHHhCCCCC--cceeeEEEEeCCEEEEEEecCCCCChHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCee
Q 015814 20 KREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYH 95 (400)
Q Consensus 20 ~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~-~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~givH 95 (400)
..|...+..+.+.+ +.+.++. ...++||||++|+.+.. .+... ... ..++.++.|++.++.++|+ .||+|
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH 138 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVH 138 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCc
Confidence 56777777775543 5555543 23589999999964322 12111 111 6788999999999999999 99999
Q ss_pred ccCCCCcEEEccCCCeeeecccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALS 122 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~ 122 (400)
|||||+||+++ ++.++++|||.+...
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999 899999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.7e-11 Score=108.17 Aligned_cols=100 Identities=15% Similarity=0.268 Sum_probs=78.8
Q ss_pred HHHHHHHHHhCC--CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCCee
Q 015814 19 IKREVATMKLVK--HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYH 95 (400)
Q Consensus 19 i~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L-H~~givH 95 (400)
.++|++.|+++. .-++.+.+++ ...++||||+.++.+......+..++++.+..++.|++.++..| |+.|++|
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVH 148 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVH 148 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 348999999995 3567777765 45679999998765543333334566777888899999999999 8999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQ 123 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~ 123 (400)
+||+|.||+++ +|.+.|+|||.|....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4789999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-11 Score=124.34 Aligned_cols=201 Identities=22% Similarity=0.214 Sum_probs=153.7
Q ss_pred HHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCC
Q 015814 22 EVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 100 (400)
Q Consensus 22 Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP 100 (400)
|+.+...+ .|.++++++..+......|+=.|||.|+++...+.-..-+.++..+....|++.++.++|+..++|+|+||
T Consensus 315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~p 394 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKP 394 (524)
T ss_pred hhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccc
Confidence 55555555 58999999988888888889999999998877775555688999999999999999999999999999999
Q ss_pred CcEEEccC-CCeeeeccccccccccccCCCccccccCCCCCC-CChhhhcCCCCCChhhHHHHHHHHHHHHhCCC-CCCC
Q 015814 101 ENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV-APEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDD 177 (400)
Q Consensus 101 ~NILl~~~-g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~-APEvl~~~~~~~~~~DIwSlGiil~elltG~~-Pf~~ 177 (400)
+||++..+ +..+++|||.++..... .....+.-++. ++|++........++|++|+|..+++.++|.. ++.+
T Consensus 395 sni~i~~~~~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~ 469 (524)
T KOG0601|consen 395 SNILISNDGFFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG 469 (524)
T ss_pred cceeeccchhhhhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccc
Confidence 99999886 78999999987642111 11122333444 36666555555699999999999999998754 3332
Q ss_pred CchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 178 SNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 178 ~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.....+..+.....+..+..+..+.+.|+.+++..|+.+.++..|+=|..
T Consensus 470 ----~~~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 470 ----VQSLTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ----ccceeeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 22333445555555556688889999999999999999999988876544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.2e-11 Score=122.61 Aligned_cols=160 Identities=19% Similarity=0.319 Sum_probs=117.4
Q ss_pred HHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccCCCeeeeccccccccccccC-------CCccccccCCCCCCCCh
Q 015814 73 EARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-------DGLLHTTCGTPNYVAPE 144 (400)
Q Consensus 73 ~~~~~~~qll~~l~~LH~~-givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-------~~~~~~~~gt~~y~APE 144 (400)
.+..=+.+...|+.|+|+. ++||+.|.|++|.++.+|.+||+.|+++.-...... .....-..-...|.|||
T Consensus 100 ~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred HhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 3344455667999999976 999999999999999999999999998654332111 00000112356799999
Q ss_pred hhhcCCCCCChhhHHHHHHHHHHHH-hCCCCCCCCchHHHHHhh----hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 015814 145 VLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 145 vl~~~~~~~~~~DIwSlGiil~ell-tG~~Pf~~~~~~~~~~~i----~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t 219 (400)
++... ..+.++|++|+||++|.+. .|+.-+...+....+..- ..+....+..++.++++=|.++|..++..||+
T Consensus 180 ~~~~~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 180 YLLGT-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred hhccc-cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 99874 4468999999999999988 455555544333333221 12233445678999999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 015814 220 IPEILEDEWFKKDY 233 (400)
Q Consensus 220 ~~eil~h~~~~~~~ 233 (400)
+.+++..|||....
T Consensus 259 ~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 259 LDLLLSIPFFSDPG 272 (700)
T ss_pred hhhhhcccccCCch
Confidence 99999999998753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-10 Score=100.61 Aligned_cols=93 Identities=25% Similarity=0.408 Sum_probs=71.9
Q ss_pred HHHHHHHHHHHhCCCCCcc-eeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC--
Q 015814 17 LQIKREVATMKLVKHPNVV-RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV-- 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi-- 93 (400)
...++|+.+++.+.+.+++ +++.+.. ...++||||++|.++.+. ......++.+++.+|+.||+.++
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~ 106 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPD 106 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCC
Confidence 3568899999999665544 5555433 334799999999887543 11123467899999999999985
Q ss_pred ---eeccCCCCcEEEccCCCeeeecccccc
Q 015814 94 ---YHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 94 ---vHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
+|+|++|.||+++ ++.++++|||.+.
T Consensus 107 ~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 107 LVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999999999999 6789999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.7e-10 Score=112.56 Aligned_cols=102 Identities=21% Similarity=0.330 Sum_probs=71.1
Q ss_pred HHHHHHHHHhCC----CCCcceeeEEE-EeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHc
Q 015814 19 IKREVATMKLVK----HPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLIN-AVDYCHSR 91 (400)
Q Consensus 19 i~~Ei~il~~l~----HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~-~l~~LH~~ 91 (400)
+.+|...+.++. |.+-+.+-.++ ...+..++||||++|++|.+..... ...+ ...+..+++. .+..+|..
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 556777776663 32223322232 2234468999999999998876432 1222 2345555655 46789999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccc
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~ 123 (400)
|++|+|+||.||+++.+|.++++|||++....
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999986544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-09 Score=96.05 Aligned_cols=98 Identities=22% Similarity=0.314 Sum_probs=77.3
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.+-++|+.++.++.--.|.--+=+..+.....|+|||++|-.|.+.+... ...+++.+-.-+.-||..||+|+
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHG 116 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHG 116 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecC
Confidence 45678999999987555543333344566677999999998888888765 24567777778889999999999
Q ss_pred cCCCCcEEEccCCCeeeecccccccc
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALS 122 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~ 122 (400)
||.++||++.+.+ +.++||||+.+.
T Consensus 117 DLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 117 DLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CCccceEEEeCCc-EEEEECCccccc
Confidence 9999999998744 999999998643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.2e-10 Score=116.74 Aligned_cols=98 Identities=21% Similarity=0.368 Sum_probs=68.4
Q ss_pred HHHHHHHHHhCC----CCCcceeeEEEEe-CCEEEEEEecCCCCChHHH--HHhCC----CCCHHHHHHHHHHHHHHHHH
Q 015814 19 IKREVATMKLVK----HPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDK--IVNHG----RMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 19 i~~Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~--i~~~~----~l~e~~~~~~~~qll~~l~~ 87 (400)
+.+|+..+.++. +.+.+.+-.++.+ .+..++||||+.|+.+.+. +...+ .+.+..+..++.|++
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 344554444442 3333443344322 3456799999999999763 44433 356666777777776
Q ss_pred HHHcCCeeccCCCCcEEEccCC----Ceeeeccccccccc
Q 015814 88 CHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 123 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g----~~kl~DFGla~~~~ 123 (400)
..|++|+|+||.||+++.+| .+++.|||++....
T Consensus 278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 48999999999999999988 99999999976543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-08 Score=96.40 Aligned_cols=103 Identities=18% Similarity=0.155 Sum_probs=80.7
Q ss_pred HHHHHHHHHHhCCCCC--cceeeEEEEe-----CCEEEEEEecCCCC-ChHHHHHh--CCCCCHHHHHHHHHHHHHHHHH
Q 015814 18 QIKREVATMKLVKHPN--VVRLYEVMGS-----KTKIFIVLEFVTGG-ELFDKIVN--HGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 18 ~i~~Ei~il~~l~Hpn--Iv~l~~~~~~-----~~~~~lv~Ey~~gg-~L~~~i~~--~~~l~e~~~~~~~~qll~~l~~ 87 (400)
...+|...+.+|..-+ ++....+.+. ....++|||+++|- +|.+.+.. ....++.....++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4778999998885333 3344444433 23578999999986 78888754 3456677888999999999999
Q ss_pred HHHcCCeeccCCCCcEEEcc-------CCCeeeecccccc
Q 015814 88 CHSRGVYHRDLKPENLLLDA-------YGNLKVSDFGLSA 120 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~-------~g~~kl~DFGla~ 120 (400)
||..||+|+|++|.|||++. ++.+.++||+.+.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999999999985 4679999999764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=101.00 Aligned_cols=178 Identities=21% Similarity=0.279 Sum_probs=133.6
Q ss_pred HHHHHHHhCCCCCcceeeEEEEe----CCEEEEEEecCCC-CChHHHHHh---------------CCCCCHHHHHHHHHH
Q 015814 21 REVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTG-GELFDKIVN---------------HGRMKEDEARRYFQQ 80 (400)
Q Consensus 21 ~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~g-g~L~~~i~~---------------~~~l~e~~~~~~~~q 80 (400)
.=+++.+++.|+|||++.+++.+ ...+++|++|.++ ++|.++--. ..+.+|..+|.|+.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 34788899999999999999874 3468999999986 577775522 235788999999999
Q ss_pred HHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHH
Q 015814 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWS 160 (400)
Q Consensus 81 ll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwS 160 (400)
|..||.++|+.|..-+-|-|.+||++.+-.++|+..|...+..... . |.+... .+-|.=-
T Consensus 402 LtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~--~~le~~----Qq~D~~~ 461 (655)
T KOG3741|consen 402 LTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------T--EPLESQ----QQNDLRD 461 (655)
T ss_pred HHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC--------------C--cchhHH----hhhhHHH
Confidence 9999999999999999999999999998899998888655433211 0 112111 3468889
Q ss_pred HHHHHHHHHhCCCC-CCCCchHHH-HHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 161 CGVILFVLLAGYLP-FDDSNLMNL-YKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 161 lGiil~elltG~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||.++..|.||..- |.....+.. ...| ...+|.+++++|.-+...++.+ -++.+++.+
T Consensus 462 lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 462 LGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999653 222222222 1222 2347889999999999999987 688888865
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.7e-08 Score=89.87 Aligned_cols=105 Identities=19% Similarity=0.359 Sum_probs=85.3
Q ss_pred HHHHHHHHHHHhCCCC--CcceeeEEEEeC----CEEEEEEecCCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHP--NVVRLYEVMGSK----TKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 17 ~~i~~Ei~il~~l~Hp--nIv~l~~~~~~~----~~~~lv~Ey~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
....+|...+..|..- .+.+.+.+.+.. ...++|+|+++|. +|.+.+......+......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4678899988888533 345666665542 2458999999984 78888877555777888999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCC---Ceeeeccccccc
Q 015814 90 SRGVYHRDLKPENLLLDAYG---NLKVSDFGLSAL 121 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g---~~kl~DFGla~~ 121 (400)
..||+|+|++|.|||++.++ .+.++||+.+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999987 799999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.7e-08 Score=87.31 Aligned_cols=107 Identities=21% Similarity=0.283 Sum_probs=81.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCC-CChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG-GELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g-g~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
-.+.++|+++|.++.--+|.--.=++.+...-.|+|||++| -++.+++..... ........+++++-+.+.-||..+
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd 133 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND 133 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC
Confidence 46788999999998755554333344455566789999987 467777765432 223333788999999999999999
Q ss_pred CeeccCCCCcEEEccCCC---eeeecccccccc
Q 015814 93 VYHRDLKPENLLLDAYGN---LKVSDFGLSALS 122 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~---~kl~DFGla~~~ 122 (400)
++|+||..+||++.++|. +-++|||++...
T Consensus 134 iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 134 IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999999999999987664 589999998654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-08 Score=90.77 Aligned_cols=100 Identities=23% Similarity=0.384 Sum_probs=69.2
Q ss_pred HHHHHHHHHHHHhCCCC--CcceeeEEEEeCCEEEEEEecCC--CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHH
Q 015814 16 LLQIKREVATMKLVKHP--NVVRLYEVMGSKTKIFIVLEFVT--GGELFDKIVNHGRMKEDEARRYFQQLINAVDY-CHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lv~Ey~~--gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~-LH~ 90 (400)
-...++|.+.|.++..- ++.+.+++. ..++||||+. |..+. .+.. ..++.+....++.+++..+.. +|+
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~-~l~~-~~~~~~~~~~~~~~il~~~~~~~~~ 125 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLP-RLKD-VDLSPEEPKELLEEILEEIIKMLHK 125 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGG-CHHH-CGGGGSTHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchh-hHHh-ccccchhHHHHHHHHHHHHHHHHHh
Confidence 46788999999999765 567777553 2359999999 64443 3333 122245677788888886665 579
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 122 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~ 122 (400)
.|++|+||.+.|||++++ .+.|+|||.+...
T Consensus 126 ~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 126 AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred cCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 999999999999999986 9999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.69 E-value=4e-08 Score=89.55 Aligned_cols=105 Identities=23% Similarity=0.344 Sum_probs=81.1
Q ss_pred HHHHHHHHHHHHhCCC--CCcceeeEEEEeC---CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKH--PNVVRLYEVMGSK---TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
..++.+|+.+++.+.+ .++.+++.+.... +..|+||||++|+++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHS 117 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999975 3467777776553 267899999999888765532 346777777777888888887773
Q ss_pred --------------------------------------------------------cCCeeccCCCCcEEEcc--CCCee
Q 015814 91 --------------------------------------------------------RGVYHRDLKPENLLLDA--YGNLK 112 (400)
Q Consensus 91 --------------------------------------------------------~givHrDlKP~NILl~~--~g~~k 112 (400)
..++|+|++|.||+++. ++.+.
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~ 197 (223)
T cd05154 118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVA 197 (223)
T ss_pred CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEE
Confidence 24699999999999998 56789
Q ss_pred eeccccccc
Q 015814 113 VSDFGLSAL 121 (400)
Q Consensus 113 l~DFGla~~ 121 (400)
|+||+.+..
T Consensus 198 iID~e~~~~ 206 (223)
T cd05154 198 VLDWELATL 206 (223)
T ss_pred EEecccccc
Confidence 999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-08 Score=102.71 Aligned_cols=204 Identities=22% Similarity=0.260 Sum_probs=145.2
Q ss_pred HHHHHHHHHHHhCCCCC-cceeeEEEEeCCEEEEEEecCCCC-ChHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 17 LQIKREVATMKLVKHPN-VVRLYEVMGSKTKIFIVLEFVTGG-ELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~Ey~~gg-~L~~~i-~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..++-+++.|.+++||| .+..++-++.+...+++|+++.+| +-.+.. .....+.+-+.....+.-..+++++|+.--
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~ 357 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK 357 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence 56778999999999999 788888888889999999999987 221111 111223444555566677888999999888
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||| ||+..+ +..|..||+........ ....+..+|+.++|||+.....+. ...|.||+|.--.++.-|.+
T Consensus 358 ~~~d----~~l~s~-~~~~~~~~~v~~~L~~~---~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 358 VHRD----NILGSE-EEVKLLDFAVPPQLTRT---MKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred cCcc----cccccc-cccccccccCCcccCcc---cccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCC
Confidence 8999 887766 78899999976543322 134567899999999999888886 77899999987777877877
Q ss_pred CCCCCchHHHHHhhhcCccCCC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 174 PFDDSNLMNLYKKISAAEFTCP------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~------~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|-..+. .....+..+. ..| .|-+..-.++...|+..-|..|+.....+-|.+|..-
T Consensus 429 Pr~~P~--~~~~~~g~~p-~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 429 PRSSPP--AVLPMIGNGP-NSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred CCCCCc--cccCCCCCCC-CccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 764421 1111111110 011 1222222357788999999999999999999888753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.5e-06 Score=83.63 Aligned_cols=170 Identities=18% Similarity=0.194 Sum_probs=120.0
Q ss_pred EEEEEecCCCCC-hHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccc
Q 015814 47 IFIVLEFVTGGE-LFDKIVN------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 119 (400)
Q Consensus 47 ~~lv~Ey~~gg~-L~~~i~~------~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla 119 (400)
+-+.|..++|.. +.+.... ..-...+.+.+..+.|+.+.+.||+.|.+-+|+.++|+|+++++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778899998853 2222222 123677889999999999999999999999999999999999999999985532
Q ss_pred cccccccCCCccccccCCCCCCCChhhh-----cCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCc-------hHHHHHh
Q 015814 120 ALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAG-YLPFDDSN-------LMNLYKK 186 (400)
Q Consensus 120 ~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGiil~elltG-~~Pf~~~~-------~~~~~~~ 186 (400)
.+. ..........|.+.|.+||.-. +.+- ....|.|.||+++|++|.| +.||.+-. ..+ ..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 221 1233334457999999999754 2222 3678999999999998875 99997521 111 11
Q ss_pred hhcC-----------ccCC---CCC--CCHHHHHHHHHhcCC--CCCCCCCHHH
Q 015814 187 ISAA-----------EFTC---PPW--LSFTARKLIARILDP--NPMTRITIPE 222 (400)
Q Consensus 187 i~~~-----------~~~~---~~~--~s~~~~~li~~mL~~--dP~~R~t~~e 222 (400)
|..+ ..+. +|| +++++..|..+|+.. +|.-|||++.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 2111 1111 122 688999999999865 4678999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.3e-07 Score=96.57 Aligned_cols=204 Identities=18% Similarity=0.197 Sum_probs=144.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCE----EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
....-|+..+..+.|+|++.++.+...... ..+..++|++-++...+..-+.++...++.+..++++|+.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 334557777888899999999988644322 3345679999999999999999999999999999999999999996
Q ss_pred CeeccCCCC---cEEEccCCCeeee--ccccccccccccCCCccccccCCCCCCCChhhhcCCCCC-ChhhHHHHHHHHH
Q 015814 93 VYHRDLKPE---NLLLDAYGNLKVS--DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG-STADLWSCGVILF 166 (400)
Q Consensus 93 ivHrDlKP~---NILl~~~g~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~-~~~DIwSlGiil~ 166 (400)
..|.-+-.. +-..+..+.+.++ ||+.+........ .....-+.-|.|||......+.. ...|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 666655444 3344556667777 8887765443221 12333466788899887655431 2369999999999
Q ss_pred HHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 167 VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.+..|..+-........+ .+.....+..+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 384 ~~~~~~~i~~~~~~~~~~---------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVPVSL---------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhcCcccccccchhhh---------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 888765542211100000 011111267889999999999999999999999998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.3e-06 Score=79.81 Aligned_cols=95 Identities=22% Similarity=0.407 Sum_probs=75.4
Q ss_pred HHHHHHHHHHHhCCCC--CcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKHP--NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...++|.++|.+|... .|.+.+++ +...+||||++|-.|... +++...+..++..|+.-+.-+-..||+
T Consensus 154 l~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiV 224 (304)
T COG0478 154 LAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIV 224 (304)
T ss_pred HHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCcc
Confidence 5678999999999655 77777765 456799999999777432 223455666777777777777789999
Q ss_pred eccCCCCcEEEccCCCeeeecccccc
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
|+|+.+-||+++++|.+.++||-.+.
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCcccc
Confidence 99999999999999999999997554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.7e-06 Score=75.48 Aligned_cols=67 Identities=25% Similarity=0.505 Sum_probs=52.6
Q ss_pred CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 45 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 45 ~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
...+++|||++|.+|.+.. .++++ +...+.+++.-+|+.|++|+|..|.|+++++ +.+++.||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEECcccc
Confidence 3456899999998876543 13332 4467778899999999999999999999986 459999998643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.3e-05 Score=72.85 Aligned_cols=104 Identities=18% Similarity=0.162 Sum_probs=79.0
Q ss_pred HHHHHHHHHHHhCCCCC--cceeeEEE--EeC--CEEEEEEecCCC-CChHHHHHhC--CCCCHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPN--VVRLYEVM--GSK--TKIFIVLEFVTG-GELFDKIVNH--GRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 17 ~~i~~Ei~il~~l~Hpn--Iv~l~~~~--~~~--~~~~lv~Ey~~g-g~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~ 87 (400)
..+.+|+..+.+|..-+ +.+..... ..+ -..+||+|-+.| -+|.+.+... .+.++.....++.++...++-
T Consensus 64 ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~ 143 (216)
T PRK09902 64 PTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKK 143 (216)
T ss_pred hHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHH
Confidence 56788999999885322 44444221 121 236799997764 4888887663 345777788999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCC--eeeecccccc
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSA 120 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~--~kl~DFGla~ 120 (400)
||+.|+.|+|+-|.||+++.+|. ++++||.-++
T Consensus 144 LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 144 MHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99999999999999999987777 9999998543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.9e-07 Score=101.53 Aligned_cols=207 Identities=16% Similarity=0.068 Sum_probs=149.9
Q ss_pred HHHHHHHhCCCCCcceeeEEEE--eCCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHc---
Q 015814 21 REVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSR--- 91 (400)
Q Consensus 21 ~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~~LH~~--- 91 (400)
.|..-++...|+++.+.+.-.. +....|.+++|+.+|.+++.|.+. ..+.+..+....++.+.+..-+|+.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3555566778999988776553 334578999999999999999653 2355566677777778888888865
Q ss_pred --CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 92 --GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 92 --givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
-.+|+++|+-|.++..+-++|++++|+.+...+ .........++|.|++|++...-.+. .++|+|+.|+-+|+..
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHh
Confidence 278999999999999999999999999873322 22234456788999999999877774 6699999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
.|..||-......+...+.++.. ..+...|.++-.....+|-..-..||.-..++.-+.|.
T Consensus 1435 ~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred cccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99888754333333333333332 33333455555666666666677888888777766654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.1e-05 Score=71.69 Aligned_cols=104 Identities=14% Similarity=0.177 Sum_probs=64.3
Q ss_pred HHHHHHHHHHHHhCCCCC--cceeeEEEEeCCEEEEEEecCCCCC-hH--------------HHHHh------C---CCC
Q 015814 16 LLQIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGE-LF--------------DKIVN------H---GRM 69 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~Ey~~gg~-L~--------------~~i~~------~---~~l 69 (400)
...+++|.++++.+..-+ +.+.+++....+...+|||+++|.. +. ..+.. . ...
T Consensus 36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~ 115 (226)
T TIGR02172 36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS 115 (226)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 356899999999996443 4677888777788899999999963 11 11110 0 001
Q ss_pred CHH-HHHHHHHHH----------HH-HHHHHH----HcCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 70 KED-EARRYFQQL----------IN-AVDYCH----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 70 ~e~-~~~~~~~ql----------l~-~l~~LH----~~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
+.. ....+..++ .. ..++|. ...++|+|+.|.||++++++ +.|+||+.+.
T Consensus 116 ~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 116 TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 100 011111111 11 112222 12578999999999999988 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.5e-05 Score=53.30 Aligned_cols=43 Identities=16% Similarity=0.321 Sum_probs=38.0
Q ss_pred cceEEEEEEEEEc-CceeEEEEEecCCCchhHHHHHHHHHHhcc
Q 015814 344 GNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKFYKNLSTCLE 386 (400)
Q Consensus 344 ~~l~~~~~i~~~~-~~~~~v~~~~~~gd~~~~~~~~~~~~~~l~ 386 (400)
..+.|.++|+++. .+++.|+|+|.+||.+.|++++.+|...|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence 4689999999998 899999999999999999999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00011 Score=68.51 Aligned_cols=103 Identities=13% Similarity=0.091 Sum_probs=64.7
Q ss_pred HHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHH-------------------hCC----CCCHH
Q 015814 17 LQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-------------------NHG----RMKED 72 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~-------------------~~~----~l~e~ 72 (400)
.++.+|+.+++.+. +--+.+++++....+..++|||+++|.+|..... ... ++...
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~ 115 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRR 115 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchh
Confidence 46788999999883 4446678887776667889999999976653310 000 01100
Q ss_pred HHHHHHHH-----------------------HHHHHHHHH-------HcCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 73 EARRYFQQ-----------------------LINAVDYCH-------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 73 ~~~~~~~q-----------------------ll~~l~~LH-------~~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
....+.+ +...+..|- ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 116 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 116 -LDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred -HHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 0000000 111112221 2348999999999999997778899999765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.78 E-value=7.9e-05 Score=68.95 Aligned_cols=99 Identities=17% Similarity=0.256 Sum_probs=74.2
Q ss_pred HHHHHHHHHhCC--CCCcceeeEEEEeCCEEEEEEecCCCCCh-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCe
Q 015814 19 IKREVATMKLVK--HPNVVRLYEVMGSKTKIFIVLEFVTGGEL-FDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVY 94 (400)
Q Consensus 19 i~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L-~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~giv 94 (400)
.++|+..|+++. +=.+.+-+.+. .-.+||||+..... .-.+. +.++....+..+..+++..+.-|-. .|+|
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LV 189 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLV 189 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence 467999999985 44556666654 34589999965311 11121 2234445799999999999999887 8999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccc
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQ 123 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~ 123 (400)
|+||..=|||+. +|.+.|+|||.|....
T Consensus 190 HgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 190 HGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999 7999999999876544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00015 Score=65.05 Aligned_cols=99 Identities=20% Similarity=0.302 Sum_probs=79.1
Q ss_pred HHHHHHHHhCCC-CCcceeeEEEEeCCEEEEEEecCCCCChHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 015814 20 KREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDK---IVNHGRMKEDEARRYFQQLINAVDYCHS---RG 92 (400)
Q Consensus 20 ~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~---i~~~~~l~e~~~~~~~~qll~~l~~LH~---~g 92 (400)
..|.-+|+.+.+ +++++++|++- -++|.||...+++... +..--..+.....+++.|+++.+.++++ ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 348899999976 69999999873 2468899987766421 2222345788999999999999999997 45
Q ss_pred CeeccCCCCcEEEccCCCeeeecccccccc
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALS 122 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~ 122 (400)
+.-.|++|+|+-++++|.+|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778899999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00035 Score=76.71 Aligned_cols=105 Identities=20% Similarity=0.481 Sum_probs=66.6
Q ss_pred HHHHHHHHHHHhCC-CCCc--ceeeEEEEeC---CEEEEEEecCCCCChHH--------------------HHH---h-C
Q 015814 17 LQIKREVATMKLVK-HPNV--VRLYEVMGSK---TKIFIVLEFVTGGELFD--------------------KIV---N-H 66 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~~lv~Ey~~gg~L~~--------------------~i~---~-~ 66 (400)
..+.+|+.+|+.+. |++| .+++.++.+. +..|+||||++|..+.+ .+. . +
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd 162 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSAD 162 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 56889999999995 7765 7777777654 45789999999864321 111 0 0
Q ss_pred ---CCC-----C----HHHHHHHHHH---------------HHHHHHHHHH-----------cCCeeccCCCCcEEEccC
Q 015814 67 ---GRM-----K----EDEARRYFQQ---------------LINAVDYCHS-----------RGVYHRDLKPENLLLDAY 108 (400)
Q Consensus 67 ---~~l-----~----e~~~~~~~~q---------------ll~~l~~LH~-----------~givHrDlKP~NILl~~~ 108 (400)
.++ + ...+..|..| +...+++|.. ..++|+|++|.|++++.+
T Consensus 163 ~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~ 242 (822)
T PLN02876 163 VDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPT 242 (822)
T ss_pred chhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCC
Confidence 001 0 1123222222 2233556632 259999999999999863
Q ss_pred -CC-eeeeccccccc
Q 015814 109 -GN-LKVSDFGLSAL 121 (400)
Q Consensus 109 -g~-~kl~DFGla~~ 121 (400)
+. .-|.||++++.
T Consensus 243 ~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 243 EDRVIGILDWELSTL 257 (822)
T ss_pred CCeEEEEEeeecccc
Confidence 33 57999998865
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00029 Score=64.24 Aligned_cols=106 Identities=20% Similarity=0.336 Sum_probs=58.9
Q ss_pred HHHHHHHHHHHHHhCCCC--CcceeeEEEE---eCCEEEEEEecCCCCChHH----------------HHH---hC----
Q 015814 15 ILLQIKREVATMKLVKHP--NVVRLYEVMG---SKTKIFIVLEFVTGGELFD----------------KIV---NH---- 66 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~Hp--nIv~l~~~~~---~~~~~~lv~Ey~~gg~L~~----------------~i~---~~---- 66 (400)
....+.+|..+++.+... -+.+++.... .....+++|++++|..+.. .+. ..
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~ 112 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPF 112 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccc
Confidence 367888999999988533 3567776442 3345799999999987766 111 11
Q ss_pred CCCCHHH---------HH----HH--------HHHHHH-HHHHHHH-------cCCeeccCCCCcEEEc-cCCCeeeecc
Q 015814 67 GRMKEDE---------AR----RY--------FQQLIN-AVDYCHS-------RGVYHRDLKPENLLLD-AYGNLKVSDF 116 (400)
Q Consensus 67 ~~l~e~~---------~~----~~--------~~qll~-~l~~LH~-------~givHrDlKP~NILl~-~~g~~kl~DF 116 (400)
.++.... .. .. ...+.. .++.+++ ..++|+|+.|.||+++ +++.+-|.||
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~ 192 (239)
T PF01636_consen 113 SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDF 192 (239)
T ss_dssp CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--G
T ss_pred cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEec
Confidence 0111000 00 00 111222 2333332 4699999999999999 5566789999
Q ss_pred cccc
Q 015814 117 GLSA 120 (400)
Q Consensus 117 Gla~ 120 (400)
+.+.
T Consensus 193 e~a~ 196 (239)
T PF01636_consen 193 EDAG 196 (239)
T ss_dssp TT-E
T ss_pred ccce
Confidence 9764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00025 Score=73.12 Aligned_cols=98 Identities=26% Similarity=0.485 Sum_probs=65.9
Q ss_pred HHHHHHHHHHHhCC-----CCCcceeeEEE-EeCCEEEEEEecCCCCChHHH--HHhCCCCC-----HHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVK-----HPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDK--IVNHGRMK-----EDEARRYFQQLIN 83 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-----HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~--i~~~~~l~-----e~~~~~~~~qll~ 83 (400)
-.+++|...+.+++ .|+|. +=.++ +-.+.-.++|||++|-.+.+. +.. .+++ +..++.+++|++
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL- 282 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH-
Confidence 34566777776663 34332 22222 223445699999999888776 444 3344 334444555544
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccc
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~ 123 (400)
..|++|.|..|.||+++.+|.+-+.|||+.....
T Consensus 283 ------~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 ------RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ------hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 3899999999999999999999999999876543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00061 Score=68.97 Aligned_cols=163 Identities=21% Similarity=0.280 Sum_probs=106.3
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeC-CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+|.--..+++.+.|+|...++++.... ....+|||++.. +|.|.+..+. +..... . .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~---~-----------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESL---L-----------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhh---c-----------ccccce
Confidence 5666778899999999999999887543 347889999954 8988887644 221110 0 222222
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
- +.++++| -+++. | |- ..++++||||+|.++.++.-|..-|
T Consensus 91 ~------------~~~~~td-~~~t~------------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 L------------NIIYITD-HFLTK------------------Y--PS------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred e------------hhhhccc-ccccc------------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 1 2334444 11110 0 00 1124899999999999999998887
Q ss_pred CCCchHHHHHhhhcCccCC------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 176 DDSNLMNLYKKISAAEFTC------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~------------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
......+....+..-.... -..++.....++.+|+-..|..||...++++++-|.....
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 7655544444332211110 0124667788999999999999999999999999986543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0019 Score=58.54 Aligned_cols=95 Identities=24% Similarity=0.361 Sum_probs=73.1
Q ss_pred HHHHHHHHHHHHhCC------CCCcceeeEEEEeCCEEEEEEecCCC------CChHHHHHhCCCCCHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK------HPNVVRLYEVMGSKTKIFIVLEFVTG------GELFDKIVNHGRMKEDEARRYFQQLIN 83 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~------HpnIv~l~~~~~~~~~~~lv~Ey~~g------g~L~~~i~~~~~l~e~~~~~~~~qll~ 83 (400)
..+.++|+.....+. +.+|.++||+.+++--.-+|+|.+.. -+|.+++.. +.+++ .+...+-.
T Consensus 55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~ 129 (199)
T PF10707_consen 55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDE 129 (199)
T ss_pred hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHH
Confidence 577888888877776 88999999999999888999997653 257777754 45665 34444555
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccC--C--Ceeeec
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAY--G--NLKVSD 115 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~--g--~~kl~D 115 (400)
-.+||-..+|+.+|++|.||++... | .+.|+|
T Consensus 130 f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 130 FKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 6678899999999999999999753 2 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00064 Score=63.05 Aligned_cols=31 Identities=35% Similarity=0.439 Sum_probs=25.7
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
.+++|+|+.|.||++++++..-|.||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998765567999997653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0021 Score=60.36 Aligned_cols=99 Identities=16% Similarity=0.263 Sum_probs=58.2
Q ss_pred HHHHHHHHHHhCCCCCc-ceeeEEEEeCCEEEEEEecCCCCChHH----------HHH-------hCC----CCC-HHHH
Q 015814 18 QIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVTGGELFD----------KIV-------NHG----RMK-EDEA 74 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~gg~L~~----------~i~-------~~~----~l~-e~~~ 74 (400)
...+|..+++.+...++ .+++... . -++||||++|..+.. .+. ... +++ ...+
T Consensus 37 ~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~ 112 (256)
T TIGR02721 37 DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARI 112 (256)
T ss_pred cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 35789999999964433 3444443 2 268999999865421 111 100 111 1222
Q ss_pred HHHHHHHH---------HHHHHHHH--------cCCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 75 RRYFQQLI---------NAVDYCHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 75 ~~~~~qll---------~~l~~LH~--------~givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
..+..++- ..+..+-. ..++|+|+.|.||++++++ +.++||..|..
T Consensus 113 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 113 AHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred HHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 33333331 11222221 2589999999999999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0023 Score=61.23 Aligned_cols=105 Identities=22% Similarity=0.177 Sum_probs=62.2
Q ss_pred HHHHHHHHHHHHhCCCCC--cceeeEE------EEeCCEEEEEEecCCCCChHH----H---H-------HhC-CCCCH-
Q 015814 16 LLQIKREVATMKLVKHPN--VVRLYEV------MGSKTKIFIVLEFVTGGELFD----K---I-------VNH-GRMKE- 71 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~lv~Ey~~gg~L~~----~---i-------~~~-~~l~e- 71 (400)
..++..|+.++..+.+.+ +.+++.. ....+..+.+++|++|..+.. . + ... ..+..
T Consensus 50 ~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~ 129 (296)
T cd05153 50 AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGE 129 (296)
T ss_pred hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCcc
Confidence 467888999998885333 4455432 233456789999999866421 0 1 000 00000
Q ss_pred -------HHHH------------HHHHHHHHHHHHHHH-------cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 72 -------DEAR------------RYFQQLINAVDYCHS-------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 72 -------~~~~------------~~~~qll~~l~~LH~-------~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
.... .....+..++.++.+ .+++|+|+.|.||++++++.+.|.||+.+.
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 130 RNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 0000 011112233444443 479999999999999997777899999754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0029 Score=61.35 Aligned_cols=104 Identities=25% Similarity=0.346 Sum_probs=67.8
Q ss_pred HHHHHHHHHHHHHHhCCCCC--cceeeEEEEeCC--EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHH-HHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPN--VVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDYC 88 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~~--~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~-qll~~l~~L 88 (400)
......++|..+++.+.--- +...++.+.++. ..|.||+|++|..+.+.. .+......+.. .+...|.-|
T Consensus 63 ~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~-----~~~~~~~~~~~~~l~~~La~L 137 (321)
T COG3173 63 ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL-----PPESLGRQFALDALADFLAEL 137 (321)
T ss_pred hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC-----CcccchHHHHHHHHHHHHHHH
Confidence 34678889999999885322 334455555444 569999999984322111 11111112222 444445544
Q ss_pred HH----------------------------------------------------------cCCeeccCCCCcEEEccCCC
Q 015814 89 HS----------------------------------------------------------RGVYHRDLKPENLLLDAYGN 110 (400)
Q Consensus 89 H~----------------------------------------------------------~givHrDlKP~NILl~~~g~ 110 (400)
|+ ..++|+|+.+.|++++.++-
T Consensus 138 H~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~ 217 (321)
T COG3173 138 HSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP 217 (321)
T ss_pred hCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe
Confidence 43 24899999999999999988
Q ss_pred eeeecccccccc
Q 015814 111 LKVSDFGLSALS 122 (400)
Q Consensus 111 ~kl~DFGla~~~ 122 (400)
+-+.||+++++-
T Consensus 218 ~gVlDwe~~~lG 229 (321)
T COG3173 218 TGVLDWELATLG 229 (321)
T ss_pred eEEEeccccccC
Confidence 999999998763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0078 Score=55.47 Aligned_cols=29 Identities=21% Similarity=0.386 Sum_probs=26.2
Q ss_pred CCeeccCCCCcEEEcc-CCCeeeecccccc
Q 015814 92 GVYHRDLKPENLLLDA-YGNLKVSDFGLSA 120 (400)
Q Consensus 92 givHrDlKP~NILl~~-~g~~kl~DFGla~ 120 (400)
+++|+|+.|.|||+++ ++.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 6999999999999998 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.011 Score=60.97 Aligned_cols=84 Identities=25% Similarity=0.441 Sum_probs=54.0
Q ss_pred cceeeEEEEeCCEEEEEEecCCCCChHH--HHHhCCCCCHHHHHHHHHHHHHHH-HHHHHcCCeeccCCCCcEEEcc---
Q 015814 34 VVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAV-DYCHSRGVYHRDLKPENLLLDA--- 107 (400)
Q Consensus 34 Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~--~i~~~~~l~e~~~~~~~~qll~~l-~~LH~~givHrDlKP~NILl~~--- 107 (400)
|.++|..+. +.-.++|||++|..+.| .|.+. +++...+ ..-+.++. +-+=..|.+|.|-.|.||+++.
T Consensus 266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~ 339 (538)
T KOG1235|consen 266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR-GISPHDI---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPE 339 (538)
T ss_pred CCeehhhcC--cceEEEEEecCCccCCCHHHHHHc-CCCHHHH---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCC
Confidence 555554433 34569999999976644 45553 3454432 22222221 1222478999999999999994
Q ss_pred -CCCeeeeccccccccc
Q 015814 108 -YGNLKVSDFGLSALSQ 123 (400)
Q Consensus 108 -~g~~kl~DFGla~~~~ 123 (400)
++.+.+-|||+.....
T Consensus 340 ~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 340 GDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccEEEEccccccccc
Confidence 5679999999876443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.009 Score=57.65 Aligned_cols=90 Identities=20% Similarity=0.299 Sum_probs=67.8
Q ss_pred HHHHHHHHHhCC-CC-CcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 19 IKREVATMKLVK-HP-NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 19 i~~Ei~il~~l~-Hp-nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
..+|+..|+.|. |- -|.+.+++ +..++|||++.|..|...- .-..+..+...++.-+--|.++|+||+
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~~Iv~la~~GlIHg 226 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMGLIVRLANHGLIHG 226 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHHHHHHHHHHHcCceec
Confidence 457999999994 32 24455543 4678999999997774321 112344566677777888999999999
Q ss_pred cCCCCcEEEccCCCeeeecccc
Q 015814 97 DLKPENLLLDAYGNLKVSDFGL 118 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGl 118 (400)
|..--||++++++.++++||-.
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred ccchheeEEecCCCEEEeechH
Confidence 9999999999999999999963
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.044 Score=52.80 Aligned_cols=44 Identities=16% Similarity=0.192 Sum_probs=34.0
Q ss_pred HHHHHHHHHHHHhCCC---CCcceeeEEEEe---CCEEEEEEecCCCCCh
Q 015814 16 LLQIKREVATMKLVKH---PNVVRLYEVMGS---KTKIFIVLEFVTGGEL 59 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~lv~Ey~~gg~L 59 (400)
...+..|...|+.|.- -.|.++++++.. .+..++|||+++|+.+
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 3688999999998843 357788877654 3668999999998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.041 Score=54.19 Aligned_cols=30 Identities=23% Similarity=0.533 Sum_probs=26.1
Q ss_pred CCeeccCCCCcEEEcc-CCCeeeeccccccc
Q 015814 92 GVYHRDLKPENLLLDA-YGNLKVSDFGLSAL 121 (400)
Q Consensus 92 givHrDlKP~NILl~~-~g~~kl~DFGla~~ 121 (400)
.++|+|+++.||++++ ++.+.++||..|..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 6899999999999986 47899999997653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.032 Score=54.62 Aligned_cols=29 Identities=34% Similarity=0.512 Sum_probs=25.3
Q ss_pred CeeccCCCCcEEEcc-CCCeeeeccccccc
Q 015814 93 VYHRDLKPENLLLDA-YGNLKVSDFGLSAL 121 (400)
Q Consensus 93 ivHrDlKP~NILl~~-~g~~kl~DFGla~~ 121 (400)
.+|.|+.|.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 47899999997653
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.15 Score=51.26 Aligned_cols=41 Identities=17% Similarity=0.224 Sum_probs=30.4
Q ss_pred HHHHHHHHHHHHhCC---CCCcceeeEEEEeCCEEEEEEecCCCCC
Q 015814 16 LLQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLEFVTGGE 58 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~Ey~~gg~ 58 (400)
.++...|.+.|+.+. ..++.+++.+ +....++||||+++..
T Consensus 74 ~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 74 LDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 567788999988873 3567888877 3455789999998744
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.051 Score=51.80 Aligned_cols=30 Identities=23% Similarity=0.407 Sum_probs=25.3
Q ss_pred CCeeccCCCCcEEEccCCC-eeeeccccccc
Q 015814 92 GVYHRDLKPENLLLDAYGN-LKVSDFGLSAL 121 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~-~kl~DFGla~~ 121 (400)
.++|+|+.|.||++++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.049 Score=52.55 Aligned_cols=30 Identities=43% Similarity=0.634 Sum_probs=27.0
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
.+++|+|+.+.|+++++++.+.|.||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.11 Score=51.00 Aligned_cols=85 Identities=25% Similarity=0.360 Sum_probs=59.3
Q ss_pred CCCcceeeEEE-EeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEccC
Q 015814 31 HPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAY 108 (400)
Q Consensus 31 HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~-givHrDlKP~NILl~~~ 108 (400)
.++..+.+-+- ...-+.|++|++- |++| ..+. .-...++..+|.+.+.-+.-+..+ ..-|||+...|||++ +
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Ccee-eeee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 34444443333 2233567777764 4344 2222 234567888888888888777766 789999999999999 8
Q ss_pred CCeeeeccccccc
Q 015814 109 GNLKVSDFGLSAL 121 (400)
Q Consensus 109 g~~kl~DFGla~~ 121 (400)
|++-|+||-+++.
T Consensus 358 GnvtLIDfklsRl 370 (488)
T COG5072 358 GNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEeeeeec
Confidence 9999999999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.13 Score=50.78 Aligned_cols=99 Identities=21% Similarity=0.286 Sum_probs=71.6
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeec
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHR 96 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~givHr 96 (400)
..+|++.|++|+..+|.----+.. . ...|||+|+-+. .-.-+| .+..++...+..+-+|++.-+.-|-+ .+.||.
T Consensus 213 AEKE~RNLkRl~~aGIP~PePIlL-k-~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHA 289 (520)
T KOG2270|consen 213 AEKEMRNLKRLNNAGIPCPEPILL-K-NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHA 289 (520)
T ss_pred HHHHHHHHHHHHhcCCCCCCceee-e-cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceecc
Confidence 457999999997666432221111 1 235899999642 222233 33568888999999999999888865 599999
Q ss_pred cCCCCcEEEccCCCeeeeccccccc
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
||.--|+|+-+ |.+.|+|.+.|--
T Consensus 290 DLSEfN~Lyhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 290 DLSEFNLLYHD-GKLYIIDVSQSVE 313 (520)
T ss_pred chhhhhheEEC-CEEEEEEcccccc
Confidence 99999999976 8999999987643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.09 Score=50.52 Aligned_cols=28 Identities=36% Similarity=0.587 Sum_probs=25.0
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLS 119 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla 119 (400)
.+++|+|+.+.||+++. +.+.|.||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 57999999999999998 77899999954
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.092 Score=50.81 Aligned_cols=30 Identities=33% Similarity=0.457 Sum_probs=25.7
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
.|++|+|+.|.||+++++...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999976556899999764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.24 Score=49.56 Aligned_cols=29 Identities=24% Similarity=0.193 Sum_probs=24.2
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
...+|.|+-+.||+.++ +.+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 46799999999999765 569999998664
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.61 E-value=0.39 Score=47.45 Aligned_cols=29 Identities=21% Similarity=0.301 Sum_probs=24.1
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
..++|+|+.|.||+++++ .++++|+.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence 468999999999999775 47799987653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.11 Score=49.80 Aligned_cols=29 Identities=31% Similarity=0.390 Sum_probs=26.2
Q ss_pred CCeeccCCCCcEEEccC----CCeeeecccccc
Q 015814 92 GVYHRDLKPENLLLDAY----GNLKVSDFGLSA 120 (400)
Q Consensus 92 givHrDlKP~NILl~~~----g~~kl~DFGla~ 120 (400)
+++|+|+.|.||+++++ +.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 68999999999999985 889999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.054 Score=48.45 Aligned_cols=29 Identities=28% Similarity=0.423 Sum_probs=25.5
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
-.+|+|+.|.|++++++| ++++||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 369999999999998877 99999998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=93.31 E-value=0.39 Score=43.54 Aligned_cols=87 Identities=22% Similarity=0.250 Sum_probs=62.0
Q ss_pred HHHHHHHHHHHHHhC---CCCCc--ceeeEEEEeC------------------CEEEEEEecCCCCChHHHHHhCCCCCH
Q 015814 15 ILLQIKREVATMKLV---KHPNV--VRLYEVMGSK------------------TKIFIVLEFVTGGELFDKIVNHGRMKE 71 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l---~HpnI--v~l~~~~~~~------------------~~~~lv~Ey~~gg~L~~~i~~~~~l~e 71 (400)
..+-+..|.+..-+| .+.++ |+.+++..-. ...-||.||++... .+
T Consensus 97 y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~-- 165 (207)
T PF13095_consen 97 YADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL-- 165 (207)
T ss_pred hcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc--
Confidence 345677777776666 45667 8999987211 22467888887643 12
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccc
Q 015814 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 119 (400)
Q Consensus 72 ~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla 119 (400)
...-+.++.+-+..+|..||+=+|+++.|.. .-||+|||.+
T Consensus 166 --~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 --QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred --chhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 2234567888888999999999999999987 3489999954
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.20 E-value=0.43 Score=42.34 Aligned_cols=96 Identities=17% Similarity=0.279 Sum_probs=66.4
Q ss_pred HHHHHHHHHHHHhCCCCCcc-eeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVV-RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
-..++.|+++|..+.-.++- ++|.+. ..++.|||+.|-+|.+.-... + ++-+..+++.---|-..||-
T Consensus 59 r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~ 127 (201)
T COG2112 59 RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIE 127 (201)
T ss_pred hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccc
Confidence 46789999999999887775 444442 234569999997775544321 1 22334455555556788999
Q ss_pred eccCC-CCcEEEccCCCeeeecccccccc
Q 015814 95 HRDLK-PENLLLDAYGNLKVSDFGLSALS 122 (400)
Q Consensus 95 HrDlK-P~NILl~~~g~~kl~DFGla~~~ 122 (400)
|..|. |...++.+++.+-|+||.-|++.
T Consensus 128 H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 128 HGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 99997 55555555569999999988743
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.42 E-value=0.36 Score=44.42 Aligned_cols=84 Identities=20% Similarity=0.254 Sum_probs=57.1
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--cCCee
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS--RGVYH 95 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~--~givH 95 (400)
-++.+.+++.++. +|+++..- ++-.+-+++|+|-.-.. ....++--=+.+|.-.|+ .+.+|
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NFSNFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------chhHHHHHhHHHHHHhhccCCCeec
Confidence 3466777777664 37777632 44567789998854211 001122222566777884 48999
Q ss_pred ccCCCCcEEEccCCCeeeecccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGL 118 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGl 118 (400)
+|-.|+||+-|+.|.+||.|=+.
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999663
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=92.17 E-value=0.73 Score=46.38 Aligned_cols=39 Identities=13% Similarity=0.121 Sum_probs=28.5
Q ss_pred HHHHHHHHHHHHhCC---CCCcceeeEEEEeCCEEEEEEecCCC
Q 015814 16 LLQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLEFVTG 56 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~Ey~~g 56 (400)
..+...|...|+.+. ..++.+++.+.. ...+++|||+++
T Consensus 78 ~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L~~ 119 (418)
T PLN02756 78 KERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYLEP 119 (418)
T ss_pred ccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeecCC
Confidence 456677788887664 347888888766 445688999987
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.95 E-value=0.17 Score=49.11 Aligned_cols=77 Identities=18% Similarity=0.243 Sum_probs=47.5
Q ss_pred EEEEEecCCCC--ChHH-HHHhCCCCC-HHHHHHHHHHHHHHHHHHH----HcCCeeccCCCCcEEEccCC---------
Q 015814 47 IFIVLEFVTGG--ELFD-KIVNHGRMK-EDEARRYFQQLINAVDYCH----SRGVYHRDLKPENLLLDAYG--------- 109 (400)
Q Consensus 47 ~~lv~Ey~~gg--~L~~-~i~~~~~l~-e~~~~~~~~qll~~l~~LH----~~givHrDlKP~NILl~~~g--------- 109 (400)
-.||++++.+. .+.. .+.+.|-.+ .+-++.++.|++.-.-.+- ..+.+|-||||+|||+-+..
T Consensus 250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 329 (444)
T PHA03111 250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKD 329 (444)
T ss_pred cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECC
Confidence 34788877542 2222 222233223 3457788888877653442 34799999999999985433
Q ss_pred ---------Ceeeeccccccccc
Q 015814 110 ---------NLKVSDFGLSALSQ 123 (400)
Q Consensus 110 ---------~~kl~DFGla~~~~ 123 (400)
.++|.||.+|....
T Consensus 330 ~~~vF~Epi~~~LnDFDfSqv~~ 352 (444)
T PHA03111 330 ATYVFNEPIKACLNDFDFSQVAN 352 (444)
T ss_pred eEEEeccchhhhhcccCHHHHcc
Confidence 24677787776544
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.84 E-value=0.21 Score=47.39 Aligned_cols=43 Identities=33% Similarity=0.460 Sum_probs=32.5
Q ss_pred HHHHHHHHHHHHc--CCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 79 QQLINAVDYCHSR--GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 79 ~qll~~l~~LH~~--givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
..+-.++.-.|.. -++|.|+.|+|+|.++.|.++|+||..|..
T Consensus 139 ~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 139 KELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3333334333433 589999999999999999999999987754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.65 E-value=0.098 Score=47.47 Aligned_cols=30 Identities=33% Similarity=0.626 Sum_probs=21.5
Q ss_pred CCeeccCCCCcEEE-ccCCCeeeeccccccc
Q 015814 92 GVYHRDLKPENLLL-DAYGNLKVSDFGLSAL 121 (400)
Q Consensus 92 givHrDlKP~NILl-~~~g~~kl~DFGla~~ 121 (400)
.++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 7889999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.25 E-value=0.15 Score=49.62 Aligned_cols=77 Identities=18% Similarity=0.227 Sum_probs=46.2
Q ss_pred EEEEecCCCC--ChHHHHHhCCCCC--HHHHHHHHHHHHHHHHH---HH-HcCCeeccCCCCcEEEccCC----------
Q 015814 48 FIVLEFVTGG--ELFDKIVNHGRMK--EDEARRYFQQLINAVDY---CH-SRGVYHRDLKPENLLLDAYG---------- 109 (400)
Q Consensus 48 ~lv~Ey~~gg--~L~~~i~~~~~l~--e~~~~~~~~qll~~l~~---LH-~~givHrDlKP~NILl~~~g---------- 109 (400)
.+|++++.+. .+.......-++. .+-++.++.|++.-.-- |- -.+.+|-||||+|||+-+..
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 3788877652 2222222222222 34577778887654311 22 34799999999999984322
Q ss_pred --------Ceeeecccccccccc
Q 015814 110 --------NLKVSDFGLSALSQQ 124 (400)
Q Consensus 110 --------~~kl~DFGla~~~~~ 124 (400)
.++|.||.+|...+-
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv~~i 349 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQVANI 349 (434)
T ss_pred EEEecccceeeecccCHHHhccc
Confidence 257888888776543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.19 E-value=0.34 Score=43.57 Aligned_cols=31 Identities=26% Similarity=0.353 Sum_probs=25.7
Q ss_pred HcCCeeccCCCCcEEEccCC-----Ceeeecccccc
Q 015814 90 SRGVYHRDLKPENLLLDAYG-----NLKVSDFGLSA 120 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g-----~~kl~DFGla~ 120 (400)
...++|||+.+.|+++..++ .+.+.||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 35699999999999998643 58999999764
|
subfamily of choline kinases |
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=91.03 E-value=3.3 Score=40.70 Aligned_cols=122 Identities=16% Similarity=0.170 Sum_probs=77.5
Q ss_pred HHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCC
Q 015814 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 101 (400)
Q Consensus 22 Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~ 101 (400)
+..++.. ..|+|+.-+. ++.+.+.|-.+-...---|+.+ .++.....++++.|.+..|.-+ .+.-.|-=+.|+
T Consensus 41 ~~~lld~-~~~f~~~eit--~~~Ds~vIsy~i~~~~~~F~~~---k~~~k~~Klr~a~~~I~~l~e~-~~tr~~~~laPe 113 (434)
T COG4499 41 LAELLDK-SPPFIVAEIT--EDNDSFVISYPIPEAAKSFASA---KRKEKTRKLRLALQNIATLSEL-NNTRYTFFLAPE 113 (434)
T ss_pred HHHHhcc-CCCccceeec--ccCceeEEEecCccccchHHHH---HHHHHHHHHHHHHHHHHHHHHh-hccceeEEecch
Confidence 3444444 4455555443 3444444544444333334444 3356667777788888888763 444566678999
Q ss_pred cEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHH-HHHHHHHHHHhCCCCCC
Q 015814 102 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW-SCGVILFVLLAGYLPFD 176 (400)
Q Consensus 102 NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw-SlGiil~elltG~~Pf~ 176 (400)
||+++.++.+-+.-+|+-... .+|...+.++| ++-|++..++.|+.+|.
T Consensus 114 Nilf~~~l~p~~vH~Glk~~l--------------------------pPye~tee~f~~~ykA~~~~~fn~k~~Fe 163 (434)
T COG4499 114 NILFDGGLTPFFVHRGLKNSL--------------------------PPYEMTEERFLKEYKALAIYAFNGKFSFE 163 (434)
T ss_pred heEEcCCCceEEEecchhccC--------------------------CCCCCCHHHHHHHHHHHHHHHHcCCccHH
Confidence 999999999999999963211 13444555665 37788888999999985
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 400 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-65 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-64 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-62 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-62 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-62 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-62 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-62 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-62 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-56 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-54 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-54 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-53 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-53 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-53 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-52 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-52 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-51 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-51 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-50 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-50 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-50 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-49 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-49 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-49 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-48 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-44 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-43 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-43 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-43 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-43 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-43 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-43 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-43 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-43 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-43 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-43 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-43 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-43 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-43 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-43 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-43 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-43 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-43 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-43 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-43 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-42 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-42 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-42 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-42 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-42 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-42 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-42 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-42 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-42 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-42 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-42 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-42 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-42 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-42 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-42 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-42 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-42 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-42 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-42 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-42 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-42 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-42 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-42 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-42 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-42 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-42 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-42 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-42 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-42 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-42 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-42 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-42 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-42 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-42 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-42 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-42 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-41 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-41 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-41 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-41 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-41 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-41 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-41 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-41 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-41 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-41 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-41 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-40 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-40 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-40 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-40 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-40 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-40 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-39 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-39 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-39 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-39 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-38 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-38 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-38 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-38 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-38 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-37 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-37 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-37 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-37 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-37 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-37 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-37 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-37 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-37 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-36 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 2e-36 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-36 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-36 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-36 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-35 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-35 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-35 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-34 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-34 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-34 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-34 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-34 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-34 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-34 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-34 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-34 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-34 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-34 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-34 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-34 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-34 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-34 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-34 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-34 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-34 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-33 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-33 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-33 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-33 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-33 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-33 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-33 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-32 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-32 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-32 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-32 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-32 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-32 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-32 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-32 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-32 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-31 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-31 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-31 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-31 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-31 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-31 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-31 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-31 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-31 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-31 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-31 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-31 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-31 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-31 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-31 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-31 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-31 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-31 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-30 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-30 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-30 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-30 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-30 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-30 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-30 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-30 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-30 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-30 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-30 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-30 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-30 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-30 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-30 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-30 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-30 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-30 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-30 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-30 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-30 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-30 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-30 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-30 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-30 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-30 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-30 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-30 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-30 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-30 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-30 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-30 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-30 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-30 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-30 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-30 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-30 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-30 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-30 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-30 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-30 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-30 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-30 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-29 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-29 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-29 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-29 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-29 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-29 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-29 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-29 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-29 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-29 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-29 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-29 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-29 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-29 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-29 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-29 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-29 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-29 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-29 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-29 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-29 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-29 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-29 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-29 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-29 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-29 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-28 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-28 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-27 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-27 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-27 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-27 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-27 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-27 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-27 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-27 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-27 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-27 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-27 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-26 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-26 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-26 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-25 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-25 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-25 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-25 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-25 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-24 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-24 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-23 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-22 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-22 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-21 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-21 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-21 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-21 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-20 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-20 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-20 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-20 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-20 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-20 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-19 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-19 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-19 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-19 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-19 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-19 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-19 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-19 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-19 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-19 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-19 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-19 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-19 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-19 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-19 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-19 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-19 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-18 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-10 | ||
| 2zfd_B | 123 | The Crystal Structure Of Plant Specific Calcium Bin | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 484 bits (1248), Expect = e-170
Identities = 133/425 (31%), Positives = 214/425 (50%), Gaps = 63/425 (14%)
Query: 10 LDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM 69
+ + ++ +I+RE+ +KL +HP++++LY+V+ + + IF+V+E+V+GGELFD I +GR+
Sbjct: 54 IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRL 113
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 129
E E+RR FQQ+++ VDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGE 170
Query: 130 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 189
L T+CG+PNY APEV++ R Y G D+WS GVIL+ LL G LPFDD ++ L+KKI
Sbjct: 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD 230
Query: 190 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD-- 247
F P +L+ + L+ +L +PM R TI +I E EWFK+D +F E +
Sbjct: 231 GIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMI 290
Query: 248 DVEAVFKDSEEHHVTEQK--------EEQPVAMNAFELI--------------------- 278
D EA+ + E+ +E++ Q A+ LI
Sbjct: 291 DDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPD 350
Query: 279 -------------------------SLSKGLNLGNLFDAEQDFKRETRFTS---RCPANE 310
+ L Q ++ + N+
Sbjct: 351 SFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPND 410
Query: 311 IINKIEEAAKPLGFDVHKKN-YKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKG 369
I+ ++ A K L ++ N Y +R+ ++ +++QV ++++ R
Sbjct: 411 IMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDD 470
Query: 370 DTLEF 374
+ LE
Sbjct: 471 EILEV 475
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-153
Identities = 108/296 (36%), Positives = 158/296 (53%), Gaps = 13/296 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++RE+ + ++HPN+VR EV+ + T + I++E+ +GGEL+++I N GR EDEAR +
Sbjct: 62 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF 121
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTC 135
FQQL++ V YCHS + HRDLK EN LLD LK+ DFG S S +T
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTV 178
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK----ISAAE 191
GTP Y+APEVL + YDG AD+WSCGV L+V+L G PF+D Y+K I + +
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238
Query: 192 FTCPP--WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT-NLDD 248
++ P +S LI+RI +P TRI+IPEI WF K+ + E +
Sbjct: 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE 298
Query: 249 VEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTS 304
E + + + P N ++ L+L + D + D + E S
Sbjct: 299 PEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMD-DFDSESEIDIDS 353
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 431 bits (1110), Expect = e-152
Identities = 113/223 (50%), Positives = 158/223 (70%), Gaps = 3/223 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+IKRE+ +KL +HP++++LY+V+ + T F+V+E+V+GGELFD I HGR++E EARR
Sbjct: 57 KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQ+++AVDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGS 173
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNY APEV++ R Y G D+WSCGVIL+ LL G LPFDD ++ L+KKI F P +
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
L+ + L+ +L +P+ R TI +I E EWFK+D +F E
Sbjct: 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 430 bits (1107), Expect = e-151
Identities = 91/252 (36%), Positives = 131/252 (51%), Gaps = 3/252 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
IK+E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+
Sbjct: 51 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF 110
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F QL+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPP 196
YVAPE+L R + D+WSCG++L +LAG LP+D S+ Y + P
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230
Query: 197 W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 254
W + L+ +IL NP RITIP+I +D W+ K K + +
Sbjct: 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGF 290
Query: 255 DSEEHHVTEQKE 266
+
Sbjct: 291 SKHIQSNLDFSP 302
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 427 bits (1101), Expect = e-151
Identities = 91/220 (41%), Positives = 128/220 (58%), Gaps = 3/220 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
IK+E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+
Sbjct: 51 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF 110
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F QL+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPP 196
YVAPE+L R + D+WSCG++L +LAG LP+D S+ Y + P
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230
Query: 197 W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234
W + L+ +IL NP RITIP+I +D W+ K K
Sbjct: 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-149
Identities = 115/273 (42%), Positives = 173/273 (63%), Gaps = 12/273 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+++RE++ +KL++HP++++LY+V+ + T I +V+E+ GGELFD IV RM EDE RR+
Sbjct: 55 RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
FQQ+I A++YCH + HRDLKPENLLLD N+K++DFGLS + + D L T+CG+
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGS 170
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNY APEV+N + Y G D+WSCG++L+V+L G LPFDD + NL+KK+++ + P +
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF 230
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF-EEKKDTNLDDVEAVFKDS 256
LS A+ LI R++ +PM RITI EI D WF + + E+ + D V K
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLG 290
Query: 257 EEHHVTEQ-------KEEQPVAMNAFELISLSK 282
E +E +E A+ L+ ++
Sbjct: 291 EAMGFSEDYIVEALRSDENNEVKEAYNLLHENQ 323
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 420 bits (1081), Expect = e-148
Identities = 72/256 (28%), Positives = 126/256 (49%), Gaps = 11/256 (4%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG--ELFDKIVNHGRMK 70
+K+E+ ++ ++H NV++L +V+ K K+++V+E+ G E+ D + R
Sbjct: 49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFP 107
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
+A YF QLI+ ++Y HS+G+ H+D+KP NLLL G LK+S G++ D
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 131 LHTTCGTPNYVAPEVLND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 189
T+ G+P + PE+ N + G D+WS GV L+ + G PF+ N+ L++ I
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK 227
Query: 190 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDV 249
+ P L+ +L+ P R +I +I + WF+K + P + D
Sbjct: 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287
Query: 250 EAVFKDS-----EEHH 260
+ + E+ H
Sbjct: 288 DRWRSMTVVPYLEDLH 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 402 bits (1035), Expect = e-141
Identities = 75/221 (33%), Positives = 113/221 (51%), Gaps = 3/221 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++ E++ + + H +VV + +F+VLE L + + E EAR Y
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+Q++ Y H V HRDLK NL L+ +K+ DFGL+ + D CGT
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGT 178
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNY+APEVL+ +G+ D+WS G I++ LL G PF+ S L Y +I E++ P
Sbjct: 179 PNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 238
++ A LI ++L +P R TI E+L DE+F Y P
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 402 bits (1035), Expect = e-140
Identities = 75/219 (34%), Positives = 113/219 (51%), Gaps = 3/219 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++ E++ + + H +VV + +F+VLE L + + E EAR Y
Sbjct: 87 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 146
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+Q++ Y H V HRDLK NL L+ +K+ DFGL+ + D CGT
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGT 204
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
PNY+APEVL+ +G+ D+WS G I++ LL G PF+ S L Y +I E++ P
Sbjct: 205 PNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
++ A LI ++L +P R TI E+L DE+F Y P
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 395 bits (1018), Expect = e-138
Identities = 72/224 (32%), Positives = 120/224 (53%), Gaps = 4/224 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARR 76
+++ EV +KHP+++ LY +++VLE GE+ + N E+EAR
Sbjct: 57 RVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH 116
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ Q+I + Y HS G+ HRDL NLLL N+K++DFGL+ + +T CG
Sbjct: 117 FMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCG 174
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 196
TPNY++PE+ + G +D+WS G + + LL G PFD + N K+ A++ P
Sbjct: 175 TPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233
Query: 197 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
+LS A+ LI ++L NP R+++ +L+ + ++ +E
Sbjct: 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-138
Identities = 81/222 (36%), Positives = 131/222 (59%), Gaps = 9/222 (4%)
Query: 16 LLQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGGELFDKIVNHGRMKEDE 73
+ Q+ +E+A +K + HPNVV+L EV+ ++ +++V E V G + + + + ED+
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQ 138
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
AR YFQ LI ++Y H + + HRD+KP NLL+ G++K++DFG+S + D LL
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--GSDALLSN 196
Query: 134 TCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
T GTP ++APE L++ + + G D+W+ GV L+ + G PF D +M L+ KI +
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256
Query: 192 FTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
P P ++ + LI R+LD NP +RI +PEI W +
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-137
Identities = 97/245 (39%), Positives = 150/245 (61%), Gaps = 3/245 (1%)
Query: 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
L ++ REV MK++ HPN+V+L+EV+ ++ +++++E+ +GGE+FD +V HGRMKE EAR
Sbjct: 58 LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR 117
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
F+Q+++AV YCH + + HRDLK ENLLLDA N+K++DFG S + G L C
Sbjct: 118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFC 174
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 195
G P Y APE+ + YDG D+WS GVIL+ L++G LPFD NL L +++ ++ P
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKD 255
++S L+ R L NP+ R T+ +I++D W ++ + + LD + D
Sbjct: 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRID 294
Query: 256 SEEHH 260
Sbjct: 295 IMVGM 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-133
Identities = 77/228 (33%), Positives = 134/228 (58%), Gaps = 8/228 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
Q++RE+ ++HPN++R+Y + +I+++LEF GEL+ ++ HGR E + +
Sbjct: 60 QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 119
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++L +A+ YCH R V HRD+KPENLL+ G LK++DFG S + +R T CGT
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGT 175
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
+Y+ PE++ + +D DLW GV+ + L G PFD + +++I + PP+
Sbjct: 176 LDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF 234
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK---PPVFEEKK 242
LS ++ LI+++L +P R+ + ++E W K + + PPV++ +
Sbjct: 235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 376 bits (969), Expect = e-131
Identities = 83/227 (36%), Positives = 129/227 (56%), Gaps = 5/227 (2%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
Q++REV ++HPN++RLY T+++++LE+ G ++ ++ + E Y
Sbjct: 55 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 114
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+L NA+ YCHS+ V HRD+KPENLLL + G LK++DFG S + R CGT
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGT 170
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
+Y+ PE++ R +D DLWS GV+ + L G PF+ + YK+IS EFT P +
Sbjct: 171 LDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 244
++ AR LI+R+L NP R + E+LE W + P + K++
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 375 bits (966), Expect = e-130
Identities = 66/261 (25%), Positives = 123/261 (47%), Gaps = 10/261 (3%)
Query: 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEA 74
L ++ E+A + V+H N++++ ++ ++ +V+E +G +LF I H R+ E A
Sbjct: 73 LGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA 132
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
F+QL++AV Y + + HRD+K EN+++ +K+ DFG +A + L +T
Sbjct: 133 SYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTF 189
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
CGT Y APEVL Y G ++WS GV L+ L+ PF + ++ A
Sbjct: 190 CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHP 243
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 254
P +S L++ +L P P R T+ +++ D W + + ++ ++ E+
Sbjct: 244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVL 303
Query: 255 DSEEHHVTEQKEEQPVAMNAF 275
+ + +
Sbjct: 304 SAASLEMGNRSLSDVAQAQEL 324
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 367 bits (943), Expect = e-126
Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 14/240 (5%)
Query: 16 LLQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFVTG-GELFDKIVNHGRMKED 72
++ EV +K V V+RL + ++LE +LFD I G ++E+
Sbjct: 90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE 149
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLL 131
AR +F Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG AL + D +
Sbjct: 150 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVY 205
Query: 132 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
GT Y PE + Y G +A +WS G++L+ ++ G +PF+ ++I +
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQ 259
Query: 192 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEA 251
+S + LI L P R T EI W + P E +L +
Sbjct: 260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 365 bits (938), Expect = e-126
Identities = 75/230 (32%), Positives = 113/230 (49%), Gaps = 16/230 (6%)
Query: 16 LLQIKREVATMKLV----KHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMK 70
+ EVA + V HP V+RL + ++ +VLE + +LFD I G +
Sbjct: 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDG 129
E +R +F Q++ A+ +CHSRGV HRD+K EN+L+D G K+ DFG AL D
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DE 193
Query: 130 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 189
GT Y PE ++ Y A +WS G++L+ ++ G +PF+ ++I
Sbjct: 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILE 247
Query: 190 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 239
AE P +S LI R L P P +R ++ EIL D W + +
Sbjct: 248 AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-120
Identities = 55/256 (21%), Positives = 106/256 (41%), Gaps = 34/256 (13%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK------- 70
K E+ + +K+ + ++ + +++I+ E++ + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 71 -EDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 128
+ + ++N+ Y H+ + + HRD+KP N+L+D G +K+SDFG S D
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV----D 204
Query: 129 GLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKK 186
+ + GT ++ PE ++ Y+G+ D+WS G+ L+V+ +PF +L+ L+
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264
Query: 187 ISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTRITIPEILEDE 227
I P +LS + L NP RIT + L+ E
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324
Query: 228 WFKKDYKPPVFEEKKD 243
W + E K+
Sbjct: 325 WLADTNIEDLREFSKE 340
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = e-100
Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 32/254 (12%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV-------------MGSKTKIFIVLEFVTGGELFDKIV 64
I EV + + H VVR Y + K+ +FI +E+ G L+D I
Sbjct: 48 TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107
Query: 65 NHGRMK-EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123
+ + DE R F+Q++ A+ Y HS+G+ HRDLKP N+ +D N+K+ DFGL+
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 124 Q------------VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171
+ L + GT YVA EVL+ G+ D++S G+I F ++
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-- 225
Query: 172 YLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNPMTRITIPEILEDE 227
Y +N+ KK+ + PP +K+I ++D +P R +L
Sbjct: 226 YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285
Query: 228 WFKKDYKPPVFEEK 241
W ++ V +E
Sbjct: 286 WLPVKHQDEVIKEA 299
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 1e-95
Identities = 85/261 (32%), Positives = 137/261 (52%), Gaps = 16/261 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++ E+ +K + HP ++++ ++ +IVLE + GGELFDK+V + R+KE + Y
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTT 134
F Q++ AV Y H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 176
Query: 135 CGTPNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA- 190
CGTP Y+APEVL G D WS GVILF+ L+GY PF + ++L +I++
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 191 -EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 247
F W +S A L+ ++L +P R T E L W + + F++ + +
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL--SEE 294
Query: 248 DVEAVFKDSEEHHVTEQKEEQ 268
+ T +K +
Sbjct: 295 NESTALPQVLAQPSTSRKRPR 315
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 2e-93
Identities = 90/225 (40%), Positives = 124/225 (55%), Gaps = 12/225 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
K+E+ MK + HPN++RLYE T I++V+E TGGELF+++V+ +E +A R
Sbjct: 53 FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 112
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
+ +++AV YCH V HRDLKPEN L LK+ DFGL+A + ++ T
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKV 169
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 193
GTP YV+P+VL Y G D WS GV+++VLL GY PF + KI F
Sbjct: 170 GTPYYVSPQVLE-GLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP 227
Query: 194 CPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
W +S A LI R+L +P RIT + LE EWF+K
Sbjct: 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 8e-93
Identities = 80/225 (35%), Positives = 122/225 (54%), Gaps = 15/225 (6%)
Query: 18 QIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
+RE ++ V HP+++ L + S + +F+V + + GELFD + + E E R
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS 204
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ L+ AV + H+ + HRDLKPEN+LLD +++SDFG S + L CG
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCG 261
Query: 137 TPNYVAPEVL------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 190
TP Y+APE+L GY G DLW+CGVILF LLAG PF + + + I
Sbjct: 262 TPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 191 --EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
+F+ P W S T + LI+R+L +P R+T + L+ +F++
Sbjct: 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-92
Identities = 80/230 (34%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 19 IKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+EV ++ V HPN+++L + + T F+V + + GELFD + + E E R+
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+ L+ + H + HRDLKPEN+LLD N+K++DFG S Q+ L CGT
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG---FSCQLDPGEKLREVCGT 186
Query: 138 PNYVAPEVL------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA- 190
P+Y+APE++ N GY G D+WS GVI++ LLAG PF M + + I +
Sbjct: 187 PSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 191 -EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237
+F P W S T + L++R L P R T E L +F++ V
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 2e-92
Identities = 87/233 (37%), Positives = 134/233 (57%), Gaps = 11/233 (4%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
++RE + ++HPN+VRL++ + ++ ++V + VTGGELF+ IV E +A
Sbjct: 52 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 111
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTC 135
QQ++ ++ YCHS G+ HR+LKPENLLL + +K++DFG L+ +V D H
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFA 168
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 193
GTP Y++PEVL Y D+W+CGVIL++LL GY PF D + LY +I A ++
Sbjct: 169 GTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227
Query: 194 CPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 244
P W ++ A+ LI +L NP RIT + L+ W + ++DT
Sbjct: 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 1e-91
Identities = 83/226 (36%), Positives = 128/226 (56%), Gaps = 16/226 (7%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++ E+ +K + HP ++++ ++ +IVLE + GGELFDK+V + R+KE + Y
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
F Q++ AV Y H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 301
Query: 135 CGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA 190
CGTP Y+APEVL GY D WS GVILF+ L+GY PF + ++L +I++
Sbjct: 302 CGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 191 --EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232
F W +S A L+ ++L +P R T E L W + +
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 5e-90
Identities = 85/225 (37%), Positives = 130/225 (57%), Gaps = 11/225 (4%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
++RE + ++HPN+VRL++ + ++ ++V + VTGGELF+ IV E +A
Sbjct: 75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTC 135
QQ++ ++ YCHS G+ HR+LKPENLLL + +K++DFGL+ +V D H
Sbjct: 135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFA 191
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 193
GTP Y++PEVL Y D+W+CGVIL++LL GY PF D + LY +I A ++
Sbjct: 192 GTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 250
Query: 194 CPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
P W ++ A+ LI +L NP RIT + L+ W +
Sbjct: 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 8e-90
Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 17/233 (7%)
Query: 18 QIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
+ E+A + ++ + ++RLY+ + I++V+E +L + + E +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERK 130
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Y++ ++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + +
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 136 GTPNYVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNL 183
GT NY+ PE + D +D+WS G IL+ + G PF + + L
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249
Query: 184 YKKI-SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235
+ I E P + ++ L +P RI+IPE+L + + P
Sbjct: 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 1e-89
Identities = 74/224 (33%), Positives = 121/224 (54%), Gaps = 15/224 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDE 73
QI+ E+ +K + HPN+++++EV ++IV+E GGEL ++IV + E
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGL 130
+Q++NA+ Y HS+ V H+DLKPEN+L + +K+ DFGL+ L + D
Sbjct: 126 VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEH 182
Query: 131 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 190
GT Y+APEV R D+WS GV+++ LL G LPF ++L + +K +
Sbjct: 183 STNAAGTALYMAPEVFK-RDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK 240
Query: 191 E--FTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
E + L+ A L+ ++L +P R + ++L EWFK+
Sbjct: 241 EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 280 bits (717), Expect = 2e-88
Identities = 71/395 (17%), Positives = 126/395 (31%), Gaps = 53/395 (13%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGR--- 68
+ E+ MK + HPNVV EV K+ + +E+ GG+L +
Sbjct: 58 RWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 117
Query: 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQV 125
+KE R + +A+ Y H + HRDLKPEN++L K+ D G ++++
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKEL 174
Query: 126 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLY 184
L GT Y+APE+L + Y T D WS G + F + G+ PF + + +
Sbjct: 175 DQGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233
Query: 185 KKISAAEFTCPPWLSFT-----------------------ARKLIARILDPNPMTRITIP 221
K+ + + +L + R T P
Sbjct: 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293
Query: 222 EILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLS 281
+ F+ + +V T E N +
Sbjct: 294 QNPNVGCFQ---------ALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQD 344
Query: 282 KGLNLGN--LFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMK 339
G+ L A + ++ + + + L F + E
Sbjct: 345 TGIPEEEQELLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRK--TVYEPQI 402
Query: 340 AGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 374
+ +V+ + L +R+ G +
Sbjct: 403 SLPAHPESVSIVLQDPKRPLTYTHLRRVWGQIWQT 437
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 4e-88
Identities = 86/224 (38%), Positives = 129/224 (57%), Gaps = 12/224 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
++ E+A +K +KH N+V L ++ S T ++V++ V+GGELFD+I+ G E +A
Sbjct: 53 LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI 112
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
QQ+++AV Y H G+ HRDLKPENLL + + ++DFGLS ++ +G++ T C
Sbjct: 113 QQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTAC 168
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 193
GTP YVAPEVL + Y D WS GVI ++LL GY PF + L++KI EF
Sbjct: 169 GTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE 227
Query: 194 CPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235
P W +S +A+ I +L+ +P R T + L W +
Sbjct: 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 6e-88
Identities = 83/221 (37%), Positives = 125/221 (56%), Gaps = 12/221 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I REV +K + HPN+++L+E++ + +IV E TGGELFD+I+ R E +A R
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
+Q+ + + Y H + HRDLKPEN+LL + ++K+ DFGLS + + +
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRI 184
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 193
GT Y+APEVL Y D+WS GVIL++LL+G PF N ++ K++ F
Sbjct: 185 GTAYYIAPEVLR-GTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 194 CPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232
P W +S A+ LI ++L +P RIT + LE W +K
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 267 bits (683), Expect = 2e-86
Identities = 61/295 (20%), Positives = 118/295 (40%), Gaps = 19/295 (6%)
Query: 18 QIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
+ E+A + ++ + ++RLY+ + I++V+E +L + + E +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERK 158
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Y++ ++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + +
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 136 GTPNYVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNL 183
G NY+ PE + D +D+WS G IL+ + G PF + + L
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277
Query: 184 YKKI-SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 242
+ I E P + ++ L +P RI+IPE+L + + P +
Sbjct: 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP--VNQMA 335
Query: 243 DTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFK 297
++++ V + + + S + F+ ++ K
Sbjct: 336 KGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 390
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 2e-86
Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 17/243 (6%)
Query: 18 QIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
+ E+A + ++ + ++RLY+ + I++V+E +L + + E +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERK 111
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Y++ ++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + +
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 136 GTPNYVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNL 183
GT NY+ PE + D +D+WS G IL+ + G PF + + L
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230
Query: 184 YKKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 242
+ I E P + ++ L +P RI+IPE+L + + P K
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290
Query: 243 DTN 245
T
Sbjct: 291 TTE 293
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 6e-86
Identities = 84/222 (37%), Positives = 127/222 (57%), Gaps = 12/222 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
++ E+ + + HPN+++L E+ + T+I +VLE VTGGELFD+IV G E +A
Sbjct: 95 VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
+Q++ AV Y H G+ HRDLKPENLL LK++DFG LS+ V L+ T C
Sbjct: 155 KQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG---LSKIVEHQVLMKTVC 211
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EF 192
GTP Y APE+L Y G D+WS G+I ++LL G+ PF D+ ++++I F
Sbjct: 212 GTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF 270
Query: 193 TCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232
P W +S A+ L+ +++ +P R+T + L+ W
Sbjct: 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 7e-85
Identities = 88/225 (39%), Positives = 128/225 (56%), Gaps = 10/225 (4%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
++RE +L+KHPN+VRL++ + + +++ + VTGGELF+ IV E +A
Sbjct: 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 116
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
QQ++ AV +CH GV HR+LKPENLLL +K++DFGL+ + +
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFA 174
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 193
GTP Y++PEVL Y G DLW+CGVIL++LL GY PF D + LY++I A +F
Sbjct: 175 GTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 233
Query: 194 CPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
P W ++ A+ LI ++L NP RIT E L+ W
Sbjct: 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 1e-84
Identities = 76/230 (33%), Positives = 123/230 (53%), Gaps = 17/230 (7%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEA 74
+KRE + ++KHP++V L E S +++V EF+ G +L +IV E A
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDG-L 130
Y +Q++ A+ YCH + HRD+KP +LL + +K+ FG++ Q+ + G +
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLV 189
Query: 131 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 190
GTP+++APEV+ Y G D+W CGVILF+LL+G LPF + L++ I
Sbjct: 190 AGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKG 247
Query: 191 --EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+ W +S +A+ L+ R+L +P RIT+ E L W K+ +
Sbjct: 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 3e-84
Identities = 49/263 (18%), Positives = 92/263 (34%), Gaps = 48/263 (18%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKED 72
RE +K + H N+V+L+ + T +++EF G L+ + + E
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDD 128
E + ++ +++ G+ HR++KP N++ D K++DFG + ++ DD
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDD 169
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDDS--- 178
+ GT Y+ P++ G+T DLWS GV + G LPF
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 179 -NLMNLYKKISAAEFTC-------------------------PPWLSFTARKLIARILDP 212
+ KI + + L ++A IL+
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289
Query: 213 NPMTRITIPEILEDEWFKKDYKP 235
+ + +
Sbjct: 290 DQEKCWGFDQFFAETSDILHRGN 312
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 3e-84
Identities = 74/232 (31%), Positives = 121/232 (52%), Gaps = 15/232 (6%)
Query: 17 LQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
E+ + + +HPN++ L +V +++V E + GGEL DKI+ E EA
Sbjct: 60 RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLL 131
+ V+Y H++GV HRDLKP N+L ++++ DFG + + ++GLL
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLL 177
Query: 132 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKIS 188
T C T N+VAPEVL +GYD + D+WS GV+L+ +L GY PF + + +I
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236
Query: 189 AA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+ + W +S TA+ L++++L +P R+T +L W + P
Sbjct: 237 SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 1e-83
Identities = 79/228 (34%), Positives = 128/228 (56%), Gaps = 12/228 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+I+REV ++ ++HPN++ L+++ +KT + ++LE V+GGELFD + + EDEA ++
Sbjct: 54 EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF 113
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+Q+++ V Y HS+ + H DLKPEN++L +K+ DFG ++ ++
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG---IAHKIEAGNEFKN 170
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--E 191
GTP +VAPE++N G AD+WS GVI ++LL+G PF ISA +
Sbjct: 171 IFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229
Query: 192 FTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237
F + S A+ I R+L +P R+TI + LE W K + V
Sbjct: 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-83
Identities = 88/278 (31%), Positives = 136/278 (48%), Gaps = 26/278 (9%)
Query: 19 IKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++E+ +KL + HPN+V+L+EV + F+V+E + GGELF++I E EA
Sbjct: 52 TQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI 111
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
++L++AV + H GV HRDLKPENLL + +K+ DFG + L D+ L T
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTP 169
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKI 187
C T +Y APE+LN GYD S DLWS GVIL+ +L+G +PF + + + KKI
Sbjct: 170 CFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228
Query: 188 SAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKD 243
F W +S A+ LI +L +P R+ + + +EW + +
Sbjct: 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS------S 282
Query: 244 TNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLS 281
L + + V + A N ++
Sbjct: 283 NPLMTPDILGSSG--AAVHTCVKATFHAFNKYKREGFC 318
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 3e-83
Identities = 83/235 (35%), Positives = 124/235 (52%), Gaps = 12/235 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
I+REV+ +K ++HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA +
Sbjct: 60 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF 119
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+Q++N V Y HS + H DLKPEN++L +K+ DFG L+ ++
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKN 176
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--E 191
GTP +VAPE++N G AD+WS GVI ++LL+G PF +SA E
Sbjct: 177 IFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 192 FTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 244
F + S A+ I R+L +P R+TI + L+ W K K
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASA 290
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-82
Identities = 74/235 (31%), Positives = 125/235 (53%), Gaps = 12/235 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+I+REV+ ++ V H NV+ L++V ++T + ++LE V+GGELFD + + E+EA +
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+Q+++ V+Y H++ + H DLKPEN++L ++K+ DFG L+ ++ D
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKN 177
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--E 191
GTP +VAPE++N G AD+WS GVI ++LL+G PF I++ +
Sbjct: 178 IFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236
Query: 192 FTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 244
F + S A+ I ++L R+TI E L W ++
Sbjct: 237 FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 3e-82
Identities = 54/314 (17%), Positives = 106/314 (33%), Gaps = 48/314 (15%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKED 72
RE +K + H N+V+L+ + T +++EF G L+ + + E
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDD 128
E + ++ +++ G+ HR++KP N++ D K++DFG + ++ DD
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDD 169
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDD---- 177
+ GT Y+ P++ G+T DLWS GV + G LPF
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 178 SNLMNLYKKISAAEFT-------------------------CPPWLSFTARKLIARILDP 212
+ KI + + L ++A IL+
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289
Query: 213 NPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAM 272
+ + + + + ++ ++ +
Sbjct: 290 DQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIIS 349
Query: 273 NAFELISLSKGLNL 286
+ ELI + L L
Sbjct: 350 SNQELIYEGRRLVL 363
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 4e-82
Identities = 75/234 (32%), Positives = 125/234 (53%), Gaps = 12/234 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I+REV+ ++ V HPN++ L++V ++T + ++LE V+GGELFD + + E+EA +
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+Q+++ V+Y H++ + H DLKPEN++L ++K+ DFG L+ ++ D
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNI 178
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EF 192
GTP +VAPE++N G AD+WS GVI ++LL+G PF I+A +F
Sbjct: 179 FGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 193 TCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 244
+ S A+ I ++L R+TI E L W ++
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 8e-82
Identities = 79/264 (29%), Positives = 114/264 (43%), Gaps = 51/264 (19%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK-------- 70
IK EV MK + HPN+ RLYEV + I +V+E GG L DK+
Sbjct: 75 IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 71 --------------------------------EDEARRYFQQLINAVDYCHSRGVYHRDL 98
E +Q+ +A+ Y H++G+ HRD+
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 99 KPENLLL--DAYGNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNYVAPEVLN--DRGYD 152
KPEN L + +K+ DFGLS + + T GTP +VAPEVLN + Y
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY- 253
Query: 153 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKLIAR 208
G D WS GV+L +LL G +PF N + ++ + F P + LS AR L++
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313
Query: 209 ILDPNPMTRITIPEILEDEWFKKD 232
+L+ N R L+ W +
Sbjct: 314 LLNRNVDERFDAMRALQHPWISQF 337
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 6e-81
Identities = 86/244 (35%), Positives = 133/244 (54%), Gaps = 16/244 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
I REV +K + HPN+++L+E++ + +IV E TGGELFD+I+ R E +A R
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI 126
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+Q+ + + Y H + HRDLKPEN+LL + ++K+ DFG LS + + +
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDR 183
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F 192
GT Y+APEVL Y D+WS GVIL++LL+G PF N ++ K++ + F
Sbjct: 184 IGTAYYIAPEVLR-GTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241
Query: 193 TCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 250
P W +S A+ LI ++L +P RIT + LE W +K E ++L +E
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS----ETPTISDLPSLE 297
Query: 251 AVFK 254
+
Sbjct: 298 SAMT 301
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 6e-81
Identities = 82/232 (35%), Positives = 128/232 (55%), Gaps = 12/232 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+I E++ +K + HPN+++L++V K ++V EF GGELF++I+N + E +A
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+Q+++ + Y H + HRD+KPEN+LL ++ N+K+ DFG LS D L
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG---LSSFFSKDYKLRDR 208
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F 192
GT Y+APEVL + Y D+WSCGVI+++LL GY PF N ++ KK+ + F
Sbjct: 209 LGTAYYIAPEVLK-KKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266
Query: 193 TCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 242
W +S A++LI +L + R T E L W KK ++K
Sbjct: 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-80
Identities = 69/240 (28%), Positives = 121/240 (50%), Gaps = 14/240 (5%)
Query: 18 QIKREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEA 74
+I E+A ++L K P V+ L+EV + ++I ++LE+ GGE+F + + E++
Sbjct: 74 EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV 133
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLL 131
R +Q++ V Y H + H DLKP+N+LL G++K+ DFG +S+++ L
Sbjct: 134 IRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG---MSRKIGHACEL 190
Query: 132 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA- 190
GTP Y+APE+LN + D+W+ G+I ++LL PF + Y IS
Sbjct: 191 REIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249
Query: 191 -EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 247
+++ + +S A I +L NP R T L W ++ +F ++ ++
Sbjct: 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 3e-80
Identities = 84/227 (37%), Positives = 128/227 (56%), Gaps = 12/227 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+ REV +K + HPN+++LYE K ++V E TGGELFD+I++ R E +A R
Sbjct: 72 SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 131
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+Q+++ + Y H + HRDLKPENLLL N+++ DFG LS +
Sbjct: 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEASKKMKDK 188
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F 192
GT Y+APEVL+ Y D+WS GVIL++LL+G PF+ +N ++ KK+ + F
Sbjct: 189 IGTAYYIAPEVLH-GTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246
Query: 193 TCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237
P W +S +A+ LI ++L P RI+ + L+ EW + K +
Sbjct: 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-80
Identities = 91/290 (31%), Positives = 136/290 (46%), Gaps = 30/290 (10%)
Query: 19 IKREVATMK-LVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--E 71
+REV + P++VR+ +V + + IV+E + GGELF +I + G E
Sbjct: 101 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 160
Query: 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDD 128
EA + + A+ Y HS + HRD+KPENLL LK++DFG +++
Sbjct: 161 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSH 217
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LY 184
L T C TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + +
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
Query: 185 KKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
+I EF P W +S + LI +L P R+TI E + W + K P
Sbjct: 277 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP---- 332
Query: 241 KKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAF--ELISLSKGLNLGN 288
T L + +D E +++ +A E I + K + N
Sbjct: 333 --QTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 380
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 9e-80
Identities = 57/226 (25%), Positives = 111/226 (49%), Gaps = 11/226 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARR 76
+K+E++ + + +H N++ L+E S ++ ++ EF++G ++F++I + E E
Sbjct: 47 LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVS 106
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTT 134
Y Q+ A+ + HS + H D++PEN++ + +K+ +FG ++Q++
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLL 163
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EF 192
P Y APEV + D+WS G +++VLL+G PF + + I A F
Sbjct: 164 FTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222
Query: 193 TCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+ +S A + R+L +R+T E L+ W K+ +
Sbjct: 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-79
Identities = 83/226 (36%), Positives = 126/226 (55%), Gaps = 12/226 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++ EVA +KL+ HPN+++LY+ K ++V+E GGELFD+I++ + E +A
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI 141
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+Q+++ V Y H + HRDLKPENLLL + +K+ DFGLSA+ + +
Sbjct: 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKER 198
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F 192
GT Y+APEVL + Y D+WS GVILF+LLAGY PF + +K+ + F
Sbjct: 199 LGTAYYIAPEVLR-KKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF 256
Query: 193 TCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
P W +S A+ LI ++L + RI+ + LE W K+
Sbjct: 257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 7e-79
Identities = 85/277 (30%), Positives = 131/277 (47%), Gaps = 31/277 (11%)
Query: 19 IKREVATM-KLVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--E 71
++EV + P++V + +V K + I++E + GGELF +I G E
Sbjct: 68 ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127
Query: 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDD 128
EA + + A+ + HS + HRD+KPENLL + LK++DFG + +
Sbjct: 128 REAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQ 183
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLY 184
L T C TP YVAPEVL YD S D+WS GVI+++LL G+ PF + +
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 185 KKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
++I F P W +S A++LI +L +P R+TI + + W + P
Sbjct: 243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP---- 298
Query: 241 KKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFEL 277
T L + +D + H E KEE A+ +
Sbjct: 299 --QTPLHTARVLQEDKD--HWDEVKEEMTSALATMRV 331
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 3e-77
Identities = 70/234 (29%), Positives = 118/234 (50%), Gaps = 11/234 (4%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRY 77
+K E++ M + H N+++LY+ SK I +V+E+V GGELFD+I++ + E + +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTC 135
+Q+ + + H + H DLKPEN+L +K+ DFG L+++ + L
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG---LARRYKPREKLKVNF 249
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 193
GTP ++APEV+N + D+WS GVI ++LL+G PF N I A +
Sbjct: 250 GTPEFLAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 194 CPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 245
+ +S A++ I+++L RI+ E L+ W +K N
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKN 362
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 4e-77
Identities = 72/247 (29%), Positives = 115/247 (46%), Gaps = 34/247 (13%)
Query: 19 IKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+ REV + + H NV+ L E + + ++V E + GG + I E EA
Sbjct: 57 VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSAL-----SQQVRDDG 129
Q + +A+D+ H++G+ HRDLKPEN+L + +K+ DF L +
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 130 LLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-- 182
L T CG+ Y+APEV+ YD DLWS GVIL++LL+GY PF +
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 183 -------------LYKKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILE 225
L++ I EF W +S A+ LI+++L + R++ ++L+
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 226 DEWFKKD 232
W +
Sbjct: 296 HPWVQGC 302
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 9e-77
Identities = 65/225 (28%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRY 77
+K E++ M + HP ++ L++ K ++ ++LEF++GGELFD+I +M E E Y
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTC 135
+Q + + H + H D+KPEN++ + +K+ DFG L+ ++ D ++ T
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTT 211
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 193
T + APE+++ G D+W+ GV+ +VLL+G PF + + + + EF
Sbjct: 212 ATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 194 CPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+ +S A+ I +L P R+T+ + LE W K D+
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 5e-76
Identities = 69/244 (28%), Positives = 120/244 (49%), Gaps = 11/244 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARR 76
+++E+ TM +++HP +V L++ ++ ++ EF++GGELF+K+ + H +M EDEA
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
Y +Q+ + + H H DLKPEN++ LK+ DFG L+ + + T
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG---LTAHLDPKQSVKVT 316
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EF 192
GT + APEV + G D+WS GV+ ++LL+G PF N + + +
Sbjct: 317 TGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM 375
Query: 193 TCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 250
+ +S + I ++L +P TR+TI + LE W P + + +
Sbjct: 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 435
Query: 251 AVFK 254
K
Sbjct: 436 DSIK 439
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-73
Identities = 38/238 (15%), Positives = 79/238 (33%), Gaps = 31/238 (13%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV-----------TGGELFDKI 63
R + LVK P ++ V + ++++ F G L
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 64 VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123
H + + Q+I + H G+ H L+P +++LD G + ++ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---- 253
Query: 124 QVRDDGLLHTTCGTPNYVAPEVLNDRG----------YDGSTADLWSCGVILFVLLAGYL 173
DG + + + PE+ R + D W+ G++++ + L
Sbjct: 254 --VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
P + + I F + R L+ L R+ + +E +++
Sbjct: 312 PITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-71
Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 20/239 (8%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKI----VNHGRM 69
+ +RE +L HPN++RL G+K + +++L F G L+++I +
Sbjct: 72 EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------S 122
ED+ + ++ H++G HRDLKP N+LL G + D G S
Sbjct: 132 TEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 123 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNL 180
+Q T +Y APE+ + + + D+WS G +L+ ++ G P+D
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 181 -MNLYKKISAAEFTCPPWLSFT--ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+ + + P + +L+ ++ +P R IP +L + P
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-71
Identities = 66/246 (26%), Positives = 106/246 (43%), Gaps = 31/246 (12%)
Query: 18 QIKREVATMK-LVKHPNVVRLY-------EVMGSKTKIFIVLEFVTGGELFDKIVN---H 66
I +EV MK L HPN+V+ E + F++L + G+L + +
Sbjct: 71 AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR 130
Query: 67 GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA---- 120
G + D + F Q AV + H + + HRDLK ENLLL G +K+ DFG +
Sbjct: 131 GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190
Query: 121 ---LSQQVRDDGLLH---TTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGY 172
S + L+ T TP Y PE+++ G D+W+ G IL++L
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
Query: 173 LPFDDSNLMNLYKKISAAEFTCPPWLSFTA--RKLIARILDPNPMTRITIPEILEDEWFK 230
PF+D + +I +++ PP + LI +L NP R++I E++
Sbjct: 251 HPFEDGAKL----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306
Query: 231 KDYKPP 236
+
Sbjct: 307 AAARNV 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 5e-70
Identities = 74/226 (32%), Positives = 114/226 (50%), Gaps = 15/226 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----E 71
+ EV ++ +KHPN+VR Y+ + + T ++IV+E+ GG+L I + + E
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 72 DEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 126
+ R QL A+ CH R V HRDLKP N+ LD N+K+ DFGL+ +
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-- 168
Query: 127 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 186
D T GTP Y++PE +N Y+ +D+WS G +L+ L A PF + L K
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227
Query: 187 ISAAEFTC-PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
I +F P S ++I R+L+ R ++ EILE+ +
Sbjct: 228 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 6e-68
Identities = 63/255 (24%), Positives = 101/255 (39%), Gaps = 36/255 (14%)
Query: 19 IKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMK 70
E+ + + HPNV+R Y + ++I LE L D + + K
Sbjct: 55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQK 113
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-------------AYGNLKVSDFG 117
E +Q+ + V + HS + HRDLKP+N+L+ + +SDFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 118 LSAL--SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD------GSTADLWSCGVILFVLL 169
L S Q L+ GT + APE+L + + D++S G + + +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 170 -AGYLPFDDSNLMN---LYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEI 223
G PF D + S E C L A LI++++D +P+ R T ++
Sbjct: 234 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
Query: 224 LEDEWFKKDYKPPVF 238
L F K F
Sbjct: 294 LRHPLFWPKSKKLEF 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 6e-68
Identities = 63/217 (29%), Positives = 116/217 (53%), Gaps = 6/217 (2%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEAR 75
+ +REVA + +KHPN+V+ E ++IV+++ GG+LF +I +ED+
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
+F Q+ A+ + H R + HRD+K +N+ L G +++ DFG++ + L
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACI 186
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC- 194
GTP Y++PE+ ++ Y+ + +D+W+ G +L+ L F+ ++ NL KI + F
Sbjct: 187 GTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV 245
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
S+ R L++++ NP R ++ ILE + K
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-67
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 14/234 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+ RE M + HP V+LY K++ L + GEL I G E R Y
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++++A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
YV+PE+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P
Sbjct: 196 AQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
Query: 198 LSFTARKLIARILDPNPMTRITIP------EILEDEWFKK-------DYKPPVF 238
AR L+ ++L + R+ + +F+ PP
Sbjct: 255 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-66
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 15/235 (6%)
Query: 18 QIKREVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM-KEDEAR 75
REV ++ +HPNV+R + + +I +E L + + E
Sbjct: 63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPI 121
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLL-----DAYGNLKVSDFGLSA-LSQQVRDDG 129
QQ + + + HS + HRDLKP N+L+ +SDFGL L+
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 130 LLHTTCGTPNYVAPEVLNDRGYDGST--ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKK 186
GT ++APE+L++ + T D++S G + + +++ G PF S
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241
Query: 187 ISAAEFTCPPW---LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 238
+ A C AR+LI +++ +P R + +L+ +F K F
Sbjct: 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQF 296
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-66
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 26/232 (11%)
Query: 18 QIKREVATMKLVKHPNVVRLYE----------------VMGSKTKIFIVLEFVTGGELFD 61
+ +REV + + H N+V +FI +EF G L
Sbjct: 50 KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109
Query: 62 KIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 119
I ++ + A F+Q+ VDY HS+ + +RDLKP N+ L +K+ DFGL
Sbjct: 110 WIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 120 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 179
+++DG + GT Y++PE ++ + Y DL++ G+IL LL +++
Sbjct: 170 T---SLKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS 225
Query: 180 LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
+ + + L+ ++L P R EIL K
Sbjct: 226 --KFFTDLRDGII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-66
Identities = 74/250 (29%), Positives = 109/250 (43%), Gaps = 49/250 (19%)
Query: 19 IKREVATM-KLVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--E 71
+REV + + P++VR+ +V + + IV+E + GGELF +I + G E
Sbjct: 57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 116
Query: 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDD 128
EA + + A+ Y HS + HRD+KPENLL LK++DFG
Sbjct: 117 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------- 166
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LY 184
A E YD S D+WS GVI+++LL GY PF ++ + +
Sbjct: 167 -------------AKETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
Query: 185 KKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
+I EF P W +S + LI +L P R+TI E + W + K P
Sbjct: 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP---- 267
Query: 241 KKDTNLDDVE 250
T L
Sbjct: 268 --QTPLHTSR 275
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-63
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 11/217 (5%)
Query: 18 QIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEAR 75
+ EV + K+ +HP VRL + +++ E G L G + E +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW 160
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Y + + A+ + HS+G+ H D+KP N+ L G K+ DFGL ++ G
Sbjct: 161 GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQE 217
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKISAAEFTC 194
G P Y+APE+L Y + AD++S G+ + + LP L + EF
Sbjct: 218 GDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF-- 273
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
LS R ++ +L+P+P R T +L ++
Sbjct: 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-62
Identities = 37/226 (16%), Positives = 77/226 (34%), Gaps = 20/226 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT-----------GGELFDKIVNHGRM 69
R + LVK P ++ V + ++++ F G L H +
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 129
+ Q+I + H G+ H L+P +++LD G + ++ F +
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH-LVRDGASAVS 267
Query: 130 LLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLLAGYLPFDDSNLMNLYK 185
+ P A +L + + D W+ G+ ++ + LP D + +
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE 327
Query: 186 KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
I + P R L+ L R+ + +E +++
Sbjct: 328 WIFRSCKNIPQP----VRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-61
Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 15/233 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDE 73
+E+ +K + HPNV++ Y ++ IVLE G+L I + + + E
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+YF QL +A+++ HSR V HRD+KP N+ + A G +K+ D GL H+
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHS 195
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAE 191
GTP Y++PE +++ GY+ +D+WS G +L+ + A PF D NL +L KKI +
Sbjct: 196 LVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254
Query: 192 FTCPPW----LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
+ PP S R+L+ ++P+P R + + + E
Sbjct: 255 Y--PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 9e-61
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 20/232 (8%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
E ++ V P +V+L + +++V+E+V GGE+F + GR E AR Y
Sbjct: 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q++ +Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTP 202
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 198
+APE++ +GY D W+ GV+++ + AGY PF + +Y+KI + + P
Sbjct: 203 EALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 199 SFTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 236
S + L+ +L + R + +I +WF + + P
Sbjct: 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-60
Identities = 35/256 (13%), Positives = 69/256 (26%), Gaps = 47/256 (18%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMG--------------------------SKTKIFIVL 51
++ + + + + +++
Sbjct: 108 RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167
Query: 52 EFVTG-----GELFDKIVNHGRMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLL 105
+ D + + A QLI S+G+ H P+NL +
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI 227
Query: 106 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-GSTADLWSCGVI 164
G L + D + + Y E LN + W G+
Sbjct: 228 MPDGRLMLGDVSAL-----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 165 LFVLLAGYLPFDDSN--LMNLYKKISAAE-------FTCPPWLSFTARKLIARILDPNPM 215
++ + +LPF + +K+ S F L + LI R L+ +
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342
Query: 216 TRITIPEILEDEWFKK 231
R+ E +E F +
Sbjct: 343 RRLLPLEAMETPEFLQ 358
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-60
Identities = 78/249 (31%), Positives = 137/249 (55%), Gaps = 25/249 (10%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
E + +V HP ++R++ +IF++++++ GGELF + R A+ Y
Sbjct: 53 TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 112
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++ A++Y HS+ + +RDLKPEN+LLD G++K++DFG + + +T CGTP
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTP 167
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 198
+Y+APEV++ + Y + D WS G++++ +LAGY PF DSN M Y+KI AE PP+
Sbjct: 168 DYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 226
Query: 199 SFTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KD----YKPPVFEE 240
+ + L++R++ + R+ ++ WFK ++ Y+PP+ +
Sbjct: 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQG 286
Query: 241 KKDT-NLDD 248
+ DT D
Sbjct: 287 QGDTSQFDK 295
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-60
Identities = 56/245 (22%), Positives = 95/245 (38%), Gaps = 29/245 (11%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV------------MGSKTKIFIVLEFVTGGELFDKIVN 65
++ REV + ++HP +VR + K ++I ++ L D +
Sbjct: 49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG 108
Query: 66 HGRMK---EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL- 121
++ F Q+ AV++ HS+G+ HRDLKP N+ +KV DFGL
Sbjct: 109 RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 122 ---------SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172
+ GT Y++PE ++ Y D++S G+ILF LL Y
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--Y 225
Query: 173 LPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
+ + +F ++ +L P+PM R I+E+ F+
Sbjct: 226 PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
Query: 232 DYKPP 236
P
Sbjct: 286 LDFPG 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-58
Identities = 63/248 (25%), Positives = 118/248 (47%), Gaps = 21/248 (8%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+ +E+ M+ ++HP +V L+ + +F+V++ + GG+L + + KE+ + +
Sbjct: 62 VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+L+ A+DY ++ + HRD+KP+N+LLD +G++ ++DF ++A + + + T GT
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTK 178
Query: 139 NYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEF 192
Y+APE+ + R GY D WS GV + LL G P+ ++ +
Sbjct: 179 PYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237
Query: 193 TCPPWLSFTARKLIARILDPNPMTRI-TIPEILEDEWFK---------KDYKPPVFEEKK 242
T P S L+ ++L+PNP R + ++ + K P F K
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPG-FIPNK 296
Query: 243 DTNLDDVE 250
D
Sbjct: 297 GRLNCDPT 304
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 9e-58
Identities = 78/237 (32%), Positives = 128/237 (54%), Gaps = 23/237 (9%)
Query: 20 KREVATM------KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE 73
+ V T V HP +V+L+ ++ K++++L+F+ GG+LF ++ E++
Sbjct: 68 RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED 127
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+ Y +L A+D+ HS G+ +RDLKPEN+LLD G++K++DFGLS S + + ++
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYS 185
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 193
CGT Y+APEV+N RG+ +AD WS GV++F +L G LPF + I A+
Sbjct: 186 FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 244
Query: 194 CPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 236
P +LS A+ L+ + NP R+ + EI +F ++ PP
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-57
Identities = 73/225 (32%), Positives = 122/225 (54%), Gaps = 17/225 (7%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
++ VKHP +V L + K++++LE+++GGELF ++ G ED A Y ++ A+
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 145
+ H +G+ +RDLKPEN++L+ G++K++DFGL S + D + HT CGT Y+APE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHTFCGTIEYMAPEI 192
Query: 146 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 205
L G+ D WS G +++ +L G PF N KI + PP+L+ AR L
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDL 251
Query: 206 IARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 236
+ ++L N +R+ E+ +F+ + +PP
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP 296
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-56
Identities = 70/134 (52%), Positives = 96/134 (71%), Gaps = 1/134 (0%)
Query: 266 EEQPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAAKPLGF 324
+E P+ MNAFE+I+LS+GLNL LFD QDF KR+TRF SR +EII IE A +GF
Sbjct: 1 DEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGF 60
Query: 325 DVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLSTC 384
H +N+K RLE + + + G L V E+++VAPSL MV+VRKA G+TLE+HKFYK L +
Sbjct: 61 KSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSK 120
Query: 385 LEDVVWKTEEDMQE 398
LE+++W+ E + +
Sbjct: 121 LENIIWRATEGIPK 134
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 36/242 (14%), Positives = 82/242 (33%), Gaps = 29/242 (11%)
Query: 13 FCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHG 67
F I Q+ +K ++ Y + +V E + G L + I
Sbjct: 111 FYIGTQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK 167
Query: 68 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-----------DAYGNLKVSDF 116
M + + +++ ++ H + H D+KP+N +L D L + D
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 117 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPF 175
G S + + C T + E+L+++ ++ D + ++ +L G Y+
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKV 286
Query: 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE---DEWFKKD 232
+ + + W + +L+ + ++L + F++
Sbjct: 287 KNEGGECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341
Query: 233 YK 234
Y
Sbjct: 342 YT 343
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-56
Identities = 74/223 (33%), Positives = 113/223 (50%), Gaps = 16/223 (7%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 86
K VKHP +V L+ + K++ VL+++ GGELF + E AR Y ++ +A+
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 146
Y HS + +RDLKPEN+LLD+ G++ ++DFGL + + + T CGTP Y+APEVL
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 147 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 206
+ + Y T D W G +L+ +L G PF N +Y I P ++ +AR L+
Sbjct: 212 HKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270
Query: 207 ARILDPNPMTRITIP----EILEDEWFK---------KDYKPP 236
+L + R+ EI +F K PP
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPP 313
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 8e-56
Identities = 65/218 (29%), Positives = 113/218 (51%), Gaps = 13/218 (5%)
Query: 29 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88
+HP + ++ +K +F V+E++ GG+L I + + A Y ++I + +
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 148
HS+G+ +RDLK +N+LLD G++K++DFG+ + + D +T CGTP+Y+APE+L
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLG 192
Query: 149 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 208
+ Y + D WS GV+L+ +L G PF + L+ I P WL A+ L+ +
Sbjct: 193 QKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
Query: 209 ILDPNPMTRI-TIPEILEDEWFK---------KDYKPP 236
+ P R+ +I + F+ K+ PP
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 289
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 75/225 (33%), Positives = 120/225 (53%), Gaps = 17/225 (7%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
++ +HP + L + ++ V+E+ GGELF + E+ AR Y ++++A+
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 145
+Y HSR V +RD+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEV
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEV 176
Query: 146 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 205
L D Y G D W GV+++ ++ G LPF + + L++ I E P LS A+ L
Sbjct: 177 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 206 IARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 236
+A +L +P R+ E++E +F K PP
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 72/225 (32%), Positives = 117/225 (52%), Gaps = 18/225 (8%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 86
HP + +L+ + ++F V+EFV GG+L I R E AR Y ++I+A+
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 146
+ H +G+ +RDLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEIL 196
Query: 147 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 206
+ Y G D W+ GV+L+ +L G+ PF+ N +L++ I E P WL A ++
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255
Query: 207 ARILDPNPMTRI------TIPEILEDEWFK---------KDYKPP 236
+ NP R+ IL +FK + +PP
Sbjct: 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP 300
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-54
Identities = 65/224 (29%), Positives = 118/224 (52%), Gaps = 17/224 (7%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 86
K P + +L+ + +++ V+E+V GG+L I GR KE A Y ++ +
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 146
+ S+G+ +RDLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEII 193
Query: 147 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 206
+ Y G + D W+ GV+L+ +LAG PF+ + L++ I P +S A +
Sbjct: 194 AYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252
Query: 207 ARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 236
++ +P R+ +I E +F+ K+ +PP
Sbjct: 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 296
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-52
Identities = 68/227 (29%), Positives = 121/227 (53%), Gaps = 22/227 (9%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
+ P +V L+ ++TK+ ++L+++ GGELF + R E E + Y +++ A+++ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--N 147
G+ +RD+K EN+LLD+ G++ ++DFGLS + + CGT Y+AP+++
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGG 235
Query: 148 DRGYDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTAR 203
D G+D + D WS GV+++ LL G PF + ++ + ++I +E P +S A+
Sbjct: 236 DSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294
Query: 204 KLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 236
LI R+L +P R+ EI E +F+ K P
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 341
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-52
Identities = 70/234 (29%), Positives = 122/234 (52%), Gaps = 27/234 (11%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 86
+ HP +V L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 146
Y H RG+ +RDLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 147 NDRGYDGSTADLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAAEFTCPPW 197
Y G + D W+ GV++F ++AG PF D + L++ I + P
Sbjct: 183 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241
Query: 198 LSFTARKLIARILDPNPMTRI------TIPEILEDEWFK---------KDYKPP 236
LS A ++ L+ +P R+ +I +F+ K PP
Sbjct: 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPP 295
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 6e-52
Identities = 75/226 (33%), Positives = 120/226 (53%), Gaps = 18/226 (7%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
++ +HP + L + ++ V+E+ GGELF + ED AR Y ++++A+
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 86 DYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 144
DY HS + V +RDLK ENL+LD G++K++DFGL + ++D + T CGTP Y+APE
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPE 319
Query: 145 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 204
VL D Y G D W GV+++ ++ G LPF + + L++ I E P L A+
Sbjct: 320 VLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 378
Query: 205 LIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 236
L++ +L +P R+ EI++ +F K PP
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 1e-51
Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 17/224 (7%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE---ARRYF 78
++ M N V + K ++I ++ L D + +++ E F
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------- 128
Q+ AV++ HS+G+ HRDLKP N+ +KV DFGL Q ++
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 188
GT Y++PE ++ Y D++S G+ILF LL Y + + +
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL--YSFSTQMERVRIITDVR 287
Query: 189 AAEFTCPPWLSF-TARKLIARILDPNPMTRITIPEILEDEWFKK 231
+F + ++ +L P+P R +I+E+ F+
Sbjct: 288 NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 65/221 (29%), Positives = 118/221 (53%), Gaps = 17/221 (7%)
Query: 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89
K P + +L+ + +++ V+E+V GG+L I GR KE A Y ++ + +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 149
S+G+ +RDLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209
Y G + D W+ GV+L+ +LAG PF+ + L++ I P +S A + +
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 576
Query: 210 LDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 236
+ +P R+ +I E +F+ K+ +PP
Sbjct: 577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-51
Identities = 70/234 (29%), Positives = 122/234 (52%), Gaps = 27/234 (11%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 86
+ HP +V L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 146
Y H RG+ +RDLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 147 NDRGYDGSTADLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAAEFTCPPW 197
Y G + D W+ GV++F ++AG PF D + L++ I + P
Sbjct: 226 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
Query: 198 LSFTARKLIARILDPNPMTRI------TIPEILEDEWFK---------KDYKPP 236
LS A ++ L+ +P R+ +I +F+ K PP
Sbjct: 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPP 338
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-50
Identities = 81/250 (32%), Positives = 127/250 (50%), Gaps = 30/250 (12%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 85
M P VV+L+ +++V+E++ GG+L ++++ + E AR Y +++ A+
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLAL 181
Query: 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAP 143
D HS G HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++P
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISP 238
Query: 144 EVLNDRGYD---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPP 196
EVL +G D G D WS GV L+ +L G PF +L+ Y KI + F
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
Query: 197 WLSFTARKLIARILDPNPMTRIT---IPEILEDEWFK---------KDYKPPV---FEEK 241
+S A+ LI L + R+ + EI +FK +D PV
Sbjct: 299 DISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSD 357
Query: 242 KDT-NLDDVE 250
DT N DD+E
Sbjct: 358 IDTSNFDDLE 367
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-50
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 24/251 (9%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
+ ++ + P +V + + K+ +L+ + GG+L + HG E + R Y
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
++I +++ H+R V +RDLKP N+LLD +G++++SD GL+ H + GT
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHG 355
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAAEFTCPP 196
Y+APEVL S+AD +S G +LF LL G+ PF + + + P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 197 WLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKP---PVFE 239
S R L+ +L + R+ E+ E +F+ + Y P P
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 475
Query: 240 EKKDTNLDDVE 250
E + D+
Sbjct: 476 EVNAADAFDIG 486
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 36/277 (12%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINA 84
+ + +L+ + +++V+E+ GG+L + G R+ + AR Y +++ A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 85 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVA 142
+D H G HRD+KP+N+LLD G+++++DFG ++R DG + GTP+Y++
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLS 231
Query: 143 PEVLNDRGYD------GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTC 194
PE+L G G D W+ GV + + G PF + Y KI +
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 195 P---PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFK-------KDYKPPV---F 238
P + AR I R+L P TR+ + +F +D PP F
Sbjct: 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDF 350
Query: 239 EEKKDT-NLDDVEAVFKDSEEHHVTEQKEEQPVAMNA 274
E DT N D VE D V+ E
Sbjct: 351 EGATDTCNFDLVE----DGLTAMVSGGGETLSDIREG 383
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-49
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 32/252 (12%)
Query: 26 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINA 84
+ + L+ +++V+++ GG+L + R+ E+ AR Y +++ A
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 85 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVA 142
+D H HRD+KP+N+L+D G+++++DFG ++ +DG + GTP+Y++
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYIS 244
Query: 143 PEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCP 195
PE+L Y G D WS GV ++ +L G PF +L+ Y KI F P
Sbjct: 245 PEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303
Query: 196 PW---LSFTARKLIARILDPNPMTRIT---IPEILEDEWFK-------KDYKPPV---FE 239
+S A+ LI R++ R+ I + + +F ++ + P
Sbjct: 304 TQVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVS 362
Query: 240 EKKDT-NLDDVE 250
DT N D +
Sbjct: 363 SPTDTSNFDVDD 374
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 28/249 (11%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLI 82
V +V L +KT + +V+ + GG++ I N + +E A Y Q++
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 83 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 142
+ +++ H R + +RDLKPEN+LLD GN+++SD GL+ + GTP ++A
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMA 357
Query: 143 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTCPPWL 198
PE+L Y + D ++ GV L+ ++A PF L +++ T P
Sbjct: 358 PELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416
Query: 199 SFTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPPVF---EEK 241
S ++ +L +P R+ + + F+ PP
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTV 476
Query: 242 KDTNLDDVE 250
N+ DV
Sbjct: 477 YAKNIQDVG 485
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-49
Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 6/125 (4%)
Query: 269 PVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHK 328
MNAF++IS S G NL LF + + R RF S A ++ ++EE V K
Sbjct: 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAK 62
Query: 329 K-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKN-LSTCLE 386
K + M++E G+KGN + E+ Q+ L M+EVRK + + + L
Sbjct: 63 KETWGMKIE----GQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFV 118
Query: 387 DVVWK 391
++V +
Sbjct: 119 ELVHE 123
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 24/243 (9%)
Query: 27 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM--KEDEARRYFQQLINA 84
+ V VV L +K + +VL + GG+L I + G+ E A Y ++
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 85 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 144
++ H + +RDLKPEN+LLD +G++++SD G L+ V + + GT Y+APE
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAPE 355
Query: 145 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSF 200
V+ + Y + D W+ G +L+ ++AG PF + + + S
Sbjct: 356 VVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 201 TARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPPVFEEKKDTNL 246
AR L +++L +P R+ + E+ E FK +PP + +
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYC 474
Query: 247 DDV 249
DV
Sbjct: 475 KDV 477
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 47/240 (19%), Positives = 82/240 (34%), Gaps = 36/240 (15%)
Query: 18 QIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKED 72
REV L +H +VVR + + I E+ GG L D I + R KE
Sbjct: 56 NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115
Query: 73 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL-------------------KV 113
E + Q+ + Y HS + H D+KP N+ + K+
Sbjct: 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
Query: 114 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-DRGYDGSTADLWSCGVILFVLLAGY 172
D G V G ++A EVL + + AD+++ + +
Sbjct: 176 GDLGH------VTRISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAE 228
Query: 173 LPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
+ + +I P LS +L+ ++ P+P R + +++
Sbjct: 229 PLPRNGDQW---HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 14/221 (6%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
E+ + P +V LY + + I +E + GG L I G + ED A Y
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 157
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC--- 135
Q + ++Y H+R + H D+K +N+LL + G+ + DFG + ++ DGL +
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGD 214
Query: 136 ---GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE- 191
GT ++APEV+ + D D+WS ++ +L G P+ L KI++
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP 273
Query: 192 --FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
PP + + I L P+ R + E+
Sbjct: 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEA-- 74
+ E+A K +KH N+V+ I I +E V GG L + G +K++E
Sbjct: 65 PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHT 133
Y +Q++ + Y H + HRD+K +N+L++ Y G LK+SDFG S + T
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTET 182
Query: 134 TCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA 190
GT Y+APE+++ RGY + AD+WS G + + G PF + K+
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 241
Query: 191 EF--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 241
+ P +S A+ I + +P+P R ++L DE+ K K + K
Sbjct: 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-42
Identities = 54/227 (23%), Positives = 109/227 (48%), Gaps = 16/227 (7%)
Query: 16 LLQIKREVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKE 71
+ K E +K ++HPN+VR Y + K I +V E +T G L + MK
Sbjct: 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 128
Query: 72 DEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDD 128
R + +Q++ + + H+R + HRDLK +N+ + G++K+ D GL+ L +
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---- 184
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKI 187
GTP ++APE+ + YD S D+++ G+ + + P+ + N +Y+++
Sbjct: 185 SFAKAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 188 SAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232
++ + +++I + N R +I ++L +F+++
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 61/265 (23%), Positives = 109/265 (41%), Gaps = 55/265 (20%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQ 79
RE+ +K +KHPN+V L EV K ++ +V E+ + ++ + R + E +
Sbjct: 51 REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW 109
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP 138
Q + AV++CH HRD+KPEN+L+ + +K+ DFG + L+ +
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YD----- 160
Query: 139 NYV------APEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYKKIS 188
+ V +PE+L D Y D+W+ G + LL+G P S++ LY
Sbjct: 161 DEVATRWYRSPELLVGDTQY--GPPVDVWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRK 217
Query: 189 A------------------AEFTCPPW------------LSFTARKLIARILDPNPMTRI 218
+ P +S+ A L+ L +P R+
Sbjct: 218 TLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL 277
Query: 219 TIPEILEDEWFKKDYKPPVFEEKKD 243
T ++L +F+ + ++ D
Sbjct: 278 TCEQLLHHPYFENIREIEDLAKEHD 302
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 49/219 (22%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYF 78
K EV ++ +H N++ + ++ IV ++ G L+ + + + + +
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+Q +DY H++ + HRDLK N+ L +K+ DFGL+ + G+
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 139 NYVAPEVLNDRGYDGST--ADLWSCGVILFVLLAGYLPFDDSNLM----------NLYKK 186
++APEV+ + + + +D+++ G++L+ L+ G LP+ + N +L
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 187 ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
+S CP + ++L+A L R + P IL
Sbjct: 247 LSKVRSNCPKRM----KRLMAECLKKKRDERPSFPRILA 281
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-39
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 25/232 (10%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
REVA MK ++HPN+V + + IV E+++ G L+ + G ++ + RR
Sbjct: 82 LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 80 ---QLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ ++Y H+R + HR+LK NLL+D +KV DFGLS L + +
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSA 199
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-- 192
GTP ++APEVL D + +D++S GVIL+ L P+ + +N + ++A F
Sbjct: 200 AGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKC 255
Query: 193 -------TCPPWLSFTARKLIARILDPNPMTRITIPEILED-EWFKKDYKPP 236
P + +I P R + I++ K PP
Sbjct: 256 KRLEIPRNLNPQV----AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 63/266 (23%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG-----ELFDKIVNHGRMKEDEAR 75
RE++ MK +KH N+VRLY+V+ ++ K+ +V EF+ + ++ + +
Sbjct: 52 REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTT 134
+ QL+ + +CH + HRDLKP+NLL++ G LK+ DFGL+ A V
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-------- 163
Query: 135 CGTPN-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD-------- 177
+ Y AP+VL R Y ST+ D+WSCG IL ++ G P +
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTY--STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221
Query: 178 ---------------SNL------------MNLYKKISAAEFTCPPWLSFTARKLIARIL 210
+ L +L + + L + +L
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLL 278
Query: 211 DPNPMTRITIPEILEDEWFKKDYKPP 236
NP R++ + L WF + Y
Sbjct: 279 QLNPDMRLSAKQALHHPWFAEYYHHA 304
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 45/224 (20%), Positives = 92/224 (41%), Gaps = 23/224 (10%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYF 78
KREV + +H NVV S + I+ G L+ + + ++ R+
Sbjct: 77 KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTC 135
Q+++ + Y H++G+ H+DLK +N+ D G + ++DFGL + Q R + L
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 136 GTPNYVAPEVLNDRGYDGST--------ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
G ++APE++ D +D+++ G I + L A PF + ++
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255
Query: 188 ------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
+ ++ + ++ R T ++++
Sbjct: 256 GTGMKPNLSQIGMGKEI----SDILLFCWAFEQEERPTFTKLMD 295
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 77/259 (29%), Positives = 117/259 (45%), Gaps = 59/259 (22%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYF 78
RE+ +K +KH N+VRL++V+ S K+ +V EF + FD +G + + + +
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFL 107
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGL 130
QL+ + +CHSR V HRDLKP+NLL++ G LK+++FGL+ S +V
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---- 163
Query: 131 LHTTCGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAGYLPF--DDSNLMNLYKK 186
T Y P+VL + Y ST+ D+WS G I L P + L +
Sbjct: 164 ------TLWYRPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-R 214
Query: 187 ISAA-----EFTCP------------------------PWLSFTARKLIARILDPNPMTR 217
I E P P L+ T R L+ +L NP+ R
Sbjct: 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274
Query: 218 ITIPEILEDEWFKKDYKPP 236
I+ E L+ +F D+ PP
Sbjct: 275 ISAEEALQHPYF-SDFCPP 292
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 69/258 (26%), Positives = 116/258 (44%), Gaps = 55/258 (21%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYF 78
RE++ +K + HPN+V L +V+ S+ + +V EF+ ++ D+ N +++ + + Y
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 137
QL+ V +CH + HRDLKP+NLL+++ G LK++DFGL+ A VR T
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--------SYT 177
Query: 138 PN-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD----------- 177
Y AP+VL + Y ST+ D+WS G I ++ G P
Sbjct: 178 HEVVTLWYRAPDVLMGSKKY--STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235
Query: 178 ------------SNLMNLYKKISAAEFTCP------PWLSFTARKLIARILDPNPMTRIT 219
L +K+ + F P L++ +L +P RI+
Sbjct: 236 LGTPNPREWPQVQELPL-WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294
Query: 220 IPEILEDEWFKKDYKPPV 237
+ + +F KD P +
Sbjct: 295 ARDAMNHPYF-KDLDPQI 311
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 65/263 (24%), Positives = 106/263 (40%), Gaps = 57/263 (21%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYF 78
RE+ +K ++H N+V L EV K + ++V EFV + + + ++Y
Sbjct: 73 REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYL 130
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 137
Q+IN + +CHS + HRD+KPEN+L+ G +K+ DFG + L+ +
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV----YD---- 182
Query: 138 PNYV------APEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK-- 185
+ V APE+L D Y A D+W+ G ++ + G P DS++ LY
Sbjct: 183 -DEVATRWYRAPELLVGDVKY--GKAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIM 238
Query: 186 KI----------------SAAEFTCPPW------------LSFTARKLIARILDPNPMTR 217
A P LS L + L +P R
Sbjct: 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR 298
Query: 218 ITIPEILEDEWFKKDYKPPVFEE 240
E+L ++F+ D F +
Sbjct: 299 PFCAELLHHDFFQMDGFAERFSQ 321
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 55/253 (21%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYF 78
RE++ +K +KH N+V+LY+V+ +K ++ +V E + +L D G ++ A+ +
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFL 106
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 137
QL+N + YCH R V HRDLKP+NLL++ G LK++DFGL+ A VR T
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYT 158
Query: 138 PN-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYKKIS 188
Y AP+VL + Y ST D+WS G I ++ G P S L +I
Sbjct: 159 HEIVTLWYRAPDVLMGSKKY--STTIDIWSVGCIFAEMVNGTPLFP-GVSEADQLM-RIF 214
Query: 189 AA-----EFTCP------------------------PWLSFTARKLIARILDPNPMTRIT 219
P L + L++++L +P RIT
Sbjct: 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274
Query: 220 IPEILEDEWFKKD 232
+ LE +FK++
Sbjct: 275 AKQALEHAYFKEN 287
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 63/261 (24%), Positives = 103/261 (39%), Gaps = 58/261 (22%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
REV+ +K ++H N++ L V+ ++ ++ E+ +L + + + + + Q
Sbjct: 82 REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLS--------ALSQQVRD 127
LIN V++CHSR HRDLKP+NLLL LK+ DFGL+ + ++
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199
Query: 128 DGLLHTTCGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD------ 177
T Y PE+L R Y ST+ D+WS I +L P D
Sbjct: 200 ---------TLWYRPPEILLGSRHY--STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248
Query: 178 -----------------SNL---MNLYKKISAAEF--TCPPWLSFTARKLIARILDPNPM 215
+ L + K L L+ +L+ +P+
Sbjct: 249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV 308
Query: 216 TRITIPEILEDEWFKKDYKPP 236
RI+ LE +F + P
Sbjct: 309 KRISAKNALEHPYFSHNDFDP 329
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 68/256 (26%), Positives = 102/256 (39%), Gaps = 56/256 (21%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYF 78
RE+ ++ + HPN++ L + G K+ I +V +F+ + N + + Y
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYM 118
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGL 130
+ ++Y H + HRDLKP NLLLD G LK++DFGL+ A + QV
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV---- 174
Query: 131 LHTTCGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK- 185
T Y APE+L R Y D+W+ G IL LL +LP DS+L L +
Sbjct: 175 ------TRWYRAPELLFGARMY--GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRI 225
Query: 186 -------------KIS----AAEFTCP---------PWLSFTARKLIARILDPNPMTRIT 219
+ F LI + NP RIT
Sbjct: 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285
Query: 220 IPEILEDEWFKKDYKP 235
+ L+ ++F P
Sbjct: 286 ATQALKMKYFSNRPGP 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 30/234 (12%)
Query: 8 KYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG 67
K +++ E+ + V HPN+V+LY + +V+E+ GG L++ +
Sbjct: 37 KQIESESERKAFIVELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAE 94
Query: 68 RMKEDEARRYFQQLI---NAVDYCHSR---GVYHRDLKPENLLLDAYGN-LKVSDFGLSA 120
+ A + V Y HS + HRDLKP NLLL A G LK+ DFG +
Sbjct: 95 PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
Query: 121 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 180
Q + G+ ++APEV Y D++S G+IL+ ++ PFD+ +
Sbjct: 155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDE--I 206
Query: 181 MNLYKKISAAEF---------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
+I A P + L+ R +P R ++ EI++
Sbjct: 207 GGPAFRIMWAVHNGTRPPLIKNLPKPI----ESLMTRCWSKDPSQRPSMEEIVK 256
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 56/259 (21%), Positives = 102/259 (39%), Gaps = 58/259 (22%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYF 78
REV+ +K +KH N+V L++++ ++ + +V E++ + D + + +
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFL 106
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGL 130
QL+ + YCH + V HRDLKP+NLL++ G LK++DFGL+ +V
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---- 162
Query: 131 LHTTCGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK- 185
T Y P++L Y ST D+W G I + + G P + L+
Sbjct: 163 ------TLWYRPPDILLGSTDY--STQIDMWGVGCIFYEMATGRPLFP-GSTVEEQLHFI 213
Query: 186 -------------------KISAAEFTCP---------PWLSFTARKLIARILDPNPMTR 217
+ + P L L+ ++L R
Sbjct: 214 FRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNR 273
Query: 218 ITIPEILEDEWFKKDYKPP 236
I+ + ++ +F +
Sbjct: 274 ISAEDAMKHPFFLSLGERI 292
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 41/236 (17%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------R 68
+EV M+ ++HPNV++ V+ ++ + E++ GG L I +
Sbjct: 53 TFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS 112
Query: 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL------- 121
+D A + Y HS + HRDL N L+ N+ V+DFGL+ L
Sbjct: 113 FAKDIAS--------GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164
Query: 122 -----SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176
S + D +T G P ++APE++N R YD D++S G++L ++
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADP 223
Query: 177 DSNLMNLYKKISAAEF-------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
D + ++ F CPP + R D +P R + ++
Sbjct: 224 DYLPRTMDFGLNVRGFLDRYCPPNCPPSF----FPITVRCCDLDPEKRPSFVKLEH 275
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-36
Identities = 40/224 (17%), Positives = 85/224 (37%), Gaps = 33/224 (14%)
Query: 20 KREVATMKLVKHPNVVRLYEVM--GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
E +++ HPNV+ + ++ ++ G L++ + D+++
Sbjct: 55 NEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA- 113
Query: 78 FQQLINAVD------YCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 129
+ A+D + H+ + L ++++D ++S + Q
Sbjct: 114 ---VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----- 165
Query: 130 LLHTTCGTPNYVAPEVLNDRGYDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
P +VAPE L + D + AD+WS V+L+ L+ +PF D + M + K+
Sbjct: 166 --PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223
Query: 188 SAAEF------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
+ P + KL+ ++ +P R I+
Sbjct: 224 ALEGLRPTIPPGISPHV----SKLMKICMNEDPAKRPKFDMIVP 263
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I++E+ + P V + Y TK++I++E++ GG D ++ G + E +
Sbjct: 67 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATIL 125
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGT 137
++++ +DY HS HRD+K N+LL +G +K++DFG++ Q+ D + T GT
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGT 182
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P ++APEV+ YD AD+WS G+ L G P + + M + I PP
Sbjct: 183 PFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPT 238
Query: 198 L----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
L S ++ + L+ P R T E+L+ ++ ++ K
Sbjct: 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 68/262 (25%), Positives = 106/262 (40%), Gaps = 60/262 (22%)
Query: 21 REVATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMK 70
REVA ++ ++ HPNVVRL +V + K+ +V E V DK +
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLP 118
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQ 123
+ + +Q + +D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ AL+
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 124 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNL 180
V T Y APEVL Y +T D+WS G I + +S
Sbjct: 179 VVV----------TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRKPLFC-GNSEA 225
Query: 181 MNLYK-----------------KISAAEFTCP---------PWLSFTARKLIARILDPNP 214
L K + F P + + +L+ +L NP
Sbjct: 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNP 285
Query: 215 MTRITIPEILEDEWFKKDYKPP 236
RI+ L+ + KD P
Sbjct: 286 HKRISAFRALQHSYLHKDEGNP 307
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
+REV + H N+V + +V ++V+E++ G L + I +HG + D A +
Sbjct: 59 EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN 118
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC--G 136
Q+++ + + H + HRD+KP+N+L+D+ LK+ DFG++ ALS+ L T G
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLG 174
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP 195
T Y +PE D T D++S G++L+ +L G PF+ ++ + K I +
Sbjct: 175 TVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT 233
Query: 196 ----PWLSFTARKLIARILDPNPMTR-ITIPEILED 226
+ + +I R + + R TI E+ +D
Sbjct: 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 24/203 (11%)
Query: 21 REVATMKLVKHPNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
E + V HP++V+++ +IV+E+V G L ++ EA
Sbjct: 128 AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAI 185
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHTT 134
Y +++ A+ Y HS G+ + DLKPEN++L LK+ D G S ++ G L
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINS----FGYL--- 237
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
GTP + APE++ R D+++ G L L + + L + +
Sbjct: 238 YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKT-- 293
Query: 195 PPWLSFTARKLIARILDPNPMTR 217
+L+ R +DP+P R
Sbjct: 294 YDSY----GRLLRRAIDPDPRQR 312
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 39/243 (16%)
Query: 3 FQDLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK 62
+D+S+ ++ ++E ++KHPN++ L V + + +V+EF GG L
Sbjct: 43 DEDISQTIENV------RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV 96
Query: 63 IVNHGRMKEDEARRYFQQLINAVDYCHSRGVY---HRDLKPENLLLDAYG--------NL 111
+ R+ D + Q+ ++Y H + HRDLK N+L+ L
Sbjct: 97 LSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155
Query: 112 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171
K++DFGL+ + + G ++APEV+ + +D+WS GV+L+ LL G
Sbjct: 156 KITDFGLA----REWHRTTKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTG 210
Query: 172 YLPFDDSNLMNLYKKISAAEF---------TCPPWLSFTARKLIARILDPNPMTRITIPE 222
+PF ++ TCP KL+ +P+P +R +
Sbjct: 211 EVPFRG---IDGLAVAYGVAMNKLALPIPSTCPEPF----AKLMEDCWNPDPHSRPSFTN 263
Query: 223 ILE 225
IL+
Sbjct: 264 ILD 266
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 69/262 (26%), Positives = 107/262 (40%), Gaps = 60/262 (22%)
Query: 21 REVATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMK 70
REVA ++ ++ HPNVVRL++V +TK+ +V E V DK+ +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVP 118
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQ 123
+ + QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ AL+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178
Query: 124 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNL 180
V T Y APEVL Y +T DLWS G I + S++
Sbjct: 179 VVV----------TLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRKPLFR-GSSDV 225
Query: 181 MNLYK-----------------KISAAEFTCP---------PWLSFTARKLIARILDPNP 214
L K + F + + L+ + L NP
Sbjct: 226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285
Query: 215 MTRITIPEILEDEWFKKDYKPP 236
RI+ L +F+ +
Sbjct: 286 AKRISAYSALSHPYFQDLERCK 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 30/243 (12%)
Query: 1 MLFQDLSKYLDAFCILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELF 60
++ D + + +REV M + HPN+V+LY + +V+EFV G+L+
Sbjct: 52 LILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLY 109
Query: 61 DKIVNHGR-MKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYG-----NLK 112
++++ +K R + ++Y ++ + HRDL+ N+ L + K
Sbjct: 110 HRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 113 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLA 170
V+DFGLS S + G ++APE + Y AD +S +IL+ +L
Sbjct: 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILT 223
Query: 171 GYLPFDDSNLMNLYKKISAAE--------FTCPPWLSFTARKLIARILDPNPMTRITIPE 222
G PFD+ + + E CPP L R +I +P R
Sbjct: 224 GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL----RNVIELCWSGDPKKRPHFSY 279
Query: 223 ILE 225
I++
Sbjct: 280 IVK 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 63/225 (28%), Positives = 118/225 (52%), Gaps = 7/225 (3%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+ EV M+ +H NVV +Y+ ++++++EF+ GG L D IV+ R+ E++
Sbjct: 89 LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVC 147
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
+ ++ A+ Y H++GV HRD+K +++LL G +K+SDFG A Q +D + GTP
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTP 205
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCP 195
++APEV++ Y D+WS G+++ ++ G P+ + + K++ + +
Sbjct: 206 YWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS 264
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
+S R + R+L +P R T E+L+ + + P
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 19/233 (8%)
Query: 18 QIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
+I ++ +K P +V+ + + T +FI +E + K G + E +
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK 128
Query: 77 YFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
++ A+ Y GV HRD+KP N+LLD G +K+ DFG+S ++ DD +
Sbjct: 129 MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSA 185
Query: 136 GTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA 190
G Y+APE ++ AD+WS G+ L L G P+ + + K+
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245
Query: 191 EFTCPPWL------SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237
E PP L S + + L + R ++LE + K+ V
Sbjct: 246 E---PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 7/225 (3%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I E+ M+ K+PN+V + ++++V+E++ GG L D +V M E +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVC 122
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++ + A+++ HS V HRD+K +N+LL G++K++DFG A Q + T GTP
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 180
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCP 195
++APEV+ + Y D+WS G++ ++ G P+ + N + I+ E P
Sbjct: 181 YWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
LS R + R L+ + R + E+L+ ++ K
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 20 KREVATMKLVKHPNVVRLY---EVMGSKTKI-FIVLEFVTGGELFDKIVNHGRMKEDEAR 75
+RE + HP +V +Y E + +IV+E+V G L D + G M A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTT 134
A+++ H G+ HRD+KP N+++ A +KV DFG++ A++
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFT 193
GT Y++PE D + D++S G +L+ +L G PF DS + Y+ + +
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPI 237
Query: 194 CP----PWLSFTARKLIARILDPNPMTR 217
P LS ++ + L NP R
Sbjct: 238 PPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 79
+RE T ++ P+VV +++ ++++ + + G +L + G + A +
Sbjct: 82 QREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVR 141
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHT--TCG 136
Q+ +A+D H+ G HRD+KPEN+L+ A + DFG+ SA + D+ L T G
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVG 197
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 196
T Y+APE ++ AD+++ +L+ L G P+ L + I+ A P
Sbjct: 198 TLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA----IP 252
Query: 197 WLSFTARKL-------IARILDPNPMTR 217
S + IAR + NP R
Sbjct: 253 RPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 64/264 (24%), Positives = 99/264 (37%), Gaps = 56/264 (21%)
Query: 21 REVATMKLVKHPNVVRLYEVM--------GSKTKIFIVLEFV----TGGELFDKIVNHGR 68
RE+ ++L+KH NVV L E+ K I++V +F G L + +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVK 120
Query: 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRD 127
E +R Q L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 128 DGLLHTTC-GTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG------------- 171
+T T Y PE+L +R Y DLW G I+ +
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238
Query: 172 -------------------YLP-FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 211
++ L+ K+ A LI ++L
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLV 297
Query: 212 PNPMTRITIPEILEDEWFKKDYKP 235
+P RI + L ++F D P
Sbjct: 298 LDPAQRIDSDDALNHDFFWSDPMP 321
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-33
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 9/227 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI RE+ + P +V Y S +I I +E + GG L + GR+ E +
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 136
Query: 78 FQQLINAVDYCHSRG-VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTC 135
+I + Y + + HRD+KP N+L+++ G +K+ DFG+S L + + +
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----SFV 191
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 195
GT +Y++PE L Y +D+WS G+ L + G P + L
Sbjct: 192 GTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG-D 249
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 242
+ + R L+ M I E + + PP
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 63/253 (24%), Positives = 116/253 (45%), Gaps = 14/253 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRY 77
I +E++ M+ P+VV+ Y T ++IV+E+ G + D I + + + EDE
Sbjct: 71 IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI 130
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
Q + ++Y H HRD+K N+LL+ G+ K++DFG++ Q +T GT
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGT 188
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK--KISAAEFTC 194
P ++APEV+ + GY+ AD+WS G+ + G P+ D + M ++ F
Sbjct: 189 PFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK 247
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 254
P S + + L +P R T ++L+ + + + + +
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDL-------INEAMD 300
Query: 255 DSEEHHVTEQKEE 267
+ ++Q+EE
Sbjct: 301 VKLKRQESQQREE 313
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 23/245 (9%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--------KIVNHGRMK 70
+ +E+ M HPN+V Y K ++++V++ ++GG + D G +
Sbjct: 60 LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDG 129
E ++++ ++Y H G HRD+K N+LL G+++++DFG+SA L+
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 130 LL--HTTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK 185
T GTP ++APEV+ RGYD AD+WS G+ L G P+ M L
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 186 ---------KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+ + + RK+I+ L +P R T E+L ++F+K
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298
Query: 237 VFEEK 241
+EK
Sbjct: 299 FLQEK 303
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 12/231 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRY 77
E+ + HP +V+L K++I++EF GG + ++ + E + +
Sbjct: 63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 122
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+Q++ A+++ HS+ + HRDLK N+L+ G+++++DFG+SA + ++ + GT
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGT 180
Query: 138 PNYVAPEV-----LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK--KISA 189
P ++APEV + D YD AD+WS G+ L + P + N M L K K
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239
Query: 190 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
P S R + LD NP TR + ++LE + E
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 56/241 (23%), Positives = 103/241 (42%), Gaps = 30/241 (12%)
Query: 18 QIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMK 70
Q+ ++ M+ P +V+ Y + + +I +E ++ FDK +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIP 123
Query: 71 EDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 129
E+ + + A+++ + HRD+KP N+LLD GN+K+ DFG+S Q+ D
Sbjct: 124 EEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180
Query: 130 LLHTTCGTPNYVAPEVL----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLY 184
G Y+APE + + +GYD +D+WS G+ L+ L G P+ N + +
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
Query: 185 KKISAAEFTCPPWL--------SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
++ + PP L S + + L + R E+L+ + +
Sbjct: 240 TQVVKGD---PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296
Query: 237 V 237
V
Sbjct: 297 V 297
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-30
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARR 76
++ E+ KL HPN+V + ++++V F+ G D I H M E
Sbjct: 73 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY 132
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC- 135
Q ++ A+DY H G HR +K ++L+ G + +S + + G
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVH 189
Query: 136 -------GTPNYVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 181
+++PEVL N +GYD +D++S G+ L G++PF D
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPAT 243
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 18 QIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKE 71
++ ++ +M+ V P V Y + + ++I +E + DK + E
Sbjct: 51 RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPE 108
Query: 72 DEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
D + ++ A+++ HS V HRD+KP N+L++A G +K+ DFG+S + DD
Sbjct: 109 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVA 165
Query: 131 LHTTCGTPNYVAPEV----LNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYK 185
G Y+APE LN +GY +D+WS G+ + L P+D K
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 224
Query: 186 KISAAEFTCPPWL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 237
++ P L S ++ L N R T PE+++ +F
Sbjct: 225 QVVEEP---SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 45/250 (18%), Positives = 89/250 (35%), Gaps = 50/250 (20%)
Query: 21 REVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
E+ +++H N++ S T+++++ + G L+D + + R
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLR 109
Query: 77 YFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFGLSAL--SQQVR 126
+ + + + H + HRDLK +N+L+ G ++D GL+ + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 127 DDGLLHTTCGTPNYVAPEVLNDRGYDGST-----ADLWSCGVILFVLLAGY--------- 172
D + GT Y+APEVL++ D+W+ G++L+ +
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 173 -LPFDDSNLMN----------LYKKI------SAAEFTCPPWLSFTARKLIARILDPNPM 215
PF D + + L+ KL+ NP
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA----KLMKECWYQNPS 285
Query: 216 TRITIPEILE 225
R+T I +
Sbjct: 286 ARLTALRIKK 295
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 59/286 (20%), Positives = 102/286 (35%), Gaps = 70/286 (24%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFV--------TGGELFDKIVNHGRMK 70
RE+A ++ +KHPNV+ L +V S K++++ ++ ++
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN----LKVSDFGLSALSQQVR 126
+ Q+++ + Y H+ V HRDLKP N+L+ G +K++D G A
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSP 185
Query: 127 DDGLLHTTCG--TPNYVAPEVL-NDRGYDGSTA-DLWSCGVIL----------------- 165
L T Y APE+L R Y + A D+W+ G I
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 166 ----------------------------FVLLAGYLPFDDSNLMNLYKKISAAEF--TCP 195
+ + N Y S ++
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP--PVFE 239
A L+ ++L +P+ RIT + ++D +F +D P VF
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFA 349
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 79/311 (25%), Positives = 126/311 (40%), Gaps = 64/311 (20%)
Query: 21 REVATMKLVKHPNVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNH-----GRM 69
RE+ M++VKHPNVV L S + + +VLE+V E + H M
Sbjct: 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTM 138
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDD 128
+ Y QL+ ++ Y HS G+ HRD+KP+NLLLD G LK+ DFG + + +
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA--KILIAGE 196
Query: 129 GLLHTTCGTPNYVAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPFD-DSNLMNLYK 185
+ C + Y APE+ Y +T D+WS G ++ L+ G F +S + L +
Sbjct: 197 PNVSYIC-SRYYRAPELIFGATNY--TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
Query: 186 KI----------------SAAEFTCPPW------------LSFTARKLIARILDPNPMTR 217
I + E P A LI+R+L+ P R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 218 ITIPEILEDEWFKKDYK------------PPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 265
+T E L +F + + PP+F K+ L + H +
Sbjct: 314 LTAIEALCHPFF-DELRTGEARMPNGRELPPLFNWTKE-ELSVRPDLISRLVPQHAEAEL 371
Query: 266 EEQPVAMNAFE 276
+ + ++ F+
Sbjct: 372 LSRGIDVHNFQ 382
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 19 IKREVATMK-LVKHPNVVRLYE------VMGSKTKIFIVLEFVTGGELFD--KIVNHGRM 69
IK+E+ +K H N+ Y G ++++V+EF G + D K +
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 129
KE+ ++++ + + H V HRD+K +N+LL +K+ DFG+SA Q R G
Sbjct: 127 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVG 184
Query: 130 LLHTTCGTPNYVAPEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 184
+T GTP ++APEV+ D YD +DLWS G+ + G P D + M
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
Query: 185 KKISAAEFTCPPWL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
I P L S + I L N R ++++ + +
Sbjct: 244 FLIPRNP---APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 20/231 (8%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
I +EV ++ ++HPN ++ + ++V+E+ G V+ ++E E
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 160
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGT 137
+ + Y HS + HRD+K N+LL G +K+ DFG ++ ++ ++ GT
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGT 213
Query: 138 PNYVAPEV---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
P ++APEV +++ YDG D+WS G+ L P + N M+ I+ E
Sbjct: 214 PYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--- 269
Query: 195 PPWL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 240
P L S R + L P R T +L+ + ++ P V +
Sbjct: 270 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 69/266 (25%), Positives = 106/266 (39%), Gaps = 66/266 (24%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMK---- 70
RE+ M+ + H N+VRL S + +VL++V ++ ++ R K
Sbjct: 96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLP 154
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLS-ALSQQVRDD 128
+ Y QL ++ Y HS G+ HRD+KP+NLLLD LK+ DFG + L +
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR----- 209
Query: 129 GLLHTTCGTPN--YV------APEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF--- 175
G PN Y+ APE+ Y +++ D+WS G +L LL G F
Sbjct: 210 -------GEPNVSYICSRYYRAPELIFGATDY--TSSIDVWSAGCVLAELLLGQPIFPGD 260
Query: 176 ------------------DDSNLMN-LYKKISAAEFTCPPWLSF-------TARKLIARI 209
+ MN Y + + PW A L +R+
Sbjct: 261 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 320
Query: 210 LDPNPMTRITIPEILEDEWFKKDYKP 235
L+ P R+T E +F + P
Sbjct: 321 LEYTPTARLTPLEACAHSFFDELRDP 346
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 50/250 (20%), Positives = 100/250 (40%), Gaps = 50/250 (20%)
Query: 21 REVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
E+ L++H N++ + GS T+++++ ++ G L+D + + + +
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLK 138
Query: 77 YFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD- 127
++ + + H+ + HRDLK +N+L+ G ++D GL+ +
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 128 -DGLLHTTCGTPNYVAPEVLNDRGYDGST-----ADLWSCGVIL---------FVLLAGY 172
D +T GT Y+ PEVL++ AD++S G+IL ++ Y
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 173 -LPFDDSNLMN----------LYKKI------SAAEFTCPPWLSFTARKLIARILDPNPM 215
LP+ D + KK+ + C + KL+ NP
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG----KLMTECWAHNPA 314
Query: 216 TRITIPEILE 225
+R+T + +
Sbjct: 315 SRLTALRVKK 324
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 41/177 (23%), Positives = 74/177 (41%), Gaps = 17/177 (9%)
Query: 20 KREVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHG-------R 68
+ EV ++ +KH N+++ ++++ F G L D + +
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCH 125
Query: 69 MKEDEAR--RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 126
+ E AR Y + I + H + HRD+K +N+LL ++DFGL+ + +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 127 DDGLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLLAGYLPFDDSN 179
G H GT Y+APEVL D+++ G++L+ L + D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 48/248 (19%), Positives = 94/248 (37%), Gaps = 46/248 (18%)
Query: 21 REVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
E+ +++H N++ + G+ T++++V ++ G LFD +N + + +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIK 143
Query: 77 YFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD- 127
+ + + H + HRDLK +N+L+ G ++D GL+ D
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 128 -DGLLHTTCGTPNYVAPEVLNDRGYDGST-----ADLWSCGVILFVLLAGY--------- 172
D + GT Y+APEVL+D AD+++ G++ + +
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 173 -LPFDDSNLMN----------LYKK----ISAAEFTCPPWLSFTARKLIARILDPNPMTR 217
LP+ D + +K I +C K++ N R
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM--AKIMRECWYANGAAR 321
Query: 218 ITIPEILE 225
+T I +
Sbjct: 322 LTALRIKK 329
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 57/256 (22%), Positives = 111/256 (43%), Gaps = 52/256 (20%)
Query: 19 IKREVATMK-LVKHPNVVRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
IKRE+ ++ L PN++ L +++ S+T + E V + ++ + + +
Sbjct: 77 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVF-EHVNNTDF-KQLYQ--TLTDYDI 132
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHT 133
R Y +++ A+DYCHS G+ HRD+KP N+++D + L++ D+GL+ ++ +
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNV 189
Query: 134 TCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPF----------------- 175
+ + PE+L + + YD S D+WS G +L ++ PF
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248
Query: 176 ---DDSNLMNLYKKISAAEF-------TCPPWLSF-----------TARKLIARILDPNP 214
D + ++ Y F + W F A + ++L +
Sbjct: 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 308
Query: 215 MTRITIPEILEDEWFK 230
+R+T E +E +F
Sbjct: 309 QSRLTAREAMEHPYFY 324
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 32/206 (15%), Positives = 60/206 (29%), Gaps = 39/206 (18%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+ + P V R+ +V+ ++ +V E++ GG L + V A R
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAM 135
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q L A D H GV P + + G++ ++
Sbjct: 136 QSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------- 174
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 195
+ D+ G L+ LL P ++ + + P
Sbjct: 175 -TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225
Query: 196 ----PWLSFTARKLIARILDPNPMTR 217
+ F + AR + + R
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE+ +K +KH NV+ L +V +++V + G +L + IV ++ +D
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHV 134
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ Q++ + Y HS + HRDLKP NL ++ LK+ DFGL+ + D +
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM---- 186
Query: 135 CGTPNYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
YV APE+ LN Y+ T D+WS G I+ LL G F ++ ++ K I
Sbjct: 187 ---TGYVATRWYRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242
Query: 188 ------------------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMT 216
SA + + ++F A L+ ++L +
Sbjct: 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302
Query: 217 RITIPEILEDEWFKKDYKP---PVFE------EKKDTNLDDV-EAVFKDSEEHHVTEQKE 266
RIT + L +F + + P PV + E +D +D+ + + +
Sbjct: 303 RITAAQALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTYDEVISFVPPPLDQ 362
Query: 267 EQ 268
E+
Sbjct: 363 EE 364
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 73/303 (24%), Positives = 121/303 (39%), Gaps = 68/303 (22%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE+ +K ++H NV+ L +V ++V+ F+ G +L K++ H ++ ED
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRI 130
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ Q++ + Y H+ G+ HRDLKP NL ++ LK+ DFGL+ R T
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT- 183
Query: 135 CGTPNYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
YV APEV LN Y T D+WS G I+ ++ G F S+ ++ K+I
Sbjct: 184 ----GYVVTRWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 188 ------------------SAAEF--TCP-----------PWLSFTARKLIARILDPNPMT 216
A + P S A L+ ++L +
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298
Query: 217 RITIPEILEDEWFKKDYKP---PVFE------EKKDTNLDDV-EAVFKDSEEHHVTEQKE 266
R+T E L +F+ + P + + D LD+ +K+ Q
Sbjct: 299 RVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLG 358
Query: 267 EQP 269
+
Sbjct: 359 ARV 361
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 69/294 (23%), Positives = 124/294 (42%), Gaps = 62/294 (21%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
RE+ + +H N++ + +++ + T ++IV + + +L K++ + D
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHIC 131
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
+ Q++ + Y HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-- 189
Query: 136 GTPNYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI- 187
YV APE+ LN +GY + D+WS G IL +L+ F + ++ I
Sbjct: 190 ---EYVATRWYRAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 188 ------SAAEFTC---------------PPWLSFT---------ARKLIARILDPNPMTR 217
S + C + + A L+ ++L NP R
Sbjct: 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305
Query: 218 ITIPEILEDEWFKKDYKP---PVFE-------EKKDTNLDDV-EAVFKDSEEHH 260
I + + L + ++ Y P P+ E E D + + E +F+++
Sbjct: 306 IEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQ 359
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 59/265 (22%), Positives = 99/265 (37%), Gaps = 49/265 (18%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--------ELFD----KIVNHGR 68
RE+ ++ + H N+V+++E++G E + ++ G
Sbjct: 57 REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP 116
Query: 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVR 126
+ E+ AR + QL+ + Y HS V HRDLKP NL ++ LK+ DFGL+ +
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 127 DDGLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK 185
G L T Y +P + L+ Y D+W+ G I +L G F ++ + +
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 186 KI-----------------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPM 215
I + T A + +IL +PM
Sbjct: 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295
Query: 216 TRITIPEILEDEWFKKDYKP---PV 237
R+T E L + P P+
Sbjct: 296 DRLTAEEALSHPYMSIYSFPMDEPI 320
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 62/307 (20%), Positives = 123/307 (40%), Gaps = 71/307 (23%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMK-EDE 73
RE+ MK V H N++ L V + ++IV+E + L I +M+ + E
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----QMELDHE 127
Query: 74 ARRYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 132
Y Q++ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMT 184
Query: 133 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----- 187
T Y APEV+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 185 PYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243
Query: 188 -------------------------------------SAAEFTCPPWLSFTARKLIARIL 210
A+ + AR L++++L
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303
Query: 211 DPNPMTRITIPEILEDEWFKK--------DYKPPVFE---EKKDTNLDDV-EAVFKDSEE 258
+ RI++ E L+ + P + + ++++ +++ E ++K+ +
Sbjct: 304 VIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMD 363
Query: 259 HHVTEQK 265
Sbjct: 364 LEHHHHH 370
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 60/310 (19%), Positives = 116/310 (37%), Gaps = 69/310 (22%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE+ MK V H N++ L V + +++V+E + L +++ + E
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMEL--DHER 165
Query: 75 RRYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
Y Q++ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTP 222
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------ 187
T Y APEV+ GY D+WS G I+ ++ + F + ++ + K+
Sbjct: 223 YVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281
Query: 188 ------------------------------------SAAEFTCPPWLSFTARKLIARILD 211
A+ + AR L++++L
Sbjct: 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341
Query: 212 PNPMTRITIPEILEDEWFKK----DYKPPVFEEKKDTNLDDV--------EAVFKDSEEH 259
+P RI++ + L+ + + D LD+ E ++K+
Sbjct: 342 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNS 401
Query: 260 HVTEQKEEQP 269
+
Sbjct: 402 EEKTKNGVVK 411
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 62/277 (22%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE+ +K ++H NV+ L +V + ++V+ F+ +L + + E++
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKI 128
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ Q++ + Y HS GV HRDLKP NL ++ LK+ DFGL+ R T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT- 181
Query: 135 CGTPNYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
YV APEV L+ Y+ T D+WS G I+ +L G F + ++ +I
Sbjct: 182 ----GYVVTRWYRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
Query: 188 ------------------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMT 216
+A + + P FT A L+ ++L+ +
Sbjct: 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 296
Query: 217 RITIPEILEDEWFKKDYKP---PVFEEKKDTNLDDVE 250
R+T + L +F+ P ++ D +L+ +
Sbjct: 297 RLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEK 333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 59/291 (20%), Positives = 113/291 (38%), Gaps = 58/291 (19%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMK-EDEA 74
RE+ + HPN++ L ++ + +++V E + +L ++++ R+ +
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQH 135
Query: 75 RRYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+YF ++ + H GV HRDL P N+LL ++ + DF L+++ D
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTH 192
Query: 134 TCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----- 187
Y APE+ + +G+ D+WS G ++ + F S N KI
Sbjct: 193 YVTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251
Query: 188 --SAAEFTC----------------PPWLSFT---------ARKLIARILDPNPMTRITI 220
+ P ++T A LIA++L+ NP RI+
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311
Query: 221 PEILEDEWFKKDYKP---PV-------FEEKKDTNLDDV-EAVFKDSEEHH 260
+ L +F+ + P F+E + D+ + + E +
Sbjct: 312 EQALRHPYFESLFDPLDLTEGLSERFHFDESVTD-VYDMHKIFTAEVERFN 361
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 38/171 (22%), Positives = 66/171 (38%), Gaps = 27/171 (15%)
Query: 21 REVATMKLVKHPNVVRLY-----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
+ + + L++H N+ R + + +V+E+ G L + H +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 76 RYFQQLINAVDYCHS---------RGVYHRDLKPENLLLDAYGNLKVSDFGLS------A 120
R + + Y H+ + HRDL N+L+ G +SDFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 121 LSQQVRDDGLLHTTCGTPNYVAPEVLNDR------GYDGSTADLWSCGVIL 165
L + +D + GT Y+APEVL D+++ G+I
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 64/297 (21%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
RE+ +K KH N++ ++ + + ++I+ E + +L ++++ + +D +
Sbjct: 58 REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQ 115
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHT 133
+ Q + AV H V HRDLKP NLL+++ +LKV DFGL +
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 134 TCGTPNYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG--------YL----- 173
G +V APEV L Y D+WSCG IL L Y
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 174 -------PFDDSNL--------------MNLYKKISAAE-FTCPPWLSFTARKLIARILD 211
P D++L + +Y + F P ++ L+ R+L
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMF---PRVNPKGIDLLQRMLV 291
Query: 212 PNPMTRITIPEILEDEWFKKDYKP---PVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 265
+P RIT E LE + + + P P E + + D + +T +
Sbjct: 292 FDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF------DHYKEALTTKD 342
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 65/300 (21%), Positives = 120/300 (40%), Gaps = 58/300 (19%)
Query: 20 KREVATMKL---VKHPNVVRLYEVMGSKTK-------IFIVLEFVTGGELFDKIVNHGRM 69
RE+ M+ + HPN+V+L + + + +V+E+V L N+ R
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122
Query: 70 K----EDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALS 122
+ + + QLI ++ H S V HRD+KP N+L++ A G LK+ DFG +
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA--K 180
Query: 123 QQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF----- 175
+ + + C + Y APE+ ++ Y +TA D+WS G I ++ G F
Sbjct: 181 KLSPSEPNVAYIC-SRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGEPIFRGDNS 237
Query: 176 ----------------DDSNLMN-LYKKISAAEFTCPPW----------LSFTARKLIAR 208
+ +N + + PW + A L++
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 209 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQ 268
+L P R+ E L +F + P + + +L + F +E ++E ++ +
Sbjct: 298 LLQYLPEERMKPYEALCHPYF-DELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAK 356
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 37/178 (20%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
RE+A + + H +VV++ +++ K ++++VLE + K+ +
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHI 158
Query: 76 RYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT 133
+ L+ V Y HS G+ HRDLKP N L++ ++KV DFGL+ + + L
Sbjct: 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 134 TCGTPN------------------YV------APEV-LNDRGYDGSTA-DLWSCGVIL 165
+ + +V APE+ L Y + A D+WS G I
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 66/323 (20%), Positives = 113/323 (34%), Gaps = 87/323 (26%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
RE+ + L H N+V L V+ + +++V +++ +L ++ + E ++Y
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANIL-EPVHKQY 113
Query: 78 FQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
QLI + Y HS G+ HRD+KP N+LL+A ++KV+DFGLS +R
Sbjct: 114 VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 137 TPN-------------YV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG----- 171
N YV APE+ L Y D+WS G IL +L G
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFP 232
Query: 172 ---------------------------------YL---------PFDDSNLMNLYKKISA 189
+ + + K
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 190 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP---PV--------F 238
+ + A L+ ++L NP RI+ + L+ + + P P
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPI 352
Query: 239 EEKKDTNLDDV-EAVFKDSEEHH 260
+ ++DD V+ +
Sbjct: 353 NDNVKHSIDDYRNLVYSEISRRK 375
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 30/178 (16%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
RE+ + +K ++RLY+++ ++IVLE +L K+ +E
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHI 131
Query: 76 RYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ L+ ++ H G+ HRDLKP N LL+ ++KV DFGL+ +D +++
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 135 CGTP--------------NYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG 171
++V APE+ L Y + D+WS G I LL
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 60/292 (20%), Positives = 102/292 (34%), Gaps = 79/292 (27%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK---------------------------------- 46
RE+ MK++ H N+++L + +
Sbjct: 49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 47 ----IFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCHSRGVYHRDL 98
+ +++E+V L + + R + Y QL AV + HS G+ HRD+
Sbjct: 109 QNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDI 167
Query: 99 KPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTA 156
KP+NLL+++ LK+ DFG + + + + + C + Y APE+ L Y +
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSA--KKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSI 223
Query: 157 DLWSCGVILFVLLAGYLPF---------------------DDSNLMN-LYKKISAAEFTC 194
DLWS G + L+ G F + MN Y ++
Sbjct: 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283
Query: 195 PPWLSF-------TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 239
W A L+ +IL P RI E + +F +
Sbjct: 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF-DHLRNSYES 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 23/227 (10%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQ 79
+E +K HPN+VRL V K I+IV+E V GG+ + G ++ +
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
++Y S+ HRDL N L+ LK+SDFG+S + DG+ + G
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQ 276
Query: 140 Y----VAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA---- 189
APE LN Y S+ D+WS G++L+ G P+ + + + +
Sbjct: 277 VPVKWTAPEALNYGRY--SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL 334
Query: 190 -AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED-EWFKKDYK 234
CP + +L+ + P R + I ++ + +K ++
Sbjct: 335 PCPELCPDAV----FRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYF 78
+E A MK +KHPN+V+L V + +I+ EF+T G L D + R +
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
Q+ +A++Y + HR+L N L+ +KV+DFG LS+ + D
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKF 381
Query: 139 NY--VAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 188
APE L + +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 382 PIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 17/189 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E M V +P+V RL + + + ++ + + G L D + H + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-- 137
Q+ ++Y R + HRDL N+L+ ++K++DFGL+ L + + + G
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKV 181
Query: 138 P-NYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--- 191
P ++A E + R Y + D+WS GV ++ ++ G P+D + + E
Sbjct: 182 PIKWMALESILHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 192 --FTCPPWL 198
C +
Sbjct: 240 QPPICTIDV 248
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYF 78
+E MK ++H +V+LY V+ S+ I+IV E+++ G L D + +
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 369
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT- 137
Q+ + + Y HRDL+ N+L+ KV+DFG L++ + D+
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKF 426
Query: 138 P-NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 188
P + APE + +D+WS G++L + G +P+ + ++
Sbjct: 427 PIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-19
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 29/229 (12%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQ 79
+E TM + HP +V+ Y V + I+IV E+++ G L + + +HG+ ++ +
Sbjct: 52 QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY 111
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--- 136
+ + + S HRDL N L+D +KVSDFG +++ V DD + +
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG---MTRYVLDDQYVSSVGTKFP 168
Query: 137 ---TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE 191
+ APEV + Y S+ D+W+ G++++ V G +P+D + K+S
Sbjct: 169 VKWS----APEVFHYFKY--SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222
Query: 192 -----FTCPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDY 233
+ +++ P R T ++L + +KD
Sbjct: 223 RLYRPHLASDTI----YQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYF 78
+E MK ++H +V+LY V+ S+ I+IV E+++ G L D + +
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT- 137
Q+ + + Y HRDL+ N+L+ KV+DFG L++ + D+
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKF 343
Query: 138 P-NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 188
P + APE + +D+WS G++L + G +P+ + ++
Sbjct: 344 PIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 43/188 (22%), Positives = 73/188 (38%), Gaps = 15/188 (7%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
E M+ + +P +VR+ + +V+E G L + + +K+ Q
Sbjct: 67 AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P 138
+ + Y HRDL N+LL K+SDFGLS + D+ P
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWP 183
Query: 139 -NYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE---- 191
+ APE +N + S+ D+WS GV+++ G P+ + + E
Sbjct: 184 VKWYAPECINYYKF--SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241
Query: 192 -FTCPPWL 198
CP +
Sbjct: 242 PAGCPREM 249
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 10/175 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E + M HPN++RL V+ IV E++ G L + H G+ + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
+ + Y G HRDL N+L+D+ KVSDFGLS + + D +TT G
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKI 216
Query: 140 YV---APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 189
+ APE + R + S+A D+WS GV+++ VL G P+ + ++ +
Sbjct: 217 PIRWTAPEAIAFRTF--SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYF 78
+E A MK +KHPN+V+L V + +I+ EF+T G L D + N +
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 136
Q+ +A++Y + HRDL N L+ +KV+DFG LS+ + D
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKF 174
Query: 137 ----TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 187
T APE L + S D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 175 PIKWT----APESLAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 50/190 (26%), Positives = 88/190 (46%), Gaps = 17/190 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E + M HPN++RL V+ + IV E++ G L + H + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTP 138
+ + + Y G HRDL N+L+++ KVSDFG L + + DD +TT G
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG---LGRVLEDDPEAAYTTRGGK 211
Query: 139 NYV---APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-- 191
+ +PE + R + ++A D+WS G++L+ V+ G P+ + + ++ K +
Sbjct: 212 IPIRWTSPEAIAYRKF--TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269
Query: 192 ---FTCPPWL 198
CP L
Sbjct: 270 PPPMDCPAAL 279
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-18
Identities = 49/150 (32%), Positives = 64/150 (42%), Gaps = 10/150 (6%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
REV M + H N++RLY V+ + +V E G L D++ H G RY
Sbjct: 70 REVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q+ + Y S+ HRDL NLLL +K+ DFGL Q +D
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKV 186
Query: 140 YV---APEVLNDRGYDGSTA-DLWSCGVIL 165
APE L R + S A D W GV L
Sbjct: 187 PFAWCAPESLKTRTF--SHASDTWMFGVTL 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 17/189 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E M V +P+V RL + + + ++ + + G L D + H + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-- 137
Q+ ++Y R + HRDL N+L+ ++K++DFGL+ L + + + G
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKV 181
Query: 138 P-NYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--- 191
P ++A E + R Y + D+WS GV ++ ++ G P+D + + E
Sbjct: 182 PIKWMALESILHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 192 --FTCPPWL 198
C +
Sbjct: 240 QPPICTIDV 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-18
Identities = 52/189 (27%), Positives = 75/189 (39%), Gaps = 16/189 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
RE M + +P +VRL V + +V+E GG L +V +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-- 137
Q+ + Y + HRDL N+LL K+SDFGLS DD
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKW 175
Query: 138 P-NYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--- 191
P + APE +N R + S+ D+WS GV ++ L G P+ + I +
Sbjct: 176 PLKWYAPECINFRKF--SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 233
Query: 192 --FTCPPWL 198
CPP L
Sbjct: 234 CPPECPPEL 242
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 50/189 (26%), Positives = 74/189 (39%), Gaps = 16/189 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
RE M + +P +VRL V + +V+E GG L +V +
Sbjct: 385 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q+ + Y + HR+L N+LL K+SDFGLS DD
Sbjct: 444 QVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKW 501
Query: 140 YV---APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--- 191
+ APE +N R + S+ D+WS GV ++ L G P+ + I +
Sbjct: 502 PLKWYAPECINFRKF--SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 559
Query: 192 --FTCPPWL 198
CPP L
Sbjct: 560 CPPECPPEL 568
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E M H N++RL V+ + I+ E++ G L + G + +
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
+ + Y + HRDL N+L+++ KVSDFGLS + + D +TT G
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKI 212
Query: 140 YV---APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDD-SN 179
+ APE ++ R + ++A D+WS G++++ V+ G P+ + SN
Sbjct: 213 PIRWTAPEAISYRKF--TSASDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 16/175 (9%)
Query: 21 REVATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RY 77
E + M ++H N+V+L V + K ++IV E++ G L D + + GR ++
Sbjct: 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+ A++Y HRDL N+L+ KVSDFGL+ + +D G L
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------ 176
Query: 138 PNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 188
P V APE L ++ + + +D+WS G++L+ + G +P+ L ++ ++
Sbjct: 177 P--VKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 39/189 (20%), Positives = 80/189 (42%), Gaps = 17/189 (8%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
+ + + H ++VRL + + + +V +++ G L D + H G + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-- 137
Q+ + Y G+ HR+L N+LL + ++V+DFG++ L + D
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKT 179
Query: 138 P-NYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--- 191
P ++A E ++ Y + D+WS GV ++ ++ G P+ L + + E
Sbjct: 180 PIKWMALESIHFGKY--THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237
Query: 192 --FTCPPWL 198
C +
Sbjct: 238 QPQICTIDV 246
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 18/176 (10%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E M + HP +V+LY V + I +V EF+ G L D + G +
Sbjct: 52 EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL 111
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--- 136
+ + Y V HRDL N L+ +KVSDFG +++ V DD +T
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG---MTRFVLDDQYTSSTGTKFP 168
Query: 137 ---TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 187
+PEV + Y S+ D+WS GV+++ V G +P+++ + + + I
Sbjct: 169 VKWA----SPEVFSFSRY--SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 42/178 (23%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYF 78
E MK ++H +VRLY V+ ++ I+I+ E++ G L D + +K +
Sbjct: 57 AEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 136
Q+ + + R HRDL+ N+L+ + K++DFG L++ + D+
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG---LARLIEDNEYTAREGAKF 172
Query: 137 ----TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 188
T APE +N + + D+WS G++L ++ G +P+ + + +
Sbjct: 173 PIKWT----APEAINYGTF--TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 21 REVATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RY 77
E + M ++H N+V+L V + K ++IV E++ G L D + + GR ++
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+ A++Y HRDL N+L+ KVSDFGL+ + +D G L
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------ 348
Query: 138 P-NYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 188
P + APE L ++ + ST D+WS G++L+ + G +P+ L ++ ++
Sbjct: 349 PVKWTAPEALREKKF--STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 19/176 (10%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
+E TM+ HP++V+L V+ ++ ++I++E T GEL + + Y
Sbjct: 65 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--- 136
QL A+ Y S+ HRD+ N+L+ + +K+ DFG LS+ + D + G
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLP 180
Query: 137 ---TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 187
APE +N R + ++A D+W GV ++ +L+ G PF ++ +I
Sbjct: 181 IKWM----APESINFRRF--TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYF 78
E MK ++H +V+L+ V+ +K I+I+ EF+ G L D + + K+ + +
Sbjct: 232 AEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 136
Q+ + + R HRDL+ N+L+ A K++DFG L++ + D+
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG---LARVIEDNEYTAREGAKF 347
Query: 137 ----TPNYVAPEVLNDRGYDGSTA-DLWSCGVIL 165
T APE +N + + D+WS G++L
Sbjct: 348 PIKWT----APEAINFGSF--TIKSDVWSFGILL 375
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 49/171 (28%), Positives = 87/171 (50%), Gaps = 9/171 (5%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
+E TM+ HP++V+L V+ ++ ++I++E T GEL + + Y
Sbjct: 440 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP 138
QL A+ Y S+ HRD+ N+L+ + +K+ DFG LS+ + D + G P
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLP 555
Query: 139 -NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 187
++APE +N R + S +D+W GV ++ +L+ G PF ++ +I
Sbjct: 556 IKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 30/182 (16%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E M + H +V+LY V + IFI+ E++ G L + + R + + +
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
+ A++Y S+ HRDL N L++ G +KVSDFG LS+ V DD
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG---LSRYVLDD----------E 174
Query: 140 YV------------APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYK 185
Y PEVL + S+ D+W+ GV+++ + G +P++ +
Sbjct: 175 YTSSVGSKFPVRWSPPEVLMYSKF--SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232
Query: 186 KI 187
I
Sbjct: 233 HI 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
E MK + HP++V+L ++ + +I++E GEL + + +K Y
Sbjct: 62 SEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--- 136
Q+ A+ Y S HRD+ N+L+ + +K+ DFG LS+ + D+ +
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG---LSRYIEDEDYYKASVTRLP 177
Query: 137 ---TPNYVAPEVLNDRGYDGSTA-DLWSCGVIL 165
+PE +N R + +TA D+W V +
Sbjct: 178 IKWM----SPESINFRRF--TTASDVWMFAVCM 204
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 21 REVATMKLVKHPNVVRLYEV--MGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRY 77
RE+ +K ++H N+V+ V + + +++E++ G L D + H R+ + +Y
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG- 136
Q+ ++Y ++ HRDL N+L++ +K+ DFG L++ + D
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG---LTKVLPQDKEFFKVKEP 176
Query: 137 -------TPNYVAPEVLNDRGYDGSTA-DLWSCGVIL 165
APE L + + S A D+WS GV+L
Sbjct: 177 GESPIFWY----APESLTESKF--SVASDVWSFGVVL 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 19/156 (12%)
Query: 21 REVATMKLVKHPNVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRY 77
RE+ +K ++H N+V+ V + + + +++E++ G L D + H R+ + +Y
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLL 131
Q+ ++Y ++ HRDL N+L++ +K+ DFGL+ + Q V++ G
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
Query: 132 HTTCGTP-NYVAPEVLNDRGYDGSTA-DLWSCGVIL 165
P + APE L + + S A D+WS GV+L
Sbjct: 211 ------PIFWYAPESLTESKF--SVASDVWSFGVVL 238
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 19/156 (12%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNH-GRMKEDEARRY 77
+E+ ++ + H N+V+ + I +++EF+ G L + + + ++ + +Y
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLL 131
Q+ +DY SR HRDL N+L+++ +K+ DFGL+ + V+DD
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 132 HTTCGTP-NYVAPEVLNDRGYDGSTA-DLWSCGVIL 165
P + APE L + A D+WS GV L
Sbjct: 192 ------PVFWYAPECLMQSKF--YIASDVWSFGVTL 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 19/156 (12%)
Query: 21 REVATMKLVKHPNVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRY 77
RE+ +K + +V+ V G + + +V+E++ G L D + H R+ Y
Sbjct: 73 REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLL 131
Q+ ++Y SR HRDL N+L+++ ++K++DFGL+ L VR+ G
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 132 HTTCGTP-NYVAPEVLNDRGYDGSTA-DLWSCGVIL 165
P + APE L+D + S D+WS GV+L
Sbjct: 193 ------PIFWYAPESLSDNIF--SRQSDVWSFGVVL 220
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 23/157 (14%)
Query: 21 REVATMKLVKHPNVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+E+ ++ + H ++++ + + +V+E+V G L D + H + + +
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQ-----QVRDDGLLH 132
QQ+ + Y H++ HRDL N+LLD +K+ DFGL+ A+ + +VR+DG
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS- 199
Query: 133 TTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 165
P V APE L + + A D+WS GV L
Sbjct: 200 -----P--VFWYAPECLKEYKF--YYASDVWSFGVTL 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 20/157 (12%)
Query: 33 NVVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVD 86
++++L G + +V E V G L K H + ++ +QL+ +D
Sbjct: 87 HILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145
Query: 87 YCHSR-GVYHRDLKPENLLLD------AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Y H R G+ H D+KPEN+L++ +K++D G + D + T
Sbjct: 146 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----YDEHYTNSIQTRE 200
Query: 140 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176
Y +PEVL + AD+WS ++F L+ G F+
Sbjct: 201 YRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFE 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 47/171 (27%), Positives = 70/171 (40%), Gaps = 41/171 (23%)
Query: 21 REVATMKLVKHPNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
RE A MK HP+V +L V G ++L F+ G+L ++ R+ E+
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPF 132
Query: 75 RRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
Q L+ VD Y SR HRDL N +L + V+DFGLS R
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS------RK 186
Query: 128 DGLLHTTCGTPNY-------------VAPEVLNDRGYDGSTADLWSCGVIL 165
+++ +Y +A E L D Y +D+W+ GV +
Sbjct: 187 ---IYSG----DYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTM 229
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 22/180 (12%)
Query: 21 REVATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYF 78
E MK HPNV+ L + + S+ +VL ++ G+L + I N + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLL 131
Q+ + Y S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 132 HTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 187
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 195 ------P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 41/169 (24%), Positives = 59/169 (34%), Gaps = 39/169 (23%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
E + H N+VR V FI++E + GG+L + +
Sbjct: 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 81 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD--- 127
L++ A D Y HRD+ N LL G K+ DFG++ RD
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYR 195
Query: 128 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 165
+L P V PE + + T D WS GV+L
Sbjct: 196 ASYYRKGGCAML------P--VKWMPPEAFMEGIFTSKT-DTWSFGVLL 235
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 48/180 (26%), Positives = 73/180 (40%), Gaps = 17/180 (9%)
Query: 18 QIKREVATM-KLVKHP-----NVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRM 69
Q E+ + L K NV+ + E + I + E + L++ K
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGF 197
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRD 127
R++ ++ +D H + H DLKPEN+LL G +KV DFG S Q
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-- 255
Query: 128 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
++T + Y APEV+ Y D+WS G IL LL GY + + +
Sbjct: 256 ---VYTYIQSRFYRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 33/169 (19%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-- 77
E+ + L HPN++ L + +++ +E+ G L D + ++ D A
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 78 -------FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123
QQL++ A D Y + HRDL N+L+ K++DFGLS
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---- 189
Query: 124 QVRDDGLLHTTCGT--PNYV---APEVLNDRGYDGSTA-DLWSCGVILF 166
R + P V A E LN Y +T D+WS GV+L+
Sbjct: 190 --RGQEVYVKKTMGRLP--VRWMAIESLNYSVY--TTNSDVWSYGVLLW 232
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 33/243 (13%)
Query: 21 REVATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYF 78
E MK HPNV+ L + + S+ +VL ++ G+L + I N + +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQVRDDGLL 131
Q+ + + S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 132 HTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 187
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 259 ------P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 188 SAAE-----FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 242
CP L +++ + P R + E++ + + E
Sbjct: 310 LQGRRLLQPEYCPDPL----YEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGEHYV 363
Query: 243 DTN 245
N
Sbjct: 364 HVN 366
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 48/171 (28%), Positives = 68/171 (39%), Gaps = 42/171 (24%)
Query: 21 REVATMKLVKHPNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
E A MK HPNV+RL V K ++L F+ G+L ++ R++
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKH 143
Query: 76 RYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD- 127
Q L+ VD Y +R HRDL N +L + V+DFGLS +
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKI 197
Query: 128 ----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 165
+ P V A E L DR Y S +D+W+ GV +
Sbjct: 198 YSGDYYRQGRIAKM------P--VKWIAIESLADRVYT-SKSDVWAFGVTM 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 42/169 (24%), Positives = 59/169 (34%), Gaps = 39/169 (23%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80
E + H N+VR V FI+LE + GG+L + +
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 81 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD--- 127
L++ A D Y HRD+ N LL G K+ DFG++ RD
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYR 236
Query: 128 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 165
+L P V PE + + S D WS GV+L
Sbjct: 237 AGYYRKGGCAML------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 276
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 41/169 (24%), Positives = 69/169 (40%), Gaps = 39/169 (23%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY--- 77
E + MK +VVRL V+ +++E +T G+L + + +
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 78 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 127
++I A + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYE 190
Query: 128 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 165
GLL P V +PE L D + + +D+WS GV+L
Sbjct: 191 TDYYRKGGKGLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVL 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 21 REVATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYF 78
RE M+ + HPNV+ L + + + ++L ++ G+L I + R + +
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLL 131
Q+ ++Y + HRDL N +LD +KV+DFGL+ S Q L
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 132 HTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 165
P V A E L + + +D+WS GV+L
Sbjct: 191 ------P--VKWTALESLQTYRFT-TKSDVWSFGVLL 218
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 7e-14
Identities = 48/182 (26%), Positives = 68/182 (37%), Gaps = 49/182 (26%)
Query: 22 EVATMKLVKHPNVVRL-------------YEVM--GSKTKIFIVLEFVTGGELFDKIVNH 66
E+ M +H N+V L Y M GS L L
Sbjct: 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS-------LLDR----LSCLDGTP 128
Query: 67 G-----RMK--EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 119
R K + A +++ H HRD+K N+LLD K+SDFGL+
Sbjct: 129 PLSWHMRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 120 ALSQQVRDDGLLHTT---CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176
S+ T GT Y+APE L RG +D++S GV+L ++ G D
Sbjct: 181 RASE---KFAQTVMTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 177 DS 178
+
Sbjct: 236 EH 237
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 39/177 (22%), Positives = 67/177 (37%), Gaps = 44/177 (24%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKIVNHGR 68
E+ + L H N+V L ++ E+ G+L +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 69 MKEDEARRYFQQLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121
M++DE + L+ + + S+ HRDL N+LL K+ DFG L
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG---L 191
Query: 122 SQQVRDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 166
++ +++D NYV APE + + Y +D+WS G+ L+
Sbjct: 192 ARDIKNDS---------NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 35/181 (19%)
Query: 22 EVATMKLVKHPNVVRLYEVMG---SKTKIFIVLEFVTGG----ELFDKIVNHG------R 68
EV + + H N++RL G + T+ +V ++ G L ++ + R
Sbjct: 77 EVEMISMAVHRNLLRLR---GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 69 MK--EDEAR--RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 124
+ AR Y D+C + + HRD+K N+LLD V DFGL+ L
Sbjct: 134 QRIALGSARGLAYLH------DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM-- 184
Query: 125 VRDDGLLHTT---CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 181
D H T GT ++APE L+ G D++ GV+L L+ G FD + L
Sbjct: 185 --DYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 182 N 182
N
Sbjct: 242 N 242
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 32/161 (19%), Positives = 55/161 (34%), Gaps = 29/161 (18%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQ 79
+ M + H ++V Y V + +V EFV G L + + + +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNL--------KVSDFGLSALSQQVRDDGLL 131
QL A+ + + H ++ +N+LL + K+SD G +S V
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---ISITVLPK--- 174
Query: 132 HTTCGTPNY-------VAPEVLNDRGYDGSTADLWSCGVIL 165
+ V PE + + D WS G L
Sbjct: 175 -------DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 40/173 (23%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-- 77
E+ M L +H N+V L + ++ E+ G+L + + R+ E +
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 78 -----FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 125
+ L++ + + S+ HRD+ N+LL K+ DFGL+
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------ 211
Query: 126 RDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 166
RD NY+ APE + D Y +D+WS G++L+
Sbjct: 212 RD------IMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 13/161 (8%)
Query: 33 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 90
+V L + + +V E + L+D + N + + R++ QQ+ A+ + +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 91 R--GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 146
+ H DLKPEN+LL +K+ DFG S Q ++ + Y +PEVL
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVL 230
Query: 147 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
YD + D+WS G IL + G F +N ++ KI
Sbjct: 231 LGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 44/176 (25%), Positives = 74/176 (42%), Gaps = 47/176 (26%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKE 71
RE + ++H ++V+ Y V G + +V E++ G+L I+ G+ ++
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 72 DEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 124
+ Q+++ A Y S+ HRDL N L+ A +K+ DFG+S
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS----- 180
Query: 125 VRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 165
RD +L P + PE + R + +T D+WS GVIL
Sbjct: 181 -RDVYSTDYYRVGGHTML------P--IRWMPPESIMYRKF--TTESDVWSFGVIL 225
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 9e-13
Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 25/171 (14%)
Query: 22 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 81
E+ T+ +HP++V L + ++ ++ +++ G L + +G + + Q+L
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRL 142
Query: 82 INAVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT- 134
+ Y H+R + HRD+K N+LLD K++DFG+S + H +
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT---ELDQTHLST 199
Query: 135 --CGTPNYVAPE-----VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 178
GT Y+ PE L ++ +D++S GV+LF +L S
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEK------SDVYSFGVVLFEVLCARSAIVQS 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 46/177 (25%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMK 70
E+ MK + KH N++ L +++++E+ + G L + ++
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 71 EDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123
E + + L++ A Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---- 238
Query: 124 QVRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 166
RD +G L P V APE L DR Y +D+WS GV+L+
Sbjct: 239 --RDIHHIDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 41/175 (23%), Positives = 66/175 (37%), Gaps = 46/175 (26%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL--------FDKIVNHGRMKED 72
RE + +++H ++VR + V + +V E++ G+L D + G
Sbjct: 92 REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 73 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 125
QL+ A Y HRDL N L+ +K+ DFG+S
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------ 205
Query: 126 RD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 165
RD +L P + PE + R + +T D+WS GV+L
Sbjct: 206 RDIYSTDYYRVGGRTML------P--IRWMPPESILYRKF--TTESDVWSFGVVL 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 45/182 (24%), Positives = 69/182 (37%), Gaps = 49/182 (26%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKI 63
E +K V HP+V++LY + +++E+ G L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64 VNHGRMKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDF 116
+ DE LI+ A Y + HRDL N+L+ +K+SDF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 117 GLSALSQQVRDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVI 164
GLS RD ++ +YV A E L D Y + +D+WS GV+
Sbjct: 195 GLS------RD---VYE---EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVL 241
Query: 165 LF 166
L+
Sbjct: 242 LW 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 46/177 (25%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMK 70
E+ MK + KH N++ L +++++E+ + G L + ++ +
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 71 EDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123
E + F+ L++ Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA---- 204
Query: 124 QVRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 166
RD +G L P V APE L DR Y +D+WS GV+++
Sbjct: 205 --RDINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 39/176 (22%), Positives = 66/176 (37%), Gaps = 47/176 (26%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY--- 77
E ++HPNVV L V+ + ++ + + G+L + +V + +
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 78 ------FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 124
++ Y S V H+DL N+L+ N+K+SD GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF----- 175
Query: 125 VRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 165
R+ + LL P + APE + + S D+WS GV+L
Sbjct: 176 -REVYAADYYKLLGNSLL------P--IRWMAPEAIMYGKF--SIDSDIWSYGVVL 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 59/274 (21%), Positives = 90/274 (32%), Gaps = 84/274 (30%)
Query: 33 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 90
V++ E I IV E + G +D I +G + D R+ Q+ +V++ HS
Sbjct: 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 91 RGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQQVRDDGLL 131
+ H DLKPEN+L +KV DFG + +
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------ 190
Query: 132 HTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK 185
H+T V APEV+ G+ D+WS G IL G+ F +
Sbjct: 191 HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 186 KISAAEFTCPPWLSFTARK----------------------------------------- 204
+ P + RK
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 205 ---LIARILDPNPMTRITIPEILEDEWFKKDYKP 235
LI ++L+ +P RIT+ E L+ +F K
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 51/275 (18%), Positives = 86/275 (31%), Gaps = 84/275 (30%)
Query: 33 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 90
V + + + I E + G F+ + + R QL +A+ + H
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141
Query: 91 RGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQQVRDDGLL 131
+ H DLKPEN+L ++V+DFG + +
Sbjct: 142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------ 195
Query: 132 HTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNL---- 180
HTT V PEV+ + G+ D+WS G ILF G+ F N
Sbjct: 196 HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 181 ----------MNLYKKISAAEF---TCPPWLSFTARK----------------------- 204
++ + ++ W ++
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309
Query: 205 ---LIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
L+ R+L+ +P RIT+ E L +F
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 46/177 (25%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMK 70
E+ MK + KH N++ L +++++E+ + G L + ++ +
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 71 EDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 123
E + F+ L++ Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA---- 250
Query: 124 QVRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 166
RD +G L P V APE L DR Y +D+WS GV+++
Sbjct: 251 --RDINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 46/265 (17%), Positives = 74/265 (27%), Gaps = 106/265 (40%)
Query: 65 NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLL------------------ 105
N+ + ++ QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 106 -------------------------------DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+K++D G + + T
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTE 252
Query: 135 CGTPN-YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK-------- 185
Y + EVL GY+ + AD+WS + F L G F+ + +
Sbjct: 253 DIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311
Query: 186 ---------------KISAAEFT----------CPPWLSF---------------TARKL 205
K S FT PW F
Sbjct: 312 IELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF 371
Query: 206 IARILDPNPMTRITIPEILEDEWFK 230
+ +L+ P R T E L W
Sbjct: 372 LLPMLELIPEKRATAAECLRHPWLN 396
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 39/184 (21%), Positives = 63/184 (34%), Gaps = 55/184 (29%)
Query: 21 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKI 63
RE A M +PN+V+L V + ++ E++ G+L D
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 64 VNHGRMKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDF 116
+ + A Y R HRDL N L+ +K++DF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 117 GLSALSQQVRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSC 161
GLS R+ + + P + PE + Y +T D+W+
Sbjct: 219 GLS------RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRY--TTESDVWAY 262
Query: 162 GVIL 165
GV+L
Sbjct: 263 GVVL 266
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 43/176 (24%), Positives = 66/176 (37%), Gaps = 43/176 (24%)
Query: 21 REVATMK-LVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFD---------KIVNHGRM 69
E+ + + H NVV L + +++EF G L
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 70 KEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 122
+ + LI + + SR HRDL N+LL +K+ DFGL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA--- 195
Query: 123 QQVRDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 166
RD ++ P+YV APE + DR Y +D+WS GV+L+
Sbjct: 196 ---RD---IYK---DPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.6 bits (159), Expect = 1e-11
Identities = 71/447 (15%), Positives = 137/447 (30%), Gaps = 107/447 (23%)
Query: 3 FQD-LSKYLDAFCILLQIK------REVATMKLVKH----PNVV----RLYEVMGSKTKI 47
++D LS + DAF K + + + + + H + V RL+ + SK +
Sbjct: 18 YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE- 76
Query: 48 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD---LKPENLL 104
+V +FV E+ N+ + Q + Y R + D N+
Sbjct: 77 EMVQKFV--EEVLRI--NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132
Query: 105 -LDAYGNLKVSDFGLSALSQQVRDDGL-LH--TTCGTPNYVAPEVLNDRGYDGSTADLWS 160
L Y L+ AL + + + G +VA +V
Sbjct: 133 RLQPYLKLR------QALLELRPAKNVLIDGVLGSGK-TWVALDVCLSYKVQ----CKMD 181
Query: 161 CGVILFVLLAGYLPFDDS---NLMNLYKKI-----SAAEFTCPPWLSF-TARKLIARILD 211
+ F L ++ L L +I S ++ + L + + + R+L
Sbjct: 182 FKI--FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 212 PNPMTRITIPEILEDEWFKKDYKPPVFEEK-------KDTNLDDVEAVFKDSEEHHVTEQ 264
P + +L + K + F + + D + + H++
Sbjct: 240 SKPYENCLL--VLLNVQNAKAWN--AFNLSCKILLTTRFKQVTDFLSA---ATTTHISL- 291
Query: 265 KEEQPVAMNAFELISL-SKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLG 323
+ + + E+ SL K L+ QD RE T+ P ++ I A
Sbjct: 292 -DHHSMTLTPDEVKSLLLKYLDC-----RPQDLPREVLTTN--PR--RLSII--AES--- 336
Query: 324 FDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLST 383
++ +N K L E + V + E+ K + LS
Sbjct: 337 ----IRDGLATWDNWKHVNCDKLTTIIESS--------LNVL----EPAEYRKMFDRLSV 380
Query: 384 CLEDV---------VW--KTEEDMQEM 399
+W + D+ +
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVV 407
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 5e-07
Identities = 72/434 (16%), Positives = 129/434 (29%), Gaps = 136/434 (31%)
Query: 16 LLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL------EFVTGGELFDKI--VNH 66
L++++ A ++L NV+ + V+GS KT + + ++ KI +N
Sbjct: 137 YLKLRQ--ALLELRPAKNVL-IDGVLGSGKT----WVALDVCLSYKVQCKMDFKIFWLNL 189
Query: 67 GRMKEDEAR-RYFQQLINAVD--YC----HSRGVYHR--DLK------------PENLL- 104
E Q+L+ +D + HS + R ++ LL
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 105 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD-LWSCGV 163
L N K +A + + +L TT R D L +
Sbjct: 250 LLNVQNAKA----WNAFNLSCK---ILLTT--------------R--FKQVTDFLSAATT 286
Query: 164 ILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEI 223
L + + +L K +L + L +L NP I E
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLK----------YLDCRPQDLPREVLTTNPRRLSIIAES 336
Query: 224 LEDE---WFKKDYKPPVFEEKKDT-------NLDDVE--------AVFKDSEEHHVTEQ- 264
+ D W D V +K T L+ E +VF S H+
Sbjct: 337 IRDGLATW---DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA--HIPTIL 391
Query: 265 ---------KEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKI 315
K + V +N SL E+ K T P+ + K+
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSL-----------VEKQPK---ESTISIPSIYLELKV 437
Query: 316 EEAAKPLGFDVHKK---NYKMRLENMKAGRKGNLNVATE---VFQ-VAPSLHMVEVRKAK 368
+ + +H+ +Y + K +L + + H+ + +
Sbjct: 438 KLENEY---ALHRSIVDHYNIP----KTFDSDDLIPPYLDQYFYSHIG--HHLKNIEHPE 488
Query: 369 GDTLEFHKFYKNLS 382
TL F + +
Sbjct: 489 RMTL-FRMVFLDFR 501
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 42/182 (23%), Positives = 68/182 (37%), Gaps = 49/182 (26%)
Query: 21 REVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKI 63
E+ M L H N+V L I+++ E+ G+L +
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 64 VNHGRMKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDF 116
+ED F+ L+ A + + HRDL N+L+ +K+ DF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 117 GLSALSQQVRDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVI 164
GL+ RD + + NYV APE L + Y +D+WS G++
Sbjct: 217 GLA------RD---IMS---DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGIL 263
Query: 165 LF 166
L+
Sbjct: 264 LW 265
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 50/271 (18%), Positives = 92/271 (33%), Gaps = 80/271 (29%)
Query: 33 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 90
N+V+ + + ++ E G L++ I + ++ + Y +++ A++Y
Sbjct: 97 NIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 91 RGVYHRDLKPENLLLDAYG-------------------------NLKVSDFGLSALSQQV 125
+ H DLKPEN+LLD +K+ DFG A
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CA----T 210
Query: 126 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY------------- 172
+ T Y APEV+ + G+D S +D+WS G +L L G
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269
Query: 173 --------LP--------------FDDSNLMNLY-------KKISAAEFTCPPWLSFTAR 203
+P + + + + L C P
Sbjct: 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329
Query: 204 K----LIARILDPNPMTRITIPEILEDEWFK 230
+ + IL +P R + E+L+ ++ +
Sbjct: 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 24/127 (18%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS-----DFGLSALSQQVRD-DGLLH- 132
QLI+ ++Y HS+ + +RD+KPEN L+ GN DF L+++ D + H
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA---LAKEYIDPETKKHI 169
Query: 133 ------TTCGTPNYVAPEVLND-RGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLM 181
+ GT Y++ +N G + S DL + G + L G LP L
Sbjct: 170 PYREHKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226
Query: 182 NLYKKIS 188
Y+KI
Sbjct: 227 ERYQKIG 233
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 35/107 (32%), Positives = 50/107 (46%), Gaps = 17/107 (15%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD-DGLLHTT- 134
Q+IN V++ HS+ HRD+KP+N L+ + + DFG L+++ RD H
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG---LAKKYRDTSTHQHIPY 167
Query: 135 ------CGTPNYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLP 174
GT Y + V G + S DL S G +L L G LP
Sbjct: 168 RENKNLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 20/124 (16%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDD-GLLHTT- 134
Q+I+ ++Y HS+ HRD+KP+N L+ + + DFG L+++ RD H
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG---LAKKYRDARTHQHIPY 169
Query: 135 ------CGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLY 184
GT Y + + G + S DL S G +L G LP + Y
Sbjct: 170 RENKNLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227
Query: 185 KKIS 188
++IS
Sbjct: 228 ERIS 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 31/134 (23%), Positives = 53/134 (39%), Gaps = 22/134 (16%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK-----VSDFGLSALSQQVRD-DGLLH- 132
Q++ V H + + +RD+KP+N L+ + V DFG + + RD H
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG---MVKFYRDPVTKQHI 170
Query: 133 ------TTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMN 182
GT Y++ + G + S DL + G + L G LP +
Sbjct: 171 PYREKKNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228
Query: 183 LYKKISAAEFTCPP 196
Y++I + + P
Sbjct: 229 KYERIGEKKQSTPL 242
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 22/109 (20%), Positives = 46/109 (42%), Gaps = 22/109 (20%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRDDG-------- 129
+L++A+++ H H ++ EN+ +D +V + +G + + G
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG---FAFRYCPSGKHVAYVEG 223
Query: 130 --LLHTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 174
H G +++ ++ +G S +DL S G + L G+LP
Sbjct: 224 SRSPHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 25/107 (23%), Positives = 45/107 (42%), Gaps = 18/107 (16%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRDDGLL------ 131
++++ ++Y H H D+K NLLL+ +V D+G L+ + +G+
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG---LAYRYCPEGVHKAYAAD 216
Query: 132 --HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 174
GT + + ++ G S DL G + L G+LP
Sbjct: 217 PKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 22/109 (20%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRDDGLL------ 131
++++ ++Y H H D+K NLLL +V +D+G LS + +G
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG---LSYRYCPNGNHKQYQEN 215
Query: 132 ----HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 174
H GT + + L+ +G S +D+ G + L G LP
Sbjct: 216 PRKGHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 6e-08
Identities = 15/86 (17%), Positives = 36/86 (41%), Gaps = 2/86 (2%)
Query: 303 TSRCPANEIINKIEEAAKPLGFDVHKKN-YKMRLENMKAGRKGNLNVATEVFQVA-PSLH 360
TS N+++ +I + D +K + + + A + + EV ++ SL+
Sbjct: 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLN 93
Query: 361 MVEVRKAKGDTLEFHKFYKNLSTCLE 386
V ++ G ++ F ++ L+
Sbjct: 94 GVRFKRISGTSIAFKNIASKIANELK 119
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 8e-08
Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 2/78 (2%)
Query: 43 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPE 101
++FIVLEF GG +++ A+ QL ++ + HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191
Query: 102 NLLLDAYGNLKVSDFGLS 119
N+LL K+
Sbjct: 192 NVLLKKTSLKKLHYTLNG 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 8e-07
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 25/99 (25%)
Query: 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 139
Q+ +++ SR HRDL N+LL +K+ DFGL+ RD P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248
Query: 140 YV------------APEVLNDRGYDGSTADLWSCGVILF 166
YV APE + DR Y + D+WS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQS-DVWSFGVLLW 286
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.97 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.33 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.17 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.85 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.72 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.55 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.41 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.38 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.35 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.21 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.16 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.74 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.61 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.89 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.19 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.66 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.35 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.5 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.32 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 90.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.09 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.79 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 88.32 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.18 | |
| 3ost_A | 128 | Serine/threonine-protein kinase KCC4; kinase assoc | 85.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.75 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-60 Score=455.75 Aligned_cols=217 Identities=29% Similarity=0.551 Sum_probs=203.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|+++|++++|||||++++++.+++.+|+|||||+||+|+++|...+.++|..++.|+.||+.||+|||++||
T Consensus 74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~I 153 (311)
T 4aw0_A 74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153 (311)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 34678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|++||+|||+|+............+.||||.|||||++.+.+| +.++|||||||++|+|++|+.
T Consensus 154 iHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~ 232 (311)
T 4aw0_A 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLP 232 (311)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987654444445667899999999999998888 489999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH------HhcCccccc
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPE------ILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~e------il~h~~~~~ 231 (400)
||.+.+..+++.++..+.+.+|..+|+++++||.+||++||.+|||++| |++||||+.
T Consensus 233 PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 233 PFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999999999999999999999999999999999999999988 589999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-59 Score=443.95 Aligned_cols=216 Identities=50% Similarity=0.932 Sum_probs=192.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....++.+|+.+|++++|||||++++++.+++.+|+||||| +|+|++++...+++++..++.++.||+.||+|||++||
T Consensus 55 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~I 133 (275)
T 3hyh_A 55 DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133 (275)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 33578999999999999999999999999999999999999 67999999999999999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++++|++||+|||+|+.... .....+.+|||.|+|||++.+.+|++.++||||+||++|+|++|+.
T Consensus 134 iHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~ 210 (275)
T 3hyh_A 134 VHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210 (275)
T ss_dssp CCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCChHHeEECCCCCEEEeecCCCeecCC---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999976543 2344578999999999999998888899999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
||.+.+...+++.+..+.+.+|.++|+++++||.+||++||.+|||++|+++||||+.+.
T Consensus 211 PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 211 PFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence 999999999999999999999999999999999999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-58 Score=442.24 Aligned_cols=212 Identities=36% Similarity=0.645 Sum_probs=191.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.++.+|+.+|++++|||||++++++.+++.+|+|||||+||+|+++|...+.+++..++.|+.|++.||+|||++||+||
T Consensus 71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 150 (304)
T 3ubd_A 71 VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 150 (304)
T ss_dssp C------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
||||+|||++.+|++||+|||+|+.... ......+.|||+.|||||++.+.+|+ .++||||+||++|||++|+.||.
T Consensus 151 DlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 151 DLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp SCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHeEEcCCCCEEecccccceeccC--CCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCC
Confidence 9999999999999999999999975433 23344678999999999999988885 89999999999999999999999
Q ss_pred CCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 177 DSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 177 ~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
+.+..+++..+....+.+|..+|+++++||++||++||.+||| ++|+++||||+.
T Consensus 228 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 228 GKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred CcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 9999999999999999999999999999999999999999998 589999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=444.39 Aligned_cols=216 Identities=28% Similarity=0.494 Sum_probs=194.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+|++++|||||++++++.+++.+|||||||+||+|++++.. +++++..++.|+.||+.||+|||++||+|
T Consensus 115 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiH 193 (346)
T 4fih_A 115 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIH 193 (346)
T ss_dssp GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 35688999999999999999999999999999999999999999999876 67999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|++||+|||+|+.... ......+.||||.|||||++.+.+| +.++|||||||++|||++|+.||
T Consensus 194 RDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF 270 (346)
T 4fih_A 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPY 270 (346)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCHHHEEECCCCCEEEecCcCceecCC--CCCcccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999986543 2234567899999999999998888 59999999999999999999999
Q ss_pred CCCchHHHHHhhhcCcc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 176 DDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
.+.+..+.+..+..... ..+..+|+++++||.+||++||.+|||++|+++||||++...+
T Consensus 271 ~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 271 FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp TTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred CCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 99998888888765533 2334589999999999999999999999999999999976543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=442.83 Aligned_cols=215 Identities=29% Similarity=0.584 Sum_probs=195.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++++|+.+|++|+|||||++++++.+++.+|||||||+||+|+++|...+ .+++..++.|+.||+.||+|||++||
T Consensus 67 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~I 146 (350)
T 4b9d_A 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146 (350)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 6789999999999999999999999999999999999999999999997543 57999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|++||+|||+|+..... .....+.|||+.|||||++.+.+|+ .++|||||||++|||++|+.
T Consensus 147 iHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~ 223 (350)
T 4b9d_A 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKH 223 (350)
T ss_dssp EETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSC
T ss_pred eeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999865431 1223567899999999999988885 89999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 174 PFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
||.+.+..+++.++..+.+ ..+..+|.++++||.+||++||.+|||++|+++||||++..
T Consensus 224 PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 224 AFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp SCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred CCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999888877765 45667999999999999999999999999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=445.05 Aligned_cols=357 Identities=37% Similarity=0.672 Sum_probs=273.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv 138 (476)
T 2y94_A 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138 (476)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 35789999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|++||+|||++..... .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..|
T Consensus 139 HrDLkp~NIll~~~~~vkL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P 215 (476)
T 2y94_A 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215 (476)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccHHHEEEecCCCeEEEeccchhhccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence 999999999999999999999999876532 33456679999999999999888877899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCccccccC--CChhhHHh-
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKD--TNLDDVEA- 251 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~~~~~~~~--~~~~~~~~- 251 (400)
|.+.+....+.++..+.+..|..+++++.+||++||+.||.+|||++++++||||+.......++.... ....+.+.
T Consensus 216 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (476)
T 2y94_A 216 FDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEAL 295 (476)
T ss_dssp SCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHH
Confidence 999998899999988888889999999999999999999999999999999999987643322211111 00000000
Q ss_pred --hh---cCcccc------------ccc-------cccc-----------cCccc-hhh--------hHHhhcCCCC---
Q 015814 252 --VF---KDSEEH------------HVT-------EQKE-----------EQPVA-MNA--------FELISLSKGL--- 284 (400)
Q Consensus 252 --~~---~~~~~~------------~~~-------~~~~-----------~~~~~-~~~--------~~~~~~s~~~--- 284 (400)
.. ...++. ... .... ..+.. ... ......+.+.
T Consensus 296 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (476)
T 2y94_A 296 KEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPR 375 (476)
T ss_dssp HSCCCC-------------------------------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCC
T ss_pred HHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCc
Confidence 00 000000 000 0000 00000 000 0000000000
Q ss_pred ---CCCCCCc--c----cccccccceEEecCCHHHHHHHHHHHhccCCceEee-eCceEEEEEeccCCCcceEEEEEEEE
Q 015814 285 ---NLGNLFD--A----EQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHK-KNYKMRLENMKAGRKGNLNVATEVFQ 354 (400)
Q Consensus 285 ---~~~~~~~--~----~~~~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~ 354 (400)
.+..... . ....++..++.|+.++.+||..+..|++.+|+.|+. +.+.++++...+.....+.|.+++|+
T Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~ 455 (476)
T 2y94_A 376 ARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQ 455 (476)
T ss_dssp CSTTCTTTSSSTTTCSCCCCCCEEESEEECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEE
T ss_pred ccccccccccccccccccccceeeecCccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEE
Confidence 0000000 0 113456678899999999999999999999999987 67899988764444566889999999
Q ss_pred EcCceeEEEEEecCCCchhH
Q 015814 355 VAPSLHMVEVRKAKGDTLEF 374 (400)
Q Consensus 355 ~~~~~~~v~~~~~~gd~~~~ 374 (400)
++++.+||||++..|+.++|
T Consensus 456 ~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 456 VDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp CSSSCEEEEEEEECCC----
T ss_pred ecCCcEEEEeeecCCCcccc
Confidence 99999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=444.78 Aligned_cols=215 Identities=28% Similarity=0.493 Sum_probs=194.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+|++++|||||++++++.+++.+|||||||+||+|++++.. +++++..++.|+.||+.||+|||++||+|
T Consensus 192 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiH 270 (423)
T 4fie_A 192 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIH 270 (423)
T ss_dssp GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 35688999999999999999999999999999999999999999999876 67999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||||+.+|++||+|||+|+.... ......+.|||+.|||||++.+.+| +.++|||||||++|||++|+.||
T Consensus 271 RDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF 347 (423)
T 4fie_A 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPY 347 (423)
T ss_dssp CCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCHHHEEEcCCCCEEEecCccceECCC--CCccccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999986543 2334567899999999999998888 59999999999999999999999
Q ss_pred CCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 176 DDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.+.+..+.+..+.... ...+..+|+++++||.+||++||.+|||++|+|+||||++...
T Consensus 348 ~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 348 FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp TTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 9999888888876553 2334568999999999999999999999999999999997543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=422.80 Aligned_cols=211 Identities=25% Similarity=0.522 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+++.+|+.+|++++|||||++++++.+ +..+|||||||+||+|.+++...+.+++..++.|+.|++.||+|||++
T Consensus 69 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~ 148 (290)
T 3fpq_A 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148 (290)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 5789999999999999999999999865 356899999999999999999989999999999999999999999999
Q ss_pred C--CeeccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 92 G--VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 92 g--ivHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
| |+||||||+|||++. +|.+||+|||+|+... .....+.+|||.|||||++.+ +| +.++|||||||++|||
T Consensus 149 ~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyel 222 (290)
T 3fpq_A 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEM 222 (290)
T ss_dssp SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHH
T ss_pred CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHH
Confidence 8 999999999999985 7999999999997532 234567899999999999875 56 5999999999999999
Q ss_pred HhCCCCCCCCc-hHHHHHhhhcCcc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 169 LAGYLPFDDSN-LMNLYKKISAAEF--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 169 ltG~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+||+.||.+.+ ...++..+..+.. ..+...++++++||.+||++||.+|||++|+++||||++.
T Consensus 223 ltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999997654 4566666655433 3455688999999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=427.65 Aligned_cols=213 Identities=26% Similarity=0.391 Sum_probs=187.4
Q ss_pred HHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCC
Q 015814 20 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 99 (400)
Q Consensus 20 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlK 99 (400)
.+|+.+|++++|||||++++++.+++.+|||||||+||+|+++|...+.+++..++.|+.|++.||+|||++||+|||||
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 177 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence 47999999999999999999999999999999999999999999998999999999999999999999999999999999
Q ss_pred CCcEEEccCC-CeeeeccccccccccccCCC---ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 100 PENLLLDAYG-NLKVSDFGLSALSQQVRDDG---LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 100 P~NILl~~~g-~~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|+|||++.+| .+||+|||+|+......... ...+.||||.|||||++.+.+|+ .++||||+||++|||++|+.||
T Consensus 178 p~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf 256 (336)
T 4g3f_A 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPW 256 (336)
T ss_dssp GGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCC
Confidence 9999999988 59999999998754322111 12346899999999999988885 8999999999999999999999
Q ss_pred CCCchHHHHHhhhcCcc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH-------------hcCcccccCC
Q 015814 176 DDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARILDPNPMTRITIPEI-------------LEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei-------------l~h~~~~~~~ 233 (400)
.+.+...+..++..... ..|+.+|+++.+||.+||++||.+|||+.|+ ++|||+....
T Consensus 257 ~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 257 TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp TTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred CCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 98887777777765543 4577899999999999999999999999998 5799987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=424.73 Aligned_cols=219 Identities=26% Similarity=0.383 Sum_probs=189.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe------CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
..+++.+|+++|+.++|||||++++++.. ...+|||||||. |+|++++...+++++..++.|++||+.||+||
T Consensus 96 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~yl 174 (398)
T 4b99_A 96 NAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 174 (398)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 35788899999999999999999999764 367999999996 58999999989999999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccc--cCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV--RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
|++||+||||||+|||++.+|.+||+|||+|+..... .......+.+||+.|+|||++.+..+++.++||||+|||+|
T Consensus 175 H~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ 254 (398)
T 4b99_A 175 HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG 254 (398)
T ss_dssp HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred HHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHH
Confidence 9999999999999999999999999999999865432 12334567899999999999988777789999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHhhhcCccCC-------------------------------CCCCCHHHHHHHHHhcCCCCC
Q 015814 167 VLLAGYLPFDDSNLMNLYKKISAAEFTC-------------------------------PPWLSFTARKLIARILDPNPM 215 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------~~~~s~~~~~li~~mL~~dP~ 215 (400)
||++|+.||.+.+..+++..|....... .+.+|+++.+||.+||..||.
T Consensus 255 ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 334 (398)
T 4b99_A 255 EMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS 334 (398)
T ss_dssp HHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence 9999999999998888777664322111 123689999999999999999
Q ss_pred CCCCHHHHhcCcccccCCC
Q 015814 216 TRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 216 ~R~t~~eil~h~~~~~~~~ 234 (400)
+|||++|+|+||||++...
T Consensus 335 ~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 335 ARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp TSCCHHHHTTSGGGTTTCC
T ss_pred HCcCHHHHhcCHhhCcCCC
Confidence 9999999999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=409.25 Aligned_cols=213 Identities=27% Similarity=0.467 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..++.+|+++|+.+ +|||||++++++.+.+++|+|||||+||+|++.+ +.+++..++.|+.||+.||+|||++||+
T Consensus 63 ~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIi 139 (361)
T 4f9c_A 63 PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIV 139 (361)
T ss_dssp HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45788999999998 6999999999999999999999999999999998 4699999999999999999999999999
Q ss_pred eccCCCCcEEEccC-CCeeeecccccccccccc--------------------------CCCccccccCCCCCCCChhhh
Q 015814 95 HRDLKPENLLLDAY-GNLKVSDFGLSALSQQVR--------------------------DDGLLHTTCGTPNYVAPEVLN 147 (400)
Q Consensus 95 HrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~--------------------------~~~~~~~~~gt~~y~APEvl~ 147 (400)
||||||+|||++.+ |.+||+|||+|+...... ......+.+||++|+|||++.
T Consensus 140 HRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 219 (361)
T 4f9c_A 140 HRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT 219 (361)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT
T ss_pred eCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 99999999999987 899999999997543211 112234568999999999998
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-chHHHHHhhhc-------------------------------------
Q 015814 148 DRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISA------------------------------------- 189 (400)
Q Consensus 148 ~~~~~~~~~DIwSlGiil~elltG~~Pf~~~-~~~~~~~~i~~------------------------------------- 189 (400)
+.++++.++||||+|||+|+|++|+.||... +..+....|..
T Consensus 220 ~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 220 KCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred CCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 8766679999999999999999999999543 32232222210
Q ss_pred -Ccc----------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 190 -AEF----------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 190 -~~~----------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
... .....+|+++++||++||+.||.+|||++|+|+||||+.
T Consensus 300 ~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 300 GMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp ----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000 011237899999999999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=400.95 Aligned_cols=214 Identities=21% Similarity=0.330 Sum_probs=191.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-------------CCCCHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-------------GRMKEDEARRYFQQL 81 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-------------~~l~e~~~~~~~~ql 81 (400)
..+++.+|+++|++++|||||++++++.+++.+|+|||||+||+|.++|... ..+++..+..++.|+
T Consensus 58 ~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 137 (299)
T 4asz_A 58 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137 (299)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHH
Confidence 3678999999999999999999999999999999999999999999999764 369999999999999
Q ss_pred HHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHH
Q 015814 82 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSC 161 (400)
Q Consensus 82 l~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSl 161 (400)
++||+|||+++|+||||||+|||+++++++||+|||+|+..............+||+.|||||++.+..|+ .++|||||
T Consensus 138 a~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~ 216 (299)
T 4asz_A 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSL 216 (299)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHH
T ss_pred HHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHH
Confidence 99999999999999999999999999999999999999865443222223345799999999999988885 99999999
Q ss_pred HHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 162 GVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 162 Giil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
||++|||+| |+.||.+.+..++...+..+. ...|+.+|+++.+||.+||+.||.+|||+++| ++|++.
T Consensus 217 Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 217 GVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 999999998 999999999888888887665 46778899999999999999999999999999 457754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=434.50 Aligned_cols=212 Identities=29% Similarity=0.450 Sum_probs=190.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
....+.++.+++.++|||||++++++.+.+.+|+|||||+||+|+++|...+.+++..++.|+.||+.||+|||++||+|
T Consensus 236 ~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiH 315 (689)
T 3v5w_A 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315 (689)
T ss_dssp HHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 44555667888889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|++||+|||+|+.... ....+.||||.|||||++.+...++.++|||||||++|||++|+.||
T Consensus 316 RDLKPeNILld~~G~vKL~DFGlA~~~~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF 391 (689)
T 3v5w_A 316 RDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391 (689)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECSS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCchHHeEEeCCCCEEecccceeeecCC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999976532 23467899999999999975433469999999999999999999999
Q ss_pred CCCc---hHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 176 DDSN---LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~---~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
.+.+ ...++..+....+.+|..+|+++++||.+||++||.+|++ ++||++||||+.
T Consensus 392 ~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 392 RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp CGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred CCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 7643 3456677777888899999999999999999999999998 799999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=395.63 Aligned_cols=211 Identities=22% Similarity=0.374 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+++|+.+|++++|||||++++++. ++.+|||||||+||+|.++|... +++++..+..++.|++.||+|||++||
T Consensus 75 ~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~I 153 (307)
T 3omv_A 75 QFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNI 153 (307)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3678999999999999999999999875 45689999999999999999764 579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC--CCCChhhHHHHHHHHHHHHhC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGiil~elltG 171 (400)
+||||||+|||+++++++||+|||+|+............+.+||+.|||||++.... .++.++|||||||++|||+||
T Consensus 154 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg 233 (307)
T 3omv_A 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233 (307)
T ss_dssp BCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHC
Confidence 999999999999999999999999998765433344456679999999999997432 235899999999999999999
Q ss_pred CCCCCCCchHHHHH-hhhcCcc-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 172 YLPFDDSNLMNLYK-KISAAEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~-~i~~~~~-----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+.||.+.+...... .+..+.. ..++.+|+++.+||.+||+.||.+|||+.||+++
T Consensus 234 ~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 234 ELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp SCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99998866544333 3333221 2345689999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=399.86 Aligned_cols=211 Identities=20% Similarity=0.322 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC---------------CCCCHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---------------GRMKEDEARRYFQ 79 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~---------------~~l~e~~~~~~~~ 79 (400)
..+++.+|+++|++++|||||++++++.+...+|||||||+||+|.+++... +++++..+..|+.
T Consensus 86 ~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 165 (329)
T 4aoj_A 86 ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165 (329)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHH
Confidence 3678999999999999999999999999999999999999999999999754 3589999999999
Q ss_pred HHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHH
Q 015814 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 159 (400)
Q Consensus 80 qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw 159 (400)
|++.||+|||+++|+||||||+|||+++++++||+|||+|+..............+||+.|||||++.+..|+ .++|||
T Consensus 166 qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvw 244 (329)
T 4aoj_A 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVW 244 (329)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHH
T ss_pred HHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-cccccc
Confidence 9999999999999999999999999999999999999999865443333334557899999999999988875 999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 160 SCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 160 SlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||||++|||+| |+.||.+.+..+....+..+ ....|+.+|+++.+|+.+||+.||.+|||++||+++
T Consensus 245 S~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 245 SFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99999999999 99999998888888877665 456788899999999999999999999999999763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=396.32 Aligned_cols=212 Identities=27% Similarity=0.479 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------------EEEEEEecCCCCChHHHHHhCCCC---CHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKT------------KIFIVLEFVTGGELFDKIVNHGRM---KEDEARRYFQ 79 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~------------~~~lv~Ey~~gg~L~~~i~~~~~l---~e~~~~~~~~ 79 (400)
..+++.+|+.+|++++|||||++++++.+.+ .+|+|||||+||+|.+++...+.+ ++..++.|+.
T Consensus 46 ~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~ 125 (299)
T 4g31_A 46 AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125 (299)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHH
Confidence 3578999999999999999999999986544 479999999999999999876654 4567899999
Q ss_pred HHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC----------CccccccCCCCCCCChhhhcC
Q 015814 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTPNYVAPEVLNDR 149 (400)
Q Consensus 80 qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~~~ 149 (400)
|+++||+|||++||+||||||+|||++.+|.+||+|||+|+........ ....+.||||.|||||++.+.
T Consensus 126 qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~ 205 (299)
T 4g31_A 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205 (299)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTC
T ss_pred HHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC
Confidence 9999999999999999999999999999999999999999865432211 122456899999999999988
Q ss_pred CCCCChhhHHHHHHHHHHHHhCCCCCCCCch-HHHHHhhhcCccCCCC---CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 150 GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTCPP---WLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 150 ~~~~~~~DIwSlGiil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~---~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|+ .++|||||||++|||++ ||.+... ......+.... +|+ ..++.+.+||++||++||.+|||+.|+++
T Consensus 206 ~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 206 SYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLK--FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp CCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTC--CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCC--CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 885 99999999999999996 8865432 22333333332 232 25677899999999999999999999999
Q ss_pred CcccccC
Q 015814 226 DEWFKKD 232 (400)
Q Consensus 226 h~~~~~~ 232 (400)
||||+.-
T Consensus 280 h~~~~~~ 286 (299)
T 4g31_A 280 NAVFEDL 286 (299)
T ss_dssp SGGGCCC
T ss_pred CHhhCCC
Confidence 9999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=394.46 Aligned_cols=210 Identities=22% Similarity=0.355 Sum_probs=190.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQ 79 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ 79 (400)
.+++++|+.+|++++|||||++++++.+.+.+|+|||||++|+|.++|... ..+++..+..++.
T Consensus 73 ~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 152 (308)
T 4gt4_A 73 REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152 (308)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHH
Confidence 578999999999999999999999999999999999999999999999653 3589999999999
Q ss_pred HHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHH
Q 015814 80 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 159 (400)
Q Consensus 80 qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw 159 (400)
|++.||+|||+++|+||||||+|||+++++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||
T Consensus 153 qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVw 231 (308)
T 4gt4_A 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIW 231 (308)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhh
Confidence 9999999999999999999999999999999999999999866544334445667899999999999988875 999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 160 SCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 160 SlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||||++|||+| |..||.+.+..++...+..+. .+.|+.+|.++.+|+.+||+.||.+|||+.||+++
T Consensus 232 SfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999998 899999999888888876654 46677899999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=424.92 Aligned_cols=216 Identities=32% Similarity=0.627 Sum_probs=196.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+++|+.+|+.++|||||++++++.+...+|||||||+||+|+++|.. .+.+++..++.|++||+.||+|||++||+
T Consensus 198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii 277 (573)
T 3uto_A 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277 (573)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 57789999999999999999999999999999999999999999999964 46799999999999999999999999999
Q ss_pred eccCCCCcEEEccC--CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLLDAY--GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~--g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||||+|||++.+ |.+||+|||+|+.... .....+.|||+.|+|||++.+.+| +.++|||||||++|+|++|.
T Consensus 278 HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~ 353 (573)
T 3uto_A 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGL 353 (573)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCSSCEECCT---TSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSC
T ss_pred eccCChhhccccCCCCCCEEEeeccceeEccC---CCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCC
Confidence 99999999999864 8999999999986542 344567899999999999999888 48999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
.||.+.+..+.+..+....+.++ +.+|.++++||++||+.||.+|||++|+|+||||+....+
T Consensus 354 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 354 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp CSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred CCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 99999999999998887766554 3589999999999999999999999999999999976544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=386.24 Aligned_cols=216 Identities=44% Similarity=0.843 Sum_probs=202.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+++.+|+.+|+.++||||+++++++.+.+.+|+||||++||+|.+++...+++++..++.++.|++.||+|||++||+
T Consensus 57 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~iv 136 (328)
T 3fe3_A 57 SLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136 (328)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 36789999999999999999999999999999999999999999999999889999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.++++||+|||++..... .......+||+.|+|||++.+..+.+.++||||+||++|+|++|+.|
T Consensus 137 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 213 (328)
T 3fe3_A 137 HRDLKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213 (328)
T ss_dssp CSCCCGGGEEECTTSCEEECSTTCCGGGSS---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCHHHEEEcCCCCEEEeeccCceecCC---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999875542 33456779999999999999888887899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
|.+.+.......+..+.+..|..+|+++.+||++||..||.+|||++|+++||||+...
T Consensus 214 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 214 FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999899999999999999999999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=389.56 Aligned_cols=210 Identities=22% Similarity=0.363 Sum_probs=182.0
Q ss_pred HHHHHHHHHHHHhCCC-CCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHH
Q 015814 16 LLQIKREVATMKLVKH-PNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRY 77 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~H-pnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~ 77 (400)
.+.+.+|+.+|++++| ||||++++++.. +..+|+|||||+||+|.++|... ..+++..+..|
T Consensus 111 ~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 190 (353)
T 4ase_A 111 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190 (353)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHH
Confidence 5779999999999965 999999999865 46789999999999999999753 34899999999
Q ss_pred HHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhh
Q 015814 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 78 ~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
+.|++.||+|||+++|+||||||+|||+++++++||+|||+|+............+.+||+.|||||++.+..|+ .++|
T Consensus 191 ~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksD 269 (353)
T 4ase_A 191 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSD 269 (353)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHH
T ss_pred HHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-Cccc
Confidence 999999999999999999999999999999999999999999865432222233456899999999999988875 9999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCchH-HHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~ellt-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||||||++|||+| |+.||.+.+.. .....+..+ .+..|+.+|+++.+||.+||+.||.+|||+.||++|
T Consensus 270 VwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 270 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred EeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999998 99999886644 444444444 457788899999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=377.63 Aligned_cols=214 Identities=34% Similarity=0.627 Sum_probs=194.3
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+.+|+.+++.+ +||||+++++++.+...+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||
T Consensus 66 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi 145 (353)
T 3txo_A 66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145 (353)
T ss_dssp THHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367788999999988 7999999999999999999999999999999999998999999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|++||+|||+|..... ......+.|||+.|+|||++.+..| +.++||||+||++|+|++|+.
T Consensus 146 vHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~ 222 (353)
T 3txo_A 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHA 222 (353)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCHHHEEECCCCCEEEccccceeeccc--CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCC
Confidence 9999999999999999999999999874322 2233456799999999999988777 489999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI------PEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~------~eil~h~~~~~ 231 (400)
||.+.+..+++..+......+|.+++.++.+||++||+.||.+||++ +++++||||+.
T Consensus 223 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 223 PFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999999999999999999999999999999999999998 89999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=371.67 Aligned_cols=213 Identities=34% Similarity=0.642 Sum_probs=197.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+|+.++||||+++++++.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+|
T Consensus 49 ~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 128 (337)
T 1o6l_A 49 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128 (337)
T ss_dssp HHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 57788999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|++||+|||++..... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||
T Consensus 129 rDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf 205 (337)
T 1o6l_A 129 RDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPF 205 (337)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CcCCHHHEEECCCCCEEEeeccchhhccc--CCCcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCC
Confidence 99999999999999999999999875322 2233456799999999999988777 58999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
.+.+....+..+......+|..+|+++.+||.+||+.||.+|| +++++++||||+.
T Consensus 206 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 206 YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999889998888888889999999999999999999999999 9999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=377.03 Aligned_cols=214 Identities=49% Similarity=0.961 Sum_probs=197.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+++.++||||+++++++.+.+..|+||||+ +|+|++++...+++++..++.++.|++.||+|||++||+|
T Consensus 53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 131 (336)
T 3h4j_B 53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131 (336)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 467899999999999999999999999999999999999 6799999998899999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.++.+||+|||++..... .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||
T Consensus 132 ~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf 208 (336)
T 3h4j_B 132 RDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208 (336)
T ss_dssp CCCSTTTEEECTTCCEEECCSSCTBTTTT---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCchhhEEEcCCCCEEEEEeccceeccC---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999876543 233456789999999999998887778999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.+......+..+..+.+..|..+|+++.+||++||+.||.+|||++|+++||||+...
T Consensus 209 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 209 DDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp BCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred CCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 9888777777777778888899999999999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=365.33 Aligned_cols=210 Identities=34% Similarity=0.740 Sum_probs=197.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++++.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+|
T Consensus 50 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 129 (318)
T 1fot_A 50 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY 129 (318)
T ss_dssp HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 57788999999999999999999999999999999999999999999999889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||
T Consensus 130 rDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf 203 (318)
T 1fot_A 130 RDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPF 203 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCChheEEEcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCC
Confidence 99999999999999999999999875432 23457899999999999887774 8999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
.+.+....+..+......+|+.++.++.+||++||..||.+|| +++++++||||+.
T Consensus 204 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 204 YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999989999988888889999999999999999999999999 9999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=371.83 Aligned_cols=212 Identities=34% Similarity=0.624 Sum_probs=194.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+|++++||||+++++++.+...+|+||||++||+|++++...+.+++..+..++.|++.||.|||++||+|
T Consensus 59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 138 (361)
T 2yab_A 59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (361)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46789999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCC----CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 96 RDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 96 rDlKP~NILl~~~g----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|||||+|||++.++ .+||+|||++..... .......+||+.|+|||++.+..| +.++||||+||++|+|++|
T Consensus 139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g 214 (361)
T 2yab_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSG 214 (361)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCSSCEECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHEEEeCCCCCccCEEEEecCCceEcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhC
Confidence 99999999998877 799999999876543 223456789999999999988777 5999999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 172 YLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
..||.+.+..+.+..+..+.+.++ +.+|.++++||.+||..||.+|||+.|+++||||+.
T Consensus 215 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 215 ASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp CCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 999999998888888887777665 458999999999999999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=371.40 Aligned_cols=213 Identities=30% Similarity=0.609 Sum_probs=197.2
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|..+++.+ +||||+++++++.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 61 ~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 140 (345)
T 1xjd_A 61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140 (345)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 56788999999987 99999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|++||+|||++..... ......+.+||+.|+|||++.+.+| +.++||||+||++|+|++|..|
T Consensus 141 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~P 217 (345)
T 1xjd_A 141 YRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSP 217 (345)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCS
T ss_pred eCCCChhhEEECCCCCEEEeEChhhhhccc--CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999875322 1223456799999999999998777 4999999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIP-EILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~-eil~h~~~~~ 231 (400)
|.+.+..+++..+......+|.++|.++.+||.+||..||.+|||+. ++++||||+.
T Consensus 218 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 218 FHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 99999999999998888889999999999999999999999999998 9999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=367.23 Aligned_cols=210 Identities=32% Similarity=0.641 Sum_probs=197.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+|+.++||||+++++++.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+|
T Consensus 85 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 164 (350)
T 1rdq_E 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164 (350)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 57788999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++..... ...+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||
T Consensus 165 rDlkp~NIll~~~g~~kL~DFg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf 238 (350)
T 1rdq_E 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccceEEECCCCCEEEcccccceeccC-----CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCC
Confidence 99999999999999999999999875432 23456899999999999987774 9999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
.+.+....+..+..+...+|..++.++.+||.+||+.||.+||+ +++|++||||+.
T Consensus 239 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 239 FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999999988888899999999999999999999999998 999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=366.93 Aligned_cols=213 Identities=30% Similarity=0.558 Sum_probs=196.9
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|..++..+ +||||+++++++.+...+|+||||++||+|.+++...+.+++..++.|+.|++.||+|||++||+
T Consensus 64 ~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~giv 143 (353)
T 2i0e_A 64 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143 (353)
T ss_dssp HHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 57788999999988 89999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|++||+|||++..... ......+.+||+.|+|||++.+.+| +.++|||||||++|+|++|+.|
T Consensus 144 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~P 220 (353)
T 2i0e_A 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAP 220 (353)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCCHHHEEEcCCCcEEEEeCCccccccc--CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCC
Confidence 999999999999999999999999875322 2233456799999999999988877 5999999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
|.+.+..+++..+......+|..+|.++.+||.+||..||.+||+ +++|++||||+.
T Consensus 221 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 221 FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 999999999999988888999999999999999999999999995 699999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=365.26 Aligned_cols=215 Identities=31% Similarity=0.601 Sum_probs=193.0
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.+++++ +||||+++++++.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++|
T Consensus 51 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 130 (345)
T 3a8x_A 51 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130 (345)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3467889999999988 899999999999999999999999999999999998889999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+|||++.+|++||+|||++..... ......+.+||+.|+|||++.+..| +.++||||+||++|+|++|+
T Consensus 131 ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~ 207 (345)
T 3a8x_A 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 207 (345)
T ss_dssp CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSS
T ss_pred ceecCCCHHHEEECCCCCEEEEeccccccccC--CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875322 2233456799999999999998777 59999999999999999999
Q ss_pred CCCCC---------CchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 015814 173 LPFDD---------SNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI------PEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~------~eil~h~~~~~ 231 (400)
.||.. .+...++..+......+|..+|.++.+||.+||+.||.+|||+ +++++||||+.
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 208 SPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp CTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99975 2344566777777888899999999999999999999999995 89999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=373.95 Aligned_cols=214 Identities=31% Similarity=0.605 Sum_probs=192.3
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|..+++++ +||||+++++++.+...+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||
T Consensus 95 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi 174 (396)
T 4dc2_A 95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174 (396)
T ss_dssp -CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 356688999999887 8999999999999999999999999999999999998899999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|++||+|||+|+.... ......+.|||+.|+|||++.+..| +.++|||||||++|+|++|+.
T Consensus 175 vHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~ 251 (396)
T 4dc2_A 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRS 251 (396)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred EeccCCHHHEEECCCCCEEEeecceeeeccc--CCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999874322 2334567799999999999998877 499999999999999999999
Q ss_pred CCCCC---------chHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 015814 174 PFDDS---------NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI------PEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~------~eil~h~~~~~ 231 (400)
||... ....++..+......+|..+|.++.+||++||+.||.+||++ ++|++||||+.
T Consensus 252 Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 252 PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99642 234466777788888999999999999999999999999985 79999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=376.68 Aligned_cols=213 Identities=40% Similarity=0.749 Sum_probs=194.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++.+.+..|+||||+.||+|++.+...+.+++..+..++.|++.||.|||++||+|
T Consensus 54 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givH 133 (444)
T 3soa_A 54 HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVH 133 (444)
T ss_dssp HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 57789999999999999999999999999999999999999999999999899999999999999999999999999999
Q ss_pred ccCCCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++. ++.+||+|||+|..... ........+||+.|+|||++.+..| +.++|||||||++|+|++|.
T Consensus 134 rDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~ 210 (444)
T 3soa_A 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGY 210 (444)
T ss_dssp CCCSSTTEEESBSSTTCCEEECCCSSCBCCCT--TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCHHHEEEeccCCCCcEEEccCceeEEecC--CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCC
Confidence 999999999984 57899999999976543 2233456789999999999988777 48999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.||.+.+....+..+..+.+.+|. .+|+++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 211 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 211 PPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999998888888877665543 47999999999999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=361.35 Aligned_cols=213 Identities=34% Similarity=0.618 Sum_probs=188.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+|
T Consensus 65 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 144 (327)
T 3a62_A 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144 (327)
T ss_dssp ------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 56788999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||
T Consensus 145 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf 221 (327)
T 3a62_A 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPF 221 (327)
T ss_dssp CCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCCHHHeEECCCCcEEEEeCCcccccccC--CccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCC
Confidence 999999999999999999999998753321 223345689999999999988777 58999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
.+.+.......+.......|+.++.++.+||.+||..||.+|| ++.++++||||+.
T Consensus 222 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 222 TGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp CCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 9999888888888888888999999999999999999999999 8899999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=361.30 Aligned_cols=213 Identities=27% Similarity=0.543 Sum_probs=192.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+++|+.+++.++||||+++++++.+...+|+||||++||+|++++...+ .+++..+..++.|++.||.|||++||+
T Consensus 45 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~giv 124 (321)
T 1tki_A 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124 (321)
T ss_dssp HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4678899999999999999999999999999999999999999999997754 799999999999999999999999999
Q ss_pred eccCCCCcEEEcc--CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl~~--~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||||+|||++. ++.+||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 125 H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEEccCCCCCEEEEECCCCeECCC---CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCC
Confidence 9999999999997 78999999999876542 233456789999999999987655 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.||.+.+.......+..+.+.++ +.+|.++.+||.+||..||.+|||+.|+++||||+..
T Consensus 201 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999988888888877776655 3589999999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=362.71 Aligned_cols=219 Identities=40% Similarity=0.705 Sum_probs=190.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+++|+.+++.++||||+++++++.+.+..|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+|
T Consensus 49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH 128 (323)
T 3tki_A 49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128 (323)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46789999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.++.+||+|||++...............+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||
T Consensus 129 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 208 (323)
T 3tki_A 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (323)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986654333344556789999999999998877678899999999999999999999
Q ss_pred CCCchH-HHHHhhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 176 DDSNLM-NLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 176 ~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
...+.. ..+..+.......+ ..++..+.+||.+||+.||.+|||++|+++||||+....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp SSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 876653 33333333333333 348999999999999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=364.42 Aligned_cols=212 Identities=39% Similarity=0.744 Sum_probs=192.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++.+....|+||||++||+|++.+...+.+++..+..++.|++.||.|||++||+|
T Consensus 72 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 151 (362)
T 2bdw_A 72 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 151 (362)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 57899999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCC---CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++.++ .+||+|||++..... .......+||+.|+|||++.+..|. .++|||||||++|+|++|.
T Consensus 152 ~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGY 227 (362)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSS
T ss_pred ccCchHHEEEecCCCCCCEEEeecCcceEecC---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCC
Confidence 99999999998654 599999999876542 2234567899999999999887774 8999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.||.+.+....+..+..+.+.+|. .++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 228 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999888888888777665553 37999999999999999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=357.20 Aligned_cols=212 Identities=38% Similarity=0.644 Sum_probs=191.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+|++++||||+++++++.+....|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+|
T Consensus 58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 137 (326)
T 2y0a_A 58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137 (326)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence 46789999999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCC----CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 96 RDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 96 rDlKP~NILl~~~g----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|||||+|||++.++ .+||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus 138 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g 213 (326)
T 2y0a_A 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSG 213 (326)
T ss_dssp CCCCGGGEEESCSSSSSCCEEECCCTTCEECCT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHEEEecCCCCCCCEEEEECCCCeECCC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHC
Confidence 99999999999887 899999999876542 223345689999999999987776 4899999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 172 YLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
..||.+.+..+....+.......+ +.+|..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 214 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp CCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 999999888877777766655544 458999999999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=351.35 Aligned_cols=213 Identities=29% Similarity=0.513 Sum_probs=188.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++++...+..|+||||++||+|.+++... .+++..+..++.|++.||+|||++||+|
T Consensus 61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H 139 (297)
T 3fxz_A 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIH 139 (297)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcee
Confidence 467889999999999999999999999999999999999999999999774 6999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+..| +.++||||+||++|+|++|..||
T Consensus 140 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf 216 (297)
T 3fxz_A 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPY 216 (297)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCCHHHEEECCCCCEEEeeCCCceecCCc--ccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998765432 223445689999999999998877 48999999999999999999999
Q ss_pred CCCchHHHHHhhhcC---ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 176 DDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.+.+.......+... ....|..++..+.+||.+||+.||.+|||++|+++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp TTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 988776555444322 334466789999999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=362.48 Aligned_cols=215 Identities=45% Similarity=0.800 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
+.+++|+.+++.++||||+++++++.+...+|+||||++||+|.+++...+++++..++.++.|++.||+|||++||+||
T Consensus 61 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~ 140 (361)
T 3uc3_A 61 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHR 140 (361)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSC
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 56889999999999999999999999999999999999999999999888899999999999999999999999999999
Q ss_pred cCCCCcEEEccCCC--eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 97 DLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 97 DlKP~NILl~~~g~--~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||+|||++.++. +||+|||+|+.... .......+||+.|+|||++.+..+.+.++||||+||++|+|++|+.|
T Consensus 141 Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~P 217 (361)
T 3uc3_A 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217 (361)
T ss_dssp CCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCceEEEeecCccccccc---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCC
Confidence 99999999988765 99999999874322 22234568999999999999888876669999999999999999999
Q ss_pred CCCCch----HHHHHhhhcCccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 175 FDDSNL----MNLYKKISAAEFTCPP--WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 175 f~~~~~----~~~~~~i~~~~~~~~~--~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|.+.+. ......+.......|. .+++++.+||.+||+.||.+|||+.|+++||||.+...
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 218 FEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp CC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred CCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 987543 3444455555555555 47999999999999999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=364.95 Aligned_cols=212 Identities=27% Similarity=0.561 Sum_probs=192.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+|+.++||||+++++++.+...+|+||||+.||+|.+++...+.+++..++.|+.|++.||.|||++||+|
T Consensus 59 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH 138 (384)
T 4fr4_A 59 VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIH 138 (384)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 57888999999999999999999999999999999999999999999999889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc---CCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++.+|.+||+|||++..... .....+.+||+.|+|||++.. .+| +.++||||+||++|+|++|+
T Consensus 139 rDlkp~NIll~~~g~vkL~DFG~a~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~ 214 (384)
T 4fr4_A 139 RDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGR 214 (384)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCT---TCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSS
T ss_pred ccCcHHHeEECCCCCEEEeccceeeeccC---CCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCC
Confidence 99999999999999999999999976432 334567799999999999974 234 58999999999999999999
Q ss_pred CCCCCC---chHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 015814 173 LPFDDS---NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-IPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-~~eil~h~~~~~ 231 (400)
.||... ........+......+|..+|.++.+||.+||+.||.+||+ ++++++||||+.
T Consensus 215 ~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 215 RPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp CSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred CCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 999743 34566666777778888999999999999999999999998 999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=365.02 Aligned_cols=213 Identities=35% Similarity=0.597 Sum_probs=188.6
Q ss_pred HHHHHHHHHH-HHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|..+ ++.++||||+++++++.+...+|+||||++||+|++++...+.+++..++.|+.|++.||+|||++||+
T Consensus 82 ~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~giv 161 (373)
T 2r5t_A 82 EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 161 (373)
T ss_dssp ---------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 5667778887 577899999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|++||+|||+++.... ......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..|
T Consensus 162 HrDlkp~NIll~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~P 238 (373)
T 2r5t_A 162 YRDLKPENILLDSQGHIVLTDFGLCKENIE--HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPP 238 (373)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCBCGGGBC--CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCHHHEEECCCCCEEEeeCcccccccc--CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999875332 22334567999999999999987774 899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~----~eil~h~~~~~ 231 (400)
|.+.+..+++..+......+|+.++.++.+||.+||+.||.+||++ .++++||||+.
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 239 FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp TCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999888888899999999999999999999999986 69999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=372.15 Aligned_cols=214 Identities=34% Similarity=0.632 Sum_probs=188.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~-~gi 93 (400)
....+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||
T Consensus 191 ~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gi 270 (446)
T 4ejn_A 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270 (446)
T ss_dssp ----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence 3567889999999999999999999999999999999999999999999988899999999999999999999998 999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|.+||+|||+|..... ......+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.
T Consensus 271 iHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~ 347 (446)
T 4ejn_A 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL 347 (446)
T ss_dssp CCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCHHHEEECCCCCEEEccCCCceeccC--CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCC
Confidence 9999999999999999999999999875332 2233456789999999999988777 599999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
||.+.+....+..+......+|..+++++.+||.+||+.||.+|| |++|+++||||+.
T Consensus 348 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 348 PFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999989998888888889999999999999999999999999 9999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=344.46 Aligned_cols=217 Identities=51% Similarity=0.953 Sum_probs=190.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+++.++||||+++++++.+....|+||||++|++|.+++...+.+++..+..++.|++.||.|||++|++
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 133 (276)
T 2h6d_A 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133 (276)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 35688999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.++.+||+|||++..... .......+||+.|+|||++.+..+.+.++||||+|+++|+|++|..|
T Consensus 134 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 210 (276)
T 2h6d_A 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210 (276)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCChhhEEECCCCCEEEeecccccccCC---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876433 22234568999999999998877766899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|...+.......+..+....|..++.++.++|.+||+.||.+|||+.++++||||+....
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 211 FDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred CCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 999888888888888888888889999999999999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=353.14 Aligned_cols=216 Identities=28% Similarity=0.424 Sum_probs=182.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.....+.+|+.++++++||||+++++++.++...|+||||++| +|.+.+.... .+++..++.++.|++.||+|||++|
T Consensus 61 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 139 (311)
T 3niz_A 61 GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139 (311)
T ss_dssp CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457788999999999999999999999999999999999986 8888887644 5999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|+
T Consensus 140 ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 217 (311)
T 3niz_A 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217 (311)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCCCchHhEEECCCCCEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence 999999999999999999999999999765431 223345689999999999987555569999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCcc------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 173 LPFDDSNLMNLYKKISAAEF------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~------------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
.||.+.+..+....+..... ...+.+++++.+||.+||+.||.+|||++|
T Consensus 218 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 218 PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp CSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 99988766555444322100 011336789999999999999999999999
Q ss_pred HhcCcccccC
Q 015814 223 ILEDEWFKKD 232 (400)
Q Consensus 223 il~h~~~~~~ 232 (400)
+++||||+.-
T Consensus 298 ll~hp~f~~~ 307 (311)
T 3niz_A 298 AMNHPYFKDL 307 (311)
T ss_dssp HHTSGGGTTS
T ss_pred HhcCcccccC
Confidence 9999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=346.47 Aligned_cols=216 Identities=31% Similarity=0.506 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....+.+|+.++++++||||+++++++.++..+|+||||+.| +|.+.+.. .+.+++..++.++.|++.||+|||++||
T Consensus 44 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 122 (292)
T 3o0g_A 44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122 (292)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 357788999999999999999999999999999999999987 55555544 6789999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+....+.++||||+||++|+|++|..
T Consensus 123 vH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~ 200 (292)
T 3o0g_A 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred ecCCCCHHHEEEcCCCCEEEeecccceecCC--ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999976542 22233456899999999999877655799999999999999998877
Q ss_pred C-CCCCchHHHHHhhhcCc-----------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 174 P-FDDSNLMNLYKKISAAE-----------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 174 P-f~~~~~~~~~~~i~~~~-----------------------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
| |.+.+.......+.... ....+.++.++++||++||+.||.+|||++|+
T Consensus 201 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 280 (292)
T 3o0g_A 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH
Confidence 7 55555555544432210 01123478899999999999999999999999
Q ss_pred hcCcccccCC
Q 015814 224 LEDEWFKKDY 233 (400)
Q Consensus 224 l~h~~~~~~~ 233 (400)
++||||+...
T Consensus 281 l~hp~f~~~~ 290 (292)
T 3o0g_A 281 LQHPYFSDFC 290 (292)
T ss_dssp HTSGGGTTC-
T ss_pred hcCcccccCC
Confidence 9999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=344.86 Aligned_cols=216 Identities=37% Similarity=0.712 Sum_probs=195.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.....+++|+.++++++||||+++++++.+....|+||||+++|+|.+.+...+++++..+..++.|++.||+|||++||
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 130 (279)
T 3fdn_A 51 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130 (279)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred hHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 33577999999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||+++.+|.+||+|||++..... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus 131 ~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~ 205 (279)
T 3fdn_A 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKP 205 (279)
T ss_dssp EECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSC
T ss_pred ecccCChHhEEEcCCCCEEEEeccccccCCc----ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999998854332 22345689999999999987666 589999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
||...+.......+.......|..++..+.+||.+||+.||.+|||+.|+++||||+....
T Consensus 206 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 206 PFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp TTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred CCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 9999998888888888888889999999999999999999999999999999999987554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=361.85 Aligned_cols=219 Identities=22% Similarity=0.365 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.+++|+.++++++||||+++++++.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++
T Consensus 68 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 147 (389)
T 3gni_B 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 147 (389)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 44688999999999999999999999999999999999999999999999876 6799999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeecccccccccccc-----CCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR-----DDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVI 164 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGii 164 (400)
||+||||||+|||++.+|.+||+|||++....... ........+||+.|+|||++.+ ..| +.++||||+||+
T Consensus 148 ~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~i 226 (389)
T 3gni_B 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGIT 226 (389)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHH
Confidence 99999999999999999999999999876432211 1122234589999999999987 345 589999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCcc----------------------------------------------CCCCCC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEF----------------------------------------------TCPPWL 198 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~----------------------------------------------~~~~~~ 198 (400)
+|+|++|+.||.+.+.......+..+.. ..+..+
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 9999999999987665544433221111 123457
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 199 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 199 s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
++++.+||++||+.||.+|||++|+++||||+...
T Consensus 307 s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 89999999999999999999999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=357.53 Aligned_cols=212 Identities=35% Similarity=0.677 Sum_probs=185.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+.+.+|+.+++.++||||+++++++.+...+|+||||++||+|.+.+... ..+++..+..++.|++.||+|||++
T Consensus 70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 149 (351)
T 3c0i_A 70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149 (351)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 467899999999999999999999999999999999999999999888543 2589999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCC---eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
||+||||||+|||++.++. +||+|||++...... .......+||+.|+|||++.+..| +.++||||+||++|+|
T Consensus 150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l 226 (351)
T 3c0i_A 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFIL 226 (351)
T ss_dssp TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHH
T ss_pred CceeccCChHHeEEecCCCCCcEEEecCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHH
Confidence 9999999999999987655 999999998765431 222345689999999999988777 5999999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
++|..||.+.. ...+..+..+.+..+ +.+|.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 227 l~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 227 LSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 99999998854 455555655555444 358999999999999999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=350.02 Aligned_cols=213 Identities=38% Similarity=0.713 Sum_probs=185.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++.+|+.++++++||||+++++++.+ ...+|+||||+++|+|.+.+. .+.+++..+..++.|++.||+|||++||
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 158 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKI 158 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 5778999999999999999999999986 678999999999999987653 4679999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC--CCChhhHHHHHHHHHHHHhC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DIwSlGiil~elltG 171 (400)
+||||||+|||++.+|.+||+|||++..... ........+||+.|+|||++.+... .+.++||||+||++|+|++|
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eccCCCHHHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999999999999999999999999876543 1223345689999999999976542 35789999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 172 YLPFDDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
..||.+.+.......+.......| +.++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 237 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 237 QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred CCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 999999888777777665554444 468999999999999999999999999999999963
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=366.84 Aligned_cols=214 Identities=35% Similarity=0.582 Sum_probs=189.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
+.+.+|+.+++.++||||+++++++.+...+|+||||++||+|.+++.. .++++..++.|+.|++.||+|||++||+||
T Consensus 114 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHr 192 (410)
T 3v8s_A 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHR 192 (410)
T ss_dssp STHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 3478999999999999999999999999999999999999999999976 579999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC---CCCChhhHHHHHHHHHHHHhCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DIwSlGiil~elltG~~ 173 (400)
||||+|||++.+|++||+|||+|....... .....+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|+.
T Consensus 193 DLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred cCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 999999999999999999999987543211 11234678999999999998655 23589999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCc--cCCC--CCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCcccccC
Q 015814 174 PFDDSNLMNLYKKISAAE--FTCP--PWLSFTARKLIARILDPNPMT--RITIPEILEDEWFKKD 232 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~li~~mL~~dP~~--R~t~~eil~h~~~~~~ 232 (400)
||.+.+....+.++.... ..+| ..+|.++++||++||..+|.+ |++++||++||||+..
T Consensus 272 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 272 PFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp TTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred CCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999988888876542 3444 469999999999999999988 9999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=353.49 Aligned_cols=216 Identities=38% Similarity=0.710 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.+. ||||+++++++.+....|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 49 ~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv 128 (325)
T 3kn6_A 49 EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128 (325)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Confidence 467789999999996 9999999999999999999999999999999999988999999999999999999999999999
Q ss_pred eccCCCCcEEEccCC---CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 95 HRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 95 HrDlKP~NILl~~~g---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
||||||+|||++.++ .+||+|||++..... ......+.+||+.|+|||++.+..|. .++||||+||++|+|++|
T Consensus 129 H~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g 205 (325)
T 3kn6_A 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSG 205 (325)
T ss_dssp CCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCC-HHHHHHHHHHHHHHHHHS
T ss_pred ecCCCHHHEEEecCCCcccEEEeccccceecCC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhC
Confidence 999999999998766 799999999975443 22334567899999999999887774 899999999999999999
Q ss_pred CCCCCCCc-------hHHHHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 172 YLPFDDSN-------LMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 172 ~~Pf~~~~-------~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
..||.+.+ ..+....+..+.+..+. .+|+++.+||.+||+.||.+|||++++++||||+....
T Consensus 206 ~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 206 QVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp SCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred CCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 99997643 34566777766665553 48999999999999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=345.14 Aligned_cols=214 Identities=31% Similarity=0.492 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++||||+++++++.+.+..|+||||+.+ +|.+.+... +.+++..++.++.|++.||+|||++||+
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 122 (288)
T 1ob3_A 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122 (288)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46788999999999999999999999999999999999986 899988764 6799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus 123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (288)
T 1ob3_A 123 HRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (288)
T ss_dssp CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCHHHEEEcCCCCEEEeECccccccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765421 22234568999999999997655456999999999999999999999
Q ss_pred CCCCchHHHHHhhhcC--cc---------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 175 FDDSNLMNLYKKISAA--EF---------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~--~~---------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|.+.+..+....+... .. .....++.++.+||.+||+.||.+|||++|+++
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 9987766554443211 00 012347899999999999999999999999999
Q ss_pred CcccccC
Q 015814 226 DEWFKKD 232 (400)
Q Consensus 226 h~~~~~~ 232 (400)
||||+..
T Consensus 281 hp~f~~~ 287 (288)
T 1ob3_A 281 HAYFKEN 287 (288)
T ss_dssp SGGGGC-
T ss_pred Ccchhhc
Confidence 9999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=348.86 Aligned_cols=216 Identities=30% Similarity=0.480 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~l~~LH 89 (400)
.+.+.+|+.++++++||||+++++++.+++..|+||||++| +|.+++... ..+++..++.++.|++.||.|||
T Consensus 47 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH 125 (317)
T 2pmi_A 47 PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125 (317)
T ss_dssp CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 36788999999999999999999999999999999999985 999988653 35899999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++||+||||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+....+.++||||+||++|+|+
T Consensus 126 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 203 (317)
T 2pmi_A 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203 (317)
T ss_dssp HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998765431 223345689999999999986554569999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCc----------------------------------cCCCCCCCHHHHHHHHHhcCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAE----------------------------------FTCPPWLSFTARKLIARILDPNPM 215 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~----------------------------------~~~~~~~s~~~~~li~~mL~~dP~ 215 (400)
+|+.||.+.+..+....+.... ...+..++.++.+||.+||+.||.
T Consensus 204 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 283 (317)
T 2pmi_A 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283 (317)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGG
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcc
Confidence 9999999888766655442210 011224788999999999999999
Q ss_pred CCCCHHHHhcCcccccCCC
Q 015814 216 TRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 216 ~R~t~~eil~h~~~~~~~~ 234 (400)
+|||++|+++||||+..+.
T Consensus 284 ~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 284 MRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GSCCHHHHTTSGGGGGGCC
T ss_pred cCCCHHHHhCChhhhcccc
Confidence 9999999999999997554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.16 Aligned_cols=206 Identities=20% Similarity=0.301 Sum_probs=160.4
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--- 91 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~--- 91 (400)
.++|+..+.+++|||||++++++...+ .+|||||||+||+|.+++.. .+++++.+..++.|++.||+|||++
T Consensus 44 ~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~ 122 (303)
T 3hmm_A 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 345777778899999999999987653 68999999999999999976 5699999999999999999999987
Q ss_pred -----CCeeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCC-----CCChhhHH
Q 015814 92 -----GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLW 159 (400)
Q Consensus 92 -----givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DIw 159 (400)
||+||||||+|||++.+|++||+|||+|+....... .....+.+||+.|||||++.+... .+.++|||
T Consensus 123 ~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVw 202 (303)
T 3hmm_A 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202 (303)
T ss_dssp TTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred ccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhh
Confidence 999999999999999999999999999986543221 112345689999999999975421 24689999
Q ss_pred HHHHHHHHHHhCCCCCCCC---------------chHHHHHhhhcCc--cCCCCC-----CCHHHHHHHHHhcCCCCCCC
Q 015814 160 SCGVILFVLLAGYLPFDDS---------------NLMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 160 SlGiil~elltG~~Pf~~~---------------~~~~~~~~i~~~~--~~~~~~-----~s~~~~~li~~mL~~dP~~R 217 (400)
||||++|||+||..||... ........+.... +..|.. .+..+.+|+.+||+.||.+|
T Consensus 203 S~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~R 282 (303)
T 3hmm_A 203 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282 (303)
T ss_dssp HHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGS
T ss_pred hHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHC
Confidence 9999999999997765321 1223333333222 233322 23467899999999999999
Q ss_pred CCHHHHhc
Q 015814 218 ITIPEILE 225 (400)
Q Consensus 218 ~t~~eil~ 225 (400)
||+.||++
T Consensus 283 Pt~~ei~~ 290 (303)
T 3hmm_A 283 LTALRIKK 290 (303)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=340.18 Aligned_cols=213 Identities=42% Similarity=0.759 Sum_probs=193.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++.+....|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+|
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 129 (277)
T 3f3z_A 50 VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAH 129 (277)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 57789999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEE---ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl---~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+||++ +.++.+||+|||++..... .......+||+.|+|||++.+. .+.++||||+||++|+|++|.
T Consensus 130 ~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~ 204 (277)
T 3f3z_A 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGY 204 (277)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSS
T ss_pred CCCCHHHEEEecCCCCCcEEEEecccceeccC---ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCC
Confidence 9999999999 7789999999999876442 2334566899999999998753 468999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||...+..+....+..+....|. .+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 205 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 205 PPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 999998888888888777766664 5899999999999999999999999999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=356.00 Aligned_cols=211 Identities=35% Similarity=0.688 Sum_probs=186.0
Q ss_pred HHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecc
Q 015814 19 IKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 97 (400)
Q Consensus 19 i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrD 97 (400)
..+|++++.++ +||||+++++++.+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+|||
T Consensus 62 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrD 141 (342)
T 2qr7_A 62 PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141 (342)
T ss_dssp CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Confidence 45789999888 79999999999999999999999999999999999988999999999999999999999999999999
Q ss_pred CCCCcEEEccC-C---CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 98 LKPENLLLDAY-G---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 98 lKP~NILl~~~-g---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
|||+|||+... + .+||+|||++..... ......+.+||+.|+|||++.+.+|. .++||||+||++|+|++|..
T Consensus 142 lkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~ 218 (342)
T 2qr7_A 142 LKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYT 218 (342)
T ss_dssp CCGGGEEESSSSCSGGGEEECCCTTCEECBC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEEecCCCCcCeEEEEECCCcccCcC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCC
Confidence 99999998543 3 499999999876543 22344567999999999999877674 89999999999999999999
Q ss_pred CCCC---CchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 174 PFDD---SNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 174 Pf~~---~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
||.+ .+..++...+..+.+..+ +.+|.++.+||++||..||.+|||+.++++||||...
T Consensus 219 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 219 PFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp SSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 9986 345667777777766544 4589999999999999999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=366.75 Aligned_cols=214 Identities=27% Similarity=0.501 Sum_probs=188.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+++|+.+++.++||||+++++++.+...+|+||||++||+|.+++.. .+.+++..++.|+.|++.||+|||++||+|
T Consensus 119 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiH 198 (437)
T 4aw2_A 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198 (437)
T ss_dssp CCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence 3488999999999999999999999999999999999999999999987 568999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----CCCCCChhhHHHHHHHHHHHHhC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGiil~elltG 171 (400)
|||||+|||++.+|.+||+|||+|....... .......+||+.|+|||++.. ....+.++||||+||++|||++|
T Consensus 199 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG 277 (437)
T 4aw2_A 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277 (437)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS
T ss_pred cccCHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC
Confidence 9999999999999999999999987543211 112234689999999999972 23336899999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcC--ccCCCC---CCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 015814 172 YLPFDDSNLMNLYKKISAA--EFTCPP---WLSFTARKLIARILDPNPMT--RITIPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~--~~~~~~---~~s~~~~~li~~mL~~dP~~--R~t~~eil~h~~~~~ 231 (400)
+.||.+.+..+.+.++... .+.+|. .+|+++++||++||..+|.+ |++++|+++||||+.
T Consensus 278 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 278 ETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 9999999988888887543 344554 38999999999999998888 999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.77 Aligned_cols=213 Identities=34% Similarity=0.738 Sum_probs=196.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..++.+|+.++++++||||+++++++.+....|+||||+++|+|.+.+...+.+++..+..++.|++.||.|||++||+|
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 137 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH 137 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 56789999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.+|.+||+|||++...... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||
T Consensus 138 ~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf 212 (284)
T 2vgo_A 138 RDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPF 212 (284)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCC
Confidence 999999999999999999999998654321 2245679999999999987766 48999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
...+.......+.......|+.++.++.+||.+||..||.+|||++++++||||+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 213 DSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp CCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 9988888888888788888899999999999999999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=339.71 Aligned_cols=219 Identities=34% Similarity=0.588 Sum_probs=199.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+++.++||||+++++++.+.+..|+||||++|++|.+.+...+.+++..+..++.|++.||+|||++||+
T Consensus 58 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 137 (294)
T 2rku_A 58 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 137 (294)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 36788999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.+|.+||+|||++...... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus 138 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p 214 (294)
T 2rku_A 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPP 214 (294)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCChHhEEEcCCCCEEEEeccCceecccC--ccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765422 122344679999999999987666 5899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
|...+..+.+..+.......|..++..+.++|.+||+.||.+|||++++++||||.....+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 215 FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp TCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred CCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 99988888888888788888889999999999999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=359.47 Aligned_cols=217 Identities=29% Similarity=0.415 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHHhCC-CCCcceeeEEEEeCC--EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 15 ILLQIKREVATMKLVK-HPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...++.+|+.+++.+. ||||+++++++...+ .+|+||||+.| +|.+.+.. +.+++..++.++.|++.||+|||++
T Consensus 51 ~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~ 128 (388)
T 3oz6_A 51 DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG 128 (388)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3577889999999997 999999999997544 79999999985 89888876 5799999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeecccccccccccc-------------------CCCccccccCCCCCCCChhhhcCCCC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR-------------------DDGLLHTTCGTPNYVAPEVLNDRGYD 152 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~APEvl~~~~~~ 152 (400)
||+||||||+|||++.+|.+||+|||+|+...... ........+||++|+|||++.+....
T Consensus 129 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (388)
T 3oz6_A 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY 208 (388)
T ss_dssp TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCC
T ss_pred CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCC
Confidence 99999999999999999999999999997643210 11223456899999999999875545
Q ss_pred CChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCcc----------------------------------------
Q 015814 153 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------------------------------------- 192 (400)
Q Consensus 153 ~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------------------- 192 (400)
+.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 209 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (388)
T 3oz6_A 209 TKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW 288 (388)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHH
T ss_pred CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcch
Confidence 6999999999999999999999999887766655432100
Q ss_pred -------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 193 -------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 193 -------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
..+..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 289 ~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 289 KNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred hhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 01225788999999999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=347.62 Aligned_cols=219 Identities=34% Similarity=0.588 Sum_probs=200.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+++.++||||+++++++.+.+..|+||||+.|++|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 84 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 163 (335)
T 2owb_A 84 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 163 (335)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCE
Confidence 36788999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.++.+||+|||++...... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.|
T Consensus 164 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p 240 (335)
T 2owb_A 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPP 240 (335)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCchhEEEcCCCCEEEeeccCceecccC--cccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCC
Confidence 9999999999999999999999998765422 222345679999999999987766 5899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
|...+..+.+..+.......|..++..+.+||.+||+.||.+|||++++++||||.....+.
T Consensus 241 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 241 FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp TCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred CCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 99988888888888888888889999999999999999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=381.40 Aligned_cols=213 Identities=30% Similarity=0.560 Sum_probs=198.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+..|..++..+ +||||+++++++.+...+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+
T Consensus 385 ~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIi 464 (674)
T 3pfq_A 385 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 464 (674)
T ss_dssp THHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEE
T ss_pred HHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 56788999999988 79999999999999999999999999999999999988999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|++||+|||+|+.... ......+.+||+.|+|||++.+.+| +.++|||||||++|||++|+.|
T Consensus 465 HrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~P 541 (674)
T 3pfq_A 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAP 541 (674)
T ss_dssp CCCCCSTTEEECSSSCEEECCCTTCEECCC--TTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCChhhEEEcCCCcEEEeecceeecccc--CCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCC
Confidence 999999999999999999999999875322 2233556799999999999988877 5999999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-----PEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~-----~eil~h~~~~~ 231 (400)
|.+.+..+++..+......+|..+|.++.+||++||+.||.+||++ ++|++||||+.
T Consensus 542 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 542 FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp SCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999999999999999999999999999999999999998 99999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=337.88 Aligned_cols=214 Identities=38% Similarity=0.732 Sum_probs=192.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++...+..|+||||++||+|.+.+...+.+++..+..++.|++.||+|||++||+|
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 128 (284)
T 3kk8_A 49 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128 (284)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCc
Confidence 57889999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCC---eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g~---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+||+++.++. +||+|||++..... ........||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 129 ~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~ 204 (284)
T 3kk8_A 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGY 204 (284)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCCTTCEECCS---SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCHHHEEEecCCCCCcEEEeeceeeEEccc---CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCC
Confidence 999999999987665 99999999875443 223345689999999999988776 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||.+.+.......+..+....| ..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 205 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred CCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999888888887776665444 34799999999999999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=339.06 Aligned_cols=219 Identities=40% Similarity=0.705 Sum_probs=190.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+++|+.+++.++||||+++++++.+....|+||||++||+|.+++.....+++..+..++.|++.||+|||++|++|
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 128 (276)
T 2yex_A 49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128 (276)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 57899999999999999999999999999999999999999999999988788999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.+|.+||+|||++...............+||+.|+|||++.+..+.+.++||||+||++|+|++|..||
T Consensus 129 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 208 (276)
T 2yex_A 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208 (276)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999876544333333456789999999999988777668899999999999999999999
Q ss_pred CCCchH-HHHHhhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 176 DDSNLM-NLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 176 ~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
...+.. ..+..+.......+ ..++..+.+||.+||+.||.+|||++++++||||+....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp SCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 876543 23333333322222 358999999999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=357.71 Aligned_cols=215 Identities=29% Similarity=0.606 Sum_probs=190.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+++|+.+|+.++||||+++++++.+...+|+||||+.||+|.+++...+ .+++..+..++.|++.||+|||++||+
T Consensus 92 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv 171 (387)
T 1kob_A 92 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171 (387)
T ss_dssp HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3578899999999999999999999999999999999999999999997654 799999999999999999999999999
Q ss_pred eccCCCCcEEEcc--CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl~~--~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||||+|||++. .+.+||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 172 HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~ 247 (387)
T 1kob_A 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGL 247 (387)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCT---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSC
T ss_pred ecccchHHeEEecCCCCceEEEecccceecCC---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCC
Confidence 9999999999974 47799999999876532 233455689999999999987766 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.||.+.+.......+......++ ..+|.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 248 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 248 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999888777777766554433 357999999999999999999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=367.46 Aligned_cols=214 Identities=37% Similarity=0.690 Sum_probs=194.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+|++++||||+++++++.+...+|+|||||+||+|.+.+...+.+++..+..++.|++.||+|||++||+|
T Consensus 90 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 169 (504)
T 3q5i_A 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVH 169 (504)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 57899999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCC---CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~g---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++.++ .+||+|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.
T Consensus 170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~ 244 (504)
T 3q5i_A 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGY 244 (504)
T ss_dssp SCCSGGGEEESSTTCCSSEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSS
T ss_pred CCCcHHHEEEecCCCCccEEEEECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCC
Confidence 99999999999876 699999999976543 233456789999999999874 45 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.||.+.+..+....+..+.+.++ +.+|.++++||++||+.||.+|||++|+++||||+....
T Consensus 245 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 245 PPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 99999999999888888776655 458999999999999999999999999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=345.03 Aligned_cols=212 Identities=34% Similarity=0.611 Sum_probs=192.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++.+....|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+|
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH 138 (321)
T 2a2a_A 59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (321)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 46789999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCC----CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 96 RDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 96 rDlKP~NILl~~~g----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|||||+||+++.++ .+||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus 139 ~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g 214 (321)
T 2a2a_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSG 214 (321)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCTTCEECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred CCCChHHEEEecCCCCcCCEEEccCccceecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHC
Confidence 99999999999988 799999999876543 222345679999999999987776 5899999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 172 YLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
..||.+.+..+....+.......+ ..++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 215 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 215 ASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp CCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred CCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 999999888888877776665554 458999999999999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=344.39 Aligned_cols=217 Identities=27% Similarity=0.453 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+.+...+.+++..+..++.|++.||+|||++||
T Consensus 44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~i 123 (311)
T 4agu_A 44 VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 34577889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||+++.+|.+||+|||++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|..
T Consensus 124 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 201 (311)
T 4agu_A 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201 (311)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCChhhEEEcCCCCEEEeeCCCchhccCc--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765432 2233456899999999999875555699999999999999999999
Q ss_pred CCCCCchHHHHHhhhcC---------------------ccCCC----------CCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 174 PFDDSNLMNLYKKISAA---------------------EFTCP----------PWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~---------------------~~~~~----------~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
||.+.+..+....+... ..+.+ +.++.++.+||.+||+.||.+|||++|
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 281 (311)
T 4agu_A 202 LWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281 (311)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence 99987765544332211 01111 347889999999999999999999999
Q ss_pred HhcCcccccC
Q 015814 223 ILEDEWFKKD 232 (400)
Q Consensus 223 il~h~~~~~~ 232 (400)
+++||||+.-
T Consensus 282 ll~hp~f~~~ 291 (311)
T 4agu_A 282 LLHHPYFENI 291 (311)
T ss_dssp HHTSGGGTTC
T ss_pred HhcChHHHhc
Confidence 9999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=368.42 Aligned_cols=213 Identities=38% Similarity=0.685 Sum_probs=193.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++.+...+|+||||+.||+|.+.+...+.+++..+..++.|++.||.|||++||+|
T Consensus 70 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 149 (484)
T 3nyv_A 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 149 (484)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 57889999999999999999999999999999999999999999999999899999999999999999999999999999
Q ss_pred ccCCCCcEEE---ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl---~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||+ +.++.+||+|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.
T Consensus 150 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~ 224 (484)
T 3nyv_A 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGC 224 (484)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCTTHHHHBCC---CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCHHHEEEecCCCCCcEEEEeeeeeEEccc---ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCC
Confidence 9999999999 4678999999999876543 334556789999999999976 45 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC--C--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP--P--WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||.+.+..+....+..+.+.++ . .+|+++++||++||+.||.+|||+.++++||||+...
T Consensus 225 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 225 PPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 99999998888888877765443 2 3899999999999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=367.15 Aligned_cols=211 Identities=38% Similarity=0.700 Sum_probs=190.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+++.++||||+++++++.+...+|+|||||+||+|++.+....++++..+..++.|++.||.|||++||+|
T Consensus 80 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 159 (494)
T 3lij_A 80 NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159 (494)
T ss_dssp THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 46788999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccC---CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAY---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~---g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++.. +.+||+|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.
T Consensus 160 ~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~ 234 (494)
T 3lij_A 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGY 234 (494)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEECBT---TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSS
T ss_pred ccCChhhEEEeCCCCCCcEEEEECCCCeECCC---CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCC
Confidence 9999999999764 4599999999976543 223456789999999999864 45 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.||.+.+..+....+..+.+.++ ..+|+.+++||++||+.||.+|||+.++++||||+.
T Consensus 235 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 235 PPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999999888888877766543 248999999999999999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=366.26 Aligned_cols=214 Identities=38% Similarity=0.695 Sum_probs=190.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+|++++||||+++++++.+...+|+||||+.||+|.+.+...+.+++..+..++.|++.||.|||++||+|
T Consensus 65 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 144 (486)
T 3mwu_A 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144 (486)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 46789999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++. ++.+||+|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.
T Consensus 145 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~ 219 (486)
T 3mwu_A 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGT 219 (486)
T ss_dssp SCCSGGGEEESSSSTTCCEEECSCSCTTTBCC---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSS
T ss_pred ccCchHHEEEecCCCCCCEEEEECCcCeECCC---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCC
Confidence 999999999954 56799999999976543 223456789999999999975 45 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC--C--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP--P--WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.||.+.+..+....+..+.+.++ . .+|+++++||++||+.||.+|||+.++++||||+....
T Consensus 220 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 220 PPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999998888888877765433 2 38999999999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=368.81 Aligned_cols=213 Identities=27% Similarity=0.429 Sum_probs=191.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.+|+.+|++++||||+++++++.+...+|+||||++||+|.+++... ..+++..++.|+.||+.||+|||++
T Consensus 229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~ 308 (543)
T 3c4z_A 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308 (543)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc
Confidence 567889999999999999999999999999999999999999999999764 3699999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
||+||||||+|||++.+|++||+|||++...... .....+.+||+.|+|||++.+.+|. .++|||||||++|+|++|
T Consensus 309 gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG 385 (543)
T 3c4z_A 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAA 385 (543)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHS
T ss_pred CCcccCCChHHEEEeCCCCEEEeecceeeeccCC--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhC
Confidence 9999999999999999999999999999764431 2223456999999999999987774 999999999999999999
Q ss_pred CCCCCCC----chHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 172 YLPFDDS----NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
+.||.+. ....++..+......+|+.+|.++.+||++||+.||.+||+ +++|++||||+.
T Consensus 386 ~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 386 RGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp SCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999875 34567777777778888999999999999999999999996 489999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=372.34 Aligned_cols=212 Identities=28% Similarity=0.461 Sum_probs=191.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+|+.+|+.++||||+++++++.+...+|+||||++||+|.+++...+. +++..++.|+.||+.||+|||++||
T Consensus 228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI 307 (576)
T 2acx_A 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307 (576)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 46688999999999999999999999999999999999999999999987554 9999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|++||+|||+|..... .....+.+||+.|+|||++.+..|. .++||||+||++|+|++|+.
T Consensus 308 vHrDLKPeNILld~~g~vKL~DFGla~~~~~---~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~ 383 (576)
T 2acx_A 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQS 383 (576)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCT---TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCchheEEEeCCCCeEEEecccceeccc---CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999976432 2334567999999999999887774 99999999999999999999
Q ss_pred CCCCCc----hHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 174 PFDDSN----LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
||.+.+ ...+...+......+|..+|.++++||++||+.||.+|| |++|+++||||+.
T Consensus 384 PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 384 PFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp SSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred CCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 998753 355666677677778888999999999999999999999 7999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=350.22 Aligned_cols=215 Identities=27% Similarity=0.411 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
....+.+|+.++++++||||+++++++.+...+|+||||+.| +|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~iv 154 (329)
T 3gbz_A 76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCL 154 (329)
T ss_dssp ----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred cchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 356778999999999999999999999999999999999985 9999999988999999999999999999999999999
Q ss_pred eccCCCCcEEEcc-----CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 95 HRDLKPENLLLDA-----YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 95 HrDlKP~NILl~~-----~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
||||||+|||++. ++.+||+|||++...... .......+||+.|+|||++.+....+.++|||||||++|+|+
T Consensus 155 H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 232 (329)
T 3gbz_A 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232 (329)
T ss_dssp CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHEEEecCCCCccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999954 455999999999765432 223345688999999999987665569999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCcc--C---------CCC-------------------CCCHHHHHHHHHhcCCCCCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEF--T---------CPP-------------------WLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~--~---------~~~-------------------~~s~~~~~li~~mL~~dP~~R~t 219 (400)
+|..||.+.+..+....+..... . .+. .++.++.+||.+||+.||.+|||
T Consensus 233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 99999998877666555432110 0 011 16789999999999999999999
Q ss_pred HHHHhcCcccccC
Q 015814 220 IPEILEDEWFKKD 232 (400)
Q Consensus 220 ~~eil~h~~~~~~ 232 (400)
++|+++||||+..
T Consensus 313 ~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 313 AKNALEHPYFSHN 325 (329)
T ss_dssp HHHHHTSGGGSSS
T ss_pred HHHHhCCcccCCC
Confidence 9999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=355.62 Aligned_cols=212 Identities=32% Similarity=0.561 Sum_probs=188.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+++|+.+|++++||||+++++++.+....|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+
T Consensus 130 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 209 (373)
T 2x4f_A 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209 (373)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 578899999999999999999999999999999999999999999998764 4699999999999999999999999999
Q ss_pred eccCCCCcEEE--ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl--~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||||+|||+ +.++.+||+|||++..... .......+||+.|+|||++....+ +.++|||||||++|+|++|.
T Consensus 210 H~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~ 285 (373)
T 2x4f_A 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGL 285 (373)
T ss_dssp CCCCCGGGEEEEETTTTEEEECCCSSCEECCT---TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSS
T ss_pred cccCCHHHEEEecCCCCcEEEEeCCCceecCC---ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCC
Confidence 99999999999 4567899999999876543 223345679999999999987655 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.||.+.+..+....+.......+ +.+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 286 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 286 SPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred CCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999888877777766554443 358999999999999999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=360.38 Aligned_cols=213 Identities=27% Similarity=0.496 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+++|+.++..++||||+++++++.+...+|+||||++||+|.+++...+ .+++..++.|+.|++.||+|||++||+
T Consensus 105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gii 184 (412)
T 2vd5_A 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184 (412)
T ss_dssp GCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4568899999999999999999999999999999999999999999998754 799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-------CCCCCChhhHHHHHHHHHH
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-------RGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-------~~~~~~~~DIwSlGiil~e 167 (400)
||||||+|||++.+|++||+|||++....... .......+||+.|+|||++.. ..| +.++||||+||++||
T Consensus 185 HrDLKp~NILld~~g~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilye 262 (412)
T 2vd5_A 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYE 262 (412)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHH
T ss_pred ecccCHHHeeecCCCCEEEeechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHH
Confidence 99999999999999999999999987643311 111234689999999999973 334 589999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCc--cCCC---CCCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCccccc
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKK 231 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~~~~li~~mL~~dP~~R---~t~~eil~h~~~~~ 231 (400)
|++|+.||.+.+..+.+.++.... ...| ..+|.++++||++||. +|.+| ++++++++||||+.
T Consensus 263 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 263 MFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999888888776432 3333 5699999999999999 99998 59999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=343.67 Aligned_cols=216 Identities=32% Similarity=0.593 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++++ +||||+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 54 ~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 133 (316)
T 2ac3_A 54 RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133 (316)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 46788999999985 79999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCC---eeeeccccccccccccC-----CCccccccCCCCCCCChhhhc-----CCCCCChhhHHHH
Q 015814 95 HRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSC 161 (400)
Q Consensus 95 HrDlKP~NILl~~~g~---~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSl 161 (400)
||||||+|||++.++. +||+|||++........ .......+||+.|+|||++.. ..+ +.++||||+
T Consensus 134 H~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~Diwsl 212 (316)
T 2ac3_A 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSL 212 (316)
T ss_dssp CCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHH
T ss_pred eCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhH
Confidence 9999999999998776 99999999875432211 112335679999999999975 334 488999999
Q ss_pred HHHHHHHHhCCCCCCCCch---------------HHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 162 GVILFVLLAGYLPFDDSNL---------------MNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~~---------------~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
||++|+|++|+.||.+.+. ...+..+..+...+| ..++.++.+||++||+.||.+|||++|
T Consensus 213 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 213 GVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp HHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 9999999999999987542 335556666666655 358999999999999999999999999
Q ss_pred HhcCcccccC
Q 015814 223 ILEDEWFKKD 232 (400)
Q Consensus 223 il~h~~~~~~ 232 (400)
+++||||+..
T Consensus 293 ~l~hp~~~~~ 302 (316)
T 2ac3_A 293 VLQHPWVQGC 302 (316)
T ss_dssp HHHSTTCC--
T ss_pred HhcChhhcCC
Confidence 9999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=339.21 Aligned_cols=216 Identities=33% Similarity=0.649 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.++++++||||+++++++.+....|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 133 (278)
T 3cok_A 54 MVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI 133 (278)
T ss_dssp CHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3578999999999999999999999999999999999999999999999875 579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||+++.++.+||+|||++....... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus 134 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~ 210 (278)
T 3cok_A 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRP 210 (278)
T ss_dssp ECSSCCGGGEEECTTCCEEECCCTTCEECC-------------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred ecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654321 22335679999999999987666 589999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
||...+.......+.......|..++.++.+||.+||+.||.+|||++++++||||....
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 211 PFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred CCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 999887777766666666777888999999999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=358.18 Aligned_cols=214 Identities=36% Similarity=0.665 Sum_probs=176.1
Q ss_pred HHHHHHHHHHH-hCCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMK-LVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 17 ~~i~~Ei~il~-~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+++|+.++. ..+||||+++++++.. ...+|+||||++||+|.+++...+ .+++..++.++.|++.||.|||
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH 178 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45778999975 4589999999999876 667999999999999999998754 5999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
++||+||||||+|||++. ++.+||+|||++..... .....+.+||+.|+|||++.+..|. .++|||||||++|
T Consensus 179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ 254 (400)
T 1nxk_A 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMY 254 (400)
T ss_dssp HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHH
T ss_pred HCCccccCcCcceEEEecCCCCccEEEEecccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHH
Confidence 999999999999999998 78999999999875432 2334567899999999999877774 8999999999999
Q ss_pred HHHhCCCCCCCCchH----HHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 167 VLLAGYLPFDDSNLM----NLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 167 elltG~~Pf~~~~~~----~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
+|++|..||.+.+.. .....+..+.+.+| ..+|.++.+||++||+.||.+|||+.++++||||.....
T Consensus 255 ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 255 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp HHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred HHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 999999999775532 24445555555444 348999999999999999999999999999999987544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.03 Aligned_cols=211 Identities=35% Similarity=0.647 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+++.+|+.++++++||||+++++++.+....|+||||++||+|.+.+.. ...+++..+..++.|++.||+|||++
T Consensus 64 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 143 (285)
T 3is5_A 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143 (285)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 47889999999999999999999999999999999999999999998854 36799999999999999999999999
Q ss_pred CCeeccCCCCcEEE---ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 92 GVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 92 givHrDlKP~NILl---~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
||+||||||+||++ +.++.+||+|||++..... .......+||+.|+|||++.+ .+ +.++||||+||++|+|
T Consensus 144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~l 218 (285)
T 3is5_A 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFL 218 (285)
T ss_dssp TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHH
T ss_pred CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHH
Confidence 99999999999999 4467899999999976543 222345689999999999863 45 5899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCccCCC---CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEFTCP---PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
++|..||.+.+.......+.......+ ..+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 219 LTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999888777766554443332 237899999999999999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=340.01 Aligned_cols=212 Identities=29% Similarity=0.456 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHhCC---CCCcceeeEEEEeCC-----EEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVK---HPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVD 86 (400)
Q Consensus 17 ~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~-----~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~ 86 (400)
..+.+|+.++++++ ||||+++++++.... .+++||||+.| +|.+++..... +++..++.++.|++.||+
T Consensus 56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 134 (308)
T 3g33_A 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134 (308)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence 45677888877775 999999999998755 58999999975 99999987654 999999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
|||++||+||||||+|||++.++.+||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|
T Consensus 135 ~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ 210 (308)
T 3g33_A 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFA 210 (308)
T ss_dssp HHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHH
T ss_pred HHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHH
Confidence 99999999999999999999999999999999876532 333456789999999999988777 48999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHhhhcCccC---------------------------CCCCCCHHHHHHHHHhcCCCCCCCCC
Q 015814 167 VLLAGYLPFDDSNLMNLYKKISAAEFT---------------------------CPPWLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~s~~~~~li~~mL~~dP~~R~t 219 (400)
+|++|+.||.+.+.......+...... ..+.++.++.+||.+||+.||.+|||
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 290 (308)
T 3g33_A 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290 (308)
T ss_dssp HTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC
Confidence 999999999998877666554321100 11347889999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 015814 220 IPEILEDEWFKKDY 233 (400)
Q Consensus 220 ~~eil~h~~~~~~~ 233 (400)
+.|+++||||++..
T Consensus 291 ~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 291 AFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHHTSTTC----
T ss_pred HHHHhcCccccCCC
Confidence 99999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=363.69 Aligned_cols=218 Identities=29% Similarity=0.365 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe-----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS-----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+++.+|+.+|++++||||+++++++.. ...+|+||||+. |+|.+.+...+.+++..++.++.||+.||+|||
T Consensus 95 ~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 173 (458)
T 3rp9_A 95 DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173 (458)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 35789999999999999999999999843 357999999985 699999998888999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccC-------------------------CCccccccCCCCCCCCh
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-------------------------DGLLHTTCGTPNYVAPE 144 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~y~APE 144 (400)
++||+||||||+|||++.+|.+||+|||+|+....... .......+||++|+|||
T Consensus 174 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 253 (458)
T 3rp9_A 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253 (458)
T ss_dssp HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred hCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence 99999999999999999999999999999976542211 11345568999999999
Q ss_pred hhhcCCCCCChhhHHHHHHHHHHHHh-----------CCCCCCCCch--------------------HHHHHhhhcC---
Q 015814 145 VLNDRGYDGSTADLWSCGVILFVLLA-----------GYLPFDDSNL--------------------MNLYKKISAA--- 190 (400)
Q Consensus 145 vl~~~~~~~~~~DIwSlGiil~ellt-----------G~~Pf~~~~~--------------------~~~~~~i~~~--- 190 (400)
++......+.++|||||||++|||++ |++||.+.+. .+....+...
T Consensus 254 ~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~ 333 (458)
T 3rp9_A 254 LILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333 (458)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCC
T ss_pred HhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCC
Confidence 87554444699999999999999998 7777766441 1111111000
Q ss_pred ----------------------------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 191 ----------------------------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 191 ----------------------------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.....+..+.++.+||++||..||.+|||++|+|+||||+...
T Consensus 334 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 334 PSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 0011234689999999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.39 Aligned_cols=214 Identities=27% Similarity=0.486 Sum_probs=187.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++......|+||||++||+|.+++.. .++++..+..++.|++.||+|||++||+|
T Consensus 86 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 164 (321)
T 2c30_A 86 RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIH 164 (321)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 46788999999999999999999999999999999999999999998865 57999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||
T Consensus 165 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCCHHHEEECCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998765432 122345689999999999987766 48999999999999999999999
Q ss_pred CCCchHHHHHhhhcCcc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.+.+.......+..... ..+..++..+.+||.+||+.||.+|||+.++++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 242 FSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp TTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred CCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 98887776666554432 22334789999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=350.11 Aligned_cols=214 Identities=38% Similarity=0.715 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+++|+.++++++||||+++++++.+....|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+|
T Consensus 92 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 171 (349)
T 2w4o_A 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171 (349)
T ss_dssp -------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 46788999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||++. ++.+||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 172 ~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~ 247 (349)
T 2w4o_A 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGF 247 (349)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCcccEEEecCCCCCCEEEccCccccccCc---ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCC
Confidence 999999999975 88999999999876543 223345789999999999987776 58999999999999999999
Q ss_pred CCCCCCchH-HHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 173 LPFDDSNLM-NLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 173 ~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||.+.... ..+..+.......+ +.++.++.+||++||..||.+|||+.++++||||+...
T Consensus 248 ~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 248 EPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp CTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred CCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999776544 35566655544332 34799999999999999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=366.28 Aligned_cols=214 Identities=26% Similarity=0.462 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
...+++.+|+.+|+.++||||+++++++... ..+|+||||+.+ +|.+.+.. .+++..++.++.|++.||+|
T Consensus 103 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~ 179 (464)
T 3ttj_A 103 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKH 179 (464)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999999654 468999999987 57777743 59999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+|||++.+|.+||+|||+|+.... .......+||+.|+|||++.+.+|. .++||||+||++|+
T Consensus 180 lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~e 255 (464)
T 3ttj_A 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGE 255 (464)
T ss_dssp HHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHH
T ss_pred HHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999976542 3345667899999999999988775 89999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCccC---------------------------C----CCC-----------CCHHHHHH
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAEFT---------------------------C----PPW-----------LSFTARKL 205 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~----~~~-----------~s~~~~~l 205 (400)
|++|+.||.+.+..+.+.++...... + |.. .++++.+|
T Consensus 256 ll~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 335 (464)
T 3ttj_A 256 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 335 (464)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHH
Confidence 99999999998877666654321110 0 000 15679999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 206 IARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 206 i~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|.+||+.||.+|||++|+|+||||+....
T Consensus 336 l~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 336 LSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999997553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=346.56 Aligned_cols=207 Identities=31% Similarity=0.536 Sum_probs=185.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+.+|+.++++++||||+++++++.+.+.+|+||||+.+| +|.+++...+.+++..+..++.|++.||+|||++||+|
T Consensus 74 ~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 153 (335)
T 3dls_A 74 GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIH 153 (335)
T ss_dssp EEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEE
Confidence 45678999999999999999999999999999999999776 99999999889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.++.+||+|||++..... .....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||
T Consensus 154 ~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 230 (335)
T 3dls_A 154 RDIKDENIVIAEDFTIKLIDFGSAAYLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230 (335)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eccCHHHEEEcCCCcEEEeecccceECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCch
Confidence 99999999999999999999999876543 233456789999999999998887778999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 176 DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.... .........|..++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 231 ~~~~------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 231 CELE------ETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp SSGG------GGTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred hhHH------HHHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 7632 12233445566789999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=346.09 Aligned_cols=215 Identities=35% Similarity=0.638 Sum_probs=190.7
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.+++++ +||||+++++++...+..|+||||++||+|.+++.....+++..+..++.|++.||.|||+.|
T Consensus 141 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g 220 (365)
T 2y7j_A 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220 (365)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3467789999999999 899999999999999999999999999999999998888999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC-----CCCCChhhHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFV 167 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DIwSlGiil~e 167 (400)
|+||||||+|||++.+|.+||+|||++..... .......+||+.|+|||++.+. ...+.++|||||||++|+
T Consensus 221 i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 297 (365)
T 2y7j_A 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297 (365)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEECCCCCEEEEecCcccccCC---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHH
Confidence 99999999999999999999999999875442 2234567899999999998642 223588999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|++|..||.+.+.......+..+.+..+ ..++..+.+||.+||+.||.+|||+.++++||||++
T Consensus 298 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 298 LLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 9999999998887777777766655443 357899999999999999999999999999999973
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=344.80 Aligned_cols=219 Identities=28% Similarity=0.410 Sum_probs=183.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEe--------CCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGS--------KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~--------~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~ 87 (400)
..+.+|+.+++.++||||+++++++.. .+.+|+||||+.| +|.+.+... ..+++..++.++.|++.||+|
T Consensus 61 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~ 139 (351)
T 3mi9_A 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139 (351)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999999877 4578999999986 777777654 579999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeecccccccccccc--CCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
||++||+||||||+|||++.+|.+||+|||++....... ........+||+.|+|||++.+....+.++||||+||++
T Consensus 140 LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 219 (351)
T 3mi9_A 140 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219 (351)
T ss_dssp HHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHH
T ss_pred HHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHH
Confidence 999999999999999999999999999999997654322 122335568999999999998755556999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHhhhcCccCCCCC--------------------------------CCHHHHHHHHHhcCCC
Q 015814 166 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--------------------------------LSFTARKLIARILDPN 213 (400)
Q Consensus 166 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------~s~~~~~li~~mL~~d 213 (400)
|+|++|..||.+.+.......+.......++. .++++.+||.+||+.|
T Consensus 220 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 299 (351)
T 3mi9_A 220 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 299 (351)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCC
Confidence 99999999999988776666554322222111 2677999999999999
Q ss_pred CCCCCCHHHHhcCcccccCCCCC
Q 015814 214 PMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 214 P~~R~t~~eil~h~~~~~~~~~~ 236 (400)
|.+|||++|+++||||+....+.
T Consensus 300 P~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 300 PAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp GGGSCCHHHHHTSGGGGSSSCCC
T ss_pred hhhCCCHHHHhCCCCcCCCCCcc
Confidence 99999999999999998765443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=350.00 Aligned_cols=213 Identities=28% Similarity=0.420 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
...+++.+|+.+|+.++||||+++++++... ..+|+||||+ |++|.+.+.. +.+++..++.++.|++.||+|
T Consensus 66 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~ 143 (367)
T 1cm8_A 66 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRY 143 (367)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence 4467899999999999999999999999765 3469999999 7899998876 679999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+|||++.+|.+||+|||+++.... .....+||++|+|||++.+....+.++||||+||++|+
T Consensus 144 LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 218 (367)
T 1cm8_A 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218 (367)
T ss_dssp HHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred HHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHH
Confidence 9999999999999999999999999999999876432 23456899999999999874444699999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCcc-------------------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAEF-------------------------------TCPPWLSFTARKLIARILDPNPMT 216 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~~s~~~~~li~~mL~~dP~~ 216 (400)
|++|+.||.+.+..+....+..... ...+..++.+.+||.+||..||.+
T Consensus 219 ll~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~ 298 (367)
T 1cm8_A 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298 (367)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhH
Confidence 9999999998877665554432110 122346899999999999999999
Q ss_pred CCCHHHHhcCcccccCC
Q 015814 217 RITIPEILEDEWFKKDY 233 (400)
Q Consensus 217 R~t~~eil~h~~~~~~~ 233 (400)
|||++++++||||+...
T Consensus 299 R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 299 RVTAGEALAHPYFESLH 315 (367)
T ss_dssp SCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHhcChHHHhhc
Confidence 99999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.53 Aligned_cols=219 Identities=27% Similarity=0.396 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
...+++.+|+.+|++++||||+++++++... ..+|+||||+.| +|.+.+.....+++..++.++.||+.||+||
T Consensus 67 ~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~L 145 (432)
T 3n9x_A 67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145 (432)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3367899999999999999999999998766 579999999875 9999999888899999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC--------------------CccccccCCCCCCCChhhhc
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--------------------GLLHTTCGTPNYVAPEVLND 148 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~APEvl~~ 148 (400)
|++||+||||||+|||++.+|.+||+|||+|+........ ....+.+||++|+|||++..
T Consensus 146 H~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp HHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT
T ss_pred HHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 9999999999999999999999999999999865432211 22466789999999999755
Q ss_pred CCCCCChhhHHHHHHHHHHHHhC-----------CCCCCCCch-----------------HHHHHhh-------------
Q 015814 149 RGYDGSTADLWSCGVILFVLLAG-----------YLPFDDSNL-----------------MNLYKKI------------- 187 (400)
Q Consensus 149 ~~~~~~~~DIwSlGiil~elltG-----------~~Pf~~~~~-----------------~~~~~~i------------- 187 (400)
....+.++||||+||++|+|++| .++|.+.+. .+....+
T Consensus 226 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~ 305 (432)
T 3n9x_A 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305 (432)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHH
T ss_pred CCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHH
Confidence 55456999999999999999985 444444321 1111111
Q ss_pred -----------hcCccCC-------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 188 -----------SAAEFTC-------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 188 -----------~~~~~~~-------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
....... .+.+++++.+||++||+.||.+|||++|+|+||||+...
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred hccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 1011111 134799999999999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=337.18 Aligned_cols=213 Identities=39% Similarity=0.738 Sum_probs=190.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++.+....|+||||++||+|.+.+...+.+++..+..++.|++.||.|||++||+|
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 129 (304)
T 2jam_A 50 DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129 (304)
T ss_dssp --HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 35788999999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred ccCCCCcEEE---ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl---~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+||++ +.++.+||+|||++..... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 130 ~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~ 204 (304)
T 2jam_A 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGY 204 (304)
T ss_dssp CSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC----BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCHHHEEEecCCCCCCEEEccCCcceecCC----CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCC
Confidence 9999999999 7789999999999865332 23345689999999999987766 48999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||.+.+.......+..+....+ +.++.++.+||.+||..||.+|||++++++||||+...
T Consensus 205 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 205 PPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp CTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999888888777766654433 45799999999999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=336.58 Aligned_cols=219 Identities=31% Similarity=0.634 Sum_probs=191.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEE--EeCCEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVM--GSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~--~~~~~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.+|+.++++++||||+++++++ .+....|+||||+.+| |.+.+.. ...+++..+..++.|++.||.|||++
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 128 (305)
T 2wtk_C 50 EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128 (305)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 57899999999999999999999998 4456799999999986 7777765 35699999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC-CCCChhhHHHHHHHHHHHHh
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGiil~ellt 170 (400)
||+||||||+||+++.+|.+||+|||++................||+.|+|||++.+.. +.+.++||||+||++|+|++
T Consensus 129 ~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (305)
T 2wtk_C 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208 (305)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH
T ss_pred CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999987654333333345567999999999997643 33578999999999999999
Q ss_pred CCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 171 GYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
|..||.+.+.......+..+....|..++..+.+||.+||+.||.+|||+.++++||||+....+
T Consensus 209 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 209 GLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred CCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 99999999888888888888888888899999999999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.29 Aligned_cols=218 Identities=35% Similarity=0.565 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-----------------------------
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----------------------------- 65 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----------------------------- 65 (400)
..+.+.+|+.++++++||||+++++++.+....|+||||++||+|.+++..
T Consensus 71 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (345)
T 3hko_A 71 DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150 (345)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccc
Confidence 367899999999999999999999999999999999999999999998852
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC--CeeeeccccccccccccCCC--c
Q 015814 66 -----------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDG--L 130 (400)
Q Consensus 66 -----------~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g--~~kl~DFGla~~~~~~~~~~--~ 130 (400)
...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 230 (345)
T 3hko_A 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230 (345)
T ss_dssp HSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----
T ss_pred ccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccccc
Confidence 11246788999999999999999999999999999999998776 89999999998654322211 2
Q ss_pred cccccCCCCCCCChhhhcC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCC----CCCHHHHHH
Q 015814 131 LHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKL 205 (400)
Q Consensus 131 ~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~l 205 (400)
....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+..+....+.......+. .+++++.+|
T Consensus 231 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 310 (345)
T 3hko_A 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDL 310 (345)
T ss_dssp ----CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHH
T ss_pred ccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHH
Confidence 3456899999999999752 33458999999999999999999999998887777766555443322 279999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 206 IARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 206 i~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|.+||+.||.+|||+.++++||||+..
T Consensus 311 i~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 311 LSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHcCCChhHCCCHHHHhcChhhccC
Confidence 999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=331.83 Aligned_cols=212 Identities=36% Similarity=0.663 Sum_probs=187.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++.+....|+||||++|++|.+++.....+++..+..++.|++.||.|||++||+|
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 131 (283)
T 3bhy_A 52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 131 (283)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 46789999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ccCCCCcEEEccCC----CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 96 RDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 96 rDlKP~NILl~~~g----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|||||+||+++.++ .+||+|||++..... ........||+.|+|||++....+ +.++||||+|+++|+|++|
T Consensus 132 ~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g 207 (283)
T 3bhy_A 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSG 207 (283)
T ss_dssp SCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred CCCChHHEEEecCCCCCCceEEEecccceeccC---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHC
Confidence 99999999999877 899999999875433 222345679999999999987766 5899999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 172 YLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
..||.+.+.......+.......+ +.++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 208 ASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp SCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 999999888877777766555443 457899999999999999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.94 Aligned_cols=218 Identities=26% Similarity=0.458 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHHhCCC--CCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+++|+.+|++++| |||+++++++.+...+|+||| +.+|+|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 50 ~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 128 (343)
T 3dbq_A 50 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 36789999999999976 999999999999999999999 567899999999899999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----------CCCCCChhhHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----------RGYDGSTADLWSCG 162 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----------~~~~~~~~DIwSlG 162 (400)
|+||||||+|||++ +|.+||+|||++...............+||+.|+|||++.+ ....+.++||||||
T Consensus 129 iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG 207 (343)
T 3dbq_A 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207 (343)
T ss_dssp CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHH
T ss_pred eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHH
Confidence 99999999999997 58899999999986654333333446789999999999965 13335899999999
Q ss_pred HHHHHHHhCCCCCCCCch-HHHHHhhh--cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 163 VILFVLLAGYLPFDDSNL-MNLYKKIS--AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~-~~~~~~i~--~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|++|+|++|+.||..... ......+. ......|...+.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 208 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 208 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp HHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred HHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 999999999999987433 22233322 2344567778899999999999999999999999999999987544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.24 Aligned_cols=216 Identities=28% Similarity=0.445 Sum_probs=180.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.++++++||||+++++++.+....|+||||++|++|.+.+...+.+++..+..++.|++.||+|||++||+
T Consensus 67 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 146 (331)
T 4aaa_A 67 VKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146 (331)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 35678899999999999999999999999999999999999999988888778899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.+|.+||+|||++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|+.|
T Consensus 147 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (331)
T 4aaa_A 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224 (331)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcChheEEEcCCCcEEEEeCCCceeecCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998754432 22334568999999999998765556999999999999999999999
Q ss_pred CCCCchHHHHHhhhcC-------------------ccCC------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 175 FDDSNLMNLYKKISAA-------------------EFTC------------PPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~-------------------~~~~------------~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
|.+.+..+....+... .... .+.++..+.+||.+||+.||.+|||+.|+
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 304 (331)
T 4aaa_A 225 FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304 (331)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred CCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence 9987765544332210 0001 12478999999999999999999999999
Q ss_pred hcCcccccC
Q 015814 224 LEDEWFKKD 232 (400)
Q Consensus 224 l~h~~~~~~ 232 (400)
++||||+..
T Consensus 305 l~hp~f~~~ 313 (331)
T 4aaa_A 305 LHHDFFQMD 313 (331)
T ss_dssp GGSHHHHGG
T ss_pred hcCchhccC
Confidence 999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.04 Aligned_cols=213 Identities=25% Similarity=0.440 Sum_probs=176.8
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.+.+|+.++++++||||+++++++.+....|+||||+.| +|.+++...+ .+++..++.++.|++.||.|||++||+||
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~ 124 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 455799999999999999999999999999999999985 8999887754 59999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.
T Consensus 125 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (324)
T 3mtl_A 125 DLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202 (324)
T ss_dssp SCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcCHHHEEECCCCCEEEccCcccccccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998754322 2233456889999999999875555699999999999999999999999
Q ss_pred CCchHHHHHhhhcCcc------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 177 DSNLMNLYKKISAAEF------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 177 ~~~~~~~~~~i~~~~~------------------------------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+.+..+....+..... ..++.++.++.+||.+||+.||.+|||++|+++|
T Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 203 GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 9887766555432110 0112468899999999999999999999999999
Q ss_pred cccccCC
Q 015814 227 EWFKKDY 233 (400)
Q Consensus 227 ~~~~~~~ 233 (400)
|||....
T Consensus 283 p~f~~~~ 289 (324)
T 3mtl_A 283 PFFLSLG 289 (324)
T ss_dssp GGGGGGC
T ss_pred hhhhhcc
Confidence 9998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=342.93 Aligned_cols=216 Identities=27% Similarity=0.389 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.+++.++||||+++++++......|+||||+.+ +|.+.+.... .+++..+..++.|++.||+|||++||+
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 134 (346)
T 1ua2_A 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134 (346)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 35688999999999999999999999999999999999987 8888887644 689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus 135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~ 212 (346)
T 1ua2_A 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 212 (346)
T ss_dssp CCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCCHHHEEEcCCCCEEEEecccceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999999998765432 23345678999999999997655456899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCc--cC---------C-----------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 175 FDDSNLMNLYKKISAAE--FT---------C-----------------PPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~--~~---------~-----------------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|.+.+..+.+..+.... .. . ...++.++.+||.+||+.||.+|||+.|+++|
T Consensus 213 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 213 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 99988776665543211 00 0 03357899999999999999999999999999
Q ss_pred cccccCCC
Q 015814 227 EWFKKDYK 234 (400)
Q Consensus 227 ~~~~~~~~ 234 (400)
|||+....
T Consensus 293 ~~f~~~~~ 300 (346)
T 1ua2_A 293 KYFSNRPG 300 (346)
T ss_dssp GGGTSSSC
T ss_pred hhhhcCCC
Confidence 99987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=347.79 Aligned_cols=218 Identities=26% Similarity=0.447 Sum_probs=181.5
Q ss_pred HHHHHHHHHHHHHhCC--CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVK--HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+++|+.+|++++ ||||+++++++.....+|+||| +.+|+|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 97 ~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ 175 (390)
T 2zmd_A 97 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175 (390)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4688999999999996 5999999999999999999999 567899999999889999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC----------CCCCChhhHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCG 162 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~----------~~~~~~~DIwSlG 162 (400)
|+||||||+|||++ ++.+||+|||++...............+||+.|+|||++.+. ...+.++||||||
T Consensus 176 ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG 254 (390)
T 2zmd_A 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254 (390)
T ss_dssp CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH
T ss_pred eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH
Confidence 99999999999996 589999999999865443222234566899999999999752 2345899999999
Q ss_pred HHHHHHHhCCCCCCCCch-HHHHHhhhc--CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 163 VILFVLLAGYLPFDDSNL-MNLYKKISA--AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~-~~~~~~i~~--~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|++|+|++|+.||..... ......+.. .....|.+.+.++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 255 vil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 255 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp HHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred HHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 999999999999987532 233333333 234567788999999999999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.93 Aligned_cols=211 Identities=25% Similarity=0.521 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+.+.+|+.++++++||||+++++++.. ...+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++
T Consensus 69 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 148 (290)
T 1t4h_A 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148 (290)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 6789999999999999999999999865 456899999999999999999888999999999999999999999999
Q ss_pred C--CeeccCCCCcEEEc-cCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 92 G--VYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 92 g--ivHrDlKP~NILl~-~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
| |+||||||+|||++ .++.+||+|||++..... ......+||+.|+|||++.+ .+ +.++||||+||++|+|
T Consensus 149 ~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l 222 (290)
T 1t4h_A 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEM 222 (290)
T ss_dssp SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHH
T ss_pred CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc----cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHH
Confidence 9 99999999999998 789999999999865332 23345679999999999874 34 5899999999999999
Q ss_pred HhCCCCCCCCch-HHHHHhhhcCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 169 LAGYLPFDDSNL-MNLYKKISAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 169 ltG~~Pf~~~~~-~~~~~~i~~~~--~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
++|..||.+... ...+..+..+. ...+...++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 999999987443 44555444332 23345578999999999999999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=344.76 Aligned_cols=214 Identities=30% Similarity=0.539 Sum_probs=186.9
Q ss_pred HHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+.+.+|+.+++++ +||||+++++++.....+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+|
T Consensus 103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 182 (355)
T 1vzo_A 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIY 182 (355)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 5567899999999 799999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC-CCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGiil~elltG~~P 174 (400)
|||||+|||++.+|.+||+|||++....... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.|
T Consensus 183 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 183 RDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp CCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999987543321 1223456899999999999853 2335899999999999999999999
Q ss_pred CCCC----chHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 175 FDDS----NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~----~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
|... ....+...+.......|..++..+.+||.+||..||.+|| |++++++||||+.
T Consensus 262 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 262 FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp TSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 9753 2345555566666778888999999999999999999999 9999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.61 Aligned_cols=216 Identities=33% Similarity=0.575 Sum_probs=190.6
Q ss_pred HHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.+++++. ||||+++++++......|+||||++||+|.+++.....+++..+..++.|++.||.|||++|
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 144 (298)
T 1phk_A 65 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34677889999999995 99999999999999999999999999999999998889999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-----CCCCCChhhHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGiil~e 167 (400)
++||||||+||+++.+|.+||+|||++..... .......+||+.|+|||++.. ....+.++||||+||++|+
T Consensus 145 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~ 221 (298)
T 1phk_A 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221 (298)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred cccCCCCcceEEEcCCCcEEEecccchhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence 99999999999999999999999999876432 223445689999999999862 2233589999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|++|..||.+.+.......+..+....+ ..++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 222 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 222 LLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 9999999999888777777766655433 2378999999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=342.64 Aligned_cols=208 Identities=25% Similarity=0.422 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHhCC-----CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK-----HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~L 88 (400)
.....+|+.+++.+. ||||+++++++...+..|+||||+ |++|.+++.... .+++..++.++.||+.||+||
T Consensus 75 ~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 153 (360)
T 3llt_A 75 TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL 153 (360)
T ss_dssp HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 567788999999996 999999999999999999999999 889999998754 599999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEcc-------------------------CCCeeeeccccccccccccCCCccccccCCCCCCCC
Q 015814 89 HSRGVYHRDLKPENLLLDA-------------------------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 143 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~-------------------------~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 143 (400)
|++||+||||||+|||++. ++.+||+|||+|..... .....+||+.|+||
T Consensus 154 H~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aP 228 (360)
T 3llt_A 154 RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAP 228 (360)
T ss_dssp HHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCH
T ss_pred HHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCc
Confidence 9999999999999999975 78999999999975432 22456899999999
Q ss_pred hhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCC--------------------------C-
Q 015814 144 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--------------------------P- 196 (400)
Q Consensus 144 Evl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~- 196 (400)
|++.+..|. .++||||+||++|+|++|+.||.+.+..+....+.......| .
T Consensus 229 E~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 307 (360)
T 3llt_A 229 EVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPEN 307 (360)
T ss_dssp HHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTT
T ss_pred HHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCccc
Confidence 999987774 899999999999999999999998776665554433222111 1
Q ss_pred -------------------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 197 -------------------WLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 197 -------------------~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
..++.+.+||.+||+.||.+|||++|+++||||+
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 308 ASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred ccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1236788999999999999999999999999995
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.29 Aligned_cols=218 Identities=26% Similarity=0.463 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+.+.+|+.++++++||||+++++++... ...|+||||+.| +|.+.+.. +.+++..+..++.|++.||+|||
T Consensus 68 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH 145 (364)
T 3qyz_A 68 YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 145 (364)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 357889999999999999999999999765 468999999985 89998876 57999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
++||+||||||+|||++.++.+||+|||++........ .......+||+.|+|||++.+....+.++||||+||++|+|
T Consensus 146 ~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 225 (364)
T 3qyz_A 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225 (364)
T ss_dssp HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHH
T ss_pred HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHH
Confidence 99999999999999999999999999999986554322 22345568999999999987655456999999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCcc-------------------------------CCCCCCCHHHHHHHHHhcCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEF-------------------------------TCPPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~~s~~~~~li~~mL~~dP~~R 217 (400)
++|+.||.+.+..+....+..... ...+.++.++.+||.+||+.||.+|
T Consensus 226 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 305 (364)
T 3qyz_A 226 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305 (364)
T ss_dssp HHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999998876665554421100 0123478999999999999999999
Q ss_pred CCHHHHhcCcccccCCC
Q 015814 218 ITIPEILEDEWFKKDYK 234 (400)
Q Consensus 218 ~t~~eil~h~~~~~~~~ 234 (400)
||+.|+++||||+....
T Consensus 306 ~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 306 IEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CCHHHHHTSGGGTTTCC
T ss_pred CCHHHHhcCcchhhccC
Confidence 99999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=335.91 Aligned_cols=216 Identities=28% Similarity=0.449 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHc
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..+++.+|+.++++++||||+++++++.+....|+||||++||+|.+++...+. +++..+..++.|++.||+|||++
T Consensus 77 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 156 (309)
T 3p86_A 77 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156 (309)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 357889999999999999999999999999999999999999999999987654 99999999999999999999999
Q ss_pred C--CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 92 G--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 92 g--ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
| |+||||||+|||++.++.+||+|||++...... .......+||+.|+|||++.+..+ +.++|||||||++|+|+
T Consensus 157 ~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell 233 (309)
T 3p86_A 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELA 233 (309)
T ss_dssp SSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHH
T ss_pred CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHH
Confidence 9 999999999999999999999999998754321 122345689999999999988776 58999999999999999
Q ss_pred hCCCCCCCCchHHHHHhh--hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CcccccCC
Q 015814 170 AGYLPFDDSNLMNLYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDY 233 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~--h~~~~~~~ 233 (400)
+|..||.+.+.......+ .......|..+++++.+||.+||..||.+|||+.++++ +++++...
T Consensus 234 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 234 TLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred hCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 999999998877766655 33455677889999999999999999999999999987 56665543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.27 Aligned_cols=208 Identities=21% Similarity=0.320 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
..++.+|+.++..+ +||||+++++++.+.+..|+||||++||+|.+++... +.+++..++.++.|++.||+|||+
T Consensus 54 ~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 133 (289)
T 1x8b_A 54 EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133 (289)
T ss_dssp HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 56788999999999 9999999999999999999999999999999999765 679999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccC-------------------CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC
Q 015814 91 RGVYHRDLKPENLLLDAY-------------------GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~-------------------g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~ 151 (400)
+||+||||||+||+++.+ +.+||+|||++...... ....||+.|+|||++.+...
T Consensus 134 ~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~ 207 (289)
T 1x8b_A 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYT 207 (289)
T ss_dssp TTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCT
T ss_pred CCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCC
Confidence 999999999999999854 47999999998765431 23469999999999987655
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 152 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 152 ~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
.+.++||||+||++|+|++|..|+...... ..+..+ ....|..++.++.+||.+||+.||.+|||+.++++||||+
T Consensus 208 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 208 HLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp THHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 557999999999999999999887655432 222223 3456677999999999999999999999999999999998
Q ss_pred cC
Q 015814 231 KD 232 (400)
Q Consensus 231 ~~ 232 (400)
..
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 64
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=349.01 Aligned_cols=218 Identities=27% Similarity=0.408 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~l 85 (400)
..+.+|+.+|++++||||+++++++.. ...+|+||||+.| +|.+.+... ..+++..++.++.||+.||
T Consensus 63 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 141 (405)
T 3rgf_A 63 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141 (405)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence 567899999999999999999999954 6789999999975 888888532 2499999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEE----ccCCCeeeecccccccccccc-CCCccccccCCCCCCCChhhhcCCCCCChhhHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWS 160 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl----~~~g~~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwS 160 (400)
+|||++||+||||||+|||+ +.++.+||+|||+|....... ........+||+.|+|||++.+..+.+.++||||
T Consensus 142 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 221 (405)
T 3rgf_A 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 221 (405)
T ss_dssp HHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHH
T ss_pred HHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHH
Confidence 99999999999999999999 677899999999998654321 1223456789999999999987665569999999
Q ss_pred HHHHHHHHHhCCCCCCCCchH---------HHHHhhhcC--ccC------------------------------------
Q 015814 161 CGVILFVLLAGYLPFDDSNLM---------NLYKKISAA--EFT------------------------------------ 193 (400)
Q Consensus 161 lGiil~elltG~~Pf~~~~~~---------~~~~~i~~~--~~~------------------------------------ 193 (400)
|||++|+|++|..||.+.+.. +....+... .+.
T Consensus 222 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (405)
T 3rgf_A 222 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301 (405)
T ss_dssp HHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhh
Confidence 999999999999999765431 222221110 000
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 194 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 194 ~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
.....+..+.+||.+||..||.+|||++|+|+||||+....+
T Consensus 302 ~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp TTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred cCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence 001127789999999999999999999999999999976543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=342.24 Aligned_cols=212 Identities=24% Similarity=0.509 Sum_probs=189.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK------IVN--HGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~------i~~--~~~l~e~~~~~~~~qll~~l~~L 88 (400)
+.+.+|+.++++++||||+++++++.+.+..|+||||++||+|.++ +.. ...+++..+..++.|++.||.||
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999999999999999998 665 56799999999999999999999
Q ss_pred HH-cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC-CCCCChhhHHHHHHHHH
Q 015814 89 HS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILF 166 (400)
Q Consensus 89 H~-~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGiil~ 166 (400)
|+ +||+||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+. .+.+.++||||+||++|
T Consensus 168 H~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 243 (348)
T 2pml_X 168 HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243 (348)
T ss_dssp HHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred hccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence 99 99999999999999999999999999998764332 33456799999999999876 45433899999999999
Q ss_pred HHHhCCCCCCCCch-HHHHHhhhcCccCCC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 167 VLLAGYLPFDDSNL-MNLYKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 167 elltG~~Pf~~~~~-~~~~~~i~~~~~~~~-------------------~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+|++|..||...+. .+....+..+....| ..++.++.+||.+||+.||.+|||+.++++|
T Consensus 244 ~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 244 VMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999998776 677777776666666 5689999999999999999999999999999
Q ss_pred cccccC
Q 015814 227 EWFKKD 232 (400)
Q Consensus 227 ~~~~~~ 232 (400)
|||+..
T Consensus 324 p~f~~~ 329 (348)
T 2pml_X 324 EWLADT 329 (348)
T ss_dssp GGGTTC
T ss_pred ccccCC
Confidence 999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=341.47 Aligned_cols=213 Identities=26% Similarity=0.464 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~-gi 93 (400)
..+.+.+|+.+++.++||||+++++++.+.+..|+||||++||+|.+++...+.+++..+..++.|++.||.|||++ ||
T Consensus 74 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i 153 (360)
T 3eqc_A 74 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 153 (360)
T ss_dssp HHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 46789999999999999999999999999999999999999999999999888999999999999999999999996 99
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|.+||+|||++...... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus 154 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~ 228 (360)
T 3eqc_A 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRY 228 (360)
T ss_dssp CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSC
T ss_pred EcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754332 2234689999999999988776 489999999999999999999
Q ss_pred CCCCCchHHHHHhh------------------------------------------hcCc-cCCC-CCCCHHHHHHHHHh
Q 015814 174 PFDDSNLMNLYKKI------------------------------------------SAAE-FTCP-PWLSFTARKLIARI 209 (400)
Q Consensus 174 Pf~~~~~~~~~~~i------------------------------------------~~~~-~~~~-~~~s~~~~~li~~m 209 (400)
||...+.......+ .... ...+ ..++.++.+||.+|
T Consensus 229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 308 (360)
T 3eqc_A 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308 (360)
T ss_dssp CSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHH
Confidence 99876654432211 1111 1111 23788999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccC
Q 015814 210 LDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 210 L~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|+.||.+|||++++++||||+..
T Consensus 309 L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 309 LIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp HCSSTTTSCCHHHHHTSHHHHHH
T ss_pred hhcChhhCCCHHHHhhChHhhcc
Confidence 99999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=350.61 Aligned_cols=211 Identities=39% Similarity=0.741 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+|++++||||+++++++. ....|+||||++||+|.+++...+++++..++.++.|++.||+|||++||+|
T Consensus 184 ~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 262 (419)
T 3i6u_A 184 ALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262 (419)
T ss_dssp -CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 346889999999999999999999985 4568999999999999999988889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCC---CeeeeccccccccccccCCCccccccCCCCCCCChhhhc---CCCCCChhhHHHHHHHHHHHH
Q 015814 96 RDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 96 rDlKP~NILl~~~g---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DIwSlGiil~ell 169 (400)
|||||+|||++.++ .+||+|||+|..... .....+.+||+.|+|||++.. ..| +.++||||+||++|+|+
T Consensus 263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICL 338 (419)
T ss_dssp SCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHH
T ss_pred cCCChHhEEEecCCCcceEEEeecccceecCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHH
Confidence 99999999997654 599999999976543 233456789999999999853 334 47999999999999999
Q ss_pred hCCCCCCCCchH-HHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 170 AGYLPFDDSNLM-NLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 170 tG~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
+|..||.+.... .....+..+....+ ..++..+.+||.+||+.||.+|||++++++||||+.
T Consensus 339 tg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 339 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 999999875432 44444555554443 358999999999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.38 Aligned_cols=214 Identities=31% Similarity=0.553 Sum_probs=185.3
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+|+.+++.+ +||||+++++++.+....|+||||+.||+|.+++... +.+++..++.++.|++.||+|||++|
T Consensus 72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g 151 (327)
T 3lm5_A 72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151 (327)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46788999999999 5799999999999999999999999999999998553 57999999999999999999999999
Q ss_pred CeeccCCCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 93 ivHrDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
|+||||||+|||++. ++.+||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|+
T Consensus 152 ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll 227 (327)
T 3lm5_A 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLL 227 (327)
T ss_dssp EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHH
T ss_pred eecCcCChHHEEEecCCCCCcEEEeeCccccccCC---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHH
Confidence 999999999999998 78999999999876543 222345689999999999987776 48999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
+|..||.+.+....+..+.......+ ..++..+.+||.+||+.||.+|||++++++||||+...
T Consensus 228 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 228 THTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 99999999888877777655544333 34889999999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=347.48 Aligned_cols=210 Identities=31% Similarity=0.442 Sum_probs=174.7
Q ss_pred HHHHHHHHhCCCCCcceeeEEEEeCC------EEEEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 20 KREVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 20 ~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
.+|+.+|+.++||||+++++++.... .+|+||||++++ +.+.+. ....+++..++.++.|++.||+|||
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH 158 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999985543 388999999874 444333 3567999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEc-cCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~~givHrDlKP~NILl~-~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
++||+||||||+|||++ .+|.+||+|||+|+.... .......+||+.|+|||++.+....+.++||||+||++|+|
T Consensus 159 ~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 235 (394)
T 4e7w_A 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL 235 (394)
T ss_dssp HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999 789999999999976532 22234568899999999997765456999999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcC-----------------cc------------CCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAA-----------------EF------------TCPPWLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~s~~~~~li~~mL~~dP~~R~t 219 (400)
++|+.||.+.+..+....+... .. .+++.+++++.+||.+||+.||.+|||
T Consensus 236 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 236 MQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 9999999998766555443221 00 123447899999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 015814 220 IPEILEDEWFKKDY 233 (400)
Q Consensus 220 ~~eil~h~~~~~~~ 233 (400)
+.|+++||||+.-.
T Consensus 316 ~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 316 AIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHTSGGGSTTT
T ss_pred HHHHhcChhhhhhc
Confidence 99999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=346.13 Aligned_cols=214 Identities=27% Similarity=0.455 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
...+.+.+|+.+++.++||||+++++++.... .+|+||||+.| +|.+.+. ..+++..+..++.|++.||+|
T Consensus 66 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~ 142 (371)
T 2xrw_A 66 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKH 142 (371)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHH
Confidence 34678889999999999999999999997654 78999999986 7888885 458999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+|||++.+|.+||+|||++..... .......+||+.|+|||++.+..|. .++||||+||++|+
T Consensus 143 lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~e 218 (371)
T 2xrw_A 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGE 218 (371)
T ss_dssp HHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHH
T ss_pred HHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHH
Confidence 9999999999999999999999999999999875432 2233456899999999999987774 89999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCccCC------------------------------------CCC------CCHHHHHH
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAEFTC------------------------------------PPW------LSFTARKL 205 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------------------~~~------~s~~~~~l 205 (400)
|++|..||.+.+....+..+....... |.. .+.++.+|
T Consensus 219 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (371)
T 2xrw_A 219 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298 (371)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHH
Confidence 999999999988766665543321100 000 15678999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 206 IARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 206 i~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|++||+.||.+|||++|+++||||+....
T Consensus 299 i~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 299 LSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 99999999999999999999999986543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=336.11 Aligned_cols=221 Identities=23% Similarity=0.336 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE------EEEEecCCCCChHHHHHhCC------CCCHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHG------RMKEDEARRYFQQLI 82 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~------~lv~Ey~~gg~L~~~i~~~~------~l~e~~~~~~~~qll 82 (400)
..+++.+|+.++++++||||+++++++...... |+||||+.||+|.+++.... .+++..+..++.|++
T Consensus 68 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 147 (323)
T 3qup_A 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147 (323)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHH
Confidence 367899999999999999999999999876655 99999999999999996533 599999999999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 83 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 83 ~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
.||+|||++||+||||||+|||++.+|.+||+|||++................||+.|+|||++.+..+ +.++||||+|
T Consensus 148 ~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG 226 (323)
T 3qup_A 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFG 226 (323)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHH
T ss_pred HHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHH
Confidence 999999999999999999999999999999999999976543322222334557889999999988776 4899999999
Q ss_pred HHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCC-------HHHHhcCcccccCC
Q 015814 163 VILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRIT-------IPEILEDEWFKKDY 233 (400)
Q Consensus 163 iil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t-------~~eil~h~~~~~~~ 233 (400)
|++|+|++ |..||.+.+.......+..+ ....++.++.++.+||.+||+.||.+||| +++++.|||+....
T Consensus 227 ~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 227 VTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred HHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 99999999 99999998887777766554 45667789999999999999999999999 77889999998754
Q ss_pred CCC
Q 015814 234 KPP 236 (400)
Q Consensus 234 ~~~ 236 (400)
..|
T Consensus 307 ~~p 309 (323)
T 3qup_A 307 QDP 309 (323)
T ss_dssp ---
T ss_pred CCC
Confidence 433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=344.86 Aligned_cols=213 Identities=26% Similarity=0.398 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
..+++.+|+.+++.++||||+++++++... ..+|+||||+ |++|.+.+.. +++++..++.++.|++.||+||
T Consensus 71 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~L 148 (367)
T 2fst_X 71 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 148 (367)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 367888999999999999999999998654 5689999999 6799988866 6799999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
|++||+||||||+|||++.+|.+||+|||+++.... .....+||++|+|||++.+....+.++||||+||++|+|
T Consensus 149 H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 223 (367)
T 2fst_X 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223 (367)
T ss_dssp HHTTCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHH
T ss_pred HHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999999999999999875432 234568999999999998744456899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCc-----------------------cCC--------CCCCCHHHHHHHHHhcCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAE-----------------------FTC--------PPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~-----------------------~~~--------~~~~s~~~~~li~~mL~~dP~~R 217 (400)
++|+.||.+.+..+....+.... ... .+..++.+.+||.+||..||.+|
T Consensus 224 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R 303 (367)
T 2fst_X 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303 (367)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccC
Confidence 99999999988766555442210 000 12368899999999999999999
Q ss_pred CCHHHHhcCcccccCCC
Q 015814 218 ITIPEILEDEWFKKDYK 234 (400)
Q Consensus 218 ~t~~eil~h~~~~~~~~ 234 (400)
||+.++++||||+....
T Consensus 304 ~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 304 ITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CCHHHHHTSGGGTTTCC
T ss_pred cCHHHHhcChhhhhccC
Confidence 99999999999987543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=337.97 Aligned_cols=213 Identities=24% Similarity=0.382 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.++++++||||+++++++.+....|+||||+. |+|.+.+. ....+++..+..++.|++.||+|||++|
T Consensus 96 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 174 (348)
T 1u5q_A 96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174 (348)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346789999999999999999999999999999999999998 47888875 4567999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh---cCCCCCChhhHHHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGiil~ell 169 (400)
|+||||||+|||++.+|.+||+|||++..... ....+||+.|+|||++. ...+ +.++||||+||++|+|+
T Consensus 175 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELA 247 (348)
T ss_dssp CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHH
T ss_pred eeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999875432 23467999999999985 3344 58999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCcc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEF--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
+|+.||.+.+.......+..... ..+..++..+.+||.+||+.||.+|||++++++||||.....
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 99999988877665555544332 224458999999999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=340.77 Aligned_cols=211 Identities=23% Similarity=0.402 Sum_probs=186.0
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHH
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRY 77 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~ 77 (400)
..+++.+|+.+|+++ +||||+++++++.+.+.+|+||||++||+|.+++...+ .++...+..+
T Consensus 129 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 208 (370)
T 2psq_A 129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208 (370)
T ss_dssp HHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHH
Confidence 367899999999999 89999999999999999999999999999999998653 4789999999
Q ss_pred HHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhh
Q 015814 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 78 ~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
+.|++.||+|||++||+||||||+|||++.+|.+||+|||++................||+.|+|||++.+..| +.++|
T Consensus 209 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~D 287 (370)
T 2psq_A 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSD 287 (370)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHH
T ss_pred HHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHH
Confidence 99999999999999999999999999999999999999999976544322223344567889999999988776 48999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||||||++|+|++ |..||.+.+..+....+..+. ...|..++.++.+||.+||+.||.+|||+.|++++
T Consensus 288 vwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 288 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999 999999988887777765553 45667799999999999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=343.57 Aligned_cols=209 Identities=26% Similarity=0.393 Sum_probs=175.9
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEe--------------------------------------CCEEEEEEecCCCCChH
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGS--------------------------------------KTKIFIVLEFVTGGELF 60 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~--------------------------------------~~~~~lv~Ey~~gg~L~ 60 (400)
..+|+.+|+.++||||+++++++.. ...+++||||++| +|.
T Consensus 47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~ 125 (383)
T 3eb0_A 47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125 (383)
T ss_dssp CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHH
T ss_pred HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHH
Confidence 3479999999999999999999843 3458999999985 766
Q ss_pred HHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEc-cCCCeeeeccccccccccccCCCcccccc
Q 015814 61 DKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTC 135 (400)
Q Consensus 61 ~~i~----~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~-~~g~~kl~DFGla~~~~~~~~~~~~~~~~ 135 (400)
+.+. ..+.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||+|..... .......+
T Consensus 126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~ 202 (383)
T 3eb0_A 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYI 202 (383)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCC
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcc
Confidence 6554 457899999999999999999999999999999999999998 578999999999975533 22334568
Q ss_pred CCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcC-----------------cc------
Q 015814 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----------------EF------ 192 (400)
Q Consensus 136 gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~------ 192 (400)
||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+... ..
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 282 (383)
T 3eb0_A 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282 (383)
T ss_dssp CCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC
T ss_pred cCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC
Confidence 8999999999987664569999999999999999999999988776655544221 00
Q ss_pred ------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 193 ------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 193 ------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.+|..+|.++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 283 AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred cccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 134557899999999999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=331.82 Aligned_cols=217 Identities=27% Similarity=0.498 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh--------CCCCCHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN--------HGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~--------~~~l~e~~~~~~~~qll~~l~~ 87 (400)
.+.+.+|+.++++++||||+++++++...+..|+||||++||+|.+++.. .+.+++..+..++.|++.||.|
T Consensus 57 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 136 (303)
T 2vwi_A 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136 (303)
T ss_dssp ---------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 56788999999999999999999999999999999999999999999974 4569999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeecccccccccccc---CCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR---DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
||++||+||||||+||+++.+|.+||+|||++....... ........+||+.|+|||++......+.++||||+||+
T Consensus 137 lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 216 (303)
T 2vwi_A 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216 (303)
T ss_dssp HHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHH
T ss_pred HHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHH
Confidence 999999999999999999999999999999987544321 11223456799999999999763333589999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCcc----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEF----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~----------~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|+|++|..||...+............. .....++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 217 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 217 AIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp HHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred HHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 9999999999988766544433222211 1224578999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=330.11 Aligned_cols=214 Identities=29% Similarity=0.480 Sum_probs=182.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|+.+++.++||||+++++++...+..|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++|++
T Consensus 60 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 139 (302)
T 2j7t_A 60 LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 139 (302)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 57788999999999999999999999999999999999999999998865 46799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh-----cCCCCCChhhHHHHHHHHHHHH
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGiil~ell 169 (400)
||||||+||+++.+|.+||+|||++........ .....+||+.|+|||++. ...+ +.++||||+||++|+|+
T Consensus 140 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~ 216 (302)
T 2j7t_A 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMA 216 (302)
T ss_dssp CCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEECCCCCEEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHh
Confidence 999999999999999999999998764322111 123457999999999984 3334 58999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCcc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|..||...+.......+..... ..+..++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 217 QIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred cCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999998887766665544432 2345589999999999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=337.93 Aligned_cols=218 Identities=24% Similarity=0.427 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
.....+++|+.++++++||||+++++++.... ..|+||||++||+|.+++...+.+++..+..++.|++.||+|||
T Consensus 54 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 133 (311)
T 3ork_A 54 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133 (311)
T ss_dssp HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44678999999999999999999999986543 35999999999999999998889999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
++||+||||||+|||++.++.+||+|||++......... ......+||+.|+|||++.+..+ +.++||||+||++|+|
T Consensus 134 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEV 212 (311)
T ss_dssp HTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHH
T ss_pred HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHH
Confidence 999999999999999999999999999998765432211 22334579999999999988776 4899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCccCC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
++|+.||.+.+.......+....... +..+|.++.+||.+||+.||.+||+..+++.|+|++..
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 213 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 99999999988776655544433322 24589999999999999999999999999999999853
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=328.15 Aligned_cols=215 Identities=23% Similarity=0.418 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|+.++++++||||+++++++.+.+..|+||||++||+|.+++...+++++..+..++.|++.||+|||++||
T Consensus 53 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 132 (294)
T 4eqm_A 53 ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132 (294)
T ss_dssp HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34688999999999999999999999999999999999999999999999998899999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||+++.+|.+||+|||++....... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus 133 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~ 210 (294)
T 4eqm_A 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEP 210 (294)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654321 122344679999999999988776 489999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCcc-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 174 PFDDSNLMNLYKKISAAEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~-----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
||.+.+............. ..++.+|+.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 211 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 211 PFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp SSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 9998887655444333322 23456899999999999999999999666666666654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=327.12 Aligned_cols=214 Identities=34% Similarity=0.571 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEE--eCCEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv~Ey~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~~LH 89 (400)
.+.+.+|+.++++++||||+++++++. .....|+||||++||+|.+++... ..+++..+..++.|++.||+|||
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 128 (279)
T 2w5a_A 49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128 (279)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 578999999999999999999999874 467899999999999999999753 24999999999999999999999
Q ss_pred HcC-----CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 90 SRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 90 ~~g-----ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
++| |+||||||+||+++.++.+||+|||++...... .......+||+.|+|||++.+..+ +.++||||+||+
T Consensus 129 ~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~i 205 (279)
T 2w5a_A 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCL 205 (279)
T ss_dssp HHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHH
T ss_pred cccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc--cccccccCCCccccChHHhccCCC-CchhhHHHHHHH
Confidence 999 999999999999999999999999998764321 112334679999999999988766 489999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|+|++|..||...+.......+..+.. ..|..++.++.++|.+||+.||.+|||+.++++|+|+...
T Consensus 206 l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 206 LYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 9999999999999888777777766654 5666789999999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=328.64 Aligned_cols=214 Identities=29% Similarity=0.501 Sum_probs=186.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.++++++||||+++++++......|+||||++||+|.+++. ....+++..+..++.|++.||.|||++|++
T Consensus 68 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 147 (314)
T 3com_A 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147 (314)
T ss_dssp CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence 4678899999999999999999999999999999999999999999997 456799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+||+++.+|.+||+|||++....... .......||+.|+|||++.+..+. .++||||+||++|+|++|..|
T Consensus 148 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p 224 (314)
T 3com_A 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPP 224 (314)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCT
T ss_pred CCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654321 123456799999999999887764 889999999999999999999
Q ss_pred CCCCchHHHHHhhhcC---ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 175 FDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|...+.......+... ....+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 225 YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp TTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred CCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9887765554443332 223345579999999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=327.68 Aligned_cols=215 Identities=28% Similarity=0.498 Sum_probs=189.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+++.++||||+++++++......|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+|
T Consensus 64 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 142 (303)
T 3a7i_A 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIH 142 (303)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 57899999999999999999999999999999999999999999998865 67999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+||+++.+|.+||+|||++....... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||
T Consensus 143 ~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~ 219 (303)
T 3a7i_A 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPH 219 (303)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999987654321 123456799999999999877664 8999999999999999999999
Q ss_pred CCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 176 DDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
...+.......+.... ...+..++..+.+||.+||+.||.+|||+.++++||||.....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 220 SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp TTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred CCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 9887766665554433 3455678999999999999999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=332.19 Aligned_cols=212 Identities=38% Similarity=0.716 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.++++++||||+++++++..+. .|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+|
T Consensus 59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 137 (322)
T 2ycf_A 59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137 (322)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 456889999999999999999999987665 8999999999999999988889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCC---eeeeccccccccccccCCCccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHHHHh
Q 015814 96 RDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 96 rDlKP~NILl~~~g~---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~ellt 170 (400)
|||||+|||++.++. +||+|||++..... .......+||+.|+|||++.. ....+.++||||+||++|+|++
T Consensus 138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~ 214 (322)
T 2ycf_A 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214 (322)
T ss_dssp CCCSGGGEEESSSSSSCCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH
T ss_pred cCCCHHHEEEecCCCCCeEEEccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999987665 99999999876432 222345689999999999852 2233589999999999999999
Q ss_pred CCCCCCCCchH-HHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 171 GYLPFDDSNLM-NLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 171 G~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|..||...... .....+..+..... ..++..+.+||.+||..||.+|||++++++||||+.
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 215 GYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp SSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred CCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 99999765432 33344444444332 457999999999999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=325.99 Aligned_cols=212 Identities=39% Similarity=0.699 Sum_probs=188.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.++++++||||+++++++......|+||||++|++|.+.+...+.+++..+..++.|++.||.|||++|++|
T Consensus 65 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H 144 (287)
T 2wei_A 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144 (287)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 57789999999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred ccCCCCcEEEccC---CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLDAY---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~~~---g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+||+++.+ +.+||+|||++...... .......||+.|+|||++.+. + +.++||||+||++|+|++|.
T Consensus 145 ~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~ 219 (287)
T 2wei_A 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGT 219 (287)
T ss_dssp SCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC---SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSS
T ss_pred cCCChhhEEEecCCCcccEEEeccCcceeecCC---CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCC
Confidence 9999999999764 46999999998765432 223445789999999998753 4 58999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.||.+.+.......+..+....+ ..+|.++.+||.+||..||.+|||+.++++||||++.
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 220 PPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999888877777766654433 3589999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.15 Aligned_cols=214 Identities=25% Similarity=0.445 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-------------------------------------------------
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKT------------------------------------------------- 45 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~------------------------------------------------- 45 (400)
..+.+.+|+.+|++++||||+++++++.+..
T Consensus 47 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (332)
T 3qd2_B 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126 (332)
T ss_dssp HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------------------------
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccc
Confidence 3578999999999999999999999985543
Q ss_pred --------EEEEEEecCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeee
Q 015814 46 --------KIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 114 (400)
Q Consensus 46 --------~~~lv~Ey~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~ 114 (400)
..|+||||++||+|.+++..... .++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+
T Consensus 127 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 206 (332)
T 3qd2_B 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 206 (332)
T ss_dssp -----CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEe
Confidence 38999999999999999987654 4566789999999999999999999999999999999999999999
Q ss_pred ccccccccccccCC----------CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 015814 115 DFGLSALSQQVRDD----------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 184 (400)
Q Consensus 115 DFGla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~ 184 (400)
|||++......... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..|+... ....
T Consensus 207 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~~--~~~~ 283 (332)
T 3qd2_B 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQMER--VRII 283 (332)
T ss_dssp CCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHHH--HHHH
T ss_pred ecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhHH--HHHH
Confidence 99998765432211 12344679999999999988777 59999999999999999998775321 2222
Q ss_pred HhhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 185 KKISAAEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 185 ~~i~~~~~~-~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
..+.....+ .+...++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 222222211 11235778899999999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=337.85 Aligned_cols=218 Identities=24% Similarity=0.402 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEe-----CCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGS-----KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~ 87 (400)
...+++.+|+.++++++||||+++++++.. ...+|+||||+. |+|.+.+.... .+++..+..++.|++.||.|
T Consensus 71 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 149 (362)
T 3pg1_A 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149 (362)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 346889999999999999999999999843 347899999998 48888887644 69999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+|||++.++.+||+|||++..... .......+||+.|+|||++.+....+.++||||+||++|+
T Consensus 150 lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 226 (362)
T 3pg1_A 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226 (362)
T ss_dssp HHHTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHH
T ss_pred HHHCcCEecCCChHHEEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHH
Confidence 9999999999999999999999999999999874332 2233456899999999999874445699999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcC------------------------cc--------CCCCCCCHHHHHHHHHhcCCCCC
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAA------------------------EF--------TCPPWLSFTARKLIARILDPNPM 215 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~------------------------~~--------~~~~~~s~~~~~li~~mL~~dP~ 215 (400)
|++|+.||.+.+..+....+... .. ..++..++.+.+||.+||+.||.
T Consensus 227 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 306 (362)
T 3pg1_A 227 MFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ 306 (362)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChh
Confidence 99999999988766555443210 00 11234688999999999999999
Q ss_pred CCCCHHHHhcCcccccCCCC
Q 015814 216 TRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 216 ~R~t~~eil~h~~~~~~~~~ 235 (400)
+|||+.|+++||||+....+
T Consensus 307 ~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 307 RRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp GSCCHHHHHTSGGGTTTCCG
T ss_pred hCCCHHHHHcCchhhhccCc
Confidence 99999999999999986544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.65 Aligned_cols=215 Identities=20% Similarity=0.311 Sum_probs=190.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~l~~L 88 (400)
..++.+|+.++++++||||+++++++.+....|+||||++||+|.+++...+ .+++..+..++.|++.||+||
T Consensus 118 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 197 (367)
T 3l9p_A 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197 (367)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH
Confidence 4678899999999999999999999999999999999999999999997643 489999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCC---CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
|++||+||||||+|||++.+| .+||+|||+|+...............||+.|+|||++.+..+. .++|||||||++
T Consensus 198 H~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il 276 (367)
T 3l9p_A 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLL 276 (367)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHH
T ss_pred HhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHH
Confidence 999999999999999999655 4999999999765443333444566789999999999887774 899999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|+|++ |..||.+.+..+....+..+. ...+..++..+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 277 ~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 277 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 99998 999999998888887776554 4556679999999999999999999999999999988754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=330.25 Aligned_cols=206 Identities=26% Similarity=0.405 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+..+|+..+.++ +||||+++++++.++...|+||||+ +|+|.+.+...+ .+++..+..++.|++.||+|||++||+
T Consensus 101 ~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 179 (311)
T 3p1a_A 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 3444555555544 9999999999999999999999999 669999887644 699999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.++.+||+|||++..... .......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..|
T Consensus 180 H~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~ 254 (311)
T 3p1a_A 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGT---AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMEL 254 (311)
T ss_dssp CCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCC
T ss_pred cCCCCHHHEEECCCCCEEEccceeeeeccc---CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875433 223345679999999999875 45 5899999999999999999766
Q ss_pred CCCCchHHHHHhhhcCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
+.+.... ..+..+. ...+..++.++.+||.+||+.||.+|||++++++||||++
T Consensus 255 ~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 255 PHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCCccHH---HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 6553322 2222221 1234568999999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=332.66 Aligned_cols=211 Identities=24% Similarity=0.439 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++++++ ||||+++++++.+ ....++||||+.+++|.+.+. .+++..++.++.|++.||+|||++|
T Consensus 74 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ 150 (330)
T 3nsz_A 74 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG 150 (330)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 367899999999997 9999999999987 677999999999999998884 4899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCC-CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|+||||||+|||++.++ .+||+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|
T Consensus 151 ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 227 (330)
T 3nsz_A 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227 (330)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCTTCEECCT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999777 899999999976543 22345568999999999998755556999999999999999999
Q ss_pred CCCCCCCc-hHHHHHh-------------hhcCccCC------------------------CCCCCHHHHHHHHHhcCCC
Q 015814 172 YLPFDDSN-LMNLYKK-------------ISAAEFTC------------------------PPWLSFTARKLIARILDPN 213 (400)
Q Consensus 172 ~~Pf~~~~-~~~~~~~-------------i~~~~~~~------------------------~~~~s~~~~~li~~mL~~d 213 (400)
..||.... ..+.... +....... +..++.++.+||.+||+.|
T Consensus 228 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 307 (330)
T 3nsz_A 228 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 307 (330)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSS
T ss_pred CCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCC
Confidence 99995432 2111111 11111111 1227899999999999999
Q ss_pred CCCCCCHHHHhcCcccccC
Q 015814 214 PMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 214 P~~R~t~~eil~h~~~~~~ 232 (400)
|.+|||++|+++||||+.-
T Consensus 308 P~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 308 HQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp GGGSCCHHHHHTSGGGTTC
T ss_pred cccCCCHHHHhcCccHhhh
Confidence 9999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=325.26 Aligned_cols=213 Identities=24% Similarity=0.375 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.++...++.++||||+++++++.+++..|+||||++| +|.+.+.. ...+++..++.++.|++.||+|||++
T Consensus 50 ~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (290)
T 3fme_A 50 KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128 (290)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 44455666668889999999999999999999999999985 87776643 56799999999999999999999998
Q ss_pred -CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh---cCCCCCChhhHHHHHHHHHH
Q 015814 92 -GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 92 -givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGiil~e 167 (400)
||+||||||+||+++.++.+||+|||++...... ......+||+.|+|||++. .....+.++||||+||++|+
T Consensus 129 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~ 205 (290)
T 3fme_A 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205 (290)
T ss_dssp SCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEECCCCCEEEeecCCccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999998765432 2233457999999999972 23334589999999999999
Q ss_pred HHhCCCCCCCCc-h-HHHHHhhhcCccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 168 LLAGYLPFDDSN-L-MNLYKKISAAEFTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 168 lltG~~Pf~~~~-~-~~~~~~i~~~~~~~~-~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
|++|..||.... . ......+.......+ ..++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 206 LAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 999999998632 2 233333333333333 4589999999999999999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=344.41 Aligned_cols=212 Identities=25% Similarity=0.377 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHhC------CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV------KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 16 ~~~i~~Ei~il~~l------~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~ 87 (400)
..++.+|+.+++.+ +||||+++++++.....+|+||||+. |+|.+++.... .+++..++.++.|++.||+|
T Consensus 137 ~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~ 215 (429)
T 3kvw_A 137 HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215 (429)
T ss_dssp HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 56778899988877 57799999999999999999999996 59999998754 49999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCC--eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~--~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
||++||+||||||+|||++.++. +||+|||+|.... ....+.+||+.|+|||++.+..| +.++|||||||++
T Consensus 216 LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il 289 (429)
T 3kvw_A 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCIL 289 (429)
T ss_dssp HHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHH
T ss_pred HHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHH
Confidence 99999999999999999999887 9999999986532 22345789999999999998877 5999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHhhhcCcc--------------------C--------------------------------
Q 015814 166 FVLLAGYLPFDDSNLMNLYKKISAAEF--------------------T-------------------------------- 193 (400)
Q Consensus 166 ~elltG~~Pf~~~~~~~~~~~i~~~~~--------------------~-------------------------------- 193 (400)
|+|++|..||.+.+..+....+..... .
T Consensus 290 ~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (429)
T 3kvw_A 290 AELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPE 369 (429)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCcc
Confidence 999999999998876655443321100 0
Q ss_pred -------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 194 -------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 194 -------~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.+...++.+.+||++||+.||.+|||++|+|+||||+....
T Consensus 370 ~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 370 SREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp CSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred chhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence 01123778999999999999999999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.67 Aligned_cols=218 Identities=28% Similarity=0.435 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...++.+|+.++++++||||+++++++... ...|+||||+.| +|.+.+.. +.+++..+..++.|++.||+|||
T Consensus 52 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH 129 (353)
T 2b9h_A 52 FALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLH 129 (353)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999987654 679999999984 89998876 67999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC--------CccccccCCCCCCCChhhhcCCCCCChhhHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSC 161 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSl 161 (400)
++||+||||||+|||++.+|.+||+|||++......... ......+||+.|+|||++......+.++||||+
T Consensus 130 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 209 (353)
T 2b9h_A 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209 (353)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence 999999999999999999999999999998765432111 112345799999999998765555689999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHhhhcC------------------------cc--------CCCCCCCHHHHHHHHHh
Q 015814 162 GVILFVLLAGYLPFDDSNLMNLYKKISAA------------------------EF--------TCPPWLSFTARKLIARI 209 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~~~~~~~~i~~~------------------------~~--------~~~~~~s~~~~~li~~m 209 (400)
||++|+|++|..||.+.+.......+... .. ..++.++.++.+||.+|
T Consensus 210 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (353)
T 2b9h_A 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM 289 (353)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHh
Confidence 99999999999999988765544332110 00 01235789999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccCCC
Q 015814 210 LDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 210 L~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
|+.||.+|||+.++++||||+....
T Consensus 290 L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 290 LVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cCcCcccCCCHHHHhcCccccccCC
Confidence 9999999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=344.21 Aligned_cols=210 Identities=29% Similarity=0.403 Sum_probs=172.7
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEeC------CEEEEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGSK------TKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lv~Ey~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
..+|+++|+.++||||+++++++... ..+++||||+++ +|.+.+. ....+++..++.++.||+.||+||
T Consensus 94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 34799999999999999999988532 247799999987 5666554 356799999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccC-CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
|++||+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|||++.+....+.++|||||||++||
T Consensus 173 H~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 249 (420)
T 1j1b_A 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249 (420)
T ss_dssp HTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHH
Confidence 99999999999999999965 5689999999976432 2223456899999999999765444699999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcC-----------------ccC------------CCCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAA-----------------EFT------------CPPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
|++|+.||.+.+..+....+... .+. +++.++.++.+||.+||..||.+||
T Consensus 250 ll~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~ 329 (420)
T 1j1b_A 250 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329 (420)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC
Confidence 99999999988765554443210 111 2345689999999999999999999
Q ss_pred CHHHHhcCcccccC
Q 015814 219 TIPEILEDEWFKKD 232 (400)
Q Consensus 219 t~~eil~h~~~~~~ 232 (400)
|+.|+++||||+..
T Consensus 330 t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 330 TPLEACAHSFFDEL 343 (420)
T ss_dssp CHHHHHTSGGGGGG
T ss_pred CHHHHhCCHhhccc
Confidence 99999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=331.68 Aligned_cols=210 Identities=21% Similarity=0.328 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC------------------------CCCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH------------------------GRMK 70 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------------------------~~l~ 70 (400)
..+.+.+|+.++++++||||+++++++.+....|+||||++||+|.+++... ..++
T Consensus 93 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 172 (343)
T 1luf_A 93 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172 (343)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCC
Confidence 4678999999999999999999999999999999999999999999999764 5689
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC
Q 015814 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 150 (400)
Q Consensus 71 e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~ 150 (400)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................||+.|+|||++.+..
T Consensus 173 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 252 (343)
T 1luf_A 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 252 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC
Confidence 99999999999999999999999999999999999999999999999987654332223334567899999999998877
Q ss_pred CCCChhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 151 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 151 ~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+ +.++||||+||++|+|++ |..||.+.+..+....+..+.. ..|..++.++.+||.+||+.||.+|||+.++++
T Consensus 253 ~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 253 Y-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp C-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-CcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6 489999999999999999 9999999888877777665543 567789999999999999999999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.58 Aligned_cols=218 Identities=28% Similarity=0.456 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEE--------------eCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMG--------------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 80 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~--------------~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~q 80 (400)
..+++.+|+.++++++||||+++++++. .....|+||||+. |+|.+.+.. +++++..++.++.|
T Consensus 51 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~q 128 (320)
T 2i6l_A 51 SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQ 128 (320)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHH
Confidence 3678899999999999999999999873 4468999999998 599998865 67999999999999
Q ss_pred HHHHHHHHHHcCCeeccCCCCcEEEc-cCCCeeeecccccccccccc-CCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 81 LINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 81 ll~~l~~LH~~givHrDlKP~NILl~-~~g~~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
++.||+|||++||+||||||+||+++ +++.+||+|||++....... .........||+.|+|||++......+.++||
T Consensus 129 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 208 (320)
T 2i6l_A 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208 (320)
T ss_dssp HHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh
Confidence 99999999999999999999999997 46789999999987654321 12233456789999999998764445689999
Q ss_pred HHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCcc------------------------------CCCCCCCHHHHHHHHH
Q 015814 159 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------------------------TCPPWLSFTARKLIAR 208 (400)
Q Consensus 159 wSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------------------~~~~~~s~~~~~li~~ 208 (400)
||+||++|+|++|+.||.+.+.......+..... ..++.++.++.+||.+
T Consensus 209 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (320)
T 2i6l_A 209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ 288 (320)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHT
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHH
Confidence 9999999999999999998876655544432110 1124589999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 209 ILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 209 mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
||+.||.+|||++++++||||+....
T Consensus 289 ~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 289 ILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp TSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HcCCCccccCCHHHHhCCcccccccC
Confidence 99999999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=347.60 Aligned_cols=205 Identities=16% Similarity=0.219 Sum_probs=169.7
Q ss_pred HHHHHHHHHH---HHHhCCCCCcceee-------EEEEeCCE-----------------EEEEEecCCCCChHHHHHhCC
Q 015814 15 ILLQIKREVA---TMKLVKHPNVVRLY-------EVMGSKTK-----------------IFIVLEFVTGGELFDKIVNHG 67 (400)
Q Consensus 15 ~~~~i~~Ei~---il~~l~HpnIv~l~-------~~~~~~~~-----------------~~lv~Ey~~gg~L~~~i~~~~ 67 (400)
..+.+.+|+. +++.++||||++++ +++.+.+. .|+||||+ +|+|.+++...+
T Consensus 116 ~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~ 194 (377)
T 3byv_A 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL 194 (377)
T ss_dssp HHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc
Confidence 3678999995 55556899999998 77766542 89999999 679999998766
Q ss_pred CCCH-------HHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCC
Q 015814 68 RMKE-------DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 140 (400)
Q Consensus 68 ~l~e-------~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 140 (400)
.+++ ..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|.... ....+.+| +.|
T Consensus 195 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y 268 (377)
T 3byv_A 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGF 268 (377)
T ss_dssp HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCc
Confidence 6666 7888899999999999999999999999999999999999999999987432 23445678 999
Q ss_pred CCChhhhcC-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHh
Q 015814 141 VAPEVLNDR-----------GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 209 (400)
Q Consensus 141 ~APEvl~~~-----------~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~m 209 (400)
+|||++.+. .| +.++|||||||++|+|++|+.||.+.+.......+. ..++.+++++.+||.+|
T Consensus 269 ~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~ 343 (377)
T 3byv_A 269 EPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGF 343 (377)
T ss_dssp CCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHH
T ss_pred cChhhhcccccccccccccccC-ChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHH
Confidence 999999876 56 599999999999999999999998766544433332 23456899999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccc
Q 015814 210 LDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 210 L~~dP~~R~t~~eil~h~~~~~ 231 (400)
|+.||.+|||+.++++||||+.
T Consensus 344 L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 344 LRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp TCSSGGGCCCHHHHHTSHHHHH
T ss_pred cCCCchhCCCHHHHhhChHHHH
Confidence 9999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=328.97 Aligned_cols=211 Identities=23% Similarity=0.357 Sum_probs=184.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC------------------------CC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR------------------------MK 70 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~------------------------l~ 70 (400)
..+++.+|+.++++++||||+++++++...+..|+||||++||+|.+++..... ++
T Consensus 69 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (314)
T 2ivs_A 69 ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148 (314)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEEC
T ss_pred HHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcC
Confidence 367899999999999999999999999999999999999999999999987543 89
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC
Q 015814 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 150 (400)
Q Consensus 71 e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~ 150 (400)
+..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+..
T Consensus 149 ~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence 99999999999999999999999999999999999999999999999987654322211223446788999999998776
Q ss_pred CCCChhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 151 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 151 ~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+ +.++||||+||++|+|++ |..||.+.+.......+..+. ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus 229 ~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 229 Y-TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp E-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6 489999999999999999 999999988877777665543 45667799999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.09 Aligned_cols=214 Identities=27% Similarity=0.411 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEe------CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~------~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~ 86 (400)
.+.+.+|+.+++++ +||||+++++++.. ....|+||||++||+|.+++... ..+++..++.++.|++.||.
T Consensus 64 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~ 143 (326)
T 2x7f_A 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143 (326)
T ss_dssp THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence 36788999999999 89999999999976 56899999999999999999864 47999999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh-----cCCCCCChhhHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSC 161 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSl 161 (400)
|||++||+||||||+||+++.+|.+||+|||++...... .......+||+.|+|||++. ...+ +.++|||||
T Consensus 144 ~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~sl 220 (326)
T 2x7f_A 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSL 220 (326)
T ss_dssp HHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------C-CTTHHHHHH
T ss_pred HHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCC-CccchHHHH
Confidence 999999999999999999999999999999998765432 12234567999999999986 3334 588999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHhhhcCcc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 162 GVILFVLLAGYLPFDDSNLMNLYKKISAAEF--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
||++|+|++|..||.+.+.......+..... ..+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 221 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 221 GITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 9999999999999988777665555443322 2244589999999999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=322.29 Aligned_cols=216 Identities=28% Similarity=0.456 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.+++.++||||+++++++...+..++||||++||+|.+++.... .+++..+..++.|++.||.|||++|
T Consensus 63 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 142 (295)
T 2clq_A 63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142 (295)
T ss_dssp -HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 5778999999999999999999999999999999999999999999997652 4678999999999999999999999
Q ss_pred CeeccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC-CCCChhhHHHHHHHHHHHHh
Q 015814 93 VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGiil~ellt 170 (400)
|+||||||+||+++. ++.+||+|||++...... ........||+.|+|||++.+.. ..+.++||||+||++|+|++
T Consensus 143 i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 220 (295)
T 2clq_A 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220 (295)
T ss_dssp EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH
T ss_pred EEccCCChhhEEEECCCCCEEEeecccccccCCC--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999998 899999999998765432 12234567999999999997643 23589999999999999999
Q ss_pred CCCCCCCCchH--HHHHh-hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 171 GYLPFDDSNLM--NLYKK-ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 171 G~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
|+.||...... ..... ........|..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 221 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 221 GKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred CCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999754322 12221 22334456777999999999999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=329.62 Aligned_cols=210 Identities=27% Similarity=0.423 Sum_probs=178.0
Q ss_pred HHHHHHHHHHHHHhCCCCC------cceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPN------VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~Hpn------Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~ 86 (400)
..+.+++|+.+++.++|+| |+++++++...+..|+||||+ +++|.+++...+ .+++..+..++.|++.||+
T Consensus 54 ~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~ 132 (339)
T 1z57_A 54 YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 3577899999999987665 999999999999999999999 889999998765 6899999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEcc-------------------CCCeeeeccccccccccccCCCccccccCCCCCCCChhhh
Q 015814 87 YCHSRGVYHRDLKPENLLLDA-------------------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 147 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~-------------------~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~ 147 (400)
|||++||+||||||+|||++. ++.+||+|||++..... .....+||+.|+|||++.
T Consensus 133 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~ 207 (339)
T 1z57_A 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVIL 207 (339)
T ss_dssp HHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHT
T ss_pred HHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhh
Confidence 999999999999999999987 67899999999875332 224568999999999998
Q ss_pred cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCC---------------------------------
Q 015814 148 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------------------------------- 194 (400)
Q Consensus 148 ~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------- 194 (400)
+..+ +.++||||+||++|+|++|..||...+..+....+.......
T Consensus 208 ~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (339)
T 1z57_A 208 ALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR 286 (339)
T ss_dssp TSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHH
T ss_pred CCCC-CcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhh
Confidence 8777 489999999999999999999999877655443332211111
Q ss_pred -----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 195 -----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 195 -----------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
+...+.++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 287 ACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred cCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 1113467889999999999999999999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=320.81 Aligned_cols=208 Identities=24% Similarity=0.399 Sum_probs=183.5
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+++.+|+.++++++||||+++++++.+....|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+|
T Consensus 50 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 129 (269)
T 4hcu_A 50 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 129 (269)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 67899999999999999999999999999999999999999999999664 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~P 174 (400)
|||||+||+++.++.+||+|||++........ .......||+.|+|||++....+. .++||||+||++|+|++ |..|
T Consensus 130 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p 207 (269)
T 4hcu_A 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIP 207 (269)
T ss_dssp SCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999875433211 122344578889999999887774 89999999999999999 9999
Q ss_pred CCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 175 FDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|.+.+.......+..+ ....|...+..+.++|.+||+.||.+|||+.++++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 208 YENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9998888887777655 445566689999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=335.46 Aligned_cols=211 Identities=23% Similarity=0.405 Sum_probs=187.6
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHH
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRY 77 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~ 77 (400)
...++.+|+.+++++ +||||+++++++.+.+..|+||||++||+|.+++.... .+++..+..+
T Consensus 117 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 196 (382)
T 3tt0_A 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196 (382)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHH
Confidence 367899999999999 99999999999999999999999999999999998754 4999999999
Q ss_pred HHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhh
Q 015814 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 78 ~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
+.|++.||+|||++||+||||||+|||++.++.+||+|||+|................||+.|+|||++.+..+ +.++|
T Consensus 197 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~D 275 (382)
T 3tt0_A 197 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSD 275 (382)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHH
T ss_pred HHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhH
Confidence 99999999999999999999999999999999999999999986554332233445567899999999988766 48999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||||||++|+|++ |..||.+.+..+....+..+ ....|..++.++.+||.+||+.||.+|||+.+++++
T Consensus 276 iwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 276 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999 99999998888887776655 445667799999999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.05 Aligned_cols=212 Identities=27% Similarity=0.417 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE------EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~------~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
...+++.+|+.+++.++||||+++++++...... |+||||+. |+|.+.+. ..+++..+..++.|++.||+|
T Consensus 83 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~ 159 (371)
T 4exu_A 83 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKY 159 (371)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999876654 99999998 48887773 459999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+....+.++|||||||++|+
T Consensus 160 LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (371)
T 4exu_A 160 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 234 (371)
T ss_dssp HHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred HHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHH
Confidence 9999999999999999999999999999999875432 23456799999999999874444689999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCc-------------------------------cCCCCCCCHHHHHHHHHhcCCCCCC
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAE-------------------------------FTCPPWLSFTARKLIARILDPNPMT 216 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~-------------------------------~~~~~~~s~~~~~li~~mL~~dP~~ 216 (400)
|++|+.||.+.+..+....+.... ...++.+++++.+||.+||+.||.+
T Consensus 235 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 314 (371)
T 4exu_A 235 MLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 314 (371)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTT
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhh
Confidence 999999999887665554432110 0112346899999999999999999
Q ss_pred CCCHHHHhcCcccccCC
Q 015814 217 RITIPEILEDEWFKKDY 233 (400)
Q Consensus 217 R~t~~eil~h~~~~~~~ 233 (400)
|||++|+++||||+...
T Consensus 315 Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 315 RLTAAQALTHPFFEPFR 331 (371)
T ss_dssp SCCHHHHHTSGGGTTTC
T ss_pred cCCHHHHhcCcccccCC
Confidence 99999999999998643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=328.50 Aligned_cols=209 Identities=22% Similarity=0.358 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.++++++||||+++++++.+.. .++|+||+.+|+|.+++... +.+++..+..++.|++.||+|||++||+
T Consensus 61 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 139 (327)
T 3poz_A 61 NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139 (327)
T ss_dssp HHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 578899999999999999999999998755 78899999999999999874 5799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..
T Consensus 140 H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~ 218 (327)
T 3poz_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCC
Confidence 999999999999999999999999987654333333334567889999999998777 489999999999999999 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||.+.+.......+..+ ....++.++.++.+++.+||+.||.+|||+.+++++
T Consensus 219 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 219 PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99988877776666544 356677799999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=328.56 Aligned_cols=209 Identities=24% Similarity=0.365 Sum_probs=181.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.++++++||||+++++++.+....|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+
T Consensus 94 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 173 (325)
T 3kul_A 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173 (325)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 577899999999999999999999999999999999999999999999754 5799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCC-ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+|||++.++.+||+|||++.......... ......||+.|+|||++.+..+. .++||||+||++|+|++ |.
T Consensus 174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~ 252 (325)
T 3kul_A 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGE 252 (325)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999998654322111 12234567889999999877764 89999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+.......+..+ ....+..++..+.+||.+||..||.+|||+.++++
T Consensus 253 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 253 RPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999998888777776554 44566779999999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=320.50 Aligned_cols=215 Identities=33% Similarity=0.573 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe-------------CCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS-------------KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQ 80 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-------------~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~q 80 (400)
..+.+.+|+.++++++||||+++++++.. ....|+||||++||+|.+++...+ .+++..+..++.|
T Consensus 45 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~q 124 (303)
T 1zy4_A 45 KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124 (303)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHH
Confidence 36789999999999999999999998754 457899999999999999998644 5889999999999
Q ss_pred HHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeecccccccccccc------------CCCccccccCCCCCCCChhhhc
Q 015814 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR------------DDGLLHTTCGTPNYVAPEVLND 148 (400)
Q Consensus 81 ll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~ 148 (400)
++.||+|||++||+||||||+||+++.+|.+||+|||++....... ........+||+.|+|||++.+
T Consensus 125 i~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred HHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 9999999999999999999999999999999999999987643211 1122345679999999999987
Q ss_pred CCCCCChhhHHHHHHHHHHHHhCCCCCCCC-chHHHHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 149 RGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 149 ~~~~~~~~DIwSlGiil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
.+..+.++||||+||++|+|++ ||... +.......+.......|+ ..+..+.++|.+||+.||.+|||+.++
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 281 (303)
T 1zy4_A 205 TGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281 (303)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHH
Confidence 6555699999999999999998 66533 334455555544444443 456779999999999999999999999
Q ss_pred hcCcccccC
Q 015814 224 LEDEWFKKD 232 (400)
Q Consensus 224 l~h~~~~~~ 232 (400)
++||||+..
T Consensus 282 l~h~~~~~~ 290 (303)
T 1zy4_A 282 LNSGWLPVK 290 (303)
T ss_dssp HHSSCSCCC
T ss_pred hCCCCcCCC
Confidence 999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=330.50 Aligned_cols=215 Identities=23% Similarity=0.303 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCE-------EEEEEecCCCCChHHHH----HhCCCCCHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTK-------IFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-------~~lv~Ey~~gg~L~~~i----~~~~~l~e~~~~~~~~qll~~l 85 (400)
.+..+|+..++.++||||+++++++..... +|+||||+.| +|.+.+ .....+++..+..++.|++.||
T Consensus 64 ~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 142 (360)
T 3e3p_A 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142 (360)
T ss_dssp CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 355678888899999999999999865433 8999999987 444433 3566799999999999999999
Q ss_pred HHHH--HcCCeeccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 86 DYCH--SRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 86 ~~LH--~~givHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
.||| ++||+||||||+|||++. ++.+||+|||++..... .......+||+.|+|||++.+....+.++||||+|
T Consensus 143 ~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG 219 (360)
T 3e3p_A 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219 (360)
T ss_dssp HHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHH
Confidence 9999 999999999999999997 89999999999976543 22234567999999999997766556999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHhhhcCc--------------------------------cCCCCCCCHHHHHHHHHhc
Q 015814 163 VILFVLLAGYLPFDDSNLMNLYKKISAAE--------------------------------FTCPPWLSFTARKLIARIL 210 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~~~~~~~i~~~~--------------------------------~~~~~~~s~~~~~li~~mL 210 (400)
|++|+|++|+.||.+.+.......+.... ...+...+.++.+||.+||
T Consensus 220 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 299 (360)
T 3e3p_A 220 CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299 (360)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHT
T ss_pred HHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHh
Confidence 99999999999999887766655543210 0111225678999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccCCCC
Q 015814 211 DPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 211 ~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
+.||.+|||+.|+++||||+....+
T Consensus 300 ~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 300 QYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred ccCccccCCHHHHhcCccccccCCc
Confidence 9999999999999999999975543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=334.25 Aligned_cols=210 Identities=22% Similarity=0.363 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCC-EEEEEEecCCCCChHHHHHhCCC-------------------------
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKT-KIFIVLEFVTGGELFDKIVNHGR------------------------- 68 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~-~~~lv~Ey~~gg~L~~~i~~~~~------------------------- 68 (400)
.+.+.+|+.+++++ +||||+++++++...+ .+|+||||++||+|.+++.....
T Consensus 69 ~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (359)
T 3vhe_A 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148 (359)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------
T ss_pred HHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchh
Confidence 57799999999999 7999999999987754 48999999999999999987543
Q ss_pred -----------------------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEcc
Q 015814 69 -----------------------------------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 107 (400)
Q Consensus 69 -----------------------------------------l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~ 107 (400)
+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~ 228 (359)
T 3vhe_A 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 228 (359)
T ss_dssp -----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred hhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC
Confidence 899999999999999999999999999999999999999
Q ss_pred CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCchHHH-HH
Q 015814 108 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL-YK 185 (400)
Q Consensus 108 ~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~-~~ 185 (400)
++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+...... ..
T Consensus 229 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 307 (359)
T 3vhe_A 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307 (359)
T ss_dssp GGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence 999999999999765432222233456789999999999887774 89999999999999998 9999988765433 33
Q ss_pred hhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 186 KISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 186 ~i~~-~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
.+.. .....|..+++++.++|.+||+.||.+|||+.++++|
T Consensus 308 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 308 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 3333 3456677899999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.70 Aligned_cols=208 Identities=25% Similarity=0.397 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+++.+|+.++++++||||+++++++.+....|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+|
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 127 (268)
T 3sxs_A 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127 (268)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 668999999999999999999999999999999999999999999998754 5999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~P 174 (400)
|||||+||+++.++.+||+|||++....... ........||+.|+|||++.+..+. .++||||+||++|+|++ |..|
T Consensus 128 ~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p 205 (268)
T 3sxs_A 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMP 205 (268)
T ss_dssp SSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCT
T ss_pred CCcCcceEEECCCCCEEEccCccceecchhh-hhcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999987543321 1112234567789999999887764 89999999999999999 9999
Q ss_pred CCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 175 FDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|...+.......+..+. ...|...++.+.++|.+||+.||.+|||+.+++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 206 YDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99988877777665554 34566689999999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=322.44 Aligned_cols=211 Identities=31% Similarity=0.454 Sum_probs=178.8
Q ss_pred HHHHHHHHHHhC---CCCCcceeeEEEE-----eCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHH
Q 015814 18 QIKREVATMKLV---KHPNVVRLYEVMG-----SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 18 ~i~~Ei~il~~l---~HpnIv~l~~~~~-----~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~ 87 (400)
.+.+|+.+++.+ +||||+++++++. .....|+||||+. |+|.+++.... .+++..+..++.|++.||.|
T Consensus 57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~ 135 (326)
T 1blx_A 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135 (326)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 566788887766 8999999999987 5677999999998 59999998754 49999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+||+++.+|.+||+|||++...... ......+||+.|+|||++.+..+ +.++||||+||++|+
T Consensus 136 lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ 211 (326)
T 1blx_A 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAE 211 (326)
T ss_dssp HHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHH
T ss_pred HHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHH
Confidence 99999999999999999999999999999998765432 22345679999999999987776 589999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCc---------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAE---------------------------FTCPPWLSFTARKLIARILDPNPMTRITI 220 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~---------------------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~ 220 (400)
|++|+.||.+.+.......+.... ...++.++..+.+||.+||+.||.+|||+
T Consensus 212 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 291 (326)
T 1blx_A 212 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291 (326)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH
Confidence 999999999887766555442110 01234578999999999999999999999
Q ss_pred HHHhcCcccccCC
Q 015814 221 PEILEDEWFKKDY 233 (400)
Q Consensus 221 ~eil~h~~~~~~~ 233 (400)
.++++||||+...
T Consensus 292 ~e~l~hp~~~~~~ 304 (326)
T 1blx_A 292 YSALSHPYFQDLE 304 (326)
T ss_dssp HHHHTSGGGTTCC
T ss_pred HHHhcCccccccc
Confidence 9999999998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.79 Aligned_cols=208 Identities=24% Similarity=0.375 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+++.+|+.++++++||||+++++++.+....|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+|
T Consensus 64 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 143 (283)
T 3gen_A 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143 (283)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 6688999999999999999999999999999999999999999999977 567999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~P 174 (400)
|||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++||||+||++|+|++ |+.|
T Consensus 144 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p 221 (283)
T 3gen_A 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMP 221 (283)
T ss_dssp SSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999876533211 11233457888999999988776 489999999999999998 9999
Q ss_pred CCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 175 FDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|...+.......+..+. ...|...++.+.++|.+||+.||.+|||+.++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 222 YERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99988887777766553 44566689999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.47 Aligned_cols=208 Identities=20% Similarity=0.358 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+.+|+.++++++||||+++++++. ....++||||+.||+|.+++... +.+++..+..++.|++.||+|||++||+|
T Consensus 60 ~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 138 (325)
T 3kex_A 60 QAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH 138 (325)
T ss_dssp CSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999999886 46688999999999999999875 57999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~P 174 (400)
|||||+|||++.+|.+||+|||++................||+.|+|||++.+..+ +.++||||+||++|+|++ |..|
T Consensus 139 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp SCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCC
Confidence 99999999999999999999999987654333334455678889999999988776 489999999999999999 9999
Q ss_pred CCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 175 FDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|.+.+.......+..+ ....|..++.++.++|.+||..||.+|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 218 YAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9988877777666554 455667789999999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=330.11 Aligned_cols=212 Identities=18% Similarity=0.298 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-----------------------CCCH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------------------RMKE 71 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-----------------------~l~e 71 (400)
.+.+.+|+.+++++ +||||+++++++...+..|+||||++||+|.+++.... .+++
T Consensus 92 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 171 (344)
T 1rjb_A 92 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171 (344)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCH
Confidence 57899999999999 89999999999999999999999999999999997653 2789
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC
Q 015814 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151 (400)
Q Consensus 72 ~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~ 151 (400)
..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................||+.|+|||++.+..+
T Consensus 172 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence 99999999999999999999999999999999999999999999999976554322223345568899999999988776
Q ss_pred CCChhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhh-hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 152 DGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 152 ~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i-~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
+.++|||||||++|+|++ |..||.+.+.......+ ..+ ....|..++.++.+||.+||..||.+|||+.++++|-.
T Consensus 252 -~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 252 -TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp -CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 489999999999999998 99999887654443333 222 34556779999999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.94 Aligned_cols=210 Identities=23% Similarity=0.421 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC--EEEEEEecCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lv~Ey~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~l~~LH~ 90 (400)
.+.+.+|+.++++++||||+++++++.... ..|+||||++||+|.+++..... +++..+..++.|++.||+|||+
T Consensus 51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 130 (319)
T 4euu_A 51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130 (319)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999999988655 78999999999999999976543 9999999999999999999999
Q ss_pred cCCeeccCCCCcEEE----ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-------CCCCCChhhHH
Q 015814 91 RGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-------RGYDGSTADLW 159 (400)
Q Consensus 91 ~givHrDlKP~NILl----~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-------~~~~~~~~DIw 159 (400)
+||+||||||+|||+ +.++.+||+|||++..... .......+||+.|+|||++.. ....+.++|||
T Consensus 131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diw 207 (319)
T 4euu_A 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207 (319)
T ss_dssp TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHH
T ss_pred CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHH
Confidence 999999999999999 7778899999999976543 223345679999999999862 23345899999
Q ss_pred HHHHHHHHHHhCCCCCCCCc----hHHHHHhhhcCcc-------------------CCC------CCCCHHHHHHHHHhc
Q 015814 160 SCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEF-------------------TCP------PWLSFTARKLIARIL 210 (400)
Q Consensus 160 SlGiil~elltG~~Pf~~~~----~~~~~~~i~~~~~-------------------~~~------~~~s~~~~~li~~mL 210 (400)
|+||++|+|++|..||.... ..+....+..+.+ ..| ..++..+.+||++||
T Consensus 208 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 287 (319)
T 4euu_A 208 SIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287 (319)
T ss_dssp HHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhc
Confidence 99999999999999996422 2233333322221 111 123567889999999
Q ss_pred CCCCCCCCCHHHHhcCcc
Q 015814 211 DPNPMTRITIPEILEDEW 228 (400)
Q Consensus 211 ~~dP~~R~t~~eil~h~~ 228 (400)
+.||.+|||++|+++||=
T Consensus 288 ~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 288 EADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCCTTTSCCHHHHHHHHH
T ss_pred cCChhhhccHHHhhhccH
Confidence 999999999999999873
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=319.04 Aligned_cols=209 Identities=25% Similarity=0.398 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.++++++||||+++++++. .+..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 136 (281)
T 1mp8_A 58 SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136 (281)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678999999999999999999999984 567899999999999999998654 6999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
|+||||||+|||++.++.+||+|||++....... ........||+.|+|||++....+. .++||||+||++|+|++ |
T Consensus 137 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g 214 (281)
T 1mp8_A 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHG 214 (281)
T ss_dssp CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTS
T ss_pred eecccccHHHEEECCCCCEEECccccccccCccc-ccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcC
Confidence 9999999999999999999999999987654321 1112334578899999999877774 89999999999999996 9
Q ss_pred CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||.+.+..+....+..+ ....++.+++++.++|.+||+.||.+|||+.++++
T Consensus 215 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 215 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999988877777666554 34567789999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=323.29 Aligned_cols=210 Identities=24% Similarity=0.389 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.++++++||||+++++++.+....|+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||
T Consensus 50 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 129 (310)
T 3s95_A 50 TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129 (310)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 367899999999999999999999999999999999999999999999987 5679999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCC------------CccccccCCCCCCCChhhhcCCCCCChhhHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSC 161 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSl 161 (400)
+||||||+|||++.++.+||+|||++......... ....+.+||+.|+|||++.+..+ +.++||||+
T Consensus 130 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~sl 208 (310)
T 3s95_A 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSF 208 (310)
T ss_dssp ECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHH
T ss_pred cCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHH
Confidence 99999999999999999999999999765432211 11125689999999999988777 489999999
Q ss_pred HHHHHHHHhCCCCCCCCchHHHHHh---hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 162 GVILFVLLAGYLPFDDSNLMNLYKK---ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 162 Giil~elltG~~Pf~~~~~~~~~~~---i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||++|+|++|..||........... ........|+.+++.+.++|.+||+.||.+|||+.++++
T Consensus 209 G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 209 GIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999875332111000 000112346778999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=320.54 Aligned_cols=204 Identities=20% Similarity=0.233 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.++++++||||+++++++.+.+..|+||||++||+|.+++...+. +++..+..++.|++.||.|||++||+
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 135 (289)
T 4fvq_A 56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI 135 (289)
T ss_dssp HHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeE
Confidence 57899999999999999999999999999999999999999999999987654 99999999999999999999999999
Q ss_pred eccCCCCcEEEccCCC--------eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 95 HRDLKPENLLLDAYGN--------LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 95 HrDlKP~NILl~~~g~--------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
||||||+|||++.++. +||+|||++..... .....||+.|+|||++.+....+.++||||+||++|
T Consensus 136 H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 209 (289)
T 4fvq_A 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLW 209 (289)
T ss_dssp CCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHH
T ss_pred CCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHH
Confidence 9999999999999887 99999999864322 234568999999999987444468999999999999
Q ss_pred HHHhC-CCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 167 VLLAG-YLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 167 elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+|++| ..||...+...... ........|...+.++.+||.+||+.||.+|||+.++++|
T Consensus 210 el~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 210 EICSGGDKPLSALDSQRKLQ-FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHTTTCCTTTTSCHHHHHH-HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCccccchHHHHH-HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99995 55665555444333 3334556667788999999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=329.65 Aligned_cols=212 Identities=27% Similarity=0.410 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCE------EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~------~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
...+++.+|+.+++.++||||+++++++..... +|+||||+.| +|.+.+. ..+++..+..++.|++.||+|
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~ 141 (353)
T 3coi_A 65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKY 141 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence 346788999999999999999999999977653 5999999984 8887764 359999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+||+++.+|.+||+|||++..... .....+||+.|+|||++.+....+.++||||+||++|+
T Consensus 142 LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~e 216 (353)
T 3coi_A 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 216 (353)
T ss_dssp HHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred HHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999999999875432 13456799999999999874445689999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcC-------------------------------ccCCCCCCCHHHHHHHHHhcCCCCCC
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAA-------------------------------EFTCPPWLSFTARKLIARILDPNPMT 216 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~-------------------------------~~~~~~~~s~~~~~li~~mL~~dP~~ 216 (400)
|++|..||.+.+..+....+... ....++.++.++.+||.+||+.||.+
T Consensus 217 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 296 (353)
T 3coi_A 217 MLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 296 (353)
T ss_dssp HHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCccc
Confidence 99999999987765544433210 01123457899999999999999999
Q ss_pred CCCHHHHhcCcccccCC
Q 015814 217 RITIPEILEDEWFKKDY 233 (400)
Q Consensus 217 R~t~~eil~h~~~~~~~ 233 (400)
|||++++++||||+...
T Consensus 297 Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 297 RLTAAQALTHPFFEPFR 313 (353)
T ss_dssp SCCHHHHHTSGGGTTTC
T ss_pred CCCHHHHhcCcchhhcc
Confidence 99999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=321.41 Aligned_cols=219 Identities=26% Similarity=0.463 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHHHhCC--CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVK--HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+++|+.++++++ ||||+++++++.+....|+||| +.+|+|.+++...+.+++..+..++.|++.||.|||++|
T Consensus 69 ~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 147 (313)
T 3cek_A 69 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147 (313)
T ss_dssp HHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4678999999999997 5999999999999999999999 567899999999889999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC----------CCCCChhhHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCG 162 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~----------~~~~~~~DIwSlG 162 (400)
|+||||||+|||+++ |.+||+|||++...............+||+.|+|||++.+. ...+.++||||||
T Consensus 148 ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG 226 (313)
T 3cek_A 148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226 (313)
T ss_dssp CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH
T ss_pred ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH
Confidence 999999999999965 89999999999765443222233456899999999998751 2335899999999
Q ss_pred HHHHHHHhCCCCCCCCch-HHHHHhhhc--CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 163 VILFVLLAGYLPFDDSNL-MNLYKKISA--AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~-~~~~~~i~~--~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
|++|+|++|..||..... ......+.. .....|...+.++.+||.+||+.||.+|||+.++++||||+....+
T Consensus 227 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 227 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp HHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred HHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 999999999999987533 222333222 2345667789999999999999999999999999999999876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=326.95 Aligned_cols=209 Identities=25% Similarity=0.413 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHhCCCCC------cceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPN------VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~Hpn------Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~ 87 (400)
.+.+.+|+.+++.++|++ ++.+++++......|+||||+ +|+|.+.+.... .+++..++.++.|++.||+|
T Consensus 60 ~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~ 138 (355)
T 2eu9_A 60 REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138 (355)
T ss_dssp HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 577889999999998766 999999999999999999999 668888887654 69999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEE-------------------ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc
Q 015814 88 CHSRGVYHRDLKPENLLL-------------------DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 148 (400)
Q Consensus 88 LH~~givHrDlKP~NILl-------------------~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~ 148 (400)
||++||+||||||+|||+ +.++.+||+|||++..... .....+||+.|+|||++.+
T Consensus 139 lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILE 213 (355)
T ss_dssp HHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTT
T ss_pred HHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeec
Confidence 999999999999999999 6678999999999875332 2245689999999999988
Q ss_pred CCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCC---------------------------------
Q 015814 149 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--------------------------------- 195 (400)
Q Consensus 149 ~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------- 195 (400)
..+. .++||||+||++|+|++|..||...+..+....+.......|
T Consensus 214 ~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (355)
T 2eu9_A 214 LGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN 292 (355)
T ss_dssp CCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH
T ss_pred CCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcccccc
Confidence 7774 899999999999999999999998776554433322111111
Q ss_pred -----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 196 -----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 196 -----------~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
...+.++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 293 CKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp CCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred CCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcC
Confidence 112457889999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=324.68 Aligned_cols=208 Identities=22% Similarity=0.356 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.++++++||||+++++++.... .++|+||+.+|+|.+++... +.+++..+..++.|++.||+|||++||+
T Consensus 61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 139 (327)
T 3lzb_A 61 NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139 (327)
T ss_dssp HHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCc
Confidence 578899999999999999999999998765 78899999999999999774 5799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+|||++.++.+||+|||++................||+.|+|||++.+..|. .++|||||||++|+|++ |..
T Consensus 140 H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~ 218 (327)
T 3lzb_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999876543333333445678899999999987774 89999999999999999 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+.......+..+ ....|+.++.++.++|.+||..||.+|||+.++++
T Consensus 219 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 219 PYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99998887777666554 35667779999999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=334.04 Aligned_cols=210 Identities=25% Similarity=0.411 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHHhCC--------CCCcceeeEEEE----eCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVK--------HPNVVRLYEVMG----SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQ 80 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~--------HpnIv~l~~~~~----~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~q 80 (400)
..+.+.+|+.+++.++ ||||+++++++. +...+|+||||+ +|+|.+.+... +.+++..++.++.|
T Consensus 76 ~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~q 154 (397)
T 1wak_A 76 YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQ 154 (397)
T ss_dssp HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHH
Confidence 3578899999999985 788999999987 556899999999 56788877654 46999999999999
Q ss_pred HHHHHHHHHHc-CCeeccCCCCcEEEccCC-------------------------------------------------C
Q 015814 81 LINAVDYCHSR-GVYHRDLKPENLLLDAYG-------------------------------------------------N 110 (400)
Q Consensus 81 ll~~l~~LH~~-givHrDlKP~NILl~~~g-------------------------------------------------~ 110 (400)
|+.||+|||++ ||+||||||+|||++.+| .
T Consensus 155 i~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (397)
T 1wak_A 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234 (397)
T ss_dssp HHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCC
T ss_pred HHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccc
Confidence 99999999999 999999999999999775 8
Q ss_pred eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCch------HHHH
Q 015814 111 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL------MNLY 184 (400)
Q Consensus 111 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~------~~~~ 184 (400)
+||+|||+|..... .....+||+.|+|||++.+..|. .++|||||||++|+|++|+.||...+. ....
T Consensus 235 ~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 308 (397)
T 1wak_A 235 VKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308 (397)
T ss_dssp EEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHH
T ss_pred eEeccccccccccc-----cCccCCCCCcccCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHH
Confidence 99999999876532 13456899999999999988774 899999999999999999999976442 1111
Q ss_pred HhhhcC------------c------------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 015814 185 KKISAA------------E------------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPE 222 (400)
Q Consensus 185 ~~i~~~------------~------------------------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~e 222 (400)
..+... . ...+...+..+.+||.+||+.||.+|||++|
T Consensus 309 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 388 (397)
T 1wak_A 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388 (397)
T ss_dssp HHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH
T ss_pred HHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH
Confidence 111100 0 0111123467889999999999999999999
Q ss_pred HhcCccccc
Q 015814 223 ILEDEWFKK 231 (400)
Q Consensus 223 il~h~~~~~ 231 (400)
+++||||+.
T Consensus 389 ~l~hp~~~~ 397 (397)
T 1wak_A 389 CLRHPWLNS 397 (397)
T ss_dssp HHTSGGGGC
T ss_pred HhhCccccC
Confidence 999999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=336.79 Aligned_cols=211 Identities=17% Similarity=0.198 Sum_probs=158.3
Q ss_pred HHHHHHHHHHHHHHhC--CCCCcceee-------EEEEeC-----------------CEEEEEEecCCCCChHHHHHhCC
Q 015814 14 CILLQIKREVATMKLV--KHPNVVRLY-------EVMGSK-----------------TKIFIVLEFVTGGELFDKIVNHG 67 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l--~HpnIv~l~-------~~~~~~-----------------~~~~lv~Ey~~gg~L~~~i~~~~ 67 (400)
...+.+++|+.+++.+ +||||++++ +++... ..+|+||||++ |+|.+++...+
T Consensus 104 ~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 182 (371)
T 3q60_A 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD 182 (371)
T ss_dssp HHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence 3467788896555555 699987755 555443 34899999999 79999998643
Q ss_pred -CCCHHHH------HHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCC
Q 015814 68 -RMKEDEA------RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 140 (400)
Q Consensus 68 -~l~e~~~------~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 140 (400)
.+++... ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|..... ......||+.|
T Consensus 183 ~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y 257 (371)
T 3q60_A 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTY 257 (371)
T ss_dssp HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGG
T ss_pred cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCC
Confidence 3444444 56669999999999999999999999999999999999999999875432 12245677999
Q ss_pred CCChhhhc--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHH--HHHh-----hhcCccCC--CCCCCHHHHHHHHHh
Q 015814 141 VAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--LYKK-----ISAAEFTC--PPWLSFTARKLIARI 209 (400)
Q Consensus 141 ~APEvl~~--~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~--~~~~-----i~~~~~~~--~~~~s~~~~~li~~m 209 (400)
+|||++.+ ..| +.++||||+||++|+|++|+.||.+.+... .+.. ........ ++.++..+.+||.+|
T Consensus 258 ~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 258 APREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp CCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHH
T ss_pred cChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHH
Confidence 99999976 456 599999999999999999999998764321 1111 11112222 346899999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccc
Q 015814 210 LDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 210 L~~dP~~R~t~~eil~h~~~~~ 231 (400)
|+.||.+|||+.++++||||+.
T Consensus 337 L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 337 LNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TCSSTTTCCCHHHHTTSHHHHH
T ss_pred cCCChhhCCCHHHHhcCHHHHH
Confidence 9999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=323.11 Aligned_cols=207 Identities=22% Similarity=0.375 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~ 78 (400)
.+++.+|+.+++++ +||||+++++++.+.+..|+||||++||+|.+++...+ .+++..++.++
T Consensus 69 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 148 (327)
T 1fvr_A 69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148 (327)
T ss_dssp -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHH
Confidence 56789999999999 99999999999999999999999999999999997754 69999999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++||+||||||+||+++.++.+||+|||++...... .......+|+.|+|||++.+..+ +.++||
T Consensus 149 ~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 224 (327)
T 1fvr_A 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDV 224 (327)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHH
T ss_pred HHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccC-Cchhcc
Confidence 99999999999999999999999999999999999999998743321 11234467899999999987766 489999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||+||++|+|++ |..||.+.+.......+..+ ....|..++..+.+||.+||..||.+|||+++++++
T Consensus 225 ~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 225 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999998 99999998888888777655 345566789999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=322.03 Aligned_cols=210 Identities=19% Similarity=0.280 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~~l 85 (400)
...+.+|+.+++.++||||+++++++.+....|+||||++||+|.+++... ..+++..+..++.|++.||
T Consensus 72 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 151 (322)
T 1p4o_A 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151 (322)
T ss_dssp HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHH
Confidence 467889999999999999999999999999999999999999999999753 3578999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
.|||++||+||||||+||+++.+|.+||+|||++................||+.|+|||++.+..+ +.++||||+||++
T Consensus 152 ~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il 230 (322)
T 1p4o_A 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVL 230 (322)
T ss_dssp HHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHH
T ss_pred HHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHH
Confidence 999999999999999999999999999999999876543322222334567899999999988776 4899999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|+|++ |..||.+.+.......+..+. ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 231 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 231 WEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999 899999988877777765544 45667799999999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=324.83 Aligned_cols=207 Identities=32% Similarity=0.560 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHhCC--CCCcceeeEEEEeCCEEEEEEecCCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 17 LQIKREVATMKLVK--HPNVVRLYEVMGSKTKIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv~Ey~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+|+.++++++ ||||+++++++......++||||+.+ ++|.+++...+.+++..++.++.|++.||+|||++||
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 170 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 170 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 45667999999996 59999999999999999999999986 8999999988899999999999999999999999999
Q ss_pred eeccCCCCcEEEc-cCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~-~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+||||||+|||++ .++.+||+|||++..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+
T Consensus 171 vH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred EeCCCCHHHEEEeCCCCCEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 9999999999999 679999999999876542 22345679999999999988777678899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||.... .+.......+..++.++.+||.+||+.||.+|||++++++||||+...
T Consensus 247 ~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 247 IPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CCCCChh------hhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 9997643 223344556778999999999999999999999999999999998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=335.49 Aligned_cols=209 Identities=26% Similarity=0.419 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|+.+|++++||||+++++++......|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+
T Consensus 156 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 235 (377)
T 3cbl_A 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235 (377)
T ss_dssp HTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcC
Confidence 5678899999999999999999999999999999999999999999997654 699999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+|||++.+|.+||+|||++................+++.|+|||++....+ +.++||||+||++|||++ |..
T Consensus 236 HrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~ 314 (377)
T 3cbl_A 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGAS 314 (377)
T ss_dssp CSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCC
T ss_pred CcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875332111111112345678999999987766 489999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+.......+..+ ..+.|..++.++.+||.+||+.||.+|||+.++++
T Consensus 315 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 315 PYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp SSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99998877766665544 45667779999999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=322.09 Aligned_cols=210 Identities=20% Similarity=0.339 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC------------------CCCHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARR 76 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~------------------~l~e~~~~~ 76 (400)
.+.+.+|+.+++++ +||||+++++++...+..|+||||++||+|.+++.... .+++..+..
T Consensus 70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (313)
T 1t46_A 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149 (313)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred HHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHH
Confidence 57899999999999 99999999999999999999999999999999998754 489999999
Q ss_pred HHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChh
Q 015814 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 156 (400)
Q Consensus 77 ~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~ 156 (400)
++.|++.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+..+ +.++
T Consensus 150 ~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~ 228 (313)
T 1t46_A 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFES 228 (313)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHH
T ss_pred HHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHH
Confidence 999999999999999999999999999999999999999999876554322222334567889999999988776 4999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCchHHHHHh-hhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 157 DLWSCGVILFVLLA-GYLPFDDSNLMNLYKK-ISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 157 DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~-i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||||+||++|+|++ |..||.+......... +... ....+..++.++.++|.+||+.||.+|||+.+++++
T Consensus 229 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99999999999999 9999988765443333 2222 334466789999999999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=322.89 Aligned_cols=215 Identities=20% Similarity=0.299 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~l~~L 88 (400)
..++.+|+.++++++||||+++++++......|+||||++||+|.+++.... .+++..+..++.|++.||.||
T Consensus 77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L 156 (327)
T 2yfx_A 77 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156 (327)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH
Confidence 5678899999999999999999999999999999999999999999998753 489999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccC---CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~---g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
|++||+||||||+|||++.+ +.+||+|||++................||+.|+|||++.+..+ +.++|||||||++
T Consensus 157 H~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il 235 (327)
T 2yfx_A 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLL 235 (327)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHH
T ss_pred hhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHH
Confidence 99999999999999999954 4699999999875543322233345678999999999988776 4899999999999
Q ss_pred HHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 166 FVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 166 ~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|+|++ |..||...+.......+..+ ....+..++..+.++|.+||+.||.+|||+.++++|.|+..
T Consensus 236 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 236 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 99998 99999988877777666554 34556679999999999999999999999999999988754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.06 Aligned_cols=205 Identities=27% Similarity=0.496 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC---
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--- 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g--- 92 (400)
.+.+++|+.+++.++||||+++++++.+.+..|+||||++||+|.+.+. .+++++..+..++.|++.||+|||++|
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~ 128 (271)
T 3dtc_A 50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Confidence 5788999999999999999999999999999999999999999988885 468999999999999999999999999
Q ss_pred CeeccCCCCcEEEcc--------CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 93 VYHRDLKPENLLLDA--------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 93 ivHrDlKP~NILl~~--------~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
|+||||||+||+++. ++.+||+|||++...... ......||+.|+|||++.+..+ +.++||||+||+
T Consensus 129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~ 203 (271)
T 3dtc_A 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVL 203 (271)
T ss_dssp CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHH
T ss_pred eeecCCchHHEEEecccccccccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCC-CchhhHHHHHHH
Confidence 999999999999986 678999999998754432 2234679999999999988776 489999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+|+|++|+.||.+.+.......+... ....+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 204 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 204 LWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999988776665554433 345567789999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.13 Aligned_cols=208 Identities=24% Similarity=0.387 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+++.+|+.++++++||||+++++++.+.+..|+||||++||+|.+++... +.+++..+..++.|++.||+|||++|++|
T Consensus 48 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 127 (267)
T 3t9t_A 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127 (267)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 67899999999999999999999999999999999999999999999875 46899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLP 174 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~P 174 (400)
|||||+||+++.++.+||+|||++....... ........||+.|+|||++.+..+ +.++||||+|+++|+|++ |..|
T Consensus 128 ~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p 205 (267)
T 3t9t_A 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIP 205 (267)
T ss_dssp SSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCC
Confidence 9999999999999999999999987643211 111233467889999999987776 489999999999999999 9999
Q ss_pred CCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 175 FDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|.+.+.......+..+. ...|...+..+.++|.+||+.||.+|||+.+++++
T Consensus 206 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 206 YENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99988877777766553 34566689999999999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.18 Aligned_cols=211 Identities=23% Similarity=0.332 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----EEEEEEecCCCCChHHHHH------hCCCCCHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIV------NHGRMKEDEARRYFQQLIN 83 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lv~Ey~~gg~L~~~i~------~~~~l~e~~~~~~~~qll~ 83 (400)
..+.+.+|+.++++++||||+++++++.... ..|+||||+++|+|.+++. ....+++..+..++.|++.
T Consensus 79 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~ 158 (313)
T 3brb_A 79 EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158 (313)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHH
Confidence 3678899999999999999999999987654 3599999999999999994 3356999999999999999
Q ss_pred HHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 84 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 84 ~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
||.|||++||+||||||+||+++.++.+||+|||++................|++.|+|||++.+..+ +.++||||+||
T Consensus 159 aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~ 237 (313)
T 3brb_A 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGV 237 (313)
T ss_dssp HHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHH
T ss_pred HHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHH
Confidence 99999999999999999999999999999999999876543222222334567889999999988776 48999999999
Q ss_pred HHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 164 ILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 164 il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
++|+|++ |..||.+.+.......+..+ ....|..++.++.++|.+||..||.+|||+.+++++
T Consensus 238 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 238 TMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999 99999988877777766554 445667799999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=314.84 Aligned_cols=208 Identities=26% Similarity=0.398 Sum_probs=183.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++.+|+.++++++||||+++++++.+....|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||
T Consensus 53 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 132 (288)
T 3kfa_A 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132 (288)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCc
Confidence 5788999999999999999999999999999999999999999999998743 59999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||+++.++.+||+|||++....... ........||+.|+|||++.+..+ +.++||||+||++|+|++ |.
T Consensus 133 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~ 210 (288)
T 3kfa_A 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGM 210 (288)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654321 122234567889999999988777 489999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+.......+... ....|..++..+.+||.+||..||.+|||+.++++
T Consensus 211 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 211 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 999988877776666544 44566779999999999999999999999999976
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.07 Aligned_cols=212 Identities=24% Similarity=0.333 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+++.+|+.++++++||||+++++++ .....|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||
T Consensus 53 ~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 131 (287)
T 1u59_A 53 DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131 (287)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 367899999999999999999999999 556689999999999999999654 469999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
+||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+..+ +.++||||+||++|+|++ |
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g 210 (287)
T 1u59_A 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYG 210 (287)
T ss_dssp ECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTS
T ss_pred eeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999876543211 111233457899999999987766 489999999999999998 9
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
+.||.+.+..+....+..+. ...|+.+++++.++|.+||+.||.+|||+.+++++.+
T Consensus 211 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 211 QKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999888777776665543 5667789999999999999999999999999998643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.84 Aligned_cols=209 Identities=21% Similarity=0.311 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+++.+|+.+++.++||||+++++++ .....|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 61 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 139 (291)
T 1xbb_A 61 LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139 (291)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 367899999999999999999999999 5677899999999999999999988899999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..+. .++||||+||++|+|++ |.
T Consensus 140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~ 218 (291)
T 1xbb_A 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQ 218 (291)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999998765432111 112234567899999999877664 89999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+.......+..+. ...|..++..+.++|.+||+.||.+|||+.++++
T Consensus 219 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 219 KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999988877777665543 4567789999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=322.92 Aligned_cols=211 Identities=23% Similarity=0.402 Sum_probs=184.3
Q ss_pred HHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHH
Q 015814 15 ILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRY 77 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~ 77 (400)
..+++.+|+.+++++ +||||+++++++...+..|+||||++||+|.+++.... .+++..+..+
T Consensus 83 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 162 (334)
T 2pvf_A 83 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162 (334)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHH
Confidence 367899999999999 89999999999999999999999999999999998654 3899999999
Q ss_pred HHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhh
Q 015814 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 78 ~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
+.|++.||+|||++||+||||||+||+++.+|.+||+|||++................||+.|+|||++.+..+ +.++|
T Consensus 163 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 241 (334)
T 2pvf_A 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSD 241 (334)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHH
Confidence 99999999999999999999999999999999999999999876543221112233467889999999987766 48999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||+||++|+|++ |..||.+.+..+....+..+. ...+..++.++.++|.+||..||.+|||+.+++++
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999 999999988887777665543 45667789999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=321.21 Aligned_cols=207 Identities=36% Similarity=0.618 Sum_probs=178.4
Q ss_pred HHHHHHHHHHHHhC----CCCCcceeeEEEEeCCEEEEEEec-CCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV----KHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l----~HpnIv~l~~~~~~~~~~~lv~Ey-~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
...+.+|+.+++++ +||||+++++++......++|||| +.+++|.+++...+.+++..+..++.|++.||+|||+
T Consensus 78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~ 157 (312)
T 2iwi_A 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157 (312)
T ss_dssp -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34566799999999 899999999999999999999999 7899999999988889999999999999999999999
Q ss_pred cCCeeccCCCCcEEEc-cCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 91 RGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 91 ~givHrDlKP~NILl~-~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
+||+||||||+||+++ .+|.+||+|||++..... .......||+.|+|||++.+..+.+.++||||+||++|+|+
T Consensus 158 ~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 233 (312)
T 2iwi_A 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233 (312)
T ss_dssp HTEECCCCSGGGEEEETTTTEEEECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred CCeeecCCChhhEEEeCCCCeEEEEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence 9999999999999999 789999999999876543 22345679999999999988777666899999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|+.||.... .+.......+..++..+.+||.+||+.||.+|||++++++||||+..
T Consensus 234 ~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 234 CGDIPFERDQ------EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HSSCSCCSHH------HHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HCCCCCCChH------HHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 9999997642 22334556777899999999999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=324.20 Aligned_cols=209 Identities=19% Similarity=0.330 Sum_probs=179.5
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--------------CCCCHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--------------GRMKEDEARRYFQQ 80 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--------------~~l~e~~~~~~~~q 80 (400)
.+.+.+|+.+++++ +||||+++++++...+..|+||||++||+|.+++... ..+++..+..++.|
T Consensus 93 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 172 (333)
T 2i1m_A 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172 (333)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHH
Confidence 57899999999999 8999999999999999999999999999999999753 35899999999999
Q ss_pred HHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHH
Q 015814 81 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWS 160 (400)
Q Consensus 81 ll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwS 160 (400)
++.||+|||++||+||||||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++||||
T Consensus 173 i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s 251 (333)
T 2i1m_A 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWS 251 (333)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHH
T ss_pred HHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHH
Confidence 999999999999999999999999999999999999999765433222223345678899999999887764 9999999
Q ss_pred HHHHHHHHHh-CCCCCCCCchHHHHHhhh-c-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 161 CGVILFVLLA-GYLPFDDSNLMNLYKKIS-A-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 161 lGiil~ellt-G~~Pf~~~~~~~~~~~i~-~-~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||++|+|++ |..||.+.........+. . .....|...+..+.++|.+||+.||.+|||+.++++
T Consensus 252 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999998 999998866544433332 2 233456678999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=326.18 Aligned_cols=210 Identities=21% Similarity=0.348 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+.+|+.++++++||||+++++++......|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||
T Consensus 89 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (373)
T 2qol_A 89 QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168 (373)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35789999999999999999999999999999999999999999999998754 69999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
+||||||+|||++.++.+||+|||++......... .......+|+.|+|||++.+..+. .++|||||||++|+|++ |
T Consensus 169 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g 247 (373)
T 2qol_A 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYG 247 (373)
T ss_dssp CCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC
T ss_pred eCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999765432211 111223467889999999887774 89999999999999998 9
Q ss_pred CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||.+.+..+....+..+ ....+..++..+.+||.+||+.||.+|||+.++++
T Consensus 248 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 248 ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999988887777766554 34455668999999999999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.03 Aligned_cols=203 Identities=21% Similarity=0.354 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+.+.+|+.++++++||||+++++++.+. ...|+||||++||+|.+++.... .+++..+..++.|++.||+|||++
T Consensus 51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (271)
T 3kmu_A 51 SRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130 (271)
T ss_dssp HHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 57799999999999999999999999877 78899999999999999998765 489999999999999999999999
Q ss_pred C--CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCC--ChhhHHHHHHHHHH
Q 015814 92 G--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG--STADLWSCGVILFV 167 (400)
Q Consensus 92 g--ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~--~~~DIwSlGiil~e 167 (400)
| |+||||||+||+++.+|.++|+|||++.... .....||+.|+|||++.+..+.. .++||||+||++|+
T Consensus 131 ~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e 203 (271)
T 3kmu_A 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203 (271)
T ss_dssp SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHH
T ss_pred CCceecCCCccceEEEcCCcceeEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHH
Confidence 9 9999999999999999999999999865322 23457899999999998765542 27999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|++|..||.+.+.......+... ....|..++.++.++|.+||+.||.+|||++++++
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 204 LVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999988877665554333 44567779999999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.83 Aligned_cols=206 Identities=21% Similarity=0.272 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
+++.+|+.+++++ +||||+++++++......|+||||+ ||+|.+++.. .+.+++..+..++.|++.||+|||++||+
T Consensus 49 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ii 127 (330)
T 2izr_A 49 PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI 127 (330)
T ss_dssp CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4688999999999 9999999999999999999999999 9999999986 36799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCC-----eeeeccccccccccccCCC-----ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 95 HRDLKPENLLLDAYGN-----LKVSDFGLSALSQQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 95 HrDlKP~NILl~~~g~-----~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
||||||+|||++.++. +||+|||++.......... .....+||+.|+|||++.+..+ +.++|||||||+
T Consensus 128 HrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~i 206 (330)
T 2izr_A 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHM 206 (330)
T ss_dssp CCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHH
T ss_pred ccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHH
Confidence 9999999999998887 9999999998654322211 1245689999999999998777 589999999999
Q ss_pred HHHHHhCCCCCCCC---chHHHHHhhhcCccCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 165 LFVLLAGYLPFDDS---NLMNLYKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 165 l~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~-----~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|+|++|..||.+. +..+.+..+.......+ ..++ ++.++|..||+.||.+||++++|++
T Consensus 207 l~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 207 FMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999999999874 34455555544333322 2244 9999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.43 Aligned_cols=210 Identities=22% Similarity=0.371 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCC-EEEEEEecCCCCChHHHHHhCCC----------------CCHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKT-KIFIVLEFVTGGELFDKIVNHGR----------------MKEDEARRY 77 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~-~~~lv~Ey~~gg~L~~~i~~~~~----------------l~e~~~~~~ 77 (400)
...+.+|+.+++++ +||||+++++++...+ .+|+||||++||+|.+++..... +++..+..+
T Consensus 74 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (316)
T 2xir_A 74 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153 (316)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHH
T ss_pred HHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHH
Confidence 56789999999999 7999999999987654 58999999999999999987654 899999999
Q ss_pred HHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhh
Q 015814 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 78 ~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
+.|++.||.|||++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+..+. .++|
T Consensus 154 ~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~D 232 (316)
T 2xir_A 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSD 232 (316)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHH
T ss_pred HHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhH
Confidence 999999999999999999999999999999999999999998765432222223345789999999999887774 8999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCchHH-HHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||+||++|+|++ |..||.+.+... ....+..+ ....|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 233 i~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999998 999998866443 33333333 345677799999999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=332.83 Aligned_cols=204 Identities=24% Similarity=0.438 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC-EEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT-KIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.+|++++||||+++++++.... .+|+||||++||+|.+++...+. +++..+..++.|++.||+|||++|
T Consensus 230 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 309 (450)
T 1k9a_A 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309 (450)
T ss_dssp SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 467899999999999999999999987655 79999999999999999987654 799999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
|+||||||+|||++.++.+||+|||+++.... ......+++.|+|||++.+..+. .++|||||||++|+|++ |
T Consensus 310 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g 383 (450)
T 1k9a_A 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFG 383 (450)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTT
T ss_pred eeCCCCCHhhEEECCCCCEEEeeCCCcccccc-----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999874322 12234678999999999887774 89999999999999998 9
Q ss_pred CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||.+.+..+....+..+ ....|..+++++.+||.+||+.||.+|||+.++++
T Consensus 384 ~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 384 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999988877777666554 45667789999999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=325.24 Aligned_cols=204 Identities=34% Similarity=0.663 Sum_probs=147.5
Q ss_pred HHHhCCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 015814 25 TMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDL 98 (400)
Q Consensus 25 il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~givHrDl 98 (400)
.++.++||||+++++++.. ....|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||
T Consensus 75 ~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dl 154 (336)
T 3fhr_A 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDV 154 (336)
T ss_dssp HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 3567799999999999876 556899999999999999998764 6999999999999999999999999999999
Q ss_pred CCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 99 KPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 99 KP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
||+|||++. ++.+||+|||++..... ......+||+.|+|||++....+ +.++||||+||++|+|++|..||
T Consensus 155 kp~NIll~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CHHHEEEEecCCCceEEEeccccceeccc----cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCC
Confidence 999999986 45599999999875432 23345689999999999977666 48999999999999999999999
Q ss_pred CCCchHHH----HHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLMNL----YKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~~~----~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.+.+.... ...+.......+ ..++.++.+||.+||+.||.+|||++++++||||+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 230 YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred CCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 77654433 222222333222 35899999999999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=325.75 Aligned_cols=211 Identities=20% Similarity=0.331 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+.+.+|+.+++.++||||+++++++...+..|+||||++||+|.+++.... .+++..+..++.|++.||+|||++
T Consensus 79 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 158 (321)
T 2qkw_B 79 IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158 (321)
T ss_dssp HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC
Confidence 5788999999999999999999999999999999999999999999986543 589999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
||+||||||+||+++.++.+||+|||++...............+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus 159 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g 237 (321)
T 2qkw_B 159 AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCA 237 (321)
T ss_dssp TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHC
T ss_pred CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhC
Confidence 999999999999999999999999999876443333333445679999999999987776 4999999999999999999
Q ss_pred CCCCCCCchHHH---HH----hhhcCc------cC----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 015814 172 YLPFDDSNLMNL---YK----KISAAE------FT----CPPWLSFTARKLIARILDPNPMTRITIPEILEDE 227 (400)
Q Consensus 172 ~~Pf~~~~~~~~---~~----~i~~~~------~~----~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~ 227 (400)
+.||.+...... .. ....+. .. .++..+..+.+++.+||+.||.+|||+.+++++-
T Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 999976443211 10 011111 11 1122456789999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.34 Aligned_cols=211 Identities=31% Similarity=0.423 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHHhCC-CC-----CcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVK-HP-----NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~-Hp-----nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~ 86 (400)
...++.+|+.+++.++ |+ +|+++++++......|+||||+.| +|.+.+... +.+++..++.++.|++.||.
T Consensus 93 ~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 171 (382)
T 2vx3_A 93 FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHH
Confidence 3577888999999885 55 499999999999999999999965 999999875 46999999999999999999
Q ss_pred HHH--HcCCeeccCCCCcEEEc--cCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHH
Q 015814 87 YCH--SRGVYHRDLKPENLLLD--AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCG 162 (400)
Q Consensus 87 ~LH--~~givHrDlKP~NILl~--~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlG 162 (400)
||| +.||+||||||+|||++ .++.+||+|||+|..... .....+||+.|+|||++.+..|. .++||||+|
T Consensus 172 ~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG 245 (382)
T 2vx3_A 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLG 245 (382)
T ss_dssp HHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHH
T ss_pred HhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHH
Confidence 999 57999999999999995 478899999999876532 23456899999999999987774 999999999
Q ss_pred HHHHHHHhCCCCCCCCchHHHHHhhhcCccCCC------------------------------------C-C--------
Q 015814 163 VILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------------------------------------P-W-------- 197 (400)
Q Consensus 163 iil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------------~-~-------- 197 (400)
|++|+|++|+.||.+.+..+....+.......| + .
T Consensus 246 ~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 325 (382)
T 2vx3_A 246 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILG 325 (382)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHT
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhh
Confidence 999999999999998877666554432110000 0 0
Q ss_pred -------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 198 -------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 198 -------------------~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.+.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 326 VETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred ccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 01378999999999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=318.50 Aligned_cols=210 Identities=21% Similarity=0.335 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+.+|+.++++++||||+++++++......|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+
T Consensus 90 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 169 (333)
T 1mqb_A 90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169 (333)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 567889999999999999999999999999999999999999999999764 5799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCC-ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+||+++.++.+||+|||++.......... ......||+.|+|||++....+ +.++||||+||++|+|++ |.
T Consensus 170 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCC
Confidence 99999999999999999999999987654322111 1223356789999999987776 489999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
.||.+.+..+....+..+ ....+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 249 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 249 RPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999988877777776554 345566789999999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=314.78 Aligned_cols=209 Identities=22% Similarity=0.446 Sum_probs=163.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+.+++|+.++++++||||++++++. .....++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||
T Consensus 63 ~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 141 (289)
T 3og7_A 63 QLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141 (289)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 367899999999999999999999965 55678999999999999999964 3569999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh---cCCCCCChhhHHHHHHHHHHHHh
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DIwSlGiil~ellt 170 (400)
+||||||+||+++.++.+||+|||++................||+.|+|||++. ...+ +.++||||+||++|+|++
T Consensus 142 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~ 220 (289)
T 3og7_A 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMT 220 (289)
T ss_dssp CCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHH
T ss_pred ccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHH
Confidence 999999999999999999999999987654433333445568999999999986 3334 479999999999999999
Q ss_pred CCCCCCCCchHH-HHHhhhcCccC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 GYLPFDDSNLMN-LYKKISAAEFT-----CPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 G~~Pf~~~~~~~-~~~~i~~~~~~-----~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|+.||.+.+... ....+..+... .+..++..+.+||.+||+.||.+|||+.++++
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 221 GQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999998755443 33333333222 23357899999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=323.13 Aligned_cols=206 Identities=15% Similarity=0.184 Sum_probs=171.9
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+|+.+++.++||||+++++++.. ....|+||||+ ||+|.+++...+.+++..+..++.|++.||+|||++||
T Consensus 94 ~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 172 (345)
T 2v62_A 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEY 172 (345)
T ss_dssp HHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 46689999999999999999999987 78899999999 99999999887789999999999999999999999999
Q ss_pred eeccCCCCcEEEccCC--CeeeeccccccccccccCC-----CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 94 vHrDlKP~NILl~~~g--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
+||||||+|||++.++ .+||+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 173 vH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ 251 (345)
T 2v62_A 173 VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCML 251 (345)
T ss_dssp ECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHH
T ss_pred eCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHH
Confidence 9999999999999887 9999999999765432211 12245689999999999987766 59999999999999
Q ss_pred HHHhCCCCCCCC--chHHHHHhhhcCccCCC---------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 167 VLLAGYLPFDDS--NLMNLYKKISAAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 167 elltG~~Pf~~~--~~~~~~~~i~~~~~~~~---------~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|++|+.||.+. +...............| ..++.++.++|.+||..||.+|||++++++
T Consensus 252 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 252 RWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999652 22222221111111112 268899999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=314.81 Aligned_cols=210 Identities=21% Similarity=0.361 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..+++.+|+.++++++||||+++++++.. ...+|+||||++||+|.+++...+ ++++..+..++.|++.||+|||++
T Consensus 54 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (295)
T 3ugc_A 54 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133 (295)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 35789999999999999999999999854 456899999999999999998754 599999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
||+||||||+|||++.++.+||+|||++......... .......||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 134 ~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~ 212 (295)
T 3ugc_A 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFT 212 (295)
T ss_dssp TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHH
T ss_pred CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999865432211 12233457788999999998877 489999999999999999
Q ss_pred CCCCCCCCchH----------------HHHHhh-hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 GYLPFDDSNLM----------------NLYKKI-SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 G~~Pf~~~~~~----------------~~~~~i-~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|..||...... .....+ .......|..++.++.+||.+||+.||.+|||+.++++
T Consensus 213 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99998764322 111111 22345567779999999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=310.74 Aligned_cols=208 Identities=23% Similarity=0.332 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|+.++++++||||+++++++.++ ..|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+
T Consensus 57 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 135 (281)
T 3cc6_A 57 KEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 135 (281)
T ss_dssp HHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 57899999999999999999999998654 5689999999999999997654 599999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+||+++.++.+||+|||++....... ........||+.|+|||++.+..+ +.++||||+||++|+|++ |+.
T Consensus 136 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~ 213 (281)
T 3cc6_A 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQ 213 (281)
T ss_dssp CCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCccceEEECCCCcEEeCccCCCccccccc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654321 112234467889999999987776 489999999999999998 999
Q ss_pred CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 174 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||...+.......+..+ ....|..+++.+.++|.+||..||.+|||+.+++++
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 214 PFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 99887766666655444 345566789999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=332.56 Aligned_cols=213 Identities=26% Similarity=0.413 Sum_probs=167.1
Q ss_pred HHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 18 QIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 18 ~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+|+.+|+.+ +||||+++++++.+....|+||||+.| +|.+++.... ..++..+..++.|++.||+|||++||+|
T Consensus 63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 141 (432)
T 3p23_A 63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141 (432)
T ss_dssp ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEe
Confidence 356899999999 799999999999999999999999974 9999997754 4566678899999999999999999999
Q ss_pred ccCCCCcEEEcc---CC--CeeeeccccccccccccC-CCccccccCCCCCCCChhhhcC--CCCCChhhHHHHHHHHHH
Q 015814 96 RDLKPENLLLDA---YG--NLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFV 167 (400)
Q Consensus 96 rDlKP~NILl~~---~g--~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGiil~e 167 (400)
|||||+|||++. ++ .+||+|||+|........ .......+||+.|+|||++.+. ...+.++||||+||++|+
T Consensus 142 rDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~e 221 (432)
T 3p23_A 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221 (432)
T ss_dssp CCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHH
Confidence 999999999953 23 578999999976543211 1233456899999999999742 223578999999999999
Q ss_pred HHh-CCCCCCCCchHHHHHhhhcCccCC---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 168 LLA-GYLPFDDSNLMNLYKKISAAEFTC---PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 168 llt-G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|++ |..||................... +...+..+.+||.+||+.||.+|||++++++||||..
T Consensus 222 llt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 222 VISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 999 999997655444433332222211 1224567899999999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=310.75 Aligned_cols=207 Identities=18% Similarity=0.235 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
+.+++|+.+++++ +|||++++++++......|+||||+ ||+|.+++...+ .+++..+..++.|++.||+|||++||+
T Consensus 50 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 128 (298)
T 1csn_A 50 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128 (298)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 5678899999999 8999999999999999999999999 999999998754 599999999999999999999999999
Q ss_pred eccCCCCcEEEccCCC-----eeeeccccccccccccCC-----CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 95 HRDLKPENLLLDAYGN-----LKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 95 HrDlKP~NILl~~~g~-----~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
||||||+|||++.+|. +||+|||++......... ......+||+.|+|||++.+..+ +.++|||||||+
T Consensus 129 H~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~i 207 (298)
T 1csn_A 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHV 207 (298)
T ss_dssp CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHH
T ss_pred cCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHH
Confidence 9999999999988776 999999999865543221 12345679999999999988776 589999999999
Q ss_pred HHHHHhCCCCCCCCc---hHHHHHhhhcCcc-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 165 LFVLLAGYLPFDDSN---LMNLYKKISAAEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 165 l~elltG~~Pf~~~~---~~~~~~~i~~~~~-----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|+|++|+.||.+.+ ....+..+..... ..++.+++++.+||.+||+.||.+|||+++|++
T Consensus 208 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 208 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 999999999998743 3333433332221 223468999999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=313.82 Aligned_cols=212 Identities=25% Similarity=0.406 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHc-CC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-GV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~-gi 93 (400)
...+..+..+++.++||||+++++++.+....|+||||+ ++.+...... .+.+++..+..++.|++.||.|||++ ||
T Consensus 68 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 146 (318)
T 2dyl_A 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146 (318)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 344555666788889999999999999999999999999 4455444433 46799999999999999999999996 99
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc----CCCCCChhhHHHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DIwSlGiil~ell 169 (400)
+||||||+||+++.++.+||+|||++..... .......+||+.|+|||++.. ....+.++||||+||++|+|+
T Consensus 147 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (318)
T 2dyl_A 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223 (318)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHH
T ss_pred EeCCCCHHHEEECCCCCEEEEECCCchhccC---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHH
Confidence 9999999999999999999999999875433 222345679999999999952 223358999999999999999
Q ss_pred hCCCCCCCC-chHHHHHhhhcCcc-CCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 170 AGYLPFDDS-NLMNLYKKISAAEF-TCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 170 tG~~Pf~~~-~~~~~~~~i~~~~~-~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
+|+.||... +.......+..... ..| ..++.++.+||.+||+.||.+|||++++++||||+.
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 224 TGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred hCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 999999873 33444444443332 223 347999999999999999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=312.38 Aligned_cols=211 Identities=24% Similarity=0.339 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEE-EeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+++.+|+.++++++||||+++++++ ..++..|+||||++||+|.+++... ..+++..+..++.|++.||+|||++
T Consensus 68 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~ 147 (298)
T 3f66_A 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147 (298)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3467899999999999999999999985 5567889999999999999999764 4689999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
||+||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+..+. .++||||+||++|+|+
T Consensus 148 ~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~ 226 (298)
T 3f66_A 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELM 226 (298)
T ss_dssp TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHH
T ss_pred CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999976543221 1223345678899999999887764 8999999999999999
Q ss_pred h-CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 170 A-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 170 t-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+ |.+||.+.+.......+..+. ...|..++..+.++|.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 227 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9 778888777766666555444 3446678999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=310.54 Aligned_cols=210 Identities=22% Similarity=0.351 Sum_probs=179.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEE-EEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKI-FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+.+.+|+.++++++||||+++++++.+.... ++||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++|
T Consensus 65 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (298)
T 3pls_A 65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144 (298)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 367889999999999999999999999776655 999999999999999987 456899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeecccccccccccc--CCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|+||||||+||+++.+|.+||+|||++....... .........||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 145 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~ 223 (298)
T 3pls_A 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLT 223 (298)
T ss_dssp CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHH
T ss_pred cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhh
Confidence 9999999999999999999999999987543321 1222344578899999999987776 489999999999999999
Q ss_pred -CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 -GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 -G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|.+||...+.......+.... ...+..++..+.++|.+||+.||.+|||+.++++
T Consensus 224 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 224 RGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 566677766666666655443 4566779999999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=313.91 Aligned_cols=210 Identities=25% Similarity=0.389 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||
T Consensus 76 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 155 (309)
T 2h34_A 76 VFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155 (309)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 34678999999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+||+++.+|.+||+|||++....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus 156 ~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~ 233 (309)
T 2h34_A 156 THRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSP 233 (309)
T ss_dssp CCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSC
T ss_pred CcCCCChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999987654321 122345679999999999987666 489999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCC-CHHHHhc
Q 015814 174 PFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRI-TIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~mL~~dP~~R~-t~~eil~ 225 (400)
||.+.+.......+.... ...++.+|.++.++|.+||+.||.+|| |++++++
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 234 PYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp SSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999887665544443332 234567899999999999999999999 8888875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=331.33 Aligned_cols=212 Identities=27% Similarity=0.406 Sum_probs=163.6
Q ss_pred HHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK-------EDEARRYFQQLINAVDYC 88 (400)
Q Consensus 17 ~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~-------e~~~~~~~~qll~~l~~L 88 (400)
+.+.+|+.+++++ +||||+++++++.+...+|+|||||. |+|.+++...+... +..+..++.|++.||+||
T Consensus 53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 131 (434)
T 2rio_A 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131 (434)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH
Confidence 5678899999876 89999999999999999999999996 59999998765433 234577999999999999
Q ss_pred HHcCCeeccCCCCcEEEccC-------------CCeeeeccccccccccccCC--CccccccCCCCCCCChhhhc-----
Q 015814 89 HSRGVYHRDLKPENLLLDAY-------------GNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLND----- 148 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~-------------g~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~----- 148 (400)
|++||+||||||+|||++.+ +.+||+|||++......... ......+||+.|+|||++.+
T Consensus 132 H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 211 (434)
T 2rio_A 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ 211 (434)
T ss_dssp HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTS
T ss_pred HHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccc
Confidence 99999999999999999764 47999999999865432211 12345689999999999965
Q ss_pred -CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcCccCCCC-------CCCHHHHHHHHHhcCCCCCCCCC
Q 015814 149 -RGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPP-------WLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 149 -~~~~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~-------~~s~~~~~li~~mL~~dP~~R~t 219 (400)
....+.++||||+||++|+|++ |..||.+...... .+..+....+. .++.++.+||.+||+.||.+|||
T Consensus 212 ~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 289 (434)
T 2rio_A 212 TKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289 (434)
T ss_dssp CCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred cccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC
Confidence 1334689999999999999999 9999976544331 22222222211 24578999999999999999999
Q ss_pred HHHHhcCccccc
Q 015814 220 IPEILEDEWFKK 231 (400)
Q Consensus 220 ~~eil~h~~~~~ 231 (400)
+.++++||||+.
T Consensus 290 ~~eil~hp~f~~ 301 (434)
T 2rio_A 290 AMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHTSGGGSC
T ss_pred HHHHHhCCccCC
Confidence 999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=333.84 Aligned_cols=207 Identities=22% Similarity=0.371 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.+|++++||||+++++++. ....|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||
T Consensus 227 ~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 305 (454)
T 1qcf_A 227 VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305 (454)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 578899999999999999999999986 567899999999999999997543 68999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||++....+ +.++|||||||++|||++ |+
T Consensus 306 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~ 383 (454)
T 1qcf_A 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGR 383 (454)
T ss_dssp CCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCC
Confidence 9999999999999999999999999976532111 11123456788999999987776 489999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+..+ ....|..++.++.+||.+||+.||.+|||+++|++
T Consensus 384 ~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 384 IPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999998887777776554 34567779999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=324.82 Aligned_cols=211 Identities=22% Similarity=0.424 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHhCC-----------CCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK-----------HPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-----------HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~ 78 (400)
.+.+.+|+.++++++ ||||+++++++.... .+++||||+ |++|.+++... +++++..+..++
T Consensus 59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~ 137 (373)
T 1q8y_A 59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS 137 (373)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHH
Confidence 467889999999886 899999999987654 789999999 88999999763 459999999999
Q ss_pred HHHHHHHHHHHHc-CCeeccCCCCcEEEccC------CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC
Q 015814 79 QQLINAVDYCHSR-GVYHRDLKPENLLLDAY------GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151 (400)
Q Consensus 79 ~qll~~l~~LH~~-givHrDlKP~NILl~~~------g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~ 151 (400)
.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||++..... .....+||+.|+|||++.+..+
T Consensus 138 ~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~ 212 (373)
T 1q8y_A 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW 212 (373)
T ss_dssp HHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC
Confidence 9999999999998 99999999999999543 4799999999876543 1234579999999999998777
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCchH------HHHHhhhc------------------------------------
Q 015814 152 DGSTADLWSCGVILFVLLAGYLPFDDSNLM------NLYKKISA------------------------------------ 189 (400)
Q Consensus 152 ~~~~~DIwSlGiil~elltG~~Pf~~~~~~------~~~~~i~~------------------------------------ 189 (400)
+.++|||||||++|+|++|..||.+.+.. .....+..
T Consensus 213 -~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (373)
T 1q8y_A 213 -GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291 (373)
T ss_dssp -CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred -CchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc
Confidence 59999999999999999999999865411 11111110
Q ss_pred ------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 190 ------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 190 ------~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
....++...+.++.+||.+||+.||.+|||++|+++||||+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 11122333567889999999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=336.29 Aligned_cols=208 Identities=26% Similarity=0.392 Sum_probs=182.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++.+|+.+|++++||||+++++++.....+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||
T Consensus 260 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 339 (495)
T 1opk_A 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339 (495)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 467899999999999999999999999999999999999999999999864 358999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+|||++.++.+||+|||+++...... ........+++.|+|||++....+ +.++|||||||++|+|++ |.
T Consensus 340 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~ 417 (495)
T 1opk_A 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGM 417 (495)
T ss_dssp ECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999997653211 111223456788999999988776 489999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+.......+..+ ....|..++..+.+||.+||+.||.+|||+.+|++
T Consensus 418 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 418 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999998877777766544 34567789999999999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=344.99 Aligned_cols=209 Identities=21% Similarity=0.312 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+++.+|+.+|++++|||||++++++.. ..+++||||++||+|.+++...+.+++..+..++.|++.||+|||++||+
T Consensus 413 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ii 491 (635)
T 4fl3_A 413 LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 491 (635)
T ss_dssp GHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 35789999999999999999999999865 45889999999999999999888999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+|||++.++.+||+|||+|+....... ........||+.|+|||++....|. .++|||||||++|+|++ |+
T Consensus 492 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp CSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999976543221 1122334578899999999887774 89999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+..+. ...|..++.++.+||.+||+.||.+|||++++++
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999988888777776553 4667789999999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=322.11 Aligned_cols=205 Identities=16% Similarity=0.168 Sum_probs=168.0
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEeC----CEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGSK----TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~~----~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
+.+|+..++.++||||+++++++... ...|+||||+ ||+|.+++... +.+++..+..++.|++.||+|||++||
T Consensus 95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 173 (364)
T 3op5_A 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEY 173 (364)
T ss_dssp HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45677788899999999999998764 5689999999 99999999876 579999999999999999999999999
Q ss_pred eeccCCCCcEEEc--cCCCeeeeccccccccccccCCC-----ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 94 YHRDLKPENLLLD--AYGNLKVSDFGLSALSQQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 94 vHrDlKP~NILl~--~~g~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
+||||||+|||++ .++.+||+|||+|.......... .....+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 174 iHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~ 252 (364)
T 3op5_A 174 VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMI 252 (364)
T ss_dssp ECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHH
T ss_pred EEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHH
Confidence 9999999999999 88999999999997654332211 1234569999999999988776 59999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHhhh-----cC------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 167 VLLAGYLPFDDSNLMNLYKKIS-----AA------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~i~-----~~------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|++|+.||.+......+.... .. ....+..++.++.++|..||..||.+|||+.+|++
T Consensus 253 el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 253 QWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 9999999998643222111110 00 00112567999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.07 Aligned_cols=209 Identities=21% Similarity=0.274 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..+..+|+.++++++||||+++++++.... .+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~ 140 (322)
T 3soc_A 62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHED 140 (322)
T ss_dssp HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhh
Confidence 355677999999999999999999998743 47999999999999999977 5699999999999999999999999
Q ss_pred ----------CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC----CCChhh
Q 015814 92 ----------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY----DGSTAD 157 (400)
Q Consensus 92 ----------givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~~D 157 (400)
||+||||||+|||++.++.+||+|||+|...............+||+.|+|||++.+... .+.++|
T Consensus 141 ~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 220 (322)
T 3soc_A 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220 (322)
T ss_dssp EEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHH
T ss_pred ccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccch
Confidence 999999999999999999999999999976654333333455789999999999976322 235789
Q ss_pred HHHHHHHHHHHHhCCCCCCCCch----------------HHHHHhhhcCcc--CCCCC-----CCHHHHHHHHHhcCCCC
Q 015814 158 LWSCGVILFVLLAGYLPFDDSNL----------------MNLYKKISAAEF--TCPPW-----LSFTARKLIARILDPNP 214 (400)
Q Consensus 158 IwSlGiil~elltG~~Pf~~~~~----------------~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~mL~~dP 214 (400)
|||+||++|+|++|+.||.+... ......+..... ..+.. .+.++.+||.+||+.||
T Consensus 221 iwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (322)
T 3soc_A 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300 (322)
T ss_dssp HHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSG
T ss_pred hHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCCh
Confidence 99999999999999999976421 122222211111 11111 23459999999999999
Q ss_pred CCCCCHHHHhc
Q 015814 215 MTRITIPEILE 225 (400)
Q Consensus 215 ~~R~t~~eil~ 225 (400)
.+|||+.++++
T Consensus 301 ~~Rps~~ell~ 311 (322)
T 3soc_A 301 EARLSAGCVGE 311 (322)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=312.11 Aligned_cols=209 Identities=22% Similarity=0.415 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeC--CEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.+++.++||||+++++++... ..+|+||||++||+|.+++.. ...+++..+..++.|++.||+|||++|
T Consensus 67 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 146 (302)
T 4e5w_A 67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146 (302)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 57889999999999999999999999876 678999999999999999954 457999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|+||||||+||+++.+|.+||+|||++......... .......||+.|+|||++.+..+. .++||||+||++|+|++|
T Consensus 147 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g 225 (302)
T 4e5w_A 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTY 225 (302)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTT
T ss_pred cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHc
Confidence 999999999999999999999999998765432211 123345688899999999887764 899999999999999999
Q ss_pred CCCCCCCc---------------hHHHHHhhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSN---------------LMNLYKKIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~---------------~~~~~~~i~-~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..|+.... .......+. ......|+.+++++.+||.+||+.||.+|||+.++++
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 226 CDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 99864321 112222222 2344567789999999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=313.53 Aligned_cols=210 Identities=23% Similarity=0.357 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..+.+.+|+.++++++||||+++++++.+....|+||||++||+|.+++.. ...+++..+..++.|++.||+|||++
T Consensus 73 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 152 (307)
T 2nru_A 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152 (307)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 467899999999999999999999999999999999999999999999974 34699999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
||+||||||+||+++.++.+||+|||++...............+||+.|+|||++.+. + +.++||||+||++|+|++|
T Consensus 153 ~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHC
T ss_pred CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHC
Confidence 9999999999999999999999999998765433222223345799999999998753 4 5899999999999999999
Q ss_pred CCCCCCCchHH----HHHhhhcCc-----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 172 YLPFDDSNLMN----LYKKISAAE-----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 172 ~~Pf~~~~~~~----~~~~i~~~~-----------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
..||....... ....+.... ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 231 LPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99998754322 222211111 11122245678999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=308.74 Aligned_cols=204 Identities=24% Similarity=0.436 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++++++||||+++++++.. ....|+||||++||+|.+++...+. +++..+..++.|++.||+|||++|
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 137 (278)
T 1byg_A 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137 (278)
T ss_dssp -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5778999999999999999999998754 4578999999999999999977543 899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
++||||||+||+++.++.+||+|||++...... .....+|+.|+|||++.+..+ +.++||||+||++|+|++ |
T Consensus 138 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g 211 (278)
T 1byg_A 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFG 211 (278)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTS
T ss_pred ccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998754321 233468899999999988776 489999999999999998 9
Q ss_pred CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||...+.......+..+ ....+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 212 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 9999988877777666544 44566779999999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=308.04 Aligned_cols=207 Identities=22% Similarity=0.362 Sum_probs=178.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.++++++||||+++++++. .+..|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 130 (279)
T 1qpc_A 52 PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130 (279)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 467899999999999999999999986 455899999999999999997543 69999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+||+++.++.+||+|||++....... ........||+.|+|||++.+..+ +.++||||+||++|+|++ |.
T Consensus 131 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~ 208 (279)
T 1qpc_A 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGR 208 (279)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTC
T ss_pred eccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654321 111233457889999999987666 489999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+..+ ....+..++.++.++|.+||..||.+|||++++++
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 209 IPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999988877777766554 34556678999999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.75 Aligned_cols=207 Identities=27% Similarity=0.426 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEe----------------CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGS----------------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYF 78 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~----------------~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~ 78 (400)
+.+.+|+.++++++||||+++++++.. ...+|+||||+++|+|.+++... ..+++..+..++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 128 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence 356789999999999999999998854 45589999999999999999754 579999999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .......||+.|+|||++.+..+ +.++||
T Consensus 129 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 204 (284)
T 2a19_B 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDY-GKEVDL 204 (284)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCC-CTHHHH
T ss_pred HHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc---ccccccCCcccccChhhhccCCC-cchhhh
Confidence 99999999999999999999999999999999999999998765432 22345679999999999988776 489999
Q ss_pred HHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 159 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 159 wSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
||+||++|+|++|..|+... ......+... ..+..++..+.++|.+||+.||.+|||+.++++|.|...
T Consensus 205 ~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFET--SKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999998532 2233333322 345668999999999999999999999999999988764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=309.96 Aligned_cols=209 Identities=27% Similarity=0.405 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+++.+|+.++++++||||+++++++.+.. .++||||+++|+|.+++... +.+++..+..++.|++.||.|||++||
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 142 (291)
T 1u46_A 64 AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142 (291)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4678999999999999999999999998765 88999999999999999764 569999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
+||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..+ +.++||||+||++|+|++ |
T Consensus 143 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g 221 (291)
T 1u46_A 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYG 221 (291)
T ss_dssp ECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999998765432211 11234567889999999987766 489999999999999999 9
Q ss_pred CCCCCCCchHHHHHhhhcCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||.+.+.......+.... ...+..++.++.++|.+||+.||.+|||+.++++
T Consensus 222 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 222 QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999988877777765443 3455678999999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.22 Aligned_cols=207 Identities=23% Similarity=0.379 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.+|++++||||+++++++.. ...|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||
T Consensus 223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 301 (452)
T 1fmk_A 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301 (452)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3678999999999999999999999866 6789999999999999999643 469999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+|||++.++.+||+|||+++...... ........+|+.|+|||++....+ +.++|||||||++|+|++ |.
T Consensus 302 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~ 379 (452)
T 1fmk_A 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGR 379 (452)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTC
T ss_pred eCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999997654311 112233457889999999988776 489999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+..+ ....|+.++..+.+||.+||+.||.+|||++++++
T Consensus 380 ~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 380 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999998887777776554 44667789999999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=316.37 Aligned_cols=212 Identities=22% Similarity=0.368 Sum_probs=156.3
Q ss_pred HHHHHHHHH-HHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..++.+|+. +++.++||||+++++++...+..|+||||+.| +|.+.+.. ...+++..+..++.|++.||.|||
T Consensus 64 ~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 142 (327)
T 3aln_A 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142 (327)
T ss_dssp HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh
Confidence 345566666 67788999999999999999999999999986 78777763 567999999999999999999999
Q ss_pred Hc-CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh----cCCCCCChhhHHHHHHH
Q 015814 90 SR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVI 164 (400)
Q Consensus 90 ~~-givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DIwSlGii 164 (400)
++ ||+||||||+||+++.+|.+||+|||++...... .......||+.|+|||++. +..+ +.++||||+||+
T Consensus 143 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~i 218 (327)
T 3aln_A 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGIT 218 (327)
T ss_dssp HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------C-CSHHHHHHHHHH
T ss_pred ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHH
Confidence 99 9999999999999999999999999998765332 2223457999999999983 4445 589999999999
Q ss_pred HHHHHhCCCCCCCCch-HHHHHhhhcCcc-CC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 165 LFVLLAGYLPFDDSNL-MNLYKKISAAEF-TC----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 165 l~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~----~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|+|++|..||.+.+. .+....+..+.. .. +..++..+.+||.+||+.||.+|||+.++++||||...
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 219 LYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp HHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 9999999999987543 233333332222 12 23479999999999999999999999999999999753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=306.11 Aligned_cols=202 Identities=28% Similarity=0.466 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC--C
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRG--V 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~g--i 93 (400)
+.+.+|+.++++++||||+++++++.+.. ++||||++||+|.+.+.... .+++..+..++.|++.||+|||++| |
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 145 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence 78899999999999999999999987666 69999999999999886654 6999999999999999999999999 9
Q ss_pred eeccCCCCcEEEccCCC-----eeeeccccccccccccCCCccccccCCCCCCCChhhhcC-CCCCChhhHHHHHHHHHH
Q 015814 94 YHRDLKPENLLLDAYGN-----LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFV 167 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~-----~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DIwSlGiil~e 167 (400)
+||||||+|||++.++. +||+|||++..... ......||+.|+|||++... ...+.++||||+||++|+
T Consensus 146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~ 220 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220 (287)
T ss_dssp BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHH
Confidence 99999999999988876 99999999864322 23456899999999998432 223589999999999999
Q ss_pred HHhCCCCCCCCchHHH--HHhhh--cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 168 LLAGYLPFDDSNLMNL--YKKIS--AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~--~~~i~--~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|++|+.||...+.... ...+. ......+..+++.+.+||.+||+.||.+|||++++++
T Consensus 221 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 221 ILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999987654332 22222 2234566779999999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=323.89 Aligned_cols=211 Identities=24% Similarity=0.340 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEE-eCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMG-SKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+++.+|+.++++++||||+++++++. .++..|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++|
T Consensus 133 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 212 (373)
T 3c1x_A 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212 (373)
T ss_dssp HHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3678999999999999999999999864 4567899999999999999997654 5889999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCC--CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
|+||||||+|||++.++.+||+|||++......... .......||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 213 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt 291 (373)
T 3c1x_A 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMT 291 (373)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHT
T ss_pred EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999754332111 11233467889999999988777 489999999999999999
Q ss_pred -CCCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 171 -GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 171 -G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|.+||.+.+..+....+..+. ...|..++..+.++|.+||+.||.+|||+.+++++
T Consensus 292 ~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 292 RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788998877666555554443 45566799999999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=306.28 Aligned_cols=208 Identities=31% Similarity=0.553 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
....+.+|+.++++++||||+++++++......|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 75 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 154 (310)
T 2wqm_A 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154 (310)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 467889999999999999999999999999999999999999999998864 4569999999999999999999999
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
+|++||||||+||+++.+|.+||+|||++...... ........||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 155 ~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~ 231 (310)
T 2wqm_A 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAA 231 (310)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHH
T ss_pred CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999998765432 122345679999999999987766 489999999999999999
Q ss_pred CCCCCCCCc--hHHHHHhhhcCccCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 GYLPFDDSN--LMNLYKKISAAEFTC--PPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 G~~Pf~~~~--~~~~~~~i~~~~~~~--~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|..||.+.. .......+....... +..++.++.+||.+||+.||.+|||+.++++
T Consensus 232 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 232 LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp SSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999997643 234444444443322 2458999999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=338.01 Aligned_cols=208 Identities=24% Similarity=0.348 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|+.+|++++||||+++++++.. ..+|+||||+.||+|.+++... ..+++..+..++.|++.||+|||++||+
T Consensus 380 ~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ii 458 (613)
T 2ozo_A 380 TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458 (613)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 5789999999999999999999999976 5689999999999999999754 4599999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+|||++.++.+||+|||+++....... ........+|+.|+|||++....|. .++|||||||++|||++ |+
T Consensus 459 HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~ 537 (613)
T 2ozo_A 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQ 537 (613)
T ss_dssp CSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSC
T ss_pred cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999976543211 1112233567899999999887774 89999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+..+. ...|+.++.++.+||.+||+.||.+|||+.++++
T Consensus 538 ~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 538 KPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999988888777776553 4667789999999999999999999999999853
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=304.11 Aligned_cols=207 Identities=19% Similarity=0.216 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEE-EeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.++.+|+.+++.++|++++..+..+ ......|+||||+ +|+|.+++.. ...+++..+..++.|++.||+|||++||+
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 127 (296)
T 3uzp_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127 (296)
T ss_dssp CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4688999999999988876666554 6778899999999 8999999974 45799999999999999999999999999
Q ss_pred eccCCCCcEEE---ccCCCeeeeccccccccccccCC-----CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 95 HRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 95 HrDlKP~NILl---~~~g~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
||||||+|||+ +.++.+||+|||++......... ......+||+.|+|||++.+..+ +.++||||+||++|
T Consensus 128 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ 206 (296)
T 3uzp_A 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLM 206 (296)
T ss_dssp CSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHH
T ss_pred eCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHH
Confidence 99999999999 47899999999998765543221 12245689999999999988776 58999999999999
Q ss_pred HHHhCCCCCCCCc---hHHHHHhhhcCccCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 167 VLLAGYLPFDDSN---LMNLYKKISAAEFTC-----PPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 167 elltG~~Pf~~~~---~~~~~~~i~~~~~~~-----~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|++|+.||.+.+ ....+..+....... ++.+|+++.++|.+||+.||.+|||++++++
T Consensus 207 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 207 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 9999999998633 223333333333322 2668999999999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=313.31 Aligned_cols=210 Identities=23% Similarity=0.374 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEE--eCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++++++||||+++++++. .....|+||||++||+|.+++.. ...+++..+..++.|++.||+|||++|
T Consensus 68 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 147 (327)
T 3lxl_A 68 QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147 (327)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 577999999999999999999999886 55679999999999999999976 456999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|+||||||+|||++.++.+||+|||++......... .......||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus 148 ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g 226 (327)
T 3lxl_A 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTY 226 (327)
T ss_dssp EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999765432111 12233468889999999988766 5899999999999999999
Q ss_pred CCCCCCCchH---------------HHHHhhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 172 YLPFDDSNLM---------------NLYKKIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 172 ~~Pf~~~~~~---------------~~~~~i~-~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
..||...... .....+. ......++.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 227 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 227 CDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999664432 1222222 22345667799999999999999999999999999753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=309.69 Aligned_cols=208 Identities=21% Similarity=0.325 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.++++++||||+++++++.+ ...+|+||||+++|+|.+++... ++++..+..++.|++.||+|||++||
T Consensus 77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~i 155 (318)
T 3lxp_A 77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHY 155 (318)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 5779999999999999999999999987 46899999999999999999764 59999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..+. .++||||+||++|+|++|.
T Consensus 156 vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~ 234 (318)
T 3lxp_A 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHC 234 (318)
T ss_dssp ECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTT
T ss_pred cCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999998765432111 122345688899999999887764 8999999999999999999
Q ss_pred CCCCCCchH---------------HHHHhhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLM---------------NLYKKIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~---------------~~~~~i~-~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||...... .....+. ......+..++.++.+||++||+.||.+|||+.++++
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 235 DSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999764322 1111222 2234566779999999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=309.97 Aligned_cols=212 Identities=24% Similarity=0.381 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEE----eCCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMG----SKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~ 86 (400)
..+.+.+|+.++++++||||+++++++. .....|+||||+.+|+|.+++.. ...+++..+..++.|++.||.
T Consensus 69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~ 148 (317)
T 2buj_A 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148 (317)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3678899999999999999999999986 34578999999999999999976 467999999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCC-------ccccccCCCCCCCChhhhcCCC--CCChhh
Q 015814 87 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-------LLHTTCGTPNYVAPEVLNDRGY--DGSTAD 157 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~--~~~~~D 157 (400)
|||++||+||||||+||+++.++.+||+|||++.......... ......||+.|+|||++....+ .+.++|
T Consensus 149 ~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 228 (317)
T 2buj_A 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228 (317)
T ss_dssp HHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH
T ss_pred HHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhh
Confidence 9999999999999999999999999999999887543211110 1123568999999999875442 258999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchH--HHHHhhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLAGYLPFDDSNLM--NLYKKIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~elltG~~Pf~~~~~~--~~~~~i~-~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||+||++|+|++|+.||...... .....+. ....+.++.++.++.++|.+||+.||.+|||+.+++++
T Consensus 229 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 229 VWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 999999999999999999642111 1111111 22334445689999999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.82 Aligned_cols=207 Identities=19% Similarity=0.234 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEE-EeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.++.+|+.+++.++|++++..+..+ ......++||||+ ||+|.+++.. .+.+++..+..++.|++.||.|||++||+
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv 127 (296)
T 4hgt_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127 (296)
T ss_dssp CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4678899999999988877666554 7788899999999 8999999975 45799999999999999999999999999
Q ss_pred eccCCCCcEEE---ccCCCeeeeccccccccccccCC-----CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 95 HRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 95 HrDlKP~NILl---~~~g~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
||||||+|||+ +.++.+||+|||++......... ......+||+.|+|||++.+..+ +.++||||+||++|
T Consensus 128 H~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ 206 (296)
T 4hgt_A 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLM 206 (296)
T ss_dssp CSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHH
T ss_pred cCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHH
Confidence 99999999999 78899999999999865443221 12335689999999999988776 58999999999999
Q ss_pred HHHhCCCCCCCCch---HHHHHhhhcCccCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 167 VLLAGYLPFDDSNL---MNLYKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 167 elltG~~Pf~~~~~---~~~~~~i~~~~~~~~-----~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|++|+.||.+.+. ...+..+.......| ..+|.++.+||.+||+.||.+|||++++++
T Consensus 207 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 207 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999999976432 233333333332223 567999999999999999999999999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=307.53 Aligned_cols=202 Identities=29% Similarity=0.484 Sum_probs=166.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH--
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHS-- 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~~LH~-- 90 (400)
.+.+.+|+.++++++||||+++++++.+ ..|+||||++||+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 122 (307)
T 2eva_A 45 RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122 (307)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5778999999999999999999998763 4789999999999999998765 37899999999999999999999
Q ss_pred -cCCeeccCCCCcEEEccCCC-eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 91 -RGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 91 -~givHrDlKP~NILl~~~g~-~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
+||+||||||+||+++.+|. +||+|||++..... ......||+.|+|||++.+..+ +.++||||+||++|+|
T Consensus 123 ~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el 196 (307)
T 2eva_A 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEV 196 (307)
T ss_dssp SSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHH
T ss_pred CCCeecCCCChhHEEEeCCCCEEEEccccccccccc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHH
Confidence 89999999999999999887 79999999865432 1234579999999999987766 4899999999999999
Q ss_pred HhCCCCCCCCch--HHHHHhh-hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 169 LAGYLPFDDSNL--MNLYKKI-SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 169 ltG~~Pf~~~~~--~~~~~~i-~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
++|+.||..... ......+ .......+..++..+.++|.+||+.||.+|||++++++
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 197 ITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999976432 2222222 22334556678999999999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=310.66 Aligned_cols=209 Identities=23% Similarity=0.321 Sum_probs=172.0
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHc--
Q 015814 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSR-- 91 (400)
Q Consensus 18 ~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~l~~LH~~-- 91 (400)
++.+|+.+++.++||||+++++++.+....|+||||++||+|.+++.... .+++..+..++.|++.||+|||++
T Consensus 73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 152 (326)
T 3uim_A 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152 (326)
T ss_dssp HHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 68899999999999999999999999999999999999999999997654 399999999999999999999999
Q ss_pred -CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh
Q 015814 92 -GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 170 (400)
Q Consensus 92 -givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt 170 (400)
||+||||||+|||++.++.+||+|||++...... ........+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 153 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~ 230 (326)
T 3uim_A 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELIT 230 (326)
T ss_dssp SCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHH
T ss_pred CCeEeCCCchhhEEECCCCCEEeccCccccccCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHh
Confidence 9999999999999999999999999999765432 2223344569999999999987776 589999999999999999
Q ss_pred CCCCCCCCch--------HHHHHhhhcC-c------c----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 171 GYLPFDDSNL--------MNLYKKISAA-E------F----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 171 G~~Pf~~~~~--------~~~~~~i~~~-~------~----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
|..||+.... .......... . . ..++..+..+.+++.+||+.||.+|||+.++++|-+
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 9999963211 1111111000 0 0 111123467899999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=316.19 Aligned_cols=205 Identities=14% Similarity=0.197 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHhCC---CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~~l~~ 87 (400)
..++.+|+.+++.++ |+||+++++++...+..|+||||++||+|.+++.. ...+++..+..++.|++.||+|
T Consensus 108 ~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~ 187 (365)
T 3e7e_A 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187 (365)
T ss_dssp HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 456788899998887 99999999999999999999999999999999973 4579999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEcc-----------CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChh
Q 015814 88 CHSRGVYHRDLKPENLLLDA-----------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 156 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~-----------~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~ 156 (400)
||++||+||||||+|||++. ++.+||+|||+|...............+||+.|+|||++.+..| +.++
T Consensus 188 lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~ 266 (365)
T 3e7e_A 188 VHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQI 266 (365)
T ss_dssp HHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHH
T ss_pred HhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-Cccc
Confidence 99999999999999999998 89999999999976554333444566789999999999998876 4999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 157 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 157 DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||||||++|+|++|+.||........ .........+.++.+.+++..||+.+|.+|++..+.+.
T Consensus 267 DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 267 DYFGVAATVYCMLFGTYMKVKNEGGEC----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp HHHHHHHHHHHHHHSSCCCEEEETTEE----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred cHHHHHHHHHHHHhCCCccccCCCCce----eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 999999999999999999965332110 00011112245778999999999999999965444433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=313.34 Aligned_cols=207 Identities=15% Similarity=0.191 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHhCCCCCcce---------------eeEEEEe-CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNVVR---------------LYEVMGS-KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYF 78 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~---------------l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~ 78 (400)
+.+.+|+.++++++||||++ +++++.. ....|+||||+ ||+|.+++... ..+++..+..++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 46789999999999999988 6777766 78899999999 99999999886 689999999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCC--CeeeeccccccccccccCC-----CccccccCCCCCCCChhhhcCCC
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGY 151 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~ 151 (400)
.|++.||+|||++||+||||||+|||++.++ .+||+|||++......... .......||+.|+|||++.+..+
T Consensus 166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 245 (352)
T 2jii_A 166 CRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP 245 (352)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC
Confidence 9999999999999999999999999999988 8999999999765433221 12234589999999999988766
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCc--hHHHHHhh---hcCccCCC------CCCCHHHHHHHHHhcCCCCCCCCCH
Q 015814 152 DGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKI---SAAEFTCP------PWLSFTARKLIARILDPNPMTRITI 220 (400)
Q Consensus 152 ~~~~~DIwSlGiil~elltG~~Pf~~~~--~~~~~~~i---~~~~~~~~------~~~s~~~~~li~~mL~~dP~~R~t~ 220 (400)
+.++|||||||++|+|++|+.||.... ........ .......+ ..++.++.+||.+||+.||.+|||+
T Consensus 246 -~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 324 (352)
T 2jii_A 246 -SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY 324 (352)
T ss_dssp -CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred -CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence 589999999999999999999998753 22222222 11211111 2368999999999999999999999
Q ss_pred HHHhc
Q 015814 221 PEILE 225 (400)
Q Consensus 221 ~eil~ 225 (400)
+++++
T Consensus 325 ~~l~~ 329 (352)
T 2jii_A 325 AMLRN 329 (352)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=311.15 Aligned_cols=208 Identities=21% Similarity=0.341 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
+.+++|+.++++++||||+++++++.+...+|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+|
T Consensus 74 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H 153 (319)
T 2y4i_B 74 KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153 (319)
T ss_dssp CCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 456789999999999999999999999999999999999999999997755 6999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeecccccccccccc---CCCccccccCCCCCCCChhhhcC--------CCCCChhhHHHHHHH
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVR---DDGLLHTTCGTPNYVAPEVLNDR--------GYDGSTADLWSCGVI 164 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APEvl~~~--------~~~~~~~DIwSlGii 164 (400)
|||||+||+++ +|.+||+|||++....... .........||+.|+|||++... ...+.++||||+||+
T Consensus 154 ~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i 232 (319)
T 2y4i_B 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232 (319)
T ss_dssp CCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred cCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence 99999999998 6899999999987543221 12233445799999999999742 223589999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCccCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|+|++|..||...+.......+..+.... +..++.++.++|.+||..||.+|||+.++++
T Consensus 233 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 233 WYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999988777776665543322 2347899999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.56 Aligned_cols=195 Identities=33% Similarity=0.641 Sum_probs=161.2
Q ss_pred HHHHHHHHHH-HhCCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATM-KLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 17 ~~i~~Ei~il-~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH 89 (400)
....+|+.++ +.++||||+++++++.. ...+|+||||++||+|.+++...+ .+++..+..++.|++.||+|||
T Consensus 55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH 134 (299)
T 3m2w_A 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134 (299)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4677899998 56699999999999987 778999999999999999998764 6999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
++||+||||||+|||++. ++.+||+|||++..... ..| +.++||||+||++|
T Consensus 135 ~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~------------------------~~~-~~~~DiwslG~il~ 189 (299)
T 3m2w_A 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------------------EKY-DKSCDMWSLGVIMY 189 (299)
T ss_dssp HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT------------------------CGG-GGHHHHHHHHHHHH
T ss_pred hCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc------------------------ccC-CchhhHHHHHHHHH
Confidence 999999999999999998 78899999998754221 223 47899999999999
Q ss_pred HHHhCCCCCCCCchHHHHHh----hhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 015814 167 VLLAGYLPFDDSNLMNLYKK----ISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~----i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~~ 236 (400)
+|++|..||.+.+....... +.......| ..++.++.+||.+||+.||.+|||+.++++||||+.....+
T Consensus 190 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 190 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp HHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred HHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 99999999987665443322 222333333 45899999999999999999999999999999998765433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=331.26 Aligned_cols=207 Identities=23% Similarity=0.379 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.+|++++||||+++++++.. ..+|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++||
T Consensus 306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 384 (535)
T 2h8h_A 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384 (535)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3678999999999999999999999866 6789999999999999999643 469999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+|||++.++.+||+|||++........ .......+++.|+|||++....+ +.++|||||||++|+|++ |+
T Consensus 385 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~ 462 (535)
T 2h8h_A 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGR 462 (535)
T ss_dssp CCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTC
T ss_pred eCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999976432110 11123456788999999988776 489999999999999999 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
.||.+.+..+....+..+ ....|..++..+.+||.+||+.||.+|||+++|++
T Consensus 463 ~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 463 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998887777776554 34567789999999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=333.70 Aligned_cols=209 Identities=25% Similarity=0.397 Sum_probs=179.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.++++++||||+++++++. .+..|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++|
T Consensus 433 ~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 511 (656)
T 2j0j_A 433 SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511 (656)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34578999999999999999999999984 466899999999999999998654 6899999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
|+||||||+|||++.+|.+||+|||++....... ........||+.|+|||++....+ +.++||||+||++|+|++ |
T Consensus 512 ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g 589 (656)
T 2j0j_A 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHG 589 (656)
T ss_dssp CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTS
T ss_pred ccccccchHhEEEeCCCCEEEEecCCCeecCCCc-ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999997654321 111233467889999999988777 489999999999999997 9
Q ss_pred CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||.+.+..+....+..+ ....|+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 590 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 590 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999998887777776554 35677889999999999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.25 Aligned_cols=208 Identities=22% Similarity=0.350 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHh--CCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-
Q 015814 17 LQIKREVATMKL--VKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH- 89 (400)
Q Consensus 17 ~~i~~Ei~il~~--l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH- 89 (400)
....+|.+++.. ++||||+++++++.. ....|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||
T Consensus 45 ~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~ 123 (301)
T 3q4u_A 45 KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHI 123 (301)
T ss_dssp HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHS
T ss_pred hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHH
Confidence 455667777766 799999999998644 3568999999999999999954 57999999999999999999999
Q ss_pred -------HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC--CccccccCCCCCCCChhhhcCCCC-----CCh
Q 015814 90 -------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYD-----GST 155 (400)
Q Consensus 90 -------~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~-----~~~ 155 (400)
++||+||||||+|||++.++.+||+|||+|......... ......+||+.|+|||++.+.... +.+
T Consensus 124 ~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 203 (301)
T 3q4u_A 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203 (301)
T ss_dssp CBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHH
T ss_pred hhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCch
Confidence 999999999999999999999999999998754432111 112345899999999999865332 258
Q ss_pred hhHHHHHHHHHHHHhC----------CCCCCCCc-----hHHHHHhhhc--CccCCCCC-----CCHHHHHHHHHhcCCC
Q 015814 156 ADLWSCGVILFVLLAG----------YLPFDDSN-----LMNLYKKISA--AEFTCPPW-----LSFTARKLIARILDPN 213 (400)
Q Consensus 156 ~DIwSlGiil~elltG----------~~Pf~~~~-----~~~~~~~i~~--~~~~~~~~-----~s~~~~~li~~mL~~d 213 (400)
+||||+||++|+|++| ..||.... .......... .....|.. .+.++.+||.+||+.|
T Consensus 204 ~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 283 (301)
T 3q4u_A 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283 (301)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSS
T ss_pred hhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcC
Confidence 9999999999999999 88885532 1222222211 11222221 3467999999999999
Q ss_pred CCCCCCHHHHhc
Q 015814 214 PMTRITIPEILE 225 (400)
Q Consensus 214 P~~R~t~~eil~ 225 (400)
|.+|||+.++++
T Consensus 284 P~~Rps~~~i~~ 295 (301)
T 3q4u_A 284 PSARLTALRIKK 295 (301)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=305.14 Aligned_cols=209 Identities=22% Similarity=0.352 Sum_probs=163.5
Q ss_pred HHHHHHHHHHHhC--CCCCcceeeEEEEeC----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLV--KHPNVVRLYEVMGSK----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 17 ~~i~~Ei~il~~l--~HpnIv~l~~~~~~~----~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
....+|.+++..+ +||||+++++++... ...|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+
T Consensus 74 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~ 152 (337)
T 3mdy_A 74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHT 152 (337)
T ss_dssp HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHS
T ss_pred chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3445566665554 999999999999887 789999999999999999976 479999999999999999999999
Q ss_pred c--------CCeeccCCCCcEEEccCCCeeeeccccccccccccCCC--ccccccCCCCCCCChhhhcCCCCCC-----h
Q 015814 91 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDRGYDGS-----T 155 (400)
Q Consensus 91 ~--------givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~~~~-----~ 155 (400)
+ ||+||||||+|||++.++.+||+|||++.......... ...+.+||+.|+|||++.+..+... +
T Consensus 153 ~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 232 (337)
T 3mdy_A 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232 (337)
T ss_dssp CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHH
T ss_pred hhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccc
Confidence 9 99999999999999999999999999987554322111 1235689999999999987665433 4
Q ss_pred hhHHHHHHHHHHHHhC----------CCCCCCCc-----hHHHHHhhh--cCccCCCC-----CCCHHHHHHHHHhcCCC
Q 015814 156 ADLWSCGVILFVLLAG----------YLPFDDSN-----LMNLYKKIS--AAEFTCPP-----WLSFTARKLIARILDPN 213 (400)
Q Consensus 156 ~DIwSlGiil~elltG----------~~Pf~~~~-----~~~~~~~i~--~~~~~~~~-----~~s~~~~~li~~mL~~d 213 (400)
+||||+||++|+|++| ..||.... .......+. ......|. .++.++.+||.+||+.|
T Consensus 233 ~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 312 (337)
T 3mdy_A 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312 (337)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSS
T ss_pred cchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhC
Confidence 9999999999999999 77775432 112222211 11222332 24567999999999999
Q ss_pred CCCCCCHHHHhcC
Q 015814 214 PMTRITIPEILED 226 (400)
Q Consensus 214 P~~R~t~~eil~h 226 (400)
|.+|||+.++++|
T Consensus 313 P~~Rps~~ell~~ 325 (337)
T 3mdy_A 313 PASRLTALRVKKT 325 (337)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=320.70 Aligned_cols=206 Identities=24% Similarity=0.440 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC--EEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
.+.+.+|+.++++++||||+++++++.... ..|+||||++||+|.+++.... .+++..++.++.|++.||+|||+
T Consensus 51 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 130 (396)
T 4eut_A 51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130 (396)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999999998755 7899999999999999997643 39999999999999999999999
Q ss_pred cCCeeccCCCCcEEE----ccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc--------CCCCCChhhH
Q 015814 91 RGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--------RGYDGSTADL 158 (400)
Q Consensus 91 ~givHrDlKP~NILl----~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--------~~~~~~~~DI 158 (400)
+||+||||||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.. ..+ +.++||
T Consensus 131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~Di 206 (396)
T 4eut_A 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDL 206 (396)
T ss_dssp TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHH
T ss_pred CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCC-CcHHHH
Confidence 999999999999999 77778999999999765432 22345679999999999865 233 478999
Q ss_pred HHHHHHHHHHHhCCCCCCCCc----hHHHHHhhhcCccC-------------------CC------CCCCHHHHHHHHHh
Q 015814 159 WSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFT-------------------CP------PWLSFTARKLIARI 209 (400)
Q Consensus 159 wSlGiil~elltG~~Pf~~~~----~~~~~~~i~~~~~~-------------------~~------~~~s~~~~~li~~m 209 (400)
||+||++|+|++|+.||.... ..+....+..+.+. .| ..++..+.++|++|
T Consensus 207 wSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~ 286 (396)
T 4eut_A 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286 (396)
T ss_dssp HHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHh
Confidence 999999999999999996422 22333333322211 11 11345788999999
Q ss_pred cCCCCCCCCCHHHHhc
Q 015814 210 LDPNPMTRITIPEILE 225 (400)
Q Consensus 210 L~~dP~~R~t~~eil~ 225 (400)
|+.||.+|||++++++
T Consensus 287 L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 287 LEADQEKCWGFDQFFA 302 (396)
T ss_dssp SCCCTTTSCCHHHHHH
T ss_pred hccChhhhccHHHHHH
Confidence 9999999999999854
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=305.31 Aligned_cols=209 Identities=28% Similarity=0.442 Sum_probs=152.6
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEE--------eCCEEEEEEecCCCCChHHHHHh---CCCCCHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMG--------SKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLIN 83 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~--------~~~~~~lv~Ey~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~ 83 (400)
...+.+|+.+++++. ||||+++++++. ....+|+||||+. |+|.+++.. .+.+++..+..++.|++.
T Consensus 69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~ 147 (337)
T 3ll6_A 69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147 (337)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHH
Confidence 577899999999995 999999999984 3456899999997 589888864 567999999999999999
Q ss_pred HHHHHHHcC--CeeccCCCCcEEEccCCCeeeeccccccccccccCC----------CccccccCCCCCCCChhhh---c
Q 015814 84 AVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTPNYVAPEVLN---D 148 (400)
Q Consensus 84 ~l~~LH~~g--ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~---~ 148 (400)
||+|||++| |+||||||+|||++.++.+||+|||++......... ......+||+.|+|||++. +
T Consensus 148 ~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (337)
T 3ll6_A 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227 (337)
T ss_dssp HHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTT
T ss_pred HHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcccc
Confidence 999999999 999999999999999999999999998765432111 1112457999999999983 3
Q ss_pred CCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 015814 149 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228 (400)
Q Consensus 149 ~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~ 228 (400)
..+ +.++|||||||++|+|++|..||............ .....+...+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 228 ~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 228 FPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp SCS-SHHHHHHHHHHHHHHHHHSSCCC--------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 334 58999999999999999999999876544333221 122334557889999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=304.59 Aligned_cols=209 Identities=22% Similarity=0.362 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCC--EEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+.+.+|+.++++++||||+++++++.... .+|+||||++||+|.+++.... .+++..+..++.|++.||+|||++|
T Consensus 86 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 165 (326)
T 2w1i_A 86 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 165 (326)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999999999999986543 7899999999999999998764 5999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|+||||||+||+++.++.+||+|||++......... .......|++.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus 166 ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg 244 (326)
T 2w1i_A 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTY 244 (326)
T ss_dssp EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHT
T ss_pred EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhc
Confidence 999999999999999999999999998765432111 11223457788999999987766 4899999999999999999
Q ss_pred CCCCCCCchH----------------HHHHhhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 172 YLPFDDSNLM----------------NLYKKIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 172 ~~Pf~~~~~~----------------~~~~~i~-~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
..||...... .+...+. ......|..++.++.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9998653211 1111222 2234566779999999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=330.67 Aligned_cols=212 Identities=27% Similarity=0.397 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe------CCEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVD 86 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lv~Ey~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~ 86 (400)
.+.+.+|+.++++++||||+++++++.. ....|+||||++||+|.+++.... .+++..++.++.|++.||+
T Consensus 56 ~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~ 135 (676)
T 3qa8_A 56 RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135 (676)
T ss_dssp HHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHH
Confidence 5778999999999999999999998755 677899999999999999998754 5999999999999999999
Q ss_pred HHHHcCCeeccCCCCcEEEccCCC---eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHH
Q 015814 87 YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 163 (400)
Q Consensus 87 ~LH~~givHrDlKP~NILl~~~g~---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGi 163 (400)
|||++||+||||||+||+++.+|. +||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||
T Consensus 136 yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGv 211 (676)
T 3qa8_A 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGT 211 (676)
T ss_dssp HHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHH
T ss_pred HHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHH
Confidence 999999999999999999998775 99999999876543 223345689999999999987777 48999999999
Q ss_pred HHHHHHhCCCCCCCCchHHHHHh--------------hhcCcc------CCC----CCCCHHHHHHHHHhcCCCCCCCCC
Q 015814 164 ILFVLLAGYLPFDDSNLMNLYKK--------------ISAAEF------TCP----PWLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 164 il~elltG~~Pf~~~~~~~~~~~--------------i~~~~~------~~~----~~~s~~~~~li~~mL~~dP~~R~t 219 (400)
++|+|++|..||.+......+.. ...+.. +.| +.++..+.+||.+||..||.+|||
T Consensus 212 iLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT 291 (676)
T 3qa8_A 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT 291 (676)
T ss_dssp HHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C
T ss_pred HHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC
Confidence 99999999999976432221100 001111 111 125678999999999999999999
Q ss_pred HHHHhcCccccc
Q 015814 220 IPEILEDEWFKK 231 (400)
Q Consensus 220 ~~eil~h~~~~~ 231 (400)
++++++||||+.
T Consensus 292 a~elL~hp~F~~ 303 (676)
T 3qa8_A 292 DPQNPNVGCFQA 303 (676)
T ss_dssp CTTCCCCTTHHH
T ss_pred HHHHhcCHHHHH
Confidence 999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=304.76 Aligned_cols=214 Identities=21% Similarity=0.312 Sum_probs=157.7
Q ss_pred HHHHHHHhCCCCCcceeeEEEEe-----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc----
Q 015814 21 REVATMKLVKHPNVVRLYEVMGS-----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---- 91 (400)
Q Consensus 21 ~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~---- 91 (400)
.|+..++.++||||+++++.+.. ...+|+||||++||+|.+++... ..++..+..++.|++.||+|||++
T Consensus 56 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 134 (336)
T 3g2f_A 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRG 134 (336)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCG
T ss_pred HHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccc
Confidence 34444556899999999986542 33679999999999999999764 468999999999999999999999
Q ss_pred -----CCeeccCCCCcEEEccCCCeeeecccccccccccc------CCCccccccCCCCCCCChhhhcCC------CCCC
Q 015814 92 -----GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR------DDGLLHTTCGTPNYVAPEVLNDRG------YDGS 154 (400)
Q Consensus 92 -----givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APEvl~~~~------~~~~ 154 (400)
||+||||||+|||++.+|.+||+|||++....... ........+||+.|+|||++.+.. ..+.
T Consensus 135 ~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp GGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred cccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence 99999999999999999999999999997654321 112233557999999999997521 2236
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCch------------------HHHHHhh--hcCccCCCCC------CCHHHHHHHHH
Q 015814 155 TADLWSCGVILFVLLAGYLPFDDSNL------------------MNLYKKI--SAAEFTCPPW------LSFTARKLIAR 208 (400)
Q Consensus 155 ~~DIwSlGiil~elltG~~Pf~~~~~------------------~~~~~~i--~~~~~~~~~~------~s~~~~~li~~ 208 (400)
++||||+||++|+|++|..||..... ....... ......+|.. .+.++.+||.+
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHH
Confidence 89999999999999999777532111 1111111 1112233332 33479999999
Q ss_pred hcCCCCCCCCCHHHHh------cCcccccCCCC
Q 015814 209 ILDPNPMTRITIPEIL------EDEWFKKDYKP 235 (400)
Q Consensus 209 mL~~dP~~R~t~~eil------~h~~~~~~~~~ 235 (400)
||+.||.+|||+.|++ .++|-++...+
T Consensus 295 cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~ 327 (336)
T 3g2f_A 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327 (336)
T ss_dssp HSCSSGGGSCCHHHHHHHHHHHHHCCCC-----
T ss_pred HhcCChhhCcchHHHHHHHHHHHHHHHhcccCC
Confidence 9999999999999994 46777665443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.68 Aligned_cols=210 Identities=21% Similarity=0.321 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHh--CCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKL--VKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~--l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+.+|+++++. ++||||+++++++.... ..|+||||+++|+|.+++.. .++++..+..++.|++.||.|||
T Consensus 78 ~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH 156 (342)
T 1b6c_B 78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLH 156 (342)
T ss_dssp HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH
Confidence 3567789999987 79999999999998776 89999999999999999976 57999999999999999999999
Q ss_pred --------HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCC--CccccccCCCCCCCChhhhcCCCCC-----C
Q 015814 90 --------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDG-----S 154 (400)
Q Consensus 90 --------~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~-----~ 154 (400)
++||+||||||+|||++.++.+||+|||++......... ......+||+.|+|||++.+..... .
T Consensus 157 ~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 236 (342)
T 1b6c_B 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236 (342)
T ss_dssp CCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHH
T ss_pred HHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCC
Confidence 899999999999999999999999999998765432111 0224457999999999997653221 5
Q ss_pred hhhHHHHHHHHHHHHhC----------CCCCCCCc-----hHHHHHhhhcCc--cCCCCC-----CCHHHHHHHHHhcCC
Q 015814 155 TADLWSCGVILFVLLAG----------YLPFDDSN-----LMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDP 212 (400)
Q Consensus 155 ~~DIwSlGiil~elltG----------~~Pf~~~~-----~~~~~~~i~~~~--~~~~~~-----~s~~~~~li~~mL~~ 212 (400)
++|||||||++|+|++| ..||.... .......+.... ...|.. .+..+.+||.+||+.
T Consensus 237 ~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (342)
T 1b6c_B 237 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316 (342)
T ss_dssp HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCS
T ss_pred cccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhcc
Confidence 79999999999999999 88996642 233333333222 222221 235788999999999
Q ss_pred CCCCCCCHHHHhcC
Q 015814 213 NPMTRITIPEILED 226 (400)
Q Consensus 213 dP~~R~t~~eil~h 226 (400)
||.+|||+.++++|
T Consensus 317 dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 317 NGAARLTALRIKKT 330 (342)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=311.40 Aligned_cols=200 Identities=20% Similarity=0.270 Sum_probs=160.9
Q ss_pred HHHHHHHHHHHHhCC---------CCCcceeeEEEE------------------------------eCCEEEEEEecCCC
Q 015814 16 LLQIKREVATMKLVK---------HPNVVRLYEVMG------------------------------SKTKIFIVLEFVTG 56 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~---------HpnIv~l~~~~~------------------------------~~~~~~lv~Ey~~g 56 (400)
.+.+.+|+.+|+.++ ||||+++.+++. ....+|+||||+++
T Consensus 67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~ 146 (336)
T 2vuw_A 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence 477889999998886 777777776642 26889999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeccCCCCcEEEccCC--------------------Ceeeec
Q 015814 57 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYG--------------------NLKVSD 115 (400)
Q Consensus 57 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH-~~givHrDlKP~NILl~~~g--------------------~~kl~D 115 (400)
|++.+.+.. +.+++..++.++.||+.||+||| ++||+||||||+|||++.+| .+||+|
T Consensus 147 g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D 225 (336)
T 2vuw_A 147 GIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225 (336)
T ss_dssp CEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred CccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence 988887755 67899999999999999999999 99999999999999999987 899999
Q ss_pred cccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH-HHHHHhCCCCCCCCch-HHHHHhhh-cCcc
Q 015814 116 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI-LFVLLAGYLPFDDSNL-MNLYKKIS-AAEF 192 (400)
Q Consensus 116 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii-l~elltG~~Pf~~~~~-~~~~~~i~-~~~~ 192 (400)
||+|+.... ...+||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+... ......+. ....
T Consensus 226 FG~a~~~~~-------~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 296 (336)
T 2vuw_A 226 YTLSRLERD-------GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF 296 (336)
T ss_dssp CTTCBEEET-------TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC
T ss_pred ccccEecCC-------CcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc
Confidence 999986542 2458999999999998654 589999998777 7789999999965322 11222222 1111
Q ss_pred C--C----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHh-cCcccc
Q 015814 193 T--C----PPWLSFTARKLIARILDPNPMTRITIPEIL-EDEWFK 230 (400)
Q Consensus 193 ~--~----~~~~s~~~~~li~~mL~~dP~~R~t~~eil-~h~~~~ 230 (400)
. . ++.+|+++.+||++||+.| |++|++ +||||+
T Consensus 297 ~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 297 KTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred CcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1 1 1236889999999999977 999999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.91 Aligned_cols=207 Identities=19% Similarity=0.227 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhCCC-CCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.++.+|+.+++.++| ++|..+..++......|+||||+ ||+|.+++.. .+.+++..+..++.||+.||+|||++||+
T Consensus 47 ~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIv 125 (483)
T 3sv0_A 47 PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125 (483)
T ss_dssp CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 457889999999976 56666667778889999999999 8999999975 45799999999999999999999999999
Q ss_pred eccCCCCcEEE---ccCCCeeeeccccccccccccCC-----CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 95 HRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 95 HrDlKP~NILl---~~~g~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
||||||+|||+ +.++.+||+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 126 HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~ 204 (483)
T 3sv0_A 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLM 204 (483)
T ss_dssp CCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHH
T ss_pred ecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHH
Confidence 99999999999 68899999999999865543221 12235689999999999988777 48999999999999
Q ss_pred HHHhCCCCCCCCch---HHHHHhhhcCcc-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 167 VLLAGYLPFDDSNL---MNLYKKISAAEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 167 elltG~~Pf~~~~~---~~~~~~i~~~~~-----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|++|+.||.+... ...+.++..... ..+..++.++.+||..||..||.+||++.+|++
T Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999987443 333433332221 223567899999999999999999999998764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.89 Aligned_cols=204 Identities=18% Similarity=0.215 Sum_probs=160.9
Q ss_pred HHHHHHHHHHHHhCCC-CCcc---------e------------eeEEEEe-----CCEEEEEEecCCCCChHHHHHh---
Q 015814 16 LLQIKREVATMKLVKH-PNVV---------R------------LYEVMGS-----KTKIFIVLEFVTGGELFDKIVN--- 65 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~H-pnIv---------~------------l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~~--- 65 (400)
.+.+++|+.+++.++| +|.. . +..++.. ...++++|+++ +|+|.+++..
T Consensus 122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~ 200 (413)
T 3dzo_A 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS 200 (413)
T ss_dssp CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence 5779999999999987 3211 1 1111111 23467888876 4699988842
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCC
Q 015814 66 ----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 141 (400)
Q Consensus 66 ----~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 141 (400)
.+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..... ..+.+| +.|+
T Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~ 274 (413)
T 3dzo_A 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFA 274 (413)
T ss_dssp HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTC
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-Ccee
Confidence 234778889999999999999999999999999999999999999999999998754432 455688 9999
Q ss_pred CChhhh----------cCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcC
Q 015814 142 APEVLN----------DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 211 (400)
Q Consensus 142 APEvl~----------~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~ 211 (400)
|||++. ...| +.++|||||||++|+|++|+.||.+.+.......+.. ....+|.++.+||.+||+
T Consensus 275 aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~ 349 (413)
T 3dzo_A 275 PPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLR 349 (413)
T ss_dssp CHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTC
T ss_pred CchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHcc
Confidence 999993 3334 4799999999999999999999988776554444322 234578999999999999
Q ss_pred CCCCCCCCHHHHhcCccccc
Q 015814 212 PNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 212 ~dP~~R~t~~eil~h~~~~~ 231 (400)
.||.+|||+.++++||||+.
T Consensus 350 ~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 350 YPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp SSGGGSCCHHHHTTSHHHHH
T ss_pred CChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.14 Aligned_cols=199 Identities=25% Similarity=0.363 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCE-----EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-----~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
....+.+|+.++++++||||+++++++...+. .|+||||++|++|.+.+.. .+++..+..++.|++.||.|||
T Consensus 122 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH 199 (681)
T 2pzi_A 122 AQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLH 199 (681)
T ss_dssp HHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 35678899999999999999999999987655 7999999999999988755 7999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++||+||||||+|||++. +.+||+|||++...... ...+||+.|+|||++.+. + +.++||||+||++|+|+
T Consensus 200 ~~giiHrDlkp~NIll~~-~~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~ 270 (681)
T 2pzi_A 200 SIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALT 270 (681)
T ss_dssp HTTEECCCCSGGGEEECS-SCEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHH
T ss_pred HCCCeecccChHHeEEeC-CcEEEEecccchhcccC------CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHH
Confidence 999999999999999988 49999999998754321 456799999999999764 3 58999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
+|..||.+....... ........++.+.+||.+||+.||.+||+..+.+.|+|+.
T Consensus 271 ~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 271 LDLPTRNGRYVDGLP------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp SCCCEETTEECSSCC------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hCCCCCccccccccc------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 999998763211000 0000011467899999999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=275.85 Aligned_cols=179 Identities=18% Similarity=0.253 Sum_probs=151.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++.. + ..+..+..++.|++.||+|||++||
T Consensus 73 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~gi 150 (286)
T 3uqc_A 73 DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGV 150 (286)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCC
Confidence 3467899999999999999999999999999999999999999999999954 3 4666788999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|.+||+++| |++| + +.++|||||||++|+|++|+.
T Consensus 151 vH~Dikp~NIll~~~g~~kl~~~~----------------------~~~~-------~-~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 151 ALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD-------A-NPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp CCCCCSGGGEEEETTSCEEECSCC----------------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEE
T ss_pred ccCCCCcccEEEcCCCCEEEEecc----------------------ccCC-------C-CchhHHHHHHHHHHHHHHCCC
Confidence 999999999999999999998544 3332 3 589999999999999999999
Q ss_pred CCCCCchHHHHH---hhhcCcc----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 PFDDSNLMNLYK---KISAAEF----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 Pf~~~~~~~~~~---~i~~~~~----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+...... +...... ..++.++.++.++|.+||+.||.+| |+.++++
T Consensus 201 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 201 PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 998866533221 1111111 1235689999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.23 Aligned_cols=197 Identities=14% Similarity=0.150 Sum_probs=143.7
Q ss_pred HHHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+++++|+++|+++ .|+||++++++++++...||||||++||+|.++|...+++++. .++.||++||+|||++|
T Consensus 283 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G 359 (569)
T 4azs_A 283 RNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG 359 (569)
T ss_dssp HHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC
Confidence 3468899999999999 7999999999999999999999999999999999998888875 48999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+|||++++|++||+|||+|+..... .....+.+||+.|+|||++.+. + ..++|+||+|++++++.+|.
T Consensus 360 IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~~~t~vGTp~YmAPE~l~g~-~-~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 360 FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSWPTNLVQSFFVFVNELFAEN-K-SWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred ceeccCchHhEEECCCCCEEEeecccCeeCCCC--CccccCceechhhccHHHhCCC-C-CCcccccccccchhhhcccc
Confidence 999999999999999999999999999765432 2345678999999999999864 3 36799999999998887665
Q ss_pred CCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
.|+. ..... .|+. ...+..+...++..+|..|+.......++|..
T Consensus 436 ~~~~--------~~l~~----~~~~-~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 436 SNWL--------YAVWQ----EPVE-RWNFVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHH--------HHHHT----SCGG-GCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred chhH--------HHhhc----CCCC-CCcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 4431 11110 1110 11245666777778888887776666666654
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=223.79 Aligned_cols=129 Identities=52% Similarity=0.893 Sum_probs=117.6
Q ss_pred CccchhhhHHhhcCCCCCCCCCCcccc-cccccceEEecCCHHHHHHHHHHHhccCCceEeeeCceEEEEEeccCCCcce
Q 015814 268 QPVAMNAFELISLSKGLNLGNLFDAEQ-DFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNL 346 (400)
Q Consensus 268 ~~~~~~~~~~~~~s~~~~~~~~~~~~~-~~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 346 (400)
.|..+|||++|++|+|+||++||+..+ .++++|||+|+.|+.+|+++|+++++.+||.|+++++++++.+..+|++|.|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 467799999999999999999997543 2688999999999999999999999999999999989999999999999999
Q ss_pred EEEEEEEEEcCceeEEEEEecCCCchhHHHHHHHHHHhccccccccchhh
Q 015814 347 NVATEVFQVAPSLHMVEVRKAKGDTLEFHKFYKNLSTCLEDVVWKTEEDM 396 (400)
Q Consensus 347 ~~~~~i~~~~~~~~~v~~~~~~gd~~~~~~~~~~~~~~l~~~v~~~~~~~ 396 (400)
++.++||+|+|+++||||+|+.||++||+++|++|++.|+||||+..++.
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~~~~~ 132 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGI 132 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC-----
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecCCCCC
Confidence 99999999999999999999999999999999999999999999865543
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=209.36 Aligned_cols=120 Identities=30% Similarity=0.465 Sum_probs=106.0
Q ss_pred ccchhhhHHhhcCCCCCCCCCCcccccccccceEEecCCHHHHHHHHHHHhccCCceEeeeCceEEEEEeccCCCcceEE
Q 015814 269 PVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNV 348 (400)
Q Consensus 269 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (400)
|..+|||++|++|+|+||++||++....+++|||+|+.|+++|+++|+++++.+||.|++++++ .++.++++|.|++
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~v 79 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFAM 79 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEEE
T ss_pred cccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEEE
Confidence 5569999999999999999999754444779999999999999999999999999999988775 5667899999999
Q ss_pred EEEEEEEcCceeEEEEEecCCCchhHHHHH-HHHHHhccccccc
Q 015814 349 ATEVFQVAPSLHMVEVRKAKGDTLEFHKFY-KNLSTCLEDVVWK 391 (400)
Q Consensus 349 ~~~i~~~~~~~~~v~~~~~~gd~~~~~~~~-~~~~~~l~~~v~~ 391 (400)
.++||+|+|+++||||+|+.||++||++|| ++|++.|+||||+
T Consensus 80 ~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 80 VVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 999999999999999999999999999965 5899999999995
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-26 Score=237.40 Aligned_cols=151 Identities=22% Similarity=0.260 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+++.+|+++|++++||||+++..+.......|+||||++||+|.+++.. +..++.|+++||+|||++||+
T Consensus 382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIi 453 (540)
T 3en9_A 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVI 453 (540)
T ss_dssp HHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCc
Confidence 356789999999999999999555555567777999999999999999865 668999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCC-----ccccccCCCCCCCChhhhc--CCCCCChhhHHHHHHHHHH
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-----LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~--~~~~~~~~DIwSlGiil~e 167 (400)
||||||+|||++. .+||+|||+|+......... ...+.+||+.|+|||++.. .+|. ..+|+||.++-..+
T Consensus 454 HrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~ 530 (540)
T 3en9_A 454 HNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMK 530 (540)
T ss_dssp CTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHH
T ss_pred cCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHH
Confidence 9999999999999 99999999998754321111 1246789999999999976 5564 77899999998888
Q ss_pred HHhCCCCCC
Q 015814 168 LLAGYLPFD 176 (400)
Q Consensus 168 lltG~~Pf~ 176 (400)
-+.++.+|.
T Consensus 531 ~v~~r~rY~ 539 (540)
T 3en9_A 531 DVERRARYV 539 (540)
T ss_dssp HHHTCSCCC
T ss_pred HHHhccccC
Confidence 887777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-20 Score=174.73 Aligned_cols=105 Identities=17% Similarity=0.282 Sum_probs=87.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+|++++ | +++++++.. +..|+||||++||+|.+ +. ...+..++.|++.||.|||++||+|
T Consensus 148 ~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiH 216 (282)
T 1zar_A 148 IRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVH 216 (282)
T ss_dssp HHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEe
Confidence 567899999999999 4 555555544 44599999999999987 42 1345679999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 147 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~ 147 (400)
|||||+|||++ +|.+||+|||+|. ++..|.|||++.
T Consensus 217 rDlkp~NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 217 GDLSQYNVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp SCCSTTSEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred CCCCHHHEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence 99999999999 9999999999875 245688999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.6e-16 Score=144.30 Aligned_cols=96 Identities=19% Similarity=0.291 Sum_probs=77.6
Q ss_pred HHHHHHHHHHHhCCCCCc--ceeeEEEEeCCEEEEEEecCCC-C----ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLVKHPNV--VRLYEVMGSKTKIFIVLEFVTG-G----ELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnI--v~l~~~~~~~~~~~lv~Ey~~g-g----~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+.+|+.+|+++.|+|| ..+++. ...++||||+.+ | +|.+.... .++..+..++.|++.||.|||
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHH
Confidence 568899999999988864 444442 246899999942 3 56655432 345678899999999999999
Q ss_pred -HcCCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 90 -SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 90 -~~givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
+.||+||||||+|||++. .++|+|||+|..
T Consensus 188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp HTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999999998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.33 E-value=6.1e-13 Score=130.80 Aligned_cols=94 Identities=17% Similarity=0.165 Sum_probs=71.4
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 98 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDl 98 (400)
..+|...|.++.++++.-..-+.... .++||||++|++|.+.. ..+.+..++.|++.+|.|||++|||||||
T Consensus 160 A~kE~~nL~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 160 AIKEFAFMKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 35788899998666553222222222 26999999998885432 22345678999999999999999999999
Q ss_pred CCCcEEEccCCC----------eeeecccccc
Q 015814 99 KPENLLLDAYGN----------LKVSDFGLSA 120 (400)
Q Consensus 99 KP~NILl~~~g~----------~kl~DFGla~ 120 (400)
||.|||++++|. +.|+||+.+-
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 999999998774 8899999654
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.17 E-value=2e-10 Score=94.03 Aligned_cols=84 Identities=18% Similarity=0.282 Sum_probs=75.8
Q ss_pred EecCCHHHHHHHHHHHhccCCceEeeeC-ceEEEEEeccCCCcceEEEEEEEEEc-CceeEEEEEecCCCchhHHHHHHH
Q 015814 303 TSRCPANEIINKIEEAAKPLGFDVHKKN-YKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKFYKN 380 (400)
Q Consensus 303 ~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~gd~~~~~~~~~~ 380 (400)
+|+.+|++|+..|+.|+..+|+.|+.++ |.+++........+.+.|.+||+++. +++++|+|+|.+||.+.|++++.+
T Consensus 34 TS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~~ 113 (120)
T 3ose_A 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK 113 (120)
T ss_dssp EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHHH
Confidence 6899999999999999999999998865 78888766555567899999999996 899999999999999999999999
Q ss_pred HHHhcc
Q 015814 381 LSTCLE 386 (400)
Q Consensus 381 ~~~~l~ 386 (400)
|...|+
T Consensus 114 il~~L~ 119 (120)
T 3ose_A 114 IANELK 119 (120)
T ss_dssp HHHHCC
T ss_pred HHHHhc
Confidence 988775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=3.8e-10 Score=104.61 Aligned_cols=100 Identities=15% Similarity=0.146 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----
Q 015814 17 LQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS----- 90 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~----- 90 (400)
..+++|+.+++.+. |..+.+++++....+..|+||||++|.+|.+.+. +......++.++..++..||+
T Consensus 54 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~ 128 (263)
T 3tm0_A 54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISD 128 (263)
T ss_dssp TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCccc
Confidence 46899999999994 7788899999999999999999999998876531 222345788999999999999
Q ss_pred ------------------------------------------------------cCCeeccCCCCcEEEccCCCeeeecc
Q 015814 91 ------------------------------------------------------RGVYHRDLKPENLLLDAYGNLKVSDF 116 (400)
Q Consensus 91 ------------------------------------------------------~givHrDlKP~NILl~~~g~~kl~DF 116 (400)
.+++|+|++|.||++++++.+.|+||
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDw 208 (263)
T 3tm0_A 129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL 208 (263)
T ss_dssp CSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCC
T ss_pred CCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEc
Confidence 45899999999999987656679999
Q ss_pred ccccc
Q 015814 117 GLSAL 121 (400)
Q Consensus 117 Gla~~ 121 (400)
+.+..
T Consensus 209 e~a~~ 213 (263)
T 3tm0_A 209 GRSGR 213 (263)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 97643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.88 E-value=1.4e-09 Score=99.86 Aligned_cols=97 Identities=15% Similarity=0.224 Sum_probs=75.5
Q ss_pred HHHHHHHHHHHhCCCCC--cceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--
Q 015814 17 LQIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-- 92 (400)
Q Consensus 17 ~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g-- 92 (400)
..+.+|+.+++.+.+.+ +.+++++....+..|+||||++|.+|. . ...+ ...++.++...+..||+..
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~ 129 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPA 129 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGG
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCC
Confidence 45789999999996545 567888888888899999999998873 2 1122 2356777888888888643
Q ss_pred --------------------------------------------------------CeeccCCCCcEEEccCCCeeeecc
Q 015814 93 --------------------------------------------------------VYHRDLKPENLLLDAYGNLKVSDF 116 (400)
Q Consensus 93 --------------------------------------------------------ivHrDlKP~NILl~~~g~~kl~DF 116 (400)
++|+|++|.||++++++.+.|+||
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~ 209 (264)
T 1nd4_A 130 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC 209 (264)
T ss_dssp GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred CCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcc
Confidence 999999999999987666779999
Q ss_pred ccccc
Q 015814 117 GLSAL 121 (400)
Q Consensus 117 Gla~~ 121 (400)
|.+..
T Consensus 210 ~~a~~ 214 (264)
T 1nd4_A 210 GRLGV 214 (264)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 98653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.6e-09 Score=102.05 Aligned_cols=104 Identities=25% Similarity=0.443 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHHhCC--CCCcceeeEEEEeC---CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK--HPNVVRLYEVMGSK---TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~ 90 (400)
...+.+|+.+++.+. +..+.+++.++.+. +..|+||||++|..+.+.. ...+++.....++.++..+|..||+
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 357889999999997 45688999888766 4478999999998775421 2347788889999999999999997
Q ss_pred ----------------------------------------------------------cCCeeccCCCCcEEEccCCC--
Q 015814 91 ----------------------------------------------------------RGVYHRDLKPENLLLDAYGN-- 110 (400)
Q Consensus 91 ----------------------------------------------------------~givHrDlKP~NILl~~~g~-- 110 (400)
.+++|+|++|.||+++.++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v 237 (359)
T 3dxp_A 158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRV 237 (359)
T ss_dssp SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCE
T ss_pred CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcE
Confidence 36899999999999998764
Q ss_pred eeeeccccccc
Q 015814 111 LKVSDFGLSAL 121 (400)
Q Consensus 111 ~kl~DFGla~~ 121 (400)
+.|.||+.+..
T Consensus 238 ~~viDwe~a~~ 248 (359)
T 3dxp_A 238 LAVLDWELSTL 248 (359)
T ss_dssp EEECCCTTCEE
T ss_pred EEEECcccccc
Confidence 68999998864
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.85 E-value=4.9e-09 Score=85.73 Aligned_cols=85 Identities=13% Similarity=0.208 Sum_probs=75.1
Q ss_pred EecCCHHHHHHHHHHHhccCCceEee-eCceEEEEEeccCCCcceEEEEEEEEEc-CceeEEEEEecCCCchhHHHHHHH
Q 015814 303 TSRCPANEIINKIEEAAKPLGFDVHK-KNYKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKFYKN 380 (400)
Q Consensus 303 ~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~gd~~~~~~~~~~ 380 (400)
+|+.++++|+..|..+++.+|+.|+. +.|.+++.......+..+.|.+||+++. .+++.|+|+|.+||.+.|++++.+
T Consensus 34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~ 113 (126)
T 1v5s_A 34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK 113 (126)
T ss_dssp CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHHH
T ss_pred ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHHH
Confidence 57889999999999999999999987 5688888765444567899999999994 689999999999999999999999
Q ss_pred HHHhccc
Q 015814 381 LSTCLED 387 (400)
Q Consensus 381 ~~~~l~~ 387 (400)
|...|+=
T Consensus 114 IL~eLkL 120 (126)
T 1v5s_A 114 IANELKL 120 (126)
T ss_dssp HHHHTTC
T ss_pred HHHHHhc
Confidence 9998873
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=8e-10 Score=105.05 Aligned_cols=153 Identities=16% Similarity=0.212 Sum_probs=103.2
Q ss_pred HHHHHHHHHHHHhC-CCCC--cceeeEEEEeCC---EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPN--VVRLYEVMGSKT---KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~Hpn--Iv~l~~~~~~~~---~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+.+|+.+|+.+ .+.. +.+.+....... ..|+||++++|..|.+... ..++.+....++.|+...+..||
T Consensus 54 ~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH 131 (304)
T 3sg8_A 54 STNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELH 131 (304)
T ss_dssp HHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHH
Confidence 57899999999988 4433 345554443333 3488999999988876443 34788888889999999999999
Q ss_pred H----------------------------------------------------------cCCeeccCCCCcEEEcc--CC
Q 015814 90 S----------------------------------------------------------RGVYHRDLKPENLLLDA--YG 109 (400)
Q Consensus 90 ~----------------------------------------------------------~givHrDlKP~NILl~~--~g 109 (400)
+ ..++|+|++|.||++++ .+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~ 211 (304)
T 3sg8_A 132 SINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNT 211 (304)
T ss_dssp HSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTE
T ss_pred cCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCC
Confidence 6 13699999999999998 45
Q ss_pred CeeeeccccccccccccCCCccccccCCCCC---CCChhhhc--CCCCC-----------ChhhHHHHHHHHHHHHhCCC
Q 015814 110 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNY---VAPEVLND--RGYDG-----------STADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 110 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~APEvl~~--~~~~~-----------~~~DIwSlGiil~elltG~~ 173 (400)
.+.|+||+.+....... .......+ ..|+.... ..|.. .-.+.|++|.++|.+.+|..
T Consensus 212 ~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~ 285 (304)
T 3sg8_A 212 ICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYM 285 (304)
T ss_dssp EEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCH
T ss_pred EEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCH
Confidence 68899999876432110 00111111 22332110 01111 12689999999999999988
Q ss_pred CCC
Q 015814 174 PFD 176 (400)
Q Consensus 174 Pf~ 176 (400)
||-
T Consensus 286 ~~~ 288 (304)
T 3sg8_A 286 DWY 288 (304)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-07 Score=74.63 Aligned_cols=86 Identities=20% Similarity=0.342 Sum_probs=74.3
Q ss_pred eEEecCCHHHHHHHHHHHhccCCceEee-eCceEEEEEeccCCCcceEEEEEEEEEcCceeEEEEEecCCC--------c
Q 015814 301 RFTSRCPANEIINKIEEAAKPLGFDVHK-KNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGD--------T 371 (400)
Q Consensus 301 rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd--------~ 371 (400)
...|...+.++|..|..|++.+|+.|+. +.|.++++...+.....+.|.+++|++.++.+|+||++..|| .
T Consensus 11 GIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~ 90 (106)
T 4eai_A 11 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHT 90 (106)
T ss_dssp SEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHH
T ss_pred cceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCc
Confidence 3468889999999999999999999987 468999886644445679999999999999999999999994 8
Q ss_pred hhHHHHHHHHHHhcc
Q 015814 372 LEFHKFYKNLSTCLE 386 (400)
Q Consensus 372 ~~~~~~~~~~~~~l~ 386 (400)
++|-++|.++...|.
T Consensus 91 ~~F~d~ca~li~~la 105 (106)
T 4eai_A 91 IEFFEMCANLIKILA 105 (106)
T ss_dssp HHHHHHHHHHHHHCC
T ss_pred EeHHHHHHHHHHHHh
Confidence 999999998877664
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.55 E-value=6.8e-07 Score=74.81 Aligned_cols=73 Identities=16% Similarity=0.301 Sum_probs=60.9
Q ss_pred eEEecCCHHHHHHHHHHHhccCCceEee-eCceEEEEEeccCCCcceEEEEEEEEEcCceeEEEEEecCCCchh
Q 015814 301 RFTSRCPANEIINKIEEAAKPLGFDVHK-KNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 373 (400)
Q Consensus 301 rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~~ 373 (400)
...|...+.+||..|..|++.+|+.|++ +.|.++++.........+.|.+++|++.++.+||||++..||+.|
T Consensus 8 GIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 8 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 3457889999999999999999999987 568999887654434469999999999999999999999999755
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.41 E-value=2.5e-06 Score=69.11 Aligned_cols=72 Identities=17% Similarity=0.296 Sum_probs=58.2
Q ss_pred EecCCHHHHHHHHHHHhccCCceEeee-CceEEEEEeccCCCcceEEEEEEEEEcCceeEEEEEecCCCchhH
Q 015814 303 TSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 374 (400)
Q Consensus 303 ~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~~~ 374 (400)
.|...+.+|+..|..|++.+|+.|+.. .|.++++.........+.+.+++|++.++.+|+||++..||..|.
T Consensus 13 rS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~ 85 (130)
T 4eag_A 13 RSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQ 85 (130)
T ss_dssp CCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC------
T ss_pred ecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhc
Confidence 477789999999999999999999875 689998876555556789999999999999999999999996553
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.4e-06 Score=73.82 Aligned_cols=75 Identities=16% Similarity=0.289 Sum_probs=61.9
Q ss_pred cceEEecCCHHHHHHHHHHHhccCCceEee-eCceEEEEEeccCCCcceEEEEEEEEEcCceeEEEEEecCCCchh
Q 015814 299 ETRFTSRCPANEIINKIEEAAKPLGFDVHK-KNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 373 (400)
Q Consensus 299 ~trf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~~ 373 (400)
.-...|+..+.+||..|..|++.+|+.|++ +.|.++++.........+.|.+++|++.++.+||||++..||+.|
T Consensus 20 hLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 20 HLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 334568889999999999999999999987 568999887644333469999999999999999999999999866
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=8.9e-07 Score=73.40 Aligned_cols=87 Identities=16% Similarity=0.164 Sum_probs=71.7
Q ss_pred ceEEecCCHHHHHHHHHHHhccCCceEeee----------CceEEEEEeccCC-----CcceEEEEEEEEEcCceeEEEE
Q 015814 300 TRFTSRCPANEIINKIEEAAKPLGFDVHKK----------NYKMRLENMKAGR-----KGNLNVATEVFQVAPSLHMVEV 364 (400)
Q Consensus 300 trf~s~~~~~~~~~~l~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~v~~ 364 (400)
-..-|+..+.+||..|..|++.+|+.|++. .|.|+++...+.. ...+.|.+++|++.++.+||||
T Consensus 15 lGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlDF 94 (137)
T 2qrd_A 15 FGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDV 94 (137)
T ss_dssp ESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEE
T ss_pred cccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEEE
Confidence 344688899999999999999999999865 4788887654321 2468999999999999999999
Q ss_pred EecCCC---------------c----hhHHHHHHHHHHhcc
Q 015814 365 RKAKGD---------------T----LEFHKFYKNLSTCLE 386 (400)
Q Consensus 365 ~~~~gd---------------~----~~~~~~~~~~~~~l~ 386 (400)
++..|+ . +.|-.+|..|...|+
T Consensus 95 k~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 95 KSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 999999 5 889999988877664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.9e-06 Score=76.89 Aligned_cols=102 Identities=15% Similarity=0.226 Sum_probs=78.5
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS---- 90 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~---- 90 (400)
...+.+|..+|+.+. +--|.+++.+..+.+..|+|||+++|.++.+..... ......+..++...|.-||+
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~ 138 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVC 138 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGG
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcc
Confidence 467889999999884 333778889999999999999999998877665432 22334566677777777774
Q ss_pred ------------------------------------------------------cCCeeccCCCCcEEEccCCCeeeecc
Q 015814 91 ------------------------------------------------------RGVYHRDLKPENLLLDAYGNLKVSDF 116 (400)
Q Consensus 91 ------------------------------------------------------~givHrDlKP~NILl~~~g~~kl~DF 116 (400)
..++|+|+.|.||++++++.+-|+||
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDw 218 (272)
T 4gkh_A 139 NCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDV 218 (272)
T ss_dssp GCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred cCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEEC
Confidence 12789999999999998777789999
Q ss_pred ccccc
Q 015814 117 GLSAL 121 (400)
Q Consensus 117 Gla~~ 121 (400)
+.+..
T Consensus 219 e~a~~ 223 (272)
T 4gkh_A 219 GRVGI 223 (272)
T ss_dssp TTCEE
T ss_pred ccccc
Confidence 98754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.2e-05 Score=76.22 Aligned_cols=104 Identities=21% Similarity=0.266 Sum_probs=75.9
Q ss_pred HHHHHHHHHHHHhCCCC---CcceeeEEEE-eCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHP---NVVRLYEVMG-SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+.+|+.+|+.+.+. .|.+.+.+.. ..+..|+||||++|..+.+..- ..++......+..|+...|..||+.
T Consensus 53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~ 130 (306)
T 3tdw_A 53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAF 130 (306)
T ss_dssp HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcC
Confidence 57899999999999653 3566666664 3455789999999988766322 2345556666666666666666642
Q ss_pred ------------------------------------------------------------CCeeccCCCCcEEEcc---C
Q 015814 92 ------------------------------------------------------------GVYHRDLKPENLLLDA---Y 108 (400)
Q Consensus 92 ------------------------------------------------------------givHrDlKP~NILl~~---~ 108 (400)
.++|+|++|.||+++. +
T Consensus 131 ~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~ 210 (306)
T 3tdw_A 131 PVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQ 210 (306)
T ss_dssp CHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSS
T ss_pred CcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCC
Confidence 3599999999999997 4
Q ss_pred CCe-eeeccccccc
Q 015814 109 GNL-KVSDFGLSAL 121 (400)
Q Consensus 109 g~~-kl~DFGla~~ 121 (400)
+.+ .|+||+.+..
T Consensus 211 ~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 211 TPLTGIIDFGDAAI 224 (306)
T ss_dssp CCEEEECCCTTCEE
T ss_pred CceEEEEehhhcCC
Confidence 564 8999998764
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.05 E-value=1.8e-05 Score=67.73 Aligned_cols=85 Identities=19% Similarity=0.235 Sum_probs=69.7
Q ss_pred eEEecCCHHHHHHHHHHHhccCCceEeee----CceEEEEEeccC---------CCcceEEEEEEEEEcCceeEEEEEec
Q 015814 301 RFTSRCPANEIINKIEEAAKPLGFDVHKK----NYKMRLENMKAG---------RKGNLNVATEVFQVAPSLHMVEVRKA 367 (400)
Q Consensus 301 rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~v~~~~~ 367 (400)
...|+..+.+||..|..|++.+|+.|++. .|.++++...+. ....+.|.+++|++.++.+||||+ .
T Consensus 54 GIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~ 132 (179)
T 3t4n_A 54 GIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK-F 132 (179)
T ss_dssp SEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEEE-E
T ss_pred ccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-e
Confidence 34688999999999999999999999874 688888753211 123499999999999999999999 7
Q ss_pred CC----------------------CchhHHHHHHHHHHhcc
Q 015814 368 KG----------------------DTLEFHKFYKNLSTCLE 386 (400)
Q Consensus 368 ~g----------------------d~~~~~~~~~~~~~~l~ 386 (400)
.| .++.|-.++.+|.-.|.
T Consensus 133 ~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa 173 (179)
T 3t4n_A 133 DGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA 173 (179)
T ss_dssp EEEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence 88 67889999888877764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00028 Score=63.27 Aligned_cols=121 Identities=18% Similarity=0.115 Sum_probs=80.5
Q ss_pred ChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCcccccc
Q 015814 58 ELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135 (400)
Q Consensus 58 ~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~-~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~ 135 (400)
+|.+.+.. +.+++|++|+.++.|.+.+|.-+-. +.-..+=+.|..|++..+|+|-..+ +.+ ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s--------------~~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AAD--------------DA 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccc--------------cc
Confidence 68888865 4589999999999999999877622 2222344557999999999988764 211 01
Q ss_pred CCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCC
Q 015814 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 212 (400)
Q Consensus 136 gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~ 212 (400)
....+.|||... .-.+.+.=|||||+++|.-+-=.+| ...+..+|+++.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 234577888764 2234788999999999987742222 122455999999999999866
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=3e-05 Score=74.70 Aligned_cols=43 Identities=16% Similarity=0.278 Sum_probs=32.1
Q ss_pred HHHHHHHHHHHhCC-C--CCcceeeEEEEeC---CEEEEEEecCCCCCh
Q 015814 17 LQIKREVATMKLVK-H--PNVVRLYEVMGSK---TKIFIVLEFVTGGEL 59 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-H--pnIv~l~~~~~~~---~~~~lv~Ey~~gg~L 59 (400)
..+.+|+.+|+.+. + -.+.+++.+..+. +..|+||||++|..+
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 45788999999884 3 3577888877654 346899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0005 Score=65.18 Aligned_cols=30 Identities=23% Similarity=0.299 Sum_probs=27.2
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0011 Score=64.68 Aligned_cols=29 Identities=21% Similarity=0.256 Sum_probs=24.8
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
..++|+|+.|.||+++.+ .+++.||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 579999999999999875 48999998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0031 Score=59.89 Aligned_cols=31 Identities=32% Similarity=0.358 Sum_probs=27.0
Q ss_pred cCCeeccCCCCcEEEccC----CCeeeeccccccc
Q 015814 91 RGVYHRDLKPENLLLDAY----GNLKVSDFGLSAL 121 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~----g~~kl~DFGla~~ 121 (400)
..++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6799999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0026 Score=59.56 Aligned_cols=29 Identities=28% Similarity=0.343 Sum_probs=24.9
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
.++|+|+.|.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5667899999997754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.004 Score=60.75 Aligned_cols=102 Identities=19% Similarity=0.242 Sum_probs=65.6
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChH----------HHH----H---hC----C-CCC--
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELF----------DKI----V---NH----G-RMK-- 70 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~----------~~i----~---~~----~-~l~-- 70 (400)
...+.+|..+++.|. +.-..++++.+.+ . +||||++|..|. ..+ . .. + ...
T Consensus 97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l 172 (379)
T 3feg_A 97 VDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL 172 (379)
T ss_dssp HHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence 355679999999884 3334677766543 2 899999985432 111 1 10 1 111
Q ss_pred HHHHHHHHHHHHH-------------------HHHHHH----H----cCCeeccCCCCcEEEccC----CCeeeeccccc
Q 015814 71 EDEARRYFQQLIN-------------------AVDYCH----S----RGVYHRDLKPENLLLDAY----GNLKVSDFGLS 119 (400)
Q Consensus 71 e~~~~~~~~qll~-------------------~l~~LH----~----~givHrDlKP~NILl~~~----g~~kl~DFGla 119 (400)
...+..|+.|+-. .++.|. + ..++|+|+.+.||+++.+ +.+.++||..|
T Consensus 173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 3456666665532 233333 2 259999999999999886 78999999987
Q ss_pred cc
Q 015814 120 AL 121 (400)
Q Consensus 120 ~~ 121 (400)
..
T Consensus 253 ~~ 254 (379)
T 3feg_A 253 SY 254 (379)
T ss_dssp EE
T ss_pred Cc
Confidence 54
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.015 Score=55.13 Aligned_cols=44 Identities=20% Similarity=0.277 Sum_probs=36.6
Q ss_pred HHHHHHHHHHHHhCC---CCCcceeeEEEEeCCEEEEEEecCCCCCh
Q 015814 16 LLQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLEFVTGGEL 59 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 59 (400)
...+.+|...|+.|. ...+.+.+.+....+..|+||||++|..+
T Consensus 72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 467889999999883 35688999888888899999999999754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.35 E-value=0.012 Score=58.25 Aligned_cols=37 Identities=14% Similarity=0.289 Sum_probs=25.3
Q ss_pred HHHHHHHHHHHhCCCCCc-ceeeEEEEeCCEEEEEEecCCCC
Q 015814 17 LQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVTGG 57 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~gg 57 (400)
..+.+|..+++.|...++ .++++.+.+ .+|+||++|.
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~ 157 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSR 157 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEE
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCc
Confidence 445579999998853334 677766542 2899999873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.016 Score=56.89 Aligned_cols=32 Identities=19% Similarity=0.282 Sum_probs=28.0
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
+...++|+|++|.||+++.++ ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356899999999999999876 99999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.50 E-value=0.043 Score=51.39 Aligned_cols=30 Identities=27% Similarity=0.330 Sum_probs=25.8
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999987666899999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.32 E-value=0.12 Score=48.41 Aligned_cols=28 Identities=18% Similarity=0.071 Sum_probs=24.4
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
..++|+|++|.||+++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4689999999999999 4 89999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=90.78 E-value=0.44 Score=43.77 Aligned_cols=23 Identities=35% Similarity=0.348 Sum_probs=19.5
Q ss_pred CCeeccCCCCcEEEccCCCeeeec
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSD 115 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~D 115 (400)
.++|+|+.+.|++++.+|. .+.|
T Consensus 189 ~LvHGDlw~gNvl~~~~g~-~~iD 211 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDDGA-VVID 211 (288)
T ss_dssp EEECSCCSGGGEEEETTEE-EECS
T ss_pred eeeecCCCCCcEEEcCCCe-EEEe
Confidence 5999999999999999874 4555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.09 E-value=0.24 Score=47.43 Aligned_cols=29 Identities=28% Similarity=0.432 Sum_probs=24.4
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
+++|+|+.|.|||+++++ +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 699999999999998654 89999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.79 E-value=0.16 Score=48.20 Aligned_cols=31 Identities=19% Similarity=0.319 Sum_probs=27.6
Q ss_pred cCCeeccCCCCcEEEccCCCeeeeccccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~~ 121 (400)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888999999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.52 E-value=1.1 Score=39.64 Aligned_cols=115 Identities=20% Similarity=0.281 Sum_probs=80.9
Q ss_pred CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCC
Q 015814 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 109 (400)
Q Consensus 30 ~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g 109 (400)
.||+++.. .+-.+++.+.+.++.-+.+-=+..| ..++....++++.+|+....++ ..-+|=-|.|+||+++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence 58888876 5667777777777765544334445 3478888889999988877443 4457778999999999999
Q ss_pred CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHH-HHHHHHHHHHhCCCCCC
Q 015814 110 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW-SCGVILFVLLAGYLPFD 176 (400)
Q Consensus 110 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw-SlGiil~elltG~~Pf~ 176 (400)
.+++.--|+-.. ++ +|.....|.| .+=|++..+++|+..|.
T Consensus 117 ~p~i~~RGik~~-------------------l~-------P~~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 LPIAKTRGLQNV-------------------VD-------PLPVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CEEESCCEETTT-------------------BS-------CCCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CEEEEEccCccC-------------------CC-------CCCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999987664211 11 2222344544 47789999999988873
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=88.32 E-value=0.27 Score=48.99 Aligned_cols=35 Identities=20% Similarity=0.335 Sum_probs=25.3
Q ss_pred HHHHHHHHhCCCCCc-ceeeEEEEeCCEEEEEEecCCCCC
Q 015814 20 KREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVTGGE 58 (400)
Q Consensus 20 ~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~gg~ 58 (400)
.+|..+++.|...++ .++++.+. +. +||||++|..
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA 187 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence 689999999965555 57777663 22 4999999743
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.18 E-value=4.4 Score=35.95 Aligned_cols=114 Identities=17% Similarity=0.158 Sum_probs=81.0
Q ss_pred CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHHcCCeeccCCCCcEEEccC
Q 015814 30 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD-YCHSRGVYHRDLKPENLLLDAY 108 (400)
Q Consensus 30 ~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~-~LH~~givHrDlKP~NILl~~~ 108 (400)
.||++ -..+-.+++.+.+.++.-+++-=+..++ .++....++++.+|+.... ++ ..-+|--|.|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 58888 4455577888888888776666667773 4788888888888887665 43 455777899999999999
Q ss_pred CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHH-HHHHHHHHHHhCCCCCC
Q 015814 109 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW-SCGVILFVLLAGYLPFD 176 (400)
Q Consensus 109 g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIw-SlGiil~elltG~~Pf~ 176 (400)
+.++|.-.|+-. -++| |.....|.| ++=|++..++.++..|.
T Consensus 121 ~~p~i~hRGi~~-------------------~lpP-------~e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 121 LEPFFLHVGVKE-------------------SLPP-------DEWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CCEEESCCEETT-------------------TBSS-------CSCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CcEEEEEcCCcc-------------------cCCC-------CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999998777421 1222 222444554 47788889988887763
|
| >3ost_A Serine/threonine-protein kinase KCC4; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.69A {Saccharomyces cerevisiae} PDB: 3osm_A | Back alignment and structure |
|---|
Probab=85.30 E-value=12 Score=29.97 Aligned_cols=85 Identities=12% Similarity=0.177 Sum_probs=61.7
Q ss_pred eEEecCCHHHHHHHHHHHh---ccCCce-EeeeCceEEEEEeccCC----CcceEEEEEEEEEcCce-eEEEEEecCCCc
Q 015814 301 RFTSRCPANEIINKIEEAA---KPLGFD-VHKKNYKMRLENMKAGR----KGNLNVATEVFQVAPSL-HMVEVRKAKGDT 371 (400)
Q Consensus 301 rf~s~~~~~~~~~~l~~~~---~~~~~~-~~~~~~~~~~~~~~~~~----~~~l~~~~~i~~~~~~~-~~v~~~~~~gd~ 371 (400)
-+++..+..++...|...+ +..|++ ++.+.....|.+..... -....|.++|++-. +. .+|-|++.+|..
T Consensus 28 ~l~t~v~k~~~~~~L~~LL~~Wk~yGlkdv~~D~~~~~ItGrvs~~N~L~LRsv~F~i~i~~~g-n~~Slv~f~q~rGSs 106 (128)
T 3ost_A 28 EIHAKIPEKRLYEGLHKLLEGWKQYGLKNLVFNITNMIITGKLVNDSILFLRSTLFEIMVLPNG-DGRSLIKFNKKTGST 106 (128)
T ss_dssp CEEESSCHHHHHHHHHHHHHTCGGGTEEEEEEETTTTEEEEEECCCCSSSCCCEEEEEEEEECS-TTCEEEEEEESSSCH
T ss_pred EEEEecCHHHHHHHHHHHHHHHHHhCccceEecCCCCEEEEEEccccccccceeEEEEEEeecC-CceEEEEEEEeeccH
Confidence 4678889999998888887 455663 55554433344433222 24588999999765 66 999999999999
Q ss_pred hhHHHHHHHHHHhcc
Q 015814 372 LEFHKFYKNLSTCLE 386 (400)
Q Consensus 372 ~~~~~~~~~~~~~l~ 386 (400)
-.|++++..|..-|+
T Consensus 107 stf~klv~eiEkVL~ 121 (128)
T 3ost_A 107 KTLTKLATEIQIILQ 121 (128)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999988766553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.75 E-value=0.59 Score=45.44 Aligned_cols=29 Identities=31% Similarity=0.448 Sum_probs=25.0
Q ss_pred CeeccCCCCcEEE------ccCCCeeeeccccccc
Q 015814 93 VYHRDLKPENLLL------DAYGNLKVSDFGLSAL 121 (400)
Q Consensus 93 ivHrDlKP~NILl------~~~g~~kl~DFGla~~ 121 (400)
++|+|+.+.|||+ ++++.+.++||.+|+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 3457799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 400 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-72 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-65 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-65 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-65 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-64 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-64 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-61 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-61 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-58 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-57 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-52 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-49 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-46 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-43 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-25 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 1e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-72
Identities = 81/215 (37%), Positives = 124/215 (57%), Gaps = 5/215 (2%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
Q++REV ++HPN++RLY T+++++LE+ G ++ ++ + E Y
Sbjct: 52 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 111
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+L NA+ YCHS+ V HRD+KPENLLL + G LK++DFG S + T CGT
Sbjct: 112 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGT 167
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
+Y+ PE++ R +D DLWS GV+ + L G PF+ + YK+IS EFT P +
Sbjct: 168 LDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 226
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232
++ AR LI+R+L NP R + E+LE W +
Sbjct: 227 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 6e-71
Identities = 91/220 (41%), Positives = 128/220 (58%), Gaps = 3/220 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
IK+E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+
Sbjct: 49 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF 108
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
F QL+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT
Sbjct: 109 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCPP 196
YVAPE+L R + D+WSCG++L +LAG LP+D S+ Y + P
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 197 W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234
W + L+ +IL NP RITIP+I +D W+ K K
Sbjct: 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-65
Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 12/231 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARR 76
E+ + HPN+V+L + + ++I++EF GG + ++ R + E + +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 114
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+Q ++A++Y H + HRDLK N+L G++K++DFG+SA + R + G
Sbjct: 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIG 172
Query: 137 TPNYVAPEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
TP ++APEV+ DR YD AD+WS G+ L + P + N M + KI+ +E
Sbjct: 173 TPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 231
Query: 192 ---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 239
P S + + + L+ N R T ++L+ + D P+ E
Sbjct: 232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 209 bits (533), Expect = 4e-65
Identities = 62/226 (27%), Positives = 116/226 (51%), Gaps = 11/226 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARR 76
+K E++ M + HP ++ L++ K ++ ++LEF++GGELFD+I +M E E
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVRDDGLLHTT 134
Y +Q + + H + H D+KPEN++ + ++K+ DFG L+ ++ D ++ T
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVT 188
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
T + APE+++ D+W+ GV+ +VLL+G PF + + + + ++
Sbjct: 189 TATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 247
Query: 195 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+S A+ I +L P R+T+ + LE W K D+
Sbjct: 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 6e-65
Identities = 66/233 (28%), Positives = 115/233 (49%), Gaps = 7/233 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+ RE M + HP V+LY K++ L + GEL I G E R Y
Sbjct: 54 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 113
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++++A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
YV+PE+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P
Sbjct: 174 AQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 232
Query: 198 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 250
AR L+ ++L + R+ E+ K P F + +++
Sbjct: 233 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH---PFF---ESVTWENLH 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-64
Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 11/233 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
I E+ M+ K+PN+V + ++++V+E++ GG L D +V M E +
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAV 121
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++ + A+++ HS V HRD+K +N+LL G++K++DFG A + T GT
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGT 179
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTC 194
P ++APEV+ + Y D+WS G++ ++ G P+ + N + I+ E
Sbjct: 180 PYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK----DYKPPVFEEKKD 243
P LS R + R LD + R + E+L+ ++ K P+ K+
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 208 bits (529), Expect = 2e-64
Identities = 70/248 (28%), Positives = 123/248 (49%), Gaps = 11/248 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARR 76
+++E+ TM +++HP +V L++ ++ ++ EF++GGELF+K+ + H +M EDEA
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
Y +Q+ + + H H DLKPEN++ LK+ DFGL+A + + T
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVT 185
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT- 193
GT + APEV + G D+WS GV+ ++LL+G PF N + + + ++
Sbjct: 186 TGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM 244
Query: 194 ---CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 250
+S + I ++L +P TR+TI + LE W P + + +
Sbjct: 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 251 AVFKDSEE 258
K +
Sbjct: 305 DSIKTKYD 312
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 3e-64
Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 10/237 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
I +EV ++ ++HPN ++ + ++V+E+ G V+ ++E E
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
+ + Y HS + HRD+K N+LL G +K+ DFG +++ ++ GT
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGT 174
Query: 138 PNYVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 195
P ++APEV+ D G D+WS G+ L P + N M+ I+ E
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 196 PW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 250
S R + L P R T +L+ + ++ P V + D V
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-61
Identities = 58/226 (25%), Positives = 111/226 (49%), Gaps = 11/226 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARR 76
+K+E++ + + +H N++ L+E S ++ ++ EF++G ++F++I + E E
Sbjct: 47 LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVS 106
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTT 134
Y Q+ A+ + HS + H D++PEN++ +K+ +FG ++Q++
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLL 163
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
P Y APEV + D+WS G +++VLL+G PF + + I AE+T
Sbjct: 164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222
Query: 195 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+S A + R+L +R+T E L+ W K+ +
Sbjct: 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 197 bits (501), Expect = 3e-61
Identities = 76/224 (33%), Positives = 118/224 (52%), Gaps = 13/224 (5%)
Query: 18 QIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
+EV + K+ HPN+++L + + T F+V + + GELFD + + E E R+
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 114
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ L+ + H + HRDLKPEN+LLD N+K++DFG S Q+ L CG
Sbjct: 115 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCG 171
Query: 137 TPNYVAPEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA- 190
TP+Y+APE++ ++ G D+WS GVI++ LLAG PF M + + I +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231
Query: 191 -EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231
+F P W S T + L++R L P R T E L +F++
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 4e-61
Identities = 86/226 (38%), Positives = 128/226 (56%), Gaps = 11/226 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++ E+A + +KHPN+V L ++ S ++++++ V+GGELFD+IV G E +A R
Sbjct: 53 SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 112
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
Q+++AV Y H G+ HRDLKPENLL D + +SDFG LS+ +L T
Sbjct: 113 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG---LSKMEDPGSVLSTA 169
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
CGTP YVAPEVL + Y + D WS GVI ++LL GY PF D N L+++I AE+
Sbjct: 170 CGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 228
Query: 195 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+S +A+ I +++ +P R T + L+ W D
Sbjct: 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-61
Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 15/223 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGR----MKE 71
+ EV ++ +KHPN+VR Y+ + +T ++IV+E+ GG+L I + + E
Sbjct: 49 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 108
Query: 72 DEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 126
+ R QL A+ CH R V HRDLKP N+ LD N+K+ DFGL+ +
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-- 166
Query: 127 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 186
D GTP Y++PE +N Y+ +D+WS G +L+ L A PF + L K
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGK 225
Query: 187 ISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228
I +F P S ++I R+L+ R ++ EILE+
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 6e-59
Identities = 55/223 (24%), Positives = 106/223 (47%), Gaps = 16/223 (7%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDE 73
+ K E +K ++HPN+VR Y+ S K I +V E +T G L + MK
Sbjct: 54 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV 113
Query: 74 ARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGL 130
R + +Q++ + + H+R + HRDLK +N+ + G++K+ D GL+ L
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASF 169
Query: 131 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISA 189
GTP ++APE+ YD S D+++ G+ + + P+ + N +Y+++++
Sbjct: 170 AKAVIGTPEFMAPEMYE-EKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
Query: 190 A--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
+ +++I + N R +I ++L +F+
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-58
Identities = 57/265 (21%), Positives = 99/265 (37%), Gaps = 50/265 (18%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
QI RE+ + P +V Y S +I I +E + GG L + GR+ E +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 78 FQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+I + Y + + HRD+KP N+L+++ G +K+ DFG+S D + ++ G
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVG 165
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----------------- 179
T +Y++PE L Y +D+WS G+ L + G P +
Sbjct: 166 TRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 180 -------------------------LMNLYKKISAAEFTCPPW--LSFTARKLIARILDP 212
+ L I P S + + + L
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 213 NPMTRITIPEILEDEWFKKDYKPPV 237
NP R + +++ + K+ V
Sbjct: 285 NPAERADLKQLMVHAFIKRSDAEEV 309
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 9e-58
Identities = 46/217 (21%), Positives = 97/217 (44%), Gaps = 10/217 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARR 76
K EV ++ +H N++ + ++ IV ++ G L+ + + + + +
Sbjct: 50 AFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+Q +DY H++ + HRDLK N+ L +K+ DFGL+ + + G
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 137 TPNYVAPEVLNDRGYDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
+ ++APEV+ + + + +D+++ G++L+ L+ G LP+ + N + + +
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228
Query: 195 PPWLSF------TARKLIARILDPNPMTRITIPEILE 225
P ++L+A L R P+IL
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-57
Identities = 79/266 (29%), Positives = 125/266 (46%), Gaps = 16/266 (6%)
Query: 18 QIKREVATM-KLVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHG--RMK 70
+ +REV + + P++VR+ +V + + IV+E + GGELF +I + G
Sbjct: 50 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 109
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 130
E EA + + A+ Y HS + HRD+KPENLL + + +++
Sbjct: 110 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
Query: 131 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 190
L T C TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +
Sbjct: 170 LTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
Query: 191 ------EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 242
EF P W +S + LI +L P R+TI E + W + K P
Sbjct: 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHT 288
Query: 243 DTNLDDVEAVFKDSEEHHVTEQKEEQ 268
L + + ++D +E + +
Sbjct: 289 SRVLKEDKERWEDVKEEMTSALATMR 314
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-57
Identities = 69/239 (28%), Positives = 120/239 (50%), Gaps = 14/239 (5%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 78
+ + +HP + ++ +K +F V+E++ GG+L I + + A Y
Sbjct: 50 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 109
Query: 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 138
++I + + HS+G+ +RDLK +N+LLD G++K++DFG+ + D +T CGTP
Sbjct: 110 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTP 167
Query: 139 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 198
+Y+APE+L + Y+ S D WS GV+L+ +L G PF + L+ I P WL
Sbjct: 168 DYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 226
Query: 199 SFTARKLIARILDPNPMTRITIP-EILEDEWFK---------KDYKPPVFEEKKDTNLD 247
A+ L+ ++ P R+ + +I + F+ K+ PP F K + D
Sbjct: 227 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP-FRPKVKSPFD 284
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 189 bits (480), Expect = 4e-57
Identities = 74/324 (22%), Positives = 133/324 (41%), Gaps = 33/324 (10%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
+ L + ++ + P +V + + K+ +L+ + GG+L + HG E +
Sbjct: 50 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM 109
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
R Y ++I +++ H+R V +RDLKP N+LLD +G++++SD GL+ H +
Sbjct: 110 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHAS 165
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAE 191
GT Y+APEVL S+AD +S G +LF LL G+ PF + +
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225
Query: 192 FTCPPWLSFTARKLIARILDPNPMTRITIP-----EILEDEWFK---------KDYKPPV 237
P S R L+ +L + R+ E+ E +F+ + Y PP+
Sbjct: 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 285
Query: 238 FEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFK 297
+ + N D + EE T+ + + + ++
Sbjct: 286 IPPRGEVNAADAFDIGSFDEE--DTKGIKLLDSDQELYRNFP----------LTISERWQ 333
Query: 298 RETRFTSRCPANEIINKIEEAAKP 321
+E T N +++E K
Sbjct: 334 QEVAETVFDTINAETDRLEARKKT 357
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 186 bits (473), Expect = 1e-56
Identities = 85/273 (31%), Positives = 143/273 (52%), Gaps = 31/273 (11%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
E + +V HP ++R++ +IF++++++ GGELF + R A+ Y
Sbjct: 50 HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY 109
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++ A++Y HS+ + +RDLKPEN+LLD G++K++DFG + V +T CGT
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGT 164
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P+Y+APEV++ + Y+ S D WS G++++ +LAGY PF DSN M Y+KI AE PP+
Sbjct: 165 PDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 223
Query: 198 LSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKKD-------------YKPPVFE 239
+ + L++R++ + R+ ++ WFK+ Y+PP+ +
Sbjct: 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQ 283
Query: 240 EKKDT-NLDDVEAVFKDSEEHHVTEQKEEQPVA 271
+ DT D EE + E P A
Sbjct: 284 GQGDTSQFDKYP------EEDINYGVQGEDPYA 310
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-56
Identities = 82/239 (34%), Positives = 124/239 (51%), Gaps = 21/239 (8%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
I+REV+ +K ++HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA +
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF 118
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHT 133
+Q++N V Y HS + H DLKPEN++L +K+ DFG L+ ++
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKN 175
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 193
GTP +VAPE++N AD+WS GVI ++LL+G PF +SA +
Sbjct: 176 IFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 194 ----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK---------KDYKPPVFE 239
S A+ I R+L +P R+TI + L+ W K + P FE
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-55
Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 17/233 (7%)
Query: 18 QIKREVATMKLVK--HPNVVRLYEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEA 74
++ EV +K V V+RL + ++LE +LFD I G ++E+ A
Sbjct: 53 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 112
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHT 133
R +F Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG AL D +
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTD 168
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 193
GT Y PE + Y G +A +WS G++L+ ++ G +PF+ +I +
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF 222
Query: 194 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNL 246
+S + LI L P R T EI W + P +E + +L
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP---QETAEIHL 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-53
Identities = 78/249 (31%), Positives = 125/249 (50%), Gaps = 21/249 (8%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
E ++ +HP + L + ++ V+E+ GGELF + E+ AR Y
Sbjct: 51 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
++++A++Y HSR V +RD+K ENL+LD G++K++DFGL + + D + T CGT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGT 168
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P Y+APEVL D Y + D W GV+++ ++ G LPF + + L++ I E P
Sbjct: 169 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227
Query: 198 LSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK-------------DYKPPVFE 239
LS A+ L+A +L +P R+ E++E +F +KP V
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTS 287
Query: 240 EKKDTNLDD 248
E DD
Sbjct: 288 EVDTRYFDD 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 174 bits (443), Expect = 1e-52
Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 10/225 (4%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMK 70
L+ +RE + HP +V +Y+ ++T +IV+E+V G L D + G M
Sbjct: 50 FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 109
Query: 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDG 129
A A+++ H G+ HRD+KP N+++ A +KV DFG++ ++
Sbjct: 110 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
Query: 130 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 189
GT Y++PE D +D++S G +L+ +L G PF + +++ +
Sbjct: 170 QTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
Query: 190 AEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230
+ P LS ++ + L NP R + + +
Sbjct: 229 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 2e-52
Identities = 60/249 (24%), Positives = 93/249 (37%), Gaps = 30/249 (12%)
Query: 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA 74
I RE+ ++ + HPN++ L + G K+ I +V +F+ N +
Sbjct: 43 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI 102
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 134
+ Y + ++Y H + HRDLKP NLLLD G LK++DFGL+ +
Sbjct: 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQ 160
Query: 135 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 194
T Y APE+L G D+W+ G IL LL + ++ +I T
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220
Query: 195 P----------------------------PWLSFTARKLIARILDPNPMTRITIPEILED 226
LI + NP RIT + L+
Sbjct: 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
Query: 227 EWFKKDYKP 235
++F P
Sbjct: 281 KYFSNRPGP 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 9e-52
Identities = 50/223 (22%), Positives = 98/223 (43%), Gaps = 11/223 (4%)
Query: 8 KYLDAFCILLQIKREVATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNH 66
K + E + M ++H N+V+L V + K ++IV E++ G L D + +
Sbjct: 36 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 95
Query: 67 GR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 124
GR + D ++ + A++Y HRDL N+L+ KVSDFGL+ +
Sbjct: 96 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155
Query: 125 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL 183
+D T + APE L ++ + +D+WS G++L+ + + G +P+ L ++
Sbjct: 156 TQD-----TGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
Query: 184 YKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
++ P +++ + R + ++ E
Sbjct: 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-51
Identities = 51/220 (23%), Positives = 83/220 (37%), Gaps = 9/220 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARR 76
++ RE M + +P +VRL V + +V+E GG L +V +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC 135
Q+ + Y + HRDL N+LL K+SDFGLS AL
Sbjct: 114 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FT 193
+ APE +N R + +D+WS GV ++ L+ G P+ + I +
Sbjct: 174 WPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232
Query: 194 CPPWLSFTARKLIARILDPNPMTRITIPEI---LEDEWFK 230
CPP L++ R + + ++
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-51
Identities = 44/219 (20%), Positives = 84/219 (38%), Gaps = 8/219 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
++ E M+ + +P +VR+ + ++ +V+E G L + + +K+
Sbjct: 54 ELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL 112
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CG 136
Q+ + Y HRDL N+LL K+SDFGLS + + T
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTC 194
+ APE +N + +D+WS GV+++ + G P+ + + E C
Sbjct: 173 PVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 231
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEI---LEDEWFK 230
P L+ + R + L + ++
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-50
Identities = 63/291 (21%), Positives = 118/291 (40%), Gaps = 40/291 (13%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDE 73
+ RE+ + +H N++ + +++ + T K ++ + G +L+ ++ + D
Sbjct: 52 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDH 110
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+ Q++ + Y HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T
Sbjct: 111 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 134 T-CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 192
T Y APE++ + + D+WS G IL +L+ F + ++ I
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 193 TCP-------------------------------PWLSFTARKLIARILDPNPMTRITIP 221
+ P A L+ ++L NP RI +
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
Query: 222 EILEDEWFKKDYKP---PVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQP 269
+ L + ++ Y P P+ E +++ + + +E E QP
Sbjct: 291 QALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 341
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 7e-50
Identities = 74/251 (29%), Positives = 121/251 (48%), Gaps = 24/251 (9%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
E ++ V P +V+L + +++V+E+V GGE+F + GR E AR Y
Sbjct: 87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY 146
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
Q++ +Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGT
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGT 201
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 197
P +APE++ +GY+ + D W+ GV+++ + AGY PF + +Y+KI + + P
Sbjct: 202 PEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
Query: 198 LSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKKD-------------YKPPVFE 239
S + L+ +L + R + +I +WF + P
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320
Query: 240 EKKDTNLDDVE 250
+N DD E
Sbjct: 321 PGDTSNFDDYE 331
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 6e-49
Identities = 56/213 (26%), Positives = 83/213 (38%), Gaps = 7/213 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARR 76
REV M + H N++RLY V + +V E G L D++ H G R
Sbjct: 57 DFIREVNAMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-C 135
Y Q+ + Y S+ HRDL NLLL +K+ DFGL Q D ++
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--F 192
+ APE L R + + +D W GV L+ + G P+ N + KI
Sbjct: 176 VPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234
Query: 193 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
P ++ + P R T + +
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 8e-49
Identities = 59/260 (22%), Positives = 92/260 (35%), Gaps = 42/260 (16%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV--------MGSKTKIFIVLEFVTGGELFDKIVNHGRM 69
RE+ ++L+KH NVV L E+ K I++V +F +
Sbjct: 55 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 114
Query: 70 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 128
E +R Q L+N + Y H + HRD+K N+L+ G LK++DFGL+ ++
Sbjct: 115 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 129 -GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
T Y PE+L G DLW G I+ + + + I
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 188 SAAEFTCPP--------------------------------WLSFTARKLIARILDPNPM 215
S + P A LI ++L +P
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 216 TRITIPEILEDEWFKKDYKP 235
RI + L ++F D P
Sbjct: 295 QRIDSDDALNHDFFWSDPMP 314
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-48
Identities = 39/235 (16%), Positives = 90/235 (38%), Gaps = 28/235 (11%)
Query: 18 QIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---------- 66
+ E+ M +L H N+V L I+++ E+ G+L + + +
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 67 -------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 113
+ ++ + Q+ +++ + HRDL N+L+ +K+
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205
Query: 114 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172
DFGL+ + + ++APE L + Y +D+WS G++L+ + + G
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGV 264
Query: 173 LPFDDSNLMNLYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
P+ + + K+ + + P + + ++ + R + P +
Sbjct: 265 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 163 bits (413), Expect = 3e-48
Identities = 67/243 (27%), Positives = 109/243 (44%), Gaps = 31/243 (12%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
RE++ +K +KH N+V+LY+V+ +K ++ +V E + V G ++ A+ +
Sbjct: 46 TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF 105
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
QL+N + YCH R V HRDLKP+NLL++ G LK++DFGL+ T
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVT 163
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---- 193
Y AP+VL +T D+WS G I ++ G F + + +I T
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 194 -------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 228
L + L++++L +P RIT + LE +
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 229 FKK 231
FK+
Sbjct: 284 FKE 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 4e-48
Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 7/214 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARR 76
E + M HPNV+ L V+ T + I+ EF+ G L N G+ +
Sbjct: 73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-- 134
+ + + Y HRDL N+L+++ KVSDFGLS + D +
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 135 -CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE- 191
+ APE + R + + +D+WS G++++ +++ G P+ D ++ I
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 192 FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
P +L+ + R +I+
Sbjct: 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-47
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 5/212 (2%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARR 76
+ E M + H +V+LY V + IFI+ E++ G L + + R + +
Sbjct: 45 EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 104
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ + A++Y S+ HRDL N L++ G +KVSDFGLS + +
Sbjct: 105 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKF 163
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTC 194
+ PEVL + +D+W+ GV+++ + + G +P++ + I
Sbjct: 164 PVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 222
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILED 226
P S ++ R T +L +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-47
Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 12/227 (5%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEAR 75
+E MK ++H +V+LY V+ S+ I+IV E+++ G L D + ++ +
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 116
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Q+ + + Y HRDL+ N+L+ KV+DFGL+ L + +
Sbjct: 117 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAK 175
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFT 193
+ APE + +D+WS G++L L G +P+ + ++
Sbjct: 176 FPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234
Query: 194 CPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKK---DYKP 235
CPP + L+ + P R T + +++F Y+P
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-47
Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 46/292 (15%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVM------GSKTKIFIVLEFVTGG---ELFDKIVNHGR 68
RE+ M+ + H N+VRL + + +VL++V
Sbjct: 59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 69 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRD 127
+ + Y QL ++ Y HS G+ HRD+KP+NLLLD LK+ DFG ++Q+
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVR 175
Query: 128 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
+ + Y APE++ S+ D+WS G +L LL G F + ++ +I
Sbjct: 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 188 SAAEFTCP-----------------------------PWLSFTARKLIARILDPNPMTRI 218
T P A L +R+L+ P R+
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 219 TIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPV 270
T E +F + P V K N D A+F + + + +
Sbjct: 296 TPLEACAHSFFDELRDPNV----KLPNGRDTPALFNFTTQELSSNPPLATIL 343
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-47
Identities = 47/218 (21%), Positives = 92/218 (42%), Gaps = 9/218 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEAR 75
E MK ++H +VRLY V ++ I+I+ E++ G L D + +K ++
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL 112
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Q+ + + R HRDL+ N+L+ + K++DFGL+ L + +
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAK 171
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFT 193
+ APE +N + +D+WS G++L ++ G +P+ + + +
Sbjct: 172 FPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 194 CPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWF 229
P +L+ P R T + +++F
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-47
Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 4/218 (1%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
+I E M V +P+V RL + + T I G L + + +
Sbjct: 57 EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
Q+ ++Y R + HRDL N+L+ ++K++DFGL+ L +
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCP 195
++A E + R Y +D+WS GV ++ L+ G P+D + + E P
Sbjct: 177 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235
Query: 196 PWLSFTARKLIARILDPNPMTRITIPEILED-EWFKKD 232
P + ++ + + +R E++ + +D
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-46
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 5/211 (2%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARR 76
E M + HP +V+LY V + I +V EF+ G L D G +
Sbjct: 46 DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG 105
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
+ + Y V HRDL N L+ +KVSDFG++ T
Sbjct: 106 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKF 164
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTC 194
+ +PEV + Y S +D+WS GV+++ + + G +P+++ + + + IS
Sbjct: 165 PVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 195 PPWLSFTARKLIARILDPNPMTRITIPEILE 225
P S +++ P R +L
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-46
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 32/248 (12%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARR 76
RE++ +K + HPN+V+L +V+ ++ K+++V EF+ + F + +
Sbjct: 47 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS 106
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
Y QL+ + +CHS V HRDLKP+NLL++ G +K++DFGL+
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVV 164
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP- 195
T Y APE+L Y + D+WS G I ++ F + ++ +I T
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 196 ----------------------------PWLSFTARKLIARILDPNPMTRITIPEILEDE 227
P L R L++++L +P RI+ L
Sbjct: 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284
Query: 228 WFKKDYKP 235
+F+ KP
Sbjct: 285 FFQDVTKP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-46
Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKE 71
+ RE+ +K ++H NV+ L +V + T ++V+ F+ G K++ H ++ E
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE 120
Query: 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 131
D + Q++ + Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEM 175
Query: 132 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
T Y APEV+ + T D+WS G I+ ++ G F S+ ++ K+I
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 192 FTCPPW-------------------------------LSFTARKLIARILDPNPMTRITI 220
T P S A L+ ++L + R+T
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 221 PEILEDEWFKK--DYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQP 269
E L +F+ D + +K D + DDV+ + + E +P
Sbjct: 296 GEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-46
Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 33/249 (13%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 77
RE+ +K +KH N+VRL++V+ S K+ +V EF +G + + + +
Sbjct: 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF 106
Query: 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 137
QL+ + +CHSR V HRDLKP+NLL++ G LK+++FGL+ T
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVT 164
Query: 138 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAEFT--- 193
Y P+VL ++ D+WS G I L P F +++ + K+I T
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 194 --------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDE 227
P L+ T R L+ +L NP+ RI+ E L+
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 228 WFKKDYKPP 236
+F D+ PP
Sbjct: 285 YF-SDFCPP 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-46
Identities = 51/256 (19%), Positives = 95/256 (37%), Gaps = 28/256 (10%)
Query: 18 QIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---------- 66
E+ + KL HPN++ L + +++ +E+ G L D +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 67 ------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120
+ + + + +DY + HRDL N+L+ K++DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG--- 172
Query: 121 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 179
LS+ ++A E LN Y + +D+WS GV+L+ +++ G P+
Sbjct: 173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 180 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED-EWFKKDYKPPV 237
LY+K+ P L+ + P R + +IL ++ K V
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
Query: 238 ----FEEKKDTNLDDV 249
+E+ +D
Sbjct: 292 NTTLYEKFTYAGIDCS 307
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-45
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 10/214 (4%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARR 76
+ +E TM+ HP++V+L V+ ++ ++I++E T GEL V +
Sbjct: 54 KFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 112
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC- 135
Y QL A+ Y S+ HRD+ N+L+ + +K+ DFG LS+ + D +
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKG 169
Query: 136 -GTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-F 192
++APE +N R + + +D+W GV ++ +L+ G PF ++ +I E
Sbjct: 170 KLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228
Query: 193 TCPPWLSFTARKLIARILDPNPMTRITIPEILED 226
PP T L+ + +P R E+
Sbjct: 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-44
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 10/224 (4%)
Query: 18 QIKREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
+ E ++ ++ P +V L+ ++TK+ ++L+++ GGELF + R E E +
Sbjct: 74 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 133
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
Y +++ A+++ H G+ +RD+K EN+LLD+ G++ ++DFGLS +
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 137 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEF 192
V D WS GV+++ LL G PF + ++I +E
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253
Query: 193 TCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231
P +S A+ LI R+L +P R+ EI E +F+K
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-44
Identities = 65/250 (26%), Positives = 101/250 (40%), Gaps = 40/250 (16%)
Query: 17 LQIKREVATMKL---VKHPNVVRLYEVM-----GSKTKIFIVLEFVTGGEL-FDKIVNHG 67
L REVA ++ +HPNVVRL++V +TK+ +V E V + V
Sbjct: 52 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP 111
Query: 68 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
+ + + QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ +
Sbjct: 112 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 171
Query: 128 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 187
+ T Y APEVL Y DLWS G I + F S+ ++ KI
Sbjct: 172 L---TSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
Query: 188 SAAEFT---------------------------CPPWLSFTARKLIARILDPNPMTRITI 220
+ + L+ + L NP RI+
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 221 PEILEDEWFK 230
L +F+
Sbjct: 288 YSALSHPYFQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (386), Expect = 5e-44
Identities = 44/234 (18%), Positives = 80/234 (34%), Gaps = 27/234 (11%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--------- 68
+RE A M +PN+V+L V + ++ E++ G+L + + +
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 69 ---------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 113
+ E +Q+ + Y R HRDL N L+ +K+
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181
Query: 114 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173
+DFGLS ++ PE + Y +D+W+ GV+L+ + + L
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGL 240
Query: 174 -PFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
P+ + + CP L+ P R + I
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 1e-43
Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 8/233 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEAR 75
+ +E A MK +KHPN+V+L V + +I+ EF+T G L D + R +
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 135
Q+ +A++Y + HRDL N L+ +KV+DFGLS L
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAK 177
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISA-AEFT 193
+ APE L + + W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 194 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNL 246
P +L+ NP R + EI + F+ ++ ++ + L
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIH--QAFETMFQESSISDEVEKEL 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-42
Identities = 63/288 (21%), Positives = 108/288 (37%), Gaps = 50/288 (17%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDE 73
+ RE+ +K +KH NV+ L +V + + L G + IV ++ +D
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 74 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 133
+ Q++ + Y HS + HRDLKP NL ++ LK+ DFGL+ D +
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTG 177
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 193
T Y APE++ + + T D+WS G I+ LL G F ++ ++ K I T
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 194 CPPWL-------------------------------SFTARKLIARILDPNPMTRITIPE 222
L + A L+ ++L + RIT +
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 223 ILEDEWFKKDYKP----------PVFEEKKDTNLDDVEAVFKDSEEHH 260
L +F + + P FE + + + +
Sbjct: 298 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 345
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-42
Identities = 43/212 (20%), Positives = 87/212 (41%), Gaps = 5/212 (2%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARR 76
E M H N++RL V+ + I+ E++ G L + G +
Sbjct: 55 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TC 135
+ + + Y + HRDL N+L+++ KVSDFGLS + + + +
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 136 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFT 193
+ APE ++ R + + +D+WS G++++ ++ G P+ + + + K I+
Sbjct: 175 IPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233
Query: 194 CPPWLSFTARKLIARILDPNPMTRITIPEILE 225
P +L+ + R +I+
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-42
Identities = 47/228 (20%), Positives = 92/228 (40%), Gaps = 20/228 (8%)
Query: 18 QIKREVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--------- 67
+ E+ MK + KH N++ L +++++E+ + G L + +
Sbjct: 64 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 68 -------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120
++ + Q+ ++Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 121 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 179
+ ++APE L DR Y +D+WS GV+L+ + G P+
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 180 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226
+ L+K + P + ++ P R T +++ED
Sbjct: 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-41
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 7/214 (3%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEAR 75
Q E MK HPNV+ L + + S+ +VL ++ G+L + +
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133
Query: 76 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT- 134
+ Q+ + + S+ HRDL N +LD +KV+DFGL+ D + + T
Sbjct: 134 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193
Query: 135 -CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAE 191
++A E L + + +D+WS GV+L+ L+ G P+ D N ++ +
Sbjct: 194 AKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252
Query: 192 FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
P + +++ + P R + E++
Sbjct: 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-41
Identities = 41/230 (17%), Positives = 86/230 (37%), Gaps = 23/230 (10%)
Query: 18 QIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--------- 67
+ E+ + L H N+V L ++ E+ G+L + +
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 68 ---------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 118
+ ++ + Q+ + + S+ HRDL N+LL K+ DFGL
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 119 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 177
+ + + + ++APE + + +D+WS G+ L+ L + G P+
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 178 SNLMNLYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
+ + + K+ P ++ D +P+ R T +I++
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 141 bits (357), Expect = 2e-39
Identities = 54/255 (21%), Positives = 101/255 (39%), Gaps = 48/255 (18%)
Query: 18 QIKREVATMK-LVKHPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEA 74
+IKRE+ ++ L PN++ L +++ +V E V + + + +
Sbjct: 75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDI 131
Query: 75 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHT 133
R Y +++ A+DYCHS G+ HRD+KP N+++D L++ D+GL+ +
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNV 188
Query: 134 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------------- 179
+ + PE+L D + D+WS G +L ++ PF +
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 180 LMNLYKKISAAEFTCPPW------------------------LSFTARKLIARILDPNPM 215
+LY I P +S A + ++L +
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 216 TRITIPEILEDEWFK 230
+R+T E +E +F
Sbjct: 309 SRLTAREAMEHPYFY 323
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 1e-38
Identities = 36/238 (15%), Positives = 71/238 (29%), Gaps = 21/238 (8%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
Q+ E K+++ + G+ +V+E + +
Sbjct: 48 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL 107
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLL---LDAYGNLKVSDFGLS-----ALSQQVRDD 128
Q+I+ ++Y HS+ HRD+KP+N L + + DFGL+ A + Q
Sbjct: 108 LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 129 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 188
GT Y + DL S G +L G LP+ +K
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 189 AAEF--------TCPPWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKDYKP 235
+ + + ++ + + ++ +
Sbjct: 227 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-38
Identities = 41/235 (17%), Positives = 87/235 (37%), Gaps = 15/235 (6%)
Query: 18 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--------- 68
+ E + MK +VVRL V+ +++E +T G+L + +
Sbjct: 69 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
Query: 69 -MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
+ + ++ + + Y ++ HRDL N ++ +K+ DFG++ +
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 128 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKK 186
+++PE L D + + WS GV+L+ + P+ + + +
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
Query: 187 ISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDYKPPVF 238
+ P +L+ NP R + EI+ E + ++ F
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-37
Identities = 44/247 (17%), Positives = 91/247 (36%), Gaps = 42/247 (17%)
Query: 20 KREVATMKLVKHPNVVRLYEVM----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 75
+ E+ +++H N++ G+ T++++V ++ G LFD + N + +
Sbjct: 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMI 103
Query: 76 RYFQQLINAVDYCHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 127
+ + + + H + HRDLK +N+L+ G ++D GL+ D
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163
Query: 128 --DGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFD---- 176
D + GT Y+APEVL+D AD+++ G++ + +
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
Query: 177 -----------DSNLMNLYKKISAAEF-------TCPPWLSFTARKLIARILDPNPMTRI 218
D ++ + K + + K++ N R+
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 219 TIPEILE 225
T I +
Sbjct: 284 TALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-37
Identities = 45/227 (19%), Positives = 84/227 (37%), Gaps = 21/227 (9%)
Query: 19 IKREVATMKLVKHPNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGR--------- 68
+ + + H NVV L + +++EF G L + +
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 69 -------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 121
+ + Y Q+ +++ SR HRDL N+LL +K+ DFGL+
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 122 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNL 180
+ D ++APE + DR Y +D+WS GV+L+ + + P+ +
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKI 242
Query: 181 MNLYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225
+ + P + + + + P R T E++E
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-36
Identities = 63/297 (21%), Positives = 113/297 (38%), Gaps = 59/297 (19%)
Query: 18 QIKREVATMKLVKHPNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKE 71
+ RE+ MK V H N++ L V + +++V+E + +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDH 118
Query: 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 131
+ Q++ + + HS G+ HRDLKP N+++ + LK+ DFGL+ + ++
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMM 175
Query: 132 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 191
T Y APEV+ GY + D+WS G I+ ++ + F + ++ + K+
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 192 FTCPPW------------------------------------------LSFTARKLIARI 209
T P + AR L++++
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 210 LDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKE 266
L +P RI++ + L+ + Y P E D D EH + E KE
Sbjct: 295 LVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQ----LDEREHTIEEWKE 347
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (328), Expect = 9e-36
Identities = 37/237 (15%), Positives = 74/237 (31%), Gaps = 20/237 (8%)
Query: 8 KYLDAFCILLQIKREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH 66
K+ Q++ E T KL+ + +Y +V++ + +
Sbjct: 36 KFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG 95
Query: 67 GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLSAL 121
+ +Q++ V H + + +RD+KP+N L+ + V DFG+
Sbjct: 96 RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155
Query: 122 -----SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176
++Q GT Y++ R DL + G + L G LP+
Sbjct: 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQ 214
Query: 177 DSNLMNL---YKKISAAEFTCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 225
Y++I + + P K + + +
Sbjct: 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (255), Expect = 5e-25
Identities = 42/285 (14%), Positives = 85/285 (29%), Gaps = 67/285 (23%)
Query: 18 QIKREVATMKLVKHPNVVRL---------------YEVMGSKTKIFIVLEFVTGGEL-FD 61
+ E+ ++ V + + + + +V E + L
Sbjct: 55 AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114
Query: 62 KIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYG-NLKVSDFGLS 119
K H + ++ +QL+ +DY H G+ H D+KPEN+L++ + ++
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 174
Query: 120 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 179
L D + T Y +PEVL + AD+WS ++F L+ G F+
Sbjct: 175 DLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDE 233
Query: 180 LMNLYK------------------------------------------------KISAAE 191
+ K + +
Sbjct: 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 293
Query: 192 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 236
+ + ++ +L +P R ++ W K
Sbjct: 294 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.7 bits (215), Expect = 1e-21
Identities = 12/86 (13%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 303 TSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLH 360
TS ++++ +I + D ++ + + + + + EV ++ SL+
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 361 MVEVRKAKGDTLEFHKFYKNLSTCLE 386
V ++ G ++ F ++ L+
Sbjct: 76 GVRFKRISGTSIAFKNIASKIANELK 101
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.6 bits (159), Expect = 3e-13
Identities = 25/155 (16%), Positives = 54/155 (34%), Gaps = 26/155 (16%)
Query: 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 76
+ E ++ ++ V ++Y G+ +++E + R++ +
Sbjct: 59 RSARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDE 107
Query: 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 136
++ V + RG+ H DL N+L+ G + + DF S + +L
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV- 165
Query: 137 TPNYVAPEVLND---RGYDGSTADLWSCGVILFVL 168
+ R Y + D+ S I +L
Sbjct: 166 -------RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.74 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.39 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.48 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 98.03 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.94 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.68 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 89.84 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-57 Score=421.96 Aligned_cols=214 Identities=38% Similarity=0.733 Sum_probs=200.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+++++|+.+|++++|||||++++++.+++.+|+|||||+||+|.+++...+.+++..++.|+.||++||+|||++||
T Consensus 48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~i 127 (263)
T d2j4za1 48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127 (263)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678999999999999999999999999999999999999999999999998999999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|++||+|||+|..... ......+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.
T Consensus 128 vHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~ 202 (263)
T d2j4za1 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKP 202 (263)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCCSCSCCCC----CCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSC
T ss_pred eeeeeccccceecCCCCEeecccceeeecCC----CcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCC
Confidence 9999999999999999999999999875432 234567899999999999988774 89999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
||.+.+..+.+..+....+.+|+.+|+++++||.+||++||.+|||++|+++||||+..
T Consensus 203 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 203 PFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp TTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 99999999999999999999999999999999999999999999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-57 Score=425.19 Aligned_cols=218 Identities=40% Similarity=0.704 Sum_probs=191.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+++.+|+.+|++++|||||++++++.+++.+|+|||||+||+|++++...+.+++..++.++.|+++||+|||++||+|
T Consensus 47 ~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiH 126 (271)
T d1nvra_ 47 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126 (271)
T ss_dssp --CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCcc
Confidence 56789999999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++++|++||+|||+|+............+.+||+.|+|||++.+.+|++.++||||+||++|+|++|+.||
T Consensus 127 rDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf 206 (271)
T d1nvra_ 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206 (271)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence 99999999999999999999999987654444444567799999999999998888778899999999999999999999
Q ss_pred CCCchH-HHHHhhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 176 DDSNLM-NLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 176 ~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
...+.. ..+..+.......+ +.+|+++.+||.+||+.||.+|||++|+++||||++..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 207 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp SSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 876543 33333333333333 34899999999999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-56 Score=420.81 Aligned_cols=216 Identities=30% Similarity=0.562 Sum_probs=196.1
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+|++++|||||++++++.+++.+|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+
T Consensus 51 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii 130 (288)
T d1uu3a_ 51 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII 130 (288)
T ss_dssp CHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEE
Confidence 36789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++++|.+||+|||+|+............+.+||+.|+|||++.+..|. .++||||+||++|+|++|+.|
T Consensus 131 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~P 209 (288)
T d1uu3a_ 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPP 209 (288)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCC
Confidence 9999999999999999999999999876544444445667899999999999988774 899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH------HhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPE------ILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~e------il~h~~~~~ 231 (400)
|.+.+..+++.++....+.+|..+|+++++||++||++||.+|||++| +++||||+.
T Consensus 210 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 210 FRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp SCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 999999999999998989999999999999999999999999999998 578899875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=420.38 Aligned_cols=214 Identities=34% Similarity=0.633 Sum_probs=200.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+++.+|+.+|++++||||+++++++.+...+|+|||||+||+|++++...+.++++.++.|+.||+.||+|||++||+
T Consensus 48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii 127 (337)
T d1o6la_ 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||+|+.... ......+.|||+.|+|||++.+.+| +.++|||||||++|+|++|+.|
T Consensus 128 HRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~p 204 (337)
T d1o6la_ 128 YRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLP 204 (337)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCHHHeEecCCCCEEEeeccccccccc--CCcccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCC
Confidence 999999999999999999999999975432 2334566899999999999999888 5899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
|.+.+..+++..+..+.+.+|..+|+++++||++||++||.+|++ ++|+++||||+.
T Consensus 205 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 205 FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 999999999999999999999999999999999999999999994 899999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=412.81 Aligned_cols=212 Identities=29% Similarity=0.516 Sum_probs=189.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+|++++|||||++++++.+.+.+|+|||||+||+|.+++.. +++++..++.|+.||+.||+|||++||+|
T Consensus 61 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiH 139 (293)
T d1yhwa1 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIH 139 (293)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 46789999999999999999999999999999999999999999988766 57999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|++||+|||+|+.... ........+||+.|+|||++.+.+|. .++||||+||++|+|++|+.||
T Consensus 140 rDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf 216 (293)
T d1yhwa1 140 RDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPY 216 (293)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCBCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCcHHHeEECCCCcEeeccchhheeecc--ccccccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCC
Confidence 99999999999999999999999986543 22334567899999999999988774 8999999999999999999999
Q ss_pred CCCchHHHHHhhhc-C--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 176 DDSNLMNLYKKISA-A--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 176 ~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
.+.+.......+.. . ....|+.+|+++++||.+||++||.+|||++|+++||||+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp TTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 98887665554433 2 23445679999999999999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-54 Score=411.58 Aligned_cols=214 Identities=40% Similarity=0.734 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
...+.+|+.+|++++|||||++++++.+++.+|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+|
T Consensus 51 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiH 130 (307)
T d1a06a_ 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130 (307)
T ss_dssp ----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeee
Confidence 46688999999999999999999999999999999999999999999999899999999999999999999999999999
Q ss_pred ccCCCCcEEEc---cCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 96 RDLKPENLLLD---AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 96 rDlKP~NILl~---~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|||||+|||+. ++|.+||+|||+|+.... .....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|+
T Consensus 131 rDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~---~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~ 206 (307)
T d1a06a_ 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGY 206 (307)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSS
T ss_pred EEecccceeecccCCCceEEEeccceeEEccC---CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCC
Confidence 99999999995 478999999999976432 3344567899999999999988875 8999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
.||.+.+..+....+..+....+ +.+|+++.+||.+||++||.+|||++|+++||||+...
T Consensus 207 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 207 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp CSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred CCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999988888888877665443 45899999999999999999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=410.61 Aligned_cols=214 Identities=29% Similarity=0.490 Sum_probs=189.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|+++|++++|||||++++++.+.+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+
T Consensus 53 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~iv 132 (288)
T d2jfla1 53 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132 (288)
T ss_dssp GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 56788999999999999999999999999999999999999999998765 45799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhh-----cCCCCCChhhHHHHHHHHHHHH
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DIwSlGiil~ell 169 (400)
||||||+|||++.+|++||+|||+|+...... ....+.+||+.|+|||++. ..+| +.++|||||||++|+|+
T Consensus 133 HrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyeml 209 (288)
T d2jfla1 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMA 209 (288)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHH
T ss_pred EeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHh
Confidence 99999999999999999999999987543321 1234578999999999984 3334 58999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCcc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
+|+.||.+.+..+.+.++..+.. ..|+.+|+++++||++||++||.+|||++|+++||||+..
T Consensus 210 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 210 EIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999888888777766543 3355689999999999999999999999999999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-53 Score=407.95 Aligned_cols=211 Identities=34% Similarity=0.733 Sum_probs=198.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+|++++|||||++++++.+.+.+|+|||||+||+|...+.....+++..++.|+.||+.||+|||++||+
T Consensus 47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ii 126 (316)
T d1fota_ 47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 126 (316)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEE
Confidence 36789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|.+||+|||+|+.... ...+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|+.|
T Consensus 127 HrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 127 YRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCT
T ss_pred ccccCchheeEcCCCCEEEecCccceEecc-----ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCC
Confidence 999999999999999999999999976543 23467999999999999988885 899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
|.+.+..+.+.++..+...+|+.+|+++.++|.+||.+||.+|+ |++++++||||+.
T Consensus 201 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 201 FYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 99999999999998899999999999999999999999999996 9999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=397.21 Aligned_cols=209 Identities=25% Similarity=0.521 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
.+++++|+++|++++|||||++++++.+ ...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++
T Consensus 52 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~ 131 (270)
T d1t4ha_ 52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 131 (270)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 5789999999999999999999999865 456899999999999999999988999999999999999999999999
Q ss_pred C--CeeccCCCCcEEEcc-CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 92 G--VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 92 g--ivHrDlKP~NILl~~-~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
| |+||||||+|||+++ +|.+||+|||+|+... .....+.+|||.|+|||++.+ +| +.++||||+||++|+|
T Consensus 132 ~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEM 205 (270)
T ss_dssp SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHH
T ss_pred CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHH
Confidence 8 999999999999974 7999999999997533 233456789999999999875 46 5999999999999999
Q ss_pred HhCCCCCCCCc-hHHHHHhhhcCcc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 015814 169 LAGYLPFDDSN-LMNLYKKISAAEF--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 230 (400)
Q Consensus 169 ltG~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~ 230 (400)
++|+.||.+.. ...+++.+..+.. .++...++++.+||.+||++||.+|||++|+++||||+
T Consensus 206 ~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999997654 4566666655432 33455899999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=400.43 Aligned_cols=211 Identities=34% Similarity=0.582 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
.+.+.+|+++|++++|||||++++++.+ .+.+|+|||||+||+|.+++.. .+.+++..++.++.|++.||+|||
T Consensus 47 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH 126 (269)
T d2java1 47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126 (269)
T ss_dssp HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5778999999999999999999999854 4668999999999999998864 457999999999999999999999
Q ss_pred HcC-----CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 90 SRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 90 ~~g-----ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
++| |+||||||+|||++.+|.+||+|||+|+..... .....+.+||+.|+|||++.+..|. .++|||||||+
T Consensus 127 ~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvi 203 (269)
T d2java1 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCL 203 (269)
T ss_dssp HHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHH
T ss_pred HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC--CCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHH
Confidence 977 999999999999999999999999999875432 2234567899999999999887774 99999999999
Q ss_pred HHHHHhCCCCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 015814 165 LFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 229 (400)
Q Consensus 165 l~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~ 229 (400)
+|+|++|+.||.+.+..++..++..+.. ..|..+|+++.+||++||+.||.+|||++|+++|||+
T Consensus 204 lyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 204 LYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999998888888877665 4566799999999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=410.29 Aligned_cols=212 Identities=26% Similarity=0.470 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~-gi 93 (400)
..+++.+|+.+|++++|||||++++++.+++.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++ ||
T Consensus 47 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~I 126 (322)
T d1s9ja_ 47 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126 (322)
T ss_dssp HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 35789999999999999999999999999999999999999999999999888999999999999999999999975 99
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.+|++||+|||+|+..... ...+.+||+.|+|||++.+..|. .++||||+||++|||++|+.
T Consensus 127 iHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~ 201 (322)
T d1s9ja_ 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRY 201 (322)
T ss_dssp CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSC
T ss_pred EccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999865432 23467999999999999988875 89999999999999999999
Q ss_pred CCCCCchHHHHHh------------------------------------------hhcCc-cCCC-CCCCHHHHHHHHHh
Q 015814 174 PFDDSNLMNLYKK------------------------------------------ISAAE-FTCP-PWLSFTARKLIARI 209 (400)
Q Consensus 174 Pf~~~~~~~~~~~------------------------------------------i~~~~-~~~~-~~~s~~~~~li~~m 209 (400)
||.+.+....... +.... ...| ..+|.++.+||.+|
T Consensus 202 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 281 (322)
T d1s9ja_ 202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281 (322)
T ss_dssp CSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHH
Confidence 9977553321110 00000 0111 12588999999999
Q ss_pred cCCCCCCCCCHHHHhcCccccc
Q 015814 210 LDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 210 L~~dP~~R~t~~eil~h~~~~~ 231 (400)
|+.||.+|||++|+|+||||++
T Consensus 282 L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 282 LIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp TCSSTTTSCCHHHHHTSHHHHH
T ss_pred cCCChhHCcCHHHHhhCHhhCc
Confidence 9999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-53 Score=403.78 Aligned_cols=215 Identities=24% Similarity=0.350 Sum_probs=190.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
...+.+.+|+.+|++++|||||++++++.+++.+|+|||||.||+|...+...+++++..++.++.|+++||.|||++||
T Consensus 57 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~i 136 (309)
T d1u5ra_ 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136 (309)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34678999999999999999999999999999999999999999998888888899999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcC--CCCCChhhHHHHHHHHHHHHhC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DIwSlGiil~elltG 171 (400)
+||||||+|||++.+|.+||+|||+|..... ..+.+||+.|+|||++.+. +.++.++|||||||++|+|++|
T Consensus 137 iHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g 210 (309)
T d1u5ra_ 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (309)
T ss_dssp BCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence 9999999999999999999999999975432 2456899999999999642 2235899999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCccC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 172 YLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
..||.+.+..+....+..+... .+..+|+++++||.+||+.||.+|||++|+++||||.+...
T Consensus 211 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 9999988887777666555433 23458999999999999999999999999999999987543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-52 Score=408.09 Aligned_cols=215 Identities=31% Similarity=0.609 Sum_probs=194.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+++|+.+|++++|||||++++++.+++.+|+|||||+||+|++++.. .+++++..++.|+.||+.||+|||++||+
T Consensus 67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii 146 (350)
T d1koaa2 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146 (350)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCe
Confidence 57789999999999999999999999999999999999999999999954 45799999999999999999999999999
Q ss_pred eccCCCCcEEEcc--CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl~~--~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||||+|||++. +|.+||+|||+|+.... .....+.+||+.|+|||++.+.+|. .++|||||||++|+|++|+
T Consensus 147 HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~---~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~ 222 (350)
T d1koaa2 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGL 222 (350)
T ss_dssp CCCCCGGGEEESSTTSCCEEECCCTTCEECCT---TSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeechhHeeeccCCCCeEEEeecchheeccc---ccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCC
Confidence 9999999999964 58899999999976543 3345678999999999999988874 8999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.||.+.+..+.+..+.......+ +.+|+++++||.+||+.||.+|||++|+++||||+....
T Consensus 223 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999999888888877766554 348999999999999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=399.48 Aligned_cols=212 Identities=38% Similarity=0.644 Sum_probs=194.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+++|+.+|++++|||||++++++.+.+.+|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+|
T Consensus 57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivH 136 (293)
T d1jksa_ 57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136 (293)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceee
Confidence 57899999999999999999999999999999999999999999999999889999999999999999999999999999
Q ss_pred ccCCCCcEEEccCC----CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 96 RDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 96 rDlKP~NILl~~~g----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|||||+|||++.+| .+||+|||+|..... .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|
T Consensus 137 rDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g 212 (293)
T d1jksa_ 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSG 212 (293)
T ss_dssp CCCSGGGEEESCSSSSSCCEEECCCTTCEECTT---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHS
T ss_pred cccccceEEEecCCCcccceEecchhhhhhcCC---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcC
Confidence 99999999998876 599999999876543 233456789999999999988766 5999999999999999999
Q ss_pred CCCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 172 YLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
+.||.+.+..+.+..+.......+ +.+|.++++||++||+.||.+|||++|+++||||+.
T Consensus 213 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 213 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp SCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999888888877766554 468999999999999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-52 Score=409.21 Aligned_cols=215 Identities=29% Similarity=0.605 Sum_probs=194.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
...+++|+.+|++++|||||++++++.+++.+|+|||||+||+|++.+...+ ++++..++.++.||+.||+|||++||+
T Consensus 70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii 149 (352)
T d1koba_ 70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149 (352)
T ss_dssp HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4678899999999999999999999999999999999999999999887654 699999999999999999999999999
Q ss_pred eccCCCCcEEEc--cCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLLD--AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl~--~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
||||||+|||++ .+|.+||+|||+|+.... .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+
T Consensus 150 HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~ 225 (352)
T d1koba_ 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGL 225 (352)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCT---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSC
T ss_pred ecccccccccccccCCCeEEEeecccceecCC---CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCC
Confidence 999999999998 578999999999986543 344567899999999999998877 49999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~ 234 (400)
.||.+.+..+.+..+..+.+.+| +.+|+++.+||.+||++||.+|||++|+|+||||+....
T Consensus 226 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 99999998888888877766554 458999999999999999999999999999999987543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-52 Score=406.92 Aligned_cols=211 Identities=32% Similarity=0.635 Sum_probs=198.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+.+.+|+.+|+.++|||||++++++.+...+|+||||+.||+|.+.+...+.+++..++.|+.||+.||.|||++||+
T Consensus 84 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~ii 163 (350)
T d1rdqe_ 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 35788999999999999999999999999999999999999999999999989999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++.+|++||+|||+|+.... ...+.+||+.|+|||++.+.+|. .++|||||||++|+|++|+.|
T Consensus 164 HRDIKP~NILl~~~g~ikL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~P 237 (350)
T d1rdqe_ 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHcccCCCCCEEeeeceeeeeccc-----ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCC
Confidence 999999999999999999999999976542 23457899999999999988875 899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
|.+.+....+..+..+.+..|..+|+++.+||++||++||.+|+ |++++++||||+.
T Consensus 238 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 238 FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 99999999999999898899999999999999999999999995 9999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-51 Score=390.26 Aligned_cols=215 Identities=33% Similarity=0.583 Sum_probs=193.1
Q ss_pred HHHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+++.+|+.+|++++ ||||+++++++.+++.+|+|||||+||+|.++|...+.+++..++.|+.||+.||+|||++|
T Consensus 51 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ 130 (277)
T d1phka_ 51 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 130 (277)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 34577889999999996 99999999999999999999999999999999999899999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhc-----CCCCCChhhHHHHHHHHHH
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DIwSlGiil~e 167 (400)
|+||||||+|||++.+|.+||+|||++..... .......+||+.|+|||++.+ ....+.++||||+||++|+
T Consensus 131 ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilye 207 (277)
T d1phka_ 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207 (277)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred CcccccccceEEEcCCCCeEEccchheeEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhh
Confidence 99999999999999999999999999976543 223455789999999999863 2234689999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 231 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~ 231 (400)
|++|+.||.+.+.......+..+....+. .+|+++++||.+||++||.+|||++|+++||||++
T Consensus 208 ml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 208 LLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred hccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 99999999999988888887776654332 48999999999999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=399.97 Aligned_cols=213 Identities=30% Similarity=0.600 Sum_probs=195.9
Q ss_pred HHHHHHHHHHHH-hCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.++. .++|||||++++++.++..+|+|||||+||+|.+++...+++++..++.++.|++.||+|||++||+
T Consensus 46 ~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~ii 125 (320)
T d1xjda_ 46 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 125 (320)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 456667777765 6899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 174 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~P 174 (400)
||||||+|||++++|++||+|||+|+.... ........+||+.|+|||++.+.+|. .++||||+||++|+|++|+.|
T Consensus 126 HrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~P 202 (320)
T d1xjda_ 126 YRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSP 202 (320)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCS
T ss_pred eccCcccceeecCCCceeccccchhhhccc--ccccccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCC
Confidence 999999999999999999999999975433 22334557899999999999988885 899999999999999999999
Q ss_pred CCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 015814 175 FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIP-EILEDEWFKK 231 (400)
Q Consensus 175 f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~-eil~h~~~~~ 231 (400)
|.+.+..+++.++..+.+.+|..+|+++.+||++||++||.+|||+. ++++||||+.
T Consensus 203 F~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 203 FHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 99999999999998889999999999999999999999999999995 8999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-51 Score=402.79 Aligned_cols=211 Identities=29% Similarity=0.455 Sum_probs=187.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 96 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givHr 96 (400)
.+.++|+.+++.++|||||++++++.+.+.+|+|||||+||+|.++|...+.+++..++.|+.||+.||+|||++||+||
T Consensus 52 ~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHr 131 (364)
T d1omwa3 52 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131 (364)
T ss_dssp HHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccce
Confidence 34455678888889999999999999999999999999999999999998999999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 015814 97 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 176 (400)
Q Consensus 97 DlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf~ 176 (400)
||||+|||++.+|.+||+|||+|+.... ......+||+.|+|||++.....++.++|||||||++|+|++|+.||.
T Consensus 132 DlKP~NILl~~~g~iKl~DFGla~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 132 DLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp CCSGGGEEECSSSCEEECCCTTCEECSS----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeccceeEEcCCCcEEEeeeceeeecCC----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986543 233567899999999999765444699999999999999999999998
Q ss_pred CCchH---HHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 015814 177 DSNLM---NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 231 (400)
Q Consensus 177 ~~~~~---~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t-----~~eil~h~~~~~ 231 (400)
+.+.. .....+.......|..+|+++++||.+||++||.+||| ++|+++||||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 208 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp SSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 75543 44555556667778889999999999999999999999 799999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-52 Score=394.75 Aligned_cols=216 Identities=27% Similarity=0.358 Sum_probs=187.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+.+.+|+.+|++++|||||++++++.+++.+|+||||+.||++...+...+.+++..++.++.||+.||+|||++||+|
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH 123 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence 46789999999999999999999999999999999999999888777776778999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||+|...... .....+.+||+.|+|||++....+++.++||||+||++|+|++|..||
T Consensus 124 rDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 201 (299)
T d1ua2a_ 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 201 (299)
T ss_dssp CCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCcceEEecCCCccccccCccccccCCC--cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC
Confidence 999999999999999999999999765432 233456789999999999986666679999999999999999999999
Q ss_pred CCCchHHHHHhhhcCccC--------------------C--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 015814 176 DDSNLMNLYKKISAAEFT--------------------C--------PPWLSFTARKLIARILDPNPMTRITIPEILEDE 227 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~~~--------------------~--------~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~ 227 (400)
.+.+..+...++...... . .+.+|+++.+||++||+.||.+|||++|+|+||
T Consensus 202 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp 281 (299)
T d1ua2a_ 202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281 (299)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH
Confidence 998877766655321100 0 123688999999999999999999999999999
Q ss_pred ccccCC
Q 015814 228 WFKKDY 233 (400)
Q Consensus 228 ~~~~~~ 233 (400)
||+...
T Consensus 282 ~f~~~p 287 (299)
T d1ua2a_ 282 YFSNRP 287 (299)
T ss_dssp GGTSSS
T ss_pred hhCCCC
Confidence 998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=396.88 Aligned_cols=212 Identities=27% Similarity=0.548 Sum_probs=193.1
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 17 LQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
..+++|+++|++++|||||++++++.+.+.+|+|||||+||+|+++|...+ .+++..++.|+.||+.||+|||++||+|
T Consensus 46 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiH 125 (321)
T d1tkia_ 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125 (321)
T ss_dssp HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCc
Confidence 568899999999999999999999999999999999999999999998765 7999999999999999999999999999
Q ss_pred ccCCCCcEEEccC--CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 96 RDLKPENLLLDAY--GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 96 rDlKP~NILl~~~--g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
|||||+|||++.+ +.+||+|||++..... .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..
T Consensus 126 rDlKp~NIll~~~~~~~ikl~DFG~~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~ 201 (321)
T d1tkia_ 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGIN 201 (321)
T ss_dssp CCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccceeecCCCceEEEEcccchhhcccc---CCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCC
Confidence 9999999999854 4799999999876432 334566789999999999988777 489999999999999999999
Q ss_pred CCCCCchHHHHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 174 PFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
||.+.+..+.+..+..+.+.++. .+|+++++||++||++||.+|||++|+++||||++.
T Consensus 202 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 202 PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999998888776653 589999999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=395.59 Aligned_cols=215 Identities=36% Similarity=0.656 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHhC-CCCCcceeeEEEEe----CCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLV-KHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 17 ~~i~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+++|+.++.++ +|||||++++++.+ ...+|+|||||+||+|+++|...+ ++++..++.|+.||+.||+|||
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH 128 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 5678999997655 89999999999876 467999999999999999998753 6999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEcc---CCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
++||+||||||+|||++. .+.+||+|||+|+.... .....+.+||+.|+|||++.+..|+ .++|||||||++|
T Consensus 129 ~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily 204 (335)
T d2ozaa1 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMY 204 (335)
T ss_dssp HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHH
T ss_pred HcCCccccccccccccccccccccccccccceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHH
Confidence 999999999999999986 46799999999976543 3334567899999999999988775 8999999999999
Q ss_pred HHHhCCCCCCCCchHH----HHHhhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 015814 167 VLLAGYLPFDDSNLMN----LYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 167 elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~----~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~~~~ 235 (400)
+|++|+.||.+.+... +...+..+.+.+|. .+|+++.+||++||+.||.+|||+.|+++||||+.....
T Consensus 205 ~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 281 (335)
T d2ozaa1 205 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281 (335)
T ss_dssp HHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence 9999999998765433 34445555555554 389999999999999999999999999999999875543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=382.01 Aligned_cols=206 Identities=33% Similarity=0.562 Sum_probs=184.9
Q ss_pred HHHHHHHHHHHhCC--CCCcceeeEEEEeCCEEEEEEecCCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 17 LQIKREVATMKLVK--HPNVVRLYEVMGSKTKIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 17 ~~i~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv~Ey~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.++.+|+.+|++++ |||||++++++.+.+..|+||||+.+ +++.+++...+.+++..++.++.|++.||+|||++||
T Consensus 52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~i 131 (273)
T d1xwsa_ 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 131 (273)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 34678999999996 89999999999999999999999986 6888999888899999999999999999999999999
Q ss_pred eeccCCCCcEEEccC-CCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 94 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~-g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
+||||||+|||++.+ +.+||+|||+|+.... ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|+
T Consensus 132 iHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~ 207 (273)
T d1xwsa_ 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207 (273)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCcccceEEecCCCeEEECccccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCC
Confidence 999999999999864 7899999999976432 23456789999999999998888778899999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 173 LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.||.+.+ .+..+...+++.+|+++++||++||++||.+|||++|+++||||++-
T Consensus 208 ~Pf~~~~------~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 208 IPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CSCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCCch------HHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9998643 34456677888999999999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=381.84 Aligned_cols=218 Identities=28% Similarity=0.468 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
..+++.+|+++|++++|||||++++++.+++.+|+||||+.|+ +.+.+. ...++++..++.++.|++.||+|||++|
T Consensus 44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~ 122 (298)
T d1gz8a_ 44 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122 (298)
T ss_dssp CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 3578999999999999999999999999999999999999865 444443 2457999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCC
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~ 172 (400)
|+||||||+|||++.++++||+|||+|..... ........+||+.|+|||++....+.+.++||||+||++|+|++|+
T Consensus 123 IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~ 200 (298)
T d1gz8a_ 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200 (298)
T ss_dssp CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEccccCchheeecccCcceeccCCcceeccC--CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCC
Confidence 99999999999999999999999999976543 2334456789999999999988888889999999999999999999
Q ss_pred CCCCCCchHHHHHhhhcCc------------------cCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 173 LPFDDSNLMNLYKKISAAE------------------FTC-----------PPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~------------------~~~-----------~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
.||.+.+..+....+.... ... .+.+|.++.+||++||++||.+|||++|+
T Consensus 201 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el 280 (298)
T d1gz8a_ 201 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280 (298)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 9999887665544432110 001 12367899999999999999999999999
Q ss_pred hcCcccccCCCC
Q 015814 224 LEDEWFKKDYKP 235 (400)
Q Consensus 224 l~h~~~~~~~~~ 235 (400)
++||||+.-.+|
T Consensus 281 l~H~ff~~~~~p 292 (298)
T d1gz8a_ 281 LAHPFFQDVTKP 292 (298)
T ss_dssp HTSGGGTTCCCC
T ss_pred hCCHhhccCCCC
Confidence 999999875544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=380.01 Aligned_cols=214 Identities=20% Similarity=0.331 Sum_probs=186.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..+++.+|+.+|++++|||||++++++.++ ..|+|||||+||+|.+++.....+++..+..++.|++.||+|||++||+
T Consensus 51 ~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ii 129 (277)
T d1xbba_ 51 LKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129 (277)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcc
Confidence 457899999999999999999999998654 5689999999999999999989999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
||||||+|||++.+|.+||+|||+|+....... ........||+.|+|||++.+..|. .++||||+||++|||+| |+
T Consensus 130 HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCC
Confidence 999999999999999999999999976543221 1122345789999999999887774 89999999999999998 99
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH---hcCcccc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEI---LEDEWFK 230 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei---l~h~~~~ 230 (400)
.||.+.+..++...+..+ ....|..+|.++.+||.+||+.||.+|||+++| |+|+|+.
T Consensus 209 ~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 209 KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 999998888888777665 456778899999999999999999999999998 4566653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=385.60 Aligned_cols=210 Identities=18% Similarity=0.309 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-----------------------CCCH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------------------RMKE 71 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-----------------------~l~e 71 (400)
...+.+|+.+|+++ +|||||++++++.+.+.+|+|||||+||+|.++|.... .+++
T Consensus 84 ~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 163 (325)
T d1rjba_ 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163 (325)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred HHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCH
Confidence 56789999999998 89999999999999999999999999999999997642 4889
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCC
Q 015814 72 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 151 (400)
Q Consensus 72 ~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~ 151 (400)
..++.|+.|+++||+|||++||+||||||+|||++.+|++||+|||+|+............+.+||+.|+|||++.+..|
T Consensus 164 ~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 164 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC
Confidence 99999999999999999999999999999999999999999999999987654333333446678999999999998877
Q ss_pred CCChhhHHHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 152 DGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 152 ~~~~~DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+ .++||||+||++|||+| |..||.+.+......++... .+..|..+|+++++||.+||+.||.+|||++||++|
T Consensus 244 ~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 244 T-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp C-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5 99999999999999998 89999887665544444333 446677899999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=375.83 Aligned_cols=210 Identities=22% Similarity=0.384 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+++|+.+|++++|||||+++++.. .+.+|+|||||+||+|.+++... +++++..+..++.|++.||+|||++||+
T Consensus 48 ~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iv 126 (276)
T d1uwha_ 48 LQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSII 126 (276)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEe
Confidence 678999999999999999999999864 45689999999999999999754 5699999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC--CCCChhhHHHHHHHHHHHHhCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGY 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~--~~~~~~DIwSlGiil~elltG~ 172 (400)
||||||+|||++.++.+||+|||+|+............+.+||+.|+|||++.... ..+.++||||+||++|||+||+
T Consensus 127 HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~ 206 (276)
T d1uwha_ 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206 (276)
T ss_dssp CSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence 99999999999999999999999998765443344456678999999999996432 2358999999999999999999
Q ss_pred CCCCCCchHHH-HHhhhcCcc-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 173 LPFDDSNLMNL-YKKISAAEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 173 ~Pf~~~~~~~~-~~~i~~~~~-----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
.||.+.+.... ...+..+.. ..+..+|+++.+||.+||+.||.+|||+++|+++
T Consensus 207 ~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 207 LPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99988665433 333333321 2355689999999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.6e-49 Score=372.28 Aligned_cols=214 Identities=31% Similarity=0.462 Sum_probs=182.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.+++.+|+.+|++++|||||++++++.+.+..|++|||+.++.+.......+.+++..++.++.|++.||+|||++||+|
T Consensus 44 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvH 123 (286)
T d1ob3a_ 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123 (286)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEe
Confidence 57899999999999999999999999999999999999998877777777788999999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 175 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~Pf 175 (400)
|||||+|||++.+|.+||+|||+|...... ........||+.|+|||++.+..+.+.++||||+||++|+|++|+.||
T Consensus 124 rDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf 201 (286)
T d1ob3a_ 124 RDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201 (286)
T ss_dssp SCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCCCceeeEcCCCCEEecccccceecccC--ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC
Confidence 999999999999999999999998765432 222345579999999999988777789999999999999999999999
Q ss_pred CCCchHHHHHhhhcCc-----------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 176 DDSNLMNLYKKISAAE-----------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 176 ~~~~~~~~~~~i~~~~-----------------------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
.+.+..+....+.... ...++.+|+++.+||++||++||++|||++|+++|
T Consensus 202 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9887666554432100 01223468899999999999999999999999999
Q ss_pred ccccc
Q 015814 227 EWFKK 231 (400)
Q Consensus 227 ~~~~~ 231 (400)
|||++
T Consensus 282 p~f~~ 286 (286)
T d1ob3a_ 282 AYFKE 286 (286)
T ss_dssp GGGGC
T ss_pred cccCc
Confidence 99974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=373.99 Aligned_cols=214 Identities=23% Similarity=0.354 Sum_probs=187.6
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+++.+|+++|++++|||||++++++.++ .+|+|||||+||+|.+++... +.+++..+..++.|++.||+|||++||
T Consensus 52 ~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~i 130 (285)
T d1u59a_ 52 DTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130 (285)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 367899999999999999999999998654 578999999999999998654 579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
+||||||+|||++.++.+||+|||+|+....... .......+||+.|+|||++....|. .++||||+||++|||+| |
T Consensus 131 iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G 209 (285)
T d1u59a_ 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYG 209 (285)
T ss_dssp ECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTS
T ss_pred ecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCC
Confidence 9999999999999999999999999986543221 1223345789999999999887774 89999999999999998 9
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH---hcCcccc
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEI---LEDEWFK 230 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei---l~h~~~~ 230 (400)
+.||.+.+..+....+..+. ...|+.+|+++.+||.+||+.||.+|||+.+| |+|+|+.
T Consensus 210 ~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 210 QKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999988888887776654 56788899999999999999999999999888 5678775
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-48 Score=373.19 Aligned_cols=210 Identities=23% Similarity=0.351 Sum_probs=176.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.+|++++|||||++++++.+.+.+|+|||||+||+|.+++... +.+++..+..++.|+++||+|||++||+
T Consensus 71 ~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii 150 (299)
T d1jpaa_ 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 150 (299)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCc
Confidence 567899999999999999999999999999999999999999999988774 4699999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCc---cccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL---LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA- 170 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~---~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt- 170 (400)
||||||+|||++.++.+||+|||+|+.......... .....||+.|+|||++.+..|. .++|||||||++|||+|
T Consensus 151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTT
T ss_pred cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhC
Confidence 999999999999999999999999987554322211 1224579999999999887775 89999999999999998
Q ss_pred CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 171 GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|+.||.+.+..++...+..+ ..+.|..+|.++.+||.+||+.||.+|||+.||+++
T Consensus 230 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp SCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999998888888777655 356677799999999999999999999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=364.68 Aligned_cols=209 Identities=24% Similarity=0.387 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|++++++++|||||++++++..++.+|+||||+++|+|.+++... ..++++.+..++.|++.||+|||++||+
T Consensus 44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~ii 123 (263)
T d1sm2a_ 44 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123 (263)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcccee
Confidence 367899999999999999999999999999999999999999999998765 4689999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+|||+++++++||+|||+|+....... .......||+.|+|||++.+..|+ .++||||+||++|||+| |.+
T Consensus 124 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp CTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred ecccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCC
Confidence 999999999999999999999999976543221 223346799999999999988875 89999999999999999 678
Q ss_pred CCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 174 PFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||...+..+....+..+. ...|..+++++.+||.+||+.||.+|||+++|++|
T Consensus 202 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 202 PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 888888778887776653 45567789999999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=369.77 Aligned_cols=211 Identities=31% Similarity=0.443 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHhC---CCCCcceeeEEEEe-----CCEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHH
Q 015814 17 LQIKREVATMKLV---KHPNVVRLYEVMGS-----KTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 17 ~~i~~Ei~il~~l---~HpnIv~l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
.++.+|+.+|+.| +||||+++++++.. ...+|++|||+.||.+..... ....+++..++.++.|++.||+|
T Consensus 52 ~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~y 131 (305)
T d1blxa_ 52 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131 (305)
T ss_dssp CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 3566788887766 79999999999853 357899999999977654443 34579999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+|||++.+|.+||+|||++..... .....+.+||+.|+|||++.+.+|+ .++||||+||++||
T Consensus 132 LH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~e 207 (305)
T d1blxa_ 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAE 207 (305)
T ss_dssp HHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHH
T ss_pred HHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHH
Confidence 9999999999999999999999999999999875433 2234567899999999999988885 99999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcC---------------------------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAA---------------------------EFTCPPWLSFTARKLIARILDPNPMTRITI 220 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~~~s~~~~~li~~mL~~dP~~R~t~ 220 (400)
|++|+.||.+.+..+....+... ....+..+|+++.+||++||++||.+|||+
T Consensus 208 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa 287 (305)
T d1blxa_ 208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287 (305)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 99999999998877665554211 001234478999999999999999999999
Q ss_pred HHHhcCccccc
Q 015814 221 PEILEDEWFKK 231 (400)
Q Consensus 221 ~eil~h~~~~~ 231 (400)
+|+|+||||+.
T Consensus 288 ~e~L~Hpff~~ 298 (305)
T d1blxa_ 288 YSALSHPYFQD 298 (305)
T ss_dssp HHHHTSGGGTT
T ss_pred HHHhcChhhcC
Confidence 99999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-48 Score=367.34 Aligned_cols=208 Identities=26% Similarity=0.381 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++.+|+.+|++++|||||++++++.+++.+|+|||||++|+|.+++... ..+++..+..++.|++.||+|||++||
T Consensus 57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i 136 (287)
T d1opja_ 57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136 (287)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCc
Confidence 467899999999999999999999999999999999999999999999764 468999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++++|++||+|||+|+...... ........||+.|+|||++.+..|+ .++||||+||++|||++|..
T Consensus 137 iHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~ 214 (287)
T d1opja_ 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGM 214 (287)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSC
T ss_pred ccCccccCeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCC
Confidence 999999999999999999999999998654321 1122334689999999999988875 99999999999999999655
Q ss_pred -CCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 174 -PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 174 -Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
||.+.+...++..+..+ ....|+.+|+++.+||.+||+.||.+|||+++|++
T Consensus 215 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 215 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 55666666666666544 45667789999999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=365.84 Aligned_cols=213 Identities=22% Similarity=0.376 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+++.+|+.+|++++|||||++++++.+ +..|+||||+++|+|.+++.... ++++..+..++.|++.||.|||++||
T Consensus 52 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~i 130 (272)
T d1qpca_ 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130 (272)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4678999999999999999999998754 56789999999999999775433 69999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+|||+++++.+||+|||+|+...... ........||+.|+|||++....|+ .++||||+||++|||+| |.
T Consensus 131 vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~ 208 (272)
T d1qpca_ 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGR 208 (272)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTC
T ss_pred ccCccchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCC
Confidence 999999999999999999999999998654321 1223456799999999999887774 89999999999999999 56
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--Cccccc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKK 231 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~--h~~~~~ 231 (400)
+||...+..+....+..+ ....|..+|+++.+||.+||+.||.+|||+++|++ |+||..
T Consensus 209 ~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 209 IPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 667777777777777655 45667789999999999999999999999999998 788863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.5e-48 Score=363.98 Aligned_cols=215 Identities=26% Similarity=0.447 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+++.+|+.+|++++||||+++++++...+ .+|+||||++||+|.+++...+++++..++.++.|++.||+|||
T Consensus 49 ~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH 128 (277)
T d1o6ya_ 49 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128 (277)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44678999999999999999999999987654 48999999999999999999899999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeecccccccccccc-CCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
++||+||||||+|||++.++.++++|||.+....... ......+.+||+.|+|||++.+..|+ .++||||+||++|+|
T Consensus 129 ~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyel 207 (277)
T d1o6ya_ 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEV 207 (277)
T ss_dssp HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHH
T ss_pred hCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHH
Confidence 9999999999999999999999999999886543322 22234567899999999999887775 899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCccCC----CCCCCHHHHHHHHHhcCCCCCCCC-CHHHHhcCcccc
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTARKLIARILDPNPMTRI-TIPEILEDEWFK 230 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~li~~mL~~dP~~R~-t~~eil~h~~~~ 230 (400)
+||+.||.+.+..+...++....... ++.+|+++.+||.+||++||.+|| |++++ .|+|.+
T Consensus 208 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 208 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred HhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 99999999988877776655544332 345899999999999999999999 55555 467764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=367.06 Aligned_cols=219 Identities=26% Similarity=0.349 Sum_probs=180.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEe--------CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGS--------KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~--------~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
..++.+|+.+|++++||||+++++++.. +..+|+||||+.++.+.........+++..++.+++|++.||.|
T Consensus 53 ~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~ 132 (318)
T d3blha1 53 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 132 (318)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHH
Confidence 5678899999999999999999998754 45689999999987766666666789999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeecccccccccccc--CCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
||++||+||||||+|||++.+|.+||+|||++....... ......+.+||+.|+|||++.+...++.++||||+||++
T Consensus 133 lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil 212 (318)
T d3blha1 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212 (318)
T ss_dssp HHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred hccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCcee
Confidence 999999999999999999999999999999997654322 222344568999999999998765556999999999999
Q ss_pred HHHHhCCCCCCCCchHHHHHhhhcCccCCCCC--------------------------------CCHHHHHHHHHhcCCC
Q 015814 166 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--------------------------------LSFTARKLIARILDPN 213 (400)
Q Consensus 166 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------~s~~~~~li~~mL~~d 213 (400)
|+|++|+.||.+.+.......+.......++. .++++.+||.+||+.|
T Consensus 213 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~d 292 (318)
T d3blha1 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292 (318)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSS
T ss_pred eeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCC
Confidence 99999999999887766655543322111110 2677899999999999
Q ss_pred CCCCCCHHHHhcCcccccCCC
Q 015814 214 PMTRITIPEILEDEWFKKDYK 234 (400)
Q Consensus 214 P~~R~t~~eil~h~~~~~~~~ 234 (400)
|++|||++|+|+||||+..+.
T Consensus 293 P~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 293 PAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp TTTSCCHHHHHHSGGGSSSSC
T ss_pred hhHCcCHHHHHcChhhccCCC
Confidence 999999999999999997543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=362.68 Aligned_cols=210 Identities=26% Similarity=0.398 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+.+.+|+.+|++++|||||++++++. .+.+|+||||+++|+|.+++.. .+.+++..+..++.|+++||+|||++|
T Consensus 50 ~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ 128 (273)
T d1mp8a_ 50 SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128 (273)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC
Confidence 34678999999999999999999999985 5678999999999999998765 447999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-C
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-G 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G 171 (400)
|+||||||+||+++.++.+||+|||+|+...... .......+||+.|+|||++.+..|. .++||||+||++|||++ |
T Consensus 129 iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g 206 (273)
T d1mp8a_ 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHG 206 (273)
T ss_dssp CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTS
T ss_pred eeccccchhheeecCCCcEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcC
Confidence 9999999999999999999999999998654322 2223455789999999999988775 89999999999999998 9
Q ss_pred CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 172 YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 172 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
.+||.+.+..+.+..+..+. .+.|+.+|+++.+||.+||+.||.+|||+.||++|
T Consensus 207 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 207 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999888888876664 56788899999999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=356.73 Aligned_cols=209 Identities=23% Similarity=0.373 Sum_probs=187.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+++.+|+.++++++||||+++++++.+.+.+|+||||+++|+|.+++.. ...+++..+..++.|+++||+|||++||+
T Consensus 43 ~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~ii 122 (258)
T d1k2pa_ 43 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122 (258)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcc
Confidence 36789999999999999999999999999999999999999999999755 45799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~~ 173 (400)
||||||+|||+++++.+||+|||+|+..... ........+||+.|+|||++.+..|+ .++||||+||++|||+| |+.
T Consensus 123 H~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~ 200 (258)
T d1k2pa_ 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKM 200 (258)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCCCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccceeEEEcCCCcEEECcchhheeccCC-CceeecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCC
Confidence 9999999999999999999999999765432 22233346799999999999988875 89999999999999998 899
Q ss_pred CCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 174 PFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 174 Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
||.+.+..++..++..+. ...|...++++.+||++||+.||.+|||+++|++|
T Consensus 201 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 201 PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999888888887653 45667789999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=370.26 Aligned_cols=213 Identities=28% Similarity=0.432 Sum_probs=181.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 87 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~ 87 (400)
...+++.+|+.+|++++|||||++++++...+ .+|+||||+ |++|...+ ..+++++..++.++.||+.||+|
T Consensus 59 ~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~ 136 (346)
T d1cm8a_ 59 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRY 136 (346)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHH
Confidence 44688999999999999999999999997654 579999999 55666655 45789999999999999999999
Q ss_pred HHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHH
Q 015814 88 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 167 (400)
Q Consensus 88 LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~e 167 (400)
||++||+||||||+|||++.++.+|++|||+|..... .....+||+.|+|||++.+..+.+.++||||+||++|+
T Consensus 137 LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 211 (346)
T d1cm8a_ 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211 (346)
T ss_dssp HHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred HHhCCCcccccCcchhhcccccccccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHH
Confidence 9999999999999999999999999999999975432 33567899999999999887777799999999999999
Q ss_pred HHhCCCCCCCCchHHHHHhhhcCc-------------------------------cCCCCCCCHHHHHHHHHhcCCCCCC
Q 015814 168 LLAGYLPFDDSNLMNLYKKISAAE-------------------------------FTCPPWLSFTARKLIARILDPNPMT 216 (400)
Q Consensus 168 lltG~~Pf~~~~~~~~~~~i~~~~-------------------------------~~~~~~~s~~~~~li~~mL~~dP~~ 216 (400)
|++|+.||.+.+.......+.... ....+.+|+++.+||++||..||.+
T Consensus 212 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 291 (346)
T d1cm8a_ 212 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291 (346)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred HHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhH
Confidence 999999999877655443321110 1123457899999999999999999
Q ss_pred CCCHHHHhcCcccccCC
Q 015814 217 RITIPEILEDEWFKKDY 233 (400)
Q Consensus 217 R~t~~eil~h~~~~~~~ 233 (400)
|||++|+|+||||+.-.
T Consensus 292 R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 292 RVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCCHHHHHHSGGGTTTC
T ss_pred CcCHHHHhcChhhCcCC
Confidence 99999999999998643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=366.80 Aligned_cols=215 Identities=31% Similarity=0.543 Sum_probs=188.0
Q ss_pred HHHHHHHHHHHHhCCC-CCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.+.+.+|+.+|++++| |||+++++++.+...+|++|||+.||+|.+.+...+.+++..++.++.||+.||+|||++||+
T Consensus 72 ~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~iv 151 (322)
T d1vzoa_ 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 151 (322)
T ss_dssp GGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEE
Confidence 4668899999999976 899999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC-CCCChhhHHHHHHHHHHHHhCCC
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DIwSlGiil~elltG~~ 173 (400)
||||||+|||++.+|.+||+|||+|+..... ......+.+||+.|+|||.+.... +.+.++|||||||+||+|++|+.
T Consensus 152 HrDiKp~Nill~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 152 YRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp CCCCCGGGEEECTTSCEEESCSSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCccceeecCCCCEEEeeccchhhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999765432 222345678999999999997644 44689999999999999999999
Q ss_pred CCCCCchHH----HHHhhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 015814 174 PFDDSNLMN----LYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 231 (400)
Q Consensus 174 Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~~~~li~~mL~~dP~~R~-----t~~eil~h~~~~~ 231 (400)
||.+.+... +...........|..+|+++.+||++||++||.+|| |++|+++||||+.
T Consensus 231 PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 231 PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp TTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 998765443 334344556677788999999999999999999999 5899999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=365.82 Aligned_cols=221 Identities=26% Similarity=0.460 Sum_probs=182.2
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
...+++.+|+.+|++++||||+++++++.... ..+++++|+.||+|++++.. +++++..++.++.|++.||+|||
T Consensus 48 ~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH 126 (345)
T d1pmea_ 48 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 126 (345)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 44678899999999999999999999987643 23444556678999999976 57999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccC-CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
++||+||||||+|||++.+|.+||+|||+|........ .......+||+.|+|||++....+++.++||||+||++|+|
T Consensus 127 ~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~em 206 (345)
T d1pmea_ 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 206 (345)
T ss_dssp HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHH
T ss_pred HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHH
Confidence 99999999999999999999999999999976544322 23345678999999999997666667999999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCc-------------------------c------CCCCCCCHHHHHHHHHhcCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAE-------------------------F------TCPPWLSFTARKLIARILDPNPMTR 217 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~-------------------------~------~~~~~~s~~~~~li~~mL~~dP~~R 217 (400)
++|+.||.+.+..+......... . ...+.+|+++++||.+||+.||.+|
T Consensus 207 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 286 (345)
T d1pmea_ 207 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286 (345)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTS
T ss_pred hhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHC
Confidence 99999998877654443321100 0 0123478899999999999999999
Q ss_pred CCHHHHhcCcccccCCCC
Q 015814 218 ITIPEILEDEWFKKDYKP 235 (400)
Q Consensus 218 ~t~~eil~h~~~~~~~~~ 235 (400)
||++|+|+||||+....+
T Consensus 287 ~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 287 IEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp CCHHHHHTSGGGTTTCCG
T ss_pred cCHHHHhcCHhhccCCCC
Confidence 999999999999876544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=367.86 Aligned_cols=211 Identities=29% Similarity=0.379 Sum_probs=174.9
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEe------CCEEEEEEecCCCCChH---HHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 19 IKREVATMKLVKHPNVVRLYEVMGS------KTKIFIVLEFVTGGELF---DKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 19 i~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lv~Ey~~gg~L~---~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+|+.+|++++||||+++++++.. ..++|+|||||++|.+. ........+++..++.++.|++.||+|||
T Consensus 60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3579999999999999999999853 34689999999876322 22345668999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCC-CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
++||+||||||+|||++.++ .+||+|||+|..... .....+.+||+.|+|||++.+..+++.++||||+||++|||
T Consensus 140 ~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el 216 (350)
T d1q5ka_ 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216 (350)
T ss_dssp TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred hcCCcccCCCcceEEEecCCCceeEecccchhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEeh
Confidence 99999999999999999875 899999999876543 23345678999999999988766567999999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcC-----------------ccC------------CCCCCCHHHHHHHHHhcCCCCCCCCC
Q 015814 169 LAGYLPFDDSNLMNLYKKISAA-----------------EFT------------CPPWLSFTARKLIARILDPNPMTRIT 219 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~~~~~s~~~~~li~~mL~~dP~~R~t 219 (400)
++|+.||...+..+....+... ... ..+.+++++.+||.+||+.||.+|||
T Consensus 217 ~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC
Confidence 9999999988766655443210 001 12347899999999999999999999
Q ss_pred HHHHhcCcccccC
Q 015814 220 IPEILEDEWFKKD 232 (400)
Q Consensus 220 ~~eil~h~~~~~~ 232 (400)
+.|+|+||||+.-
T Consensus 297 a~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 297 PLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHTSGGGGGG
T ss_pred HHHHhcCHhhccc
Confidence 9999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=363.68 Aligned_cols=211 Identities=21% Similarity=0.348 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
..+++.+|+.+|++++|||||++++++.++ ..+++|||+.+|+|.+.+... ..+++..+..++.|++.||+|||++||
T Consensus 54 ~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~i 132 (317)
T d1xkka_ 54 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132 (317)
T ss_dssp THHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 367899999999999999999999999765 567888999999999988764 579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+|||++.++++||+|||+|+...............||+.|+|||++.+..| +.++||||+||++|||+| |.
T Consensus 133 iHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~ 211 (317)
T d1xkka_ 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGS 211 (317)
T ss_dssp CCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCC
Confidence 9999999999999999999999999987654333333344578999999999998877 499999999999999998 89
Q ss_pred CCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 015814 173 LPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 227 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~ 227 (400)
.||++.+..++...+..+. ...|+.+++++.+||.+||+.||.+|||+.||++|.
T Consensus 212 ~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 212 KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 9999988888877776654 567778999999999999999999999999999873
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=354.07 Aligned_cols=216 Identities=30% Similarity=0.468 Sum_probs=186.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
....++.+|+.+|+.++||||+++++++.+....++||+|+.|++|...+...+.+++..++.++.|++.||+|||++||
T Consensus 43 ~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~I 122 (292)
T d1unla_ 43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122 (292)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCE
Confidence 34789999999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhCCC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 173 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG~~ 173 (400)
+||||||+|||++.++++||+|||.|...... ........+++.|+|||++....+.+.++||||+||++|+|++|+.
T Consensus 123 vHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~ 200 (292)
T d1unla_ 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred eeecccCcccccccCCceeeeecchhhcccCC--CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCC
Confidence 99999999999999999999999999765432 2233445678899999999887777799999999999999999999
Q ss_pred CC-CCCchHHHHHhhhcCc-----------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 015814 174 PF-DDSNLMNLYKKISAAE-----------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEI 223 (400)
Q Consensus 174 Pf-~~~~~~~~~~~i~~~~-----------------------------~~~~~~~s~~~~~li~~mL~~dP~~R~t~~ei 223 (400)
|| .+.+..+...++.... ...++.+++++.+||++||++||.+|||++|+
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 85 4555555554432110 11223468899999999999999999999999
Q ss_pred hcCccccc
Q 015814 224 LEDEWFKK 231 (400)
Q Consensus 224 l~h~~~~~ 231 (400)
|+||||+.
T Consensus 281 L~Hp~f~~ 288 (292)
T d1unla_ 281 LQHPYFSD 288 (292)
T ss_dssp TTSGGGSS
T ss_pred hcChhhcC
Confidence 99999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=353.68 Aligned_cols=209 Identities=21% Similarity=0.323 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
..++.+|+.+|++++|||||++++++.+....++||||+.+|++.+.+... +.+++..+..++.|++.||+|||++||+
T Consensus 53 ~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~ii 132 (283)
T d1mqba_ 53 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 132 (283)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccc
Confidence 567899999999999999999999999999999999999999999988665 5799999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCeeeeccccccccccccCC-CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC-C
Q 015814 95 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-Y 172 (400)
Q Consensus 95 HrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG-~ 172 (400)
||||||+|||++.++.+||+|||+|+........ .......||+.|+|||++.+..|. .++||||+||++|||++| .
T Consensus 133 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~ 211 (283)
T d1mqba_ 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGE 211 (283)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSC
T ss_pred cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCC
Confidence 9999999999999999999999999865432221 122345789999999999887775 899999999999999995 5
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|+.+.+..+.+..+..+ ..+.|..++.++.+||.+||+.||.+|||+.+|++
T Consensus 212 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 212 RPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 556666777777776555 44666779999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=354.45 Aligned_cols=214 Identities=23% Similarity=0.391 Sum_probs=179.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGV 93 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~~LH~~gi 93 (400)
.+.+.+|+.+|++++|||||++++++.+ +.+|+||||+++|+|...+.. .+.+++..+..++.|++.||+|||++||
T Consensus 56 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~i 134 (285)
T d1fmka3 56 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134 (285)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhe
Confidence 3678999999999999999999999854 567899999999999988854 3579999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-CC
Q 015814 94 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GY 172 (400)
Q Consensus 94 vHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt-G~ 172 (400)
+||||||+|||++.+|++||+|||+|+...... .......+||+.|+|||++....+. .++||||+||++|||++ |.
T Consensus 135 vH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~ 212 (285)
T d1fmka3 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGR 212 (285)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTC
T ss_pred ecccccceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCC
Confidence 999999999999999999999999997654321 2223446799999999999988775 89999999999999999 56
Q ss_pred CCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CcccccC
Q 015814 173 LPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKD 232 (400)
Q Consensus 173 ~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~--h~~~~~~ 232 (400)
+|+.+.+..++...+..+ ..+.|+.+|+++++||.+||+.||++|||+++|++ ++||...
T Consensus 213 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 213 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 666777777777776554 45678889999999999999999999999999988 8888754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-46 Score=353.40 Aligned_cols=210 Identities=20% Similarity=0.310 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC------------------------CCC
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------------------RMK 70 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~------------------------~l~ 70 (400)
..+++.+|+.+|++++||||+++++++.+....+++|||+++|+|.+++.... .++
T Consensus 59 ~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 138 (301)
T d1lufa_ 59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138 (301)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred HHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCC
Confidence 36789999999999999999999999999999999999999999999996532 378
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCC
Q 015814 71 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 150 (400)
Q Consensus 71 e~~~~~~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~ 150 (400)
+..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+............+.+||+.|+|||++.+..
T Consensus 139 ~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 139 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 89999999999999999999999999999999999999999999999998665544444455678999999999999888
Q ss_pred CCCChhhHHHHHHHHHHHHhCC-CCCCCCchHHHHHhhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 151 YDGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 151 ~~~~~~DIwSlGiil~elltG~-~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|+ .++|||||||++|||++|. .||.+.+..+....+..+.. ..|..+++++.+||.+||+.||.+|||+.||++
T Consensus 219 ~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 219 YT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-hhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 75 8999999999999999984 68999888888888776654 457779999999999999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=351.41 Aligned_cols=210 Identities=27% Similarity=0.397 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
...+++.+|+.+|++++|||||++++++.+ ..+++||||+++|++.+.+... +.+++..+..++.|++.||.|||++|
T Consensus 53 ~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ 131 (273)
T d1u46a_ 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 131 (273)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 446789999999999999999999999965 4678999999999999887654 46999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCCCeeeeccccccccccccCCC-ccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-
Q 015814 93 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA- 170 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt- 170 (400)
|+||||||+|||++.++.+||+|||+++......... .....+||+.|+|||++.+..| +.++|||||||++|||+|
T Consensus 132 iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~ 210 (273)
T d1u46a_ 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTY 210 (273)
T ss_dssp EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTT
T ss_pred EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhC
Confidence 9999999999999999999999999998754432221 2234467889999999998766 489999999999999998
Q ss_pred CCCCCCCCchHHHHHhhhcCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|..||.+.+..+...++.... ++.|+.+|.++.+||.+||+.||.+|||+++|++
T Consensus 211 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 211 GQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp SCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 899999999988888875553 3556678999999999999999999999999963
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=352.39 Aligned_cols=209 Identities=22% Similarity=0.409 Sum_probs=188.9
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~----------------~l~e~~~~~~~ 78 (400)
..++.+|+..+.++ +|||||++++++.++..+|+||||+++|+|.++|.... .+++..+..++
T Consensus 62 ~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 141 (299)
T d1fgka_ 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141 (299)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHH
Confidence 57788899999888 89999999999999999999999999999999997543 48999999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..............+||+.|+|||++.+..|+ .++||
T Consensus 142 ~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~Di 220 (299)
T d1fgka_ 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDV 220 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHH
T ss_pred HHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhh
Confidence 99999999999999999999999999999999999999999877655444445667899999999999988875 99999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 159 WSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 159 wSlGiil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||||++|||++ |..||.+.+....+..+..+ .+..|.++|+++.+||.+||+.||.+|||+.||++
T Consensus 221 wS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 999999999998 79999998888888877654 45677889999999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=362.27 Aligned_cols=214 Identities=26% Similarity=0.364 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 89 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH 89 (400)
..+++.+|+.+|++++|||||++++++... ...+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||
T Consensus 60 ~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH 138 (348)
T d2gfsa1 60 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH 138 (348)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHH
Confidence 357889999999999999999999998643 334566777889999998855 67999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 90 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 90 ~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
++||+||||||+|||++.+|.+|++|||+|..... ...+.+||+.|+|||++.+..+.+.++||||+||++|+|+
T Consensus 139 ~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH
T ss_pred hCCCcccccCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHH
Confidence 99999999999999999999999999999875432 2345689999999999888777789999999999999999
Q ss_pred hCCCCCCCCchHHHHHhhhcCccCC-------------------------------CCCCCHHHHHHHHHhcCCCCCCCC
Q 015814 170 AGYLPFDDSNLMNLYKKISAAEFTC-------------------------------PPWLSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 170 tG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------~~~~s~~~~~li~~mL~~dP~~R~ 218 (400)
+|+.||.+.+.......+....... ...+|+++++||++||..||.+||
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence 9999999887766555543221110 124689999999999999999999
Q ss_pred CHHHHhcCcccccCCC
Q 015814 219 TIPEILEDEWFKKDYK 234 (400)
Q Consensus 219 t~~eil~h~~~~~~~~ 234 (400)
|++|+|+||||++...
T Consensus 294 ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 294 TAAQALAHAYFAQYHD 309 (348)
T ss_dssp CHHHHHTSGGGTTTCC
T ss_pred CHHHHhcCHhhCCCCC
Confidence 9999999999986543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=355.97 Aligned_cols=211 Identities=24% Similarity=0.437 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHhCC-CCCcceeeEEEEe--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015814 16 LLQIKREVATMKLVK-HPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 92 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~g 92 (400)
.+++.+|+.+|+.++ ||||+++++++.. ...+|+|||||.+|+|.... +.+++..++.++.||+.||+|||++|
T Consensus 73 ~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g 149 (328)
T d3bqca1 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149 (328)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc
Confidence 367899999999995 9999999999974 45699999999999987654 57999999999999999999999999
Q ss_pred CeeccCCCCcEEEccCC-CeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHhC
Q 015814 93 VYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 171 (400)
Q Consensus 93 ivHrDlKP~NILl~~~g-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~elltG 171 (400)
|+||||||+|||++.++ .+||+|||+|+.... .......+||+.|+|||++.+....+.++||||+||++|+|++|
T Consensus 150 IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g 226 (328)
T d3bqca1 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226 (328)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCGGGCEECCT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred cccccccccceEEcCCCCeeeecccccceeccC---CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccC
Confidence 99999999999999765 599999999976543 23345678999999999998766557999999999999999999
Q ss_pred CCCCCCCch-HHHHHhhh-------------cCc----------------------c--CCCCCCCHHHHHHHHHhcCCC
Q 015814 172 YLPFDDSNL-MNLYKKIS-------------AAE----------------------F--TCPPWLSFTARKLIARILDPN 213 (400)
Q Consensus 172 ~~Pf~~~~~-~~~~~~i~-------------~~~----------------------~--~~~~~~s~~~~~li~~mL~~d 213 (400)
..||..... ......+. ... . .....+|+++.+||++||..|
T Consensus 227 ~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 306 (328)
T d3bqca1 227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306 (328)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSS
T ss_pred CCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCC
Confidence 999965432 11111110 000 0 011226889999999999999
Q ss_pred CCCCCCHHHHhcCcccccC
Q 015814 214 PMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 214 P~~R~t~~eil~h~~~~~~ 232 (400)
|.+|||++|+|+||||+.-
T Consensus 307 P~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 307 HQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp GGGSCCHHHHHTSGGGTTS
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=353.80 Aligned_cols=207 Identities=21% Similarity=0.363 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYF 78 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~~ 78 (400)
.+.+.+|+++|+++ +|||||++++++.+++..|+||||++||+|.++|... ..+++..+..++
T Consensus 54 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 133 (309)
T d1fvra_ 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133 (309)
T ss_dssp -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHH
Confidence 56799999999999 7999999999999999999999999999999999654 569999999999
Q ss_pred HHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhH
Q 015814 79 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 158 (400)
Q Consensus 79 ~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DI 158 (400)
.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...... .....+||+.|+|||.+.+..|. .++||
T Consensus 134 ~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~-~~sDv 209 (309)
T d1fvra_ 134 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYT-TNSDV 209 (309)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEEC-HHHHH
T ss_pred HHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCC-cccee
Confidence 999999999999999999999999999999999999999987544322 22456799999999999988874 89999
Q ss_pred HHHHHHHHHHHhC-CCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 159 WSCGVILFVLLAG-YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 159 wSlGiil~elltG-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||||++|||++| .+||.+.+..+++..+..+ .+..|..+++++.+||.+||+.||++|||+.||++|
T Consensus 210 wSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 210 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999996 5689999988988887665 456677899999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=352.78 Aligned_cols=210 Identities=22% Similarity=0.348 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRY 77 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~----------------~~l~e~~~~~~ 77 (400)
.+.+.+|+.++.++ +||||+.+++++.. +..+|+|||||+||+|.+++... ..+++..+..|
T Consensus 60 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (299)
T d1ywna1 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139 (299)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHH
Confidence 46677888888777 68999999998765 45689999999999999999753 24889999999
Q ss_pred HHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhh
Q 015814 78 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 157 (400)
Q Consensus 78 ~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~D 157 (400)
+.|+++||+|||++||+||||||+|||++++|++||+|||+|+............+.+||+.|+|||++.+..| +.++|
T Consensus 140 ~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sD 218 (299)
T d1ywna1 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSD 218 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHH
T ss_pred HHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-Ccccc
Confidence 99999999999999999999999999999999999999999986554433334456689999999999998777 59999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCchHHHH-HhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 158 LWSCGVILFVLLAG-YLPFDDSNLMNLY-KKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 158 IwSlGiil~elltG-~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
|||+||++|||++| ..||.+.+....+ ..+..+ .+..|..+|+++.+||.+||+.||.+|||++|+++|
T Consensus 219 iwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred eeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999986 5788776654433 333333 456677899999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=346.29 Aligned_cols=205 Identities=23% Similarity=0.420 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
..+++.+|++++++++||||+++++++.. .+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++
T Consensus 43 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~ 122 (262)
T d1byga_ 43 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122 (262)
T ss_dssp --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC
Confidence 35788999999999999999999998854 566899999999999999996643 589999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHHh-
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA- 170 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ellt- 170 (400)
+|+||||||+|||++.+|++||+|||+++.... ...+.+||+.|+|||++.+..| +.++||||+||++|||+|
T Consensus 123 ~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~ 196 (262)
T d1byga_ 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSF 196 (262)
T ss_dssp TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred ceeccccchHhheecCCCCEeecccccceecCC-----CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHC
Confidence 999999999999999999999999999875432 2344578999999999988777 599999999999999998
Q ss_pred CCCCCCCCchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 171 GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 171 G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|++||...+..+....+..+ .+..|+.+++++.+||.+||+.||.+|||+.++++
T Consensus 197 ~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 197 GRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp SCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 89999998888888887654 56778889999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=358.81 Aligned_cols=212 Identities=26% Similarity=0.461 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEe------CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 015814 15 ILLQIKREVATMKLVKHPNVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 88 (400)
Q Consensus 15 ~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~L 88 (400)
..+++.+|+.+|++++|||||++++++.. ...+|+|||||.|+ +++.+ ...+++..++.+++|++.||+||
T Consensus 59 ~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~L 135 (355)
T d2b1pa1 59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHL 135 (355)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHh
Confidence 36789999999999999999999999953 47899999999764 55555 35699999999999999999999
Q ss_pred HHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHH
Q 015814 89 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 168 (400)
Q Consensus 89 H~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~el 168 (400)
|++||+||||||+|||++.++.+|++|||+++.... .......+||+.|+|||++.+..| +.++||||+||++|+|
T Consensus 136 H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~el 211 (355)
T d2b1pa1 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEM 211 (355)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHH
T ss_pred hhcccccccCCccccccccccceeeechhhhhcccc---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHH
Confidence 999999999999999999999999999999875443 233456689999999999998777 4899999999999999
Q ss_pred HhCCCCCCCCchHHHHHhhhcCc----------------------cC--------------CC------CCCCHHHHHHH
Q 015814 169 LAGYLPFDDSNLMNLYKKISAAE----------------------FT--------------CP------PWLSFTARKLI 206 (400)
Q Consensus 169 ltG~~Pf~~~~~~~~~~~i~~~~----------------------~~--------------~~------~~~s~~~~~li 206 (400)
++|+.||.+.+......++.... .. .+ ...|+++.+||
T Consensus 212 l~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll 291 (355)
T d2b1pa1 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred hhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHH
Confidence 99999998877655544332100 00 00 01356789999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccccCC
Q 015814 207 ARILDPNPMTRITIPEILEDEWFKKDY 233 (400)
Q Consensus 207 ~~mL~~dP~~R~t~~eil~h~~~~~~~ 233 (400)
++||..||++|||++|+|+||||+...
T Consensus 292 ~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 292 SKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=346.53 Aligned_cols=209 Identities=19% Similarity=0.275 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAV 85 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~~l 85 (400)
...+.+|+.++++++|||||++++++..+...++||||+++|+|.+++... ..++...+..++.|++.||
T Consensus 67 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl 146 (308)
T d1p4oa_ 67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146 (308)
T ss_dssp HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 467899999999999999999999999999999999999999999988643 2468889999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHH
Q 015814 86 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 165 (400)
Q Consensus 86 ~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil 165 (400)
.|||+++|+||||||+|||+++++++||+|||+|+..............+||+.|+|||.+.+..|. .++||||+||++
T Consensus 147 ~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il 225 (308)
T d1p4oa_ 147 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVL 225 (308)
T ss_dssp HHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHH
T ss_pred HHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHH
Confidence 9999999999999999999999999999999999876554333334455789999999999988775 899999999999
Q ss_pred HHHHhC-CCCCCCCchHHHHHhhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 166 FVLLAG-YLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 166 ~elltG-~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||+|| ..||.+.+..+.+..+..+. ...|+.+|+.+.+||.+||+.||.+|||+.+|++
T Consensus 226 ~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 226 WEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 68999999888888776654 4567789999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=346.75 Aligned_cols=209 Identities=20% Similarity=0.345 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHhC-CCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC------------------CCCHHHHHH
Q 015814 16 LLQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARR 76 (400)
Q Consensus 16 ~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~------------------~l~e~~~~~ 76 (400)
...+.+|+.+++++ +|||||++++++.+....|+|||||+||+|.+++.... .+++..+..
T Consensus 70 ~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (311)
T d1t46a_ 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHH
Confidence 56788999999999 79999999999999999999999999999999997543 589999999
Q ss_pred HHHHHHHHHHHHHHcCCeeccCCCCcEEEccCCCeeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCCCChh
Q 015814 77 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 156 (400)
Q Consensus 77 ~~~qll~~l~~LH~~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~ 156 (400)
++.|++.||+|||++|++||||||+||+++.++++|++|||+++..............+||+.|+|||++.+..+ +.++
T Consensus 150 ~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~ 228 (311)
T d1t46a_ 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFES 228 (311)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHH
T ss_pred HHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcc
Confidence 999999999999999999999999999999999999999999987654333333445689999999999988766 5999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCchHHHHHhh-hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 157 DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 157 DIwSlGiil~ellt-G~~Pf~~~~~~~~~~~i-~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
|||||||++|||+| |.+||.+.+..+.+.++ ..+ ....|..+|.++.+||.+||+.||.+|||+++|++
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999998 67777776665544443 333 34556678999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=338.62 Aligned_cols=212 Identities=22% Similarity=0.281 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEe-CCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHc
Q 015814 14 CILLQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 91 (400)
Q Consensus 14 ~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~ 91 (400)
...+++.+|+++|++++|||||++++++.. +...++|||||++|+|.+++.... .+++..+..++.|++.||.|||+.
T Consensus 70 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~ 149 (311)
T d1r0pa_ 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149 (311)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc
Confidence 346889999999999999999999999765 568999999999999999887544 577889999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHHHHH
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 169 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ell 169 (400)
||+||||||+|||+++++.+||+|||+++....... ........||+.|+|||++....+ +.++|||||||++|||+
T Consensus 150 ~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~ 228 (311)
T d1r0pa_ 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELM 228 (311)
T ss_dssp TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHH
T ss_pred CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHH
Confidence 999999999999999999999999999986543221 122234578999999999988777 59999999999999999
Q ss_pred hCCCCCCC-CchHHHHHhhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 015814 170 AGYLPFDD-SNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 226 (400)
Q Consensus 170 tG~~Pf~~-~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h 226 (400)
+|..||.. .+..+....+..+ .+..|+.+++++.+||.+||+.||.+|||+.||++|
T Consensus 229 t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 229 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 97777654 3344444544444 456677899999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-41 Score=319.59 Aligned_cols=216 Identities=18% Similarity=0.186 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhCCCCCc-ceeeEEEEeCCEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.++.+|++++++++|+|+ +.+++++.+.+..++||||+.| +|.+.+. ..+.+++..+..++.|++.||+|||++||+
T Consensus 47 ~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii 125 (299)
T d1ckia_ 47 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125 (299)
T ss_dssp CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCee
Confidence 457889999999987665 5556667888999999999955 6666654 455799999999999999999999999999
Q ss_pred eccCCCCcEEEcc---CCCeeeeccccccccccccCC-----CccccccCCCCCCCChhhhcCCCCCChhhHHHHHHHHH
Q 015814 95 HRDLKPENLLLDA---YGNLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 166 (400)
Q Consensus 95 HrDlKP~NILl~~---~g~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGiil~ 166 (400)
||||||+|||++. ++.+||+|||+|+........ ....+.+||+.|+|||++.+.+|. .++||||+||++|
T Consensus 126 HrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~ 204 (299)
T d1ckia_ 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLM 204 (299)
T ss_dssp CSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHH
T ss_pred eccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHH
Confidence 9999999999864 457999999999876543221 223456899999999999988874 9999999999999
Q ss_pred HHHhCCCCCCCCchHHHHHh---hhcCc-----cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH---HhcCcccccCCC
Q 015814 167 VLLAGYLPFDDSNLMNLYKK---ISAAE-----FTCPPWLSFTARKLIARILDPNPMTRITIPE---ILEDEWFKKDYK 234 (400)
Q Consensus 167 elltG~~Pf~~~~~~~~~~~---i~~~~-----~~~~~~~s~~~~~li~~mL~~dP~~R~t~~e---il~h~~~~~~~~ 234 (400)
||++|..||........... ..... ...++.+|+++.++|.+||+.||.+||++++ +++|+|.+....
T Consensus 205 el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 205 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp HHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred HHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 99999999987554433222 11111 1223568999999999999999999999875 567887765543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=322.17 Aligned_cols=205 Identities=20% Similarity=0.304 Sum_probs=159.1
Q ss_pred HHHHHHHHhCCCCCcceeeEEEEeCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----
Q 015814 20 KREVATMKLVKHPNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS----- 90 (400)
Q Consensus 20 ~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~----- 90 (400)
++|+..+++++|||||++++++.+.+ .+|+||||+++|+|.+++.. .+++++....++.|++.||+|||+
T Consensus 45 e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~ 123 (303)
T d1vjya_ 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGT 123 (303)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred HHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 34566667889999999999987653 68999999999999999987 469999999999999999999996
Q ss_pred ---cCCeeccCCCCcEEEccCCCeeeeccccccccccccC--CCccccccCCCCCCCChhhhcCCC-----CCChhhHHH
Q 015814 91 ---RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWS 160 (400)
Q Consensus 91 ---~givHrDlKP~NILl~~~g~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DIwS 160 (400)
+||+||||||+|||++.+|++||+|||+++....... .......+||+.|+|||++.+... .+.++||||
T Consensus 124 ~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S 203 (303)
T d1vjya_ 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203 (303)
T ss_dssp TCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred ccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhh
Confidence 5999999999999999999999999999986543221 122345689999999999875432 236899999
Q ss_pred HHHHHHHHHhCCCCCCCC---------------chHHHHHhhhcCc--cCCCCC-----CCHHHHHHHHHhcCCCCCCCC
Q 015814 161 CGVILFVLLAGYLPFDDS---------------NLMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDPNPMTRI 218 (400)
Q Consensus 161 lGiil~elltG~~Pf~~~---------------~~~~~~~~i~~~~--~~~~~~-----~s~~~~~li~~mL~~dP~~R~ 218 (400)
|||++|||+||..||... +............ +.+|.. .+..+.+|+.+||+.||.+||
T Consensus 204 ~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 283 (303)
T d1vjya_ 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283 (303)
T ss_dssp HHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC
T ss_pred hHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc
Confidence 999999999998887431 1122222222222 122221 224588999999999999999
Q ss_pred CHHHHhc
Q 015814 219 TIPEILE 225 (400)
Q Consensus 219 t~~eil~ 225 (400)
|+.||++
T Consensus 284 s~~ei~~ 290 (303)
T d1vjya_ 284 TALRIKK 290 (303)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.1e-40 Score=311.25 Aligned_cols=207 Identities=18% Similarity=0.230 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHhCCC-CCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 015814 17 LQIKREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVY 94 (400)
Q Consensus 17 ~~i~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~~LH~~giv 94 (400)
.++++|+++++.+.| +||+.+++++......|+||||+ ||+|.+.+...+ .+++..+..++.|++.||+|||++||+
T Consensus 45 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~gii 123 (293)
T d1csna_ 45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123 (293)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCce
Confidence 467889999999965 99999999999999999999999 679999887654 699999999999999999999999999
Q ss_pred eccCCCCcEEEcc-----CCCeeeeccccccccccccC-----CCccccccCCCCCCCChhhhcCCCCCChhhHHHHHHH
Q 015814 95 HRDLKPENLLLDA-----YGNLKVSDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 164 (400)
Q Consensus 95 HrDlKP~NILl~~-----~g~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DIwSlGii 164 (400)
||||||+|||++. ++.+||+|||+|+....... .....+.+||+.|+|||++.+..|. .++||||+||+
T Consensus 124 HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~ 202 (293)
T d1csna_ 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHV 202 (293)
T ss_dssp CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHH
T ss_pred eccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHH
Confidence 9999999999974 57899999999987553221 1223456899999999999987774 89999999999
Q ss_pred HHHHHhCCCCCCCCch---HHHHHhhhcCcc-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 015814 165 LFVLLAGYLPFDDSNL---MNLYKKISAAEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 225 (400)
Q Consensus 165 l~elltG~~Pf~~~~~---~~~~~~i~~~~~-----~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~ 225 (400)
+|+|++|..||.+.+. ...+.++..... ..++.+|+++.+++..|+..+|.+||+++.+.+
T Consensus 203 l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 203 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 9999999999976433 233333322211 123568899999999999999999999887754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.1e-38 Score=304.26 Aligned_cols=211 Identities=21% Similarity=0.398 Sum_probs=161.1
Q ss_pred HHHHHHHHHHHHhCC-----------CCCcceeeEEEEe--CCEEEEEEecCCCCChHHHH---HhCCCCCHHHHHHHHH
Q 015814 16 LLQIKREVATMKLVK-----------HPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKI---VNHGRMKEDEARRYFQ 79 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~-----------HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i---~~~~~l~e~~~~~~~~ 79 (400)
.+.+.+|+.+++.++ ||||+++++++.. ....+++|+++.++...... .....+++..++.++.
T Consensus 53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~ 132 (362)
T d1q8ya_ 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132 (362)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHH
Confidence 467788999988875 5789999988754 46677777777665433332 2345789999999999
Q ss_pred HHHHHHHHHHH-cCCeeccCCCCcEEEccCCC------eeeeccccccccccccCCCccccccCCCCCCCChhhhcCCCC
Q 015814 80 QLINAVDYCHS-RGVYHRDLKPENLLLDAYGN------LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 152 (400)
Q Consensus 80 qll~~l~~LH~-~givHrDlKP~NILl~~~g~------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~ 152 (400)
|++.||+|||+ .||+||||||+|||++.+|. ++++|||.|..... .....+||+.|+|||++...+|+
T Consensus 133 qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp HHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCC
Confidence 99999999998 89999999999999987664 99999999875432 22456899999999999988885
Q ss_pred CChhhHHHHHHHHHHHHhCCCCCCCCchH------HHHHhh---h---------c-------------------------
Q 015814 153 GSTADLWSCGVILFVLLAGYLPFDDSNLM------NLYKKI---S---------A------------------------- 189 (400)
Q Consensus 153 ~~~~DIwSlGiil~elltG~~Pf~~~~~~------~~~~~i---~---------~------------------------- 189 (400)
.++||||+||++++|++|+.||...... ...... . .
T Consensus 208 -~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (362)
T d1q8ya_ 208 -CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 286 (362)
T ss_dssp -THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCH
T ss_pred -ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCch
Confidence 8999999999999999999999653321 000000 0 0
Q ss_pred -----CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 015814 190 -----AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 232 (400)
Q Consensus 190 -----~~~~~~~~~s~~~~~li~~mL~~dP~~R~t~~eil~h~~~~~~ 232 (400)
.....+...++++.+||.+||+.||.+|||++|+|+||||+.-
T Consensus 287 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 287 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 0000111235789999999999999999999999999999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.74 E-value=1.2e-19 Score=159.88 Aligned_cols=96 Identities=21% Similarity=0.384 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015814 16 LLQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 95 (400)
Q Consensus 16 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~~givH 95 (400)
.....+|+..+.++.|++++..+++.. .+++|||++++.+. .+++..+..++.|++.|++|||++||+|
T Consensus 58 ~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiH 126 (191)
T d1zara2 58 IRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVH 126 (191)
T ss_dssp HHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEE
Confidence 345678999999999999999887632 26999999986542 3566677889999999999999999999
Q ss_pred ccCCCCcEEEccCCCeeeeccccccccc
Q 015814 96 RDLKPENLLLDAYGNLKVSDFGLSALSQ 123 (400)
Q Consensus 96 rDlKP~NILl~~~g~~kl~DFGla~~~~ 123 (400)
|||||+|||+++++ ++|+|||+|....
T Consensus 127 rDiKP~NILv~~~~-~~liDFG~a~~~~ 153 (191)
T d1zara2 127 GDLSQYNVLVSEEG-IWIIDFPQSVEVG 153 (191)
T ss_dssp SCCSTTSEEEETTE-EEECCCTTCEETT
T ss_pred ccCChhheeeeCCC-EEEEECCCcccCC
Confidence 99999999999754 8999999986543
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.39 E-value=8.9e-13 Score=102.71 Aligned_cols=84 Identities=14% Similarity=0.246 Sum_probs=78.2
Q ss_pred EecCCHHHHHHHHHHHhccCCceEeee-CceEEEEEeccCCCcceEEEEEEEEEc-CceeEEEEEecCCCchhHHHHHHH
Q 015814 303 TSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKFYKN 380 (400)
Q Consensus 303 ~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~gd~~~~~~~~~~ 380 (400)
+|+.+|++|+.+|+.|++.+|+.|+++ +|.++.....+++++.+.|.++|+++. +++++|+|+|.+||.++|++++.+
T Consensus 16 TS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~~ 95 (102)
T d1ul7a_ 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK 95 (102)
T ss_dssp CBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHHH
T ss_pred CcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHHH
Confidence 689999999999999999999999876 589999988888899999999999995 799999999999999999999999
Q ss_pred HHHhcc
Q 015814 381 LSTCLE 386 (400)
Q Consensus 381 ~~~~l~ 386 (400)
|...|+
T Consensus 96 il~~l~ 101 (102)
T d1ul7a_ 96 IANELK 101 (102)
T ss_dssp HHHHCC
T ss_pred HHHhcc
Confidence 988775
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.48 E-value=4.2e-07 Score=73.42 Aligned_cols=72 Identities=17% Similarity=0.309 Sum_probs=62.7
Q ss_pred EEecCCHHHHHHHHHHHhccCCceEee-eCceEEEEEeccCCCcceEEEEEEEEEcCceeEEEEEecCCCchh
Q 015814 302 FTSRCPANEIINKIEEAAKPLGFDVHK-KNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 373 (400)
Q Consensus 302 f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~~ 373 (400)
..|+..+.+||..+..|++.+|+.|++ +.|.++++.........+.|.+++|+++++.|||||++..|+-.|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 458889999999999999999999987 568999998766666789999999999999999999999998655
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=98.03 E-value=8.4e-06 Score=64.35 Aligned_cols=86 Identities=17% Similarity=0.254 Sum_probs=66.0
Q ss_pred eEEecCCHHHHHHHHHHHhccCCceEeeeC----------ceEEEEEec-----cCCCcceEEEEEEEEEcCceeEEEEE
Q 015814 301 RFTSRCPANEIINKIEEAAKPLGFDVHKKN----------YKMRLENMK-----AGRKGNLNVATEVFQVAPSLHMVEVR 365 (400)
Q Consensus 301 rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~-----~~~~~~l~~~~~i~~~~~~~~~v~~~ 365 (400)
..-|+..|.+||..|..|++.+|+.|++-+ |.|+++-.. ......+.+.+++|+++++.+||||+
T Consensus 6 GIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK 85 (127)
T d2qrda1 6 GVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVK 85 (127)
T ss_dssp SEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEE
T ss_pred ccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEc
Confidence 346889999999999999999999997633 678887542 22234589999999999999999998
Q ss_pred -----ecCC--------------CchhHHHHHHHHHHhcc
Q 015814 366 -----KAKG--------------DTLEFHKFYKNLSTCLE 386 (400)
Q Consensus 366 -----~~~g--------------d~~~~~~~~~~~~~~l~ 386 (400)
.+.| .+.+|-.++.+|.-.|.
T Consensus 86 ~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~ 125 (127)
T d2qrda1 86 SNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 125 (127)
T ss_dssp EEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred cCCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence 1222 24668888887766654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.94 E-value=7.2e-06 Score=73.13 Aligned_cols=100 Identities=14% Similarity=0.141 Sum_probs=71.5
Q ss_pred HHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----
Q 015814 17 LQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS----- 90 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~~LH~----- 90 (400)
..+.+|...++.+. +--+.+++.+...++..|+||++++|..+.+..... .....+..++...+..||+
T Consensus 54 ~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~ 128 (263)
T d1j7la_ 54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISD 128 (263)
T ss_dssp TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTT
T ss_pred hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccc
Confidence 45788999988774 433678888888899999999999998775543221 1222344455555555553
Q ss_pred ------------------------------------------------------cCCeeccCCCCcEEEccCCCeeeecc
Q 015814 91 ------------------------------------------------------RGVYHRDLKPENLLLDAYGNLKVSDF 116 (400)
Q Consensus 91 ------------------------------------------------------~givHrDlKP~NILl~~~g~~kl~DF 116 (400)
..++|+|+.|.||++++++.+-|.||
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDw 208 (263)
T d1j7la_ 129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL 208 (263)
T ss_dssp CSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred cccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeec
Confidence 12789999999999998666679999
Q ss_pred ccccc
Q 015814 117 GLSAL 121 (400)
Q Consensus 117 Gla~~ 121 (400)
+.+..
T Consensus 209 e~a~~ 213 (263)
T d1j7la_ 209 GRSGR 213 (263)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 97653
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.68 E-value=5.4e-05 Score=62.69 Aligned_cols=68 Identities=18% Similarity=0.213 Sum_probs=50.5
Q ss_pred cceEEecCCHHHHHHHHHHHhccCCceEeee----CceEEEEEecc---------CCCcceEEEEEEEEEcCceeEEEEE
Q 015814 299 ETRFTSRCPANEIINKIEEAAKPLGFDVHKK----NYKMRLENMKA---------GRKGNLNVATEVFQVAPSLHMVEVR 365 (400)
Q Consensus 299 ~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~---------~~~~~l~~~~~i~~~~~~~~~v~~~ 365 (400)
.-..-|+.++.++|..|..|++.+|+.|++- .|.|+++...+ .....+.|.+++|++.++.+||||+
T Consensus 47 hfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDFK 126 (171)
T d2qlva1 47 HFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK 126 (171)
T ss_dssp EESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEEE
T ss_pred eeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEEe
Confidence 3345699999999999999999999999764 37888875321 1123489999999999999999997
Q ss_pred e
Q 015814 366 K 366 (400)
Q Consensus 366 ~ 366 (400)
-
T Consensus 127 ~ 127 (171)
T d2qlva1 127 F 127 (171)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.49 E-value=3.9e-05 Score=67.78 Aligned_cols=43 Identities=16% Similarity=0.296 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHhCCC--CCcceeeEEEEeCCEEEEEEecCCCCCh
Q 015814 17 LQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFVTGGEL 59 (400)
Q Consensus 17 ~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~Ey~~gg~L 59 (400)
..+..|...|+.+.. -.+.+++.+..+++..|+||++++|.++
T Consensus 49 ~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 49 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 357889999888743 3356788888888899999999998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.91 E-value=0.00047 Score=65.33 Aligned_cols=28 Identities=21% Similarity=0.260 Sum_probs=24.6
Q ss_pred CCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 92 GVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 92 givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
.++|+|+.|.|||++++ .++|.||.+|.
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence 58999999999999875 48999998765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.47 E-value=0.0053 Score=57.61 Aligned_cols=38 Identities=13% Similarity=0.196 Sum_probs=27.2
Q ss_pred HHHHHHHHHHHhCC-CCCcceeeEEEEeCCEEEEEEecCCCCC
Q 015814 17 LQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGE 58 (400)
Q Consensus 17 ~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg~ 58 (400)
-...+|..+++.+. +.-..++++++.+ .+||||++|..
T Consensus 89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 127 (395)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecccc
Confidence 35678999999885 4334577777642 57899998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.67 E-value=0.0073 Score=54.52 Aligned_cols=30 Identities=27% Similarity=0.330 Sum_probs=26.9
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
.|++|+|+.++||++++++..-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999988777899999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=89.84 E-value=0.1 Score=47.03 Aligned_cols=28 Identities=21% Similarity=0.175 Sum_probs=22.8
Q ss_pred cCCeeccCCCCcEEEccCCCeeeecccccc
Q 015814 91 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 120 (400)
Q Consensus 91 ~givHrDlKP~NILl~~~g~~kl~DFGla~ 120 (400)
.+++|+|+.|.|||+++ | ..+.||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 36899999999999974 3 4589999664
|